data_1p88_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1p88 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.566 ' HD3' HG22 ' A' ' 174' ' ' THR . 37.7 mtm-85 . . . . . 0 CA--C 1.52 -0.193 0 N-CA-C 112.094 0.405 . . . . 2.8599999999999999 112.094 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.522 ' CB ' ' HG ' ' A' ' 41' ' ' LEU . . . -35.76 -42.75 0.27 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.584 -0.735 . . . . 1.0800000000000001 112.601 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.51 HD23 ' HA ' ' A' ' 29' ' ' LEU . 12.4 mt -75.9 -39.55 56.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.896 0.379 . . . . 1.02 111.587 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.7 tp -64.91 -50.85 64.88 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.034 -0.53 . . . . 1.0700000000000001 110.873 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.528 HD23 ' CE2' ' A' ' 231' ' ' TYR . 31.4 mt -64.78 -28.06 69.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.992 -0.549 . . . . 1.1799999999999999 109.684 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.75 -40.03 94.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.523 -0.762 . . . . 0.95999999999999996 110.238 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.48 ' HB1' ' HG ' ' A' ' 57' ' ' LEU . . . -77.82 -39.46 43.64 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.046 -0.525 . . . . 0.94999999999999996 111.273 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.487 ' CD2' ' HA ' ' A' ' 81' ' ' PRO . 20.7 mt -70.69 -3.0 16.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.95 -0.568 . . . . 1.1000000000000001 110.534 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.494 ' HB1' ' O ' ' A' ' 31' ' ' LEU . . . -96.39 172.9 7.65 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 113.144 0.794 . . . . 1.0800000000000001 113.144 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.444 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.2 OUTLIER -110.11 108.76 19.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.845 -1.07 . . . . 1.29 108.593 178.001 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 120.57 170.1 14.09 Favored Glycine 0 C--N 1.319 -0.38 0 C-N-CA 120.822 -0.704 . . . . 0.72999999999999998 111.375 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.517 ' HG3' HG21 ' A' ' 76' ' ' ILE . 0.1 OUTLIER -94.48 119.3 32.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.227 0.514 . . . . 2.21 111.609 -179.228 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.539 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 1.0 OUTLIER -120.3 142.13 49.38 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 120.715 0.293 . . . . 1.0700000000000001 110.401 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 69.5 t -102.08 139.21 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-O 121.324 0.583 . . . . 1.0700000000000001 111.937 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.522 ' HG ' ' CB ' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -113.21 114.96 27.48 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 107.217 -1.401 . . . . 1.0800000000000001 107.217 175.759 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.548 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.6 OUTLIER -102.81 149.34 24.58 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.487 -0.485 . . . . 1.0900000000000001 111.04 -178.317 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 69.4 24.5 5.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.03 -0.532 . . . . 1.8400000000000001 111.756 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.508 ' CD2' ' HB3' ' A' ' 41' ' ' LEU . 86.8 mt -52.92 -177.47 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.832 0.349 . . . . 1.0 110.138 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.4 tp -108.75 131.39 54.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.439 -0.346 . . . . 1.1699999999999999 110.369 178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -89.17 88.87 7.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.855 0.359 . . . . 1.6399999999999999 110.247 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 49' ' ' ASP . 0.6 OUTLIER -165.48 144.64 6.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 1.54 110.073 -179.154 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -36.1 -32.31 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.638 0.256 . . . . 1.6100000000000001 111.449 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.49 ' HB3' ' O ' ' A' ' 94' ' ' ASN . 4.6 p30 -56.13 -42.2 76.55 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.899 0.381 . . . . 1.5600000000000001 110.841 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.42 ' N ' ' O ' ' A' ' 47' ' ' SER . 84.1 t -84.4 -45.82 17.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.036 -0.529 . . . . 1.1100000000000001 110.531 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.434 ' HA ' ' CD1' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -48.73 -38.65 22.17 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.989 -0.285 . . . . 2.6699999999999999 110.615 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.564 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 19.6 m-70 -79.88 -36.22 36.88 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 109.634 -0.506 . . . . 0.28999999999999998 109.634 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.457 ' O ' HD23 ' A' ' 57' ' ' LEU . 8.5 tpt -53.36 -31.55 45.14 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 106.086 -1.82 . . . . 0.93999999999999995 106.086 176.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.554 ' HB3' ' CE2' ' A' ' 64' ' ' TYR . 2.2 mt -83.42 -45.41 13.69 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 113.914 -1.494 . . . . 1.04 108.645 176.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.656 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 18.2 t-20 -58.94 -39.75 82.59 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 115.82 -0.627 . . . . 1.8600000000000001 111.002 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.37 -49.96 73.45 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.69 0.757 . . . . 1.04 109.249 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.631 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.5 OUTLIER -57.95 -37.66 74.55 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.246 -1.39 . . . . 1.02 107.246 176.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.656 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -62.59 -44.43 96.34 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.005 -1.452 . . . . 1.0900000000000001 112.021 179.227 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.453 ' HB3' HD11 ' A' ' 90' ' ' LEU . . . -67.78 -39.13 84.13 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.712 0.634 . . . . 1.02 112.712 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.26 -17.13 60.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.426 0.631 . . . . 1.0600000000000001 110.28 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.81 37.16 3.75 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 114.894 -1.048 . . . . 0.35999999999999999 113.935 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.631 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 22.0 t -90.3 125.57 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 109.09 -0.707 . . . . 1.1100000000000001 109.09 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.707 ' O ' HG12 ' A' ' 76' ' ' ILE . 12.5 m -86.55 130.61 34.43 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 120.469 -0.492 . . . . 1.47 111.13 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.561 ' HB3' HG22 ' A' ' 75' ' ' ILE . 32.4 p90 -159.78 168.87 24.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.18 -0.464 . . . . 0.80000000000000004 110.291 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 99.0 m -134.76 148.65 50.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.561 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.409 ' CD1' ' HB2' ' A' ' 73' ' ' CYS . 14.4 tp -117.19 136.79 52.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.09 0.472 . . . . 1.1899999999999999 110.776 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.499 ' HB2' ' CB ' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -63.94 -158.99 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.612 -0.722 . . . . 2.1099999999999999 111.281 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -95.7 -31.98 12.97 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.413 -0.358 . . . . 2.2200000000000002 111.178 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.53 1.09 30.95 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.413 -0.358 . . . . 1.8899999999999999 111.375 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 59.79 24.72 13.7 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.48 -0.327 . . . . 2.4700000000000002 111.67 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -122.4 -11.23 8.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.823 0.344 . . . . 1.0 111.406 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.499 ' CB ' ' HB2' ' A' ' 67' ' ' SER . 2.0 mtt180 -112.56 117.96 33.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.439 -0.346 . . . . 3.6000000000000001 110.275 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.479 ' HB3' HD13 ' A' ' 44' ' ' LEU . 43.4 t -131.11 127.52 38.27 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 120.958 0.408 . . . . 0.73999999999999999 111.735 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.517 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 51.3 tt0 -112.24 133.1 54.55 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 109.04 -0.726 . . . . 1.49 109.04 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.561 HG22 ' HB3' ' A' ' 64' ' ' TYR . 11.8 mt -128.7 123.86 60.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 113.948 1.092 . . . . 1.05 113.948 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.707 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -67.73 98.86 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 109.157 -0.683 . . . . 1.5900000000000001 109.157 175.764 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -37.23 142.91 0.2 Allowed Glycine 0 C--N 1.321 -0.262 0 CA-C-N 115.138 -0.937 . . . . 0.22 113.579 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -90.31 -13.32 35.45 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.917 0.389 . . . . 1.8700000000000001 111.113 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.444 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 86.24 14.51 66.34 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.037 -0.601 . . . . 0.28999999999999998 112.606 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.401 ' O ' HD22 ' A' ' 34' ' ' LEU . . . 145.36 -155.58 26.55 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.792 -0.718 . . . . 0.22 112.581 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.487 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 5.8 Cg_endo -49.3 127.41 17.76 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.682 2.255 . . . . 0.93000000000000005 112.436 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.462 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 0.3 OUTLIER -74.88 109.25 8.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.124 -0.489 . . . . 1.1000000000000001 109.935 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -80.42 124.12 28.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.2 0.524 . . . . 0.67000000000000004 112.111 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.608 ' HB3' HD12 ' A' ' 113' ' ' ILE . . . -89.34 124.2 34.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.505 -0.77 . . . . 1.03 111.275 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.51 122.92 20.0 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 105.621 -1.992 . . . . 1.95 105.621 176.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.24 -175.39 5.5 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 108.559 -1.816 . . . . 0.22 108.559 -175.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.38 145.03 30.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 118.787 1.294 . . . . 1.0700000000000001 111.832 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.534 ' HB3' HG13 ' A' ' 113' ' ' ILE . 0.8 OUTLIER -114.16 161.78 17.35 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.003 -0.998 . . . . 1.01 112.278 -178.656 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -139.63 102.89 4.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.612 -1.176 . . . . 1.8700000000000001 108.707 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.596 ' HB2' HD23 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -99.2 127.54 45.19 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 120.99 0.424 . . . . 1.04 111.276 -178.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -99.09 95.51 7.16 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.86 -0.609 . . . . 1.8400000000000001 109.679 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.444 HD23 ' O ' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -104.03 54.82 0.73 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.846 -0.615 . . . . 1.0900000000000001 110.085 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -56.63 -68.5 1.66 Allowed Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.71 -0.677 . . . . 0.82999999999999996 112.984 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.49 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 33.2 m-20 -79.12 -1.76 37.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.575 0.226 . . . . 2.3799999999999999 110.801 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.411 ' CB ' ' HA ' ' A' ' 49' ' ' ASP . . . -92.76 45.58 1.19 Allowed 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 116.475 -0.33 . . . . 1.1799999999999999 110.919 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -50.42 -27.58 12.17 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.429 -0.891 . . . . 0.81999999999999995 112.032 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.1 p -88.83 -14.94 35.77 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.529 0.196 . . . . 1.3700000000000001 111.529 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.434 ' O ' ' HG2' ' A' ' 101' ' ' PRO . . . -93.46 -37.19 12.07 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.074 0.398 . . . . 1.2 112.074 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.1 tpp -59.17 -46.37 88.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.693 -0.23 . . . . 1.0800000000000001 110.737 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' A' ' 171' ' ' GLN . 2.2 mpt_? -52.89 -60.68 6.08 Favored Pre-proline 0 C--N 1.324 -0.537 0 C-N-CA 120.755 -0.378 . . . . 2.0499999999999998 110.056 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 100' ' ' ARG . 18.1 Cg_endo -60.31 -31.63 93.11 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.422 2.082 . . . . 0.78000000000000003 112.773 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.1 mt -73.76 -54.03 8.98 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 120.403 -0.519 . . . . 1.04 109.945 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.451 ' O ' HD12 ' A' ' 153' ' ' LEU . . . -47.42 -29.6 2.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.673 -0.694 . . . . 1.0700000000000001 110.543 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.446 ' HB1' ' HB3' ' A' ' 175' ' ' ALA . . . -88.08 -52.11 5.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.872 -0.604 . . . . 1.03 112.226 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.401 ' HB2' HD13 ' A' ' 34' ' ' LEU . . . -59.89 -35.42 74.8 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.193 0.812 . . . . 0.98999999999999999 113.193 -177.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.3 mt -78.74 -10.98 59.96 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 112.705 0.631 . . . . 1.03 112.705 -177.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.623 ' HB3' ' HB2' ' A' ' 138' ' ' ALA . 99.0 m -93.07 24.86 3.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.287 0.565 . . . . 1.8500000000000001 110.067 178.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.414 ' CD2' ' HB2' ' A' ' 182' ' ' LEU . 0.5 OUTLIER -85.51 -75.95 0.35 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.335 -0.848 . . . . 1.1399999999999999 111.213 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -76.76 -105.61 0.14 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.581 -0.819 . . . . 1.1399999999999999 112.141 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.63 96.33 1.5 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.057 0.456 . . . . 1.55 110.523 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.675 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 0.0 OUTLIER -141.39 140.1 33.61 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.76 -0.654 . . . . 2.52 110.799 -178.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.798 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 5.6 m-20 -95.44 99.25 11.18 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 109.087 -0.708 . . . . 1.1200000000000001 109.087 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.608 HD12 ' HB3' ' A' ' 84' ' ' ALA . 1.3 mp -123.28 144.11 33.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.553 -0.749 . . . . 1.3200000000000001 111.663 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.679 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 48.0 t -113.9 113.22 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 107.922 -1.14 . . . . 1.05 107.922 176.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.596 HD23 ' HB2' ' A' ' 90' ' ' LEU . 25.7 mt -101.23 105.67 16.81 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 119.869 -0.733 . . . . 1.02 110.346 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.48 -171.61 2.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.573 -0.285 . . . . 1.1000000000000001 111.315 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -167.27 -166.22 25.98 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.547 -0.835 . . . . 0.28999999999999998 113.278 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.591 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 40.2 mt-10 -85.85 166.82 27.42 Favored Pre-proline 0 C--N 1.33 -0.273 0 C-N-CA 122.606 0.363 . . . . 1.79 110.678 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.591 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 2.1 Cg_endo -44.83 -37.25 11.74 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.725 2.283 . . . . 0.81000000000000005 112.696 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -67.62 -26.55 66.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.807 0.337 . . . . 2.75 110.381 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.489 ' O ' ' HG3' ' A' ' 149' ' ' PRO . 7.3 tpt -62.5 -31.81 72.62 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.532 -0.544 . . . . 1.1499999999999999 109.532 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.7 -18.08 58.22 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 115.923 -0.58 . . . . 2.04 110.257 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -85.25 4.9 32.64 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.957 0.408 . . . . 2.3199999999999998 110.086 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.9 mtt-85 -127.16 80.58 71.38 Favored Pre-proline 0 N--CA 1.455 -0.197 0 CA-C-N 116.013 -0.54 . . . . 2.7599999999999998 110.51 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.83 148.89 63.8 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.583 2.188 . . . . 0.84999999999999998 111.712 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.458 HG12 HD11 ' A' ' 151' ' ' LEU . 1.2 tt -126.13 10.4 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 112.386 0.513 . . . . 1.0600000000000001 112.386 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.521 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -59.99 -39.83 96.16 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.559 -0.829 . . . . 0.28999999999999998 113.107 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -57.41 -37.02 72.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.747 0.308 . . . . 2.2000000000000002 111.03 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.476 ' HB2' ' CD2' ' A' ' 172' ' ' PHE . 12.5 tp -75.65 -44.49 42.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.273 0.559 . . . . 1.1100000000000001 110.514 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.658 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 47.8 t -55.48 -48.13 77.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.367 -0.833 . . . . 1.05 111.275 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.651 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 4.1 m-20 -67.77 -41.45 83.25 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 120.993 0.425 . . . . 1.3200000000000001 110.562 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.419 ' HB2' ' CG1' ' A' ' 162' ' ' VAL . . . -56.84 -44.06 81.72 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.553 -0.749 . . . . 1.01 110.003 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.48 ' O ' ' HB1' ' A' ' 138' ' ' ALA . 6.5 mt -77.4 -51.32 11.0 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.596 -0.729 . . . . 1.0600000000000001 110.769 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.658 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -55.16 -26.41 38.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.598 -0.728 . . . . 3.3799999999999999 109.912 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.651 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 3.4 tp -69.51 -32.5 71.4 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.175 -0.466 . . . . 1.1899999999999999 110.556 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.47 12.06 41.76 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.646 -0.788 . . . . 0.20000000000000001 112.049 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.91 5.57 58.41 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.25 -0.976 . . . . 0.25 112.689 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.623 ' HB2' ' HB3' ' A' ' 107' ' ' CYS . . . -75.77 149.66 37.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.029 0.442 . . . . 0.98999999999999999 111.305 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.0 mttp -97.0 109.22 22.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.948 -0.569 . . . . 2.5499999999999998 110.277 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.445 ' HB ' HG13 ' A' ' 130' ' ' VAL . 28.1 mt -140.6 126.9 21.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.838 0.351 . . . . 1.1100000000000001 111.638 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.603 HG21 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -124.2 139.96 53.43 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.124 -0.489 . . . . 1.0600000000000001 110.258 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -80.56 130.14 34.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.837 0.351 . . . . 0.78000000000000003 110.867 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.628 ' HB2' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -88.5 -85.03 0.19 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.136 -0.484 . . . . 1.0800000000000001 112.076 -178.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.448 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 1.2 mt-10 -66.28 -83.87 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.838 -0.345 . . . . 1.77 110.586 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.457 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 75.5 mt-30 -109.49 153.95 23.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.407 -0.36 . . . . 2.3199999999999998 110.139 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -69.1 131.74 45.47 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.874 0.368 . . . . 1.6599999999999999 110.865 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.521 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 0.9 OUTLIER 71.43 19.93 5.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.934 -0.575 . . . . 1.24 111.155 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.564 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 14.6 m-85 -106.8 169.12 7.15 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 112.277 0.473 . . . . 1.03 112.277 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.742 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 65.4 Cg_exo -36.09 -57.26 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.86 3.04 . . . . 0.31 115.481 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.742 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 52.3 Cg_exo -56.79 144.97 85.72 Favored 'Trans proline' 0 C--N 1.353 0.806 0 CA-C-N 120.432 1.19 . . . . 0.23000000000000001 112.05 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.679 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 12.2 mt -156.81 134.98 11.2 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.841 -1.072 . . . . 1.1200000000000001 109.894 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.603 ' HB2' HG21 ' A' ' 141' ' ' THR . 3.7 mtt180 -105.33 105.43 15.47 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.009 -1.108 . . . . 2.5600000000000001 108.009 176.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.798 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 3.4 mt -94.35 144.62 25.39 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.865 -1.061 . . . . 1.0600000000000001 110.904 -177.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.675 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 3.6 mt-30 -145.87 27.23 1.2 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.508 -0.769 . . . . 1.1799999999999999 110.72 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 51.06 179.05 0.03 OUTLIER Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.015 -0.612 . . . . 0.40000000000000002 112.622 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 125.68 -10.27 7.58 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.143 -1.027 . . . . 0.33000000000000002 113.405 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.432 ' CB ' ' O ' ' A' ' 107' ' ' CYS . 21.4 t80 -58.87 122.64 14.12 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 117.381 0.591 . . . . 0.81999999999999995 110.482 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' THR . . . . . 0.678 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 73.1 p -117.53 -38.29 3.33 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.334 0.588 . . . . 1.1200000000000001 111.625 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.535 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 144.64 -170.92 26.11 Favored Glycine 0 C--N 1.308 -1.022 0 C-N-CA 120.239 -0.981 . . . . 0.26000000000000001 112.583 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.491 ' O ' HG22 ' A' ' 162' ' ' VAL . . . 112.58 155.06 12.19 Favored Glycine 0 N--CA 1.436 -1.323 0 N-CA-C 111.189 -0.764 . . . . 0.62 111.189 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -47.76 125.67 9.04 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 120.833 0.349 . . . . 2.5600000000000001 110.68 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 74.7 t -117.11 144.42 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.66 -0.496 . . . . 1.1299999999999999 109.66 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -113.26 119.39 37.57 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.865 -0.334 . . . . 1.1200000000000001 110.794 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.469 ' HB ' ' CG2' ' A' ' 189' ' ' ILE . 1.1 t -131.83 119.17 40.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 120.598 -0.441 . . . . 1.1200000000000001 109.851 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.44 138.39 46.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 1.48 111.288 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.463 ' CA ' HG22 ' A' ' 191' ' ' ILE . . . . . . . . 0 N--CA 1.446 -0.658 0 C-N-CA 120.588 -0.815 . . . . 0.52000000000000002 112.431 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.432 ' HB2' ' HB3' ' A' ' 200' ' ' TYR . 71.9 p . . . . . 0 C--O 1.231 0.13 0 N-CA-C 111.993 0.368 . . . . 1.8300000000000001 111.993 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.494 ' O ' ' HB3' ' A' ' 100' ' ' ARG . 8.7 mp0 -85.5 -11.01 55.25 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.815 -0.354 . . . . 2.8799999999999999 111.111 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.476 ' CD2' ' HB2' ' A' ' 129' ' ' LEU . 10.8 m-85 -75.07 -59.19 2.85 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.317 -0.623 . . . . 0.51000000000000001 109.317 178.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.408 ' CD1' ' CG1' ' A' ' 191' ' ' ILE . 0.3 OUTLIER -60.7 -39.14 87.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.475 -0.784 . . . . 1.3200000000000001 109.18 178.42 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.566 HG22 ' HD3' ' A' ' 27' ' ' ARG . 1.7 m -59.84 -38.96 83.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.922 -1.036 . . . . 1.05 109.62 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 100' ' ' ARG . . . -60.65 -41.5 95.08 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.815 -0.629 . . . . 0.91000000000000003 110.911 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.37 -32.16 54.78 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.473 -0.785 . . . . 1.3700000000000001 110.891 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.715 ' O ' ' HE3' ' A' ' 208' ' ' MET . 3.5 mp -61.51 -38.44 87.36 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.342 -0.845 . . . . 1.1699999999999999 110.759 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' MET . . . . . 0.518 ' HE1' ' HA ' ' A' ' 27' ' ' ARG . 1.5 mtp -82.65 -40.6 20.49 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.51 0.559 . . . . 0.94999999999999996 112.51 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 50.3 m -77.1 -39.43 49.56 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.343 -0.844 . . . . 1.02 113.071 -178.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.513 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . -58.7 -42.52 94.72 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 114.428 1.27 . . . . 1.0600000000000001 114.428 -177.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 27.0 Cg_endo -64.82 -27.56 59.42 Favored 'Trans proline' 0 CA--C 1.501 -1.154 0 CA-C-N 119.795 0.962 . . . . 0.73999999999999999 112.387 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.414 ' HB2' ' CD2' ' A' ' 108' ' ' LEU . 4.0 mt -83.26 -2.36 55.42 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 109.31 -0.626 . . . . 1.3400000000000001 109.31 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.587 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . -78.17 135.8 61.9 Favored Pre-proline 0 C--O 1.224 -0.274 0 CA-C-N 116.049 -0.523 . . . . 1.0900000000000001 110.122 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.678 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 11.3 Cg_endo -51.14 -34.4 47.77 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.378 2.052 . . . . 0.27000000000000002 113.11 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -112.4 143.64 43.18 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.697 -0.683 . . . . 2.0899999999999999 111.112 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -58.07 153.43 14.67 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.285 -0.416 . . . . 2.2400000000000002 110.286 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.535 ' OG1' ' HA2' ' A' ' 159' ' ' GLY . 56.4 m -133.75 145.65 50.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.077 0.465 . . . . 1.0800000000000001 112.223 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 54.6 t -124.48 117.58 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.584 -0.735 . . . . 1.1100000000000001 110.197 178.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 3.4 mp -100.13 117.9 45.99 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 N-CA-C 108.731 -0.84 . . . . 1.0900000000000001 108.731 177.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 7.7 ttt180 -100.66 124.71 46.64 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.322 -0.992 . . . . 2.8999999999999999 108.322 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.546 ' HB ' ' HA ' ' A' ' 221' ' ' GLN . 1.6 mp -92.27 122.37 43.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.933 -1.03 . . . . 1.0600000000000001 111.746 -176.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -80.46 96.87 6.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.072 -1.422 . . . . 1.49 110.595 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 101.56 -132.39 10.94 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.747 -0.74 . . . . 0.52000000000000002 111.884 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -116.74 127.51 54.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.711 0.291 . . . . 1.1000000000000001 111.628 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 1.1 mt -40.42 144.87 0.2 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.157 -0.474 . . . . 1.2 111.269 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 10.5 p -72.52 -30.74 35.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.995 -0.548 . . . . 1.27 112.2 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' SER . . . . . 0.461 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 0.2 OUTLIER -165.23 63.61 0.12 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.977 0.417 . . . . 1.2 110.734 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.45 ' N ' ' CD ' ' A' ' 199' ' ' PRO . 6.1 tttm -40.25 -46.21 5.41 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 115.851 -0.613 . . . . 2.5800000000000001 111.355 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . 0.461 ' HD2' ' C ' ' A' ' 197' ' ' SER . 87.6 Cg_exo -47.37 -34.09 18.22 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.027 1.818 . . . . 0.95999999999999996 111.798 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.559 ' HA ' ' CD1' ' A' ' 203' ' ' ILE . 0.3 OUTLIER -70.34 -42.06 72.39 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.804 -0.813 . . . . 2.2599999999999998 108.804 178.056 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 26.4 mm -63.21 -33.8 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 114.819 -1.082 . . . . 1.1000000000000001 110.44 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.7 -45.28 94.8 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.121 0.486 . . . . 1.1399999999999999 109.914 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.559 ' CD1' ' HA ' ' A' ' 200' ' ' TYR . 3.8 mt -62.14 -50.95 77.95 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 CA-C-O 121.633 0.73 . . . . 1.29 110.163 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 208' ' ' MET . 74.9 m -51.63 -51.11 58.29 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.478 -1.237 . . . . 1.1100000000000001 111.449 -178.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.415 ' O ' ' CE ' ' A' ' 209' ' ' LYS . 21.3 mt -66.84 -28.59 68.47 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 120.892 0.377 . . . . 1.05 111.661 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . 0.401 ' HA ' ' HE3' ' A' ' 209' ' ' LYS . 1.9 t30 -78.48 -46.64 19.18 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.588 0.708 . . . . 1.98 109.827 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.452 ' O ' ' CG2' ' A' ' 210' ' ' THR . 0.2 OUTLIER -71.11 -30.31 66.36 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.687 -1.142 . . . . 1.22 109.192 178.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' MET . . . . . 0.715 ' HE3' ' O ' ' A' ' 177' ' ' LEU . 35.5 mtp -72.76 -35.03 67.37 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.848 -0.615 . . . . 0.93999999999999995 109.534 177.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.482 ' HD3' ' HG2' ' A' ' 214' ' ' GLU . 10.4 mtmt -60.97 -36.39 79.3 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 115.092 -0.958 . . . . 1.6499999999999999 110.856 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.452 ' CG2' ' O ' ' A' ' 207' ' ' LEU . 4.8 t -62.04 -22.98 66.19 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.633 -0.712 . . . . 1.3200000000000001 109.33 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.514 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 61.3 m-85 -85.76 -9.07 57.68 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.749 -0.66 . . . . 1.73 111.587 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 111.54 5.33 26.17 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 116.006 1.162 . . . . 2.9300000000000002 116.006 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.5 m -123.54 148.96 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 118.969 1.385 . . . . 2.0099999999999998 112.81 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.482 ' HG2' ' HD3' ' A' ' 209' ' ' LYS . 8.5 mt-10 -131.01 135.88 48.0 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.341 -0.845 . . . . 2.6699999999999999 111.291 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.45 HG21 ' HB ' ' A' ' 225' ' ' VAL . 20.0 mm -118.26 148.59 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 120.772 0.32 . . . . 1.48 110.225 178.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.517 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 9.2 tt0 -104.86 116.56 32.2 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.302 -0.408 . . . . 1.54 112.004 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.94 151.25 24.37 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.091 -0.504 . . . . 2.2400000000000002 110.396 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . 0.454 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 5.0 tp60 -108.18 -143.23 0.38 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.477 0.179 . . . . 2.48 110.785 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -73.3 66.51 0.92 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.886 0.374 . . . . 3.1400000000000001 111.491 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 6.4 t80 58.43 33.65 23.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.788 0.804 . . . . 1.52 111.11 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.597 ' O ' ' CD1' ' A' ' 223' ' ' PHE . 5.1 pt20 -165.74 -129.99 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 106.69 -1.596 . . . . 2.0899999999999999 106.69 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.581 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -3.06 128.7 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 114.36 1.244 . . . . 1.79 114.36 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.597 ' CD1' ' O ' ' A' ' 221' ' ' GLN . 5.1 m-85 -123.02 140.93 52.52 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.262 -1.79 . . . . 0.82999999999999996 110.042 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.517 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 42.3 t -123.03 112.78 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 121.329 0.585 . . . . 1.1299999999999999 109.841 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.45 ' HB ' HG21 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -119.44 135.27 60.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.222 -0.899 . . . . 1.21 111.49 -178.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.416 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 3.7 mptt -83.76 127.8 34.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.038 -0.528 . . . . 3.1899999999999999 109.823 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.428 ' CA ' ' O ' ' A' ' 183' ' ' ALA . . . -83.03 167.99 46.41 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.442 -0.885 . . . . 0.38 113.347 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 77.73 19.81 75.02 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 121.703 -0.284 . . . . 0.29999999999999999 113.412 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 19.6 mt-30 -77.22 -176.22 4.0 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.39 0.614 . . . . 2.02 111.728 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.6 147.67 30.3 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.116 -0.947 . . . . 1.76 110.636 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' TYR . . . . . 0.528 ' CE2' HD23 ' A' ' 31' ' ' LEU . 6.3 m-30 -103.19 132.06 49.74 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.975 -0.557 . . . . 1.0900000000000001 110.995 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -119.74 155.14 33.04 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.697 -0.483 . . . . 2.5499999999999998 109.697 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.468 ' HB2' ' OG1' ' A' ' 39' ' ' THR . 51.8 p -82.42 109.71 17.57 Favored Pre-proline 0 N--CA 1.451 -0.411 0 C-N-CA 121.077 -0.249 . . . . 1.8400000000000001 110.56 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.539 ' HD2' ' OG1' ' A' ' 39' ' ' THR . 54.9 Cg_endo -68.45 -2.34 8.97 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.089 1.859 . . . . 0.39000000000000001 112.233 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 102.21 -94.7 1.21 Allowed Glycine 0 C--O 1.227 -0.313 0 C-N-CA 120.629 -0.796 . . . . 0.29999999999999999 111.666 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 95.9 m -121.51 135.41 55.03 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.344 -0.613 . . . . 1.0700000000000001 109.344 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . 0.424 ' CE2' HG21 ' A' ' 210' ' ' THR . 12.3 t80 -133.58 134.74 43.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.93 0.395 . . . . 1.21 111.516 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.548 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -98.91 113.05 25.01 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.981 -0.554 . . . . 1.1499999999999999 111.529 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 25.1 t -84.59 112.75 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.731 -0.668 . . . . 1.1200000000000001 110.908 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.251 -0.881 . . . . 1.6899999999999999 111.124 -179.699 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.746 HH12 ' HB ' ' A' ' 203' ' ' ILE . 29.1 mtm180 . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.876 0.37 . . . . 0.0 110.985 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.629 ' HB3' ' HG ' ' A' ' 41' ' ' LEU . . . -39.32 -48.42 1.86 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.667 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.589 HD22 HD13 ' A' ' 75' ' ' ILE . 11.0 mt -72.31 -36.42 68.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.905 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.486 HD21 ' HB2' ' A' ' 101' ' ' PRO . 35.9 tp -65.86 -50.19 65.44 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.719 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.652 HD23 ' CE2' ' A' ' 231' ' ' TYR . 60.0 mt -67.0 -27.64 67.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.728 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.418 ' HA ' ' HE1' ' A' ' 211' ' ' PHE . . . -65.91 -39.18 90.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.14 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.593 ' CB ' ' HG ' ' A' ' 57' ' ' LEU . . . -81.73 -41.07 21.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.212 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.692 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 14.4 mt -68.33 -4.01 12.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.227 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.534 ' HB1' ' HB3' ' A' ' 231' ' ' TYR . . . -97.6 179.19 4.93 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -177.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.556 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.4 OUTLIER -112.19 113.5 25.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.931 178.543 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 114.12 169.08 16.52 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.608 -178.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.559 ' HG2' ' HG2' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -95.06 117.57 30.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 117.154 0.477 . . . . 0.0 111.475 -179.223 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 235' ' ' GLY . 0.9 OUTLIER -119.58 145.71 46.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.445 -179.697 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.436 HG21 ' CG ' ' A' ' 74' ' ' GLU . 75.8 t -104.37 142.31 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 CA-C-O 121.344 0.592 . . . . 0.0 112.548 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.629 ' HG ' ' HB3' ' A' ' 28' ' ' ALA . 0.3 OUTLIER -116.51 116.36 27.49 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 174.632 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.505 HG21 HD21 ' A' ' 238' ' ' LEU . 0.5 OUTLIER -102.96 151.35 22.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.108 -177.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.7 t30 66.08 27.26 10.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.179 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.566 HD13 ' HB3' ' A' ' 73' ' ' CYS . 86.2 mt -54.68 -172.94 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.413 ' HB3' HG23 ' A' ' 50' ' ' VAL . 29.7 tp -114.03 131.38 56.38 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -88.46 88.45 7.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.149 0.5 . . . . 0.0 110.565 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 49' ' ' ASP . 1.7 m -164.31 142.91 7.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.1 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.402 ' HA ' ' HB3' ' A' ' 51' ' ' ARG . 0.6 OUTLIER -36.42 -30.45 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.602 0.239 . . . . 0.0 111.455 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.607 ' HB3' ' O ' ' A' ' 94' ' ' ASN . 1.5 p30 -58.19 -42.77 86.82 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 121.028 0.442 . . . . 0.0 110.905 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.462 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 88.8 t -84.24 -44.66 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.57 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.562 ' HA ' HD11 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -50.89 -39.01 53.11 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.017 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.654 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 7.4 m-70 -80.31 -32.58 37.96 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.595 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.614 ' O ' HD13 ' A' ' 57' ' ' LEU . 9.5 tpt -55.0 -34.62 63.6 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.643 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -82.42 -41.54 19.75 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 114.22 -1.354 . . . . 0.0 108.58 176.346 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.736 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 34.4 t30 -59.13 -41.56 88.52 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-O 120.922 0.391 . . . . 0.0 110.749 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.464 ' HB3' HD11 ' A' ' 102' ' ' LEU . . . -59.24 -46.76 87.62 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 121.702 0.763 . . . . 0.0 108.96 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.827 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.4 OUTLIER -63.41 -41.11 98.71 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.245 -1.343 . . . . 0.0 107.745 177.243 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.736 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -59.78 -32.9 71.03 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 114.187 -1.369 . . . . 0.0 111.564 179.044 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.535 ' O ' HD23 ' A' ' 88' ' ' LEU . . . -77.66 -38.33 47.91 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.073 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.486 ' CB ' ' HB3' ' A' ' 82' ' ' LEU . 0.5 OUTLIER -79.89 -12.91 59.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.407 0.622 . . . . 0.0 110.566 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.43 33.33 5.42 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 114.967 -1.015 . . . . 0.0 114.244 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.827 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 40.5 t -90.55 117.67 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.782 ' O ' HG12 ' A' ' 76' ' ' ILE . 26.0 m -82.98 132.89 35.13 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 121.078 0.466 . . . . 0.0 112.167 -178.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.643 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 41.1 p90 -158.31 171.87 19.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.463 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 62.1 m -131.37 148.51 52.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.182 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.408 ' CD1' ' HB2' ' A' ' 73' ' ' CYS . 12.5 tp -115.04 133.7 55.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.177 0.513 . . . . 0.0 110.685 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.489 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 0.6 OUTLIER -61.21 -167.22 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.378 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.75 -44.47 14.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.553 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.33 1.79 10.79 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.596 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 58.81 39.83 23.62 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.868 0.366 . . . . 0.0 111.54 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -133.95 -10.46 2.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.225 179.292 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.556 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 14.8 mtp180 -114.92 120.59 40.45 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.566 ' HB3' HD13 ' A' ' 44' ' ' LEU . 34.2 t -129.53 125.62 36.72 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.559 ' HG2' ' HG2' ' A' ' 38' ' ' LYS . 56.8 tt0 -106.98 130.62 54.6 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 176.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.589 HD13 HD22 ' A' ' 29' ' ' LEU . 10.4 mt -127.72 124.49 63.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -177.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.782 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -68.51 99.62 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-O 121.104 0.478 . . . . 0.0 109.712 175.813 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -38.77 143.71 0.29 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.843 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -89.31 -10.71 45.75 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.093 0.473 . . . . 0.0 110.921 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.556 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 90.14 3.11 73.32 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.14 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.584 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 150.07 -148.49 19.8 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.012 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.561 ' CG ' ' HB3' ' A' ' 108' ' ' LEU . 88.1 Cg_exo -49.09 125.14 12.73 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.783 2.322 . . . . 0.0 112.973 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.546 HD22 ' CD2' ' A' ' 34' ' ' LEU . 0.7 OUTLIER -74.58 110.52 8.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.792 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -82.08 135.06 35.37 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.072 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.722 ' HB3' HD11 ' A' ' 113' ' ' ILE . . . -98.03 123.78 42.22 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.061 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -71.04 123.67 22.61 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.61 175.71 0.96 Allowed Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -175.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.65 144.8 47.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 118.735 1.268 . . . . 0.0 111.411 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.573 HD22 ' HB1' ' A' ' 84' ' ' ALA . 1.3 tp -116.26 160.54 20.31 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.393 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 22.4 mt-10 -139.22 104.23 4.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.288 178.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.446 ' HA ' HD11 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -100.63 118.83 37.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.143 -178.699 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -92.99 96.26 9.98 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.906 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.436 ' N ' ' O ' ' A' ' 116' ' ' THR . 0.1 OUTLIER -104.89 47.31 0.88 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.089 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.728 ' HA3' ' H ' ' A' ' 118' ' ' GLU . . . -54.4 -44.66 76.78 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.848 -0.692 . . . . 0.0 113.281 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.607 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 74.2 m-20 -94.43 -6.89 42.99 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.666 0.27 . . . . 0.0 110.733 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.544 ' CB ' ' HA ' ' A' ' 49' ' ' ASP . . . -98.16 61.7 1.49 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.011 0.434 . . . . 0.0 111.311 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.6 ' O ' ' HD3' ' A' ' 100' ' ' ARG . . . -63.82 -25.2 68.94 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.068 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.428 ' HA ' ' HG2' ' A' ' 171' ' ' GLN . 0.9 OUTLIER -88.19 -17.11 31.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.707 0.289 . . . . 0.0 110.882 179.497 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.443 ' O ' ' HG2' ' A' ' 101' ' ' PRO . . . -95.27 -29.21 14.61 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.925 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.636 ' SD ' ' HB3' ' A' ' 115' ' ' LEU . 5.6 tpp -64.3 -47.4 79.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.168 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.648 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 1.9 mpt_? -54.34 -58.87 11.9 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 100' ' ' ARG . 18.1 Cg_endo -59.71 -33.04 96.57 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.286 1.991 . . . . 0.0 112.635 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 0.4 OUTLIER -74.16 -53.43 9.88 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.056 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.549 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -50.04 -28.09 6.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.429 0.633 . . . . 0.0 110.279 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.729 ' C ' ' HG1' ' A' ' 179' ' ' THR . . . -86.96 -54.44 4.34 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.316 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.409 ' HB2' HD11 ' A' ' 34' ' ' LEU . . . -59.93 -32.76 71.09 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -176.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 102' ' ' LEU . 20.2 mt -78.99 -12.89 60.05 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.046 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.556 ' HB3' ' HB2' ' A' ' 138' ' ' ALA . 20.2 m -81.23 15.32 1.99 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.219 0.533 . . . . 0.0 110.936 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.561 ' HB3' ' CG ' ' A' ' 81' ' ' PRO . 2.3 mt -91.91 -71.02 0.66 Allowed 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.267 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.86 146.19 22.06 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.707 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.426 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 3.2 p -58.16 98.84 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.803 0.335 . . . . 0.0 111.141 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.622 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 9.7 m120 -148.28 135.51 20.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.874 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.878 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 5.0 m-20 -91.66 101.05 13.67 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.252 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.722 HD11 ' HB3' ' A' ' 84' ' ' ALA . 31.5 mm -118.89 137.48 52.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.161 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.822 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 62.9 t -110.17 112.39 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 176.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.636 ' HB3' ' SD ' ' A' ' 99' ' ' MET . 63.9 mt -102.21 105.83 16.56 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.327 -178.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.592 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -119.37 -175.37 2.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.844 0.354 . . . . 0.0 111.624 -178.921 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.48 ' HA3' ' HA2' ' A' ' 93' ' ' GLY . . . -166.17 178.07 40.91 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.994 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.728 ' H ' ' HA3' ' A' ' 93' ' ' GLY . 3.9 mt-10 -70.79 172.63 5.97 Favored Pre-proline 0 C--N 1.328 -0.333 0 C-N-CA 123.096 0.558 . . . . 0.0 110.793 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.619 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 81.5 Cg_exo -46.65 -39.57 23.34 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.682 2.254 . . . . 0.0 113.105 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.416 ' O ' ' HB3' ' A' ' 123' ' ' GLU . 2.1 mpp_? -67.8 -23.57 65.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.681 0.277 . . . . 0.0 110.961 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.639 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 10.8 tpt -60.92 -35.65 77.25 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.417 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 3.5 mptp? -62.78 -16.86 59.79 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.149 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.628 ' O ' ' HG3' ' A' ' 123' ' ' GLU . 1.0 OUTLIER -80.92 -0.17 38.05 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.307 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.411 ' HB3' HH22 ' A' ' 100' ' ' ARG . 6.5 mtt180 -126.31 83.71 63.45 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.71 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.525 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 15.8 Cg_endo -56.86 148.75 65.03 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.646 2.231 . . . . 0.0 111.538 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.536 HG12 HD11 ' A' ' 151' ' ' LEU . 0.7 OUTLIER -123.48 -0.76 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.012 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.565 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -53.69 -39.01 60.16 Favored Glycine 0 CA--C 1.516 0.138 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.707 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.552 ' CD2' ' HB2' ' A' ' 165' ' ' ASP . 1.4 m80 -55.58 -39.29 70.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.023 0.412 . . . . 0.0 110.735 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.529 ' HG ' HD13 ' A' ' 133' ' ' LEU . 14.4 tp -75.36 -40.86 57.7 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.347 0.594 . . . . 0.0 110.141 178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.762 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 55.1 t -56.19 -48.17 79.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.562 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.722 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 75.2 m-20 -69.5 -37.26 77.12 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.133 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.649 ' O ' HG12 ' A' ' 162' ' ' VAL . . . -58.99 -49.62 77.2 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.936 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.613 HD23 ' CB ' ' A' ' 104' ' ' ALA . 6.6 mt -73.6 -47.44 40.36 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.591 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.762 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -59.53 -27.47 66.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.702 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.722 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 5.6 tp -70.89 -28.69 64.73 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.998 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 159' ' ' GLY . . . -85.55 15.26 47.27 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.709 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.91 4.73 61.45 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.522 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.556 ' HB2' ' HB3' ' A' ' 107' ' ' CYS . . . -73.95 152.99 39.96 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 120.865 0.364 . . . . 0.0 111.417 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.436 ' CB ' ' HB2' ' A' ' 154' ' ' GLN . 13.5 mmtm -102.29 103.43 13.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.249 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.613 ' HB ' ' HG3' ' A' ' 134' ' ' ARG . 14.7 mt -134.86 127.35 48.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.431 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.621 HG21 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -124.62 139.23 54.06 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.101 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.492 ' HH ' ' HB ' ' A' ' 130' ' ' VAL . 36.3 m-85 -78.08 130.35 36.31 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.125 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.694 ' HB2' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -91.09 -90.26 0.16 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.57 -179.723 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.818 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 2.6 mt-10 -58.99 -81.51 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 122.083 -0.386 . . . . 0.0 110.903 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.407 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 14.2 mt-30 -114.73 151.86 33.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.505 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -66.93 135.2 53.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.919 0.39 . . . . 0.0 110.68 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.565 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 4.3 m-20 66.91 19.73 10.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.196 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.572 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 10.9 m-85 -110.28 169.64 6.15 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 121.085 0.469 . . . . 0.0 112.128 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.9 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 36.5 Cg_exo -33.23 -62.32 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 124.547 3.498 . . . . 0.0 116.252 -177.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.9 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 52.4 Cg_exo -53.56 145.73 46.28 Favored 'Trans proline' 0 C--N 1.352 0.746 0 CA-C-N 120.723 1.294 . . . . 0.0 112.678 -178.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.822 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 6.5 mt -156.3 136.31 12.76 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.62 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.621 ' HB2' HG21 ' A' ' 141' ' ' THR . 11.7 mtt180 -106.42 103.18 12.58 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.878 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 6.6 mt -93.6 145.39 24.57 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.797 -178.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.622 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 2.6 mp0 -147.35 26.93 1.04 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.43 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 52.14 -158.59 3.11 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.027 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.39 -12.86 43.69 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 119.922 -1.132 . . . . 0.0 112.917 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.536 ' HD2' ' HB1' ' A' ' 138' ' ' ALA . 51.6 t80 -60.29 122.75 15.27 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 117.14 0.47 . . . . 0.0 110.852 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' THR . . . . . 0.662 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 54.3 p -115.31 -33.12 5.41 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.575 0.703 . . . . 0.0 111.206 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.405 ' O ' ' HA2' ' A' ' 136' ' ' GLY . . . 136.46 -160.39 24.74 Favored Glycine 0 C--N 1.305 -1.148 0 CA-C-N 114.667 -1.151 . . . . 0.0 112.247 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.474 ' O ' HG21 ' A' ' 162' ' ' VAL . . . 105.97 154.85 21.35 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 120.625 -0.797 . . . . 0.0 111.35 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -47.04 119.22 2.44 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 120.869 0.366 . . . . 0.0 110.944 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.749 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 75.3 t -110.36 129.87 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.929 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.11 119.41 37.79 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.521 -0.472 . . . . 0.0 109.74 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 191' ' ' ILE . 1.0 OUTLIER -132.32 120.19 42.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.552 ' HB2' ' CD2' ' A' ' 128' ' ' HIS . 0.6 OUTLIER -53.32 141.89 22.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.246 -179.228 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.507 ' HA2' ' CG2' ' A' ' 191' ' ' ILE . . . . . . . . 0 N--CA 1.448 -0.527 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.653 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.509 ' N ' HG13 ' A' ' 196' ' ' VAL . 2.8 p . . . . . 0 N--CA 1.462 0.17 0 CA-C-O 120.847 0.356 . . . . 0.0 111.056 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.648 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 1.5 mp0 -81.62 -11.66 59.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.361 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.525 ' HZ ' ' O ' ' A' ' 125' ' ' PRO . 5.3 m-85 -69.53 -51.84 31.96 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.718 0.77 . . . . 0.0 109.272 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.589 HD22 ' CE1' ' A' ' 223' ' ' PHE . 0.4 OUTLIER -67.48 -43.21 81.51 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.513 -1.222 . . . . 0.0 109.106 178.71 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.742 HG22 ' HD3' ' A' ' 27' ' ' ARG . 5.1 m -55.01 -33.52 62.69 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.55 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.657 ' HB3' ' HB1' ' A' ' 104' ' ' ALA . . . -66.92 -41.05 87.74 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.874 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.502 HD23 ' HB3' ' A' ' 132' ' ' ALA . 1.1 mt -76.17 -34.89 59.36 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.404 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.769 ' O ' ' HE1' ' A' ' 208' ' ' MET . 3.8 mp -60.37 -36.95 79.24 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.336 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' MET . . . . . 0.652 ' HE2' ' CD2' ' A' ' 31' ' ' LEU . 6.0 mtp -81.6 -43.68 18.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.558 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.729 ' HG1' ' C ' ' A' ' 104' ' ' ALA . 88.2 m -72.16 -42.48 65.86 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.988 -178.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.554 ' HB2' ' HB ' ' A' ' 187' ' ' THR . . . -59.28 -38.93 68.57 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -176.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.62 ' HA ' ' O ' ' A' ' 226' ' ' LYS . 27.0 Cg_endo -65.79 -29.67 50.42 Favored 'Trans proline' 0 CA--C 1.499 -1.236 0 CA-C-N 120.163 1.094 . . . . 0.0 111.699 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.498 ' HB2' ' CD2' ' A' ' 108' ' ' LEU . 5.6 mt -83.8 2.0 40.28 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.765 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.529 ' O ' ' HA3' ' A' ' 227' ' ' GLY . . . -84.7 138.29 38.05 Favored Pre-proline 0 C--O 1.224 -0.285 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.201 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.662 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 12.1 Cg_endo -51.47 -31.19 38.01 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.444 2.096 . . . . 0.0 113.028 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.45 140.89 48.87 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.522 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -57.07 147.77 23.51 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.197 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.554 ' HB ' ' HB2' ' A' ' 180' ' ' ALA . 78.8 m -122.99 147.29 46.8 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 36.0 t -126.24 117.9 49.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.749 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 2.6 mp -103.83 117.35 49.19 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.954 0 C-N-CA 120.029 -0.669 . . . . 0.0 109.368 178.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.604 ' CG ' ' HG3' ' A' ' 222' ' ' GLN . 1.3 ttt85 -99.85 124.68 45.41 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.579 ' HB ' ' HA ' ' A' ' 221' ' ' GLN . 1.5 mp -94.08 123.48 46.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.976 -176.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -76.21 96.33 3.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.835 -1.529 . . . . 0.0 110.47 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 97.75 -126.72 8.98 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.972 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.59 132.72 56.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.845 0.355 . . . . 0.0 111.633 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.442 HD11 HG13 ' A' ' 201' ' ' ILE . 0.9 OUTLIER -42.07 144.42 0.46 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.044 179.267 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.509 HG13 ' N ' ' A' ' 170' ' ' SER . 12.5 p -73.87 -26.52 21.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.165 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' SER . . . . . 0.462 ' CB ' ' HB3' ' A' ' 170' ' ' SER . 0.3 OUTLIER -168.51 65.05 0.07 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.176 0.513 . . . . 0.0 109.741 -179.663 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.471 ' N ' ' CD ' ' A' ' 199' ' ' PRO . 0.0 OUTLIER -42.93 -46.02 12.55 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.096 -179.812 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 198' ' ' LYS . 79.8 Cg_exo -48.27 -34.83 25.65 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.903 1.735 . . . . 0.0 111.638 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.496 ' HA ' ' CD1' ' A' ' 203' ' ' ILE . 0.3 OUTLIER -67.91 -42.45 81.12 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.401 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.442 HG13 HD11 ' A' ' 195' ' ' LEU . 20.0 mm -60.12 -39.49 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.026 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -57.15 -47.2 81.76 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.224 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.746 ' HB ' HH12 ' A' ' 27' ' ' ARG . 4.9 mt -60.55 -50.38 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 CA-C-O 121.486 0.66 . . . . 0.0 109.457 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.484 ' O ' ' HG3' ' A' ' 208' ' ' MET . 89.7 m -52.83 -52.01 58.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.756 -177.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.632 ' O ' ' HE2' ' A' ' 209' ' ' LYS . 45.2 mt -65.02 -31.36 72.55 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 120.985 0.422 . . . . 0.0 111.415 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -76.86 -44.89 30.35 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.751 0.786 . . . . 0.0 109.743 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.527 HD22 ' HB2' ' A' ' 27' ' ' ARG . 8.0 tp -71.8 -29.6 64.63 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.301 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' MET . . . . . 0.769 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 41.7 mtp -75.99 -35.42 59.6 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.652 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 3.5 mtmt -61.54 -38.66 88.25 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 114.438 -1.255 . . . . 0.0 111.001 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.474 HG23 ' N ' ' A' ' 211' ' ' PHE . 6.1 t -61.54 -31.64 71.67 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.388 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.573 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 40.6 m-85 -78.74 -5.26 52.74 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.83 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.29 5.62 28.22 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 115.891 1.116 . . . . 0.0 115.891 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.3 m -123.53 148.69 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 118.878 1.339 . . . . 0.0 112.78 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.467 ' HG2' ' HD3' ' A' ' 209' ' ' LYS . 20.4 mt-10 -129.18 140.14 51.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.893 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.604 HG22 ' HB ' ' A' ' 225' ' ' VAL . 16.3 mm -122.76 148.3 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 120.699 0.285 . . . . 0.0 110.314 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.704 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 38.8 tt0 -101.21 115.09 29.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.656 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -81.51 150.78 28.08 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.302 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . 0.456 ' HB2' ' HB3' ' A' ' 222' ' ' GLN . 5.5 tp60 -108.3 -136.7 0.36 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.759 -0.2 . . . . 0.0 111.321 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.408 ' CD2' ' HG3' ' A' ' 218' ' ' GLN . 77.3 m-70 -84.6 69.53 10.63 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 120.832 0.349 . . . . 0.0 110.307 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.424 ' CE1' ' HG3' ' A' ' 198' ' ' LYS . 4.0 t80 54.16 31.28 13.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 122.11 0.957 . . . . 0.0 109.967 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.596 ' O ' ' CD1' ' A' ' 223' ' ' PHE . 0.0 OUTLIER -160.69 -128.32 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 113.632 -1.622 . . . . 0.0 106.838 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.708 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -4.53 129.24 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -179.446 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.596 ' CD1' ' O ' ' A' ' 221' ' ' GLN . 0.7 OUTLIER -124.44 128.33 48.85 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.104 -1.862 . . . . 0.0 109.091 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.704 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 46.2 t -111.24 114.06 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 121.544 0.688 . . . . 0.0 109.393 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.604 ' HB ' HG22 ' A' ' 215' ' ' ILE . 0.4 OUTLIER -124.35 119.91 57.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.181 -178.651 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 181' ' ' PRO . 4.0 pttt -74.17 143.41 45.25 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.529 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -92.93 -173.15 40.82 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.678 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 62.72 21.13 62.64 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 121.49 -0.386 . . . . 0.0 113.253 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' GLN . . . . . 0.417 ' HB2' ' HB2' ' A' ' 181' ' ' PRO . 17.9 mt-30 -80.68 -172.94 3.88 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.272 0.558 . . . . 0.0 111.361 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 2.3 t -158.18 147.95 19.86 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.625 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' TYR . . . . . 0.692 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 7.8 m-85 -99.04 136.02 39.61 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.149 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -123.09 148.02 46.11 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.485 ' HB2' ' OG1' ' A' ' 39' ' ' THR . 19.5 p -72.47 110.93 9.2 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.575 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.447 ' HD2' ' OG1' ' A' ' 39' ' ' THR . 55.7 Cg_endo -69.95 1.1 4.87 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.195 1.93 . . . . 0.0 112.141 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 100.28 -99.61 2.05 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 93.0 m -120.03 136.82 54.42 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 41' ' ' LEU . 10.9 t80 -132.96 128.07 35.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.974 0.416 . . . . 0.0 111.707 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.505 HD21 HG21 ' A' ' 42' ' ' THR . 0.2 OUTLIER -92.97 111.87 23.64 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.587 179.526 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.427 ' N ' HD21 ' A' ' 238' ' ' LEU . 21.7 t -85.87 111.68 21.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.143 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . 0.503 ' HG3' HD11 ' A' ' 238' ' ' LEU . 1.6 mt-10 . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.15 -0.928 . . . . 0.0 111.083 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.705 ' HA ' ' HE3' ' A' ' 178' ' ' MET . 78.6 mtm-85 . . . . . 0 N--CA 1.452 -0.339 0 CA-C-O 120.982 0.42 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.671 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -43.21 -45.16 5.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.139 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.566 ' CD1' ' HG ' ' A' ' 54' ' ' LEU . 9.8 mt -75.54 -33.42 60.68 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.043 0.449 . . . . 0.0 111.154 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.578 HD22 ' CB ' ' A' ' 101' ' ' PRO . 66.1 tp -69.55 -50.11 48.04 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.115 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.769 HD21 ' CE2' ' A' ' 231' ' ' TYR . 21.4 mt -68.61 -26.8 65.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.94 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.559 ' HB2' HD11 ' A' ' 75' ' ' ILE . . . -65.22 -39.35 92.63 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.645 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.726 ' HB2' HG23 ' A' ' 62' ' ' VAL . . . -81.35 -41.32 22.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.071 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.682 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 14.2 mt -67.32 -3.4 7.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.0 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.678 ' HB1' ' HB3' ' A' ' 231' ' ' TYR . . . -98.51 177.89 5.19 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -177.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.528 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.7 OUTLIER -110.87 112.29 24.02 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.787 178.281 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 114.83 167.11 15.46 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.819 ' HE3' HD11 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -94.89 117.83 30.79 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 117.144 0.472 . . . . 0.0 111.55 -179.097 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.633 ' HG1' ' HD2' ' A' ' 234' ' ' PRO . 0.8 OUTLIER -119.61 146.84 45.17 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.94 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.577 HG21 ' CG ' ' A' ' 74' ' ' GLU . 91.8 t -103.55 142.14 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 CA-C-O 121.77 0.795 . . . . 0.0 112.653 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.671 ' HG ' ' HB1' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -117.25 116.3 26.99 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 174.437 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.564 HG23 HD22 ' A' ' 238' ' ' LEU . 0.6 OUTLIER -105.06 152.41 22.79 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.437 -177.32 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.483 ' HB2' HD21 ' A' ' 238' ' ' LEU . 52.2 t30 66.57 26.67 9.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.098 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.722 HD23 HG21 ' A' ' 239' ' ' VAL . 65.1 mt -55.05 -170.82 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.529 ' HB3' HG21 ' A' ' 50' ' ' VAL . 48.9 tp -114.15 131.71 56.34 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.816 0.341 . . . . 0.0 110.245 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -88.98 87.06 7.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.097 0.475 . . . . 0.0 110.738 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.48 ' HB3' ' OD1' ' A' ' 49' ' ' ASP . 27.8 t -164.14 142.61 7.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.06 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.424 ' OD2' ' HB2' ' A' ' 94' ' ' ASN . 33.9 p-10 -36.71 -29.14 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.524 ' HB2' ' HA ' ' A' ' 95' ' ' ALA . 37.6 p-10 -60.58 -42.48 96.77 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.187 0.518 . . . . 0.0 110.365 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.529 HG21 ' HB3' ' A' ' 45' ' ' LEU . 99.3 t -82.13 -46.02 19.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.701 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.67 ' HA ' ' CD1' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -49.28 -39.34 30.45 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.465 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.665 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 11.3 m-70 -78.86 -32.33 45.96 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.197 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.51 ' HE2' HD11 ' A' ' 57' ' ' LEU . 8.0 tpt -54.2 -37.43 64.53 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 176.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.67 ' CD1' ' HA ' ' A' ' 51' ' ' ARG . 0.3 OUTLIER -80.58 -43.94 19.79 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.666 176.105 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.751 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 2.0 t30 -58.41 -36.41 73.54 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.01 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.606 ' HB3' HD13 ' A' ' 102' ' ' LEU . . . -63.52 -44.61 93.78 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 122.034 0.921 . . . . 0.0 108.88 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.854 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -64.95 -40.97 95.82 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.558 -1.655 . . . . 0.0 107.011 177.164 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.751 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.2 m -60.19 -31.69 70.38 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 113.757 -1.565 . . . . 0.0 111.233 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.612 ' HB3' HD21 ' A' ' 88' ' ' LEU . . . -79.55 -37.53 36.26 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.024 -179.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.577 HD11 ' HB2' ' A' ' 82' ' ' LEU . 0.5 OUTLIER -81.73 -14.45 56.5 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.375 0.607 . . . . 0.0 110.765 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.87 33.32 5.04 Favored Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.292 -0.867 . . . . 0.0 114.47 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.854 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 21.6 t -90.44 118.71 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.828 ' O ' HG12 ' A' ' 76' ' ' ILE . 7.5 t -84.03 136.02 34.2 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 120.944 0.402 . . . . 0.0 110.799 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.623 ' HB3' ' CG2' ' A' ' 75' ' ' ILE . 35.3 p90 -160.71 170.39 20.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.542 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.406 HG23 ' N ' ' A' ' 66' ' ' LEU . 83.5 m -133.65 147.89 51.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.491 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.47 HD13 ' HB2' ' A' ' 73' ' ' CYS . 10.5 tp -116.56 136.22 53.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.182 0.515 . . . . 0.0 110.956 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.542 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 1.6 m -61.43 -167.44 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.912 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.42 -31.76 18.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.811 0.339 . . . . 0.0 110.926 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.425 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 0.2 OUTLIER -76.64 1.26 17.44 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.266 179.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 56.86 27.84 13.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.752 0.31 . . . . 0.0 111.515 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -127.25 -11.26 5.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.293 179.716 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.542 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 2.1 mtt85 -111.06 121.42 45.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.325 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.574 ' HB3' HD13 ' A' ' 44' ' ' LEU . 40.4 t -130.8 125.14 32.94 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 112.386 0.514 . . . . 0.0 112.386 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.577 ' CG ' HG21 ' A' ' 40' ' ' VAL . 29.7 tt0 -107.72 131.3 54.57 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 176.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.657 HG22 ' O ' ' A' ' 63' ' ' SER . 7.8 mt -127.57 123.22 60.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.828 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -68.53 100.93 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 121.682 0.753 . . . . 0.0 109.16 176.027 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -38.88 144.79 0.23 Allowed Glycine 0 C--N 1.32 -0.351 0 CA-C-N 114.415 -1.266 . . . . 0.0 114.16 -178.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.443 ' CB ' ' CD1' ' A' ' 82' ' ' LEU . 33.6 t30 -90.45 -11.2 41.06 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 120.962 0.41 . . . . 0.0 110.612 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.528 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 86.56 9.18 75.86 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.435 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.595 ' O ' HD21 ' A' ' 34' ' ' LEU . . . 146.51 -151.12 23.42 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.888 -0.673 . . . . 0.0 111.976 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.531 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 9.3 Cg_endo -50.75 128.67 24.87 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.511 2.141 . . . . 0.0 111.805 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.577 ' HB2' HD11 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -77.68 115.04 17.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.304 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.442 ' HA ' ' CG ' ' A' ' 111' ' ' ASN . 4.5 p80 -83.22 134.83 34.94 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.127 0.489 . . . . 0.0 112.022 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.808 ' HB3' HD12 ' A' ' 113' ' ' ILE . . . -96.48 123.57 40.18 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.863 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -71.71 123.65 23.04 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 176.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.93 178.17 1.01 Allowed Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 -175.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 112' ' ' ASP . . . -73.41 144.87 46.19 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 118.601 1.2 . . . . 0.0 111.342 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.731 ' CB ' HG13 ' A' ' 113' ' ' ILE . 0.9 OUTLIER -112.94 161.08 17.41 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.064 -178.491 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 4.1 mt-10 -143.0 102.8 4.07 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.108 177.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.596 ' O ' HD23 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -98.29 122.08 41.01 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.779 -178.696 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -96.07 96.58 8.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.694 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.596 HD23 ' O ' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -114.29 57.93 0.69 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.193 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.766 ' HA3' ' H ' ' A' ' 118' ' ' GLU . . . -59.64 -48.42 86.12 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.145 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.424 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 0.7 OUTLIER -94.87 -2.18 51.23 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.642 0.258 . . . . 0.0 110.687 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.553 ' CB ' ' HB3' ' A' ' 92' ' ' LEU . . . -92.63 45.53 1.2 Allowed 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.803 0.335 . . . . 0.0 110.989 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.637 ' O ' ' HD3' ' A' ' 100' ' ' ARG . . . -53.14 -23.26 16.2 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.352 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.514 ' HA ' ' HG2' ' A' ' 171' ' ' GLN . 15.9 p -88.7 -19.02 26.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.414 0.149 . . . . 0.0 111.037 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.588 ' C ' ' HD2' ' A' ' 101' ' ' PRO . . . -98.12 -26.83 14.45 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.603 ' SD ' ' HB3' ' A' ' 115' ' ' LEU . 9.8 tpp -63.92 -44.03 94.13 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.712 0.291 . . . . 0.0 111.016 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.748 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 1.1 mpt_? -60.72 -55.74 41.9 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.748 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 23.7 Cg_exo -61.16 -32.14 90.77 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 121.633 1.555 . . . . 0.0 111.411 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.606 HD13 ' HB3' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -74.62 -53.31 9.59 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.804 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.699 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -51.58 -28.57 14.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.523 0.678 . . . . 0.0 110.236 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.739 ' HB1' ' HB2' ' A' ' 175' ' ' ALA . . . -86.76 -53.85 4.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.807 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.439 ' HB2' HD13 ' A' ' 34' ' ' LEU . . . -59.82 -28.06 67.14 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -176.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.57 ' HB2' ' CD1' ' A' ' 153' ' ' LEU . 35.2 mt -81.62 -28.16 33.82 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.139 -177.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.59 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 12.4 p -72.95 12.26 0.55 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.189 0.519 . . . . 0.0 111.085 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.608 ' HG ' HG21 ' A' ' 179' ' ' THR . 1.4 mt -79.81 -76.6 0.21 Allowed 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.083 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.488 ' O ' ' HA3' ' A' ' 155' ' ' GLY . . . -71.78 -117.54 0.05 OUTLIER Glycine 0 N--CA 1.454 -0.146 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.884 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -150.9 96.85 2.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.964 0.411 . . . . 0.0 110.884 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.68 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 18.6 m-80 -149.06 139.37 22.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.273 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.87 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 1.9 m-20 -94.34 96.32 9.46 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.046 0.45 . . . . 0.0 110.126 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.808 HD12 ' HB3' ' A' ' 84' ' ' ALA . 1.4 mp -118.99 144.21 27.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.48 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.784 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 47.8 t -110.05 112.95 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.603 ' HB3' ' SD ' ' A' ' 99' ' ' MET . 59.7 mt -101.98 106.67 17.62 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.02 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.671 HG22 ' HG3' ' A' ' 150' ' ' PRO . 0.7 OUTLIER -122.66 -172.15 2.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.165 -178.709 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.624 ' HA3' ' HA2' ' A' ' 93' ' ' GLY . . . -167.07 179.05 41.01 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.832 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.767 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 8.4 pt-20 -71.16 173.51 4.87 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 123.277 0.631 . . . . 0.0 110.549 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.767 ' HD2' ' HB2' ' A' ' 118' ' ' GLU . 7.6 Cg_endo -47.47 -36.61 24.28 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.699 2.266 . . . . 0.0 113.606 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.472 ' CG ' ' HG3' ' A' ' 118' ' ' GLU . 0.4 OUTLIER -67.37 -25.06 65.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.905 0.383 . . . . 0.0 110.443 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.641 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 8.1 tpt -60.55 -35.53 76.26 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.611 ' HE3' ' HG2' ' A' ' 149' ' ' PRO . 0.1 OUTLIER -62.51 -16.84 57.88 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.995 179.266 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.651 ' O ' ' HG3' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -85.06 -1.85 57.31 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.186 0.517 . . . . 0.0 109.645 178.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.614 ' HB3' HH22 ' A' ' 100' ' ' ARG . 1.3 mpt_? -126.12 86.35 58.08 Favored Pre-proline 0 CA--C 1.531 0.25 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.746 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.549 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 17.9 Cg_endo -58.7 148.71 81.32 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.677 2.251 . . . . 0.0 111.696 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.577 HG12 HD13 ' A' ' 151' ' ' LEU . 0.7 OUTLIER -123.01 -0.13 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.194 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.622 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -53.98 -34.7 52.47 Favored Glycine 0 CA--C 1.516 0.12 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.513 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.484 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 57.4 m80 -58.5 -40.01 81.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.163 0.506 . . . . 0.0 110.851 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.741 ' HG ' HD13 ' A' ' 133' ' ' LEU . 34.0 tp -75.33 -39.28 59.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.202 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.725 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 54.8 t -56.91 -47.78 82.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.555 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.749 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 77.7 m-20 -71.23 -38.5 71.96 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.472 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.732 ' HB3' HD22 ' A' ' 176' ' ' LEU . . . -60.15 -44.66 94.81 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.534 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.741 HD13 ' HG ' ' A' ' 129' ' ' LEU . 5.7 mt -75.73 -50.27 15.79 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 121.086 0.47 . . . . 0.0 110.66 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.725 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -57.81 -28.3 63.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.055 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.749 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 5.5 tp -67.63 -30.97 70.68 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-O 121.004 0.431 . . . . 0.0 110.312 178.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 159' ' ' GLY . . . -81.4 12.75 37.64 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.892 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.16 3.74 63.33 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.459 -0.876 . . . . 0.0 112.429 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.59 ' HB2' ' HB2' ' A' ' 107' ' ' CYS . . . -73.88 153.87 39.67 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.837 0.351 . . . . 0.0 111.654 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 9.4 mttp -100.85 104.58 15.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.643 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.6 ' HB ' ' HG3' ' A' ' 134' ' ' ARG . 30.3 mt -136.27 125.23 37.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.954 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.858 HG21 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -124.15 139.99 53.4 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.005 0.431 . . . . 0.0 110.554 -179.483 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.489 ' CE1' HG21 ' A' ' 130' ' ' VAL . 43.7 m-85 -79.6 132.07 36.17 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.358 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.62 ' HB2' ' CB ' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -96.46 -88.5 0.28 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.795 -179.578 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.707 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 36.0 mt-10 -57.38 -80.98 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.546 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.544 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 15.0 mt-30 -117.77 148.95 41.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.991 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.64 135.22 56.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.951 0.405 . . . . 0.0 110.154 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.622 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 5.6 m-20 65.93 20.05 11.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.293 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.607 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 14.5 m-85 -111.72 169.25 6.53 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 121.202 0.525 . . . . 0.0 111.838 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.91 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 21.8 Cg_exo -31.19 -65.36 0.09 OUTLIER 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 124.385 3.39 . . . . 0.0 116.271 -178.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.91 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 72.3 Cg_exo -50.84 145.95 22.53 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 121.186 1.257 . . . . 0.0 113.305 -178.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.784 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 7.3 mt -156.49 136.64 12.82 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.422 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.858 ' HB2' HG21 ' A' ' 141' ' ' THR . 4.3 mtt180 -106.81 102.25 11.63 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.87 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 9.8 mt -92.53 145.53 24.37 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.909 -178.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.68 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 6.8 mt-30 -148.33 24.98 1.0 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.455 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 55.19 -166.99 2.79 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.53 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 112.6 -14.44 24.84 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.16 -1.019 . . . . 0.0 113.387 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.596 ' HE2' ' HA ' ' A' ' 133' ' ' LEU . 4.3 t80 -58.69 122.6 13.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.434 0.617 . . . . 0.0 110.395 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' THR . . . . . 0.684 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 82.0 p -115.86 -26.75 7.25 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 121.375 0.607 . . . . 0.0 111.39 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.45 ' O ' ' HA2' ' A' ' 136' ' ' GLY . . . 132.66 -159.62 23.51 Favored Glycine 0 N--CA 1.438 -1.189 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.346 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 104.77 151.99 21.49 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.729 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -46.29 116.36 1.25 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.01 -0.595 . . . . 0.0 110.66 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.722 ' HB ' HG13 ' A' ' 189' ' ' ILE . 79.2 t -108.81 137.94 38.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.693 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.41 119.67 39.49 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.629 -0.429 . . . . 0.0 110.796 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.636 ' O ' ' HA ' ' A' ' 191' ' ' ILE . 1.7 t -130.25 119.96 47.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.408 ' HA ' ' CG ' ' A' ' 192' ' ' LYS . 4.1 t70 -59.56 141.71 54.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.942 0.401 . . . . 0.0 110.797 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.479 ' HA2' HG22 ' A' ' 191' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.373 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.219 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.117 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.741 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 0.1 OUTLIER -88.17 -14.72 37.94 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.399 -178.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.615 ' CD2' ' HB2' ' A' ' 129' ' ' LEU . 8.4 m-85 -72.54 -49.8 30.14 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.472 0.653 . . . . 0.0 109.545 178.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.675 HD21 HD13 ' A' ' 177' ' ' LEU . 0.5 OUTLIER -70.46 -43.7 69.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.39 178.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.679 HG23 ' HD3' ' A' ' 27' ' ' ARG . 1.5 m -56.79 -34.58 67.79 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.458 178.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.739 ' HB2' ' HB1' ' A' ' 104' ' ' ALA . . . -63.98 -39.78 94.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.493 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.732 HD22 ' HB3' ' A' ' 132' ' ' ALA . 0.0 OUTLIER -77.01 -33.82 57.48 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.496 179.4 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.819 ' O ' ' HE3' ' A' ' 208' ' ' MET . 3.0 mp -59.56 -37.96 79.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.384 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' MET . . . . . 0.717 ' HE2' HD23 ' A' ' 31' ' ' LEU . 1.9 mtp -82.02 -43.12 18.38 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.47 0.652 . . . . 0.0 112.498 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.676 ' HG1' ' C ' ' A' ' 104' ' ' ALA . 100.0 m -72.94 -43.25 62.56 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.792 -1.094 . . . . 0.0 113.077 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.63 ' HB3' ' HB ' ' A' ' 187' ' ' THR . . . -59.33 -38.98 68.87 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -177.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.586 ' HD3' HG23 ' A' ' 225' ' ' VAL . 33.6 Cg_endo -66.29 -28.34 47.42 Favored 'Trans proline' 0 CA--C 1.501 -1.129 0 C-N-CA 120.904 1.069 . . . . 0.0 111.37 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.486 HD11 HD11 ' A' ' 34' ' ' LEU . 7.3 mt -84.72 1.82 44.78 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.913 -1.039 . . . . 0.0 109.206 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.508 ' O ' ' HA3' ' A' ' 227' ' ' GLY . . . -83.15 135.2 44.86 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.03 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.684 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 10.8 Cg_endo -49.23 -32.12 24.17 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.54 2.16 . . . . 0.0 113.015 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -115.03 140.16 49.28 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.586 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -55.61 145.65 22.85 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.301 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.63 ' HB ' ' HB3' ' A' ' 180' ' ' ALA . 86.3 m -122.39 144.0 49.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.231 0.539 . . . . 0.0 112.335 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.706 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 50.3 t -125.11 118.18 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 176.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.81 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 4.9 mp -101.56 117.47 46.9 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.93 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.569 ' HB2' ' HG3' ' A' ' 222' ' ' GLN . 0.2 OUTLIER -100.43 124.19 45.61 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.103 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.64 ' CG1' HD13 ' A' ' 173' ' ' LEU . 1.6 mp -93.52 123.33 45.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.96 -176.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.408 ' CG ' ' HA ' ' A' ' 165' ' ' ASP . 38.0 mttt -80.08 97.23 6.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.002 -1.454 . . . . 0.0 110.47 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 98.39 -133.92 11.51 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.171 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.07 125.73 52.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.225 0.536 . . . . 0.0 111.719 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.839 HD11 HG13 ' A' ' 201' ' ' ILE . 1.9 mt -41.84 145.66 0.31 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.55 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 8.0 p -70.57 -29.12 37.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.725 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' SER . . . . . 0.469 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 28.6 t -168.16 65.49 0.07 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.98 0.419 . . . . 0.0 110.737 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.665 ' N ' ' HD2' ' A' ' 199' ' ' PRO . 2.5 tmpt? -37.26 -47.46 2.07 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.806 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . 0.665 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 4.8 Cg_endo -47.31 -34.06 17.78 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.376 2.051 . . . . 0.0 111.434 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.64 ' HA ' ' CD1' ' A' ' 203' ' ' ILE . 0.2 OUTLIER -67.11 -43.49 82.34 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.685 0.755 . . . . 0.0 109.065 178.072 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.839 HG13 HD11 ' A' ' 195' ' ' LEU . 27.8 mm -64.44 -32.46 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.921 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.74 -41.94 95.56 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.796 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.64 ' CD1' ' HA ' ' A' ' 200' ' ' TYR . 4.4 mt -61.47 -50.14 81.57 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 CA-C-O 121.701 0.762 . . . . 0.0 109.41 178.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.516 HG22 ' CG2' ' A' ' 174' ' ' THR . 100.0 m -53.71 -52.32 60.45 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.119 -178.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.75 ' O ' ' HE2' ' A' ' 209' ' ' LYS . 44.6 mt -65.99 -30.79 71.4 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.109 0.481 . . . . 0.0 111.56 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -77.2 -46.71 22.4 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.772 0.796 . . . . 0.0 109.715 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.803 ' O ' HG23 ' A' ' 210' ' ' THR . 3.3 tp -70.34 -29.55 66.28 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.242 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' MET . . . . . 0.819 ' HE3' ' O ' ' A' ' 177' ' ' LEU . 49.8 mtp -73.85 -34.14 64.39 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.591 0.71 . . . . 0.0 109.194 177.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.75 ' HE2' ' O ' ' A' ' 205' ' ' LEU . 5.1 mtmm -61.59 -40.17 93.82 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.236 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.803 HG23 ' O ' ' A' ' 207' ' ' LEU . 4.7 t -60.52 -28.35 68.33 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.069 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.687 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 49.5 m-85 -80.25 -7.67 59.11 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.519 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.7 7.64 25.47 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 115.503 0.961 . . . . 0.0 115.503 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.676 HG13 ' CE1' ' A' ' 231' ' ' TYR . 5.3 m -123.42 148.83 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 118.775 1.287 . . . . 0.0 112.811 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.553 ' HG2' ' CG ' ' A' ' 209' ' ' LYS . 4.7 mt-10 -130.22 138.19 50.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.818 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.584 HG21 ' HB ' ' A' ' 225' ' ' VAL . 22.1 mm -122.41 147.74 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-O 120.836 0.35 . . . . 0.0 110.236 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.69 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 20.5 tt0 -103.63 115.86 31.29 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.774 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.51 149.44 27.54 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.588 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . 0.723 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -108.07 -144.86 0.39 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.594 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 8.1 m-70 -72.66 65.3 0.68 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.917 0.389 . . . . 0.0 111.523 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 1.7 t80 56.52 32.73 21.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.838 0.827 . . . . 0.0 110.609 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.649 ' O ' ' CD1' ' A' ' 223' ' ' PHE . 9.1 pt20 -159.78 -126.22 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.81 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.4 OUTLIER -10.11 134.98 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 115.024 1.491 . . . . 0.0 115.024 -179.671 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.706 ' O ' ' HA ' ' A' ' 188' ' ' VAL . 0.9 OUTLIER -126.31 138.24 53.57 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 113.032 -1.894 . . . . 0.0 110.139 -179.518 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.69 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 36.9 t -118.24 114.19 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.586 HG23 ' HD3' ' A' ' 181' ' ' PRO . 0.5 OUTLIER -122.4 120.39 60.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.806 -178.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.591 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -74.65 122.74 23.66 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.517 179.232 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -74.39 -173.39 29.78 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.251 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 62.23 19.65 59.78 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 121.401 -0.428 . . . . 0.0 113.158 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' GLN . . . . . 0.591 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 47.1 mt-30 -75.52 -171.96 1.67 Allowed 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.347 0.594 . . . . 0.0 111.006 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 23.3 t -155.55 147.45 23.32 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.133 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' TYR . . . . . 0.769 ' CE2' HD21 ' A' ' 31' ' ' LEU . 2.2 m-30 -102.01 134.97 44.38 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.7 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . 0.412 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 2.6 mt-30 -126.21 145.55 50.34 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.429 ' HB2' ' OG1' ' A' ' 39' ' ' THR . 25.0 p -72.39 109.42 5.88 Favored Pre-proline 0 N--CA 1.445 -0.685 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.7 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.633 ' HD2' ' HG1' ' A' ' 39' ' ' THR . 43.5 Cg_endo -66.75 0.1 3.98 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.865 1.71 . . . . 0.0 112.185 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 101.38 -102.55 2.41 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.498 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 90.0 m -117.3 132.86 56.52 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . 0.582 ' CD2' HG21 ' A' ' 210' ' ' THR . 6.5 t80 -132.64 127.42 34.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.129 0.49 . . . . 0.0 111.696 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.569 HD12 ' HG2' ' A' ' 240' ' ' GLU . 0.2 OUTLIER -90.16 113.0 24.69 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.396 179.391 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.722 HG21 HD23 ' A' ' 44' ' ' LEU . 21.2 t -85.78 111.38 20.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.622 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . 0.569 ' HG2' HD12 ' A' ' 238' ' ' LEU . 32.5 mt-10 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.235 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.819 ' HB2' HD22 ' A' ' 207' ' ' LEU . 16.4 mtm-85 . . . . . 0 N--CA 1.455 -0.203 0 CA-C-O 120.823 0.344 . . . . 0.0 110.989 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.652 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -35.55 -47.97 0.48 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.643 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.578 HD22 HD12 ' A' ' 75' ' ' ILE . 9.8 mt -73.48 -34.44 65.33 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.872 0.368 . . . . 0.0 111.433 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.636 HD21 ' HB2' ' A' ' 101' ' ' PRO . 54.3 tp -68.46 -50.1 54.98 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.732 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.626 ' HB2' ' CE2' ' A' ' 211' ' ' PHE . 49.0 mt -68.23 -26.71 65.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.583 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.63 -38.27 88.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.552 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.633 ' CB ' ' HG ' ' A' ' 57' ' ' LEU . . . -81.26 -41.53 22.05 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.996 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.764 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 9.9 mt -68.93 -2.91 10.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.279 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.561 ' HA ' ' CB ' ' A' ' 231' ' ' TYR . . . -100.13 179.26 4.54 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -176.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.557 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.3 OUTLIER -112.59 113.83 26.17 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.012 178.615 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 113.11 166.85 16.68 Favored Glycine 0 C--N 1.322 -0.243 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.321 -178.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 1.1 ttmt -95.37 117.68 30.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 117.155 0.478 . . . . 0.0 111.59 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.56 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 0.8 OUTLIER -117.73 148.59 41.87 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.387 179.59 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.462 HG21 ' HB2' ' A' ' 74' ' ' GLU . 92.4 t -105.47 141.27 21.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.144 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.652 ' HG ' ' HB1' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -114.8 116.27 28.34 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 174.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.586 HG21 ' CD2' ' A' ' 238' ' ' LEU . 0.5 OUTLIER -102.84 151.67 22.16 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.869 0.366 . . . . 0.0 111.437 -177.48 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.44 ' HB2' HD23 ' A' ' 238' ' ' LEU . 5.3 t-20 64.97 28.29 12.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.844 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.531 HD21 HG23 ' A' ' 239' ' ' VAL . 91.4 mt -53.55 -174.26 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.195 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.46 ' HB3' HG22 ' A' ' 50' ' ' VAL . 56.6 tp -113.19 131.42 55.88 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -88.89 88.76 7.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.98 0.419 . . . . 0.0 110.323 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 50' ' ' VAL . 6.2 m -164.76 143.15 6.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.116 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -36.34 -30.95 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 O-C-N 123.046 0.216 . . . . 0.0 111.575 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.691 ' CB ' ' HA ' ' A' ' 95' ' ' ALA . 1.4 p30 -57.78 -42.57 84.39 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-O 121.103 0.478 . . . . 0.0 110.617 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.519 HG13 HD13 ' A' ' 54' ' ' LEU . 74.6 t -83.91 -44.44 18.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.115 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.582 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -50.21 -39.18 43.44 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.606 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 9.6 m-70 -80.39 -32.43 37.58 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.771 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.624 ' O ' HD12 ' A' ' 57' ' ' LEU . 8.4 tpt -54.79 -34.64 62.92 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 176.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.59 ' HB3' ' CE2' ' A' ' 64' ' ' TYR . 0.4 OUTLIER -83.49 -44.06 15.12 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.902 176.34 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.72 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 1.7 t30 -59.23 -37.8 78.43 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.816 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 52' ' ' HIS . . . -62.15 -47.78 83.03 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.844 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.2 OUTLIER -61.42 -40.95 96.32 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.161 -1.382 . . . . 0.0 107.556 177.001 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.72 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.1 m -59.31 -33.93 71.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.056 -1.429 . . . . 0.0 111.417 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.587 ' C ' HD22 ' A' ' 88' ' ' LEU . . . -78.34 -38.39 42.19 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.318 -178.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.509 HD11 ' HB2' ' A' ' 82' ' ' LEU . 0.6 OUTLIER -79.49 -14.37 58.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.42 0.629 . . . . 0.0 110.531 -179.626 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.77 35.78 4.48 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 114.938 -1.028 . . . . 0.0 113.854 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.844 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 25.0 t -90.41 121.29 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.767 ' O ' HG12 ' A' ' 76' ' ' ILE . 6.8 t -86.06 135.67 33.53 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.143 0.497 . . . . 0.0 111.148 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.59 ' CE2' ' HB3' ' A' ' 54' ' ' LEU . 36.0 p90 -161.99 172.29 16.22 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.324 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.9 m -134.66 147.32 50.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.321 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.469 HD11 ' HB2' ' A' ' 73' ' ' CYS . 5.5 tp -117.79 138.28 52.17 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.163 0.506 . . . . 0.0 110.852 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.494 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 1.1 m -63.88 -164.51 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.94 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -93.18 -34.04 13.76 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.438 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.52 1.06 15.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.661 0.267 . . . . 0.0 111.276 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 57.6 39.86 27.25 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.943 0.402 . . . . 0.0 111.059 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.47 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 1.1 p -139.18 -10.52 1.27 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.441 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.494 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 7.6 mtt180 -114.16 117.67 31.85 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.469 ' HB2' HD11 ' A' ' 66' ' ' LEU . 13.9 t -130.08 128.91 42.86 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.56 ' HA ' ' O ' ' A' ' 39' ' ' THR . 29.0 tt0 -112.11 128.95 56.36 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 176.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.58 ' HA ' ' CB ' ' A' ' 64' ' ' TYR . 16.2 mt -124.22 123.35 66.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -178.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.767 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -68.73 97.92 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-O 121.427 0.632 . . . . 0.0 109.664 175.833 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -37.82 144.25 0.19 Allowed Glycine 0 C--N 1.322 -0.237 0 CA-C-N 114.804 -1.089 . . . . 0.0 113.974 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -90.17 -10.87 42.89 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.957 0.408 . . . . 0.0 110.91 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.557 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 93.36 -1.35 69.49 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.921 -0.582 . . . . 0.0 112.6 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.578 ' O ' HD22 ' A' ' 34' ' ' LEU . . . 154.69 -145.96 13.58 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.172 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.564 ' HG3' ' HB3' ' A' ' 108' ' ' LEU . 53.7 Cg_exo -49.8 124.84 13.12 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.74 2.293 . . . . 0.0 112.718 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.513 HD21 ' CD2' ' A' ' 34' ' ' LEU . 0.9 OUTLIER -77.25 106.38 8.94 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.637 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -81.92 138.77 34.94 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.519 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.729 ' HB1' HD11 ' A' ' 113' ' ' ILE . . . -100.38 126.96 46.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.955 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.77 123.69 22.53 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 176.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.62 174.2 0.76 Allowed Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 -175.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.84 144.69 47.37 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 118.588 1.194 . . . . 0.0 111.556 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.686 HD21 ' HB2' ' A' ' 84' ' ' ALA . 1.2 tp -116.43 160.43 20.57 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.224 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 2.3 mt-10 -138.77 102.99 4.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.078 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.528 ' HB2' HD22 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -98.77 120.85 39.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.152 -178.716 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.447 ' CE1' ' HB ' ' A' ' 116' ' ' THR . 0.2 OUTLIER -94.1 96.67 9.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.572 179.217 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.578 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -104.35 56.7 0.71 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.952 -179.822 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.603 ' CA ' ' H ' ' A' ' 118' ' ' GLU . . . -62.92 -70.01 1.16 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.017 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.438 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 3.3 m-80 -76.04 18.47 0.27 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.356 -0.238 . . . . 0.0 110.356 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.691 ' HA ' ' CB ' ' A' ' 49' ' ' ASP . . . -93.59 -70.62 0.69 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.38 -66.82 0.25 Allowed Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.093 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.476 ' HA ' ' HG2' ' A' ' 171' ' ' GLN . 8.4 p -71.88 -8.15 52.66 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.432 ' O ' ' HG2' ' A' ' 101' ' ' PRO . . . -99.65 -34.46 10.2 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.577 0.227 . . . . 0.0 111.468 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.7 -45.58 89.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.755 0.312 . . . . 0.0 110.193 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.671 ' CB ' ' HB3' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -52.73 -60.88 5.55 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.142 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.636 ' HB2' HD21 ' A' ' 30' ' ' LEU . 19.5 Cg_endo -60.13 -30.61 91.78 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.342 2.028 . . . . 0.0 112.646 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.507 HD22 ' HA ' ' A' ' 102' ' ' LEU . 0.8 OUTLIER -75.91 -53.31 8.61 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.159 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.528 ' O ' HD12 ' A' ' 153' ' ' LEU . . . -49.45 -27.98 4.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.227 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.627 ' CB ' HD21 ' A' ' 133' ' ' LEU . . . -87.1 -54.1 4.5 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.787 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.445 ' HB2' HD13 ' A' ' 34' ' ' LEU . . . -60.6 -31.19 70.37 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -177.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.517 HD13 HG13 ' A' ' 113' ' ' ILE . 30.3 mt -79.27 -21.61 45.85 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.509 -177.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.758 ' HB3' ' HB2' ' A' ' 138' ' ' ALA . 89.8 m -82.18 17.94 1.52 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.198 0.523 . . . . 0.0 111.186 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.63 HD11 HD11 ' A' ' 182' ' ' LEU . 2.8 mt -81.23 -77.0 0.22 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.275 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.14 -109.0 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.392 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 m -156.79 96.69 1.64 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.08 0.467 . . . . 0.0 111.108 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.517 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 37.8 p-10 -147.0 139.19 24.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.174 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.882 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 2.5 m-20 -90.87 101.0 13.76 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.771 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.729 HD11 ' HB1' ' A' ' 84' ' ' ALA . 28.7 mm -120.81 137.59 54.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.574 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.796 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 58.0 t -110.22 112.29 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 175.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.528 HD22 ' HB2' ' A' ' 90' ' ' LEU . 24.9 mt -102.27 107.09 18.01 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.608 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.447 ' HB ' ' CE1' ' A' ' 91' ' ' PHE . 0.7 OUTLIER -117.38 -173.91 2.51 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.087 -179.085 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.489 ' HA3' ' HG2' ' A' ' 121' ' ' MET . . . -163.14 -174.54 33.16 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.921 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.603 ' H ' ' CA ' ' A' ' 93' ' ' GLY . 15.1 mt-10 -76.77 172.7 8.95 Favored Pre-proline 0 C--N 1.328 -0.352 0 C-N-CA 122.853 0.461 . . . . 0.0 110.582 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.558 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 87.4 Cg_exo -47.52 -38.6 28.2 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.448 2.099 . . . . 0.0 112.488 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.416 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 38.8 mtm180 -69.25 -23.19 63.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.962 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.704 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 11.0 tpt -60.69 -31.86 71.11 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -16.88 63.27 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.768 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 120' ' ' ARG . 3.4 mm-40 -82.56 -0.54 47.3 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.775 0.321 . . . . 0.0 110.534 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.416 ' O ' ' NH2' ' A' ' 100' ' ' ARG . 3.5 mtp85 -127.44 87.1 57.03 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.892 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.459 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 18.4 Cg_endo -59.51 148.81 85.5 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.519 2.146 . . . . 0.0 111.399 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.577 HG12 HD13 ' A' ' 151' ' ' LEU . 0.6 OUTLIER -120.48 6.08 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.908 0.385 . . . . 0.0 111.947 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.618 ' HA3' ' OD1' ' A' ' 147' ' ' ASN . . . -55.55 -44.14 85.74 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.94 -0.648 . . . . 0.0 114.179 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.464 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 60.0 m-70 -55.63 -36.26 66.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 117.442 0.621 . . . . 0.0 110.06 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.67 HD12 ' HA ' ' A' ' 172' ' ' PHE . 21.5 tp -75.85 -43.27 46.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.143 0.497 . . . . 0.0 110.162 178.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.788 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 40.5 t -56.4 -47.78 80.94 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.385 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.714 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 0.1 OUTLIER -70.95 -36.23 72.49 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.405 -179.702 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.556 ' HB2' HD22 ' A' ' 176' ' ' LEU . . . -61.65 -50.27 73.21 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.803 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.633 HD22 HD21 ' A' ' 176' ' ' LEU . 9.7 mt -70.74 -48.0 56.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.933 178.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.788 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -59.22 -27.38 65.69 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.72 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.714 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.5 OUTLIER -68.47 -31.72 71.22 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.966 0.412 . . . . 0.0 110.759 178.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.56 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -83.84 14.71 41.24 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.894 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.69 3.87 62.3 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.589 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.758 ' HB2' ' HB3' ' A' ' 107' ' ' CYS . . . -71.9 150.45 44.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.884 0.373 . . . . 0.0 111.298 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 0.5 OUTLIER -98.88 102.97 14.87 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.122 178.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.531 ' HB ' ' HG3' ' A' ' 134' ' ' ARG . 8.8 mt -134.77 126.93 48.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.264 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.625 HG21 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -124.35 139.44 53.9 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.204 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -79.03 130.04 35.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.121 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.69 ' HB2' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -91.72 -89.04 0.18 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.542 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.628 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 6.3 mm-40 -59.67 -81.19 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.529 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' A' ' 148' ' ' TYR . 18.5 mt-30 -113.91 151.49 32.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.128 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -67.25 137.52 56.21 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.618 ' OD1' ' HA3' ' A' ' 127' ' ' GLY . 7.9 m-80 65.55 19.13 11.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.138 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.509 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 8.2 m-85 -110.14 168.88 7.0 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-O 121.105 0.479 . . . . 0.0 112.167 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.913 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 37.8 Cg_exo -32.49 -62.27 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 124.409 3.406 . . . . 0.0 116.087 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.913 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 66.6 Cg_exo -54.86 145.26 62.71 Favored 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-N 120.515 1.219 . . . . 0.0 112.747 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.796 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 12.3 mt -156.17 133.97 11.1 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.602 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.625 ' HB2' HG21 ' A' ' 141' ' ' THR . 3.2 mtt180 -105.74 102.68 12.11 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 176.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.882 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 10.0 mt -91.73 147.97 22.59 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.941 -178.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.573 ' HG3' ' O ' ' A' ' 153' ' ' LEU . 3.5 mt-30 -148.73 27.48 0.89 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.352 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 51.73 -175.61 0.12 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.162 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 121.46 -11.81 9.65 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.182 -1.009 . . . . 0.0 112.817 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.802 ' HE2' ' HA ' ' A' ' 180' ' ' ALA . 50.8 t80 -59.78 123.14 16.05 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.006 0.403 . . . . 0.0 110.832 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' THR . . . . . 0.693 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 81.4 p -118.38 -28.43 5.75 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.301 0.572 . . . . 0.0 111.682 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.471 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 134.35 -161.73 24.47 Favored Glycine 0 C--N 1.308 -1.02 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.503 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 105.21 153.3 21.68 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.351 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -47.09 119.39 2.54 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.292 -0.454 . . . . 0.0 111.077 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.667 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 78.7 t -111.28 134.96 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.48 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.44 119.65 39.46 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.269 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 191' ' ' ILE . 1.0 OUTLIER -131.14 120.13 46.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.05 0.453 . . . . 0.0 110.424 179.453 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -52.18 137.43 28.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.466 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.438 ' HA2' ' CG2' ' A' ' 191' ' ' ILE . . . . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.962 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.715 ' HB3' ' HB3' ' A' ' 197' ' ' SER . 53.3 p . . . . . 0 CA--C 1.521 -0.137 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.671 ' HB3' ' CB ' ' A' ' 100' ' ' ARG . 1.2 mp0 -86.53 -10.15 54.66 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.28 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.67 ' HA ' HD12 ' A' ' 129' ' ' LEU . 3.6 m-85 -75.02 -53.0 9.68 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.556 HD21 HD12 ' A' ' 177' ' ' LEU . 0.9 OUTLIER -65.9 -39.97 91.09 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.112 178.409 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.499 ' HB ' ' HA ' ' A' ' 171' ' ' GLN . 1.8 m -60.15 -32.24 70.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.354 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.589 ' HB3' ' HB1' ' A' ' 104' ' ' ALA . . . -66.81 -41.48 87.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.44 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.633 HD21 HD22 ' A' ' 133' ' ' LEU . 0.2 OUTLIER -76.31 -35.42 58.83 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.794 -179.809 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.822 ' O ' ' HE3' ' A' ' 208' ' ' MET . 4.1 mp -59.59 -36.82 77.01 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.514 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' MET . . . . . 0.595 ' HE1' ' HB3' ' A' ' 27' ' ' ARG . 2.6 mtp -81.88 -45.35 15.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.559 0.695 . . . . 0.0 112.219 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.513 HG22 ' HG ' ' A' ' 108' ' ' LEU . 93.0 m -70.9 -42.04 70.5 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.739 -1.119 . . . . 0.0 112.596 -178.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.802 ' HA ' ' HE2' ' A' ' 157' ' ' PHE . . . -59.86 -41.62 86.43 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.562 ' HD3' ' O ' ' A' ' 177' ' ' LEU . 17.9 Cg_endo -63.88 -30.07 67.65 Favored 'Trans proline' 0 CA--C 1.502 -1.122 0 C-N-CA 120.822 1.015 . . . . 0.0 111.321 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.63 HD11 HD11 ' A' ' 108' ' ' LEU . 10.8 mt -84.5 2.9 38.91 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.701 178.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.526 ' O ' ' HA3' ' A' ' 227' ' ' GLY . . . -84.74 135.94 39.78 Favored Pre-proline 0 N--CA 1.454 -0.237 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.693 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 14.2 Cg_endo -52.51 -29.7 41.33 Favored 'Trans proline' 0 CA--C 1.518 -0.316 0 C-N-CA 122.523 2.149 . . . . 0.0 112.95 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.5 138.37 50.69 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.587 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -55.94 142.9 33.91 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.353 -0.385 . . . . 0.0 109.99 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.576 ' O ' HG12 ' A' ' 225' ' ' VAL . 88.8 m -120.89 147.45 45.4 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.871 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.674 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 55.1 t -128.26 117.84 46.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 176.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.785 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 5.2 mp -99.82 117.7 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.906 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.578 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -100.63 123.63 45.1 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.569 ' HB ' ' HA ' ' A' ' 221' ' ' GLN . 1.5 mp -93.77 121.16 44.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.454 -176.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -79.08 96.95 5.95 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.824 -1.534 . . . . 0.0 110.648 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 100.24 -132.73 11.04 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.958 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -114.09 127.52 55.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.051 0.453 . . . . 0.0 111.267 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.667 HD11 ' HD2' ' A' ' 198' ' ' LYS . 1.1 mt -42.33 145.22 0.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.917 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 12.9 p -71.61 -29.92 36.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.346 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' SER . . . . . 0.715 ' HB3' ' HB3' ' A' ' 170' ' ' SER . 5.9 t -164.92 62.15 0.13 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.84 0.352 . . . . 0.0 111.174 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.667 ' HD2' HD11 ' A' ' 195' ' ' LEU . 13.5 tptp -36.45 -49.08 1.8 Allowed Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.571 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 6.3 Cg_endo -48.0 -34.69 23.56 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.097 1.864 . . . . 0.0 112.178 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.643 ' HA ' ' CD1' ' A' ' 203' ' ' ILE . 0.2 OUTLIER -68.34 -44.82 74.46 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.492 HG13 HD13 ' A' ' 195' ' ' LEU . 19.2 mm -59.84 -35.68 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.194 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.6 -41.53 97.58 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.014 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.643 ' CD1' ' HA ' ' A' ' 200' ' ' TYR . 4.1 mt -63.98 -49.27 82.38 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.915 0 CA-C-O 121.711 0.767 . . . . 0.0 109.233 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.517 ' O ' ' HG3' ' A' ' 208' ' ' MET . 88.5 m -53.6 -51.19 63.82 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.933 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.631 ' O ' ' HE2' ' A' ' 209' ' ' LYS . 33.4 mt -65.24 -32.7 74.5 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 120.541 -0.464 . . . . 0.0 111.465 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -76.89 -46.04 25.9 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.717 0.77 . . . . 0.0 109.414 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.819 HD22 ' HB2' ' A' ' 27' ' ' ARG . 4.4 tp -67.41 -33.28 74.84 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.595 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' MET . . . . . 0.822 ' HE3' ' O ' ' A' ' 177' ' ' LEU . 42.9 mtp -74.99 -33.89 61.91 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.62 0.724 . . . . 0.0 109.232 177.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.631 ' HE2' ' O ' ' A' ' 205' ' ' LEU . 4.5 mtmt -61.35 -39.05 89.16 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.667 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.452 ' O ' ' HB3' ' A' ' 234' ' ' PRO . 5.8 t -61.93 -27.21 68.66 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.422 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.626 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 57.0 m-85 -84.07 -6.74 59.46 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.627 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.97 6.87 25.87 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 116.282 1.273 . . . . 0.0 116.282 177.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.6 m -123.17 148.41 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 118.973 1.387 . . . . 0.0 112.198 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.483 ' HG2' ' HD3' ' A' ' 209' ' ' LYS . 10.9 mt-10 -130.06 141.69 50.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.972 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.551 ' HB ' ' CD2' ' A' ' 205' ' ' LEU . 21.1 mm -123.7 148.33 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-O 120.851 0.358 . . . . 0.0 110.502 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.632 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 1.5 tt0 -102.87 118.52 37.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.918 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . 0.456 ' ND2' ' HE2' ' A' ' 198' ' ' LYS . 1.5 t30 -83.01 150.8 26.13 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.601 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . 0.657 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 9.8 mm-40 -109.48 -142.44 0.38 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 121.203 -0.199 . . . . 0.0 110.615 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.56 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 0.3 OUTLIER -75.02 65.91 1.52 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.88 0.371 . . . . 0.0 111.632 -179.023 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 4.0 t80 55.56 37.53 29.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.929 0.871 . . . . 0.0 110.598 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.603 ' O ' ' CD1' ' A' ' 223' ' ' PHE . 12.6 pt20 -167.1 -125.29 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.785 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -9.0 133.62 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 179.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.674 ' O ' ' HA ' ' A' ' 188' ' ' VAL . 0.6 OUTLIER -124.84 138.55 54.26 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 112.975 -1.921 . . . . 0.0 109.853 -179.082 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.632 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 27.0 t -119.47 113.9 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-O 121.319 0.58 . . . . 0.0 109.506 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.585 HG11 ' CB ' ' A' ' 180' ' ' ALA . 0.5 OUTLIER -120.94 121.12 64.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.034 -179.197 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.538 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 2.7 mptp? -75.63 118.99 19.06 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -69.1 -174.58 10.37 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.046 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 62.36 21.31 62.03 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 121.226 -0.511 . . . . 0.0 113.076 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 8.1 mm100 -68.11 -166.2 0.06 Allowed 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.434 0.635 . . . . 0.0 111.157 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 75.0 m -158.02 147.28 19.57 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.602 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' TYR . . . . . 0.764 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 3.8 m-30 -111.09 127.97 55.73 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.59 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.97 150.78 41.56 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.473 ' CA ' ' HG1' ' A' ' 39' ' ' THR . 60.4 p -76.33 110.91 12.66 Favored Pre-proline 0 N--CA 1.442 -0.835 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.822 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.452 ' HB3' ' O ' ' A' ' 210' ' ' THR . 36.5 Cg_endo -65.94 -2.75 7.14 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.044 1.829 . . . . 0.0 112.29 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 99.81 -103.13 2.63 Favored Glycine 0 C--O 1.225 -0.442 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 73.0 m -115.46 133.93 55.57 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . 0.427 ' O ' ' HA ' ' A' ' 41' ' ' LEU . 8.3 t80 -132.62 126.95 33.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.959 0.409 . . . . 0.0 111.405 -178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.586 ' CD2' HG21 ' A' ' 42' ' ' THR . 0.3 OUTLIER -90.82 110.53 21.74 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.597 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.531 HG23 HD21 ' A' ' 44' ' ' LEU . 21.8 t -83.63 113.0 21.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.094 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . 0.408 ' HG2' HD12 ' A' ' 238' ' ' LEU . 11.3 mt-10 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.253 -0.879 . . . . 0.0 111.245 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.644 ' HB3' ' HE2' ' A' ' 178' ' ' MET . 78.1 mtm180 . . . . . 0 N--CA 1.454 -0.225 0 CA-C-O 120.91 0.386 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.602 ' CB ' ' HG ' ' A' ' 41' ' ' LEU . . . -43.12 -48.54 6.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.737 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.609 HD23 HD12 ' A' ' 75' ' ' ILE . 11.3 mt -72.09 -32.42 67.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.898 0.38 . . . . 0.0 111.371 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.606 HD23 ' HB2' ' A' ' 101' ' ' PRO . 53.2 tp -68.66 -50.18 53.17 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.355 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.734 HD13 ' HG2' ' A' ' 208' ' ' MET . 33.4 mt -68.16 -26.43 65.75 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.77 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.538 ' HA ' ' HE1' ' A' ' 211' ' ' PHE . . . -65.84 -39.52 90.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.302 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.575 ' CB ' ' HG ' ' A' ' 57' ' ' LEU . . . -81.44 -41.24 22.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.269 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.622 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 13.3 mt -67.72 -4.57 12.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.245 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.545 ' HA ' ' CB ' ' A' ' 231' ' ' TYR . . . -94.58 177.51 5.9 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.63 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.1 OUTLIER -117.48 114.89 24.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.623 178.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.626 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 128.51 -142.84 13.91 Favored Glycine 0 C--O 1.224 -0.508 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.025 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.439 ' HG3' HG21 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -136.66 117.47 14.1 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.186 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 235' ' ' GLY . 0.8 OUTLIER -128.68 145.79 51.06 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.541 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.48 HG22 ' CB ' ' A' ' 74' ' ' GLU . 78.3 t -109.3 143.58 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 CA-C-O 121.51 0.671 . . . . 0.0 112.312 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.602 ' HG ' ' CB ' ' A' ' 28' ' ' ALA . 0.3 OUTLIER -115.84 116.3 27.77 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 174.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.479 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.5 OUTLIER -103.53 151.57 22.72 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.863 0.364 . . . . 0.0 111.277 -177.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.512 ' HB2' HD21 ' A' ' 238' ' ' LEU . 7.2 t30 65.78 26.37 11.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.044 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' A' ' 73' ' ' CYS . 84.6 mt -54.6 -172.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.832 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.5 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 61.9 tp -112.94 131.59 55.68 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.384 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -89.39 86.96 6.92 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.965 0.412 . . . . 0.0 110.153 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 49' ' ' ASP . 4.0 m -165.09 143.37 6.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.462 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 47' ' ' SER . 34.6 m-20 -34.71 -31.64 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.714 0.292 . . . . 0.0 111.721 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.535 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 2.0 p30 -57.91 -42.2 84.26 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.066 0.46 . . . . 0.0 110.848 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.5 ' CG2' ' HB3' ' A' ' 45' ' ' LEU . 92.9 t -84.47 -45.1 17.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.655 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -48.34 -39.67 22.79 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.636 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.625 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 23.2 m-70 -80.15 -32.17 38.9 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.021 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.62 ' O ' HD13 ' A' ' 57' ' ' LEU . 9.4 tpt -55.55 -35.31 65.58 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.67 ' HB3' ' CE2' ' A' ' 64' ' ' TYR . 0.4 OUTLIER -81.93 -44.2 17.08 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.102 -1.408 . . . . 0.0 108.694 176.149 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.751 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 4.7 t-20 -58.8 -35.59 73.09 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.742 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' A' ' 52' ' ' HIS . . . -63.04 -46.8 85.84 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.81 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.4 OUTLIER -63.96 -39.37 93.99 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.758 -1.565 . . . . 0.0 107.752 177.276 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.751 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -59.27 -41.0 87.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.154 178.793 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.549 ' O ' HD21 ' A' ' 88' ' ' LEU . . . -71.21 -38.51 72.04 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.139 -178.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.549 HD12 ' HB2' ' A' ' 82' ' ' LEU . 0.6 OUTLIER -78.83 -16.23 57.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.241 0.543 . . . . 0.0 110.834 -179.69 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.82 35.22 4.37 Favored Glycine 0 C--N 1.319 -0.369 0 CA-C-N 115.272 -0.876 . . . . 0.0 114.372 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.81 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 39.7 t -90.56 120.5 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.805 ' O ' HG12 ' A' ' 76' ' ' ILE . 27.1 m -83.26 127.43 33.64 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.538 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.67 ' CE2' ' HB3' ' A' ' 54' ' ' LEU . 42.7 p90 -155.84 172.17 18.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.848 0.356 . . . . 0.0 110.266 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 87.0 m -133.94 148.91 51.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.221 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.0 tp -117.05 135.85 53.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.969 0.414 . . . . 0.0 110.4 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.46 ' HB3' ' CB ' ' A' ' 72' ' ' ARG . 33.8 p -61.71 -172.19 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.382 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.89 -43.53 19.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.189 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.36 0.54 11.86 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.555 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.1 mtp85 59.54 46.74 11.7 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.069 0.462 . . . . 0.0 110.956 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.506 HG21 ' O ' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -141.24 -14.91 0.87 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.973 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.558 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 8.6 mtp180 -113.94 116.74 29.73 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.587 ' HB3' HD11 ' A' ' 44' ' ' LEU . 28.9 t -124.89 123.18 39.36 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.526 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 34.3 tt0 -104.37 134.36 47.71 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 176.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.613 ' CG2' ' HB3' ' A' ' 64' ' ' TYR . 8.1 mt -131.32 122.21 50.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -177.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.805 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -67.89 98.63 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.695 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -35.68 140.81 0.18 Allowed Glycine 0 CA--C 1.518 0.219 0 CA-C-N 115.232 -0.895 . . . . 0.0 114.02 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -86.82 -11.43 50.91 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.101 0.477 . . . . 0.0 110.786 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.63 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 90.73 -1.01 77.8 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.205 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.521 ' O ' HD22 ' A' ' 34' ' ' LEU . . . 154.34 -150.02 21.52 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.5 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 87.3 Cg_exo -49.32 121.54 7.16 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.759 2.306 . . . . 0.0 112.639 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.549 ' HB2' HD12 ' A' ' 60' ' ' LEU . 0.7 OUTLIER -70.71 112.12 6.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.726 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.424 ' HA ' ' CG ' ' A' ' 111' ' ' ASN . 4.9 p80 -82.93 136.14 34.66 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.772 ' HB3' HD23 ' A' ' 88' ' ' LEU . . . -97.9 123.64 41.97 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.762 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -70.92 123.44 22.01 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 176.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.27 177.14 1.01 Allowed Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 108.692 -1.763 . . . . 0.0 108.692 -175.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.97 144.3 47.31 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 118.738 1.269 . . . . 0.0 111.085 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.772 HD23 ' HB3' ' A' ' 84' ' ' ALA . 1.0 OUTLIER -115.77 160.41 20.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.179 -178.829 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 9.9 mt-10 -139.71 103.85 4.77 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.86 178.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.669 ' HB2' HD23 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -97.19 122.73 40.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.884 0.373 . . . . 0.0 110.928 -178.531 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -95.47 96.31 9.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.817 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.578 HD23 ' O ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -107.29 46.28 0.94 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.538 -179.392 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.598 ' CA ' ' H ' ' A' ' 118' ' ' GLU . . . -56.38 -27.74 53.95 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.721 -0.672 . . . . 0.0 113.152 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.508 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 1.0 OUTLIER -106.65 -21.14 13.14 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.586 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 49' ' ' ASP . . . -86.02 57.84 4.71 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.057 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.555 ' O ' ' HD3' ' A' ' 100' ' ' ARG . . . -59.82 -38.04 93.4 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.051 -1.071 . . . . 0.0 111.146 178.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.448 HG23 ' HG3' ' A' ' 171' ' ' GLN . 0.6 OUTLIER -78.46 -15.67 58.38 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.506 0.188 . . . . 0.0 111.506 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.501 ' HA ' ' HG2' ' A' ' 101' ' ' PRO . . . -96.91 -27.33 14.71 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.716 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.659 ' SD ' ' HB3' ' A' ' 115' ' ' LEU . 4.3 tpp -62.07 -41.2 97.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.903 0.382 . . . . 0.0 110.156 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.56 ' O ' HD22 ' A' ' 129' ' ' LEU . 1.6 mpt_? -59.52 -60.11 11.65 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.606 ' HB2' HD23 ' A' ' 30' ' ' LEU . 18.6 Cg_endo -58.87 -31.11 94.72 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.057 1.838 . . . . 0.0 112.029 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.558 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -74.84 -53.34 9.28 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.055 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.623 ' HA ' HD13 ' A' ' 153' ' ' LEU . . . -50.35 -28.56 8.2 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.475 0.655 . . . . 0.0 110.503 178.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.651 ' HB3' ' HB3' ' A' ' 175' ' ' ALA . . . -87.19 -52.99 5.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.214 -0.903 . . . . 0.0 113.065 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.516 ' HA ' ' HG1' ' A' ' 179' ' ' THR . . . -60.39 -27.83 67.75 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.713 0.635 . . . . 0.0 112.713 -177.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 102' ' ' LEU . 33.6 mt -82.23 -27.08 32.7 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.585 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . 11.1 p -74.38 12.33 0.79 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.18 0.514 . . . . 0.0 111.422 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.599 ' HG ' HG21 ' A' ' 179' ' ' THR . 1.3 mt -78.14 -76.57 0.18 Allowed 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.433 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.408 ' O ' ' HA3' ' A' ' 155' ' ' GLY . . . -71.79 -115.57 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.64 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.9 p -150.88 95.49 2.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.97 0.414 . . . . 0.0 110.245 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.599 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 14.8 m120 -148.47 138.36 22.31 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.51 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.916 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 0.7 OUTLIER -90.35 100.01 12.92 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.15 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.686 HD12 ' HB2' ' A' ' 84' ' ' ALA . 24.7 mm -119.27 136.54 56.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.496 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.752 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 60.9 t -108.33 111.98 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 176.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.669 HD23 ' HB2' ' A' ' 90' ' ' LEU . 52.7 mt -102.25 107.96 19.18 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.53 -178.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.512 ' CG2' ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -124.2 -170.41 2.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.89 0.376 . . . . 0.0 111.675 -179.04 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.527 ' HA3' ' HG2' ' A' ' 121' ' ' MET . . . -168.59 -169.05 31.54 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.144 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.743 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 50.7 mt-10 -81.24 172.73 9.04 Favored Pre-proline 0 N--CA 1.455 -0.223 0 C-N-CA 123.213 0.605 . . . . 0.0 110.254 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.743 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 8.0 Cg_endo -48.1 -39.62 33.64 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.666 2.244 . . . . 0.0 112.336 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 120' ' ' ARG . 10.2 ttp180 -67.97 -23.95 65.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.702 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.602 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 9.7 tpt -61.14 -31.87 71.58 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.511 ' HZ1' ' HD3' ' A' ' 150' ' ' PRO . 12.0 mmtt -63.63 -17.14 62.59 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.559 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -79.57 0.65 29.02 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.845 0.355 . . . . 0.0 110.621 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.55 ' HB3' ' NH2' ' A' ' 100' ' ' ARG . 0.8 OUTLIER -126.98 83.03 66.96 Favored Pre-proline 0 N--CA 1.454 -0.262 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.235 179.546 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.508 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 43.6 Cg_exo -56.29 148.68 59.6 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.577 2.184 . . . . 0.0 111.618 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.606 HG12 HD11 ' A' ' 151' ' ' LEU . 1.3 tt -128.84 22.56 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.517 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -69.2 -46.4 57.93 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.183 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.66 ' CE1' ' HB2' ' A' ' 165' ' ' ASP . 1.7 m-70 -55.68 -37.58 68.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.832 0.349 . . . . 0.0 110.929 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.694 ' HG ' HD13 ' A' ' 133' ' ' LEU . 16.9 tp -70.19 -44.32 68.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.353 0.597 . . . . 0.0 109.527 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.724 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 36.2 t -56.85 -47.31 83.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.16 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.755 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 2.8 m-20 -71.04 -38.29 72.54 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 120.881 0.372 . . . . 0.0 110.704 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.608 ' O ' HG13 ' A' ' 162' ' ' VAL . . . -57.96 -46.97 84.28 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.537 0.684 . . . . 0.0 109.87 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.694 HD13 ' HG ' ' A' ' 129' ' ' LEU . 5.8 mt -76.02 -50.18 15.54 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.798 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.724 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -57.17 -27.7 62.15 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.01 179.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.755 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 5.0 tp -70.55 -30.09 66.72 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.941 0.4 . . . . 0.0 110.915 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 159' ' ' GLY . . . -84.22 14.42 44.92 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.838 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.63 4.48 60.58 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.892 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.585 ' HB3' ' HB2' ' A' ' 107' ' ' CYS . . . -75.2 155.75 36.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.985 0.421 . . . . 0.0 111.533 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 3.7 mttm -102.58 105.55 16.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.303 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.671 ' HB ' ' HG3' ' A' ' 134' ' ' ARG . 13.6 mt -138.68 127.57 30.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.542 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.753 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -126.38 139.83 52.97 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.594 -179.544 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.423 ' HE1' HG23 ' A' ' 130' ' ' VAL . 36.0 m-85 -78.07 132.37 37.7 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.382 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.685 ' HB2' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -95.16 -90.97 0.22 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.909 -179.568 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.795 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 16.0 mm-40 -59.15 -81.05 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.025 0.44 . . . . 0.0 110.692 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.48 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 31.6 mt-30 -113.09 148.86 34.38 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.788 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 4.7 mt-10 -65.5 132.54 49.17 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.428 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.517 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 2.1 m-20 67.85 17.82 9.67 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.124 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.594 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 16.8 m-85 -108.75 169.17 6.8 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.035 0.445 . . . . 0.0 111.603 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.889 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 8.2 Cg_exo -32.23 -62.73 0.14 Allowed 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 124.164 3.243 . . . . 0.0 116.656 -177.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.889 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 59.2 Cg_exo -53.05 143.89 48.51 Favored 'Trans proline' 0 C--N 1.351 0.68 0 CA-C-N 120.982 1.387 . . . . 0.0 112.892 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.752 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 10.4 mt -155.58 133.23 11.15 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.67 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.753 ' HB2' HG22 ' A' ' 141' ' ' THR . 2.8 mtt85 -103.29 100.76 10.66 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.916 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 10.0 mt -90.62 148.54 22.59 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.987 -178.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.599 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 3.6 mt-30 -149.64 23.79 0.88 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.048 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 54.52 -168.57 1.78 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.226 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 114.89 -14.57 19.45 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.243 -0.98 . . . . 0.0 113.216 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HD2' ' HB2' ' A' ' 138' ' ' ALA . 45.4 t80 -58.18 122.75 13.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 117.396 0.598 . . . . 0.0 110.742 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' THR . . . . . 0.692 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 76.6 p -114.87 -29.88 6.59 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.375 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.48 ' O ' ' HA2' ' A' ' 136' ' ' GLY . . . 133.73 -157.99 23.06 Favored Glycine 0 C--N 1.305 -1.153 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.115 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.469 ' O ' HG21 ' A' ' 162' ' ' VAL . . . 103.06 153.57 24.26 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.289 -0.958 . . . . 0.0 111.347 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -47.16 115.84 1.21 Allowed 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.296 -0.452 . . . . 0.0 111.081 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 60.9 t -107.85 140.28 26.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.64 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.96 119.79 40.1 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.057 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.6 ' O ' ' HA ' ' A' ' 191' ' ' ILE . 1.6 t -129.27 120.56 51.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.66 ' HB2' ' CE1' ' A' ' 128' ' ' HIS . 7.8 t0 -55.04 139.62 40.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.234 0.54 . . . . 0.0 112.066 -178.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.558 ' HA2' ' CG2' ' A' ' 191' ' ' ILE . . . . . . . . 0 N--CA 1.446 -0.682 0 CA-C-N 115.47 -0.787 . . . . 0.0 112.68 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.516 ' HB3' ' HB2' ' A' ' 197' ' ' SER . 46.2 p . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.597 0.237 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.585 ' HA ' ' HB ' ' A' ' 174' ' ' THR . 8.3 mm-40 -89.6 -12.09 40.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.579 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.583 ' HA ' HD12 ' A' ' 129' ' ' LEU . 3.1 m-85 -69.26 -54.36 15.08 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.577 HD13 HD23 ' A' ' 195' ' ' LEU . 1.0 OUTLIER -64.84 -46.69 80.84 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.793 178.468 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.585 ' HB ' ' HA ' ' A' ' 171' ' ' GLN . 4.1 m -54.41 -35.0 62.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.172 178.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.651 ' HB3' ' HB3' ' A' ' 104' ' ' ALA . . . -64.13 -46.77 82.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.497 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.668 HD23 ' CD1' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -76.52 -31.75 57.86 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.315 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.748 ' O ' ' HE3' ' A' ' 208' ' ' MET . 1.6 mp -58.99 -39.18 81.02 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.181 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' MET . . . . . 0.66 ' HE3' ' CD2' ' A' ' 31' ' ' LEU . 2.0 mtp -81.08 -40.71 23.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.892 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.599 HG21 ' HG ' ' A' ' 108' ' ' LEU . 66.4 m -71.28 -41.85 69.48 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.949 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.596 ' HB2' ' HB ' ' A' ' 187' ' ' THR . . . -59.63 -40.51 79.95 Favored Pre-proline 0 C--N 1.321 -0.674 0 N-CA-C 115.132 1.531 . . . . 0.0 115.132 -176.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.571 ' HD3' HG22 ' A' ' 225' ' ' VAL . 27.9 Cg_endo -64.93 -28.82 58.11 Favored 'Trans proline' 0 CA--C 1.502 -1.112 0 CA-C-N 120.081 1.064 . . . . 0.0 111.511 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.492 ' CB ' HD21 ' A' ' 108' ' ' LEU . 8.1 mt -83.58 0.81 45.07 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.485 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.537 ' O ' ' HA3' ' A' ' 227' ' ' GLY . . . -83.36 136.89 42.58 Favored Pre-proline 0 C--O 1.223 -0.304 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.287 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.692 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 11.1 Cg_endo -50.53 -32.53 35.25 Favored 'Trans proline' 0 CA--C 1.516 -0.415 0 C-N-CA 122.715 2.277 . . . . 0.0 113.363 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -114.96 141.35 48.09 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.717 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -56.1 141.88 38.74 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.124 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.596 ' HB ' ' HB2' ' A' ' 180' ' ' ALA . 91.5 m -119.97 143.41 48.04 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 50.8 t -123.69 118.15 53.37 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 176.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.789 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 2.7 mp -102.55 117.85 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.598 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -100.65 123.66 45.16 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.241 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.6 ' HA ' ' O ' ' A' ' 164' ' ' VAL . 1.6 mp -93.69 119.59 41.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.605 -1.179 . . . . 0.0 111.142 -176.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.476 ' HE2' ' N ' ' A' ' 165' ' ' ASP . 1.7 mtmt -75.26 97.06 3.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.834 -178.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 99.64 -133.06 11.16 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.693 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -112.66 131.09 55.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.855 0.36 . . . . 0.0 111.135 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.577 HD23 HD13 ' A' ' 173' ' ' LEU . 1.5 mt -41.77 144.48 0.4 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.836 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.41 ' N ' ' O ' ' A' ' 166' ' ' GLY . 14.2 p -73.75 -27.72 23.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.184 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' SER . . . . . 0.516 ' HB2' ' HB3' ' A' ' 170' ' ' SER . 0.3 OUTLIER -165.51 63.01 0.11 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.184 0.516 . . . . 0.0 110.25 -179.19 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.674 ' N ' ' HD2' ' A' ' 199' ' ' PRO . 0.0 OUTLIER -42.07 -46.63 10.44 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.5 179.7 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . 0.674 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 9.5 Cg_endo -49.31 -33.09 27.67 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 121.944 1.763 . . . . 0.0 111.39 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.575 ' HA ' ' CD1' ' A' ' 203' ' ' ILE . 0.1 OUTLIER -69.1 -43.82 73.7 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.785 0.803 . . . . 0.0 108.87 178.242 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.668 HG23 ' HE2' ' A' ' 223' ' ' PHE . 27.5 mm -62.69 -35.79 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.452 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.29 -44.13 95.65 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.695 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.575 ' CD1' ' HA ' ' A' ' 200' ' ' TYR . 4.0 mt -63.12 -49.76 82.04 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.927 0 CA-C-O 121.66 0.743 . . . . 0.0 108.996 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.481 ' O ' ' HG3' ' A' ' 208' ' ' MET . 90.8 m -53.02 -51.48 61.54 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.893 -178.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.545 ' O ' ' HE2' ' A' ' 209' ' ' LYS . 29.3 mt -66.13 -30.48 70.97 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.437 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . 0.442 ' HA ' ' HE3' ' A' ' 209' ' ' LYS . 29.8 m-20 -77.02 -46.13 24.84 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.837 0.827 . . . . 0.0 109.527 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.756 ' O ' HG23 ' A' ' 210' ' ' THR . 5.1 tp -70.55 -29.47 65.93 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.09 -1.413 . . . . 0.0 109.618 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' MET . . . . . 0.748 ' HE3' ' O ' ' A' ' 177' ' ' LEU . 52.2 mtp -77.13 -34.09 56.66 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.687 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 9.4 mtmt -62.04 -40.59 96.26 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.015 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.756 HG23 ' O ' ' A' ' 207' ' ' LEU . 5.0 t -60.5 -31.25 70.31 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.583 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.576 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 56.1 m-85 -78.61 -5.94 54.27 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.871 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.6 7.95 25.27 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.166 -1.016 . . . . 0.0 115.638 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.687 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 5.1 m -124.0 148.07 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 118.768 1.284 . . . . 0.0 112.829 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.453 ' CG ' ' HG2' ' A' ' 209' ' ' LYS . 16.2 mt-10 -130.02 137.72 50.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.126 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.675 HD12 ' HB ' ' A' ' 225' ' ' VAL . 18.0 mm -120.56 148.38 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-O 120.875 0.369 . . . . 0.0 110.557 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.643 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 2.4 tt0 -103.01 116.22 32.1 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.864 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . 0.511 ' H ' ' ND2' ' A' ' 217' ' ' ASN . 0.9 OUTLIER -82.79 151.21 26.2 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.969 179.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . 0.606 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 10.2 mm100 -109.47 -139.12 0.38 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 121.146 -0.222 . . . . 0.0 110.821 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.614 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 5.5 t-80 -78.82 66.6 4.34 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 3.7 t80 57.25 33.38 23.22 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.974 0.893 . . . . 0.0 110.234 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.614 ' HG2' ' O ' ' A' ' 219' ' ' HIS . 3.3 pt20 -163.92 -126.63 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.789 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -8.56 132.66 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.668 ' HE2' HG23 ' A' ' 201' ' ' ILE . 0.9 OUTLIER -124.76 138.69 54.27 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 112.867 -1.97 . . . . 0.0 110.181 -179.295 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.643 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 38.7 t -118.37 114.44 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.675 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.4 OUTLIER -121.78 125.66 73.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.443 -178.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.531 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -79.79 127.65 32.48 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.206 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.537 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -79.46 -173.84 45.24 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.404 -178.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 62.75 21.0 62.57 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 121.61 -0.329 . . . . 0.0 113.193 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' GLN . . . . . 0.531 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 12.5 mt-30 -76.78 -175.39 3.41 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.364 0.602 . . . . 0.0 111.557 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.22 147.81 28.84 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.654 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' TYR . . . . . 0.658 ' CE2' HD23 ' A' ' 31' ' ' LEU . 1.9 m-30 -104.47 131.71 51.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.109 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.42 144.83 48.79 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.435 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 50.1 m -69.99 110.81 7.34 Favored Pre-proline 0 N--CA 1.45 -0.453 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.259 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.492 ' HD2' ' OG1' ' A' ' 39' ' ' THR . 40.5 Cg_endo -66.44 -1.0 4.91 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.017 1.811 . . . . 0.0 112.41 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 99.45 -96.41 1.66 Allowed Glycine 0 C--O 1.226 -0.383 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.631 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 30.7 m -119.91 134.4 55.25 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . 0.57 ' HB3' HD11 ' A' ' 41' ' ' LEU . 12.8 t80 -132.97 126.76 32.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.997 0.427 . . . . 0.0 111.314 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.512 HD21 ' HB2' ' A' ' 43' ' ' ASN . 0.2 OUTLIER -93.25 112.2 24.06 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.033 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.53 HG23 HD21 ' A' ' 44' ' ' LEU . 25.0 t -86.74 111.83 22.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.789 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.211 -179.667 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.714 ' HB2' HD22 ' A' ' 207' ' ' LEU . 6.6 mtm105 . . . . . 0 CA--C 1.521 -0.171 0 CA-C-O 120.877 0.37 . . . . 0.0 111.316 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.57 ' CB ' ' HG ' ' A' ' 41' ' ' LEU . . . -35.21 -45.41 0.3 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.378 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.583 HD23 HD13 ' A' ' 75' ' ' ILE . 11.4 mt -75.65 -38.93 58.46 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.977 0.418 . . . . 0.0 111.608 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.482 HD21 ' HE3' ' A' ' 178' ' ' MET . 51.5 tp -65.22 -49.67 68.8 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.435 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.633 ' CD2' ' HE2' ' A' ' 178' ' ' MET . 45.3 mt -67.09 -26.9 66.94 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.657 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.401 ' HA ' ' HE1' ' A' ' 211' ' ' PHE . . . -66.28 -40.05 89.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.044 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.566 ' CB ' ' HG ' ' A' ' 57' ' ' LEU . . . -81.21 -41.21 22.66 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.793 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.636 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 13.3 mt -67.95 -3.69 10.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.246 178.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.555 ' HB2' ' HB3' ' A' ' 231' ' ' TYR . . . -100.22 178.34 4.8 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.543 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.1 OUTLIER -113.04 113.6 25.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.8 178.186 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.472 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 116.75 167.91 14.73 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.357 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.598 ' HG3' HG22 ' A' ' 76' ' ' ILE . 1.1 ttmt -95.45 117.95 31.3 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 117.127 0.463 . . . . 0.0 111.692 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.526 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 0.9 OUTLIER -120.19 148.12 44.06 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.321 179.753 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.462 ' O ' ' N ' ' A' ' 237' ' ' TYR . 98.8 t -107.41 141.64 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 0.3 OUTLIER -116.1 116.0 27.07 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 174.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.574 HG22 HD23 ' A' ' 238' ' ' LEU . 0.6 OUTLIER -103.92 152.83 21.51 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.93 -178.314 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.448 ' HB2' HD22 ' A' ' 238' ' ' LEU . 2.8 t-20 65.69 26.81 11.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.469 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.516 HD12 ' HB3' ' A' ' 73' ' ' CYS . 76.2 mt -54.14 -173.31 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.789 0.328 . . . . 0.0 110.127 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.8 tp -111.69 131.31 55.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.469 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -87.78 88.79 7.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.992 0.425 . . . . 0.0 110.11 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 50' ' ' VAL . 74.6 m -163.97 142.66 7.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.994 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.416 ' HA ' ' HB3' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -37.44 -29.92 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.736 0.303 . . . . 0.0 111.374 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.531 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 1.2 p30 -58.3 -42.51 86.8 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 121.043 0.449 . . . . 0.0 110.631 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.44 ' N ' ' O ' ' A' ' 47' ' ' SER . 93.0 t -84.12 -44.55 18.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.672 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.76 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -49.32 -39.72 32.4 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.447 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.569 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 22.6 m-70 -81.04 -32.67 33.97 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.081 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.512 ' O ' HD12 ' A' ' 57' ' ' LEU . 7.5 tpt -53.69 -34.64 59.44 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 176.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.76 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.7 OUTLIER -82.52 -44.46 15.89 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 113.892 -1.503 . . . . 0.0 108.837 176.698 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.783 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 24.8 t-20 -57.97 -42.28 84.68 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-O 120.882 0.372 . . . . 0.0 110.655 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.437 ' HA ' ' HG ' ' A' ' 90' ' ' LEU . . . -57.27 -46.8 82.74 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.875 0.845 . . . . 0.0 109.012 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.758 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -64.33 -37.61 88.1 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.134 -1.394 . . . . 0.0 107.779 177.21 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.783 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -64.14 -33.13 75.07 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.179 -1.373 . . . . 0.0 111.933 179.411 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.447 ' CB ' HD23 ' A' ' 88' ' ' LEU . . . -76.21 -37.55 57.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.221 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.461 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -81.4 -12.5 58.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.289 0.566 . . . . 0.0 110.686 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.06 35.54 5.02 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.262 -0.881 . . . . 0.0 114.293 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.758 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 39.8 t -90.45 123.24 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.778 ' O ' HG12 ' A' ' 76' ' ' ILE . 7.2 m -85.32 131.44 34.41 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.0 0.428 . . . . 0.0 111.723 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.61 ' CE2' ' HB3' ' A' ' 54' ' ' LEU . 40.6 p90 -158.7 171.08 20.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.685 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 98.1 m -135.19 149.03 49.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.301 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.441 ' CD1' ' HB2' ' A' ' 73' ' ' CYS . 11.7 tp -120.25 138.69 53.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.028 0.442 . . . . 0.0 110.874 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 87.1 p -57.71 -175.31 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.339 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.1 -42.24 23.96 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.197 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -76.41 0.67 18.79 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.398 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.9 mtt-85 59.36 53.56 5.19 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.873 0.368 . . . . 0.0 111.176 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -149.19 4.16 0.61 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.76 179.657 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.596 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 9.5 ttm180 -136.97 110.78 8.14 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.516 ' HB3' HD12 ' A' ' 44' ' ' LEU . 36.9 t -121.61 134.48 55.0 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.566 ' HG2' ' CD ' ' A' ' 38' ' ' LYS . 24.6 tt0 -115.45 132.61 56.57 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.245 -0.888 . . . . 0.0 108.728 177.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.589 HG21 ' O ' ' A' ' 63' ' ' SER . 12.2 mt -127.79 123.45 61.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -177.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.778 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -67.72 100.13 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 175.178 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -39.19 144.73 0.27 Allowed Glycine 0 C--N 1.323 -0.189 0 CA-C-N 115.145 -0.934 . . . . 0.0 113.483 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -90.02 -12.41 38.69 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.947 0.404 . . . . 0.0 111.038 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.543 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 95.19 1.63 62.65 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.94 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.4 ' O ' HD21 ' A' ' 34' ' ' LEU . . . 150.88 -148.96 20.69 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.683 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.482 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 77.3 Cg_exo -49.63 123.52 10.63 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.712 2.274 . . . . 0.0 112.218 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.488 HD12 HD21 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -74.27 106.33 5.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.225 -179.5 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -83.66 132.42 34.88 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.573 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.494 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -96.86 126.81 42.28 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.065 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.19 123.93 23.32 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.31 175.3 1.15 Allowed Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 -175.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 112' ' ' ASP . . . -74.04 144.98 44.85 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 118.559 1.179 . . . . 0.0 112.215 -178.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.509 ' HB3' HG13 ' A' ' 113' ' ' ILE . 0.9 OUTLIER -115.26 161.12 18.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.649 -1.16 . . . . 0.0 112.557 -178.273 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.422 ' HG3' ' HB ' ' A' ' 114' ' ' VAL . 1.6 tt0 -140.26 112.26 7.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.758 177.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.511 ' HB2' HD21 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -108.64 117.87 35.3 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.505 -178.427 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.453 ' CE1' ' HB ' ' A' ' 116' ' ' THR . 0.1 OUTLIER -88.97 96.67 10.82 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.508 179.042 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.466 ' HB3' ' HB2' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -105.37 53.04 0.72 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.267 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.44 ' CA ' ' H ' ' A' ' 118' ' ' GLU . . . -53.13 -75.11 0.24 Allowed Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.711 -0.677 . . . . 0.0 113.022 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.486 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 3.1 m120 -75.49 -1.06 22.4 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.768 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.531 ' HB1' ' HA ' ' A' ' 49' ' ' ASP . . . -87.96 47.66 1.53 Allowed 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.363 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -56.37 -23.59 42.23 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.173 -1.013 . . . . 0.0 111.458 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.1 p -92.91 -16.69 24.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.464 0.173 . . . . 0.0 111.176 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' A' ' 101' ' ' PRO . . . -95.5 -37.17 11.01 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.437 ' HB2' ' HB2' ' A' ' 92' ' ' LEU . 2.2 tpp -59.3 -44.52 92.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.594 0.235 . . . . 0.0 110.524 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.567 ' HB3' ' O ' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -54.13 -60.22 8.03 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.284 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 100' ' ' ARG . 18.3 Cg_endo -62.0 -32.89 84.32 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.396 2.064 . . . . 0.0 112.831 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.492 HD12 HD23 ' A' ' 115' ' ' LEU . 0.1 OUTLIER -70.86 -52.84 17.78 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.052 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.539 ' HA ' HD12 ' A' ' 153' ' ' LEU . . . -51.72 -28.72 15.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.26 0.552 . . . . 0.0 110.53 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.524 ' HB2' ' HB3' ' A' ' 175' ' ' ALA . . . -86.06 -52.97 5.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.428 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.414 ' CB ' HD13 ' A' ' 30' ' ' LEU . . . -60.57 -34.27 73.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 102' ' ' LEU . 31.6 mt -78.52 -17.82 55.65 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.559 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 9.6 p -84.68 22.6 1.29 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.245 0.545 . . . . 0.0 110.598 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.48 ' CD2' ' HB2' ' A' ' 182' ' ' LEU . 0.4 OUTLIER -90.04 -73.86 0.51 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.427 -179.71 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -73.19 -116.31 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.699 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.24 94.15 2.09 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.141 0.496 . . . . 0.0 110.58 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.598 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 22.7 p30 -146.44 138.32 24.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.467 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.886 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 0.9 OUTLIER -95.21 100.65 12.42 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.656 179.122 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.509 HG13 ' HB3' ' A' ' 88' ' ' LEU . 1.1 mp -120.66 147.68 24.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.494 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.855 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 58.0 t -117.53 113.22 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 176.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.511 HD21 ' HB2' ' A' ' 90' ' ' LEU . 33.9 mt -102.12 105.41 16.11 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.296 -0.561 . . . . 0.0 111.324 -177.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.453 ' HB ' ' CE1' ' A' ' 91' ' ' PHE . 0.2 OUTLIER -118.14 -172.12 2.2 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.768 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -164.93 -167.97 26.34 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.206 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.563 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 16.9 mt-10 -78.31 171.86 11.38 Favored Pre-proline 0 C--N 1.332 -0.158 0 C-N-CA 122.661 0.384 . . . . 0.0 110.356 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.563 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 71.0 Cg_exo -49.5 -39.57 45.33 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.377 2.052 . . . . 0.0 112.77 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -68.23 -23.4 64.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.619 0.247 . . . . 0.0 110.971 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.523 ' O ' ' HG3' ' A' ' 149' ' ' PRO . 9.8 tpt -60.81 -34.45 74.55 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.455 ' HA ' ' HG2' ' A' ' 149' ' ' PRO . 0.0 OUTLIER -61.62 -16.77 51.33 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.614 179.166 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.3 3.19 32.47 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.837 0.351 . . . . 0.0 110.209 178.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -127.3 84.79 62.51 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.149 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -57.13 148.64 68.21 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.867 2.378 . . . . 0.0 112.068 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.469 ' O ' HG21 ' A' ' 130' ' ' VAL . 0.9 OUTLIER -122.53 0.93 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -179.355 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.508 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -53.36 -39.43 59.19 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.219 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 42.5 m-70 -56.01 -41.61 75.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.783 0.325 . . . . 0.0 110.381 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.49 HD11 ' HB3' ' A' ' 175' ' ' ALA . 12.6 tp -75.48 -43.98 46.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.284 0.564 . . . . 0.0 110.055 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.653 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 69.5 t -56.41 -47.36 81.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.593 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.719 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 0.7 OUTLIER -69.2 -38.95 78.88 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.696 -179.603 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.405 ' CB ' HD21 ' A' ' 176' ' ' LEU . . . -58.39 -49.13 78.34 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.596 178.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.487 HD21 ' CB ' ' A' ' 104' ' ' ALA . 7.2 mt -69.92 -50.37 42.8 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.323 178.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.722 ' HG3' ' HB ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -58.14 -27.88 64.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.798 179.56 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.719 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 1.0 OUTLIER -69.79 -30.85 68.5 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.912 178.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -83.36 14.79 38.18 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.966 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 93.69 7.97 61.15 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.593 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.523 ' HB2' ' HB2' ' A' ' 107' ' ' CYS . . . -78.21 152.03 32.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.834 0.349 . . . . 0.0 111.035 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 19.9 mtpt -100.73 103.96 15.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.126 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.722 ' HB ' ' HG3' ' A' ' 134' ' ' ARG . 34.7 mt -135.65 124.16 38.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.195 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.689 HG21 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -120.54 139.51 52.82 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.938 -179.589 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -81.04 132.43 35.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.847 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.631 ' HB2' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -92.52 -87.16 0.23 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.775 -179.217 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.684 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 2.7 mt-10 -57.38 -82.46 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.397 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.42 ' NE2' ' CE1' ' A' ' 148' ' ' TYR . 25.1 mt-30 -116.69 154.3 30.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.341 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 6.0 mt-10 -66.88 132.82 48.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.373 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.508 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 2.7 m120 71.44 17.08 5.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.442 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.542 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 14.8 m-85 -107.0 168.22 8.36 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.812 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 75.0 Cg_exo -35.96 -60.33 0.35 Allowed 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.991 3.127 . . . . 0.0 115.921 -177.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.812 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 77.8 Cg_exo -52.35 145.5 35.79 Favored 'Trans proline' 0 C--N 1.352 0.736 0 CA-C-N 120.61 1.253 . . . . 0.0 112.118 -178.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.855 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 8.4 mt -156.41 137.59 13.73 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.808 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.689 ' HB2' HG21 ' A' ' 141' ' ' THR . 7.6 mtt85 -109.24 101.6 10.61 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.886 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 7.9 mt -90.35 148.01 23.11 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.283 -177.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.598 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 5.7 mt-30 -149.87 24.81 0.85 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.365 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 56.99 -162.04 7.52 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.322 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.35 -16.13 38.39 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.365 -0.922 . . . . 0.0 113.619 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.449 ' CB ' ' O ' ' A' ' 107' ' ' CYS . 11.2 t80 -58.66 122.38 13.34 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 117.858 0.829 . . . . 0.0 110.155 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' THR . . . . . 0.694 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 56.9 p -114.76 -31.84 6.01 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 121.594 0.711 . . . . 0.0 111.171 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.422 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 137.19 -160.09 24.9 Favored Glycine 0 C--N 1.307 -1.068 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.049 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.403 ' O ' HG22 ' A' ' 162' ' ' VAL . . . 105.5 152.95 21.14 Favored Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.008 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -47.01 116.47 1.37 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.98 -0.61 . . . . 0.0 110.83 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 68.6 t -109.49 144.88 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.48 119.97 39.4 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.477 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 191' ' ' ILE . 1.0 OUTLIER -131.86 121.37 47.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.695 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.89 137.94 37.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.954 0.407 . . . . 0.0 111.191 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.495 ' CA ' HG22 ' A' ' 191' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.43 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.75 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.463 ' HB2' ' HB3' ' A' ' 200' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.116 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.567 ' O ' ' HB3' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -82.24 -11.08 58.88 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.811 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.473 ' CD1' ' HG2' ' A' ' 100' ' ' ARG . 6.4 m-85 -74.13 -54.88 6.86 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.453 HD11 ' CZ ' ' A' ' 223' ' ' PHE . 0.5 OUTLIER -65.62 -37.78 87.54 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.436 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.606 HG22 ' HD3' ' A' ' 27' ' ' ARG . 4.4 m -58.26 -34.57 70.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.063 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.524 ' HB3' ' HB2' ' A' ' 104' ' ' ALA . . . -68.28 -39.05 82.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.843 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.407 ' O ' ' CB ' ' A' ' 180' ' ' ALA . 0.3 OUTLIER -76.78 -34.26 58.0 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.275 0.559 . . . . 0.0 110.899 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.706 ' O ' ' HE3' ' A' ' 208' ' ' MET . 2.4 mp -59.68 -38.41 81.47 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.529 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' MET . . . . . 0.685 ' HE1' ' CB ' ' A' ' 27' ' ' ARG . 3.8 mtp -81.76 -43.61 18.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.389 0.614 . . . . 0.0 112.509 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.462 HG23 ' HG ' ' A' ' 108' ' ' LEU . 48.5 m -73.11 -39.88 65.42 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.684 -178.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.611 ' HB2' ' HB ' ' A' ' 187' ' ' THR . . . -59.49 -41.55 87.34 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -177.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 30.3 Cg_endo -65.59 -28.32 52.97 Favored 'Trans proline' 0 CA--C 1.501 -1.161 0 C-N-CA 121.046 1.164 . . . . 0.0 111.723 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.48 ' HB2' ' CD2' ' A' ' 108' ' ' LEU . 5.4 mt -83.15 -0.19 48.1 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.079 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . -82.19 137.29 46.0 Favored Pre-proline 0 N--CA 1.455 -0.209 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.183 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.694 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 11.7 Cg_endo -50.94 -33.18 40.94 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.685 2.257 . . . . 0.0 113.357 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -113.28 139.52 48.76 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.842 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' A' ' 186' ' ' ASP . 0.8 OUTLIER -53.68 144.59 17.44 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.15 179.227 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.611 ' HB ' ' HB2' ' A' ' 180' ' ' ALA . 94.1 m -123.83 145.88 48.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.258 0.552 . . . . 0.0 112.441 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.668 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 40.2 t -126.63 117.83 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.366 177.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.709 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 3.5 mp -101.12 118.08 47.32 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.601 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 3.6 ttt180 -100.93 124.82 47.2 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.553 ' HB ' ' HA ' ' A' ' 221' ' ' GLN . 1.5 mp -93.61 123.41 45.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.952 -175.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -83.03 96.88 8.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.11 -1.405 . . . . 0.0 110.361 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 102.06 -134.28 11.7 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.804 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -116.43 127.32 54.5 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.549 HD13 HG13 ' A' ' 201' ' ' ILE . 1.0 OUTLIER -41.37 144.72 0.31 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.486 179.447 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.415 ' N ' ' O ' ' A' ' 166' ' ' GLY . 11.1 p -72.92 -30.53 32.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.999 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' SER . . . . . 0.48 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 0.2 OUTLIER -162.09 62.43 0.23 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.024 0.44 . . . . 0.0 110.611 -179.412 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.467 ' N ' ' CD ' ' A' ' 199' ' ' PRO . 3.1 tttp -39.68 -45.92 4.31 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.175 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . 0.48 ' HD2' ' C ' ' A' ' 197' ' ' SER . 88.6 Cg_exo -47.8 -37.35 28.18 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 121.99 1.794 . . . . 0.0 111.622 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.572 ' HA ' ' CD1' ' A' ' 203' ' ' ILE . 0.3 OUTLIER -64.18 -45.79 86.83 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.549 HG13 HD13 ' A' ' 195' ' ' LEU . 12.5 mm -60.76 -37.33 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.584 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.423 ' OD2' ' HE3' ' A' ' 198' ' ' LYS . 83.8 m-20 -59.06 -46.78 87.39 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.857 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.572 ' CD1' ' HA ' ' A' ' 200' ' ' TYR . 3.1 mt -61.17 -46.26 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.977 0 CA-C-O 121.719 0.771 . . . . 0.0 108.986 178.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.499 ' O ' ' HG3' ' A' ' 208' ' ' MET . 92.5 m -54.13 -51.44 64.23 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.699 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.466 ' CD2' ' HB ' ' A' ' 215' ' ' ILE . 26.8 mt -68.53 -28.37 66.93 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 120.531 -0.467 . . . . 0.0 111.246 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . 0.478 ' HA ' ' HE3' ' A' ' 209' ' ' LYS . 15.0 t30 -77.84 -46.09 22.48 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.793 0.806 . . . . 0.0 109.577 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.714 HD22 ' HB2' ' A' ' 27' ' ' ARG . 3.1 tp -69.57 -34.46 74.21 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.188 -1.369 . . . . 0.0 109.297 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' MET . . . . . 0.706 ' HE3' ' O ' ' A' ' 177' ' ' LEU . 50.1 mtp -72.57 -33.82 67.03 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.467 0.651 . . . . 0.0 109.328 177.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.595 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 15.5 mtmt -62.57 -37.57 86.69 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.862 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.489 ' O ' ' HB3' ' A' ' 234' ' ' PRO . 5.8 t -62.86 -28.45 70.03 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.409 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.545 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 39.3 m-85 -82.82 -6.04 59.24 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.913 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.99 6.9 25.81 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 116.226 1.25 . . . . 0.0 116.226 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.2 m -123.66 148.7 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 119.101 1.451 . . . . 0.0 112.729 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.491 ' HG2' ' HD3' ' A' ' 209' ' ' LYS . 18.9 mt-10 -129.63 140.66 51.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.821 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.466 ' HB ' ' CD2' ' A' ' 205' ' ' LEU . 15.9 mm -123.29 148.31 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-O 120.871 0.367 . . . . 0.0 110.691 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.614 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 31.0 tt0 -103.45 119.19 38.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.603 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . 0.544 ' H ' ' ND2' ' A' ' 217' ' ' ASN . 0.0 OUTLIER -82.85 151.17 26.15 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.541 179.431 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . 0.721 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -112.58 -146.09 0.4 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 121.182 -0.207 . . . . 0.0 110.49 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.4 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 7.0 m80 -68.01 66.23 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 3.4 t80 52.93 34.6 17.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.887 0.851 . . . . 0.0 110.266 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.63 ' O ' ' CD1' ' A' ' 223' ' ' PHE . 0.0 OUTLIER -164.35 -124.09 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 179.652 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.721 ' O ' ' HB2' ' A' ' 218' ' ' GLN . 0.0 OUTLIER -8.36 133.59 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.668 ' O ' ' HA ' ' A' ' 188' ' ' VAL . 0.8 OUTLIER -124.75 139.26 54.01 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.269 -1.787 . . . . 0.0 109.79 -179.218 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.614 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 40.1 t -120.96 113.87 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.55 HG22 ' HD3' ' A' ' 181' ' ' PRO . 0.3 OUTLIER -122.16 126.05 73.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.531 -178.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.517 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -74.4 126.76 31.4 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.608 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -81.92 -178.97 52.71 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.268 -0.968 . . . . 0.0 113.021 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 66.01 21.25 69.57 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 121.375 -0.44 . . . . 0.0 112.872 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' GLN . . . . . 0.517 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 27.2 mt-30 -78.72 -176.04 4.71 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.213 0.53 . . . . 0.0 111.476 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.4 t -148.64 147.77 29.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.043 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' TYR . . . . . 0.636 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 7.2 m-85 -103.32 129.95 50.47 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.87 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -121.53 148.07 44.97 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.756 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.422 ' HB2' ' OG1' ' A' ' 39' ' ' THR . 10.9 p -71.52 110.99 8.68 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 120.981 -0.287 . . . . 0.0 110.516 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.489 ' HB3' ' O ' ' A' ' 210' ' ' THR . 55.7 Cg_endo -70.08 1.66 4.44 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.199 1.933 . . . . 0.0 112.213 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 98.59 -101.75 2.51 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 56.1 m -117.39 137.78 52.25 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . 0.523 ' HB3' HD13 ' A' ' 41' ' ' LEU . 10.6 t80 -134.32 125.49 27.74 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.928 0.394 . . . . 0.0 111.314 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.574 HD23 HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -94.78 110.91 22.72 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.105 0.479 . . . . 0.0 111.017 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 21.7 t -81.61 111.11 17.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.212 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . 0.415 ' HG3' HD12 ' A' ' 238' ' ' LEU . 6.3 mt-10 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.078 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.698 ' HA ' ' HE1' ' A' ' 178' ' ' MET . 1.0 OUTLIER . . . . . 0 CA--C 1.516 -0.351 0 CA-C-O 121.277 0.56 . . . . 0.0 110.69 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.641 ' CB ' ' HG ' ' A' ' 41' ' ' LEU . . . -37.23 -46.83 0.75 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.001 -0.999 . . . . 0.0 112.321 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.525 HD23 HD13 ' A' ' 75' ' ' ILE . 11.0 mt -75.51 -33.14 60.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.937 0.399 . . . . 0.0 111.256 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.458 ' HB2' ' HE2' ' A' ' 53' ' ' MET . 46.4 tp -68.6 -49.71 57.15 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.489 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.724 HD12 ' HG2' ' A' ' 208' ' ' MET . 39.5 mt -68.71 -26.99 65.55 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.451 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.447 ' HA ' ' HE1' ' A' ' 211' ' ' PHE . . . -65.29 -37.46 87.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.084 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.585 ' HB1' ' HG ' ' A' ' 57' ' ' LEU . . . -80.83 -41.12 23.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.234 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.648 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 32.4 mt -67.52 -3.78 9.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.368 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 78' ' ' ASN . . . -83.57 171.95 12.83 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -112.31 34.67 4.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.984 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -168.81 175.43 43.31 Favored Glycine 0 C--N 1.309 -0.936 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.74 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.649 ' HG3' HD11 ' A' ' 76' ' ' ILE . 10.6 ttmt -95.39 117.83 31.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.642 0.721 . . . . 0.0 111.373 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 235' ' ' GLY . 0.9 OUTLIER -123.14 148.28 45.89 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.615 -179.291 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.434 HG23 ' HG3' ' A' ' 74' ' ' GLU . 76.1 t -104.78 141.42 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 CA-C-O 121.393 0.616 . . . . 0.0 112.474 -179.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.641 ' HG ' ' CB ' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -114.51 116.2 28.45 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 175.034 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.593 HG22 HD22 ' A' ' 238' ' ' LEU . 0.5 OUTLIER -102.99 151.68 22.2 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.149 -178.364 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.48 ' HB2' HD21 ' A' ' 238' ' ' LEU . 1.8 t-20 68.15 25.64 7.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.419 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.545 HD13 ' HB3' ' A' ' 73' ' ' CYS . 70.9 mt -53.4 -175.6 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.411 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 54.1 tp -113.0 130.91 55.97 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.509 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.417 ' O ' ' CG ' ' A' ' 46' ' ' ASP . 10.1 p-10 -85.45 87.41 7.39 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.302 0.573 . . . . 0.0 110.619 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 50' ' ' VAL . 4.4 m -164.02 142.91 7.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.306 -178.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -36.27 -32.08 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.689 0.281 . . . . 0.0 111.578 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HA ' ' CB ' ' A' ' 95' ' ' ALA . 29.4 p-10 -57.74 -42.62 84.3 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.055 0.455 . . . . 0.0 110.66 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.446 ' N ' ' O ' ' A' ' 47' ' ' SER . 98.5 t -82.73 -45.78 19.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.788 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.556 ' HA ' HD13 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -48.65 -40.08 26.59 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.292 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.631 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 13.8 m-70 -78.62 -33.2 47.56 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.017 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.488 ' O ' HD12 ' A' ' 57' ' ' LEU . 7.8 tpt -54.36 -32.41 56.86 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 176.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.556 HD13 ' HA ' ' A' ' 51' ' ' ARG . 0.6 OUTLIER -84.08 -42.48 16.05 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.53 176.411 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.756 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 25.2 t-20 -60.25 -42.62 95.68 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.538 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.469 ' HB2' HD12 ' A' ' 102' ' ' LEU . . . -57.66 -47.23 82.87 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.752 0.787 . . . . 0.0 109.207 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.799 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -64.23 -39.71 94.54 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.253 -1.34 . . . . 0.0 107.775 177.147 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.756 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.1 m -61.44 -35.4 77.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.802 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.452 ' CB ' HD21 ' A' ' 88' ' ' LEU . . . -75.97 -38.04 57.91 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.267 -178.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.491 HD11 ' HB2' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -80.59 -14.01 58.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.287 0.565 . . . . 0.0 110.657 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.94 34.97 4.99 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.217 -0.901 . . . . 0.0 114.259 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.799 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 35.6 t -90.5 121.71 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.761 ' O ' HG12 ' A' ' 76' ' ' ILE . 2.7 t -85.68 135.06 33.92 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.462 -178.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.604 ' CB ' HG12 ' A' ' 75' ' ' ILE . 40.1 p90 -161.33 172.07 17.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.577 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 85.9 m -135.68 146.41 47.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.462 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.471 ' CD1' ' HB2' ' A' ' 73' ' ' CYS . 9.3 tp -117.78 136.53 53.34 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.088 0.47 . . . . 0.0 110.716 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.405 ' HB2' ' CB ' ' A' ' 72' ' ' ARG . 1.2 t -59.95 -162.7 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.133 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -95.01 -29.4 14.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.157 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.03 1.88 25.94 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.181 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 56.42 33.51 22.57 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.38 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.433 HG21 ' O ' ' A' ' 44' ' ' LEU . 1.1 p -130.95 -9.25 3.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.575 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -117.61 121.48 41.03 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.191 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.545 ' HB3' HD13 ' A' ' 44' ' ' LEU . 37.9 t -132.07 129.1 39.54 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.245 0.545 . . . . 0.0 112.041 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.527 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 64.2 tt0 -112.22 130.29 55.97 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 177.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.604 HG12 ' CB ' ' A' ' 64' ' ' TYR . 17.9 mt -126.35 122.17 60.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 -177.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.761 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -67.67 103.72 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-O 121.343 0.592 . . . . 0.0 109.508 175.78 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 35' ' ' ALA . . . -43.44 151.44 0.45 Allowed Glycine 0 C--N 1.32 -0.324 0 CA-C-N 115.219 -0.9 . . . . 0.0 113.847 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 35' ' ' ALA . 5.8 t30 -97.34 -17.25 19.86 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.795 0.331 . . . . 0.0 111.347 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.11 -0.48 56.12 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.159 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.496 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 154.8 -150.71 22.32 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.167 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.575 ' CG ' ' HB3' ' A' ' 108' ' ' LEU . 73.1 Cg_exo -50.15 125.26 14.48 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.992 2.462 . . . . 0.0 112.98 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.491 ' HB2' HD11 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -74.21 106.27 5.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.901 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -81.67 133.77 35.4 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.333 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.508 ' HB2' HD22 ' A' ' 88' ' ' LEU . . . -97.05 129.8 44.44 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.25 123.97 23.45 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 176.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.59 -178.81 2.2 Favored Glycine 0 N--CA 1.44 -1.049 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 -175.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' A' ' 112' ' ' ASP . . . -80.06 144.5 33.1 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 118.725 1.262 . . . . 0.0 112.025 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.545 ' HB3' HG13 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -114.63 161.06 18.59 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.089 -178.833 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.452 ' HG3' ' HB ' ' A' ' 114' ' ' VAL . 28.9 mp0 -139.31 105.28 5.19 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.099 178.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.593 ' HB2' HD23 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -105.11 116.92 32.76 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.886 -178.476 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.441 ' CE2' ' HB ' ' A' ' 116' ' ' THR . 7.6 m-85 -96.59 96.8 8.9 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.496 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -103.88 57.57 0.73 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.275 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.57 ' HA3' ' H ' ' A' ' 118' ' ' GLU . . . -50.35 -68.04 1.61 Allowed Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.592 -0.731 . . . . 0.0 113.499 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.502 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 83.5 m-20 -76.49 1.07 17.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.554 0.216 . . . . 0.0 111.299 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.567 ' CB ' ' HA ' ' A' ' 49' ' ' ASP . . . -99.87 54.12 0.92 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.948 0.404 . . . . 0.0 111.656 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -56.85 -25.39 52.41 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.31 -0.947 . . . . 0.0 111.339 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.404 ' O ' ' HG3' ' A' ' 101' ' ' PRO . 0.1 OUTLIER -89.05 -14.36 36.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.685 -0.257 . . . . 0.0 111.656 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.51 ' HB3' ' CB ' ' A' ' 95' ' ' ALA . . . -96.83 -32.56 12.04 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -61.73 -43.25 99.22 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.541 HH22 ' HB3' ' A' ' 124' ' ' ARG . 6.7 mpt_? -56.81 -60.5 9.24 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 100' ' ' ARG . 14.1 Cg_endo -58.57 -34.73 99.05 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.513 2.142 . . . . 0.0 112.446 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.49 HD21 ' HA ' ' A' ' 102' ' ' LEU . 0.2 OUTLIER -72.07 -52.49 16.6 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.145 179.703 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.634 ' HA ' HD12 ' A' ' 153' ' ' LEU . . . -53.13 -27.83 22.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.483 0.659 . . . . 0.0 110.311 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.543 ' CB ' HD22 ' A' ' 133' ' ' LEU . . . -86.5 -54.5 4.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.343 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.65 -34.44 74.29 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -177.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.528 ' HB2' ' CD1' ' A' ' 153' ' ' LEU . 31.2 mt -78.54 -23.06 46.41 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -176.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.544 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 13.7 p -78.42 16.1 0.87 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.161 0.505 . . . . 0.0 110.791 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.575 ' HB3' ' CG ' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -82.98 -75.81 0.3 Allowed 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.032 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -70.69 -113.77 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.134 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.57 94.44 1.9 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.206 0.527 . . . . 0.0 110.793 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.659 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 0.8 OUTLIER -145.27 139.12 26.88 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.378 -179.113 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.883 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 1.2 m-20 -97.74 98.26 9.7 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.545 HG13 ' HB3' ' A' ' 88' ' ' LEU . 1.6 mp -120.35 147.92 23.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.253 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.769 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 47.1 t -115.34 113.76 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 176.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.593 HD23 ' HB2' ' A' ' 90' ' ' LEU . 77.6 mt -101.72 106.36 17.37 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.518 -178.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.557 HG21 ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -119.04 -169.36 1.72 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.318 -179.232 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.447 ' HA3' ' HG2' ' A' ' 121' ' ' MET . . . -171.35 -179.64 42.57 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.524 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.629 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 39.0 mt-10 -70.15 169.61 12.86 Favored Pre-proline 0 C--N 1.331 -0.211 0 C-N-CA 123.207 0.603 . . . . 0.0 111.08 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.629 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 4.1 Cg_endo -45.08 -40.04 15.34 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.082 2.521 . . . . 0.0 113.077 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.3 mtm180 -67.84 -23.93 65.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.73 0.3 . . . . 0.0 110.716 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.609 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 10.5 tpt -60.96 -36.21 78.78 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.443 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 0.0 OUTLIER -61.47 -16.5 47.76 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.665 179.249 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -83.99 3.18 35.46 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.541 ' HB3' HH22 ' A' ' 100' ' ' ARG . 66.0 mtt-85 -127.62 83.26 66.55 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.352 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.462 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 38.1 Cg_exo -56.79 149.28 61.08 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.761 2.307 . . . . 0.0 111.701 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.525 HG12 HD13 ' A' ' 151' ' ' LEU . 1.0 OUTLIER -129.07 8.66 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.377 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.545 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -59.88 -39.84 96.02 Favored Glycine 0 CA--C 1.517 0.193 0 C-N-CA 120.749 -0.739 . . . . 0.0 113.764 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.583 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 26.0 m80 -55.71 -37.97 69.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.902 0.351 . . . . 0.0 110.54 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.616 ' HG ' ' CD1' ' A' ' 133' ' ' LEU . 29.3 tp -75.42 -40.46 57.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.241 0.544 . . . . 0.0 109.804 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.74 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 40.3 t -56.54 -47.98 81.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.331 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.68 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 0.1 OUTLIER -72.18 -35.94 69.13 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 121.298 0.571 . . . . 0.0 109.58 179.272 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.533 ' HA ' HG13 ' A' ' 162' ' ' VAL . . . -57.31 -47.73 80.76 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.75 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.616 ' CD1' ' HG ' ' A' ' 129' ' ' LEU . 3.5 mt -75.94 -50.32 15.27 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.06 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.74 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.1 OUTLIER -54.71 -28.32 47.13 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.107 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.68 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 8.1 tp -69.01 -31.82 70.91 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 120.958 0.408 . . . . 0.0 110.902 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.471 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -81.86 11.64 46.45 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.787 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.49 6.54 56.44 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.764 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.634 ' HB1' ' HD1' ' A' ' 157' ' ' PHE . . . -76.36 153.59 35.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.973 0.416 . . . . 0.0 111.481 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 0.4 OUTLIER -102.83 106.35 16.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.646 178.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.586 ' HB ' ' HG3' ' A' ' 134' ' ' ARG . 23.1 mt -137.91 125.88 30.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.485 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.736 HG23 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -123.56 139.48 53.96 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.519 -179.541 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.489 ' HE1' HG23 ' A' ' 130' ' ' VAL . 40.3 m-85 -79.71 131.05 35.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.469 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.653 ' HB2' ' CB ' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -91.52 -91.04 0.16 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.62 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.593 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 7.6 mm-40 -58.56 -81.68 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.676 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.491 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 0.2 OUTLIER -112.76 151.21 30.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.914 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 12.8 mt-10 -67.41 129.75 40.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.827 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.545 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 2.8 m120 71.04 17.91 6.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.068 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.616 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 16.8 m-85 -108.59 169.48 6.49 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 121.046 0.45 . . . . 0.0 111.992 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.902 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 48.9 Cg_exo -31.43 -62.67 0.12 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 124.384 3.389 . . . . 0.0 116.061 -177.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.902 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 65.3 Cg_exo -52.5 144.79 39.83 Favored 'Trans proline' 0 C--N 1.354 0.827 0 CA-C-N 120.626 1.259 . . . . 0.0 112.683 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.769 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 7.4 mt -155.9 136.85 13.59 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.023 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.736 ' HB2' HG23 ' A' ' 141' ' ' THR . 5.8 mtt180 -108.08 102.77 11.9 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.883 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 7.0 mt -90.73 145.83 24.49 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.861 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.659 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 6.5 mt-30 -149.3 26.19 0.87 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.164 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 53.78 -163.22 2.98 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.421 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 108.38 -16.27 35.06 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.005 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.694 ' HE2' ' HA ' ' A' ' 180' ' ' ALA . 67.0 t80 -58.55 122.97 14.71 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 117.081 0.44 . . . . 0.0 110.693 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' THR . . . . . 0.704 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 60.7 p -116.9 -28.84 6.18 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.495 0.664 . . . . 0.0 111.431 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 120.95 -169.47 14.27 Favored Glycine 0 C--N 1.306 -1.092 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.215 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.593 ' O ' ' HA ' ' A' ' 187' ' ' THR . . . 128.39 -126.13 5.26 Favored Glycine 0 N--CA 1.434 -1.468 0 N-CA-C 111.126 -0.789 . . . . 0.0 111.126 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.41 130.34 55.73 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.783 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 82.0 t -130.21 123.54 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 121.004 0.431 . . . . 0.0 110.687 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.17 119.99 38.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.665 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 191' ' ' ILE . 1.0 OUTLIER -130.14 120.51 49.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.953 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.666 ' HA ' ' HG3' ' A' ' 192' ' ' LYS . 0.1 OUTLIER -51.94 137.89 25.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.298 0.571 . . . . 0.0 111.649 -179.737 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.485 ' HA2' ' CG2' ' A' ' 191' ' ' ILE . . . . . . . . 0 N--CA 1.441 -0.968 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.603 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.465 ' N ' HG13 ' A' ' 196' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.462 0.127 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.527 ' HA ' ' HB ' ' A' ' 174' ' ' THR . 0.0 OUTLIER -74.37 -6.01 45.64 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.122 -179.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.583 ' CE2' ' HB2' ' A' ' 128' ' ' HIS . 5.5 m-85 -76.27 -55.96 5.08 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.574 HD21 HD13 ' A' ' 191' ' ' ILE . 0.4 OUTLIER -61.74 -40.95 96.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.606 0.717 . . . . 0.0 109.084 178.057 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.607 HG21 ' HD3' ' A' ' 27' ' ' ARG . 5.5 m -55.82 -36.49 67.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.528 -1.214 . . . . 0.0 110.01 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.435 ' CB ' ' HB2' ' A' ' 104' ' ' ALA . . . -69.17 -40.29 78.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.563 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.594 HD22 HD23 ' A' ' 133' ' ' LEU . 0.4 OUTLIER -76.64 -33.32 58.34 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.149 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.809 ' O ' ' HE2' ' A' ' 208' ' ' MET . 5.1 mp -59.76 -38.13 80.94 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.908 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' MET . . . . . 0.698 ' HE1' ' HA ' ' A' ' 27' ' ' ARG . 0.4 OUTLIER -82.07 -43.03 18.4 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.469 0.652 . . . . 0.0 112.112 -179.66 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.463 HG21 ' HG ' ' A' ' 108' ' ' LEU . 54.4 m -71.41 -41.13 69.97 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.471 -178.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.694 ' HA ' ' HE2' ' A' ' 157' ' ' PHE . . . -59.72 -42.15 89.78 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -177.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 29.8 Cg_endo -64.77 -29.04 59.45 Favored 'Trans proline' 0 CA--C 1.5 -1.205 0 C-N-CA 120.956 1.104 . . . . 0.0 111.637 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.47 ' HB2' ' CD2' ' A' ' 108' ' ' LEU . 6.9 mt -83.73 1.56 42.12 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.358 178.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . -83.59 138.53 41.12 Favored Pre-proline 0 C--O 1.224 -0.289 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.704 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 12.9 Cg_endo -51.84 -31.86 44.26 Favored 'Trans proline' 0 CA--C 1.518 -0.28 0 C-N-CA 122.45 2.1 . . . . 0.0 113.117 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -114.89 143.6 44.88 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.892 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -57.8 141.01 50.36 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.076 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 160' ' ' GLY . 70.7 m -119.01 145.85 45.51 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.663 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 35.3 t -125.63 118.94 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.438 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.783 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 4.1 mp -104.03 117.09 48.99 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.655 0 C-N-CA 120.079 -0.648 . . . . 0.0 109.276 178.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.814 ' HG3' ' HG3' ' A' ' 222' ' ' GLN . 1.7 ttt180 -99.88 123.57 44.27 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.656 ' HB ' ' CB ' ' A' ' 221' ' ' GLN . 1.3 mp -93.11 121.88 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.088 -176.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.666 ' HG3' ' HA ' ' A' ' 165' ' ' ASP . 0.5 OUTLIER -74.87 96.62 3.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.346 -178.594 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 97.36 -126.9 9.03 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.793 -0.717 . . . . 0.0 111.702 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -116.85 133.54 55.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.769 0.318 . . . . 0.0 111.321 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.527 HD11 ' HD2' ' A' ' 198' ' ' LYS . 0.8 OUTLIER -41.91 144.68 0.4 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.211 0.529 . . . . 0.0 111.902 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.469 ' HB ' ' O ' ' A' ' 166' ' ' GLY . 13.9 p -74.48 -25.38 19.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.975 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' SER . . . . . 0.459 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 0.3 OUTLIER -168.48 64.7 0.07 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.833 0.349 . . . . 0.0 110.934 -179.531 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.527 ' HD2' HD11 ' A' ' 195' ' ' LEU . 4.4 tptp -39.48 -46.23 4.13 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.382 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . 0.461 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 72.6 Cg_exo -49.61 -36.78 41.72 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.006 1.804 . . . . 0.0 111.843 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.545 ' HA ' ' CD1' ' A' ' 203' ' ' ILE . 0.2 OUTLIER -65.62 -44.53 86.2 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 178.42 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.671 HG22 ' HE2' ' A' ' 223' ' ' PHE . 30.9 mm -60.9 -38.4 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.472 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.45 -43.63 93.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.229 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.545 ' CD1' ' HA ' ' A' ' 200' ' ' TYR . 4.6 mt -62.43 -50.95 77.83 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 CA-C-O 121.569 0.7 . . . . 0.0 109.635 178.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 208' ' ' MET . 78.5 m -53.66 -51.65 62.49 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.991 -178.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.531 ' O ' ' HE2' ' A' ' 209' ' ' LYS . 32.2 mt -65.31 -30.18 71.0 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.001 0.429 . . . . 0.0 111.534 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . 0.523 ' HA ' ' HE3' ' A' ' 209' ' ' LYS . 1.0 OUTLIER -77.5 -46.37 22.65 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.734 0.778 . . . . 0.0 109.77 179.007 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.548 HD21 ' HD2' ' A' ' 27' ' ' ARG . 2.6 tp -71.26 -30.02 65.8 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.24 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' MET . . . . . 0.809 ' HE2' ' O ' ' A' ' 177' ' ' LEU . 40.8 mtp -75.04 -35.63 61.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 12.8 mtmt -60.65 -37.71 82.43 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.046 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.427 HG21 ' N ' ' A' ' 211' ' ' PHE . 5.8 t -62.61 -28.88 70.2 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.718 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.55 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 42.7 m-85 -80.52 -6.98 59.01 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.579 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.99 7.65 24.9 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 115.98 1.152 . . . . 0.0 115.98 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.2 m -123.36 148.59 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 118.929 1.364 . . . . 0.0 112.794 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.489 ' HG2' ' HD3' ' A' ' 209' ' ' LYS . 18.0 mt-10 -130.84 136.21 48.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.811 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.586 HG22 ' HB ' ' A' ' 225' ' ' VAL . 16.8 mm -118.66 148.12 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 120.845 0.355 . . . . 0.0 110.565 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.525 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 2.6 tt0 -100.63 118.26 36.42 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.916 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -82.84 150.98 26.24 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.934 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . 0.484 ' CB ' ' HB3' ' A' ' 222' ' ' GLN . 3.5 tp60 -106.74 -138.26 0.37 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.114 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.467 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 0.1 OUTLIER -84.87 66.67 9.81 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.827 0.346 . . . . 0.0 111.008 -179.451 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 5.5 t80 60.07 33.04 21.24 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.82 0.819 . . . . 0.0 110.439 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.656 ' CB ' ' HB ' ' A' ' 191' ' ' ILE . 1.8 pt20 -166.39 -124.77 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.814 ' HG3' ' HG3' ' A' ' 190' ' ' ARG . 0.7 OUTLIER -5.43 130.09 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.671 ' HE2' HG22 ' A' ' 201' ' ' ILE . 1.2 m-85 -125.07 133.37 52.93 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 112.977 -1.92 . . . . 0.0 109.509 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.525 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 61.3 t -116.96 113.51 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-O 121.573 0.702 . . . . 0.0 109.206 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.586 ' HB ' HG22 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -120.22 122.29 67.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.152 -178.776 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.554 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 0.1 OUTLIER -76.84 123.43 26.24 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.806 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -75.54 -177.11 40.71 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.718 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 65.5 21.72 69.0 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 121.573 -0.346 . . . . 0.0 113.036 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' GLN . . . . . 0.554 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 15.7 mt-30 -77.41 179.58 6.36 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.298 0.57 . . . . 0.0 111.338 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 13.6 t -138.01 147.8 44.53 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.869 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' TYR . . . . . 0.648 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 1.1 m-30 -107.83 123.76 49.07 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.894 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.96 161.3 20.02 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.553 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.12 113.34 57.95 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-O 120.835 0.35 . . . . 0.0 111.43 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.65 1.98 3.88 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.656 2.237 . . . . 0.0 112.875 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 98.99 -100.5 2.29 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.344 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 92.2 m -119.35 133.15 55.87 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -129.74 133.21 46.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.873 0.368 . . . . 0.0 111.117 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.593 HD22 HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -97.18 110.52 23.05 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.201 0.524 . . . . 0.0 110.524 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.407 HG22 HD21 ' A' ' 44' ' ' LEU . 21.9 t -79.06 113.51 18.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.421 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . 0.487 ' HG2' HD13 ' A' ' 238' ' ' LEU . 7.8 mt-10 . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.212 -0.899 . . . . 0.0 111.156 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.535 HH21 ' HB3' ' A' ' 171' ' ' GLN . 0.5 OUTLIER . . . . . 0 CA--C 1.518 -0.274 0 CA-C-O 121.345 0.593 . . . . 0.0 110.171 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.691 ' HB3' ' HG ' ' A' ' 41' ' ' LEU . . . -40.73 -44.39 2.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.958 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.472 HD12 HD21 ' A' ' 54' ' ' LEU . 14.2 mt -71.68 -37.47 70.74 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.918 0.39 . . . . 0.0 111.213 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.428 ' HB2' ' HE1' ' A' ' 53' ' ' MET . 56.9 tp -65.32 -49.95 67.48 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.917 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.544 ' HB2' ' CE2' ' A' ' 211' ' ' PHE . 20.1 mt -69.33 -26.17 64.57 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.456 ' HA ' ' CE1' ' A' ' 211' ' ' PHE . . . -63.79 -41.82 97.85 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.221 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.572 ' CB ' ' HG ' ' A' ' 57' ' ' LEU . . . -80.47 -40.17 26.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.73 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.623 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 9.1 mt -67.48 -3.4 8.43 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.451 178.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.549 ' HB1' ' HB3' ' A' ' 231' ' ' TYR . . . -99.84 177.26 5.17 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -177.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.525 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.3 OUTLIER -111.28 114.39 27.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.656 178.357 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 114.28 167.48 15.97 Favored Glycine 0 C--O 1.228 -0.28 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.202 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.515 ' CD ' ' HG2' ' A' ' 74' ' ' GLU . 0.6 OUTLIER -95.34 117.53 30.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 117.284 0.542 . . . . 0.0 111.55 -179.439 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.52 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 0.9 OUTLIER -118.8 147.03 44.34 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.242 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.531 HG23 ' HG3' ' A' ' 74' ' ' GLU . 96.6 t -105.91 141.25 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 CA-C-O 121.385 0.612 . . . . 0.0 112.437 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.691 ' HG ' ' HB3' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -116.02 116.32 27.69 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 174.733 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.565 HG23 HD21 ' A' ' 238' ' ' LEU . 0.5 OUTLIER -103.15 152.93 20.86 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.228 -177.75 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.4 t30 68.8 24.71 6.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.514 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.511 HD12 ' HB3' ' A' ' 73' ' ' CYS . 34.8 mt -53.86 -175.55 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.951 0.405 . . . . 0.0 110.151 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.533 ' HB3' HG21 ' A' ' 50' ' ' VAL . 28.3 tp -111.78 132.28 54.77 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.163 -0.472 . . . . 0.0 109.995 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -88.52 89.26 7.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.835 0.35 . . . . 0.0 110.896 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 50' ' ' VAL . 36.5 m -163.79 142.17 7.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.057 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.562 ' HA ' ' HB3' ' A' ' 51' ' ' ARG . 1.6 p30 -37.89 -31.25 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.662 0.268 . . . . 0.0 111.429 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.432 ' HA ' ' CB ' ' A' ' 95' ' ' ALA . 0.7 OUTLIER -57.29 -42.72 82.25 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.024 0.44 . . . . 0.0 110.435 179.308 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.533 HG21 ' HB3' ' A' ' 45' ' ' LEU . 98.0 t -81.66 -45.08 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.562 ' HB3' ' HA ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -49.62 -39.13 34.64 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 177.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.614 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 14.7 m-70 -78.64 -33.25 47.38 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.908 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.565 ' O ' HD13 ' A' ' 57' ' ' LEU . 9.4 tpt -55.5 -35.58 65.74 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 176.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.548 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -81.88 -44.43 16.85 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 114.162 -1.381 . . . . 0.0 108.522 176.598 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.803 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 0.3 OUTLIER -57.31 -38.59 74.27 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.354 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 52' ' ' HIS . . . -60.54 -44.79 95.73 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.779 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.2 OUTLIER -65.59 -38.83 90.6 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.1 -1.409 . . . . 0.0 107.752 176.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.803 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.2 m -63.02 -33.76 76.11 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.528 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 55' ' ' ASN . . . -74.22 -37.13 63.93 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.341 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.497 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -83.54 -13.92 53.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.171 0.51 . . . . 0.0 111.058 -179.464 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.07 35.01 4.65 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.42 -0.809 . . . . 0.0 114.123 178.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.779 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 38.2 t -90.69 122.13 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.742 ' O ' HG12 ' A' ' 76' ' ' ILE . 5.5 m -84.88 132.54 34.38 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 120.911 0.386 . . . . 0.0 111.711 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.586 ' CB ' HG12 ' A' ' 75' ' ' ILE . 41.4 p90 -158.03 167.93 28.51 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.378 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 74' ' ' GLU . 40.7 m -129.81 147.31 51.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.372 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.437 ' CD1' ' HB2' ' A' ' 73' ' ' CYS . 12.3 tp -115.59 132.4 56.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.235 0.541 . . . . 0.0 110.487 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.503 ' HB2' ' CB ' ' A' ' 72' ' ' ARG . 0.2 OUTLIER -59.22 -161.2 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.554 -179.451 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -95.56 -32.02 13.03 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.549 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -79.84 1.24 27.7 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.261 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 30.6 mtt-85 57.88 35.33 25.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.996 0.426 . . . . 0.0 110.888 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.444 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -134.21 -4.5 2.71 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.626 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.503 ' CB ' ' HB2' ' A' ' 67' ' ' SER . 3.4 mtp-105 -121.62 122.09 38.86 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.526 ' SG ' ' CD2' ' A' ' 54' ' ' LEU . 28.8 t -131.18 126.9 36.81 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 120.989 0.424 . . . . 0.0 112.069 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.531 ' HG3' HG23 ' A' ' 40' ' ' VAL . 58.6 tt0 -110.63 131.65 54.87 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 176.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.586 HG12 ' CB ' ' A' ' 64' ' ' TYR . 13.2 mt -126.42 121.81 59.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.742 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -67.23 98.4 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-O 121.486 0.66 . . . . 0.0 109.252 175.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -35.15 145.04 0.06 OUTLIER Glycine 0 C--N 1.32 -0.344 0 CA-C-N 114.56 -1.2 . . . . 0.0 114.125 -178.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.454 ' CB ' HD11 ' A' ' 82' ' ' LEU . 1.1 t-20 -90.74 -13.11 34.66 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.06 0.457 . . . . 0.0 110.789 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.525 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 91.81 1.78 70.25 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.697 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.536 ' O ' HD21 ' A' ' 34' ' ' LEU . . . 149.97 -147.61 18.01 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.035 -0.602 . . . . 0.0 111.742 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.414 ' HD2' ' HA3' ' A' ' 80' ' ' GLY . 5.7 Cg_endo -49.05 122.66 8.71 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.596 2.198 . . . . 0.0 112.524 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.497 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . 0.5 OUTLIER -73.33 110.75 7.86 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.27 179.653 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -82.24 130.31 35.06 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.425 ' CB ' HD11 ' A' ' 113' ' ' ILE . . . -94.46 122.79 37.39 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.672 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -71.19 123.74 22.89 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 176.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.86 174.54 1.2 Allowed Glycine 0 N--CA 1.439 -1.124 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 -175.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.95 144.8 47.14 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 118.705 1.253 . . . . 0.0 111.923 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.519 ' CB ' HG13 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -112.27 160.94 17.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.001 -0.999 . . . . 0.0 112.127 -178.622 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 18.8 mt-10 -140.21 101.3 4.11 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.022 177.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 114' ' ' VAL . 0.0 OUTLIER -100.79 120.1 39.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.872 0.368 . . . . 0.0 111.346 -178.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.402 ' CE1' ' HB ' ' A' ' 116' ' ' THR . 1.4 m-85 -95.27 96.45 9.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.823 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.499 ' HB3' ' HB2' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -103.54 52.89 0.76 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.351 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.496 ' HA3' ' H ' ' A' ' 118' ' ' GLU . . . -49.82 -75.13 0.22 Allowed Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.408 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -77.51 -0.68 27.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.501 0.191 . . . . 0.0 110.97 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.499 ' HB2' ' HB3' ' A' ' 92' ' ' LEU . . . -92.18 46.53 1.27 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.81 0.338 . . . . 0.0 111.336 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -52.74 -24.37 18.5 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.297 -0.954 . . . . 0.0 111.811 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.69 -19.69 27.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.471 0.177 . . . . 0.0 111.167 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.521 ' C ' ' HD2' ' A' ' 101' ' ' PRO . . . -94.18 -31.69 14.03 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.648 0.261 . . . . 0.0 111.452 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.56 ' SD ' ' HB3' ' A' ' 115' ' ' LEU . 5.3 tpp -64.57 -47.35 79.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.716 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.625 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -55.18 -56.35 29.33 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.625 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 18.7 Cg_exo -64.73 -30.49 59.43 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.126 1.884 . . . . 0.0 112.63 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.535 HD21 ' HA ' ' A' ' 102' ' ' LEU . 0.1 OUTLIER -72.57 -53.16 12.72 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.193 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.546 ' HA ' HD13 ' A' ' 153' ' ' LEU . . . -52.89 -27.08 16.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.33 0.586 . . . . 0.0 110.509 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.511 ' C ' ' OG1' ' A' ' 179' ' ' THR . . . -86.62 -53.92 4.68 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.131 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.401 ' HB1' HD12 ' A' ' 34' ' ' LEU . . . -60.57 -36.51 78.67 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -177.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.461 HD23 HD12 ' A' ' 60' ' ' LEU . 27.4 mt -76.28 -12.88 60.15 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.569 ' HB3' ' HB2' ' A' ' 138' ' ' ALA . 69.3 m -86.73 20.12 2.67 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.25 0.548 . . . . 0.0 110.427 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.492 ' HG ' HG22 ' A' ' 179' ' ' THR . 2.4 mt -85.93 -75.02 0.39 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.019 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -69.7 -117.07 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.487 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.35 96.4 1.92 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.045 0.45 . . . . 0.0 110.123 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.699 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 8.8 m120 -148.51 143.99 27.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.116 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.838 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 13.4 m-20 -95.99 99.98 11.7 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.303 0.573 . . . . 0.0 110.149 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.519 HG13 ' CB ' ' A' ' 88' ' ' LEU . 1.9 mp -118.15 146.08 23.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.941 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.783 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 48.5 t -115.49 112.86 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 176.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.56 ' HB3' ' SD ' ' A' ' 99' ' ' MET . 31.0 mt -102.03 106.52 17.43 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.497 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.435 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -118.88 -170.83 1.98 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.037 -179.044 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.478 ' HA3' ' HG2' ' A' ' 121' ' ' MET . . . -170.08 179.13 42.53 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.968 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.672 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 2.9 mt-10 -72.32 169.72 15.61 Favored Pre-proline 0 C--N 1.332 -0.188 0 C-N-CA 123.573 0.749 . . . . 0.0 111.248 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.672 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 2.5 Cg_endo -43.56 -39.78 9.98 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.096 2.531 . . . . 0.0 113.193 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.8 mtm-85 -67.63 -24.4 65.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.667 0.27 . . . . 0.0 110.838 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.607 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 9.2 tpt -61.1 -34.94 75.75 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.414 ' HE3' ' HG2' ' A' ' 149' ' ' PRO . 0.0 OUTLIER -61.92 -16.69 52.81 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.463 179.139 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -87.59 4.17 44.76 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.934 0.397 . . . . 0.0 109.986 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 34.1 mtt85 -127.12 83.77 65.15 Favored Pre-proline 0 N--CA 1.454 -0.242 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.866 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.5 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 19.7 Cg_endo -58.02 148.76 75.12 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.675 2.25 . . . . 0.0 111.501 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.545 HG12 HD11 ' A' ' 151' ' ' LEU . 0.6 OUTLIER -125.48 -2.49 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -179.262 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.541 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -54.03 -34.7 52.73 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.713 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.493 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 13.3 m80 -58.53 -40.14 82.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.146 0.473 . . . . 0.0 110.142 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.589 ' HG ' ' CD1' ' A' ' 133' ' ' LEU . 16.4 tp -76.12 -40.59 52.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.705 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.732 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 46.1 t -56.0 -47.42 80.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.262 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.777 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 3.3 m-20 -71.27 -35.93 71.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.019 0.437 . . . . 0.0 110.025 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.419 ' CB ' HD22 ' A' ' 176' ' ' LEU . . . -60.84 -44.55 96.81 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.578 178.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.589 ' CD1' ' HG ' ' A' ' 129' ' ' LEU . 6.2 mt -77.08 -50.32 13.32 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.315 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.732 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -56.75 -27.94 60.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.759 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.777 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 5.6 tp -69.45 -31.76 70.27 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.779 178.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.483 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -83.09 13.52 44.13 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.038 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.78 3.15 58.3 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.941 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.569 ' HB2' ' HB3' ' A' ' 107' ' ' CYS . . . -71.53 152.12 43.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.737 0.304 . . . . 0.0 111.568 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 0.6 OUTLIER -101.74 101.44 11.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.76 178.418 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.685 ' HB ' ' HG3' ' A' ' 134' ' ' ARG . 19.8 mt -133.39 126.91 53.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.369 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.578 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -124.05 139.56 53.82 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 116.262 -0.427 . . . . 0.0 109.938 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.438 ' HH ' ' HB ' ' A' ' 130' ' ' VAL . 31.3 m-85 -80.58 132.81 35.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.652 0.263 . . . . 0.0 111.278 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.644 ' HB2' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -92.57 -91.33 0.17 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.698 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.55 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 40.6 mt-10 -57.18 -81.87 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.649 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.407 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 23.2 mt-30 -113.61 151.05 32.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.788 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 0.8 OUTLIER -67.91 130.98 44.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.839 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.541 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 1.9 m-20 71.82 17.75 5.29 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.04 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.567 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 18.7 m-85 -111.14 168.25 7.85 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-O 121.294 0.569 . . . . 0.0 112.352 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.861 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 1.4 Cg_exo -29.59 -63.12 0.09 OUTLIER 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 124.796 3.664 . . . . 0.0 116.779 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.861 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 58.5 Cg_exo -54.37 147.18 47.7 Favored 'Trans proline' 0 C--N 1.356 0.954 0 CA-C-N 121.301 1.501 . . . . 0.0 112.94 -178.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.783 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 7.8 mt -156.81 136.57 12.44 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.938 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.578 ' HB2' HG22 ' A' ' 141' ' ' THR . 6.8 mtp180 -106.99 102.75 12.08 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.838 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 6.6 mt -91.12 145.45 24.67 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.569 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.699 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 5.6 mt-30 -147.24 24.79 1.13 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.472 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 53.41 -173.38 0.46 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.894 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 118.35 -10.07 13.17 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.039 -1.076 . . . . 0.0 112.948 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.621 ' HE2' ' HA ' ' A' ' 180' ' ' ALA . 44.6 t80 -61.41 124.62 21.12 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 117.257 0.529 . . . . 0.0 110.441 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' THR . . . . . 0.664 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 66.4 p -118.32 -29.51 5.5 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 121.429 0.633 . . . . 0.0 111.411 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 133.13 -160.68 23.99 Favored Glycine 0 C--N 1.308 -1.02 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.416 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.456 ' O ' HG21 ' A' ' 162' ' ' VAL . . . 105.46 154.31 21.77 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.814 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -46.72 114.47 0.83 Allowed 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.407 -0.396 . . . . 0.0 111.019 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.765 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 69.1 t -107.9 121.66 61.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.317 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -91.6 119.69 31.73 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.682 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.516 HG13 ' HG ' ' A' ' 173' ' ' LEU . 1.2 t -132.27 122.29 47.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.72 139.43 50.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.059 0.456 . . . . 0.0 111.638 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.484 ' CA ' HG21 ' A' ' 191' ' ' ILE . . . . . . . . 0 N--CA 1.449 -0.485 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.657 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.554 ' HB2' ' HB3' ' A' ' 200' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.155 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.59 ' O ' ' HB2' ' A' ' 175' ' ' ALA . 0.0 OUTLIER -81.71 -12.2 58.73 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.983 -179.692 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.551 ' CD2' ' HB2' ' A' ' 129' ' ' LEU . 6.2 m-85 -75.33 -56.67 4.49 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.538 HD21 ' CZ ' ' A' ' 223' ' ' PHE . 0.2 OUTLIER -62.26 -43.6 98.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.454 178.587 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.58 ' O ' ' HG3' ' A' ' 178' ' ' MET . 1.8 m -56.06 -41.11 74.58 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.902 178.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 171' ' ' GLN . . . -57.87 -37.79 74.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.52 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.419 HD22 ' CB ' ' A' ' 132' ' ' ALA . 0.7 OUTLIER -76.63 -37.04 57.03 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.383 0.611 . . . . 0.0 110.238 178.88 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.579 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 4.3 mp -59.61 -34.48 72.82 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.693 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' MET . . . . . 0.58 ' HG3' ' O ' ' A' ' 174' ' ' THR . 8.8 mtp -81.84 -42.38 19.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.373 0.606 . . . . 0.0 112.185 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.511 ' OG1' ' C ' ' A' ' 104' ' ' ALA . 88.3 m -75.04 -40.82 60.12 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.546 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.621 ' HA ' ' HE2' ' A' ' 157' ' ' PHE . . . -59.88 -39.74 72.61 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 -176.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.579 ' HD3' ' O ' ' A' ' 177' ' ' LEU . 31.2 Cg_endo -68.4 -27.4 33.86 Favored 'Trans proline' 0 CA--C 1.498 -1.305 0 CA-C-N 120.241 1.122 . . . . 0.0 111.949 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.468 ' HB2' ' CD2' ' A' ' 108' ' ' LEU . 9.6 mt -85.05 0.35 51.84 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . -81.79 137.43 47.26 Favored Pre-proline 0 C--O 1.224 -0.241 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.187 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.664 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 14.3 Cg_endo -52.27 -30.68 43.27 Favored 'Trans proline' 0 CA--C 1.519 -0.269 0 C-N-CA 122.483 2.122 . . . . 0.0 113.178 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.76 138.48 50.69 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.905 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -55.1 142.3 31.23 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.049 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.529 ' HB ' ' HB1' ' A' ' 180' ' ' ALA . 87.0 m -120.31 144.42 47.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.205 0.526 . . . . 0.0 112.21 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 18.0 t -125.73 118.03 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.187 177.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.765 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 2.7 mp -101.16 117.86 47.04 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.655 ' HG3' ' HG3' ' A' ' 222' ' ' GLN . 0.2 OUTLIER -99.78 123.66 44.26 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.585 ' HB ' ' HA ' ' A' ' 221' ' ' GLN . 1.7 mp -93.71 124.99 46.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.063 -175.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -83.05 96.92 8.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.064 -1.426 . . . . 0.0 110.502 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 100.98 -129.81 10.02 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.933 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.32 129.0 56.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.709 0.29 . . . . 0.0 111.577 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.577 HD11 HG13 ' A' ' 201' ' ' ILE . 1.9 mt -41.43 144.68 0.33 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 170' ' ' SER . 8.6 p -71.56 -36.64 60.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.196 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' SER . . . . . 0.426 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 2.0 t -160.72 62.33 0.31 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.258 0.552 . . . . 0.0 109.977 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.659 ' N ' ' HD2' ' A' ' 199' ' ' PRO . 5.5 tmtt? -38.93 -47.68 3.72 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.829 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 5.0 Cg_endo -46.68 -33.71 14.09 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.178 1.919 . . . . 0.0 111.771 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.554 ' HB3' ' HB2' ' A' ' 170' ' ' SER . 0.2 OUTLIER -67.26 -44.36 79.59 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.577 HG13 HD11 ' A' ' 195' ' ' LEU . 14.7 mm -56.71 -39.79 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 CA-C-N 114.286 -1.324 . . . . 0.0 110.348 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -58.05 -45.15 87.51 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.044 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.533 ' CD1' ' HA ' ' A' ' 200' ' ' TYR . 4.8 mt -61.27 -50.4 80.6 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.022 0 CA-C-O 121.786 0.803 . . . . 0.0 109.068 178.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.491 HG21 ' HG3' ' A' ' 208' ' ' MET . 87.1 m -53.15 -51.6 61.46 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.971 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.523 ' O ' ' HE2' ' A' ' 209' ' ' LYS . 34.1 mt -67.99 -29.24 68.22 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 120.98 0.419 . . . . 0.0 111.663 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -78.07 -46.56 20.51 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.733 0.778 . . . . 0.0 109.664 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.526 ' HB3' ' O ' ' A' ' 203' ' ' ILE . 2.3 tp -69.7 -29.65 67.11 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.288 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' MET . . . . . 0.567 ' CE ' ' HA ' ' A' ' 178' ' ' MET . 3.9 mmm -75.98 -34.23 59.77 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.551 0.691 . . . . 0.0 109.624 178.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.627 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 7.4 mtmt -63.52 -35.97 82.22 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.439 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.459 ' O ' ' HB3' ' A' ' 234' ' ' PRO . 3.9 t -62.6 -27.29 69.09 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.629 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.544 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 27.5 m-85 -83.64 -6.81 59.54 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.019 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.63 7.29 26.05 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 115.782 1.073 . . . . 0.0 115.782 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 5.0 m -123.29 148.76 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 118.513 1.157 . . . . 0.0 112.049 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.454 ' CG ' ' HG2' ' A' ' 209' ' ' LYS . 13.2 mt-10 -130.09 134.33 47.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.403 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.564 HG22 ' HB ' ' A' ' 225' ' ' VAL . 8.9 mm -117.5 148.66 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 120.818 0.342 . . . . 0.0 110.247 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.591 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 19.9 tt0 -104.81 116.65 32.37 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.612 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.18 151.01 27.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.596 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . 0.671 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -109.08 -148.31 0.42 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.65 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.519 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 0.2 OUTLIER -72.38 66.91 0.69 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.847 0.356 . . . . 0.0 111.515 -179.491 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 1.7 t80 56.75 31.73 19.95 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.06 0.934 . . . . 0.0 110.625 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.585 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 0.4 OUTLIER -159.33 -129.27 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 178.779 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.741 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.1 OUTLIER -4.02 131.12 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 179.698 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.626 ' O ' ' HA ' ' A' ' 188' ' ' VAL . 1.1 m-85 -125.17 129.89 51.05 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 113.107 -1.86 . . . . 0.0 108.852 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.591 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 42.9 t -114.98 113.94 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-O 121.602 0.715 . . . . 0.0 109.62 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.564 ' HB ' HG22 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -120.35 124.3 72.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.121 -178.877 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.583 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 2.0 mptt -76.76 125.06 28.62 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -78.64 -178.31 50.01 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.393 -0.908 . . . . 0.0 113.23 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 64.81 21.26 67.26 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 121.346 -0.454 . . . . 0.0 112.935 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' GLN . . . . . 0.583 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 34.5 mt-30 -75.2 176.39 7.39 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.386 0.612 . . . . 0.0 111.649 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 5.4 p -136.09 147.88 48.03 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.323 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' TYR . . . . . 0.623 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 5.2 m-30 -107.75 132.07 53.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.759 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.63 147.92 48.23 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.505 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.38 111.46 14.11 Favored Pre-proline 0 N--CA 1.45 -0.435 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.657 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.459 ' HB3' ' O ' ' A' ' 210' ' ' THR . 56.2 Cg_endo -69.59 3.04 2.91 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.454 2.102 . . . . 0.0 112.622 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 95.84 -103.9 3.02 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.242 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 27.2 m -115.42 137.11 52.4 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 41' ' ' LEU . 7.5 t80 -132.72 126.7 33.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.955 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.565 HD21 HG23 ' A' ' 42' ' ' THR . 0.2 OUTLIER -94.53 111.03 22.79 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.099 0.476 . . . . 0.0 110.942 -179.685 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 43.1 t -81.02 113.36 20.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.95 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . 0.534 ' HG3' HD12 ' A' ' 238' ' ' LEU . 6.1 mt-10 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.164 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.875 ' HD3' HG21 ' A' ' 174' ' ' THR . 66.4 mtm-85 . . . . . 0 CA--C 1.518 -0.28 0 CA-C-O 121.52 0.676 . . . . 0.0 110.338 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.701 ' HB2' ' HG ' ' A' ' 41' ' ' LEU . . . -40.73 -45.89 2.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.633 -1.167 . . . . 0.0 112.077 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.535 HD21 HD12 ' A' ' 75' ' ' ILE . 12.6 mt -73.87 -34.57 64.52 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 120.92 0.39 . . . . 0.0 111.163 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.678 HD21 ' HB2' ' A' ' 101' ' ' PRO . 45.6 tp -68.58 -50.33 52.52 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.911 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.595 HD23 ' HE1' ' A' ' 178' ' ' MET . 50.7 mt -67.08 -27.15 67.12 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.416 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.447 ' HB2' HD12 ' A' ' 75' ' ' ILE . . . -66.14 -39.18 89.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.104 178.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.585 ' CB ' ' HG ' ' A' ' 57' ' ' LEU . . . -80.73 -40.79 24.64 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.013 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.744 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 14.0 mt -67.54 -3.61 9.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.102 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.644 ' HB2' ' HB3' ' A' ' 231' ' ' TYR . . . -99.72 -179.86 4.31 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -177.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.601 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.3 OUTLIER -113.89 111.52 21.84 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.526 178.165 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 116.72 166.15 14.2 Favored Glycine 0 C--N 1.32 -0.315 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -178.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.732 ' HG3' HD13 ' A' ' 76' ' ' ILE . 2.5 ttmt -95.81 118.66 32.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.992 0.396 . . . . 0.0 111.902 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.552 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.9 OUTLIER -117.47 145.08 44.41 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.249 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.51 HG22 ' CG ' ' A' ' 74' ' ' GLU . 97.1 t -102.66 141.34 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-O 121.581 0.705 . . . . 0.0 112.423 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.701 ' HG ' ' HB2' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -115.74 116.47 28.12 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 174.403 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.521 HG23 HD22 ' A' ' 238' ' ' LEU . 0.5 OUTLIER -103.93 148.11 26.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.868 0.365 . . . . 0.0 110.992 -177.601 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.431 ' HB2' HD21 ' A' ' 238' ' ' LEU . 2.0 t30 69.12 26.18 5.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.063 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.59 ' CD1' ' HB2' ' A' ' 73' ' ' CYS . 79.6 mt -52.66 -178.21 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.153 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 34.7 tp -109.79 131.21 55.27 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.205 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -86.78 87.14 7.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.008 0.433 . . . . 0.0 110.386 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.554 ' HB3' ' OD1' ' A' ' 49' ' ' ASP . 11.2 t -164.11 142.64 7.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.702 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.531 ' HB2' ' HB2' ' A' ' 94' ' ' ASN . 5.2 m-20 -37.09 -30.3 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.634 ' CB ' ' HA ' ' A' ' 95' ' ' ALA . 34.5 p-10 -56.85 -42.59 80.0 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.36 0.6 . . . . 0.0 110.208 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.519 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 64.6 t -83.44 -47.95 17.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.191 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.616 ' HA ' HD11 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -50.41 -37.97 40.59 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 178.72 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.649 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 7.4 m-70 -80.44 -32.69 37.26 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.842 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.601 ' O ' HD12 ' A' ' 57' ' ' LEU . 8.6 tpt -55.09 -35.27 64.41 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 176.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.616 HD11 ' HA ' ' A' ' 51' ' ' ARG . 0.5 OUTLIER -81.82 -42.49 19.6 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.398 176.328 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.769 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 24.6 t30 -60.77 -34.25 74.17 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.178 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.594 ' N ' ' O ' ' A' ' 52' ' ' HIS . . . -64.6 -46.95 80.46 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.857 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.2 OUTLIER -63.89 -39.61 94.58 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 113.914 -1.494 . . . . 0.0 107.807 177.103 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.769 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 2.6 m -59.96 -34.46 73.31 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.36 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.469 ' HB3' HD23 ' A' ' 88' ' ' LEU . . . -76.84 -36.91 56.51 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.485 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.445 HD11 ' HB2' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -82.74 -13.92 55.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.419 0.628 . . . . 0.0 110.719 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.14 35.02 5.18 Favored Glycine 0 C--N 1.32 -0.361 0 CA-C-N 115.228 -0.896 . . . . 0.0 114.174 177.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.857 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 38.6 t -90.27 118.53 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.817 ' O ' HG12 ' A' ' 76' ' ' ILE . 10.8 m -81.39 134.5 35.57 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.293 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.614 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 42.0 p90 -158.23 160.58 37.29 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.473 ' N ' ' O ' ' A' ' 74' ' ' GLU . 63.3 m -122.82 149.65 43.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.565 0.221 . . . . 0.0 110.993 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.783 HD21 ' HA ' ' A' ' 70' ' ' ARG . 4.0 tp -121.01 138.96 53.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.925 0.393 . . . . 0.0 110.636 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.461 ' HB2' ' CB ' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -69.66 -165.64 0.09 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.675 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.99 -23.43 22.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.171 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.412 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 0.1 OUTLIER -81.35 1.15 34.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.272 179.716 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.783 ' HA ' HD21 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 53.09 26.41 4.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.807 0.337 . . . . 0.0 111.286 179.773 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.412 ' OG1' ' HB3' ' A' ' 69' ' ' ASP . 1.3 p -127.93 -10.86 5.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.86 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.524 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 7.2 mtp180 -112.88 115.48 28.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.105 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.59 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -133.12 128.32 35.86 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -179.342 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.55 ' HA ' ' O ' ' A' ' 39' ' ' THR . 13.7 tt0 -107.73 133.78 51.65 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.613 178.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.593 ' HA ' ' CB ' ' A' ' 64' ' ' TYR . 8.2 mt -123.45 122.27 64.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.817 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -68.13 101.58 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-O 121.462 0.648 . . . . 0.0 109.516 175.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -39.61 143.2 0.46 Allowed Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 114.737 -1.12 . . . . 0.0 113.844 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.402 HD21 HD13 ' A' ' 82' ' ' LEU . 6.2 t-20 -87.89 -7.54 57.04 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 120.771 0.319 . . . . 0.0 110.82 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.601 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 88.38 2.66 79.48 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.278 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.46 ' C ' HD22 ' A' ' 34' ' ' LEU . . . 151.35 -147.43 17.35 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.005 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.639 ' HG3' ' HB3' ' A' ' 108' ' ' LEU . 77.0 Cg_exo -49.72 127.59 19.16 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.379 2.052 . . . . 0.0 112.727 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.628 HD22 HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -72.78 110.54 7.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.125 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.468 ' HA ' ' CG ' ' A' ' 111' ' ' ASN . 4.6 p80 -82.19 133.99 35.28 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.88 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.494 ' CB ' HD12 ' A' ' 113' ' ' ILE . . . -98.69 124.33 43.44 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.047 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -71.19 123.36 22.02 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 176.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.88 176.97 0.82 Allowed Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -175.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 112' ' ' ASP . . . -73.1 144.7 46.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 118.668 1.234 . . . . 0.0 111.11 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.551 ' CB ' HG13 ' A' ' 113' ' ' ILE . 0.4 OUTLIER -112.81 160.99 17.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.34 -178.532 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 7.3 mt-10 -141.53 102.91 4.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.43 177.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.664 ' HB2' HD21 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -102.25 115.5 30.68 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.657 -177.693 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.458 ' CD1' ' HB ' ' A' ' 116' ' ' THR . 0.9 OUTLIER -90.52 98.12 11.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.734 179.085 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.535 ' HB3' ' CB ' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -103.66 52.9 0.76 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.602 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.615 ' CA ' ' H ' ' A' ' 118' ' ' GLU . . . -59.86 -67.28 2.24 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.421 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.534 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 69.5 m-80 -75.43 15.26 0.48 Allowed 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.413 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.634 ' HA ' ' CB ' ' A' ' 49' ' ' ASP . . . -94.88 -70.15 0.72 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.56 -68.08 0.4 Allowed Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.923 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.417 ' O ' ' CD ' ' A' ' 101' ' ' PRO . 2.6 p -71.65 -8.42 53.98 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.528 ' O ' ' HB2' ' A' ' 102' ' ' LEU . . . -98.88 -30.1 12.58 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.655 0.264 . . . . 0.0 111.043 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -64.67 -42.75 95.15 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.551 ' CB ' ' HB3' ' A' ' 171' ' ' GLN . 1.4 mpt_? -55.84 -60.95 7.24 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.796 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.678 ' HB2' HD21 ' A' ' 30' ' ' LEU . 21.0 Cg_endo -60.78 -30.47 90.3 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.469 2.113 . . . . 0.0 112.488 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.528 ' HB2' ' O ' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -75.22 -52.5 10.77 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 120.335 -0.546 . . . . 0.0 109.998 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.626 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -51.6 -27.26 10.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.5 0.666 . . . . 0.0 110.509 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.633 ' CB ' HD22 ' A' ' 133' ' ' LEU . . . -86.55 -53.99 4.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.377 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.413 ' CB ' HD13 ' A' ' 34' ' ' LEU . . . -60.63 -33.61 73.02 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -177.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.52 ' HB2' ' CD1' ' A' ' 153' ' ' LEU . 26.9 mt -78.35 -20.76 50.67 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.55 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 0.0 OUTLIER -83.22 21.89 1.06 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.335 0.588 . . . . 0.0 110.87 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.639 ' HB3' ' HG3' ' A' ' 81' ' ' PRO . 0.5 OUTLIER -85.75 -76.05 0.35 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.74 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -70.28 -110.31 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.64 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.1 m -158.38 96.08 1.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.957 0.408 . . . . 0.0 110.595 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.641 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 13.7 m-80 -148.99 140.14 23.07 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.275 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.857 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 1.9 m-20 -92.95 98.59 11.46 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.171 0.51 . . . . 0.0 110.087 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.57 ' N ' HD11 ' A' ' 113' ' ' ILE . 1.5 mp -119.17 145.68 24.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.918 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.786 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 59.1 t -113.63 112.97 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 176.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.664 HD21 ' HB2' ' A' ' 90' ' ' LEU . 58.8 mt -102.63 110.99 23.1 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.903 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.458 ' HB ' ' CD1' ' A' ' 91' ' ' PHE . 0.2 OUTLIER -125.06 -171.97 2.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.253 -179.712 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -166.73 -173.12 34.77 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.514 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.661 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 1.3 mm-40 -76.83 172.49 9.54 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 123.245 0.618 . . . . 0.0 110.123 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.661 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 7.4 Cg_endo -47.97 -33.06 19.4 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.605 2.203 . . . . 0.0 112.744 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -67.62 -28.18 67.52 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.021 0.439 . . . . 0.0 110.219 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.577 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 9.8 tpt -61.19 -39.56 90.66 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.559 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.443 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 0.0 OUTLIER -63.01 -16.96 61.58 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.29 179.747 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.562 ' O ' ' HG3' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -85.68 -3.95 59.03 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.47 ' HB3' ' NH2' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -123.74 88.63 51.97 Favored Pre-proline 0 N--CA 1.452 -0.332 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.763 179.807 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.452 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 15.8 Cg_endo -56.67 149.09 61.04 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.651 2.234 . . . . 0.0 111.599 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.665 HG12 HD12 ' A' ' 151' ' ' LEU . 0.8 OUTLIER -119.88 8.98 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.946 0.403 . . . . 0.0 111.763 -179.121 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.435 ' HA3' ' OD1' ' A' ' 147' ' ' ASN . . . -57.19 -45.24 92.83 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.801 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.569 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 3.9 m80 -55.25 -38.62 68.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.013 0.406 . . . . 0.0 110.782 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.599 ' HG ' HD12 ' A' ' 133' ' ' LEU . 17.7 tp -74.8 -45.71 41.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.962 0.411 . . . . 0.0 110.372 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.76 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 49.9 t -56.58 -47.73 81.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.339 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.723 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 0.5 OUTLIER -71.88 -34.43 69.18 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.029 0.442 . . . . 0.0 110.297 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.527 ' HB2' HD22 ' A' ' 176' ' ' LEU . . . -62.42 -45.0 95.07 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.901 178.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.654 HD23 HD21 ' A' ' 176' ' ' LEU . 6.2 mt -77.27 -50.32 13.13 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.357 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.76 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -55.88 -27.59 52.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.764 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.723 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.6 OUTLIER -67.83 -33.02 73.96 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.586 178.616 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.53 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -82.55 13.63 40.25 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.015 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.07 2.45 60.83 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.329 -0.939 . . . . 0.0 112.833 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.65 ' HB1' ' HD1' ' A' ' 157' ' ' PHE . . . -70.74 152.42 43.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.895 0.379 . . . . 0.0 111.048 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 37.6 mttm -101.28 103.2 14.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.346 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.594 ' HB ' ' HG3' ' A' ' 134' ' ' ARG . 25.7 mt -134.4 126.48 48.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.367 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.726 HG23 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -121.72 139.37 53.66 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.718 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.433 ' HE1' HG21 ' A' ' 130' ' ' VAL . 47.5 m-85 -81.6 130.02 34.9 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.033 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.621 ' HB2' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -90.96 -91.59 0.15 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.473 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.59 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 17.7 mt-10 -56.1 -80.98 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.021 0.439 . . . . 0.0 110.439 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.508 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 31.6 mt-30 -115.67 151.32 35.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.426 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 31.2 mt-10 -67.9 137.54 55.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.117 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 146' ' ' GLU . 1.2 m-80 66.36 20.21 10.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.965 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.623 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 20.5 m-85 -113.79 170.04 5.82 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.93 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 27.6 Cg_exo -32.57 -63.39 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 124.345 3.363 . . . . 0.0 116.221 -177.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.93 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 77.8 Cg_exo -53.55 146.84 41.13 Favored 'Trans proline' 0 C--N 1.353 0.809 0 CA-C-N 120.706 1.288 . . . . 0.0 112.588 -178.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.786 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 9.7 mt -156.32 136.45 12.85 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.345 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.726 ' HB2' HG23 ' A' ' 141' ' ' THR . 0.0 OUTLIER -108.5 102.94 11.99 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.022 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.857 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 8.5 mt -91.29 146.81 23.51 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.738 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.641 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 2.8 mt-30 -148.83 25.74 0.92 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.368 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.55 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 54.88 -170.26 1.5 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.85 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 114.79 -15.43 19.26 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.119 -1.039 . . . . 0.0 113.389 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.702 ' HE2' ' HA ' ' A' ' 180' ' ' ALA . 55.4 t80 -58.33 123.69 16.98 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 117.258 0.529 . . . . 0.0 110.647 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' THR . . . . . 0.63 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 75.7 p -117.05 -33.55 4.68 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 121.382 0.61 . . . . 0.0 111.392 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.456 ' HA2' ' HG1' ' A' ' 187' ' ' THR . . . 138.56 -161.64 25.75 Favored Glycine 0 C--N 1.307 -1.083 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.987 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.451 ' O ' HG22 ' A' ' 162' ' ' VAL . . . 105.22 153.95 21.93 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.54 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -46.93 116.53 1.38 Allowed 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.321 -0.44 . . . . 0.0 111.093 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.767 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 73.4 t -109.59 130.62 62.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.829 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.16 120.38 39.41 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.522 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 191' ' ' ILE . 1.2 t -133.78 120.03 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 120.922 0.391 . . . . 0.0 110.12 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.44 141.83 18.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.657 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.499 ' HA2' ' CG2' ' A' ' 191' ' ' ILE . . . . . . . . 0 N--CA 1.446 -0.671 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.076 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.429 ' N ' HG13 ' A' ' 196' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.718 0.294 . . . . 0.0 111.361 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.551 ' HB3' ' CB ' ' A' ' 100' ' ' ARG . 0.8 OUTLIER -76.53 -10.64 59.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.937 -179.092 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.569 ' CE2' ' HB2' ' A' ' 128' ' ' HIS . 8.4 m-85 -72.48 -50.43 26.09 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.581 0.705 . . . . 0.0 109.559 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.714 HD22 ' CZ ' ' A' ' 223' ' ' PHE . 0.2 OUTLIER -68.64 -43.5 76.15 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.16 178.693 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.875 HG21 ' HD3' ' A' ' 27' ' ' ARG . 2.1 m -54.03 -35.31 61.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.501 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.533 ' HB3' ' HB1' ' A' ' 104' ' ' ALA . . . -63.88 -45.23 90.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.495 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.654 HD21 HD23 ' A' ' 133' ' ' LEU . 0.1 OUTLIER -76.58 -33.07 58.49 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.054 -179.814 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.789 ' O ' ' HE1' ' A' ' 208' ' ' MET . 3.4 mp -59.97 -39.1 84.48 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.62 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' MET . . . . . 0.632 ' HE2' ' HA ' ' A' ' 27' ' ' ARG . 1.9 mtp -81.55 -44.35 17.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.407 0.622 . . . . 0.0 112.226 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.485 HG21 ' HG ' ' A' ' 108' ' ' LEU . 58.3 m -71.4 -41.0 70.17 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.796 -178.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.702 ' HA ' ' HE2' ' A' ' 157' ' ' PHE . . . -59.9 -39.84 73.36 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -176.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.551 ' HD3' HG21 ' A' ' 225' ' ' VAL . 28.2 Cg_endo -65.66 -28.59 52.29 Favored 'Trans proline' 0 CA--C 1.497 -1.354 0 CA-C-N 120.108 1.074 . . . . 0.0 111.657 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.538 ' HB2' ' CD2' ' A' ' 108' ' ' LEU . 4.7 mt -84.06 0.49 48.08 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.724 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.499 ' O ' ' HA3' ' A' ' 227' ' ' GLY . . . -83.19 136.57 43.37 Favored Pre-proline 0 C--O 1.224 -0.279 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.856 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.63 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 10.7 Cg_endo -50.18 -33.49 35.98 Favored 'Trans proline' 0 CA--C 1.518 -0.278 0 C-N-CA 122.597 2.198 . . . . 0.0 113.443 -179.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.79 139.54 48.32 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.731 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 187' ' ' THR . 10.1 t0 -55.33 143.89 26.95 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.835 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.67 ' O ' HG12 ' A' ' 225' ' ' VAL . 87.8 m -121.2 148.98 43.52 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.949 0.404 . . . . 0.0 111.606 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 44.0 t -130.38 117.75 40.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.795 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 4.6 mp -100.23 119.79 48.79 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.561 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 0.1 OUTLIER -100.78 125.57 47.28 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.558 ' HB ' ' HA ' ' A' ' 221' ' ' GLN . 1.6 mp -94.04 125.18 46.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.807 -176.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -77.91 96.86 5.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 113.948 -1.478 . . . . 0.0 110.458 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 96.58 -126.99 9.03 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.263 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -116.41 130.87 56.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.79 0.329 . . . . 0.0 111.582 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.608 HD13 HG13 ' A' ' 201' ' ' ILE . 1.5 mt -41.72 144.22 0.42 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.385 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.429 HG13 ' N ' ' A' ' 170' ' ' SER . 14.8 p -72.33 -28.28 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.039 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' SER . . . . . 0.447 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 0.1 OUTLIER -168.85 65.19 0.06 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.058 0.456 . . . . 0.0 110.49 -179.15 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.458 ' N ' ' CD ' ' A' ' 199' ' ' PRO . 0.0 OUTLIER -40.66 -46.72 6.44 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.498 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 198' ' ' LYS . 83.5 Cg_exo -47.49 -33.81 18.36 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 121.842 1.694 . . . . 0.0 111.411 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.537 ' HA ' ' CD1' ' A' ' 203' ' ' ILE . 0.2 OUTLIER -69.16 -41.94 76.57 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.373 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.608 HG13 HD13 ' A' ' 195' ' ' LEU . 18.5 mm -64.64 -38.69 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.917 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.15 -44.14 83.14 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.256 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.537 ' CD1' ' HA ' ' A' ' 200' ' ' TYR . 4.1 mt -62.79 -48.82 86.27 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.918 0 CA-C-O 121.739 0.781 . . . . 0.0 109.358 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.503 ' O ' ' HG3' ' A' ' 208' ' ' MET . 87.6 m -54.12 -51.26 64.79 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.121 -178.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.614 ' O ' ' HE3' ' A' ' 209' ' ' LYS . 32.5 mt -65.77 -31.15 71.96 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 120.922 0.392 . . . . 0.0 111.517 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -77.48 -46.07 23.62 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.901 0.858 . . . . 0.0 109.51 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.817 ' O ' HG22 ' A' ' 210' ' ' THR . 6.4 tp -69.91 -30.46 67.88 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.526 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' MET . . . . . 0.789 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 37.9 mtp -76.38 -34.2 58.88 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.584 0.707 . . . . 0.0 109.231 177.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.689 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 2.6 mtmt -60.95 -38.3 85.37 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.346 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.817 HG22 ' O ' ' A' ' 207' ' ' LEU . 4.7 t -60.92 -33.37 73.05 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.161 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.534 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 50.0 m-85 -76.1 -5.94 48.9 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.801 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 109.51 7.33 28.16 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 115.671 1.028 . . . . 0.0 115.671 177.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.8 m -123.62 148.58 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 118.549 1.174 . . . . 0.0 112.799 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.446 ' HG2' ' CG ' ' A' ' 209' ' ' LYS . 6.0 mt-10 -129.9 138.61 51.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.659 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.581 HG23 ' HB ' ' A' ' 225' ' ' VAL . 17.1 mm -122.04 148.64 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.671 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 1.6 tp10 -103.89 117.76 35.09 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.983 0.421 . . . . 0.0 111.905 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -83.02 151.11 25.96 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.525 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . 0.673 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 5.4 mm-40 -109.43 -144.1 0.39 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.72 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.567 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 7.8 t-80 -73.9 65.88 1.1 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.813 0.34 . . . . 0.0 111.492 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 4.1 t80 56.01 35.12 25.0 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.931 0.872 . . . . 0.0 110.785 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.598 ' O ' ' CD1' ' A' ' 223' ' ' PHE . 1.7 pt20 -163.92 -127.45 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.795 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -8.04 134.43 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.714 ' CZ ' HD22 ' A' ' 173' ' ' LEU . 0.6 OUTLIER -125.35 137.32 54.04 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 113.038 -1.892 . . . . 0.0 109.654 -179.234 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.671 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 23.7 t -117.39 114.27 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 187' ' ' THR . 0.5 OUTLIER -122.25 120.71 61.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.804 -179.393 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.488 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -74.59 127.37 32.92 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -80.03 -171.29 42.47 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.236 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 61.51 21.16 59.91 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 121.398 -0.43 . . . . 0.0 113.006 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 23.9 mt-30 -80.63 -173.45 4.15 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.257 0.551 . . . . 0.0 111.158 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 17.2 t -151.94 147.64 26.81 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.934 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' TYR . . . . . 0.744 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 4.7 m-85 -100.74 130.23 46.75 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.452 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.99 146.77 46.34 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.55 111.04 8.88 Favored Pre-proline 0 N--CA 1.447 -0.59 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.383 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.552 ' HD2' ' OG1' ' A' ' 39' ' ' THR . 54.6 Cg_endo -69.6 -0.32 6.61 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 121.942 1.762 . . . . 0.0 112.076 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 99.6 -101.18 2.34 Favored Glycine 0 C--O 1.226 -0.349 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.772 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 90.3 m -119.03 135.55 54.57 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . 0.521 ' CD2' HG23 ' A' ' 210' ' ' THR . 1.5 t80 -131.21 129.73 42.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.906 0.384 . . . . 0.0 111.046 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.53 HD11 ' HG2' ' A' ' 240' ' ' GLU . 0.1 OUTLIER -95.0 110.96 22.81 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.382 179.242 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 21.7 t -82.57 111.91 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.092 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . 0.53 ' HG2' HD11 ' A' ' 238' ' ' LEU . 3.3 mt-10 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.975 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.728 ' HA ' ' HE1' ' A' ' 178' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.515 -0.396 0 CA-C-O 121.277 0.561 . . . . 0.0 110.754 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.613 ' CB ' ' HG ' ' A' ' 41' ' ' LEU . . . -40.5 -47.53 2.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.004 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.54 HD13 ' CD2' ' A' ' 54' ' ' LEU . 12.9 mt -75.76 -35.36 60.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.846 0.355 . . . . 0.0 111.882 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.515 ' HB2' ' HE2' ' A' ' 53' ' ' MET . 50.7 tp -68.92 -49.8 54.94 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.186 0.517 . . . . 0.0 110.674 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.695 ' HB2' ' CE2' ' A' ' 211' ' ' PHE . 27.5 mt -67.91 -27.02 66.28 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.395 179.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.3 -40.27 89.87 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.092 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.556 ' CB ' ' HG ' ' A' ' 57' ' ' LEU . . . -81.1 -41.31 22.71 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.253 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.62 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 16.1 mt -67.94 -4.15 12.14 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.066 178.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.563 ' HB1' ' HB3' ' A' ' 231' ' ' TYR . . . -96.9 176.56 5.93 Favored 'General case' 0 CA--C 1.523 -0.089 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -177.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.547 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.3 OUTLIER -109.84 112.65 24.81 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.636 -1.166 . . . . 0.0 108.941 178.367 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 116.78 166.68 14.35 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.595 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.62 ' HG2' ' HG2' ' A' ' 74' ' ' GLU . 10.6 tttt -95.09 117.81 30.83 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.809 0.304 . . . . 0.0 111.174 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.691 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 0.8 OUTLIER -119.2 148.24 43.32 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-O 120.644 0.259 . . . . 0.0 111.559 -179.462 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.525 HG21 ' CG ' ' A' ' 74' ' ' GLU . 56.8 t -103.67 135.63 40.4 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.668 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.613 ' HG ' ' CB ' ' A' ' 28' ' ' ALA . 0.3 OUTLIER -111.23 115.97 30.25 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 174.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.551 HG21 HD22 ' A' ' 238' ' ' LEU . 0.6 OUTLIER -104.23 149.89 24.89 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.232 -177.93 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.421 ' HB2' HD21 ' A' ' 238' ' ' LEU . 10.4 t-20 69.18 26.01 5.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.268 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.543 HD13 ' HB3' ' A' ' 73' ' ' CYS . 67.5 mt -55.59 -174.87 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.402 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 41.6 tp -111.42 131.68 55.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.594 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -88.83 89.36 7.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.96 0.41 . . . . 0.0 110.312 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -164.02 142.72 7.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.062 -179.104 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.407 ' HA ' ' HB3' ' A' ' 51' ' ' ARG . 0.6 OUTLIER -36.6 -31.25 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.57 0.224 . . . . 0.0 111.342 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.493 ' HB3' ' O ' ' A' ' 94' ' ' ASN . 1.6 p30 -58.7 -42.64 89.07 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.906 0.384 . . . . 0.0 110.712 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.454 ' N ' ' O ' ' A' ' 47' ' ' SER . 82.0 t -81.85 -44.18 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.66 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.543 ' HA ' HD13 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -49.5 -40.07 36.27 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.525 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.658 ' HA ' ' HB2' ' A' ' 55' ' ' ASN . 19.9 m-70 -79.62 -32.29 41.72 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.978 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.515 ' HE2' ' HB2' ' A' ' 30' ' ' LEU . 7.3 tpt -53.74 -35.61 61.41 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 176.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.543 HD13 ' HA ' ' A' ' 51' ' ' ARG . 0.3 OUTLIER -84.03 -45.76 12.74 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 114.317 -1.31 . . . . 0.0 109.028 176.482 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.724 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -57.77 -36.38 72.06 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.776 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 52' ' ' HIS . . . -65.81 -43.05 89.82 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.755 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -65.34 -38.43 90.11 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 176.84 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.724 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.1 m -61.81 -39.67 92.57 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 113.875 -1.511 . . . . 0.0 111.813 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.572 ' CB ' HD12 ' A' ' 90' ' ' LEU . . . -71.07 -37.24 72.46 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.392 -178.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.07 -16.25 55.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.345 0.593 . . . . 0.0 110.429 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.88 35.57 3.96 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.142 -0.935 . . . . 0.0 114.194 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.755 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 25.4 t -90.6 122.37 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.752 ' O ' HG12 ' A' ' 76' ' ' ILE . 12.9 m -85.02 131.88 34.41 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.887 0.375 . . . . 0.0 111.523 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.572 ' HB3' ' CG2' ' A' ' 75' ' ' ILE . 40.1 p90 -158.69 172.23 18.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.535 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 86.5 m -131.59 148.38 52.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.785 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.436 ' CD1' ' HB2' ' A' ' 73' ' ' CYS . 14.6 tp -119.68 134.78 55.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.162 0.506 . . . . 0.0 111.114 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.401 ' CB ' ' HB2' ' A' ' 72' ' ' ARG . 88.1 p -61.71 -169.26 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.001 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.91 -41.7 18.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.311 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.36 1.98 17.25 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.634 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 59.81 30.01 19.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.733 0.302 . . . . 0.0 111.262 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.437 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 2.0 p -119.6 -14.73 9.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.911 0.386 . . . . 0.0 111.217 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 14.7 mtp180 -113.43 119.23 36.88 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.4 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.543 ' HB3' HD13 ' A' ' 44' ' ' LEU . 42.5 t -131.12 126.9 36.94 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.691 ' HA ' ' O ' ' A' ' 39' ' ' THR . 35.9 tt0 -110.98 129.06 56.0 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.6 HG22 ' O ' ' A' ' 63' ' ' SER . 10.7 mt -126.59 123.56 63.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -177.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.752 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -67.69 99.27 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-O 121.571 0.701 . . . . 0.0 109.256 175.672 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -37.77 146.41 0.12 Allowed Glycine 0 C--N 1.32 -0.343 0 CA-C-N 114.53 -1.214 . . . . 0.0 114.05 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.87 -11.21 39.9 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.959 0.409 . . . . 0.0 111.046 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.547 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 89.86 -0.57 79.65 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.258 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.515 ' O ' HD22 ' A' ' 34' ' ' LEU . . . 152.81 -148.36 19.11 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.902 -0.665 . . . . 0.0 112.143 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.54 ' HG3' ' HB3' ' A' ' 108' ' ' LEU . 77.7 Cg_exo -49.36 127.98 19.23 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.788 2.325 . . . . 0.0 112.704 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.456 HD21 HD22 ' A' ' 34' ' ' LEU . 0.9 OUTLIER -78.23 105.64 9.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.901 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -82.13 128.1 33.79 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.055 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.547 ' HB1' HD11 ' A' ' 113' ' ' ILE . . . -92.44 126.44 37.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.041 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.97 123.89 23.08 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 176.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.85 172.88 0.91 Allowed Glycine 0 N--CA 1.438 -1.185 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 -175.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.34 144.88 46.33 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 118.469 1.135 . . . . 0.0 111.762 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.51 HD22 ' CB ' ' A' ' 59' ' ' ALA . 1.2 tp -113.71 160.54 18.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.047 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 10.9 mt-10 -139.75 102.13 4.36 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.958 178.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.622 ' HB2' HD22 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -101.56 130.01 47.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.955 0.407 . . . . 0.0 111.346 -178.736 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.449 ' CE1' ' HB ' ' A' ' 116' ' ' THR . 16.5 m-85 -101.03 96.77 7.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.608 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 99' ' ' MET . 0.0 OUTLIER -110.34 51.22 0.77 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.814 -179.596 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.72 ' HA3' ' H ' ' A' ' 118' ' ' GLU . . . -58.26 -61.16 7.73 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.817 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.493 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 17.9 m-80 -76.97 -3.16 37.49 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.111 -0.235 . . . . 0.0 110.585 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.471 ' HB2' ' HB3' ' A' ' 92' ' ' LEU . . . -94.47 56.3 2.09 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.915 0.388 . . . . 0.0 111.338 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -56.75 -29.99 59.06 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.468 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.505 ' HA ' ' HG2' ' A' ' 171' ' ' GLN . 6.1 p -93.84 -6.54 45.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.682 -0.259 . . . . 0.0 111.421 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 102' ' ' LEU . . . -101.63 -37.85 8.18 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.836 0.351 . . . . 0.0 111.185 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.507 ' HB2' ' HB2' ' A' ' 92' ' ' LEU . 3.0 tpp -61.72 -45.58 93.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.339 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.465 ' NH2' ' HD3' ' A' ' 124' ' ' ARG . 0.1 OUTLIER -53.63 -60.5 6.99 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.227 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.479 ' HG3' ' O ' ' A' ' 97' ' ' THR . 18.5 Cg_endo -60.77 -33.16 93.33 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.477 2.118 . . . . 0.0 112.86 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.475 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 0.2 OUTLIER -71.56 -53.13 14.8 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.836 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.496 ' O ' HD12 ' A' ' 153' ' ' LEU . . . -51.38 -28.52 12.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.177 0.513 . . . . 0.0 110.311 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.496 ' HB2' ' HB1' ' A' ' 175' ' ' ALA . . . -86.6 -52.52 5.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.599 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.51 -34.09 73.59 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 102' ' ' LEU . 37.3 mt -78.68 -15.6 58.29 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -176.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.605 ' HB3' ' HB2' ' A' ' 138' ' ' ALA . 90.3 m -87.84 22.8 2.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.322 0.582 . . . . 0.0 110.433 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.54 ' HB3' ' HG3' ' A' ' 81' ' ' PRO . 2.0 mt -87.16 -75.04 0.42 Allowed 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.545 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.63 -113.6 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.235 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.07 96.4 2.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.049 0.452 . . . . 0.0 110.762 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.583 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 0.1 OUTLIER -148.25 140.91 24.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.53 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.862 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 3.4 m-20 -94.21 102.49 14.52 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.831 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.547 HD11 ' HB1' ' A' ' 84' ' ' ALA . 20.7 mm -121.35 140.92 43.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.556 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.868 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 61.8 t -111.71 112.37 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 175.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.622 HD22 ' HB2' ' A' ' 90' ' ' LEU . 74.6 mt -102.17 105.85 16.61 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.492 -178.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.449 ' HB ' ' CE1' ' A' ' 91' ' ' PHE . 0.2 OUTLIER -114.66 -170.48 1.75 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.322 -178.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.531 ' HA3' ' HG2' ' A' ' 121' ' ' MET . . . -171.4 175.15 45.01 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.629 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.723 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 36.6 mm-40 -68.9 169.41 11.31 Favored Pre-proline 0 CA--C 1.531 0.227 0 C-N-CA 123.214 0.605 . . . . 0.0 111.339 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.723 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 2.8 Cg_endo -44.35 -40.82 13.38 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.192 2.595 . . . . 0.0 113.196 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.44 -23.73 65.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.679 0.276 . . . . 0.0 110.722 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.569 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 9.1 tpt -62.2 -35.13 77.94 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -16.85 54.35 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.59 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.01 1.59 52.33 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.859 0.362 . . . . 0.0 110.333 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.465 ' HD3' ' NH2' ' A' ' 100' ' ' ARG . 55.6 mtt-85 -127.03 84.22 64.04 Favored Pre-proline 0 CA--C 1.529 0.161 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.57 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -56.49 148.57 62.31 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.715 2.277 . . . . 0.0 111.755 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.405 HG12 HD11 ' A' ' 151' ' ' LEU . 0.8 OUTLIER -124.17 8.43 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.27 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.559 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -61.61 -36.54 92.79 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.061 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.19 -40.08 76.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.74 0.27 . . . . 0.0 110.67 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.558 ' HG ' ' CD1' ' A' ' 133' ' ' LEU . 14.1 tp -75.37 -41.39 56.56 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.425 0.631 . . . . 0.0 110.023 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.87 HG22 HD21 ' A' ' 151' ' ' LEU . 39.8 t -56.42 -47.74 81.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.579 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.785 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 4.7 m-20 -72.08 -31.81 66.43 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.422 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.441 ' HB1' ' CG1' ' A' ' 162' ' ' VAL . . . -64.1 -49.81 70.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.449 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.558 ' CD1' ' HG ' ' A' ' 129' ' ' LEU . 7.7 mt -71.65 -48.93 44.45 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.845 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.783 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -57.85 -27.77 63.51 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.651 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.785 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 1.5 tp -67.19 -33.45 75.42 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.466 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.494 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -81.81 12.73 40.41 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.966 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.34 3.34 60.06 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.325 -0.941 . . . . 0.0 112.749 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.605 ' HB2' ' HB3' ' A' ' 107' ' ' CYS . . . -71.59 149.43 45.65 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.882 0.341 . . . . 0.0 111.234 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 21.6 mttm -97.78 103.24 15.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.149 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.504 ' HB ' ' HG3' ' A' ' 134' ' ' ARG . 21.0 mt -134.02 126.89 50.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.309 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.63 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -123.51 139.71 53.74 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.925 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.416 ' HE1' HG23 ' A' ' 130' ' ' VAL . 43.4 m-85 -81.41 132.62 35.33 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.409 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.708 ' HB2' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -90.17 -82.26 0.28 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.297 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.794 ' HG3' ' H ' ' A' ' 145' ' ' GLN . 11.2 pt-20 -63.5 -78.2 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.926 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.794 ' H ' ' HG3' ' A' ' 144' ' ' GLU . 1.5 mt-30 -121.38 154.19 36.81 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 6.8 mt-10 -64.48 135.6 56.22 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.074 0.464 . . . . 0.0 111.285 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.559 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 9.2 m-20 71.83 18.73 5.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.086 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.52 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 18.6 m-85 -107.77 167.12 9.79 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.863 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 51.3 Cg_exo -35.69 -63.3 0.2 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 124.159 3.239 . . . . 0.0 116.07 -177.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.863 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 71.5 Cg_exo -50.72 145.6 22.86 Favored 'Trans proline' 0 C--N 1.355 0.885 0 CA-C-N 120.773 1.312 . . . . 0.0 112.393 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.87 HD21 HG22 ' A' ' 130' ' ' VAL . 8.5 mt -155.89 137.04 13.76 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.846 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.694 ' HG3' HD12 ' A' ' 143' ' ' LEU . 0.2 OUTLIER -106.78 101.59 11.02 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 177.411 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.862 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 6.6 mt -91.46 145.61 24.48 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.023 -178.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.583 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 3.0 mt-30 -147.79 29.27 0.92 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.691 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 51.37 -170.3 0.34 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.222 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 114.83 -12.09 20.54 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.086 -1.054 . . . . 0.0 113.369 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.634 ' HE2' ' HA ' ' A' ' 180' ' ' ALA . 54.4 t80 -58.82 122.82 14.52 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 117.51 0.655 . . . . 0.0 110.595 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' THR . . . . . 0.751 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 43.3 p -113.12 -38.37 4.48 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 121.668 0.747 . . . . 0.0 111.243 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 139.04 -165.03 25.76 Favored Glycine 0 C--N 1.306 -1.089 0 CA-C-N 114.526 -1.216 . . . . 0.0 112.304 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.476 ' O ' HG22 ' A' ' 162' ' ' VAL . . . 109.48 155.59 16.2 Favored Glycine 0 N--CA 1.437 -1.298 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.882 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -46.94 115.48 1.08 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.216 -0.492 . . . . 0.0 111.333 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 72.1 t -108.02 137.71 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -107.09 119.77 40.29 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.256 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 191' ' ' ILE . 1.0 OUTLIER -132.09 120.43 43.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.113 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.429 ' CA ' ' HE3' ' A' ' 192' ' ' LYS . 23.0 t0 -55.58 138.51 46.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.933 0.396 . . . . 0.0 111.141 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.562 ' CA ' HG23 ' A' ' 191' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.427 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.204 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.587 ' HB2' ' HB3' ' A' ' 200' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.101 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.589 ' HA ' ' HB ' ' A' ' 174' ' ' THR . 0.5 OUTLIER -92.7 -13.85 28.83 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.443 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.442 ' HE1' ' CZ ' ' A' ' 100' ' ' ARG . 5.9 m-85 -66.73 -54.36 23.78 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.533 HD21 ' CE1' ' A' ' 223' ' ' PHE . 0.2 OUTLIER -64.95 -45.91 83.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.921 178.675 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.589 ' HB ' ' HA ' ' A' ' 171' ' ' GLN . 1.1 m -55.1 -33.01 62.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.969 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.496 ' HB1' ' HB2' ' A' ' 104' ' ' ALA . . . -66.39 -41.61 89.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.329 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.457 HD22 ' CD2' ' A' ' 133' ' ' LEU . 0.2 OUTLIER -76.71 -32.51 57.88 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.545 179.361 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.695 ' O ' ' HE1' ' A' ' 208' ' ' MET . 2.7 mp -59.89 -39.35 85.02 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.142 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' MET . . . . . 0.728 ' HE1' ' HA ' ' A' ' 27' ' ' ARG . 0.7 OUTLIER -82.16 -41.43 20.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.351 0.596 . . . . 0.0 111.912 179.751 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 100.0 m -71.06 -42.07 69.9 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.644 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.634 ' HA ' ' HE2' ' A' ' 157' ' ' PHE . . . -59.08 -40.37 80.93 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -176.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 38.1 Cg_endo -66.76 -28.78 43.34 Favored 'Trans proline' 0 CA--C 1.498 -1.292 0 C-N-CA 120.787 0.992 . . . . 0.0 112.06 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.501 ' HB2' ' CD2' ' A' ' 108' ' ' LEU . 5.3 mt -84.67 1.5 46.0 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.626 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . -82.86 139.46 43.19 Favored Pre-proline 0 C--O 1.223 -0.298 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.226 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.751 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 11.6 Cg_endo -52.03 -33.37 52.54 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.206 1.938 . . . . 0.0 112.782 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.53 143.05 45.6 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.582 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -58.54 145.27 39.81 Favored 'General case' 0 N--CA 1.46 0.074 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.453 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.615 ' HB ' ' HB2' ' A' ' 180' ' ' ALA . 65.9 m -122.14 144.42 48.95 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 25.2 t -122.45 117.81 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.069 176.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.7 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 2.7 mp -101.53 117.63 47.11 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.738 ' HG3' ' HG3' ' A' ' 222' ' ' GLN . 0.1 OUTLIER -99.4 122.49 42.58 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.4 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.562 HG23 ' CA ' ' A' ' 166' ' ' GLY . 1.6 mp -93.47 119.72 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.954 -175.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.429 ' HE3' ' CA ' ' A' ' 165' ' ' ASP . 0.7 OUTLIER -75.14 96.63 3.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.769 -179.468 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 95.47 -134.11 11.78 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.265 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -117.09 137.27 52.39 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.478 HD21 HG13 ' A' ' 201' ' ' ILE . 8.9 mt -40.81 147.03 0.13 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.184 0.516 . . . . 0.0 111.124 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.66 -21.07 25.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.896 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' SER . . . . . 0.821 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 26.7 t -138.55 -67.43 0.46 Allowed 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.249 178.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.553 ' HB3' ' O ' ' A' ' 197' ' ' SER . 8.0 tmtt? 96.82 -56.57 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 114.656 -1.157 . . . . 0.0 111.177 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . 0.821 ' HD2' ' C ' ' A' ' 197' ' ' SER . 18.3 Cg_endo -62.71 -25.7 75.09 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 120.868 1.045 . . . . 0.0 110.021 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.587 ' HB3' ' HB2' ' A' ' 170' ' ' SER . 0.2 OUTLIER -67.48 -48.2 67.83 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.784 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.478 HG13 HD21 ' A' ' 195' ' ' LEU . 15.6 mm -63.28 -35.09 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.443 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.15 -42.86 99.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.102 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.571 ' CD1' ' HA ' ' A' ' 200' ' ' TYR . 4.5 mt -60.36 -50.78 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.493 ' O ' ' HG3' ' A' ' 208' ' ' MET . 45.8 m -53.47 -51.85 61.37 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.107 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.574 ' O ' ' HD3' ' A' ' 209' ' ' LYS . 36.8 mt -65.54 -30.62 71.39 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.38 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . 0.414 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 2.6 m-80 -77.86 -46.3 21.82 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.772 0.796 . . . . 0.0 109.956 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.568 ' HB3' ' O ' ' A' ' 203' ' ' ILE . 0.8 OUTLIER -68.76 -29.77 68.22 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.211 178.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' MET . . . . . 0.695 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 37.0 mtp -69.95 -33.23 71.84 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.655 178.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.598 ' HE2' ' HA ' ' A' ' 214' ' ' GLU . 6.7 mmtp -57.54 -38.6 74.98 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.813 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.407 HG21 ' HG3' ' A' ' 234' ' ' PRO . 1.0 OUTLIER -60.6 -27.25 67.59 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.645 -178.523 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.695 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 76.9 m-85 -85.19 -8.88 58.38 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.541 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.1 9.38 24.23 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 115.658 1.023 . . . . 0.0 115.658 177.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.479 HG22 ' HE2' ' A' ' 208' ' ' MET . 4.2 m -124.18 148.84 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 118.683 1.242 . . . . 0.0 112.133 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.598 ' HA ' ' HE2' ' A' ' 209' ' ' LYS . 22.5 mt-10 -129.74 141.75 50.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.149 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.533 HG22 ' HB ' ' A' ' 225' ' ' VAL . 24.7 mm -123.5 148.45 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-O 120.89 0.376 . . . . 0.0 110.552 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.58 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 40.2 tt0 -104.74 116.44 32.03 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.726 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -82.49 150.18 27.15 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . 0.617 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.2 OUTLIER -110.16 -148.05 0.42 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.606 0.241 . . . . 0.0 110.909 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.531 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 4.0 t-160 -67.83 63.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.453 ' CE1' ' HG3' ' A' ' 198' ' ' LYS . 6.3 t80 58.87 33.88 23.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.902 0.858 . . . . 0.0 110.867 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.621 ' O ' ' O ' ' A' ' 222' ' ' GLN . 12.2 pt20 -164.69 -124.63 0.02 OUTLIER 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.738 ' HG3' ' HG3' ' A' ' 190' ' ' ARG . 0.5 OUTLIER -3.97 132.37 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 179.495 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.647 ' O ' ' HA ' ' A' ' 188' ' ' VAL . 3.2 m-85 -126.55 129.89 49.48 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.432 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.58 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 41.6 t -114.17 113.68 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 121.588 0.708 . . . . 0.0 109.739 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.533 ' HB ' HG22 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -123.15 125.51 72.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.095 -179.028 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 181' ' ' PRO . 0.0 OUTLIER -76.62 141.52 41.02 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.838 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -91.18 -178.21 43.15 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.457 -178.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 66.47 20.22 69.53 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 121.54 -0.362 . . . . 0.0 113.081 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' GLN . . . . . 0.496 ' NE2' ' HB3' ' A' ' 181' ' ' PRO . 47.7 mt-30 -77.79 -173.77 3.2 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.19 0.519 . . . . 0.0 110.896 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.14 147.57 24.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.543 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' TYR . . . . . 0.62 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 5.5 m-85 -99.26 133.81 43.02 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.056 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -120.76 148.84 43.44 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.429 ' CA ' ' HG1' ' A' ' 39' ' ' THR . 84.1 p -76.54 111.43 15.72 Favored Pre-proline 0 N--CA 1.446 -0.636 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.834 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.41 ' HD2' ' HG1' ' A' ' 39' ' ' THR . 46.7 Cg_endo -68.3 -2.38 8.91 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.947 1.765 . . . . 0.0 112.422 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 96.34 -84.0 0.82 Allowed Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.29 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 93.5 m -130.56 127.13 38.45 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -130.33 134.47 47.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.995 0.426 . . . . 0.0 111.373 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.551 HD22 HG21 ' A' ' 42' ' ' THR . 0.1 OUTLIER -97.94 110.73 23.25 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.687 179.846 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 20.1 t -81.65 112.77 20.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.11 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . 0.517 ' HG3' HD11 ' A' ' 238' ' ' LEU . 10.3 mt-10 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.347 -0.835 . . . . 0.0 111.129 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.59 ' HA ' ' HE1' ' A' ' 178' ' ' MET . 77.3 mtm-85 . . . . . 0 CA--C 1.52 -0.206 0 CA-C-O 121.046 0.45 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.576 ' CB ' ' HG ' ' A' ' 41' ' ' LEU . . . -46.07 -42.38 13.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.763 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.498 HD13 ' CD2' ' A' ' 54' ' ' LEU . 10.6 mt -71.1 -34.56 71.22 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 120.983 0.42 . . . . 0.0 110.833 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.415 ' CD2' ' HB2' ' A' ' 101' ' ' PRO . 53.3 tp -68.9 -49.74 55.63 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.377 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.566 ' HB2' ' CE2' ' A' ' 211' ' ' PHE . 34.1 mt -67.28 -27.13 66.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.521 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.77 -39.03 90.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.056 178.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.593 ' CB ' ' HG ' ' A' ' 57' ' ' LEU . . . -81.32 -41.39 22.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.615 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.501 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 21.9 mt -69.05 -3.36 12.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.286 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.562 ' HB1' ' HB3' ' A' ' 231' ' ' TYR . . . -96.81 176.1 6.11 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.504 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.1 OUTLIER -112.18 113.4 25.63 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.596 178.247 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 115.59 167.99 15.29 Favored Glycine 0 C--N 1.32 -0.323 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -178.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.496 ' HG3' HG22 ' A' ' 76' ' ' ILE . 1.0 OUTLIER -95.3 117.78 30.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 117.32 0.56 . . . . 0.0 111.443 -179.371 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.503 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.9 OUTLIER -119.6 145.84 46.06 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.22 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.566 HG22 ' CG ' ' A' ' 74' ' ' GLU . 96.6 t -104.91 139.08 26.96 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.584 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 0.4 OUTLIER -114.77 116.1 28.1 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 174.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.622 HG23 HD21 ' A' ' 238' ' ' LEU . 0.6 OUTLIER -105.06 152.3 22.92 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.078 -178.29 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 36.9 t30 68.99 25.44 5.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.724 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.455 HD12 ' HB3' ' A' ' 73' ' ' CYS . 16.0 mt -55.32 -169.97 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.407 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 32.9 tp -112.46 131.9 55.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.596 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -89.05 85.92 6.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.021 0.439 . . . . 0.0 110.55 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.46 ' O ' ' N ' ' A' ' 50' ' ' VAL . 1.0 OUTLIER -164.25 142.88 7.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.926 -179.479 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 47' ' ' SER . 0.5 OUTLIER -33.07 -34.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.764 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.491 ' CB ' ' HA ' ' A' ' 95' ' ' ALA . 3.1 p30 -55.33 -42.59 73.97 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.043 0.449 . . . . 0.0 110.836 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.46 ' N ' ' O ' ' A' ' 47' ' ' SER . 78.5 t -84.63 -44.51 17.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.013 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.613 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -50.68 -39.77 51.93 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.653 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.656 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 18.9 m-70 -80.9 -32.42 34.79 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.888 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.556 ' O ' HD13 ' A' ' 57' ' ' LEU . 9.0 tpt -53.5 -34.74 59.17 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 176.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.636 ' HB3' ' CE2' ' A' ' 64' ' ' TYR . 0.4 OUTLIER -83.49 -43.04 16.21 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.648 176.465 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.742 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 67.0 t30 -56.73 -42.11 78.67 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-O 121.05 0.452 . . . . 0.0 110.131 179.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.474 ' HB1' HD13 ' A' ' 102' ' ' LEU . . . -57.11 -49.06 77.07 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.812 0.815 . . . . 0.0 108.956 178.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.757 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -61.8 -37.83 85.87 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.006 -1.452 . . . . 0.0 107.871 177.066 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.742 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -63.8 -35.02 79.24 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.877 179.271 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.436 ' O ' HD22 ' A' ' 88' ' ' LEU . . . -73.52 -37.59 65.6 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.356 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -82.24 -13.13 57.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.255 0.55 . . . . 0.0 110.893 -179.622 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.58 35.76 4.81 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.38 -0.827 . . . . 0.0 114.137 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.757 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 37.2 t -90.51 124.34 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.78 ' O ' HG12 ' A' ' 76' ' ' ILE . 4.3 m -85.96 130.8 34.43 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.499 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.636 ' CE2' ' HB3' ' A' ' 54' ' ' LEU . 38.4 p90 -157.64 171.68 19.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.84 0.352 . . . . 0.0 110.622 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 74' ' ' GLU . 99.7 m -138.1 149.16 45.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.305 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.472 ' CD1' ' HB2' ' A' ' 73' ' ' CYS . 7.3 tp -117.76 137.34 52.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.968 0.413 . . . . 0.0 110.756 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.7 p -59.93 179.91 0.12 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.989 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.79 -28.32 40.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.88 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -80.29 -0.11 35.16 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.247 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 55.89 48.73 17.4 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.797 0.332 . . . . 0.0 111.197 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -153.4 0.63 0.25 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.277 -0.419 . . . . 0.0 112.081 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.584 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.5 OUTLIER -129.48 110.97 12.3 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.472 ' HB2' ' CD1' ' A' ' 66' ' ' LEU . 42.9 t -118.37 132.34 56.27 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.566 ' CG ' HG22 ' A' ' 40' ' ' VAL . 43.4 tt0 -111.76 133.13 54.19 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.572 HG12 ' CB ' ' A' ' 64' ' ' TYR . 11.3 mt -130.46 122.97 54.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -178.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.78 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -67.75 100.93 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.763 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -39.27 144.17 0.33 Allowed Glycine 0 C--N 1.319 -0.39 0 CA-C-N 114.717 -1.128 . . . . 0.0 113.844 -178.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -88.86 -11.36 44.91 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.003 0.43 . . . . 0.0 110.861 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.504 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 85.86 15.61 65.03 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.217 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.436 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 139.55 -150.34 21.31 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.326 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.507 ' HB3' ' CB ' ' A' ' 108' ' ' LEU . 4.2 Cg_endo -49.2 123.55 10.27 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.71 2.274 . . . . 0.0 113.13 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.456 ' HB2' HD11 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -72.24 108.54 5.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.139 179.198 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.404 ' HA ' ' CG ' ' A' ' 111' ' ' ASN . 4.4 p80 -81.87 131.88 35.26 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.413 ' HB2' ' CD2' ' A' ' 88' ' ' LEU . . . -96.0 120.45 36.3 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.669 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -70.96 123.94 23.2 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.46 173.87 1.39 Allowed Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 -175.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.03 144.75 47.04 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 118.616 1.208 . . . . 0.0 111.816 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.551 ' CB ' HG13 ' A' ' 113' ' ' ILE . 0.7 OUTLIER -112.52 161.03 17.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.198 -178.536 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 32.6 mt-10 -142.05 101.39 3.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.136 177.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.47 ' N ' ' O ' ' A' ' 114' ' ' VAL . 0.0 OUTLIER -100.2 125.79 46.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.314 -178.622 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -98.37 96.44 8.03 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.688 HD21 HD23 ' A' ' 115' ' ' LEU . 0.1 OUTLIER -105.18 48.25 0.84 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.472 -179.479 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.58 ' HA3' ' H ' ' A' ' 118' ' ' GLU . . . -53.6 -66.0 3.04 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.65 -0.705 . . . . 0.0 113.247 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.462 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 23.0 m-80 -76.27 -0.98 24.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.559 0.218 . . . . 0.0 110.913 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.491 ' HA ' ' CB ' ' A' ' 49' ' ' ASP . . . -91.86 68.73 5.45 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.989 0.423 . . . . 0.0 111.307 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.07 -24.38 71.74 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.76 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.409 ' O ' ' HG3' ' A' ' 101' ' ' PRO . 0.6 OUTLIER -106.54 4.79 28.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.463 0.173 . . . . 0.0 111.167 179.595 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.411 ' O ' ' HG2' ' A' ' 101' ' ' PRO . . . -107.26 -40.82 5.29 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.875 0.369 . . . . 0.0 111.503 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.44 ' HB2' ' HB2' ' A' ' 92' ' ' LEU . 6.3 tpp -59.96 -46.31 89.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.609 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.486 ' HB2' ' HB2' ' A' ' 171' ' ' GLN . 5.3 mpt_? -53.72 -60.24 7.69 Favored Pre-proline 0 C--N 1.323 -0.571 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.006 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 100' ' ' ARG . 11.7 Cg_endo -59.24 -34.38 98.14 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 121.958 1.772 . . . . 0.0 112.409 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.479 ' HA ' HD23 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -71.31 -53.25 14.88 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.025 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.514 ' HA ' HD12 ' A' ' 115' ' ' LEU . . . -51.29 -28.34 11.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.534 178.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.498 ' CB ' HD21 ' A' ' 133' ' ' LEU . . . -86.75 -53.65 4.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.357 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.32 -37.47 80.69 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -177.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 102' ' ' LEU . 25.8 mt -75.24 -11.62 60.11 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.215 -177.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.578 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 21.9 m -83.23 17.76 1.95 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.185 0.517 . . . . 0.0 110.247 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.507 ' CB ' ' HB3' ' A' ' 81' ' ' PRO . 2.6 mt -95.92 -68.36 0.8 Allowed 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.365 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.07 151.96 27.83 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.669 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 m -66.54 98.29 0.49 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.982 0.42 . . . . 0.0 110.855 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.673 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 5.8 m-80 -148.53 137.44 21.62 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.103 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.798 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 1.7 m-20 -95.29 100.28 12.09 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.191 0.52 . . . . 0.0 109.926 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.551 HG13 ' CB ' ' A' ' 88' ' ' LEU . 1.6 mp -118.38 148.37 21.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.903 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.767 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 43.9 t -118.0 112.58 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 176.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.688 HD23 HD21 ' A' ' 92' ' ' LEU . 24.0 mt -102.36 105.58 16.22 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.905 -178.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.42 -170.39 1.8 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.802 0.334 . . . . 0.0 111.206 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.556 ' HA3' ' HG2' ' A' ' 121' ' ' MET . . . -168.32 172.58 42.94 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.006 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.596 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 18.1 mt-10 -68.85 176.36 1.55 Allowed Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 122.639 0.375 . . . . 0.0 110.903 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.596 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 81.7 Cg_exo -47.78 -41.06 31.89 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.759 2.306 . . . . 0.0 113.581 -179.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -67.37 -23.15 65.56 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.661 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.556 ' HG2' ' HA3' ' A' ' 117' ' ' GLY . 10.5 tpt -61.84 -35.19 77.55 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.462 ' HA ' ' HG2' ' A' ' 149' ' ' PRO . 3.4 mmtp -61.64 -16.78 51.56 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.673 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -86.34 3.48 43.28 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 120.827 0.346 . . . . 0.0 110.289 178.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.419 ' HB3' ' NH2' ' A' ' 100' ' ' ARG . 3.5 mtt180 -127.3 81.18 70.5 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.075 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.408 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 14.8 Cg_endo -56.9 149.21 62.56 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.937 2.425 . . . . 0.0 112.032 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.441 HG12 HD11 ' A' ' 151' ' ' LEU . 0.7 OUTLIER -124.14 17.67 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.349 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.415 ' HA3' ' CB ' ' A' ' 147' ' ' ASN . . . -61.29 -46.16 95.0 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.927 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.604 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 37.6 m80 -56.87 -35.53 69.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.982 0.391 . . . . 0.0 111.322 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.572 ' HG ' ' CD1' ' A' ' 133' ' ' LEU . 15.4 tp -75.79 -47.71 24.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.927 0.394 . . . . 0.0 111.318 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.694 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 51.9 t -56.25 -47.43 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.395 -178.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.657 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 82.8 m-20 -68.81 -39.8 79.86 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.031 0.443 . . . . 0.0 110.12 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.426 ' HB2' ' CG1' ' A' ' 162' ' ' VAL . . . -59.4 -45.24 92.06 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.012 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.572 ' CD1' ' HG ' ' A' ' 129' ' ' LEU . 10.7 mt -75.15 -48.42 23.74 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.446 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.694 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -58.65 -28.37 65.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.959 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.657 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 5.8 tp -68.3 -32.57 72.81 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.278 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 159' ' ' GLY . . . -79.35 9.96 38.5 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.153 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.39 6.64 57.48 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.329 -0.939 . . . . 0.0 112.755 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.48 151.97 39.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.882 0.372 . . . . 0.0 111.146 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.433 ' CB ' ' HB2' ' A' ' 154' ' ' GLN . 9.9 mmmt -99.22 100.14 11.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.687 178.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.656 ' HB ' ' HG3' ' A' ' 134' ' ' ARG . 28.5 mt -131.68 127.44 59.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.477 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.734 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -125.14 139.03 54.12 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.004 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -78.54 133.48 37.36 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.847 0.356 . . . . 0.0 110.955 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.818 ' HB2' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -94.02 -87.84 0.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.734 -179.55 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.491 ' HB2' ' CG ' ' A' ' 150' ' ' PRO . 2.5 mm-40 -59.36 -81.99 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.34 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.42 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 35.0 mt-30 -115.14 154.45 28.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.112 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 5.0 mt-10 -67.66 131.96 46.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.31 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 146' ' ' GLU . 1.1 m-20 70.57 19.41 6.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.954 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.548 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 13.2 m-85 -109.72 168.63 7.41 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.61 ' HB2' ' CD ' ' A' ' 150' ' ' PRO . 10.5 Cg_exo -30.91 -62.1 0.12 Allowed 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 125.264 3.976 . . . . 0.0 117.477 -177.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.818 ' HB2' ' HB2' ' A' ' 143' ' ' LEU . 26.3 Cg_endo -62.24 150.17 87.93 Favored 'Trans proline' 0 C--N 1.351 0.677 0 CA-C-N 120.655 1.27 . . . . 0.0 112.117 -177.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.767 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 7.6 mt -155.64 138.63 15.43 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.866 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.734 ' HB2' HG22 ' A' ' 141' ' ' THR . 0.7 OUTLIER -104.71 104.31 14.09 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 176.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.798 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 4.1 mt -95.6 141.54 28.99 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.817 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.673 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 2.8 mt-30 -145.47 31.1 1.09 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.665 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 48.18 -158.02 0.84 Allowed Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.323 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.44 -11.08 46.95 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.264 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.442 ' CB ' ' O ' ' A' ' 107' ' ' CYS . 31.6 t80 -59.77 122.93 15.41 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 117.467 0.634 . . . . 0.0 110.367 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' THR . . . . . 0.719 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 70.0 p -115.96 -35.53 4.41 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 121.54 0.686 . . . . 0.0 111.182 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.435 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 140.21 -160.76 26.4 Favored Glycine 0 C--N 1.307 -1.049 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.085 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 105.88 152.64 20.43 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.545 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -47.02 123.03 4.85 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.084 -0.558 . . . . 0.0 110.597 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 42.7 t -116.06 146.39 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.123 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -113.27 120.16 40.22 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.117 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 191' ' ' ILE . 1.0 OUTLIER -133.95 119.92 33.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.465 ' HB2' ' HD2' ' A' ' 128' ' ' HIS . 0.8 OUTLIER -56.47 141.18 43.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.929 0.395 . . . . 0.0 111.041 -179.223 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.513 ' CA ' HG21 ' A' ' 191' ' ' ILE . . . . . . . . 0 N--CA 1.447 -0.618 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.595 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.084 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.486 ' HB2' ' HB2' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -86.26 -11.86 51.16 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.005 -179.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.604 ' CE2' ' HB2' ' A' ' 128' ' ' HIS . 5.9 m-85 -71.3 -56.77 5.35 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.635 HD13 ' CG1' ' A' ' 191' ' ' ILE . 0.5 OUTLIER -62.81 -44.43 96.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.39 178.741 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.47 ' HB ' ' HA ' ' A' ' 171' ' ' GLN . 2.5 m -54.82 -33.19 61.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.826 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.423 ' CB ' ' HB3' ' A' ' 104' ' ' ALA . . . -68.32 -39.3 82.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.242 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.402 HD21 HD22 ' A' ' 133' ' ' LEU . 0.7 OUTLIER -76.58 -35.45 58.16 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.839 179.753 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.76 ' O ' ' HE1' ' A' ' 208' ' ' MET . 3.8 mp -59.82 -37.85 80.37 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.191 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' MET . . . . . 0.59 ' HE1' ' HA ' ' A' ' 27' ' ' ARG . 2.6 mtp -81.68 -43.15 18.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.338 0.59 . . . . 0.0 112.086 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 95.9 m -72.01 -42.4 66.43 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.105 -178.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.611 ' HB3' ' HB ' ' A' ' 187' ' ' THR . . . -58.71 -41.44 88.86 Favored Pre-proline 0 C--N 1.32 -0.716 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -176.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 28.5 Cg_endo -64.43 -28.54 62.53 Favored 'Trans proline' 0 CA--C 1.501 -1.167 0 C-N-CA 120.831 1.02 . . . . 0.0 112.128 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.433 ' HB2' ' CD2' ' A' ' 108' ' ' LEU . 5.6 mt -84.26 0.83 47.43 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.51 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . -83.51 137.71 41.71 Favored Pre-proline 0 C--O 1.224 -0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.396 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.719 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 11.4 Cg_endo -51.34 -34.31 49.47 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.688 2.258 . . . . 0.0 113.404 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.81 140.2 46.66 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.733 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -55.16 143.69 26.62 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.046 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.611 ' HB ' ' HB3' ' A' ' 180' ' ' ALA . 92.0 m -123.6 148.23 46.6 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.687 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 40.3 t -128.7 118.27 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.878 177.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.696 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 5.0 mp -99.09 119.09 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.568 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 2.4 ttt180 -100.74 125.46 47.2 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.635 ' CG1' HD13 ' A' ' 173' ' ' LEU . 1.5 mp -93.37 127.33 45.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.867 -176.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -82.65 96.67 8.19 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.231 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 98.66 -127.55 9.28 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.708 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -116.66 133.54 55.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.708 0.29 . . . . 0.0 111.471 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.466 HD13 HG13 ' A' ' 201' ' ' ILE . 1.1 mt -41.62 144.13 0.42 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.166 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.446 ' HB ' ' O ' ' A' ' 166' ' ' GLY . 12.4 p -72.87 -25.03 21.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.637 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' SER . . . . . 0.542 ' C ' ' CD ' ' A' ' 199' ' ' PRO . 0.4 OUTLIER -170.78 68.63 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.096 0.474 . . . . 0.0 110.235 -179.575 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.723 ' HG3' ' HD3' ' A' ' 199' ' ' PRO . 0.0 OUTLIER -48.17 -29.37 1.4 Allowed Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.344 179.712 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . 0.723 ' HD3' ' HG3' ' A' ' 198' ' ' LYS . 23.3 Cg_exo -64.78 -28.9 59.41 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 121.094 1.196 . . . . 0.0 110.724 178.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.543 ' HA ' ' CD1' ' A' ' 203' ' ' ILE . 0.1 OUTLIER -69.79 -42.3 73.93 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 177.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.466 HG13 HD13 ' A' ' 195' ' ' LEU . 11.9 mm -60.15 -39.61 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.255 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -58.07 -44.86 87.74 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.327 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.543 ' CD1' ' HA ' ' A' ' 200' ' ' TYR . 4.0 mt -62.66 -50.42 79.83 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 CA-C-O 121.569 0.699 . . . . 0.0 109.551 178.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.468 ' O ' ' HG3' ' A' ' 208' ' ' MET . 97.4 m -53.43 -51.54 62.31 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.843 -178.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.481 ' CD2' ' HB ' ' A' ' 215' ' ' ILE . 29.8 mt -67.01 -29.22 68.99 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.028 0.442 . . . . 0.0 111.369 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . 0.419 ' HA ' ' HE3' ' A' ' 209' ' ' LYS . 5.1 t-20 -77.63 -46.47 21.96 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.633 0.73 . . . . 0.0 109.876 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.442 ' O ' ' CG2' ' A' ' 210' ' ' THR . 4.4 tp -71.75 -29.7 64.79 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.574 -1.193 . . . . 0.0 109.404 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' MET . . . . . 0.76 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 43.0 mtp -76.13 -35.31 59.3 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 14.4 mtmt -61.43 -38.71 88.14 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.654 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.449 ' O ' ' HB3' ' A' ' 234' ' ' PRO . 6.6 t -61.04 -26.85 67.92 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.3 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.566 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 27.6 m-85 -83.88 -7.31 59.47 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.903 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.89 7.43 25.37 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 116.31 1.284 . . . . 0.0 116.31 177.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.2 m -123.55 148.54 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 118.983 1.392 . . . . 0.0 112.604 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.478 ' HG2' ' HD3' ' A' ' 209' ' ' LYS . 12.0 mt-10 -130.35 139.41 50.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.008 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.537 HG23 ' HB ' ' A' ' 225' ' ' VAL . 18.4 mm -122.46 148.78 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 120.836 0.351 . . . . 0.0 110.744 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.572 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 1.3 tp10 -104.67 122.4 45.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.032 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.84 151.01 23.72 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.182 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . 0.523 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 2.8 mm-40 -111.12 -141.57 0.38 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.14 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.513 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 28.3 m170 -73.92 65.03 1.03 Allowed 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 2.0 t80 57.24 36.3 27.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.706 0.765 . . . . 0.0 110.944 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.628 ' O ' ' CD1' ' A' ' 223' ' ' PHE . 4.5 pt20 -168.73 -124.5 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.696 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -8.61 130.88 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.687 ' O ' ' HA ' ' A' ' 188' ' ' VAL . 0.7 OUTLIER -121.87 140.23 52.65 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.119 -1.855 . . . . 0.0 109.625 -179.163 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.572 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 40.1 t -120.84 114.25 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-O 121.297 0.57 . . . . 0.0 109.696 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.537 ' HB ' HG23 ' A' ' 215' ' ' ILE . 0.2 OUTLIER -122.29 125.87 73.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.087 -179.017 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.454 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -77.88 127.55 32.56 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -80.52 -178.51 52.11 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.351 -178.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 67.5 21.01 72.29 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 121.623 -0.322 . . . . 0.0 113.285 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 46.5 mt-30 -78.32 -173.43 3.27 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.268 0.556 . . . . 0.0 111.214 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.09 147.8 26.25 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.365 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' TYR . . . . . 0.562 ' HB3' ' HB1' ' A' ' 35' ' ' ALA . 7.2 m-85 -102.89 130.35 49.9 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.886 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.04 151.78 37.62 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.48 111.09 12.45 Favored Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.97 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.503 ' HD2' ' OG1' ' A' ' 39' ' ' THR . 52.0 Cg_endo -69.37 1.11 4.46 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.249 1.966 . . . . 0.0 112.27 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 98.68 -101.04 2.4 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.303 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 49.2 m -118.42 136.97 53.46 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . 0.465 ' N ' ' O ' ' A' ' 40' ' ' VAL . 9.3 t80 -133.23 124.2 26.95 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.989 0.423 . . . . 0.0 111.362 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.671 HD13 ' HG2' ' A' ' 240' ' ' GLU . 0.2 OUTLIER -94.99 110.83 22.69 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.8 179.866 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 21.5 t -77.93 112.52 16.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.474 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . 0.671 ' HG2' HD13 ' A' ' 238' ' ' LEU . 2.7 mt-10 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.296 -0.859 . . . . 0.0 111.018 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.504 ' HB2' HD22 ' A' ' 44' ' ' LEU . 22.7 t . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.328 0.109 . . . . 2.4900000000000002 110.933 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.8 m120 63.84 -81.91 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.682 0.277 . . . . 1.6899999999999999 111.713 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.566 ' HD3' HG22 ' A' ' 174' ' ' THR . 37.7 mtm-85 -76.94 -61.51 1.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.094 0.405 . . . . 2.8599999999999999 112.094 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.522 ' CB ' ' HG ' ' A' ' 41' ' ' LEU . . . -35.76 -42.75 0.27 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.584 -0.735 . . . . 1.0800000000000001 112.601 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.51 HD23 ' HA ' ' A' ' 29' ' ' LEU . 12.4 mt -75.9 -39.55 56.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.896 0.379 . . . . 1.02 111.587 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.7 tp -64.91 -50.85 64.88 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.034 -0.53 . . . . 1.0700000000000001 110.873 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.528 HD23 ' CE2' ' A' ' 231' ' ' TYR . 31.4 mt -64.78 -28.06 69.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.992 -0.549 . . . . 1.1799999999999999 109.684 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.75 -40.03 94.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.523 -0.762 . . . . 0.95999999999999996 110.238 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.48 ' HB1' ' HG ' ' A' ' 57' ' ' LEU . . . -77.82 -39.46 43.64 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.046 -0.525 . . . . 0.94999999999999996 111.273 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.487 ' CD2' ' HA ' ' A' ' 81' ' ' PRO . 20.7 mt -70.69 -3.0 16.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.95 -0.568 . . . . 1.1000000000000001 110.534 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.494 ' HB1' ' O ' ' A' ' 31' ' ' LEU . . . -96.39 172.9 7.65 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 113.144 0.794 . . . . 1.0800000000000001 113.144 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.444 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.2 OUTLIER -110.11 108.76 19.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.845 -1.07 . . . . 1.29 108.593 178.001 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 120.57 170.1 14.09 Favored Glycine 0 C--N 1.319 -0.38 0 C-N-CA 120.822 -0.704 . . . . 0.72999999999999998 111.375 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.517 ' HG3' HG21 ' A' ' 76' ' ' ILE . 0.1 OUTLIER -94.48 119.3 32.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.227 0.514 . . . . 2.21 111.609 -179.228 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.539 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 1.0 OUTLIER -120.3 142.13 49.38 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 120.715 0.293 . . . . 1.0700000000000001 110.401 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 69.5 t -102.08 139.21 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-O 121.324 0.583 . . . . 1.0700000000000001 111.937 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.522 ' HG ' ' CB ' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -113.21 114.96 27.48 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 107.217 -1.401 . . . . 1.0800000000000001 107.217 175.759 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.548 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.6 OUTLIER -102.81 149.34 24.58 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.487 -0.485 . . . . 1.0900000000000001 111.04 -178.317 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 69.4 24.5 5.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.03 -0.532 . . . . 1.8400000000000001 111.756 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.508 ' CD2' ' HB3' ' A' ' 41' ' ' LEU . 86.8 mt -52.92 -177.47 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.832 0.349 . . . . 1.0 110.138 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.4 tp -108.75 131.39 54.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.439 -0.346 . . . . 1.1699999999999999 110.369 178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -89.17 88.87 7.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.855 0.359 . . . . 1.6399999999999999 110.247 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 49' ' ' ASP . 0.6 OUTLIER -165.48 144.64 6.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 1.54 110.073 -179.154 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -36.1 -32.31 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.638 0.256 . . . . 1.6100000000000001 111.449 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.49 ' HB3' ' O ' ' A' ' 94' ' ' ASN . 4.6 p30 -56.13 -42.2 76.55 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.899 0.381 . . . . 1.5600000000000001 110.841 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.42 ' N ' ' O ' ' A' ' 47' ' ' SER . 84.1 t -84.4 -45.82 17.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.036 -0.529 . . . . 1.1100000000000001 110.531 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.434 ' HA ' ' CD1' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -48.73 -38.65 22.17 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.989 -0.285 . . . . 2.6699999999999999 110.615 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.564 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 19.6 m-70 -79.88 -36.22 36.88 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 109.634 -0.506 . . . . 0.28999999999999998 109.634 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.457 ' O ' HD23 ' A' ' 57' ' ' LEU . 8.5 tpt -53.36 -31.55 45.14 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 106.086 -1.82 . . . . 0.93999999999999995 106.086 176.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.554 ' HB3' ' CE2' ' A' ' 64' ' ' TYR . 2.2 mt -83.42 -45.41 13.69 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 113.914 -1.494 . . . . 1.04 108.645 176.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.656 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 18.2 t-20 -58.94 -39.75 82.59 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 115.82 -0.627 . . . . 1.8600000000000001 111.002 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.37 -49.96 73.45 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.69 0.757 . . . . 1.04 109.249 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.631 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.5 OUTLIER -57.95 -37.66 74.55 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.246 -1.39 . . . . 1.02 107.246 176.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.656 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -62.59 -44.43 96.34 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.005 -1.452 . . . . 1.0900000000000001 112.021 179.227 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.453 ' HB3' HD11 ' A' ' 90' ' ' LEU . . . -67.78 -39.13 84.13 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.712 0.634 . . . . 1.02 112.712 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.26 -17.13 60.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.426 0.631 . . . . 1.0600000000000001 110.28 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.81 37.16 3.75 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 114.894 -1.048 . . . . 0.35999999999999999 113.935 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.631 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 22.0 t -90.3 125.57 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 109.09 -0.707 . . . . 1.1100000000000001 109.09 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.707 ' O ' HG12 ' A' ' 76' ' ' ILE . 12.5 m -86.55 130.61 34.43 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 120.469 -0.492 . . . . 1.47 111.13 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.561 ' HB3' HG22 ' A' ' 75' ' ' ILE . 32.4 p90 -159.78 168.87 24.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.18 -0.464 . . . . 0.80000000000000004 110.291 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 99.0 m -134.76 148.65 50.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.561 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.409 ' CD1' ' HB2' ' A' ' 73' ' ' CYS . 14.4 tp -117.19 136.79 52.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.09 0.472 . . . . 1.1899999999999999 110.776 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.499 ' HB2' ' CB ' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -63.94 -158.99 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.612 -0.722 . . . . 2.1099999999999999 111.281 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -95.7 -31.98 12.97 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.413 -0.358 . . . . 2.2200000000000002 111.178 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.53 1.09 30.95 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.413 -0.358 . . . . 1.8899999999999999 111.375 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 59.79 24.72 13.7 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.48 -0.327 . . . . 2.4700000000000002 111.67 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -122.4 -11.23 8.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.823 0.344 . . . . 1.0 111.406 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.499 ' CB ' ' HB2' ' A' ' 67' ' ' SER . 2.0 mtt180 -112.56 117.96 33.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.439 -0.346 . . . . 3.6000000000000001 110.275 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.479 ' HB3' HD13 ' A' ' 44' ' ' LEU . 43.4 t -131.11 127.52 38.27 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 120.958 0.408 . . . . 0.73999999999999999 111.735 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.517 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 51.3 tt0 -112.24 133.1 54.55 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 109.04 -0.726 . . . . 1.49 109.04 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.561 HG22 ' HB3' ' A' ' 64' ' ' TYR . 11.8 mt -128.7 123.86 60.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 113.948 1.092 . . . . 1.05 113.948 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.707 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -67.73 98.86 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 109.157 -0.683 . . . . 1.5900000000000001 109.157 175.764 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -37.23 142.91 0.2 Allowed Glycine 0 C--N 1.321 -0.262 0 CA-C-N 115.138 -0.937 . . . . 0.22 113.579 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -90.31 -13.32 35.45 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.917 0.389 . . . . 1.8700000000000001 111.113 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.444 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 86.24 14.51 66.34 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.037 -0.601 . . . . 0.28999999999999998 112.606 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.401 ' O ' HD22 ' A' ' 34' ' ' LEU . . . 145.36 -155.58 26.55 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.792 -0.718 . . . . 0.22 112.581 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.487 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 5.8 Cg_endo -49.3 127.41 17.76 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.682 2.255 . . . . 0.93000000000000005 112.436 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.462 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 0.3 OUTLIER -74.88 109.25 8.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.124 -0.489 . . . . 1.1000000000000001 109.935 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -80.42 124.12 28.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.2 0.524 . . . . 0.67000000000000004 112.111 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.608 ' HB3' HD12 ' A' ' 113' ' ' ILE . . . -89.34 124.2 34.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.505 -0.77 . . . . 1.03 111.275 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.51 122.92 20.0 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 105.621 -1.992 . . . . 1.95 105.621 176.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.24 -175.39 5.5 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 108.559 -1.816 . . . . 0.22 108.559 -175.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.38 145.03 30.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 118.787 1.294 . . . . 1.0700000000000001 111.832 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.534 ' HB3' HG13 ' A' ' 113' ' ' ILE . 0.8 OUTLIER -114.16 161.78 17.35 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.003 -0.998 . . . . 1.01 112.278 -178.656 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -139.63 102.89 4.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.612 -1.176 . . . . 1.8700000000000001 108.707 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.596 ' HB2' HD23 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -99.2 127.54 45.19 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 120.99 0.424 . . . . 1.04 111.276 -178.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -99.09 95.51 7.16 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.86 -0.609 . . . . 1.8400000000000001 109.679 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.444 HD23 ' O ' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -104.03 54.82 0.73 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.846 -0.615 . . . . 1.0900000000000001 110.085 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -56.63 -68.5 1.66 Allowed Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.71 -0.677 . . . . 0.82999999999999996 112.984 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.49 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 33.2 m-20 -79.12 -1.76 37.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.575 0.226 . . . . 2.3799999999999999 110.801 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.411 ' CB ' ' HA ' ' A' ' 49' ' ' ASP . . . -92.76 45.58 1.19 Allowed 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 116.475 -0.33 . . . . 1.1799999999999999 110.919 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -50.42 -27.58 12.17 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.429 -0.891 . . . . 0.81999999999999995 112.032 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.1 p -88.83 -14.94 35.77 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.529 0.196 . . . . 1.3700000000000001 111.529 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.434 ' O ' ' HG2' ' A' ' 101' ' ' PRO . . . -93.46 -37.19 12.07 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.074 0.398 . . . . 1.2 112.074 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.1 tpp -59.17 -46.37 88.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.693 -0.23 . . . . 1.0800000000000001 110.737 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' A' ' 171' ' ' GLN . 2.2 mpt_? -52.89 -60.68 6.08 Favored Pre-proline 0 C--N 1.324 -0.537 0 C-N-CA 120.755 -0.378 . . . . 2.0499999999999998 110.056 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 100' ' ' ARG . 18.1 Cg_endo -60.31 -31.63 93.11 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.422 2.082 . . . . 0.78000000000000003 112.773 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.1 mt -73.76 -54.03 8.98 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 120.403 -0.519 . . . . 1.04 109.945 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.451 ' O ' HD12 ' A' ' 153' ' ' LEU . . . -47.42 -29.6 2.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.673 -0.694 . . . . 1.0700000000000001 110.543 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.446 ' HB1' ' HB3' ' A' ' 175' ' ' ALA . . . -88.08 -52.11 5.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.872 -0.604 . . . . 1.03 112.226 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.401 ' HB2' HD13 ' A' ' 34' ' ' LEU . . . -59.89 -35.42 74.8 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.193 0.812 . . . . 0.98999999999999999 113.193 -177.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.3 mt -78.74 -10.98 59.96 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 112.705 0.631 . . . . 1.03 112.705 -177.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.623 ' HB3' ' HB2' ' A' ' 138' ' ' ALA . 99.0 m -93.07 24.86 3.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.287 0.565 . . . . 1.8500000000000001 110.067 178.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.414 ' CD2' ' HB2' ' A' ' 182' ' ' LEU . 0.5 OUTLIER -85.51 -75.95 0.35 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.335 -0.848 . . . . 1.1399999999999999 111.213 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -76.76 -105.61 0.14 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.581 -0.819 . . . . 1.1399999999999999 112.141 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.63 96.33 1.5 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.057 0.456 . . . . 1.55 110.523 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.675 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 0.0 OUTLIER -141.39 140.1 33.61 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.76 -0.654 . . . . 2.52 110.799 -178.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.798 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 5.6 m-20 -95.44 99.25 11.18 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 109.087 -0.708 . . . . 1.1200000000000001 109.087 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.608 HD12 ' HB3' ' A' ' 84' ' ' ALA . 1.3 mp -123.28 144.11 33.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.553 -0.749 . . . . 1.3200000000000001 111.663 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.679 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 48.0 t -113.9 113.22 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 107.922 -1.14 . . . . 1.05 107.922 176.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.596 HD23 ' HB2' ' A' ' 90' ' ' LEU . 25.7 mt -101.23 105.67 16.81 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 119.869 -0.733 . . . . 1.02 110.346 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.48 -171.61 2.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.573 -0.285 . . . . 1.1000000000000001 111.315 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -167.27 -166.22 25.98 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.547 -0.835 . . . . 0.28999999999999998 113.278 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.591 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 40.2 mt-10 -85.85 166.82 27.42 Favored Pre-proline 0 C--N 1.33 -0.273 0 C-N-CA 122.606 0.363 . . . . 1.79 110.678 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.591 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 2.1 Cg_endo -44.83 -37.25 11.74 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.725 2.283 . . . . 0.81000000000000005 112.696 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -67.62 -26.55 66.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.807 0.337 . . . . 2.75 110.381 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.489 ' O ' ' HG3' ' A' ' 149' ' ' PRO . 7.3 tpt -62.5 -31.81 72.62 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.532 -0.544 . . . . 1.1499999999999999 109.532 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.7 -18.08 58.22 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 115.923 -0.58 . . . . 2.04 110.257 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -85.25 4.9 32.64 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.957 0.408 . . . . 2.3199999999999998 110.086 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.9 mtt-85 -127.16 80.58 71.38 Favored Pre-proline 0 N--CA 1.455 -0.197 0 CA-C-N 116.013 -0.54 . . . . 2.7599999999999998 110.51 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.83 148.89 63.8 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.583 2.188 . . . . 0.84999999999999998 111.712 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.458 HG12 HD11 ' A' ' 151' ' ' LEU . 1.2 tt -126.13 10.4 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 112.386 0.513 . . . . 1.0600000000000001 112.386 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.521 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -59.99 -39.83 96.16 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.559 -0.829 . . . . 0.28999999999999998 113.107 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -57.41 -37.02 72.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.747 0.308 . . . . 2.2000000000000002 111.03 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.476 ' HB2' ' CD2' ' A' ' 172' ' ' PHE . 12.5 tp -75.65 -44.49 42.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.273 0.559 . . . . 1.1100000000000001 110.514 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.658 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 47.8 t -55.48 -48.13 77.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.367 -0.833 . . . . 1.05 111.275 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.651 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 4.1 m-20 -67.77 -41.45 83.25 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 120.993 0.425 . . . . 1.3200000000000001 110.562 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.419 ' HB2' ' CG1' ' A' ' 162' ' ' VAL . . . -56.84 -44.06 81.72 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.553 -0.749 . . . . 1.01 110.003 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.48 ' O ' ' HB1' ' A' ' 138' ' ' ALA . 6.5 mt -77.4 -51.32 11.0 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.596 -0.729 . . . . 1.0600000000000001 110.769 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.658 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -55.16 -26.41 38.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.598 -0.728 . . . . 3.3799999999999999 109.912 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.651 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 3.4 tp -69.51 -32.5 71.4 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.175 -0.466 . . . . 1.1899999999999999 110.556 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.47 12.06 41.76 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.646 -0.788 . . . . 0.20000000000000001 112.049 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.91 5.57 58.41 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.25 -0.976 . . . . 0.25 112.689 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.623 ' HB2' ' HB3' ' A' ' 107' ' ' CYS . . . -75.77 149.66 37.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.029 0.442 . . . . 0.98999999999999999 111.305 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.0 mttp -97.0 109.22 22.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.948 -0.569 . . . . 2.5499999999999998 110.277 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.445 ' HB ' HG13 ' A' ' 130' ' ' VAL . 28.1 mt -140.6 126.9 21.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.838 0.351 . . . . 1.1100000000000001 111.638 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.603 HG21 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -124.2 139.96 53.43 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.124 -0.489 . . . . 1.0600000000000001 110.258 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -80.56 130.14 34.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.837 0.351 . . . . 0.78000000000000003 110.867 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.628 ' HB2' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -88.5 -85.03 0.19 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.136 -0.484 . . . . 1.0800000000000001 112.076 -178.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.448 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 1.2 mt-10 -66.28 -83.87 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.838 -0.345 . . . . 1.77 110.586 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.457 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 75.5 mt-30 -109.49 153.95 23.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.407 -0.36 . . . . 2.3199999999999998 110.139 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -69.1 131.74 45.47 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.874 0.368 . . . . 1.6599999999999999 110.865 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.521 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 0.9 OUTLIER 71.43 19.93 5.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.934 -0.575 . . . . 1.24 111.155 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.564 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 14.6 m-85 -106.8 169.12 7.15 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 112.277 0.473 . . . . 1.03 112.277 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.742 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 65.4 Cg_exo -36.09 -57.26 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.86 3.04 . . . . 0.31 115.481 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.742 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 52.3 Cg_exo -56.79 144.97 85.72 Favored 'Trans proline' 0 C--N 1.353 0.806 0 CA-C-N 120.432 1.19 . . . . 0.23000000000000001 112.05 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.679 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 12.2 mt -156.81 134.98 11.2 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.841 -1.072 . . . . 1.1200000000000001 109.894 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.603 ' HB2' HG21 ' A' ' 141' ' ' THR . 3.7 mtt180 -105.33 105.43 15.47 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.009 -1.108 . . . . 2.5600000000000001 108.009 176.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.798 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 3.4 mt -94.35 144.62 25.39 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.865 -1.061 . . . . 1.0600000000000001 110.904 -177.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.675 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 3.6 mt-30 -145.87 27.23 1.2 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.508 -0.769 . . . . 1.1799999999999999 110.72 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 51.06 179.05 0.03 OUTLIER Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.015 -0.612 . . . . 0.40000000000000002 112.622 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 125.68 -10.27 7.58 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.143 -1.027 . . . . 0.33000000000000002 113.405 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.432 ' CB ' ' O ' ' A' ' 107' ' ' CYS . 21.4 t80 -58.87 122.64 14.12 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 117.381 0.591 . . . . 0.81999999999999995 110.482 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.678 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 73.1 p -117.53 -38.29 3.33 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.334 0.588 . . . . 1.1200000000000001 111.625 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.535 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 144.64 -170.92 26.11 Favored Glycine 0 C--N 1.308 -1.022 0 C-N-CA 120.239 -0.981 . . . . 0.26000000000000001 112.583 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.491 ' O ' HG22 ' A' ' 162' ' ' VAL . . . 112.58 155.06 12.19 Favored Glycine 0 N--CA 1.436 -1.323 0 N-CA-C 111.189 -0.764 . . . . 0.62 111.189 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -47.76 125.67 9.04 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 120.833 0.349 . . . . 2.5600000000000001 110.68 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 74.7 t -117.11 144.42 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.66 -0.496 . . . . 1.1299999999999999 109.66 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -113.26 119.39 37.57 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.865 -0.334 . . . . 1.1200000000000001 110.794 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.469 ' HB ' ' CG2' ' A' ' 189' ' ' ILE . 1.1 t -131.83 119.17 40.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 120.598 -0.441 . . . . 1.1200000000000001 109.851 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.428 ' HB3' HG21 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -55.44 138.39 46.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 1.48 111.288 -178.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.463 ' CA ' HG22 ' A' ' 191' ' ' ILE . . . -60.8 -46.17 95.02 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.588 -0.815 . . . . 0.52000000000000002 112.431 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.417 ' O ' HG22 ' A' ' 168' ' ' VAL . 4.3 m -91.5 87.36 6.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.729 0.3 . . . . 1.8799999999999999 111.432 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.475 HG12 ' CD2' ' A' ' 172' ' ' PHE . 72.4 t -146.22 -79.86 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.248 0.547 . . . . 1.8700000000000001 110.674 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.444 ' HB2' ' CD1' ' A' ' 172' ' ' PHE . 0.6 OUTLIER -169.99 132.8 1.13 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.362 -0.835 . . . . 1.55 110.685 179.868 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.432 ' HB2' ' HB3' ' A' ' 200' ' ' TYR . 71.9 p -58.22 -16.96 15.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.919 -0.582 . . . . 1.8300000000000001 111.993 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.494 ' O ' ' HB3' ' A' ' 100' ' ' ARG . 8.7 mp0 -85.5 -11.01 55.25 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.815 -0.354 . . . . 2.8799999999999999 111.111 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.476 ' CD2' ' HB2' ' A' ' 129' ' ' LEU . 10.8 m-85 -75.07 -59.19 2.85 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.317 -0.623 . . . . 0.51000000000000001 109.317 178.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.408 ' CD1' ' CG1' ' A' ' 191' ' ' ILE . 0.3 OUTLIER -60.7 -39.14 87.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.475 -0.784 . . . . 1.3200000000000001 109.18 178.42 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.566 HG22 ' HD3' ' A' ' 27' ' ' ARG . 1.7 m -59.84 -38.96 83.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.922 -1.036 . . . . 1.05 109.62 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 100' ' ' ARG . . . -60.65 -41.5 95.08 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.815 -0.629 . . . . 0.91000000000000003 110.911 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.37 -32.16 54.78 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.473 -0.785 . . . . 1.3700000000000001 110.891 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.715 ' O ' ' HE3' ' A' ' 208' ' ' MET . 3.5 mp -61.51 -38.44 87.36 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.342 -0.845 . . . . 1.1699999999999999 110.759 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.518 ' HE1' ' HA ' ' A' ' 27' ' ' ARG . 1.5 mtp -82.65 -40.6 20.49 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.51 0.559 . . . . 0.94999999999999996 112.51 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 50.3 m -77.1 -39.43 49.56 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.343 -0.844 . . . . 1.02 113.071 -178.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.513 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . -58.7 -42.52 94.72 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 114.428 1.27 . . . . 1.0600000000000001 114.428 -177.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 27.0 Cg_endo -64.82 -27.56 59.42 Favored 'Trans proline' 0 CA--C 1.501 -1.154 0 CA-C-N 119.795 0.962 . . . . 0.73999999999999999 112.387 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.414 ' HB2' ' CD2' ' A' ' 108' ' ' LEU . 4.0 mt -83.26 -2.36 55.42 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 109.31 -0.626 . . . . 1.3400000000000001 109.31 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.587 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . -78.17 135.8 61.9 Favored Pre-proline 0 C--O 1.224 -0.274 0 CA-C-N 116.049 -0.523 . . . . 1.0900000000000001 110.122 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.678 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 11.3 Cg_endo -51.14 -34.4 47.77 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.378 2.052 . . . . 0.27000000000000002 113.11 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -112.4 143.64 43.18 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.697 -0.683 . . . . 2.0899999999999999 111.112 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -58.07 153.43 14.67 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.285 -0.416 . . . . 2.2400000000000002 110.286 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.535 ' OG1' ' HA2' ' A' ' 159' ' ' GLY . 56.4 m -133.75 145.65 50.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.077 0.465 . . . . 1.0800000000000001 112.223 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 54.6 t -124.48 117.58 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.584 -0.735 . . . . 1.1100000000000001 110.197 178.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 3.4 mp -100.13 117.9 45.99 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 N-CA-C 108.731 -0.84 . . . . 1.0900000000000001 108.731 177.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 7.7 ttt180 -100.66 124.71 46.64 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.322 -0.992 . . . . 2.8999999999999999 108.322 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.546 ' HB ' ' HA ' ' A' ' 221' ' ' GLN . 1.6 mp -92.27 122.37 43.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.933 -1.03 . . . . 1.0600000000000001 111.746 -176.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -80.46 96.87 6.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.072 -1.422 . . . . 1.49 110.595 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 101.56 -132.39 10.94 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.747 -0.74 . . . . 0.52000000000000002 111.884 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -116.74 127.51 54.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.711 0.291 . . . . 1.1000000000000001 111.628 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 1.1 mt -40.42 144.87 0.2 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.157 -0.474 . . . . 1.2 111.269 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 10.5 p -72.52 -30.74 35.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.995 -0.548 . . . . 1.27 112.2 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.461 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 0.2 OUTLIER -165.23 63.61 0.12 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.977 0.417 . . . . 1.2 110.734 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.45 ' N ' ' CD ' ' A' ' 199' ' ' PRO . 6.1 tttm -40.25 -46.21 5.41 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 115.851 -0.613 . . . . 2.5800000000000001 111.355 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.461 ' HD2' ' C ' ' A' ' 197' ' ' SER . 87.6 Cg_exo -47.37 -34.09 18.22 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.027 1.818 . . . . 0.95999999999999996 111.798 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.559 ' HA ' ' CD1' ' A' ' 203' ' ' ILE . 0.3 OUTLIER -70.34 -42.06 72.39 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.804 -0.813 . . . . 2.2599999999999998 108.804 178.056 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 26.4 mm -63.21 -33.8 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 114.819 -1.082 . . . . 1.1000000000000001 110.44 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.7 -45.28 94.8 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.121 0.486 . . . . 1.1399999999999999 109.914 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.559 ' CD1' ' HA ' ' A' ' 200' ' ' TYR . 3.8 mt -62.14 -50.95 77.95 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 CA-C-O 121.633 0.73 . . . . 1.29 110.163 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 208' ' ' MET . 74.9 m -51.63 -51.11 58.29 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.478 -1.237 . . . . 1.1100000000000001 111.449 -178.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.415 ' O ' ' CE ' ' A' ' 209' ' ' LYS . 21.3 mt -66.84 -28.59 68.47 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 120.892 0.377 . . . . 1.05 111.661 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . 0.401 ' HA ' ' HE3' ' A' ' 209' ' ' LYS . 1.9 t30 -78.48 -46.64 19.18 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.588 0.708 . . . . 1.98 109.827 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.452 ' O ' ' CG2' ' A' ' 210' ' ' THR . 0.2 OUTLIER -71.11 -30.31 66.36 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.687 -1.142 . . . . 1.22 109.192 178.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' MET . . . . . 0.715 ' HE3' ' O ' ' A' ' 177' ' ' LEU . 35.5 mtp -72.76 -35.03 67.37 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.848 -0.615 . . . . 0.93999999999999995 109.534 177.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.482 ' HD3' ' HG2' ' A' ' 214' ' ' GLU . 10.4 mtmt -60.97 -36.39 79.3 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 115.092 -0.958 . . . . 1.6499999999999999 110.856 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.452 ' CG2' ' O ' ' A' ' 207' ' ' LEU . 4.8 t -62.04 -22.98 66.19 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.633 -0.712 . . . . 1.3200000000000001 109.33 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.514 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 61.3 m-85 -85.76 -9.07 57.68 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.749 -0.66 . . . . 1.73 111.587 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 111.54 5.33 26.17 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 116.006 1.162 . . . . 2.9300000000000002 116.006 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.5 m -123.54 148.96 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 118.969 1.385 . . . . 2.0099999999999998 112.81 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.482 ' HG2' ' HD3' ' A' ' 209' ' ' LYS . 8.5 mt-10 -131.01 135.88 48.0 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.341 -0.845 . . . . 2.6699999999999999 111.291 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.45 HG21 ' HB ' ' A' ' 225' ' ' VAL . 20.0 mm -118.26 148.59 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 120.772 0.32 . . . . 1.48 110.225 178.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.517 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 9.2 tt0 -104.86 116.56 32.2 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.302 -0.408 . . . . 1.54 112.004 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.94 151.25 24.37 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.091 -0.504 . . . . 2.2400000000000002 110.396 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . 0.454 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 5.0 tp60 -108.18 -143.23 0.38 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.477 0.179 . . . . 2.48 110.785 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -73.3 66.51 0.92 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.886 0.374 . . . . 3.1400000000000001 111.491 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 6.4 t80 58.43 33.65 23.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.788 0.804 . . . . 1.52 111.11 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.597 ' O ' ' CD1' ' A' ' 223' ' ' PHE . 5.1 pt20 -165.74 -129.99 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 106.69 -1.596 . . . . 2.0899999999999999 106.69 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.581 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -3.06 128.7 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 114.36 1.244 . . . . 1.79 114.36 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.597 ' CD1' ' O ' ' A' ' 221' ' ' GLN . 5.1 m-85 -123.02 140.93 52.52 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.262 -1.79 . . . . 0.82999999999999996 110.042 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.517 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 42.3 t -123.03 112.78 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 121.329 0.585 . . . . 1.1299999999999999 109.841 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.45 ' HB ' HG21 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -119.44 135.27 60.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.222 -0.899 . . . . 1.21 111.49 -178.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.416 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 3.7 mptt -83.76 127.8 34.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.038 -0.528 . . . . 3.1899999999999999 109.823 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.428 ' CA ' ' O ' ' A' ' 183' ' ' ALA . . . -83.03 167.99 46.41 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.442 -0.885 . . . . 0.38 113.347 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 77.73 19.81 75.02 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 121.703 -0.284 . . . . 0.29999999999999999 113.412 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 19.6 mt-30 -77.22 -176.22 4.0 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.39 0.614 . . . . 2.02 111.728 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.6 147.67 30.3 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.116 -0.947 . . . . 1.76 110.636 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' TYR . . . . . 0.528 ' CE2' HD23 ' A' ' 31' ' ' LEU . 6.3 m-30 -103.19 132.06 49.74 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.975 -0.557 . . . . 1.0900000000000001 110.995 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -119.74 155.14 33.04 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.697 -0.483 . . . . 2.5499999999999998 109.697 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.468 ' HB2' ' OG1' ' A' ' 39' ' ' THR . 51.8 p -82.42 109.71 17.57 Favored Pre-proline 0 N--CA 1.451 -0.411 0 C-N-CA 121.077 -0.249 . . . . 1.8400000000000001 110.56 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.539 ' HD2' ' OG1' ' A' ' 39' ' ' THR . 54.9 Cg_endo -68.45 -2.34 8.97 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.089 1.859 . . . . 0.39000000000000001 112.233 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 102.21 -94.7 1.21 Allowed Glycine 0 C--O 1.227 -0.313 0 C-N-CA 120.629 -0.796 . . . . 0.29999999999999999 111.666 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 95.9 m -121.51 135.41 55.03 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.344 -0.613 . . . . 1.0700000000000001 109.344 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.424 ' CE2' HG21 ' A' ' 210' ' ' THR . 12.3 t80 -133.58 134.74 43.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.93 0.395 . . . . 1.21 111.516 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.548 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -98.91 113.05 25.01 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.981 -0.554 . . . . 1.1499999999999999 111.529 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 25.1 t -84.59 112.75 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.731 -0.668 . . . . 1.1200000000000001 110.908 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.251 -0.881 . . . . 1.6899999999999999 111.124 -179.699 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.578 ' HB3' HD21 ' A' ' 44' ' ' LEU . 65.4 p . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.795 0.331 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 19.8 m120 56.93 -87.43 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.514 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.746 HH12 ' HB ' ' A' ' 203' ' ' ILE . 29.1 mtm180 -74.69 -58.41 3.31 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.876 0.37 . . . . 0.0 110.985 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.629 ' HB3' ' HG ' ' A' ' 41' ' ' LEU . . . -39.32 -48.42 1.86 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.667 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.589 HD22 HD13 ' A' ' 75' ' ' ILE . 11.0 mt -72.31 -36.42 68.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.905 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.486 HD21 ' HB2' ' A' ' 101' ' ' PRO . 35.9 tp -65.86 -50.19 65.44 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.719 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.652 HD23 ' CE2' ' A' ' 231' ' ' TYR . 60.0 mt -67.0 -27.64 67.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.728 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.418 ' HA ' ' HE1' ' A' ' 211' ' ' PHE . . . -65.91 -39.18 90.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.14 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.593 ' CB ' ' HG ' ' A' ' 57' ' ' LEU . . . -81.73 -41.07 21.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.212 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.692 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 14.4 mt -68.33 -4.01 12.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.227 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.534 ' HB1' ' HB3' ' A' ' 231' ' ' TYR . . . -97.6 179.19 4.93 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -177.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.556 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.4 OUTLIER -112.19 113.5 25.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.931 178.543 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 114.12 169.08 16.52 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.608 -178.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.559 ' HG2' ' HG2' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -95.06 117.57 30.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 117.154 0.477 . . . . 0.0 111.475 -179.223 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 235' ' ' GLY . 0.9 OUTLIER -119.58 145.71 46.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.445 -179.697 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.436 HG21 ' CG ' ' A' ' 74' ' ' GLU . 75.8 t -104.37 142.31 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 CA-C-O 121.344 0.592 . . . . 0.0 112.548 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.629 ' HG ' ' HB3' ' A' ' 28' ' ' ALA . 0.3 OUTLIER -116.51 116.36 27.49 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 174.632 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.505 HG21 HD21 ' A' ' 238' ' ' LEU . 0.5 OUTLIER -102.96 151.35 22.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.108 -177.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.7 t30 66.08 27.26 10.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.179 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.578 HD21 ' HB3' ' A' ' 25' ' ' SER . 86.2 mt -54.68 -172.94 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.413 ' HB3' HG23 ' A' ' 50' ' ' VAL . 29.7 tp -114.03 131.38 56.38 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -88.46 88.45 7.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.149 0.5 . . . . 0.0 110.565 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 49' ' ' ASP . 1.7 m -164.31 142.91 7.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.1 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.402 ' HA ' ' HB3' ' A' ' 51' ' ' ARG . 0.6 OUTLIER -36.42 -30.45 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.602 0.239 . . . . 0.0 111.455 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.607 ' HB3' ' O ' ' A' ' 94' ' ' ASN . 1.5 p30 -58.19 -42.77 86.82 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 121.028 0.442 . . . . 0.0 110.905 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.462 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 88.8 t -84.24 -44.66 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.57 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.562 ' HA ' HD11 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -50.89 -39.01 53.11 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.017 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.654 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 7.4 m-70 -80.31 -32.58 37.96 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.595 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.614 ' O ' HD13 ' A' ' 57' ' ' LEU . 9.5 tpt -55.0 -34.62 63.6 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.643 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -82.42 -41.54 19.75 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 114.22 -1.354 . . . . 0.0 108.58 176.346 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.736 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 34.4 t30 -59.13 -41.56 88.52 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-O 120.922 0.391 . . . . 0.0 110.749 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.464 ' HB3' HD11 ' A' ' 102' ' ' LEU . . . -59.24 -46.76 87.62 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 121.702 0.763 . . . . 0.0 108.96 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.827 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.4 OUTLIER -63.41 -41.11 98.71 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.245 -1.343 . . . . 0.0 107.745 177.243 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.736 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -59.78 -32.9 71.03 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 114.187 -1.369 . . . . 0.0 111.564 179.044 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.535 ' O ' HD23 ' A' ' 88' ' ' LEU . . . -77.66 -38.33 47.91 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.073 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.486 ' CB ' ' HB3' ' A' ' 82' ' ' LEU . 0.5 OUTLIER -79.89 -12.91 59.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.407 0.622 . . . . 0.0 110.566 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.43 33.33 5.42 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 114.967 -1.015 . . . . 0.0 114.244 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.827 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 40.5 t -90.55 117.67 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.782 ' O ' HG12 ' A' ' 76' ' ' ILE . 26.0 m -82.98 132.89 35.13 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 121.078 0.466 . . . . 0.0 112.167 -178.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.643 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 41.1 p90 -158.31 171.87 19.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.463 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 62.1 m -131.37 148.51 52.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.182 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.408 ' CD1' ' HB2' ' A' ' 73' ' ' CYS . 12.5 tp -115.04 133.7 55.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.177 0.513 . . . . 0.0 110.685 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.489 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 0.6 OUTLIER -61.21 -167.22 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.378 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.75 -44.47 14.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.553 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.33 1.79 10.79 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.596 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 58.81 39.83 23.62 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.868 0.366 . . . . 0.0 111.54 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -133.95 -10.46 2.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.225 179.292 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.556 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 14.8 mtp180 -114.92 120.59 40.45 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.566 ' HB3' HD13 ' A' ' 44' ' ' LEU . 34.2 t -129.53 125.62 36.72 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.559 ' HG2' ' HG2' ' A' ' 38' ' ' LYS . 56.8 tt0 -106.98 130.62 54.6 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 176.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.589 HD13 HD22 ' A' ' 29' ' ' LEU . 10.4 mt -127.72 124.49 63.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -177.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.782 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -68.51 99.62 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-O 121.104 0.478 . . . . 0.0 109.712 175.813 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -38.77 143.71 0.29 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.843 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -89.31 -10.71 45.75 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.093 0.473 . . . . 0.0 110.921 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.556 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 90.14 3.11 73.32 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.14 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.584 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 150.07 -148.49 19.8 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.012 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.561 ' CG ' ' HB3' ' A' ' 108' ' ' LEU . 88.1 Cg_exo -49.09 125.14 12.73 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.783 2.322 . . . . 0.0 112.973 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.546 HD22 ' CD2' ' A' ' 34' ' ' LEU . 0.7 OUTLIER -74.58 110.52 8.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.792 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -82.08 135.06 35.37 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.072 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.722 ' HB3' HD11 ' A' ' 113' ' ' ILE . . . -98.03 123.78 42.22 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.061 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -71.04 123.67 22.61 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.61 175.71 0.96 Allowed Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -175.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.65 144.8 47.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 118.735 1.268 . . . . 0.0 111.411 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.573 HD22 ' HB1' ' A' ' 84' ' ' ALA . 1.3 tp -116.26 160.54 20.31 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.393 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 22.4 mt-10 -139.22 104.23 4.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.288 178.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.446 ' HA ' HD11 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -100.63 118.83 37.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.143 -178.699 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -92.99 96.26 9.98 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.906 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.436 ' N ' ' O ' ' A' ' 116' ' ' THR . 0.1 OUTLIER -104.89 47.31 0.88 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.089 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.728 ' HA3' ' H ' ' A' ' 118' ' ' GLU . . . -54.4 -44.66 76.78 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.848 -0.692 . . . . 0.0 113.281 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.607 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 74.2 m-20 -94.43 -6.89 42.99 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.666 0.27 . . . . 0.0 110.733 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.544 ' CB ' ' HA ' ' A' ' 49' ' ' ASP . . . -98.16 61.7 1.49 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.011 0.434 . . . . 0.0 111.311 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.6 ' O ' ' HD3' ' A' ' 100' ' ' ARG . . . -63.82 -25.2 68.94 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.068 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.428 ' HA ' ' HG2' ' A' ' 171' ' ' GLN . 0.9 OUTLIER -88.19 -17.11 31.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.707 0.289 . . . . 0.0 110.882 179.497 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.443 ' O ' ' HG2' ' A' ' 101' ' ' PRO . . . -95.27 -29.21 14.61 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.925 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.636 ' SD ' ' HB3' ' A' ' 115' ' ' LEU . 5.6 tpp -64.3 -47.4 79.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.168 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.648 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 1.9 mpt_? -54.34 -58.87 11.9 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 100' ' ' ARG . 18.1 Cg_endo -59.71 -33.04 96.57 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.286 1.991 . . . . 0.0 112.635 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 0.4 OUTLIER -74.16 -53.43 9.88 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.056 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.549 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -50.04 -28.09 6.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.429 0.633 . . . . 0.0 110.279 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.729 ' C ' ' HG1' ' A' ' 179' ' ' THR . . . -86.96 -54.44 4.34 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.316 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.409 ' HB2' HD11 ' A' ' 34' ' ' LEU . . . -59.93 -32.76 71.09 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -176.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 102' ' ' LEU . 20.2 mt -78.99 -12.89 60.05 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.046 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.556 ' HB3' ' HB2' ' A' ' 138' ' ' ALA . 20.2 m -81.23 15.32 1.99 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.219 0.533 . . . . 0.0 110.936 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.561 ' HB3' ' CG ' ' A' ' 81' ' ' PRO . 2.3 mt -91.91 -71.02 0.66 Allowed 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.267 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.86 146.19 22.06 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.707 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.426 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 3.2 p -58.16 98.84 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.803 0.335 . . . . 0.0 111.141 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.622 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 9.7 m120 -148.28 135.51 20.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.874 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.878 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 5.0 m-20 -91.66 101.05 13.67 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.252 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.722 HD11 ' HB3' ' A' ' 84' ' ' ALA . 31.5 mm -118.89 137.48 52.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.161 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.822 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 62.9 t -110.17 112.39 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 176.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.636 ' HB3' ' SD ' ' A' ' 99' ' ' MET . 63.9 mt -102.21 105.83 16.56 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.327 -178.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.592 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -119.37 -175.37 2.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.844 0.354 . . . . 0.0 111.624 -178.921 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.48 ' HA3' ' HA2' ' A' ' 93' ' ' GLY . . . -166.17 178.07 40.91 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.994 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.728 ' H ' ' HA3' ' A' ' 93' ' ' GLY . 3.9 mt-10 -70.79 172.63 5.97 Favored Pre-proline 0 C--N 1.328 -0.333 0 C-N-CA 123.096 0.558 . . . . 0.0 110.793 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.619 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 81.5 Cg_exo -46.65 -39.57 23.34 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.682 2.254 . . . . 0.0 113.105 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.416 ' O ' ' HB3' ' A' ' 123' ' ' GLU . 2.1 mpp_? -67.8 -23.57 65.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.681 0.277 . . . . 0.0 110.961 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.639 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 10.8 tpt -60.92 -35.65 77.25 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.417 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 3.5 mptp? -62.78 -16.86 59.79 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.149 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.628 ' O ' ' HG3' ' A' ' 123' ' ' GLU . 1.0 OUTLIER -80.92 -0.17 38.05 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.307 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.411 ' HB3' HH22 ' A' ' 100' ' ' ARG . 6.5 mtt180 -126.31 83.71 63.45 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.71 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.525 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 15.8 Cg_endo -56.86 148.75 65.03 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.646 2.231 . . . . 0.0 111.538 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.536 HG12 HD11 ' A' ' 151' ' ' LEU . 0.7 OUTLIER -123.48 -0.76 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.012 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.565 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -53.69 -39.01 60.16 Favored Glycine 0 CA--C 1.516 0.138 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.707 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.552 ' CD2' ' HB2' ' A' ' 165' ' ' ASP . 1.4 m80 -55.58 -39.29 70.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.023 0.412 . . . . 0.0 110.735 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.529 ' HG ' HD13 ' A' ' 133' ' ' LEU . 14.4 tp -75.36 -40.86 57.7 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.347 0.594 . . . . 0.0 110.141 178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.762 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 55.1 t -56.19 -48.17 79.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.562 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.722 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 75.2 m-20 -69.5 -37.26 77.12 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.133 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.649 ' O ' HG12 ' A' ' 162' ' ' VAL . . . -58.99 -49.62 77.2 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.936 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.613 HD23 ' CB ' ' A' ' 104' ' ' ALA . 6.6 mt -73.6 -47.44 40.36 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.591 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.762 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -59.53 -27.47 66.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.702 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.722 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 5.6 tp -70.89 -28.69 64.73 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.998 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 159' ' ' GLY . . . -85.55 15.26 47.27 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.709 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.91 4.73 61.45 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.522 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.556 ' HB2' ' HB3' ' A' ' 107' ' ' CYS . . . -73.95 152.99 39.96 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 120.865 0.364 . . . . 0.0 111.417 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.436 ' CB ' ' HB2' ' A' ' 154' ' ' GLN . 13.5 mmtm -102.29 103.43 13.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.249 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.613 ' HB ' ' HG3' ' A' ' 134' ' ' ARG . 14.7 mt -134.86 127.35 48.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.431 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.621 HG21 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -124.62 139.23 54.06 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.101 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.492 ' HH ' ' HB ' ' A' ' 130' ' ' VAL . 36.3 m-85 -78.08 130.35 36.31 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.125 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.694 ' HB2' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -91.09 -90.26 0.16 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.57 -179.723 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.818 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 2.6 mt-10 -58.99 -81.51 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 122.083 -0.386 . . . . 0.0 110.903 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.407 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 14.2 mt-30 -114.73 151.86 33.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.505 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -66.93 135.2 53.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.919 0.39 . . . . 0.0 110.68 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.565 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 4.3 m-20 66.91 19.73 10.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.196 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.572 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 10.9 m-85 -110.28 169.64 6.15 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 121.085 0.469 . . . . 0.0 112.128 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.9 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 36.5 Cg_exo -33.23 -62.32 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 124.547 3.498 . . . . 0.0 116.252 -177.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.9 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 52.4 Cg_exo -53.56 145.73 46.28 Favored 'Trans proline' 0 C--N 1.352 0.746 0 CA-C-N 120.723 1.294 . . . . 0.0 112.678 -178.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.822 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 6.5 mt -156.3 136.31 12.76 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.62 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.621 ' HB2' HG21 ' A' ' 141' ' ' THR . 11.7 mtt180 -106.42 103.18 12.58 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.878 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 6.6 mt -93.6 145.39 24.57 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.797 -178.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.622 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 2.6 mp0 -147.35 26.93 1.04 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.43 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 52.14 -158.59 3.11 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.027 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.39 -12.86 43.69 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 119.922 -1.132 . . . . 0.0 112.917 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.536 ' HD2' ' HB1' ' A' ' 138' ' ' ALA . 51.6 t80 -60.29 122.75 15.27 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 117.14 0.47 . . . . 0.0 110.852 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.662 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 54.3 p -115.31 -33.12 5.41 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.575 0.703 . . . . 0.0 111.206 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.405 ' O ' ' HA2' ' A' ' 136' ' ' GLY . . . 136.46 -160.39 24.74 Favored Glycine 0 C--N 1.305 -1.148 0 CA-C-N 114.667 -1.151 . . . . 0.0 112.247 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.474 ' O ' HG21 ' A' ' 162' ' ' VAL . . . 105.97 154.85 21.35 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 120.625 -0.797 . . . . 0.0 111.35 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -47.04 119.22 2.44 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 120.869 0.366 . . . . 0.0 110.944 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.749 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 75.3 t -110.36 129.87 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.929 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.11 119.41 37.79 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.521 -0.472 . . . . 0.0 109.74 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 191' ' ' ILE . 1.0 OUTLIER -132.32 120.19 42.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.552 ' HB2' ' CD2' ' A' ' 128' ' ' HIS . 0.6 OUTLIER -53.32 141.89 22.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.246 -179.228 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.507 ' HA2' ' CG2' ' A' ' 191' ' ' ILE . . . -60.38 -51.69 57.21 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.653 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 88.8 p -92.93 95.41 9.48 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.454 0.169 . . . . 0.0 111.188 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.452 HG21 ' CB ' ' A' ' 128' ' ' HIS . 8.5 p -179.31 67.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 120.997 0.427 . . . . 0.0 111.539 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.443 ' CB ' ' CD1' ' A' ' 172' ' ' PHE . 0.4 OUTLIER 64.53 126.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.599 179.292 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.509 ' N ' HG13 ' A' ' 196' ' ' VAL . 2.8 p -72.29 -16.98 61.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.056 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.648 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 1.5 mp0 -81.62 -11.66 59.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.361 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.525 ' HZ ' ' O ' ' A' ' 125' ' ' PRO . 5.3 m-85 -69.53 -51.84 31.96 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.718 0.77 . . . . 0.0 109.272 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.589 HD22 ' CE1' ' A' ' 223' ' ' PHE . 0.4 OUTLIER -67.48 -43.21 81.51 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.513 -1.222 . . . . 0.0 109.106 178.71 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.742 HG22 ' HD3' ' A' ' 27' ' ' ARG . 5.1 m -55.01 -33.52 62.69 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.55 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.657 ' HB3' ' HB1' ' A' ' 104' ' ' ALA . . . -66.92 -41.05 87.74 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.874 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.502 HD23 ' HB3' ' A' ' 132' ' ' ALA . 1.1 mt -76.17 -34.89 59.36 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.404 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.769 ' O ' ' HE1' ' A' ' 208' ' ' MET . 3.8 mp -60.37 -36.95 79.24 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.336 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.652 ' HE2' ' CD2' ' A' ' 31' ' ' LEU . 6.0 mtp -81.6 -43.68 18.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.558 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.729 ' HG1' ' C ' ' A' ' 104' ' ' ALA . 88.2 m -72.16 -42.48 65.86 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.988 -178.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.554 ' HB2' ' HB ' ' A' ' 187' ' ' THR . . . -59.28 -38.93 68.57 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -176.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.62 ' HA ' ' O ' ' A' ' 226' ' ' LYS . 27.0 Cg_endo -65.79 -29.67 50.42 Favored 'Trans proline' 0 CA--C 1.499 -1.236 0 CA-C-N 120.163 1.094 . . . . 0.0 111.699 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.498 ' HB2' ' CD2' ' A' ' 108' ' ' LEU . 5.6 mt -83.8 2.0 40.28 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.765 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.529 ' O ' ' HA3' ' A' ' 227' ' ' GLY . . . -84.7 138.29 38.05 Favored Pre-proline 0 C--O 1.224 -0.285 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.201 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.662 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 12.1 Cg_endo -51.47 -31.19 38.01 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.444 2.096 . . . . 0.0 113.028 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.45 140.89 48.87 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.522 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -57.07 147.77 23.51 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.197 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.554 ' HB ' ' HB2' ' A' ' 180' ' ' ALA . 78.8 m -122.99 147.29 46.8 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 36.0 t -126.24 117.9 49.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.749 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 2.6 mp -103.83 117.35 49.19 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.954 0 C-N-CA 120.029 -0.669 . . . . 0.0 109.368 178.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.604 ' CG ' ' HG3' ' A' ' 222' ' ' GLN . 1.3 ttt85 -99.85 124.68 45.41 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.579 ' HB ' ' HA ' ' A' ' 221' ' ' GLN . 1.5 mp -94.08 123.48 46.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.976 -176.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -76.21 96.33 3.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.835 -1.529 . . . . 0.0 110.47 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 97.75 -126.72 8.98 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.972 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.59 132.72 56.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.845 0.355 . . . . 0.0 111.633 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.442 HD11 HG13 ' A' ' 201' ' ' ILE . 0.9 OUTLIER -42.07 144.42 0.46 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.044 179.267 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.509 HG13 ' N ' ' A' ' 170' ' ' SER . 12.5 p -73.87 -26.52 21.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.165 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.462 ' CB ' ' HB3' ' A' ' 170' ' ' SER . 0.3 OUTLIER -168.51 65.05 0.07 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.176 0.513 . . . . 0.0 109.741 -179.663 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.471 ' N ' ' CD ' ' A' ' 199' ' ' PRO . 0.0 OUTLIER -42.93 -46.02 12.55 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.096 -179.812 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 198' ' ' LYS . 79.8 Cg_exo -48.27 -34.83 25.65 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.903 1.735 . . . . 0.0 111.638 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.496 ' HA ' ' CD1' ' A' ' 203' ' ' ILE . 0.3 OUTLIER -67.91 -42.45 81.12 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.401 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.442 HG13 HD11 ' A' ' 195' ' ' LEU . 20.0 mm -60.12 -39.49 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.026 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -57.15 -47.2 81.76 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.224 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.746 ' HB ' HH12 ' A' ' 27' ' ' ARG . 4.9 mt -60.55 -50.38 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 CA-C-O 121.486 0.66 . . . . 0.0 109.457 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.484 ' O ' ' HG3' ' A' ' 208' ' ' MET . 89.7 m -52.83 -52.01 58.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.756 -177.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.632 ' O ' ' HE2' ' A' ' 209' ' ' LYS . 45.2 mt -65.02 -31.36 72.55 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 120.985 0.422 . . . . 0.0 111.415 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -76.86 -44.89 30.35 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.751 0.786 . . . . 0.0 109.743 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.527 HD22 ' HB2' ' A' ' 27' ' ' ARG . 8.0 tp -71.8 -29.6 64.63 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.301 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' MET . . . . . 0.769 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 41.7 mtp -75.99 -35.42 59.6 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.652 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 3.5 mtmt -61.54 -38.66 88.25 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 114.438 -1.255 . . . . 0.0 111.001 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.474 HG23 ' N ' ' A' ' 211' ' ' PHE . 6.1 t -61.54 -31.64 71.67 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.388 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.573 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 40.6 m-85 -78.74 -5.26 52.74 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.83 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.29 5.62 28.22 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 115.891 1.116 . . . . 0.0 115.891 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.3 m -123.53 148.69 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 118.878 1.339 . . . . 0.0 112.78 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.467 ' HG2' ' HD3' ' A' ' 209' ' ' LYS . 20.4 mt-10 -129.18 140.14 51.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.893 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.604 HG22 ' HB ' ' A' ' 225' ' ' VAL . 16.3 mm -122.76 148.3 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 120.699 0.285 . . . . 0.0 110.314 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.704 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 38.8 tt0 -101.21 115.09 29.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.656 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -81.51 150.78 28.08 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.302 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . 0.456 ' HB2' ' HB3' ' A' ' 222' ' ' GLN . 5.5 tp60 -108.3 -136.7 0.36 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.759 -0.2 . . . . 0.0 111.321 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.408 ' CD2' ' HG3' ' A' ' 218' ' ' GLN . 77.3 m-70 -84.6 69.53 10.63 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 120.832 0.349 . . . . 0.0 110.307 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.424 ' CE1' ' HG3' ' A' ' 198' ' ' LYS . 4.0 t80 54.16 31.28 13.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 122.11 0.957 . . . . 0.0 109.967 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.596 ' O ' ' CD1' ' A' ' 223' ' ' PHE . 0.0 OUTLIER -160.69 -128.32 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 113.632 -1.622 . . . . 0.0 106.838 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.708 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -4.53 129.24 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -179.446 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.596 ' CD1' ' O ' ' A' ' 221' ' ' GLN . 0.7 OUTLIER -124.44 128.33 48.85 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.104 -1.862 . . . . 0.0 109.091 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.704 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 46.2 t -111.24 114.06 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 121.544 0.688 . . . . 0.0 109.393 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.604 ' HB ' HG22 ' A' ' 215' ' ' ILE . 0.4 OUTLIER -124.35 119.91 57.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.181 -178.651 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 181' ' ' PRO . 4.0 pttt -74.17 143.41 45.25 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.529 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -92.93 -173.15 40.82 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.678 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 62.72 21.13 62.64 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 121.49 -0.386 . . . . 0.0 113.253 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . 0.417 ' HB2' ' HB2' ' A' ' 181' ' ' PRO . 17.9 mt-30 -80.68 -172.94 3.88 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.272 0.558 . . . . 0.0 111.361 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 2.3 t -158.18 147.95 19.86 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.625 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' TYR . . . . . 0.692 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 7.8 m-85 -99.04 136.02 39.61 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.149 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -123.09 148.02 46.11 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.485 ' HB2' ' OG1' ' A' ' 39' ' ' THR . 19.5 p -72.47 110.93 9.2 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.575 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.447 ' HD2' ' OG1' ' A' ' 39' ' ' THR . 55.7 Cg_endo -69.95 1.1 4.87 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.195 1.93 . . . . 0.0 112.141 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 100.28 -99.61 2.05 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 93.0 m -120.03 136.82 54.42 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 41' ' ' LEU . 10.9 t80 -132.96 128.07 35.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.974 0.416 . . . . 0.0 111.707 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.505 HD21 HG21 ' A' ' 42' ' ' THR . 0.2 OUTLIER -92.97 111.87 23.64 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.587 179.526 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.427 ' N ' HD21 ' A' ' 238' ' ' LEU . 21.7 t -85.87 111.68 21.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.143 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.503 ' HG3' HD11 ' A' ' 238' ' ' LEU . 1.6 mt-10 . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.15 -0.928 . . . . 0.0 111.083 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.64 ' HB2' HD21 ' A' ' 44' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 120.843 0.354 . . . . 0.0 111.601 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.427 ' OD1' ' OG1' ' A' ' 97' ' ' THR . 70.0 m-80 62.99 -81.2 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.191 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.705 ' HA ' ' HE3' ' A' ' 178' ' ' MET . 78.6 mtm-85 -74.15 -57.48 3.93 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.671 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -43.21 -45.16 5.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.139 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.634 ' HG ' ' OG ' ' A' ' 25' ' ' SER . 9.8 mt -75.54 -33.42 60.68 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.043 0.449 . . . . 0.0 111.154 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.578 HD22 ' CB ' ' A' ' 101' ' ' PRO . 66.1 tp -69.55 -50.11 48.04 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.115 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.769 HD21 ' CE2' ' A' ' 231' ' ' TYR . 21.4 mt -68.61 -26.8 65.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.94 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.559 ' HB2' HD11 ' A' ' 75' ' ' ILE . . . -65.22 -39.35 92.63 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.645 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.726 ' HB2' HG23 ' A' ' 62' ' ' VAL . . . -81.35 -41.32 22.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.071 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.682 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 14.2 mt -67.32 -3.4 7.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.0 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.678 ' HB1' ' HB3' ' A' ' 231' ' ' TYR . . . -98.51 177.89 5.19 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -177.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.528 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.7 OUTLIER -110.87 112.29 24.02 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.787 178.281 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 114.83 167.11 15.46 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.819 ' HE3' HD11 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -94.89 117.83 30.79 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 117.144 0.472 . . . . 0.0 111.55 -179.097 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.633 ' HG1' ' HD2' ' A' ' 234' ' ' PRO . 0.8 OUTLIER -119.61 146.84 45.17 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.94 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.577 HG21 ' CG ' ' A' ' 74' ' ' GLU . 91.8 t -103.55 142.14 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 CA-C-O 121.77 0.795 . . . . 0.0 112.653 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.671 ' HG ' ' HB1' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -117.25 116.3 26.99 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 174.437 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.564 HG23 HD22 ' A' ' 238' ' ' LEU . 0.6 OUTLIER -105.06 152.41 22.79 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.437 -177.32 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.483 ' HB2' HD21 ' A' ' 238' ' ' LEU . 52.2 t30 66.57 26.67 9.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.098 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.722 HD23 HG21 ' A' ' 239' ' ' VAL . 65.1 mt -55.05 -170.82 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.529 ' HB3' HG21 ' A' ' 50' ' ' VAL . 48.9 tp -114.15 131.71 56.34 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.816 0.341 . . . . 0.0 110.245 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -88.98 87.06 7.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.097 0.475 . . . . 0.0 110.738 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.48 ' HB3' ' OD1' ' A' ' 49' ' ' ASP . 27.8 t -164.14 142.61 7.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.06 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.424 ' OD2' ' HB2' ' A' ' 94' ' ' ASN . 33.9 p-10 -36.71 -29.14 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.524 ' HB2' ' HA ' ' A' ' 95' ' ' ALA . 37.6 p-10 -60.58 -42.48 96.77 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.187 0.518 . . . . 0.0 110.365 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.529 HG21 ' HB3' ' A' ' 45' ' ' LEU . 99.3 t -82.13 -46.02 19.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.701 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.67 ' HA ' ' CD1' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -49.28 -39.34 30.45 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.465 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.665 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 11.3 m-70 -78.86 -32.33 45.96 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.197 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.51 ' HE2' HD11 ' A' ' 57' ' ' LEU . 8.0 tpt -54.2 -37.43 64.53 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 176.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.67 ' CD1' ' HA ' ' A' ' 51' ' ' ARG . 0.3 OUTLIER -80.58 -43.94 19.79 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.666 176.105 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.751 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 2.0 t30 -58.41 -36.41 73.54 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.01 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.606 ' HB3' HD13 ' A' ' 102' ' ' LEU . . . -63.52 -44.61 93.78 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 122.034 0.921 . . . . 0.0 108.88 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.854 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -64.95 -40.97 95.82 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.558 -1.655 . . . . 0.0 107.011 177.164 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.751 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.2 m -60.19 -31.69 70.38 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 113.757 -1.565 . . . . 0.0 111.233 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.612 ' HB3' HD21 ' A' ' 88' ' ' LEU . . . -79.55 -37.53 36.26 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.024 -179.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.577 HD11 ' HB2' ' A' ' 82' ' ' LEU . 0.5 OUTLIER -81.73 -14.45 56.5 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.375 0.607 . . . . 0.0 110.765 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.87 33.32 5.04 Favored Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.292 -0.867 . . . . 0.0 114.47 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.854 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 21.6 t -90.44 118.71 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.828 ' O ' HG12 ' A' ' 76' ' ' ILE . 7.5 t -84.03 136.02 34.2 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 120.944 0.402 . . . . 0.0 110.799 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.623 ' HB3' ' CG2' ' A' ' 75' ' ' ILE . 35.3 p90 -160.71 170.39 20.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.542 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.406 HG23 ' N ' ' A' ' 66' ' ' LEU . 83.5 m -133.65 147.89 51.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.491 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.47 HD13 ' HB2' ' A' ' 73' ' ' CYS . 10.5 tp -116.56 136.22 53.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.182 0.515 . . . . 0.0 110.956 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.542 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 1.6 m -61.43 -167.44 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.912 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.42 -31.76 18.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.811 0.339 . . . . 0.0 110.926 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.425 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 0.2 OUTLIER -76.64 1.26 17.44 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.266 179.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 56.86 27.84 13.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.752 0.31 . . . . 0.0 111.515 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -127.25 -11.26 5.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.293 179.716 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.542 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 2.1 mtt85 -111.06 121.42 45.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.325 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.574 ' HB3' HD13 ' A' ' 44' ' ' LEU . 40.4 t -130.8 125.14 32.94 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 112.386 0.514 . . . . 0.0 112.386 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.577 ' CG ' HG21 ' A' ' 40' ' ' VAL . 29.7 tt0 -107.72 131.3 54.57 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 176.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.657 HG22 ' O ' ' A' ' 63' ' ' SER . 7.8 mt -127.57 123.22 60.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.828 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -68.53 100.93 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 121.682 0.753 . . . . 0.0 109.16 176.027 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -38.88 144.79 0.23 Allowed Glycine 0 C--N 1.32 -0.351 0 CA-C-N 114.415 -1.266 . . . . 0.0 114.16 -178.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.443 ' CB ' ' CD1' ' A' ' 82' ' ' LEU . 33.6 t30 -90.45 -11.2 41.06 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 120.962 0.41 . . . . 0.0 110.612 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.528 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 86.56 9.18 75.86 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.435 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.595 ' O ' HD21 ' A' ' 34' ' ' LEU . . . 146.51 -151.12 23.42 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.888 -0.673 . . . . 0.0 111.976 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.531 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 9.3 Cg_endo -50.75 128.67 24.87 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.511 2.141 . . . . 0.0 111.805 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.577 ' HB2' HD11 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -77.68 115.04 17.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.304 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.442 ' HA ' ' CG ' ' A' ' 111' ' ' ASN . 4.5 p80 -83.22 134.83 34.94 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.127 0.489 . . . . 0.0 112.022 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.808 ' HB3' HD12 ' A' ' 113' ' ' ILE . . . -96.48 123.57 40.18 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.863 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -71.71 123.65 23.04 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 176.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.93 178.17 1.01 Allowed Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 -175.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 112' ' ' ASP . . . -73.41 144.87 46.19 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 118.601 1.2 . . . . 0.0 111.342 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.731 ' CB ' HG13 ' A' ' 113' ' ' ILE . 0.9 OUTLIER -112.94 161.08 17.41 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.064 -178.491 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 4.1 mt-10 -143.0 102.8 4.07 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.108 177.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.596 ' O ' HD23 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -98.29 122.08 41.01 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.779 -178.696 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -96.07 96.58 8.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.694 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.596 HD23 ' O ' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -114.29 57.93 0.69 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.193 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.766 ' HA3' ' H ' ' A' ' 118' ' ' GLU . . . -59.64 -48.42 86.12 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.145 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.424 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 0.7 OUTLIER -94.87 -2.18 51.23 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.642 0.258 . . . . 0.0 110.687 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.553 ' CB ' ' HB3' ' A' ' 92' ' ' LEU . . . -92.63 45.53 1.2 Allowed 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.803 0.335 . . . . 0.0 110.989 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.637 ' O ' ' HD3' ' A' ' 100' ' ' ARG . . . -53.14 -23.26 16.2 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.352 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.514 ' HA ' ' HG2' ' A' ' 171' ' ' GLN . 15.9 p -88.7 -19.02 26.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.414 0.149 . . . . 0.0 111.037 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.588 ' C ' ' HD2' ' A' ' 101' ' ' PRO . . . -98.12 -26.83 14.45 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.603 ' SD ' ' HB3' ' A' ' 115' ' ' LEU . 9.8 tpp -63.92 -44.03 94.13 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.712 0.291 . . . . 0.0 111.016 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.748 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 1.1 mpt_? -60.72 -55.74 41.9 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.748 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 23.7 Cg_exo -61.16 -32.14 90.77 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 121.633 1.555 . . . . 0.0 111.411 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.606 HD13 ' HB3' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -74.62 -53.31 9.59 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.804 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.699 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -51.58 -28.57 14.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.523 0.678 . . . . 0.0 110.236 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.739 ' HB1' ' HB2' ' A' ' 175' ' ' ALA . . . -86.76 -53.85 4.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.807 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.439 ' HB2' HD13 ' A' ' 34' ' ' LEU . . . -59.82 -28.06 67.14 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -176.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.57 ' HB2' ' CD1' ' A' ' 153' ' ' LEU . 35.2 mt -81.62 -28.16 33.82 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.139 -177.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.59 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 12.4 p -72.95 12.26 0.55 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.189 0.519 . . . . 0.0 111.085 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.608 ' HG ' HG21 ' A' ' 179' ' ' THR . 1.4 mt -79.81 -76.6 0.21 Allowed 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.083 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.488 ' O ' ' HA3' ' A' ' 155' ' ' GLY . . . -71.78 -117.54 0.05 OUTLIER Glycine 0 N--CA 1.454 -0.146 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.884 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -150.9 96.85 2.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.964 0.411 . . . . 0.0 110.884 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.68 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 18.6 m-80 -149.06 139.37 22.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.273 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.87 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 1.9 m-20 -94.34 96.32 9.46 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.046 0.45 . . . . 0.0 110.126 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.808 HD12 ' HB3' ' A' ' 84' ' ' ALA . 1.4 mp -118.99 144.21 27.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.48 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.784 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 47.8 t -110.05 112.95 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.603 ' HB3' ' SD ' ' A' ' 99' ' ' MET . 59.7 mt -101.98 106.67 17.62 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.02 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.671 HG22 ' HG3' ' A' ' 150' ' ' PRO . 0.7 OUTLIER -122.66 -172.15 2.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.165 -178.709 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.624 ' HA3' ' HA2' ' A' ' 93' ' ' GLY . . . -167.07 179.05 41.01 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.832 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.767 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 8.4 pt-20 -71.16 173.51 4.87 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 123.277 0.631 . . . . 0.0 110.549 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.767 ' HD2' ' HB2' ' A' ' 118' ' ' GLU . 7.6 Cg_endo -47.47 -36.61 24.28 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.699 2.266 . . . . 0.0 113.606 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.472 ' CG ' ' HG3' ' A' ' 118' ' ' GLU . 0.4 OUTLIER -67.37 -25.06 65.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.905 0.383 . . . . 0.0 110.443 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.641 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 8.1 tpt -60.55 -35.53 76.26 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.611 ' HE3' ' HG2' ' A' ' 149' ' ' PRO . 0.1 OUTLIER -62.51 -16.84 57.88 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.995 179.266 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.651 ' O ' ' HG3' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -85.06 -1.85 57.31 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.186 0.517 . . . . 0.0 109.645 178.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.614 ' HB3' HH22 ' A' ' 100' ' ' ARG . 1.3 mpt_? -126.12 86.35 58.08 Favored Pre-proline 0 CA--C 1.531 0.25 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.746 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.549 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 17.9 Cg_endo -58.7 148.71 81.32 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.677 2.251 . . . . 0.0 111.696 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.577 HG12 HD13 ' A' ' 151' ' ' LEU . 0.7 OUTLIER -123.01 -0.13 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.194 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.622 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -53.98 -34.7 52.47 Favored Glycine 0 CA--C 1.516 0.12 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.513 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.512 ' CD2' HG22 ' A' ' 168' ' ' VAL . 57.4 m80 -58.5 -40.01 81.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.163 0.506 . . . . 0.0 110.851 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.741 ' HG ' HD13 ' A' ' 133' ' ' LEU . 34.0 tp -75.33 -39.28 59.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.202 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.725 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 54.8 t -56.91 -47.78 82.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.555 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.749 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 77.7 m-20 -71.23 -38.5 71.96 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.472 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.732 ' HB3' HD22 ' A' ' 176' ' ' LEU . . . -60.15 -44.66 94.81 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.534 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.741 HD13 ' HG ' ' A' ' 129' ' ' LEU . 5.7 mt -75.73 -50.27 15.79 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 121.086 0.47 . . . . 0.0 110.66 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.725 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -57.81 -28.3 63.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.055 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.749 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 5.5 tp -67.63 -30.97 70.68 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-O 121.004 0.431 . . . . 0.0 110.312 178.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 159' ' ' GLY . . . -81.4 12.75 37.64 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.892 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.16 3.74 63.33 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.459 -0.876 . . . . 0.0 112.429 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.59 ' HB2' ' HB2' ' A' ' 107' ' ' CYS . . . -73.88 153.87 39.67 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.837 0.351 . . . . 0.0 111.654 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 9.4 mttp -100.85 104.58 15.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.643 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.6 ' HB ' ' HG3' ' A' ' 134' ' ' ARG . 30.3 mt -136.27 125.23 37.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.954 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.858 HG21 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -124.15 139.99 53.4 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.005 0.431 . . . . 0.0 110.554 -179.483 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.489 ' CE1' HG21 ' A' ' 130' ' ' VAL . 43.7 m-85 -79.6 132.07 36.17 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.358 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.62 ' HB2' ' CB ' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -96.46 -88.5 0.28 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.795 -179.578 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.707 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 36.0 mt-10 -57.38 -80.98 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.546 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.544 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 15.0 mt-30 -117.77 148.95 41.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.991 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.64 135.22 56.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.951 0.405 . . . . 0.0 110.154 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.622 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 5.6 m-20 65.93 20.05 11.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.293 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.607 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 14.5 m-85 -111.72 169.25 6.53 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 121.202 0.525 . . . . 0.0 111.838 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.91 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 21.8 Cg_exo -31.19 -65.36 0.09 OUTLIER 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 124.385 3.39 . . . . 0.0 116.271 -178.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.91 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 72.3 Cg_exo -50.84 145.95 22.53 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 121.186 1.257 . . . . 0.0 113.305 -178.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.784 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 7.3 mt -156.49 136.64 12.82 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.422 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.858 ' HB2' HG21 ' A' ' 141' ' ' THR . 4.3 mtt180 -106.81 102.25 11.63 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.87 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 9.8 mt -92.53 145.53 24.37 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.909 -178.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.68 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 6.8 mt-30 -148.33 24.98 1.0 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.455 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 55.19 -166.99 2.79 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.53 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 112.6 -14.44 24.84 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.16 -1.019 . . . . 0.0 113.387 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.596 ' HE2' ' HA ' ' A' ' 133' ' ' LEU . 4.3 t80 -58.69 122.6 13.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.434 0.617 . . . . 0.0 110.395 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.684 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 82.0 p -115.86 -26.75 7.25 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 121.375 0.607 . . . . 0.0 111.39 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.45 ' O ' ' HA2' ' A' ' 136' ' ' GLY . . . 132.66 -159.62 23.51 Favored Glycine 0 N--CA 1.438 -1.189 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.346 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 104.77 151.99 21.49 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.729 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -46.29 116.36 1.25 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.01 -0.595 . . . . 0.0 110.66 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.722 ' HB ' HG13 ' A' ' 189' ' ' ILE . 79.2 t -108.81 137.94 38.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.693 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.41 119.67 39.49 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.629 -0.429 . . . . 0.0 110.796 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.636 ' O ' ' HA ' ' A' ' 191' ' ' ILE . 1.7 t -130.25 119.96 47.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.824 ' HB3' HG21 ' A' ' 168' ' ' VAL . 4.1 t70 -59.56 141.71 54.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.942 0.401 . . . . 0.0 110.797 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.479 ' HA2' HG22 ' A' ' 191' ' ' ILE . . . -63.4 -26.23 69.32 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.219 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.4 t -82.66 -10.86 58.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.673 0.273 . . . . 0.0 111.313 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.824 HG21 ' HB3' ' A' ' 165' ' ' ASP . 26.8 t -61.34 150.98 7.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.287 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.602 ' HB3' ' CD1' ' A' ' 172' ' ' PHE . 2.5 t -50.34 159.26 0.49 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.071 0.463 . . . . 0.0 111.134 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.11 -17.37 60.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.865 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.741 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 0.1 OUTLIER -88.17 -14.72 37.94 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.399 -178.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.615 ' CD2' ' HB2' ' A' ' 129' ' ' LEU . 8.4 m-85 -72.54 -49.8 30.14 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.472 0.653 . . . . 0.0 109.545 178.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.675 HD21 HD13 ' A' ' 177' ' ' LEU . 0.5 OUTLIER -70.46 -43.7 69.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.39 178.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.679 HG23 ' HD3' ' A' ' 27' ' ' ARG . 1.5 m -56.79 -34.58 67.79 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.458 178.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.739 ' HB2' ' HB1' ' A' ' 104' ' ' ALA . . . -63.98 -39.78 94.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.493 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.732 HD22 ' HB3' ' A' ' 132' ' ' ALA . 0.0 OUTLIER -77.01 -33.82 57.48 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.496 179.4 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.819 ' O ' ' HE3' ' A' ' 208' ' ' MET . 3.0 mp -59.56 -37.96 79.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.384 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.717 ' HE2' HD23 ' A' ' 31' ' ' LEU . 1.9 mtp -82.02 -43.12 18.38 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.47 0.652 . . . . 0.0 112.498 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.676 ' HG1' ' C ' ' A' ' 104' ' ' ALA . 100.0 m -72.94 -43.25 62.56 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.792 -1.094 . . . . 0.0 113.077 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.63 ' HB3' ' HB ' ' A' ' 187' ' ' THR . . . -59.33 -38.98 68.87 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -177.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.586 ' HD3' HG23 ' A' ' 225' ' ' VAL . 33.6 Cg_endo -66.29 -28.34 47.42 Favored 'Trans proline' 0 CA--C 1.501 -1.129 0 C-N-CA 120.904 1.069 . . . . 0.0 111.37 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.486 HD11 HD11 ' A' ' 34' ' ' LEU . 7.3 mt -84.72 1.82 44.78 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.913 -1.039 . . . . 0.0 109.206 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.508 ' O ' ' HA3' ' A' ' 227' ' ' GLY . . . -83.15 135.2 44.86 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.03 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.684 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 10.8 Cg_endo -49.23 -32.12 24.17 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.54 2.16 . . . . 0.0 113.015 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -115.03 140.16 49.28 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.586 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -55.61 145.65 22.85 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.301 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.63 ' HB ' ' HB3' ' A' ' 180' ' ' ALA . 86.3 m -122.39 144.0 49.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.231 0.539 . . . . 0.0 112.335 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.706 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 50.3 t -125.11 118.18 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 176.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.81 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 4.9 mp -101.56 117.47 46.9 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.93 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.569 ' HB2' ' HG3' ' A' ' 222' ' ' GLN . 0.2 OUTLIER -100.43 124.19 45.61 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.103 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.64 ' CG1' HD13 ' A' ' 173' ' ' LEU . 1.6 mp -93.52 123.33 45.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.96 -176.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.408 ' CG ' ' HA ' ' A' ' 165' ' ' ASP . 38.0 mttt -80.08 97.23 6.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.002 -1.454 . . . . 0.0 110.47 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 98.39 -133.92 11.51 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.171 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.07 125.73 52.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.225 0.536 . . . . 0.0 111.719 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.839 HD11 HG13 ' A' ' 201' ' ' ILE . 1.9 mt -41.84 145.66 0.31 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.55 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.558 HG11 ' O ' ' A' ' 168' ' ' VAL . 8.0 p -70.57 -29.12 37.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.725 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.469 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 28.6 t -168.16 65.49 0.07 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.98 0.419 . . . . 0.0 110.737 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.665 ' N ' ' HD2' ' A' ' 199' ' ' PRO . 2.5 tmpt? -37.26 -47.46 2.07 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.806 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.665 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 4.8 Cg_endo -47.31 -34.06 17.78 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.376 2.051 . . . . 0.0 111.434 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.64 ' HA ' ' CD1' ' A' ' 203' ' ' ILE . 0.2 OUTLIER -67.11 -43.49 82.34 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.685 0.755 . . . . 0.0 109.065 178.072 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.839 HG13 HD11 ' A' ' 195' ' ' LEU . 27.8 mm -64.44 -32.46 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.921 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.74 -41.94 95.56 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.796 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.64 ' CD1' ' HA ' ' A' ' 200' ' ' TYR . 4.4 mt -61.47 -50.14 81.57 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 CA-C-O 121.701 0.762 . . . . 0.0 109.41 178.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.516 HG22 ' CG2' ' A' ' 174' ' ' THR . 100.0 m -53.71 -52.32 60.45 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.119 -178.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.75 ' O ' ' HE2' ' A' ' 209' ' ' LYS . 44.6 mt -65.99 -30.79 71.4 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.109 0.481 . . . . 0.0 111.56 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -77.2 -46.71 22.4 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.772 0.796 . . . . 0.0 109.715 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.803 ' O ' HG23 ' A' ' 210' ' ' THR . 3.3 tp -70.34 -29.55 66.28 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.242 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' MET . . . . . 0.819 ' HE3' ' O ' ' A' ' 177' ' ' LEU . 49.8 mtp -73.85 -34.14 64.39 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.591 0.71 . . . . 0.0 109.194 177.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.75 ' HE2' ' O ' ' A' ' 205' ' ' LEU . 5.1 mtmm -61.59 -40.17 93.82 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.236 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.803 HG23 ' O ' ' A' ' 207' ' ' LEU . 4.7 t -60.52 -28.35 68.33 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.069 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.687 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 49.5 m-85 -80.25 -7.67 59.11 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.519 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.7 7.64 25.47 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 115.503 0.961 . . . . 0.0 115.503 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.676 HG13 ' CE1' ' A' ' 231' ' ' TYR . 5.3 m -123.42 148.83 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 118.775 1.287 . . . . 0.0 112.811 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.553 ' HG2' ' CG ' ' A' ' 209' ' ' LYS . 4.7 mt-10 -130.22 138.19 50.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.818 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.584 HG21 ' HB ' ' A' ' 225' ' ' VAL . 22.1 mm -122.41 147.74 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-O 120.836 0.35 . . . . 0.0 110.236 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.69 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 20.5 tt0 -103.63 115.86 31.29 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.774 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.51 149.44 27.54 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.588 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . 0.723 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -108.07 -144.86 0.39 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.594 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 8.1 m-70 -72.66 65.3 0.68 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.917 0.389 . . . . 0.0 111.523 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 1.7 t80 56.52 32.73 21.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.838 0.827 . . . . 0.0 110.609 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.649 ' O ' ' CD1' ' A' ' 223' ' ' PHE . 9.1 pt20 -159.78 -126.22 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.81 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.4 OUTLIER -10.11 134.98 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 115.024 1.491 . . . . 0.0 115.024 -179.671 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.706 ' O ' ' HA ' ' A' ' 188' ' ' VAL . 0.9 OUTLIER -126.31 138.24 53.57 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 113.032 -1.894 . . . . 0.0 110.139 -179.518 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.69 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 36.9 t -118.24 114.19 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.586 HG23 ' HD3' ' A' ' 181' ' ' PRO . 0.5 OUTLIER -122.4 120.39 60.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.806 -178.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.591 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -74.65 122.74 23.66 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.517 179.232 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -74.39 -173.39 29.78 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.251 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 62.23 19.65 59.78 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 121.401 -0.428 . . . . 0.0 113.158 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . 0.591 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 47.1 mt-30 -75.52 -171.96 1.67 Allowed 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.347 0.594 . . . . 0.0 111.006 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 23.3 t -155.55 147.45 23.32 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.133 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' TYR . . . . . 0.769 ' CE2' HD21 ' A' ' 31' ' ' LEU . 2.2 m-30 -102.01 134.97 44.38 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.7 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . 0.412 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 2.6 mt-30 -126.21 145.55 50.34 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.429 ' HB2' ' OG1' ' A' ' 39' ' ' THR . 25.0 p -72.39 109.42 5.88 Favored Pre-proline 0 N--CA 1.445 -0.685 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.7 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.633 ' HD2' ' HG1' ' A' ' 39' ' ' THR . 43.5 Cg_endo -66.75 0.1 3.98 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.865 1.71 . . . . 0.0 112.185 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 101.38 -102.55 2.41 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.498 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 90.0 m -117.3 132.86 56.52 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.582 ' CD2' HG21 ' A' ' 210' ' ' THR . 6.5 t80 -132.64 127.42 34.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.129 0.49 . . . . 0.0 111.696 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.569 HD12 ' HG2' ' A' ' 240' ' ' GLU . 0.2 OUTLIER -90.16 113.0 24.69 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.396 179.391 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.722 HG21 HD23 ' A' ' 44' ' ' LEU . 21.2 t -85.78 111.38 20.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.622 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.569 ' HG2' HD12 ' A' ' 238' ' ' LEU . 32.5 mt-10 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.235 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.57 ' HB3' HD22 ' A' ' 44' ' ' LEU . 88.4 p . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.726 0.298 . . . . 0.0 111.222 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.4 m120 59.63 -95.21 0.05 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.816 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.819 ' HB2' HD22 ' A' ' 207' ' ' LEU . 16.4 mtm-85 -76.43 -56.05 4.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.823 0.344 . . . . 0.0 110.989 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.652 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -35.55 -47.97 0.48 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.643 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.578 HD22 HD12 ' A' ' 75' ' ' ILE . 9.8 mt -73.48 -34.44 65.33 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.872 0.368 . . . . 0.0 111.433 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.636 HD21 ' HB2' ' A' ' 101' ' ' PRO . 54.3 tp -68.46 -50.1 54.98 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.732 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.626 ' HB2' ' CE2' ' A' ' 211' ' ' PHE . 49.0 mt -68.23 -26.71 65.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.583 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.63 -38.27 88.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.552 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.633 ' CB ' ' HG ' ' A' ' 57' ' ' LEU . . . -81.26 -41.53 22.05 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.996 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.764 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 9.9 mt -68.93 -2.91 10.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.279 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.561 ' HA ' ' CB ' ' A' ' 231' ' ' TYR . . . -100.13 179.26 4.54 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -176.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.557 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.3 OUTLIER -112.59 113.83 26.17 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.012 178.615 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 113.11 166.85 16.68 Favored Glycine 0 C--N 1.322 -0.243 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.321 -178.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 1.1 ttmt -95.37 117.68 30.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 117.155 0.478 . . . . 0.0 111.59 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.56 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 0.8 OUTLIER -117.73 148.59 41.87 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.387 179.59 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.462 HG21 ' HB2' ' A' ' 74' ' ' GLU . 92.4 t -105.47 141.27 21.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.144 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.652 ' HG ' ' HB1' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -114.8 116.27 28.34 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 174.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.586 HG21 ' CD2' ' A' ' 238' ' ' LEU . 0.5 OUTLIER -102.84 151.67 22.16 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.869 0.366 . . . . 0.0 111.437 -177.48 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.44 ' HB2' HD23 ' A' ' 238' ' ' LEU . 5.3 t-20 64.97 28.29 12.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.844 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.57 HD22 ' HB3' ' A' ' 25' ' ' SER . 91.4 mt -53.55 -174.26 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.195 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.46 ' HB3' HG22 ' A' ' 50' ' ' VAL . 56.6 tp -113.19 131.42 55.88 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -88.89 88.76 7.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.98 0.419 . . . . 0.0 110.323 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 50' ' ' VAL . 6.2 m -164.76 143.15 6.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.116 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -36.34 -30.95 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 O-C-N 123.046 0.216 . . . . 0.0 111.575 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.691 ' CB ' ' HA ' ' A' ' 95' ' ' ALA . 1.4 p30 -57.78 -42.57 84.39 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-O 121.103 0.478 . . . . 0.0 110.617 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.519 HG13 HD13 ' A' ' 54' ' ' LEU . 74.6 t -83.91 -44.44 18.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.115 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.582 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -50.21 -39.18 43.44 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.606 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 9.6 m-70 -80.39 -32.43 37.58 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.771 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.624 ' O ' HD12 ' A' ' 57' ' ' LEU . 8.4 tpt -54.79 -34.64 62.92 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 176.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.59 ' HB3' ' CE2' ' A' ' 64' ' ' TYR . 0.4 OUTLIER -83.49 -44.06 15.12 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.902 176.34 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.72 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 1.7 t30 -59.23 -37.8 78.43 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.816 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 52' ' ' HIS . . . -62.15 -47.78 83.03 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.844 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.2 OUTLIER -61.42 -40.95 96.32 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.161 -1.382 . . . . 0.0 107.556 177.001 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.72 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.1 m -59.31 -33.93 71.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.056 -1.429 . . . . 0.0 111.417 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.587 ' C ' HD22 ' A' ' 88' ' ' LEU . . . -78.34 -38.39 42.19 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.318 -178.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.509 HD11 ' HB2' ' A' ' 82' ' ' LEU . 0.6 OUTLIER -79.49 -14.37 58.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.42 0.629 . . . . 0.0 110.531 -179.626 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.77 35.78 4.48 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 114.938 -1.028 . . . . 0.0 113.854 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.844 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 25.0 t -90.41 121.29 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.767 ' O ' HG12 ' A' ' 76' ' ' ILE . 6.8 t -86.06 135.67 33.53 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.143 0.497 . . . . 0.0 111.148 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.59 ' CE2' ' HB3' ' A' ' 54' ' ' LEU . 36.0 p90 -161.99 172.29 16.22 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.324 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.9 m -134.66 147.32 50.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.321 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.469 HD11 ' HB2' ' A' ' 73' ' ' CYS . 5.5 tp -117.79 138.28 52.17 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.163 0.506 . . . . 0.0 110.852 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.494 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 1.1 m -63.88 -164.51 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.94 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -93.18 -34.04 13.76 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.438 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.52 1.06 15.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.661 0.267 . . . . 0.0 111.276 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 57.6 39.86 27.25 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.943 0.402 . . . . 0.0 111.059 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.47 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 1.1 p -139.18 -10.52 1.27 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.441 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.494 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 7.6 mtt180 -114.16 117.67 31.85 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.469 ' HB2' HD11 ' A' ' 66' ' ' LEU . 13.9 t -130.08 128.91 42.86 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.56 ' HA ' ' O ' ' A' ' 39' ' ' THR . 29.0 tt0 -112.11 128.95 56.36 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 176.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.58 ' HA ' ' CB ' ' A' ' 64' ' ' TYR . 16.2 mt -124.22 123.35 66.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -178.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.767 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -68.73 97.92 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-O 121.427 0.632 . . . . 0.0 109.664 175.833 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -37.82 144.25 0.19 Allowed Glycine 0 C--N 1.322 -0.237 0 CA-C-N 114.804 -1.089 . . . . 0.0 113.974 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -90.17 -10.87 42.89 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.957 0.408 . . . . 0.0 110.91 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.557 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 93.36 -1.35 69.49 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.921 -0.582 . . . . 0.0 112.6 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.578 ' O ' HD22 ' A' ' 34' ' ' LEU . . . 154.69 -145.96 13.58 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.172 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.564 ' HG3' ' HB3' ' A' ' 108' ' ' LEU . 53.7 Cg_exo -49.8 124.84 13.12 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.74 2.293 . . . . 0.0 112.718 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.513 HD21 ' CD2' ' A' ' 34' ' ' LEU . 0.9 OUTLIER -77.25 106.38 8.94 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.637 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -81.92 138.77 34.94 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.519 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.729 ' HB1' HD11 ' A' ' 113' ' ' ILE . . . -100.38 126.96 46.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.955 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.77 123.69 22.53 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 176.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.62 174.2 0.76 Allowed Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 -175.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.84 144.69 47.37 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 118.588 1.194 . . . . 0.0 111.556 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.686 HD21 ' HB2' ' A' ' 84' ' ' ALA . 1.2 tp -116.43 160.43 20.57 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.224 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 2.3 mt-10 -138.77 102.99 4.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.078 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.528 ' HB2' HD22 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -98.77 120.85 39.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.152 -178.716 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.447 ' CE1' ' HB ' ' A' ' 116' ' ' THR . 0.2 OUTLIER -94.1 96.67 9.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.572 179.217 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.578 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -104.35 56.7 0.71 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.952 -179.822 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.603 ' CA ' ' H ' ' A' ' 118' ' ' GLU . . . -62.92 -70.01 1.16 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.017 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.438 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 3.3 m-80 -76.04 18.47 0.27 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.356 -0.238 . . . . 0.0 110.356 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.691 ' HA ' ' CB ' ' A' ' 49' ' ' ASP . . . -93.59 -70.62 0.69 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.38 -66.82 0.25 Allowed Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.093 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.476 ' HA ' ' HG2' ' A' ' 171' ' ' GLN . 8.4 p -71.88 -8.15 52.66 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.432 ' O ' ' HG2' ' A' ' 101' ' ' PRO . . . -99.65 -34.46 10.2 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.577 0.227 . . . . 0.0 111.468 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.7 -45.58 89.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.755 0.312 . . . . 0.0 110.193 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.671 ' CB ' ' HB3' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -52.73 -60.88 5.55 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.142 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.636 ' HB2' HD21 ' A' ' 30' ' ' LEU . 19.5 Cg_endo -60.13 -30.61 91.78 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.342 2.028 . . . . 0.0 112.646 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.507 HD22 ' HA ' ' A' ' 102' ' ' LEU . 0.8 OUTLIER -75.91 -53.31 8.61 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.159 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.528 ' O ' HD12 ' A' ' 153' ' ' LEU . . . -49.45 -27.98 4.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.227 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.627 ' CB ' HD21 ' A' ' 133' ' ' LEU . . . -87.1 -54.1 4.5 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.787 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.445 ' HB2' HD13 ' A' ' 34' ' ' LEU . . . -60.6 -31.19 70.37 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -177.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.517 HD13 HG13 ' A' ' 113' ' ' ILE . 30.3 mt -79.27 -21.61 45.85 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.509 -177.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.758 ' HB3' ' HB2' ' A' ' 138' ' ' ALA . 89.8 m -82.18 17.94 1.52 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.198 0.523 . . . . 0.0 111.186 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.63 HD11 HD11 ' A' ' 182' ' ' LEU . 2.8 mt -81.23 -77.0 0.22 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.275 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.14 -109.0 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.392 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 m -156.79 96.69 1.64 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.08 0.467 . . . . 0.0 111.108 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.517 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 37.8 p-10 -147.0 139.19 24.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.174 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.882 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 2.5 m-20 -90.87 101.0 13.76 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.771 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.729 HD11 ' HB1' ' A' ' 84' ' ' ALA . 28.7 mm -120.81 137.59 54.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.574 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.796 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 58.0 t -110.22 112.29 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 175.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.528 HD22 ' HB2' ' A' ' 90' ' ' LEU . 24.9 mt -102.27 107.09 18.01 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.608 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.447 ' HB ' ' CE1' ' A' ' 91' ' ' PHE . 0.7 OUTLIER -117.38 -173.91 2.51 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.087 -179.085 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.489 ' HA3' ' HG2' ' A' ' 121' ' ' MET . . . -163.14 -174.54 33.16 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.921 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.603 ' H ' ' CA ' ' A' ' 93' ' ' GLY . 15.1 mt-10 -76.77 172.7 8.95 Favored Pre-proline 0 C--N 1.328 -0.352 0 C-N-CA 122.853 0.461 . . . . 0.0 110.582 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.558 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 87.4 Cg_exo -47.52 -38.6 28.2 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.448 2.099 . . . . 0.0 112.488 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.416 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 38.8 mtm180 -69.25 -23.19 63.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.962 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.704 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 11.0 tpt -60.69 -31.86 71.11 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -16.88 63.27 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.768 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 120' ' ' ARG . 3.4 mm-40 -82.56 -0.54 47.3 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.775 0.321 . . . . 0.0 110.534 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.416 ' O ' ' NH2' ' A' ' 100' ' ' ARG . 3.5 mtp85 -127.44 87.1 57.03 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.892 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.459 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 18.4 Cg_endo -59.51 148.81 85.5 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.519 2.146 . . . . 0.0 111.399 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.577 HG12 HD13 ' A' ' 151' ' ' LEU . 0.6 OUTLIER -120.48 6.08 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.908 0.385 . . . . 0.0 111.947 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.618 ' HA3' ' OD1' ' A' ' 147' ' ' ASN . . . -55.55 -44.14 85.74 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.94 -0.648 . . . . 0.0 114.179 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.464 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 60.0 m-70 -55.63 -36.26 66.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 117.442 0.621 . . . . 0.0 110.06 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.67 HD12 ' HA ' ' A' ' 172' ' ' PHE . 21.5 tp -75.85 -43.27 46.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.143 0.497 . . . . 0.0 110.162 178.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.788 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 40.5 t -56.4 -47.78 80.94 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.385 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.714 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 0.1 OUTLIER -70.95 -36.23 72.49 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.405 -179.702 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.556 ' HB2' HD22 ' A' ' 176' ' ' LEU . . . -61.65 -50.27 73.21 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.803 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.633 HD22 HD21 ' A' ' 176' ' ' LEU . 9.7 mt -70.74 -48.0 56.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.933 178.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.788 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -59.22 -27.38 65.69 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.72 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.714 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.5 OUTLIER -68.47 -31.72 71.22 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.966 0.412 . . . . 0.0 110.759 178.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.56 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -83.84 14.71 41.24 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.894 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.69 3.87 62.3 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.589 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.758 ' HB2' ' HB3' ' A' ' 107' ' ' CYS . . . -71.9 150.45 44.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.884 0.373 . . . . 0.0 111.298 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 0.5 OUTLIER -98.88 102.97 14.87 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.122 178.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.531 ' HB ' ' HG3' ' A' ' 134' ' ' ARG . 8.8 mt -134.77 126.93 48.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.264 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.625 HG21 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -124.35 139.44 53.9 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.204 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -79.03 130.04 35.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.121 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.69 ' HB2' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -91.72 -89.04 0.18 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.542 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.628 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 6.3 mm-40 -59.67 -81.19 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.529 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' A' ' 148' ' ' TYR . 18.5 mt-30 -113.91 151.49 32.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.128 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -67.25 137.52 56.21 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.618 ' OD1' ' HA3' ' A' ' 127' ' ' GLY . 7.9 m-80 65.55 19.13 11.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.138 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.509 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 8.2 m-85 -110.14 168.88 7.0 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-O 121.105 0.479 . . . . 0.0 112.167 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.913 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 37.8 Cg_exo -32.49 -62.27 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 124.409 3.406 . . . . 0.0 116.087 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.913 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 66.6 Cg_exo -54.86 145.26 62.71 Favored 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-N 120.515 1.219 . . . . 0.0 112.747 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.796 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 12.3 mt -156.17 133.97 11.1 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.602 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.625 ' HB2' HG21 ' A' ' 141' ' ' THR . 3.2 mtt180 -105.74 102.68 12.11 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 176.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.882 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 10.0 mt -91.73 147.97 22.59 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.941 -178.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.573 ' HG3' ' O ' ' A' ' 153' ' ' LEU . 3.5 mt-30 -148.73 27.48 0.89 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.352 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 51.73 -175.61 0.12 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.162 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 121.46 -11.81 9.65 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.182 -1.009 . . . . 0.0 112.817 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.802 ' HE2' ' HA ' ' A' ' 180' ' ' ALA . 50.8 t80 -59.78 123.14 16.05 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.006 0.403 . . . . 0.0 110.832 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.693 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 81.4 p -118.38 -28.43 5.75 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.301 0.572 . . . . 0.0 111.682 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.471 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 134.35 -161.73 24.47 Favored Glycine 0 C--N 1.308 -1.02 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.503 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 105.21 153.3 21.68 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.351 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -47.09 119.39 2.54 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.292 -0.454 . . . . 0.0 111.077 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.667 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 78.7 t -111.28 134.96 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.48 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.44 119.65 39.46 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.269 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 191' ' ' ILE . 1.0 OUTLIER -131.14 120.13 46.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.05 0.453 . . . . 0.0 110.424 179.453 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.45 ' HB2' HG22 ' A' ' 168' ' ' VAL . 1.9 m-20 -52.18 137.43 28.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.466 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.438 ' HA2' ' CG2' ' A' ' 191' ' ' ILE . . . -61.83 -48.47 83.66 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.962 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.3 m -88.64 87.97 7.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.968 0.413 . . . . 0.0 110.365 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.563 ' H ' ' HB ' ' A' ' 196' ' ' VAL . 46.5 t -147.41 -105.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.964 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.69 ' HB2' ' CD1' ' A' ' 172' ' ' PHE . 40.7 m -141.98 128.41 20.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.942 0.401 . . . . 0.0 110.076 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.715 ' HB3' ' HB3' ' A' ' 197' ' ' SER . 53.3 p -55.5 -19.21 8.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.245 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.671 ' HB3' ' CB ' ' A' ' 100' ' ' ARG . 1.2 mp0 -86.53 -10.15 54.66 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.28 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.69 ' CD1' ' HB2' ' A' ' 169' ' ' SER . 3.6 m-85 -75.02 -53.0 9.68 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.556 HD21 HD12 ' A' ' 177' ' ' LEU . 0.9 OUTLIER -65.9 -39.97 91.09 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.112 178.409 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.499 ' HB ' ' HA ' ' A' ' 171' ' ' GLN . 1.8 m -60.15 -32.24 70.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.354 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.589 ' HB3' ' HB1' ' A' ' 104' ' ' ALA . . . -66.81 -41.48 87.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.44 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.633 HD21 HD22 ' A' ' 133' ' ' LEU . 0.2 OUTLIER -76.31 -35.42 58.83 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.794 -179.809 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.822 ' O ' ' HE3' ' A' ' 208' ' ' MET . 4.1 mp -59.59 -36.82 77.01 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.514 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.595 ' HE1' ' HB3' ' A' ' 27' ' ' ARG . 2.6 mtp -81.88 -45.35 15.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.559 0.695 . . . . 0.0 112.219 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.513 HG22 ' HG ' ' A' ' 108' ' ' LEU . 93.0 m -70.9 -42.04 70.5 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.739 -1.119 . . . . 0.0 112.596 -178.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.802 ' HA ' ' HE2' ' A' ' 157' ' ' PHE . . . -59.86 -41.62 86.43 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.562 ' HD3' ' O ' ' A' ' 177' ' ' LEU . 17.9 Cg_endo -63.88 -30.07 67.65 Favored 'Trans proline' 0 CA--C 1.502 -1.122 0 C-N-CA 120.822 1.015 . . . . 0.0 111.321 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.63 HD11 HD11 ' A' ' 108' ' ' LEU . 10.8 mt -84.5 2.9 38.91 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.701 178.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.526 ' O ' ' HA3' ' A' ' 227' ' ' GLY . . . -84.74 135.94 39.78 Favored Pre-proline 0 N--CA 1.454 -0.237 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.693 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 14.2 Cg_endo -52.51 -29.7 41.33 Favored 'Trans proline' 0 CA--C 1.518 -0.316 0 C-N-CA 122.523 2.149 . . . . 0.0 112.95 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.5 138.37 50.69 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.587 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -55.94 142.9 33.91 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.353 -0.385 . . . . 0.0 109.99 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.576 ' O ' HG12 ' A' ' 225' ' ' VAL . 88.8 m -120.89 147.45 45.4 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.871 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.674 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 55.1 t -128.26 117.84 46.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 176.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.785 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 5.2 mp -99.82 117.7 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.906 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.578 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -100.63 123.63 45.1 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.569 ' HB ' ' HA ' ' A' ' 221' ' ' GLN . 1.5 mp -93.77 121.16 44.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.454 -176.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -79.08 96.95 5.95 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.824 -1.534 . . . . 0.0 110.648 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 100.24 -132.73 11.04 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.958 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -114.09 127.52 55.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.051 0.453 . . . . 0.0 111.267 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.667 HD11 ' HD2' ' A' ' 198' ' ' LYS . 1.1 mt -42.33 145.22 0.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.917 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.563 ' HB ' ' H ' ' A' ' 168' ' ' VAL . 12.9 p -71.61 -29.92 36.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.346 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.715 ' HB3' ' HB3' ' A' ' 170' ' ' SER . 5.9 t -164.92 62.15 0.13 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.84 0.352 . . . . 0.0 111.174 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.667 ' HD2' HD11 ' A' ' 195' ' ' LEU . 13.5 tptp -36.45 -49.08 1.8 Allowed Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.571 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 6.3 Cg_endo -48.0 -34.69 23.56 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.097 1.864 . . . . 0.0 112.178 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.643 ' HA ' ' CD1' ' A' ' 203' ' ' ILE . 0.2 OUTLIER -68.34 -44.82 74.46 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.492 HG13 HD13 ' A' ' 195' ' ' LEU . 19.2 mm -59.84 -35.68 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.194 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.6 -41.53 97.58 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.014 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.643 ' CD1' ' HA ' ' A' ' 200' ' ' TYR . 4.1 mt -63.98 -49.27 82.38 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.915 0 CA-C-O 121.711 0.767 . . . . 0.0 109.233 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.517 ' O ' ' HG3' ' A' ' 208' ' ' MET . 88.5 m -53.6 -51.19 63.82 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.933 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.631 ' O ' ' HE2' ' A' ' 209' ' ' LYS . 33.4 mt -65.24 -32.7 74.5 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 120.541 -0.464 . . . . 0.0 111.465 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -76.89 -46.04 25.9 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.717 0.77 . . . . 0.0 109.414 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.819 HD22 ' HB2' ' A' ' 27' ' ' ARG . 4.4 tp -67.41 -33.28 74.84 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.595 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' MET . . . . . 0.822 ' HE3' ' O ' ' A' ' 177' ' ' LEU . 42.9 mtp -74.99 -33.89 61.91 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.62 0.724 . . . . 0.0 109.232 177.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.631 ' HE2' ' O ' ' A' ' 205' ' ' LEU . 4.5 mtmt -61.35 -39.05 89.16 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.667 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.452 ' O ' ' HB3' ' A' ' 234' ' ' PRO . 5.8 t -61.93 -27.21 68.66 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.422 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.626 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 57.0 m-85 -84.07 -6.74 59.46 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.627 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.97 6.87 25.87 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 116.282 1.273 . . . . 0.0 116.282 177.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.6 m -123.17 148.41 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 118.973 1.387 . . . . 0.0 112.198 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.483 ' HG2' ' HD3' ' A' ' 209' ' ' LYS . 10.9 mt-10 -130.06 141.69 50.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.972 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.551 ' HB ' ' CD2' ' A' ' 205' ' ' LEU . 21.1 mm -123.7 148.33 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-O 120.851 0.358 . . . . 0.0 110.502 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.632 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 1.5 tt0 -102.87 118.52 37.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.918 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.456 ' ND2' ' HE2' ' A' ' 198' ' ' LYS . 1.5 t30 -83.01 150.8 26.13 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.601 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . 0.657 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 9.8 mm-40 -109.48 -142.44 0.38 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 121.203 -0.199 . . . . 0.0 110.615 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.56 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 0.3 OUTLIER -75.02 65.91 1.52 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.88 0.371 . . . . 0.0 111.632 -179.023 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 4.0 t80 55.56 37.53 29.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.929 0.871 . . . . 0.0 110.598 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.603 ' O ' ' CD1' ' A' ' 223' ' ' PHE . 12.6 pt20 -167.1 -125.29 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.785 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -9.0 133.62 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 179.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.674 ' O ' ' HA ' ' A' ' 188' ' ' VAL . 0.6 OUTLIER -124.84 138.55 54.26 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 112.975 -1.921 . . . . 0.0 109.853 -179.082 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.632 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 27.0 t -119.47 113.9 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-O 121.319 0.58 . . . . 0.0 109.506 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.585 HG11 ' CB ' ' A' ' 180' ' ' ALA . 0.5 OUTLIER -120.94 121.12 64.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.034 -179.197 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.538 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 2.7 mptp? -75.63 118.99 19.06 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -69.1 -174.58 10.37 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.046 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 62.36 21.31 62.03 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 121.226 -0.511 . . . . 0.0 113.076 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 8.1 mm100 -68.11 -166.2 0.06 Allowed 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.434 0.635 . . . . 0.0 111.157 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 75.0 m -158.02 147.28 19.57 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.602 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' TYR . . . . . 0.764 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 3.8 m-30 -111.09 127.97 55.73 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.59 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.97 150.78 41.56 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.473 ' CA ' ' HG1' ' A' ' 39' ' ' THR . 60.4 p -76.33 110.91 12.66 Favored Pre-proline 0 N--CA 1.442 -0.835 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.822 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.452 ' HB3' ' O ' ' A' ' 210' ' ' THR . 36.5 Cg_endo -65.94 -2.75 7.14 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.044 1.829 . . . . 0.0 112.29 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 99.81 -103.13 2.63 Favored Glycine 0 C--O 1.225 -0.442 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 73.0 m -115.46 133.93 55.57 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.427 ' O ' ' HA ' ' A' ' 41' ' ' LEU . 8.3 t80 -132.62 126.95 33.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.959 0.409 . . . . 0.0 111.405 -178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.586 ' CD2' HG21 ' A' ' 42' ' ' THR . 0.3 OUTLIER -90.82 110.53 21.74 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.597 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.531 HG23 HD21 ' A' ' 44' ' ' LEU . 21.8 t -83.63 113.0 21.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.094 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.408 ' HG2' HD12 ' A' ' 238' ' ' LEU . 11.3 mt-10 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.253 -0.879 . . . . 0.0 111.245 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.716 ' HB2' HD22 ' A' ' 44' ' ' LEU . 7.6 t . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 120.868 0.366 . . . . 0.0 111.282 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 63.07 -80.87 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.303 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.644 ' HB3' ' HE2' ' A' ' 178' ' ' MET . 78.1 mtm180 -74.37 -57.99 3.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.095 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.602 ' CB ' ' HG ' ' A' ' 41' ' ' LEU . . . -43.12 -48.54 6.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.737 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.609 HD23 HD12 ' A' ' 75' ' ' ILE . 11.3 mt -72.09 -32.42 67.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.898 0.38 . . . . 0.0 111.371 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.606 HD23 ' HB2' ' A' ' 101' ' ' PRO . 53.2 tp -68.66 -50.18 53.17 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.355 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.734 HD13 ' HG2' ' A' ' 208' ' ' MET . 33.4 mt -68.16 -26.43 65.75 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.77 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.538 ' HA ' ' HE1' ' A' ' 211' ' ' PHE . . . -65.84 -39.52 90.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.302 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.575 ' CB ' ' HG ' ' A' ' 57' ' ' LEU . . . -81.44 -41.24 22.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.269 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.622 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 13.3 mt -67.72 -4.57 12.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.245 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.545 ' HA ' ' CB ' ' A' ' 231' ' ' TYR . . . -94.58 177.51 5.9 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.63 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.1 OUTLIER -117.48 114.89 24.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.623 178.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.626 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 128.51 -142.84 13.91 Favored Glycine 0 C--O 1.224 -0.508 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.025 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.439 ' HG3' HG21 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -136.66 117.47 14.1 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.186 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 235' ' ' GLY . 0.8 OUTLIER -128.68 145.79 51.06 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.541 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.48 HG22 ' CB ' ' A' ' 74' ' ' GLU . 78.3 t -109.3 143.58 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 CA-C-O 121.51 0.671 . . . . 0.0 112.312 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.602 ' HG ' ' CB ' ' A' ' 28' ' ' ALA . 0.3 OUTLIER -115.84 116.3 27.77 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 174.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.479 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.5 OUTLIER -103.53 151.57 22.72 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.863 0.364 . . . . 0.0 111.277 -177.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.512 ' HB2' HD21 ' A' ' 238' ' ' LEU . 7.2 t30 65.78 26.37 11.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.044 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.716 HD22 ' HB2' ' A' ' 25' ' ' SER . 84.6 mt -54.6 -172.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.832 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.5 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 61.9 tp -112.94 131.59 55.68 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.384 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -89.39 86.96 6.92 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.965 0.412 . . . . 0.0 110.153 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 49' ' ' ASP . 4.0 m -165.09 143.37 6.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.462 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 47' ' ' SER . 34.6 m-20 -34.71 -31.64 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.714 0.292 . . . . 0.0 111.721 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.535 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 2.0 p30 -57.91 -42.2 84.26 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.066 0.46 . . . . 0.0 110.848 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.5 ' CG2' ' HB3' ' A' ' 45' ' ' LEU . 92.9 t -84.47 -45.1 17.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.655 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -48.34 -39.67 22.79 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.636 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.625 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 23.2 m-70 -80.15 -32.17 38.9 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.021 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.62 ' O ' HD13 ' A' ' 57' ' ' LEU . 9.4 tpt -55.55 -35.31 65.58 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.67 ' HB3' ' CE2' ' A' ' 64' ' ' TYR . 0.4 OUTLIER -81.93 -44.2 17.08 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.102 -1.408 . . . . 0.0 108.694 176.149 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.751 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 4.7 t-20 -58.8 -35.59 73.09 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.742 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' A' ' 52' ' ' HIS . . . -63.04 -46.8 85.84 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.81 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.4 OUTLIER -63.96 -39.37 93.99 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.758 -1.565 . . . . 0.0 107.752 177.276 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.751 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -59.27 -41.0 87.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.154 178.793 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.549 ' O ' HD21 ' A' ' 88' ' ' LEU . . . -71.21 -38.51 72.04 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.139 -178.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.549 HD12 ' HB2' ' A' ' 82' ' ' LEU . 0.6 OUTLIER -78.83 -16.23 57.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.241 0.543 . . . . 0.0 110.834 -179.69 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.82 35.22 4.37 Favored Glycine 0 C--N 1.319 -0.369 0 CA-C-N 115.272 -0.876 . . . . 0.0 114.372 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.81 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 39.7 t -90.56 120.5 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.805 ' O ' HG12 ' A' ' 76' ' ' ILE . 27.1 m -83.26 127.43 33.64 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.538 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.67 ' CE2' ' HB3' ' A' ' 54' ' ' LEU . 42.7 p90 -155.84 172.17 18.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.848 0.356 . . . . 0.0 110.266 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 87.0 m -133.94 148.91 51.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.221 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.0 tp -117.05 135.85 53.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.969 0.414 . . . . 0.0 110.4 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.46 ' HB3' ' CB ' ' A' ' 72' ' ' ARG . 33.8 p -61.71 -172.19 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.382 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.89 -43.53 19.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.189 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.36 0.54 11.86 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.555 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.1 mtp85 59.54 46.74 11.7 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.069 0.462 . . . . 0.0 110.956 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.506 HG21 ' O ' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -141.24 -14.91 0.87 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.973 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.558 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 8.6 mtp180 -113.94 116.74 29.73 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.587 ' HB3' HD11 ' A' ' 44' ' ' LEU . 28.9 t -124.89 123.18 39.36 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.526 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 34.3 tt0 -104.37 134.36 47.71 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 176.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.613 ' CG2' ' HB3' ' A' ' 64' ' ' TYR . 8.1 mt -131.32 122.21 50.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -177.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.805 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -67.89 98.63 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.695 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -35.68 140.81 0.18 Allowed Glycine 0 CA--C 1.518 0.219 0 CA-C-N 115.232 -0.895 . . . . 0.0 114.02 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -86.82 -11.43 50.91 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.101 0.477 . . . . 0.0 110.786 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.63 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 90.73 -1.01 77.8 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.205 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.521 ' O ' HD22 ' A' ' 34' ' ' LEU . . . 154.34 -150.02 21.52 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.5 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 87.3 Cg_exo -49.32 121.54 7.16 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.759 2.306 . . . . 0.0 112.639 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.549 ' HB2' HD12 ' A' ' 60' ' ' LEU . 0.7 OUTLIER -70.71 112.12 6.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.726 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.424 ' HA ' ' CG ' ' A' ' 111' ' ' ASN . 4.9 p80 -82.93 136.14 34.66 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.772 ' HB3' HD23 ' A' ' 88' ' ' LEU . . . -97.9 123.64 41.97 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.762 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -70.92 123.44 22.01 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 176.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.27 177.14 1.01 Allowed Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 108.692 -1.763 . . . . 0.0 108.692 -175.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.97 144.3 47.31 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 118.738 1.269 . . . . 0.0 111.085 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.772 HD23 ' HB3' ' A' ' 84' ' ' ALA . 1.0 OUTLIER -115.77 160.41 20.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.179 -178.829 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 9.9 mt-10 -139.71 103.85 4.77 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.86 178.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.669 ' HB2' HD23 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -97.19 122.73 40.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.884 0.373 . . . . 0.0 110.928 -178.531 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -95.47 96.31 9.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.817 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.578 HD23 ' O ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -107.29 46.28 0.94 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.538 -179.392 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.598 ' CA ' ' H ' ' A' ' 118' ' ' GLU . . . -56.38 -27.74 53.95 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.721 -0.672 . . . . 0.0 113.152 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.508 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 1.0 OUTLIER -106.65 -21.14 13.14 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.586 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 49' ' ' ASP . . . -86.02 57.84 4.71 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.057 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.555 ' O ' ' HD3' ' A' ' 100' ' ' ARG . . . -59.82 -38.04 93.4 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.051 -1.071 . . . . 0.0 111.146 178.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.448 HG23 ' HG3' ' A' ' 171' ' ' GLN . 0.6 OUTLIER -78.46 -15.67 58.38 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.506 0.188 . . . . 0.0 111.506 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.501 ' HA ' ' HG2' ' A' ' 101' ' ' PRO . . . -96.91 -27.33 14.71 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.716 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.659 ' SD ' ' HB3' ' A' ' 115' ' ' LEU . 4.3 tpp -62.07 -41.2 97.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.903 0.382 . . . . 0.0 110.156 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.56 ' O ' HD22 ' A' ' 129' ' ' LEU . 1.6 mpt_? -59.52 -60.11 11.65 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.606 ' HB2' HD23 ' A' ' 30' ' ' LEU . 18.6 Cg_endo -58.87 -31.11 94.72 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.057 1.838 . . . . 0.0 112.029 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.558 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -74.84 -53.34 9.28 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.055 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.623 ' HA ' HD13 ' A' ' 153' ' ' LEU . . . -50.35 -28.56 8.2 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.475 0.655 . . . . 0.0 110.503 178.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.651 ' HB3' ' HB3' ' A' ' 175' ' ' ALA . . . -87.19 -52.99 5.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.214 -0.903 . . . . 0.0 113.065 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.516 ' HA ' ' HG1' ' A' ' 179' ' ' THR . . . -60.39 -27.83 67.75 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.713 0.635 . . . . 0.0 112.713 -177.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 102' ' ' LEU . 33.6 mt -82.23 -27.08 32.7 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.585 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . 11.1 p -74.38 12.33 0.79 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.18 0.514 . . . . 0.0 111.422 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.599 ' HG ' HG21 ' A' ' 179' ' ' THR . 1.3 mt -78.14 -76.57 0.18 Allowed 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.433 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.408 ' O ' ' HA3' ' A' ' 155' ' ' GLY . . . -71.79 -115.57 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.64 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.9 p -150.88 95.49 2.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.97 0.414 . . . . 0.0 110.245 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.599 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 14.8 m120 -148.47 138.36 22.31 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.51 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.916 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 0.7 OUTLIER -90.35 100.01 12.92 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.15 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.686 HD12 ' HB2' ' A' ' 84' ' ' ALA . 24.7 mm -119.27 136.54 56.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.496 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.752 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 60.9 t -108.33 111.98 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 176.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.669 HD23 ' HB2' ' A' ' 90' ' ' LEU . 52.7 mt -102.25 107.96 19.18 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.53 -178.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.512 ' CG2' ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -124.2 -170.41 2.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.89 0.376 . . . . 0.0 111.675 -179.04 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.527 ' HA3' ' HG2' ' A' ' 121' ' ' MET . . . -168.59 -169.05 31.54 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.144 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.743 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 50.7 mt-10 -81.24 172.73 9.04 Favored Pre-proline 0 N--CA 1.455 -0.223 0 C-N-CA 123.213 0.605 . . . . 0.0 110.254 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.743 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 8.0 Cg_endo -48.1 -39.62 33.64 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.666 2.244 . . . . 0.0 112.336 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 120' ' ' ARG . 10.2 ttp180 -67.97 -23.95 65.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.702 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.602 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 9.7 tpt -61.14 -31.87 71.58 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.511 ' HZ1' ' HD3' ' A' ' 150' ' ' PRO . 12.0 mmtt -63.63 -17.14 62.59 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.559 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -79.57 0.65 29.02 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.845 0.355 . . . . 0.0 110.621 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.55 ' HB3' ' NH2' ' A' ' 100' ' ' ARG . 0.8 OUTLIER -126.98 83.03 66.96 Favored Pre-proline 0 N--CA 1.454 -0.262 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.235 179.546 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.508 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 43.6 Cg_exo -56.29 148.68 59.6 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.577 2.184 . . . . 0.0 111.618 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.606 HG12 HD11 ' A' ' 151' ' ' LEU . 1.3 tt -128.84 22.56 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.517 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -69.2 -46.4 57.93 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.183 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.66 ' CE1' ' HB2' ' A' ' 165' ' ' ASP . 1.7 m-70 -55.68 -37.58 68.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.832 0.349 . . . . 0.0 110.929 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.694 ' HG ' HD13 ' A' ' 133' ' ' LEU . 16.9 tp -70.19 -44.32 68.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.353 0.597 . . . . 0.0 109.527 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.724 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 36.2 t -56.85 -47.31 83.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.16 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.755 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 2.8 m-20 -71.04 -38.29 72.54 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 120.881 0.372 . . . . 0.0 110.704 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.608 ' O ' HG13 ' A' ' 162' ' ' VAL . . . -57.96 -46.97 84.28 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.537 0.684 . . . . 0.0 109.87 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.694 HD13 ' HG ' ' A' ' 129' ' ' LEU . 5.8 mt -76.02 -50.18 15.54 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.798 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.724 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -57.17 -27.7 62.15 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.01 179.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.755 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 5.0 tp -70.55 -30.09 66.72 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.941 0.4 . . . . 0.0 110.915 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 159' ' ' GLY . . . -84.22 14.42 44.92 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.838 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.63 4.48 60.58 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.892 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.585 ' HB3' ' HB2' ' A' ' 107' ' ' CYS . . . -75.2 155.75 36.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.985 0.421 . . . . 0.0 111.533 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 3.7 mttm -102.58 105.55 16.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.303 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.671 ' HB ' ' HG3' ' A' ' 134' ' ' ARG . 13.6 mt -138.68 127.57 30.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.542 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.753 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -126.38 139.83 52.97 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.594 -179.544 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.423 ' HE1' HG23 ' A' ' 130' ' ' VAL . 36.0 m-85 -78.07 132.37 37.7 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.382 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.685 ' HB2' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -95.16 -90.97 0.22 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.909 -179.568 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.795 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 16.0 mm-40 -59.15 -81.05 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.025 0.44 . . . . 0.0 110.692 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.48 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 31.6 mt-30 -113.09 148.86 34.38 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.788 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 4.7 mt-10 -65.5 132.54 49.17 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.428 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.517 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 2.1 m-20 67.85 17.82 9.67 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.124 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.594 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 16.8 m-85 -108.75 169.17 6.8 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.035 0.445 . . . . 0.0 111.603 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.889 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 8.2 Cg_exo -32.23 -62.73 0.14 Allowed 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 124.164 3.243 . . . . 0.0 116.656 -177.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.889 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 59.2 Cg_exo -53.05 143.89 48.51 Favored 'Trans proline' 0 C--N 1.351 0.68 0 CA-C-N 120.982 1.387 . . . . 0.0 112.892 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.752 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 10.4 mt -155.58 133.23 11.15 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.67 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.753 ' HB2' HG22 ' A' ' 141' ' ' THR . 2.8 mtt85 -103.29 100.76 10.66 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.916 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 10.0 mt -90.62 148.54 22.59 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.987 -178.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.599 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 3.6 mt-30 -149.64 23.79 0.88 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.048 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 54.52 -168.57 1.78 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.226 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 114.89 -14.57 19.45 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.243 -0.98 . . . . 0.0 113.216 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HD2' ' HB2' ' A' ' 138' ' ' ALA . 45.4 t80 -58.18 122.75 13.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 117.396 0.598 . . . . 0.0 110.742 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.692 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 76.6 p -114.87 -29.88 6.59 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.375 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.48 ' O ' ' HA2' ' A' ' 136' ' ' GLY . . . 133.73 -157.99 23.06 Favored Glycine 0 C--N 1.305 -1.153 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.115 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.469 ' O ' HG21 ' A' ' 162' ' ' VAL . . . 103.06 153.57 24.26 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.289 -0.958 . . . . 0.0 111.347 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -47.16 115.84 1.21 Allowed 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.296 -0.452 . . . . 0.0 111.081 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 60.9 t -107.85 140.28 26.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.64 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.96 119.79 40.1 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.057 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.6 ' O ' ' HA ' ' A' ' 191' ' ' ILE . 1.6 t -129.27 120.56 51.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.66 ' HB2' ' CE1' ' A' ' 128' ' ' HIS . 7.8 t0 -55.04 139.62 40.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.234 0.54 . . . . 0.0 112.066 -178.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.558 ' HA2' ' CG2' ' A' ' 191' ' ' ILE . . . -62.11 -12.73 38.58 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.47 -0.787 . . . . 0.0 112.68 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.578 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -145.06 98.85 3.23 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.028 0.442 . . . . 0.0 111.483 -179.462 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.59 HG23 ' HB2' ' A' ' 128' ' ' HIS . 10.5 p -160.82 -33.31 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.401 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.503 ' CB ' ' CD1' ' A' ' 172' ' ' PHE . 0.6 OUTLIER 167.26 126.91 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.976 179.455 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.516 ' HB3' ' HB2' ' A' ' 197' ' ' SER . 46.2 p -67.25 -17.49 64.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.249 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.585 ' HA ' ' HB ' ' A' ' 174' ' ' THR . 8.3 mm-40 -89.6 -12.09 40.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.579 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.583 ' HA ' HD12 ' A' ' 129' ' ' LEU . 3.1 m-85 -69.26 -54.36 15.08 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.577 HD13 HD23 ' A' ' 195' ' ' LEU . 1.0 OUTLIER -64.84 -46.69 80.84 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.793 178.468 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.585 ' HB ' ' HA ' ' A' ' 171' ' ' GLN . 4.1 m -54.41 -35.0 62.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.172 178.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.651 ' HB3' ' HB3' ' A' ' 104' ' ' ALA . . . -64.13 -46.77 82.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.497 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.668 HD23 ' CD1' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -76.52 -31.75 57.86 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.315 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.748 ' O ' ' HE3' ' A' ' 208' ' ' MET . 1.6 mp -58.99 -39.18 81.02 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.181 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.66 ' HE3' ' CD2' ' A' ' 31' ' ' LEU . 2.0 mtp -81.08 -40.71 23.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.892 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.599 HG21 ' HG ' ' A' ' 108' ' ' LEU . 66.4 m -71.28 -41.85 69.48 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.949 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.596 ' HB2' ' HB ' ' A' ' 187' ' ' THR . . . -59.63 -40.51 79.95 Favored Pre-proline 0 C--N 1.321 -0.674 0 N-CA-C 115.132 1.531 . . . . 0.0 115.132 -176.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.571 ' HD3' HG22 ' A' ' 225' ' ' VAL . 27.9 Cg_endo -64.93 -28.82 58.11 Favored 'Trans proline' 0 CA--C 1.502 -1.112 0 CA-C-N 120.081 1.064 . . . . 0.0 111.511 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.492 ' CB ' HD21 ' A' ' 108' ' ' LEU . 8.1 mt -83.58 0.81 45.07 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.485 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.537 ' O ' ' HA3' ' A' ' 227' ' ' GLY . . . -83.36 136.89 42.58 Favored Pre-proline 0 C--O 1.223 -0.304 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.287 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.692 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 11.1 Cg_endo -50.53 -32.53 35.25 Favored 'Trans proline' 0 CA--C 1.516 -0.415 0 C-N-CA 122.715 2.277 . . . . 0.0 113.363 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -114.96 141.35 48.09 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.717 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -56.1 141.88 38.74 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.124 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.596 ' HB ' ' HB2' ' A' ' 180' ' ' ALA . 91.5 m -119.97 143.41 48.04 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 50.8 t -123.69 118.15 53.37 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 176.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.789 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 2.7 mp -102.55 117.85 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.598 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -100.65 123.66 45.16 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.241 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.6 ' HA ' ' O ' ' A' ' 164' ' ' VAL . 1.6 mp -93.69 119.59 41.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.605 -1.179 . . . . 0.0 111.142 -176.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.476 ' HE2' ' N ' ' A' ' 165' ' ' ASP . 1.7 mtmt -75.26 97.06 3.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.834 -178.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 99.64 -133.06 11.16 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.693 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -112.66 131.09 55.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.855 0.36 . . . . 0.0 111.135 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.577 HD23 HD13 ' A' ' 173' ' ' LEU . 1.5 mt -41.77 144.48 0.4 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.836 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.578 ' HB ' ' HA ' ' A' ' 167' ' ' SER . 14.2 p -73.75 -27.72 23.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.184 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.516 ' HB2' ' HB3' ' A' ' 170' ' ' SER . 0.3 OUTLIER -165.51 63.01 0.11 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.184 0.516 . . . . 0.0 110.25 -179.19 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.674 ' N ' ' HD2' ' A' ' 199' ' ' PRO . 0.0 OUTLIER -42.07 -46.63 10.44 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.5 179.7 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.674 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 9.5 Cg_endo -49.31 -33.09 27.67 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 121.944 1.763 . . . . 0.0 111.39 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.575 ' HA ' ' CD1' ' A' ' 203' ' ' ILE . 0.1 OUTLIER -69.1 -43.82 73.7 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.785 0.803 . . . . 0.0 108.87 178.242 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.668 HG23 ' HE2' ' A' ' 223' ' ' PHE . 27.5 mm -62.69 -35.79 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.452 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.29 -44.13 95.65 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.695 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.575 ' CD1' ' HA ' ' A' ' 200' ' ' TYR . 4.0 mt -63.12 -49.76 82.04 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.927 0 CA-C-O 121.66 0.743 . . . . 0.0 108.996 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.481 ' O ' ' HG3' ' A' ' 208' ' ' MET . 90.8 m -53.02 -51.48 61.54 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.893 -178.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.545 ' O ' ' HE2' ' A' ' 209' ' ' LYS . 29.3 mt -66.13 -30.48 70.97 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.437 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . 0.442 ' HA ' ' HE3' ' A' ' 209' ' ' LYS . 29.8 m-20 -77.02 -46.13 24.84 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.837 0.827 . . . . 0.0 109.527 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.756 ' O ' HG23 ' A' ' 210' ' ' THR . 5.1 tp -70.55 -29.47 65.93 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.09 -1.413 . . . . 0.0 109.618 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' MET . . . . . 0.748 ' HE3' ' O ' ' A' ' 177' ' ' LEU . 52.2 mtp -77.13 -34.09 56.66 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.687 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 9.4 mtmt -62.04 -40.59 96.26 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.015 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.756 HG23 ' O ' ' A' ' 207' ' ' LEU . 5.0 t -60.5 -31.25 70.31 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.583 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.576 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 56.1 m-85 -78.61 -5.94 54.27 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.871 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.6 7.95 25.27 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.166 -1.016 . . . . 0.0 115.638 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.687 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 5.1 m -124.0 148.07 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 118.768 1.284 . . . . 0.0 112.829 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.453 ' CG ' ' HG2' ' A' ' 209' ' ' LYS . 16.2 mt-10 -130.02 137.72 50.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.126 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.675 HD12 ' HB ' ' A' ' 225' ' ' VAL . 18.0 mm -120.56 148.38 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-O 120.875 0.369 . . . . 0.0 110.557 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.643 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 2.4 tt0 -103.01 116.22 32.1 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.864 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.511 ' H ' ' ND2' ' A' ' 217' ' ' ASN . 0.9 OUTLIER -82.79 151.21 26.2 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.969 179.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . 0.606 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 10.2 mm100 -109.47 -139.12 0.38 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 121.146 -0.222 . . . . 0.0 110.821 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.614 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 5.5 t-80 -78.82 66.6 4.34 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 3.7 t80 57.25 33.38 23.22 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.974 0.893 . . . . 0.0 110.234 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.614 ' HG2' ' O ' ' A' ' 219' ' ' HIS . 3.3 pt20 -163.92 -126.63 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.789 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -8.56 132.66 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.668 ' HE2' HG23 ' A' ' 201' ' ' ILE . 0.9 OUTLIER -124.76 138.69 54.27 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 112.867 -1.97 . . . . 0.0 110.181 -179.295 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.643 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 38.7 t -118.37 114.44 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.675 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.4 OUTLIER -121.78 125.66 73.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.443 -178.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.531 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -79.79 127.65 32.48 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.206 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.537 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -79.46 -173.84 45.24 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.404 -178.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 62.75 21.0 62.57 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 121.61 -0.329 . . . . 0.0 113.193 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . 0.531 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 12.5 mt-30 -76.78 -175.39 3.41 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.364 0.602 . . . . 0.0 111.557 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.22 147.81 28.84 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.654 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' TYR . . . . . 0.658 ' CE2' HD23 ' A' ' 31' ' ' LEU . 1.9 m-30 -104.47 131.71 51.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.109 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.42 144.83 48.79 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.435 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 50.1 m -69.99 110.81 7.34 Favored Pre-proline 0 N--CA 1.45 -0.453 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.259 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.492 ' HD2' ' OG1' ' A' ' 39' ' ' THR . 40.5 Cg_endo -66.44 -1.0 4.91 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.017 1.811 . . . . 0.0 112.41 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 99.45 -96.41 1.66 Allowed Glycine 0 C--O 1.226 -0.383 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.631 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 30.7 m -119.91 134.4 55.25 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.57 ' HB3' HD11 ' A' ' 41' ' ' LEU . 12.8 t80 -132.97 126.76 32.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.997 0.427 . . . . 0.0 111.314 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.512 HD21 ' HB2' ' A' ' 43' ' ' ASN . 0.2 OUTLIER -93.25 112.2 24.06 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.033 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.53 HG23 HD21 ' A' ' 44' ' ' LEU . 25.0 t -86.74 111.83 22.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.789 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.211 -179.667 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.501 ' OG ' ' HG ' ' A' ' 29' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.845 0.355 . . . . 0.0 111.195 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.7 m120 67.25 -82.34 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.97 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.714 ' HB2' HD22 ' A' ' 207' ' ' LEU . 6.6 mtm105 -76.01 -62.49 1.58 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.877 0.37 . . . . 0.0 111.316 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.57 ' CB ' ' HG ' ' A' ' 41' ' ' LEU . . . -35.21 -45.41 0.3 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.378 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.583 HD23 HD13 ' A' ' 75' ' ' ILE . 11.4 mt -75.65 -38.93 58.46 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.977 0.418 . . . . 0.0 111.608 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.482 HD21 ' HE3' ' A' ' 178' ' ' MET . 51.5 tp -65.22 -49.67 68.8 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.435 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.633 ' CD2' ' HE2' ' A' ' 178' ' ' MET . 45.3 mt -67.09 -26.9 66.94 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.657 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.401 ' HA ' ' HE1' ' A' ' 211' ' ' PHE . . . -66.28 -40.05 89.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.044 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.566 ' CB ' ' HG ' ' A' ' 57' ' ' LEU . . . -81.21 -41.21 22.66 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.793 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.636 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 13.3 mt -67.95 -3.69 10.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.246 178.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.555 ' HB2' ' HB3' ' A' ' 231' ' ' TYR . . . -100.22 178.34 4.8 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.543 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.1 OUTLIER -113.04 113.6 25.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.8 178.186 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.472 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 116.75 167.91 14.73 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.357 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.598 ' HG3' HG22 ' A' ' 76' ' ' ILE . 1.1 ttmt -95.45 117.95 31.3 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 117.127 0.463 . . . . 0.0 111.692 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.526 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 0.9 OUTLIER -120.19 148.12 44.06 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.321 179.753 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.462 ' O ' ' N ' ' A' ' 237' ' ' TYR . 98.8 t -107.41 141.64 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 0.3 OUTLIER -116.1 116.0 27.07 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 174.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.574 HG22 HD23 ' A' ' 238' ' ' LEU . 0.6 OUTLIER -103.92 152.83 21.51 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.93 -178.314 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.448 ' HB2' HD22 ' A' ' 238' ' ' LEU . 2.8 t-20 65.69 26.81 11.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.469 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.516 HD12 ' HB3' ' A' ' 73' ' ' CYS . 76.2 mt -54.14 -173.31 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.789 0.328 . . . . 0.0 110.127 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.8 tp -111.69 131.31 55.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.469 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -87.78 88.79 7.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.992 0.425 . . . . 0.0 110.11 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 50' ' ' VAL . 74.6 m -163.97 142.66 7.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.994 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.416 ' HA ' ' HB3' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -37.44 -29.92 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.736 0.303 . . . . 0.0 111.374 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.531 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 1.2 p30 -58.3 -42.51 86.8 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 121.043 0.449 . . . . 0.0 110.631 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.44 ' N ' ' O ' ' A' ' 47' ' ' SER . 93.0 t -84.12 -44.55 18.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.672 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.76 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -49.32 -39.72 32.4 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.447 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.569 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 22.6 m-70 -81.04 -32.67 33.97 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.081 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.512 ' O ' HD12 ' A' ' 57' ' ' LEU . 7.5 tpt -53.69 -34.64 59.44 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 176.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.76 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.7 OUTLIER -82.52 -44.46 15.89 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 113.892 -1.503 . . . . 0.0 108.837 176.698 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.783 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 24.8 t-20 -57.97 -42.28 84.68 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-O 120.882 0.372 . . . . 0.0 110.655 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.437 ' HA ' ' HG ' ' A' ' 90' ' ' LEU . . . -57.27 -46.8 82.74 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.875 0.845 . . . . 0.0 109.012 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.758 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -64.33 -37.61 88.1 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.134 -1.394 . . . . 0.0 107.779 177.21 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.783 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -64.14 -33.13 75.07 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.179 -1.373 . . . . 0.0 111.933 179.411 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.447 ' CB ' HD23 ' A' ' 88' ' ' LEU . . . -76.21 -37.55 57.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.221 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.461 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -81.4 -12.5 58.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.289 0.566 . . . . 0.0 110.686 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.06 35.54 5.02 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.262 -0.881 . . . . 0.0 114.293 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.758 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 39.8 t -90.45 123.24 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.778 ' O ' HG12 ' A' ' 76' ' ' ILE . 7.2 m -85.32 131.44 34.41 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.0 0.428 . . . . 0.0 111.723 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.61 ' CE2' ' HB3' ' A' ' 54' ' ' LEU . 40.6 p90 -158.7 171.08 20.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.685 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 98.1 m -135.19 149.03 49.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.301 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.441 ' CD1' ' HB2' ' A' ' 73' ' ' CYS . 11.7 tp -120.25 138.69 53.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.028 0.442 . . . . 0.0 110.874 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 87.1 p -57.71 -175.31 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.339 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.1 -42.24 23.96 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.197 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -76.41 0.67 18.79 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.398 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.9 mtt-85 59.36 53.56 5.19 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.873 0.368 . . . . 0.0 111.176 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -149.19 4.16 0.61 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.76 179.657 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.596 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 9.5 ttm180 -136.97 110.78 8.14 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.516 ' HB3' HD12 ' A' ' 44' ' ' LEU . 36.9 t -121.61 134.48 55.0 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.566 ' HG2' ' CD ' ' A' ' 38' ' ' LYS . 24.6 tt0 -115.45 132.61 56.57 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.245 -0.888 . . . . 0.0 108.728 177.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.589 HG21 ' O ' ' A' ' 63' ' ' SER . 12.2 mt -127.79 123.45 61.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -177.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.778 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -67.72 100.13 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 175.178 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -39.19 144.73 0.27 Allowed Glycine 0 C--N 1.323 -0.189 0 CA-C-N 115.145 -0.934 . . . . 0.0 113.483 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -90.02 -12.41 38.69 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.947 0.404 . . . . 0.0 111.038 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.543 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 95.19 1.63 62.65 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.94 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.4 ' O ' HD21 ' A' ' 34' ' ' LEU . . . 150.88 -148.96 20.69 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.683 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.482 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 77.3 Cg_exo -49.63 123.52 10.63 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.712 2.274 . . . . 0.0 112.218 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.488 HD12 HD21 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -74.27 106.33 5.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.225 -179.5 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -83.66 132.42 34.88 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.573 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.494 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -96.86 126.81 42.28 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.065 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.19 123.93 23.32 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.31 175.3 1.15 Allowed Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 -175.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 112' ' ' ASP . . . -74.04 144.98 44.85 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 118.559 1.179 . . . . 0.0 112.215 -178.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.509 ' HB3' HG13 ' A' ' 113' ' ' ILE . 0.9 OUTLIER -115.26 161.12 18.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.649 -1.16 . . . . 0.0 112.557 -178.273 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.422 ' HG3' ' HB ' ' A' ' 114' ' ' VAL . 1.6 tt0 -140.26 112.26 7.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.758 177.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.511 ' HB2' HD21 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -108.64 117.87 35.3 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.505 -178.427 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.453 ' CE1' ' HB ' ' A' ' 116' ' ' THR . 0.1 OUTLIER -88.97 96.67 10.82 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.508 179.042 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.466 ' HB3' ' HB2' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -105.37 53.04 0.72 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.267 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.44 ' CA ' ' H ' ' A' ' 118' ' ' GLU . . . -53.13 -75.11 0.24 Allowed Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.711 -0.677 . . . . 0.0 113.022 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.486 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 3.1 m120 -75.49 -1.06 22.4 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.768 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.531 ' HB1' ' HA ' ' A' ' 49' ' ' ASP . . . -87.96 47.66 1.53 Allowed 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.363 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -56.37 -23.59 42.23 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.173 -1.013 . . . . 0.0 111.458 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.1 p -92.91 -16.69 24.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.464 0.173 . . . . 0.0 111.176 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' A' ' 101' ' ' PRO . . . -95.5 -37.17 11.01 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.437 ' HB2' ' HB2' ' A' ' 92' ' ' LEU . 2.2 tpp -59.3 -44.52 92.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.594 0.235 . . . . 0.0 110.524 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.567 ' HB3' ' O ' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -54.13 -60.22 8.03 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.284 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 100' ' ' ARG . 18.3 Cg_endo -62.0 -32.89 84.32 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.396 2.064 . . . . 0.0 112.831 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.492 HD12 HD23 ' A' ' 115' ' ' LEU . 0.1 OUTLIER -70.86 -52.84 17.78 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.052 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.539 ' HA ' HD12 ' A' ' 153' ' ' LEU . . . -51.72 -28.72 15.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.26 0.552 . . . . 0.0 110.53 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.524 ' HB2' ' HB3' ' A' ' 175' ' ' ALA . . . -86.06 -52.97 5.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.428 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.414 ' CB ' HD13 ' A' ' 30' ' ' LEU . . . -60.57 -34.27 73.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 102' ' ' LEU . 31.6 mt -78.52 -17.82 55.65 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.559 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 9.6 p -84.68 22.6 1.29 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.245 0.545 . . . . 0.0 110.598 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.48 ' CD2' ' HB2' ' A' ' 182' ' ' LEU . 0.4 OUTLIER -90.04 -73.86 0.51 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.427 -179.71 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -73.19 -116.31 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.699 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.24 94.15 2.09 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.141 0.496 . . . . 0.0 110.58 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.598 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 22.7 p30 -146.44 138.32 24.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.467 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.886 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 0.9 OUTLIER -95.21 100.65 12.42 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.656 179.122 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.509 HG13 ' HB3' ' A' ' 88' ' ' LEU . 1.1 mp -120.66 147.68 24.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.494 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.855 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 58.0 t -117.53 113.22 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 176.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.511 HD21 ' HB2' ' A' ' 90' ' ' LEU . 33.9 mt -102.12 105.41 16.11 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.296 -0.561 . . . . 0.0 111.324 -177.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.453 ' HB ' ' CE1' ' A' ' 91' ' ' PHE . 0.2 OUTLIER -118.14 -172.12 2.2 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.768 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -164.93 -167.97 26.34 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.206 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.563 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 16.9 mt-10 -78.31 171.86 11.38 Favored Pre-proline 0 C--N 1.332 -0.158 0 C-N-CA 122.661 0.384 . . . . 0.0 110.356 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.563 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 71.0 Cg_exo -49.5 -39.57 45.33 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.377 2.052 . . . . 0.0 112.77 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -68.23 -23.4 64.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.619 0.247 . . . . 0.0 110.971 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.523 ' O ' ' HG3' ' A' ' 149' ' ' PRO . 9.8 tpt -60.81 -34.45 74.55 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.455 ' HA ' ' HG2' ' A' ' 149' ' ' PRO . 0.0 OUTLIER -61.62 -16.77 51.33 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.614 179.166 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.3 3.19 32.47 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.837 0.351 . . . . 0.0 110.209 178.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -127.3 84.79 62.51 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.149 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -57.13 148.64 68.21 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.867 2.378 . . . . 0.0 112.068 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.469 ' O ' HG21 ' A' ' 130' ' ' VAL . 0.9 OUTLIER -122.53 0.93 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -179.355 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.508 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -53.36 -39.43 59.19 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.219 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 42.5 m-70 -56.01 -41.61 75.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.783 0.325 . . . . 0.0 110.381 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.49 HD11 ' HB3' ' A' ' 175' ' ' ALA . 12.6 tp -75.48 -43.98 46.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.284 0.564 . . . . 0.0 110.055 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.653 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 69.5 t -56.41 -47.36 81.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.593 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.719 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 0.7 OUTLIER -69.2 -38.95 78.88 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.696 -179.603 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.405 ' CB ' HD21 ' A' ' 176' ' ' LEU . . . -58.39 -49.13 78.34 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.596 178.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.487 HD21 ' CB ' ' A' ' 104' ' ' ALA . 7.2 mt -69.92 -50.37 42.8 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.323 178.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.722 ' HG3' ' HB ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -58.14 -27.88 64.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.798 179.56 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.719 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 1.0 OUTLIER -69.79 -30.85 68.5 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.912 178.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -83.36 14.79 38.18 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.966 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 93.69 7.97 61.15 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.593 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.523 ' HB2' ' HB2' ' A' ' 107' ' ' CYS . . . -78.21 152.03 32.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.834 0.349 . . . . 0.0 111.035 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 19.9 mtpt -100.73 103.96 15.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.126 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.722 ' HB ' ' HG3' ' A' ' 134' ' ' ARG . 34.7 mt -135.65 124.16 38.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.195 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.689 HG21 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -120.54 139.51 52.82 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.938 -179.589 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -81.04 132.43 35.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.847 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.631 ' HB2' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -92.52 -87.16 0.23 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.775 -179.217 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.684 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 2.7 mt-10 -57.38 -82.46 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.397 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.42 ' NE2' ' CE1' ' A' ' 148' ' ' TYR . 25.1 mt-30 -116.69 154.3 30.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.341 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 6.0 mt-10 -66.88 132.82 48.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.373 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.508 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 2.7 m120 71.44 17.08 5.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.442 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.542 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 14.8 m-85 -107.0 168.22 8.36 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.812 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 75.0 Cg_exo -35.96 -60.33 0.35 Allowed 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.991 3.127 . . . . 0.0 115.921 -177.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.812 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 77.8 Cg_exo -52.35 145.5 35.79 Favored 'Trans proline' 0 C--N 1.352 0.736 0 CA-C-N 120.61 1.253 . . . . 0.0 112.118 -178.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.855 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 8.4 mt -156.41 137.59 13.73 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.808 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.689 ' HB2' HG21 ' A' ' 141' ' ' THR . 7.6 mtt85 -109.24 101.6 10.61 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.886 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 7.9 mt -90.35 148.01 23.11 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.283 -177.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.598 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 5.7 mt-30 -149.87 24.81 0.85 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.365 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 56.99 -162.04 7.52 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.322 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.35 -16.13 38.39 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.365 -0.922 . . . . 0.0 113.619 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.449 ' CB ' ' O ' ' A' ' 107' ' ' CYS . 11.2 t80 -58.66 122.38 13.34 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 117.858 0.829 . . . . 0.0 110.155 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.694 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 56.9 p -114.76 -31.84 6.01 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 121.594 0.711 . . . . 0.0 111.171 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.422 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 137.19 -160.09 24.9 Favored Glycine 0 C--N 1.307 -1.068 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.049 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.403 ' O ' HG22 ' A' ' 162' ' ' VAL . . . 105.5 152.95 21.14 Favored Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.008 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -47.01 116.47 1.37 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.98 -0.61 . . . . 0.0 110.83 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 68.6 t -109.49 144.88 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.48 119.97 39.4 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.477 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 191' ' ' ILE . 1.0 OUTLIER -131.86 121.37 47.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.695 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.89 137.94 37.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.954 0.407 . . . . 0.0 111.191 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.495 ' CA ' HG22 ' A' ' 191' ' ' ILE . . . -58.99 -22.84 56.09 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.75 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 13.2 m -84.6 -134.53 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.965 -0.384 . . . . 0.0 109.965 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 2.9 t 67.15 -124.8 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 O-C-N 122.341 -0.225 . . . . 0.0 111.018 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.435 ' HB2' ' CE1' ' A' ' 172' ' ' PHE . 0.1 OUTLIER -136.92 145.24 44.03 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.901 0.382 . . . . 0.0 110.418 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.463 ' HB2' ' HB3' ' A' ' 200' ' ' TYR . 0.1 OUTLIER -60.73 -17.54 49.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.878 -179.581 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.567 ' O ' ' HB3' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -82.24 -11.08 58.88 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.811 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.473 ' CD1' ' HG2' ' A' ' 100' ' ' ARG . 6.4 m-85 -74.13 -54.88 6.86 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.453 HD11 ' CZ ' ' A' ' 223' ' ' PHE . 0.5 OUTLIER -65.62 -37.78 87.54 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.436 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.606 HG22 ' HD3' ' A' ' 27' ' ' ARG . 4.4 m -58.26 -34.57 70.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.063 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.524 ' HB3' ' HB2' ' A' ' 104' ' ' ALA . . . -68.28 -39.05 82.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.843 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.407 ' O ' ' CB ' ' A' ' 180' ' ' ALA . 0.3 OUTLIER -76.78 -34.26 58.0 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.275 0.559 . . . . 0.0 110.899 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.706 ' O ' ' HE3' ' A' ' 208' ' ' MET . 2.4 mp -59.68 -38.41 81.47 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.529 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.685 ' HE1' ' CB ' ' A' ' 27' ' ' ARG . 3.8 mtp -81.76 -43.61 18.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.389 0.614 . . . . 0.0 112.509 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.462 HG23 ' HG ' ' A' ' 108' ' ' LEU . 48.5 m -73.11 -39.88 65.42 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.684 -178.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.611 ' HB2' ' HB ' ' A' ' 187' ' ' THR . . . -59.49 -41.55 87.34 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -177.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 30.3 Cg_endo -65.59 -28.32 52.97 Favored 'Trans proline' 0 CA--C 1.501 -1.161 0 C-N-CA 121.046 1.164 . . . . 0.0 111.723 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.48 ' HB2' ' CD2' ' A' ' 108' ' ' LEU . 5.4 mt -83.15 -0.19 48.1 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.079 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . -82.19 137.29 46.0 Favored Pre-proline 0 N--CA 1.455 -0.209 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.183 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.694 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 11.7 Cg_endo -50.94 -33.18 40.94 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.685 2.257 . . . . 0.0 113.357 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -113.28 139.52 48.76 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.842 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' A' ' 186' ' ' ASP . 0.8 OUTLIER -53.68 144.59 17.44 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.15 179.227 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.611 ' HB ' ' HB2' ' A' ' 180' ' ' ALA . 94.1 m -123.83 145.88 48.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.258 0.552 . . . . 0.0 112.441 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.668 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 40.2 t -126.63 117.83 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.366 177.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.709 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 3.5 mp -101.12 118.08 47.32 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.601 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 3.6 ttt180 -100.93 124.82 47.2 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.553 ' HB ' ' HA ' ' A' ' 221' ' ' GLN . 1.5 mp -93.61 123.41 45.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.952 -175.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -83.03 96.88 8.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.11 -1.405 . . . . 0.0 110.361 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 102.06 -134.28 11.7 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.804 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -116.43 127.32 54.5 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.549 HD13 HG13 ' A' ' 201' ' ' ILE . 1.0 OUTLIER -41.37 144.72 0.31 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.486 179.447 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.415 ' N ' ' O ' ' A' ' 166' ' ' GLY . 11.1 p -72.92 -30.53 32.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.999 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.48 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 0.2 OUTLIER -162.09 62.43 0.23 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.024 0.44 . . . . 0.0 110.611 -179.412 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.467 ' N ' ' CD ' ' A' ' 199' ' ' PRO . 3.1 tttp -39.68 -45.92 4.31 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.175 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.48 ' HD2' ' C ' ' A' ' 197' ' ' SER . 88.6 Cg_exo -47.8 -37.35 28.18 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 121.99 1.794 . . . . 0.0 111.622 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.572 ' HA ' ' CD1' ' A' ' 203' ' ' ILE . 0.3 OUTLIER -64.18 -45.79 86.83 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.549 HG13 HD13 ' A' ' 195' ' ' LEU . 12.5 mm -60.76 -37.33 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.584 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.423 ' OD2' ' HE3' ' A' ' 198' ' ' LYS . 83.8 m-20 -59.06 -46.78 87.39 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.857 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.572 ' CD1' ' HA ' ' A' ' 200' ' ' TYR . 3.1 mt -61.17 -46.26 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.977 0 CA-C-O 121.719 0.771 . . . . 0.0 108.986 178.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.499 ' O ' ' HG3' ' A' ' 208' ' ' MET . 92.5 m -54.13 -51.44 64.23 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.699 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.466 ' CD2' ' HB ' ' A' ' 215' ' ' ILE . 26.8 mt -68.53 -28.37 66.93 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 120.531 -0.467 . . . . 0.0 111.246 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . 0.478 ' HA ' ' HE3' ' A' ' 209' ' ' LYS . 15.0 t30 -77.84 -46.09 22.48 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.793 0.806 . . . . 0.0 109.577 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.714 HD22 ' HB2' ' A' ' 27' ' ' ARG . 3.1 tp -69.57 -34.46 74.21 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.188 -1.369 . . . . 0.0 109.297 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' MET . . . . . 0.706 ' HE3' ' O ' ' A' ' 177' ' ' LEU . 50.1 mtp -72.57 -33.82 67.03 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.467 0.651 . . . . 0.0 109.328 177.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.595 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 15.5 mtmt -62.57 -37.57 86.69 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.862 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.489 ' O ' ' HB3' ' A' ' 234' ' ' PRO . 5.8 t -62.86 -28.45 70.03 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.409 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.545 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 39.3 m-85 -82.82 -6.04 59.24 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.913 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.99 6.9 25.81 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 116.226 1.25 . . . . 0.0 116.226 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.2 m -123.66 148.7 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 119.101 1.451 . . . . 0.0 112.729 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.491 ' HG2' ' HD3' ' A' ' 209' ' ' LYS . 18.9 mt-10 -129.63 140.66 51.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.821 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.466 ' HB ' ' CD2' ' A' ' 205' ' ' LEU . 15.9 mm -123.29 148.31 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-O 120.871 0.367 . . . . 0.0 110.691 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.614 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 31.0 tt0 -103.45 119.19 38.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.603 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.544 ' H ' ' ND2' ' A' ' 217' ' ' ASN . 0.0 OUTLIER -82.85 151.17 26.15 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.541 179.431 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . 0.721 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -112.58 -146.09 0.4 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 121.182 -0.207 . . . . 0.0 110.49 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.4 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 7.0 m80 -68.01 66.23 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 3.4 t80 52.93 34.6 17.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.887 0.851 . . . . 0.0 110.266 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.63 ' O ' ' CD1' ' A' ' 223' ' ' PHE . 0.0 OUTLIER -164.35 -124.09 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 179.652 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.721 ' O ' ' HB2' ' A' ' 218' ' ' GLN . 0.0 OUTLIER -8.36 133.59 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.668 ' O ' ' HA ' ' A' ' 188' ' ' VAL . 0.8 OUTLIER -124.75 139.26 54.01 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.269 -1.787 . . . . 0.0 109.79 -179.218 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.614 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 40.1 t -120.96 113.87 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.55 HG22 ' HD3' ' A' ' 181' ' ' PRO . 0.3 OUTLIER -122.16 126.05 73.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.531 -178.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.517 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -74.4 126.76 31.4 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.608 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -81.92 -178.97 52.71 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.268 -0.968 . . . . 0.0 113.021 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 66.01 21.25 69.57 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 121.375 -0.44 . . . . 0.0 112.872 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . 0.517 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 27.2 mt-30 -78.72 -176.04 4.71 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.213 0.53 . . . . 0.0 111.476 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.4 t -148.64 147.77 29.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.043 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' TYR . . . . . 0.636 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 7.2 m-85 -103.32 129.95 50.47 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.87 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -121.53 148.07 44.97 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.756 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.422 ' HB2' ' OG1' ' A' ' 39' ' ' THR . 10.9 p -71.52 110.99 8.68 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 120.981 -0.287 . . . . 0.0 110.516 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.489 ' HB3' ' O ' ' A' ' 210' ' ' THR . 55.7 Cg_endo -70.08 1.66 4.44 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.199 1.933 . . . . 0.0 112.213 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 98.59 -101.75 2.51 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 56.1 m -117.39 137.78 52.25 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.523 ' HB3' HD13 ' A' ' 41' ' ' LEU . 10.6 t80 -134.32 125.49 27.74 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.928 0.394 . . . . 0.0 111.314 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.574 HD23 HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -94.78 110.91 22.72 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.105 0.479 . . . . 0.0 111.017 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 21.7 t -81.61 111.11 17.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.212 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.415 ' HG3' HD12 ' A' ' 238' ' ' LEU . 6.3 mt-10 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.078 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.503 ' OG ' ' CD2' ' A' ' 44' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.88 0.371 . . . . 0.0 111.437 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 33.7 m120 61.96 -78.41 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.946 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.698 ' HA ' ' HE1' ' A' ' 178' ' ' MET . 1.0 OUTLIER -73.75 -63.2 1.26 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.277 0.56 . . . . 0.0 110.69 179.602 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.641 ' CB ' ' HG ' ' A' ' 41' ' ' LEU . . . -37.23 -46.83 0.75 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.001 -0.999 . . . . 0.0 112.321 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.525 HD23 HD13 ' A' ' 75' ' ' ILE . 11.0 mt -75.51 -33.14 60.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.937 0.399 . . . . 0.0 111.256 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.458 ' HB2' ' HE2' ' A' ' 53' ' ' MET . 46.4 tp -68.6 -49.71 57.15 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.489 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.724 HD12 ' HG2' ' A' ' 208' ' ' MET . 39.5 mt -68.71 -26.99 65.55 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.451 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.447 ' HA ' ' HE1' ' A' ' 211' ' ' PHE . . . -65.29 -37.46 87.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.084 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.585 ' HB1' ' HG ' ' A' ' 57' ' ' LEU . . . -80.83 -41.12 23.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.234 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.648 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 32.4 mt -67.52 -3.78 9.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.368 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 78' ' ' ASN . . . -83.57 171.95 12.83 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -112.31 34.67 4.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.984 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -168.81 175.43 43.31 Favored Glycine 0 C--N 1.309 -0.936 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.74 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.649 ' HG3' HD11 ' A' ' 76' ' ' ILE . 10.6 ttmt -95.39 117.83 31.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.642 0.721 . . . . 0.0 111.373 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 235' ' ' GLY . 0.9 OUTLIER -123.14 148.28 45.89 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.615 -179.291 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.434 HG23 ' HG3' ' A' ' 74' ' ' GLU . 76.1 t -104.78 141.42 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 CA-C-O 121.393 0.616 . . . . 0.0 112.474 -179.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.641 ' HG ' ' CB ' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -114.51 116.2 28.45 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 175.034 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.593 HG22 HD22 ' A' ' 238' ' ' LEU . 0.5 OUTLIER -102.99 151.68 22.2 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.149 -178.364 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.48 ' HB2' HD21 ' A' ' 238' ' ' LEU . 1.8 t-20 68.15 25.64 7.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.419 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.545 HD13 ' HB3' ' A' ' 73' ' ' CYS . 70.9 mt -53.4 -175.6 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.411 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 54.1 tp -113.0 130.91 55.97 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.509 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.417 ' O ' ' CG ' ' A' ' 46' ' ' ASP . 10.1 p-10 -85.45 87.41 7.39 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.302 0.573 . . . . 0.0 110.619 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 50' ' ' VAL . 4.4 m -164.02 142.91 7.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.306 -178.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -36.27 -32.08 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.689 0.281 . . . . 0.0 111.578 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HA ' ' CB ' ' A' ' 95' ' ' ALA . 29.4 p-10 -57.74 -42.62 84.3 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.055 0.455 . . . . 0.0 110.66 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.446 ' N ' ' O ' ' A' ' 47' ' ' SER . 98.5 t -82.73 -45.78 19.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.788 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.556 ' HA ' HD13 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -48.65 -40.08 26.59 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.292 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.631 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 13.8 m-70 -78.62 -33.2 47.56 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.017 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.488 ' O ' HD12 ' A' ' 57' ' ' LEU . 7.8 tpt -54.36 -32.41 56.86 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 176.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.556 HD13 ' HA ' ' A' ' 51' ' ' ARG . 0.6 OUTLIER -84.08 -42.48 16.05 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.53 176.411 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.756 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 25.2 t-20 -60.25 -42.62 95.68 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.538 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.469 ' HB2' HD12 ' A' ' 102' ' ' LEU . . . -57.66 -47.23 82.87 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.752 0.787 . . . . 0.0 109.207 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.799 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -64.23 -39.71 94.54 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.253 -1.34 . . . . 0.0 107.775 177.147 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.756 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.1 m -61.44 -35.4 77.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.802 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.452 ' CB ' HD21 ' A' ' 88' ' ' LEU . . . -75.97 -38.04 57.91 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.267 -178.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.491 HD11 ' HB2' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -80.59 -14.01 58.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.287 0.565 . . . . 0.0 110.657 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.94 34.97 4.99 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.217 -0.901 . . . . 0.0 114.259 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.799 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 35.6 t -90.5 121.71 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.761 ' O ' HG12 ' A' ' 76' ' ' ILE . 2.7 t -85.68 135.06 33.92 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.462 -178.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.604 ' CB ' HG12 ' A' ' 75' ' ' ILE . 40.1 p90 -161.33 172.07 17.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.577 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 85.9 m -135.68 146.41 47.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.462 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.471 ' CD1' ' HB2' ' A' ' 73' ' ' CYS . 9.3 tp -117.78 136.53 53.34 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.088 0.47 . . . . 0.0 110.716 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.405 ' HB2' ' CB ' ' A' ' 72' ' ' ARG . 1.2 t -59.95 -162.7 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.133 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -95.01 -29.4 14.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.157 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.03 1.88 25.94 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.181 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 56.42 33.51 22.57 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.38 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.433 HG21 ' O ' ' A' ' 44' ' ' LEU . 1.1 p -130.95 -9.25 3.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.575 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -117.61 121.48 41.03 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.191 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.545 ' HB3' HD13 ' A' ' 44' ' ' LEU . 37.9 t -132.07 129.1 39.54 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.245 0.545 . . . . 0.0 112.041 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.527 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 64.2 tt0 -112.22 130.29 55.97 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 177.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.604 HG12 ' CB ' ' A' ' 64' ' ' TYR . 17.9 mt -126.35 122.17 60.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 -177.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.761 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -67.67 103.72 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-O 121.343 0.592 . . . . 0.0 109.508 175.78 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 35' ' ' ALA . . . -43.44 151.44 0.45 Allowed Glycine 0 C--N 1.32 -0.324 0 CA-C-N 115.219 -0.9 . . . . 0.0 113.847 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 35' ' ' ALA . 5.8 t30 -97.34 -17.25 19.86 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.795 0.331 . . . . 0.0 111.347 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.11 -0.48 56.12 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.159 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.496 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 154.8 -150.71 22.32 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.167 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.575 ' CG ' ' HB3' ' A' ' 108' ' ' LEU . 73.1 Cg_exo -50.15 125.26 14.48 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.992 2.462 . . . . 0.0 112.98 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.491 ' HB2' HD11 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -74.21 106.27 5.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.901 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -81.67 133.77 35.4 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.333 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.508 ' HB2' HD22 ' A' ' 88' ' ' LEU . . . -97.05 129.8 44.44 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.25 123.97 23.45 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 176.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.59 -178.81 2.2 Favored Glycine 0 N--CA 1.44 -1.049 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 -175.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' A' ' 112' ' ' ASP . . . -80.06 144.5 33.1 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 118.725 1.262 . . . . 0.0 112.025 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.545 ' HB3' HG13 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -114.63 161.06 18.59 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.089 -178.833 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.452 ' HG3' ' HB ' ' A' ' 114' ' ' VAL . 28.9 mp0 -139.31 105.28 5.19 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.099 178.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.593 ' HB2' HD23 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -105.11 116.92 32.76 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.886 -178.476 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.441 ' CE2' ' HB ' ' A' ' 116' ' ' THR . 7.6 m-85 -96.59 96.8 8.9 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.496 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -103.88 57.57 0.73 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.275 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.57 ' HA3' ' H ' ' A' ' 118' ' ' GLU . . . -50.35 -68.04 1.61 Allowed Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.592 -0.731 . . . . 0.0 113.499 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.502 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 83.5 m-20 -76.49 1.07 17.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.554 0.216 . . . . 0.0 111.299 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.567 ' CB ' ' HA ' ' A' ' 49' ' ' ASP . . . -99.87 54.12 0.92 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.948 0.404 . . . . 0.0 111.656 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -56.85 -25.39 52.41 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.31 -0.947 . . . . 0.0 111.339 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.404 ' O ' ' HG3' ' A' ' 101' ' ' PRO . 0.1 OUTLIER -89.05 -14.36 36.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.685 -0.257 . . . . 0.0 111.656 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.51 ' HB3' ' CB ' ' A' ' 95' ' ' ALA . . . -96.83 -32.56 12.04 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -61.73 -43.25 99.22 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.541 HH22 ' HB3' ' A' ' 124' ' ' ARG . 6.7 mpt_? -56.81 -60.5 9.24 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 100' ' ' ARG . 14.1 Cg_endo -58.57 -34.73 99.05 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.513 2.142 . . . . 0.0 112.446 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.49 HD21 ' HA ' ' A' ' 102' ' ' LEU . 0.2 OUTLIER -72.07 -52.49 16.6 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.145 179.703 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.634 ' HA ' HD12 ' A' ' 153' ' ' LEU . . . -53.13 -27.83 22.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.483 0.659 . . . . 0.0 110.311 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.543 ' CB ' HD22 ' A' ' 133' ' ' LEU . . . -86.5 -54.5 4.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.343 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.65 -34.44 74.29 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -177.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.528 ' HB2' ' CD1' ' A' ' 153' ' ' LEU . 31.2 mt -78.54 -23.06 46.41 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -176.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.544 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 13.7 p -78.42 16.1 0.87 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.161 0.505 . . . . 0.0 110.791 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.575 ' HB3' ' CG ' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -82.98 -75.81 0.3 Allowed 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.032 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -70.69 -113.77 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.134 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.57 94.44 1.9 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.206 0.527 . . . . 0.0 110.793 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.659 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 0.8 OUTLIER -145.27 139.12 26.88 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.378 -179.113 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.883 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 1.2 m-20 -97.74 98.26 9.7 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.545 HG13 ' HB3' ' A' ' 88' ' ' LEU . 1.6 mp -120.35 147.92 23.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.253 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.769 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 47.1 t -115.34 113.76 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 176.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.593 HD23 ' HB2' ' A' ' 90' ' ' LEU . 77.6 mt -101.72 106.36 17.37 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.518 -178.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.557 HG21 ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -119.04 -169.36 1.72 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.318 -179.232 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.447 ' HA3' ' HG2' ' A' ' 121' ' ' MET . . . -171.35 -179.64 42.57 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.524 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.629 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 39.0 mt-10 -70.15 169.61 12.86 Favored Pre-proline 0 C--N 1.331 -0.211 0 C-N-CA 123.207 0.603 . . . . 0.0 111.08 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.629 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 4.1 Cg_endo -45.08 -40.04 15.34 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.082 2.521 . . . . 0.0 113.077 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.3 mtm180 -67.84 -23.93 65.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.73 0.3 . . . . 0.0 110.716 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.609 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 10.5 tpt -60.96 -36.21 78.78 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.443 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 0.0 OUTLIER -61.47 -16.5 47.76 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.665 179.249 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -83.99 3.18 35.46 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.541 ' HB3' HH22 ' A' ' 100' ' ' ARG . 66.0 mtt-85 -127.62 83.26 66.55 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.352 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.462 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 38.1 Cg_exo -56.79 149.28 61.08 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.761 2.307 . . . . 0.0 111.701 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.525 HG12 HD13 ' A' ' 151' ' ' LEU . 1.0 OUTLIER -129.07 8.66 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.377 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.545 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -59.88 -39.84 96.02 Favored Glycine 0 CA--C 1.517 0.193 0 C-N-CA 120.749 -0.739 . . . . 0.0 113.764 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.583 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 26.0 m80 -55.71 -37.97 69.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.902 0.351 . . . . 0.0 110.54 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.616 ' HG ' ' CD1' ' A' ' 133' ' ' LEU . 29.3 tp -75.42 -40.46 57.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.241 0.544 . . . . 0.0 109.804 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.74 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 40.3 t -56.54 -47.98 81.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.331 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.68 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 0.1 OUTLIER -72.18 -35.94 69.13 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 121.298 0.571 . . . . 0.0 109.58 179.272 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.533 ' HA ' HG13 ' A' ' 162' ' ' VAL . . . -57.31 -47.73 80.76 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.75 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.616 ' CD1' ' HG ' ' A' ' 129' ' ' LEU . 3.5 mt -75.94 -50.32 15.27 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.06 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.74 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.1 OUTLIER -54.71 -28.32 47.13 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.107 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.68 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 8.1 tp -69.01 -31.82 70.91 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 120.958 0.408 . . . . 0.0 110.902 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.471 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -81.86 11.64 46.45 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.787 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.49 6.54 56.44 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.764 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.634 ' HB1' ' HD1' ' A' ' 157' ' ' PHE . . . -76.36 153.59 35.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.973 0.416 . . . . 0.0 111.481 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 0.4 OUTLIER -102.83 106.35 16.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.646 178.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.586 ' HB ' ' HG3' ' A' ' 134' ' ' ARG . 23.1 mt -137.91 125.88 30.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.485 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.736 HG23 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -123.56 139.48 53.96 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.519 -179.541 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.489 ' HE1' HG23 ' A' ' 130' ' ' VAL . 40.3 m-85 -79.71 131.05 35.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.469 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.653 ' HB2' ' CB ' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -91.52 -91.04 0.16 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.62 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.593 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 7.6 mm-40 -58.56 -81.68 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.676 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.491 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 0.2 OUTLIER -112.76 151.21 30.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.914 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 12.8 mt-10 -67.41 129.75 40.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.827 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.545 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 2.8 m120 71.04 17.91 6.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.068 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.616 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 16.8 m-85 -108.59 169.48 6.49 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 121.046 0.45 . . . . 0.0 111.992 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.902 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 48.9 Cg_exo -31.43 -62.67 0.12 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 124.384 3.389 . . . . 0.0 116.061 -177.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.902 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 65.3 Cg_exo -52.5 144.79 39.83 Favored 'Trans proline' 0 C--N 1.354 0.827 0 CA-C-N 120.626 1.259 . . . . 0.0 112.683 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.769 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 7.4 mt -155.9 136.85 13.59 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.023 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.736 ' HB2' HG23 ' A' ' 141' ' ' THR . 5.8 mtt180 -108.08 102.77 11.9 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.883 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 7.0 mt -90.73 145.83 24.49 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.861 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.659 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 6.5 mt-30 -149.3 26.19 0.87 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.164 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 53.78 -163.22 2.98 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.421 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 108.38 -16.27 35.06 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.005 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.694 ' HE2' ' HA ' ' A' ' 180' ' ' ALA . 67.0 t80 -58.55 122.97 14.71 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 117.081 0.44 . . . . 0.0 110.693 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.704 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 60.7 p -116.9 -28.84 6.18 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.495 0.664 . . . . 0.0 111.431 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 120.95 -169.47 14.27 Favored Glycine 0 C--N 1.306 -1.092 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.215 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.593 ' O ' ' HA ' ' A' ' 187' ' ' THR . . . 128.39 -126.13 5.26 Favored Glycine 0 N--CA 1.434 -1.468 0 N-CA-C 111.126 -0.789 . . . . 0.0 111.126 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.41 130.34 55.73 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.783 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 82.0 t -130.21 123.54 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 121.004 0.431 . . . . 0.0 110.687 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.17 119.99 38.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.665 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 191' ' ' ILE . 1.0 OUTLIER -130.14 120.51 49.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.953 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.666 ' HA ' ' HG3' ' A' ' 192' ' ' LYS . 0.1 OUTLIER -51.94 137.89 25.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.298 0.571 . . . . 0.0 111.649 -179.737 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.485 ' HA2' ' CG2' ' A' ' 191' ' ' ILE . . . -59.63 -50.6 66.03 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.603 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 92.5 p -95.93 91.96 6.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.705 0.288 . . . . 0.0 111.04 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.539 HG11 ' O ' ' A' ' 165' ' ' ASP . 8.7 p -175.58 58.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.008 0.432 . . . . 0.0 111.243 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.64 ' HB2' ' CD1' ' A' ' 172' ' ' PHE . 2.0 m 67.99 128.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.959 0.409 . . . . 0.0 110.833 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.465 ' N ' HG13 ' A' ' 196' ' ' VAL . 0.3 OUTLIER -75.74 -17.4 59.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.698 -179.393 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.527 ' HA ' ' HB ' ' A' ' 174' ' ' THR . 0.0 OUTLIER -74.37 -6.01 45.64 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.122 -179.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.64 ' CD1' ' HB2' ' A' ' 169' ' ' SER . 5.5 m-85 -76.27 -55.96 5.08 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.574 HD21 HD13 ' A' ' 191' ' ' ILE . 0.4 OUTLIER -61.74 -40.95 96.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.606 0.717 . . . . 0.0 109.084 178.057 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.607 HG21 ' HD3' ' A' ' 27' ' ' ARG . 5.5 m -55.82 -36.49 67.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.528 -1.214 . . . . 0.0 110.01 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.435 ' CB ' ' HB2' ' A' ' 104' ' ' ALA . . . -69.17 -40.29 78.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.563 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.594 HD22 HD23 ' A' ' 133' ' ' LEU . 0.4 OUTLIER -76.64 -33.32 58.34 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.149 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.809 ' O ' ' HE2' ' A' ' 208' ' ' MET . 5.1 mp -59.76 -38.13 80.94 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.908 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.698 ' HE1' ' HA ' ' A' ' 27' ' ' ARG . 0.4 OUTLIER -82.07 -43.03 18.4 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.469 0.652 . . . . 0.0 112.112 -179.66 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.463 HG21 ' HG ' ' A' ' 108' ' ' LEU . 54.4 m -71.41 -41.13 69.97 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.471 -178.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.694 ' HA ' ' HE2' ' A' ' 157' ' ' PHE . . . -59.72 -42.15 89.78 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -177.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 29.8 Cg_endo -64.77 -29.04 59.45 Favored 'Trans proline' 0 CA--C 1.5 -1.205 0 C-N-CA 120.956 1.104 . . . . 0.0 111.637 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.47 ' HB2' ' CD2' ' A' ' 108' ' ' LEU . 6.9 mt -83.73 1.56 42.12 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.358 178.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . -83.59 138.53 41.12 Favored Pre-proline 0 C--O 1.224 -0.289 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.704 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 12.9 Cg_endo -51.84 -31.86 44.26 Favored 'Trans proline' 0 CA--C 1.518 -0.28 0 C-N-CA 122.45 2.1 . . . . 0.0 113.117 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -114.89 143.6 44.88 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.892 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -57.8 141.01 50.36 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.076 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 160' ' ' GLY . 70.7 m -119.01 145.85 45.51 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.663 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 35.3 t -125.63 118.94 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.438 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.783 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 4.1 mp -104.03 117.09 48.99 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.655 0 C-N-CA 120.079 -0.648 . . . . 0.0 109.276 178.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.814 ' HG3' ' HG3' ' A' ' 222' ' ' GLN . 1.7 ttt180 -99.88 123.57 44.27 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.656 ' HB ' ' CB ' ' A' ' 221' ' ' GLN . 1.3 mp -93.11 121.88 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.088 -176.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.666 ' HG3' ' HA ' ' A' ' 165' ' ' ASP . 0.5 OUTLIER -74.87 96.62 3.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.346 -178.594 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 97.36 -126.9 9.03 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.793 -0.717 . . . . 0.0 111.702 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -116.85 133.54 55.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.769 0.318 . . . . 0.0 111.321 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.527 HD11 ' HD2' ' A' ' 198' ' ' LYS . 0.8 OUTLIER -41.91 144.68 0.4 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.211 0.529 . . . . 0.0 111.902 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.469 ' HB ' ' O ' ' A' ' 166' ' ' GLY . 13.9 p -74.48 -25.38 19.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.975 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.459 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 0.3 OUTLIER -168.48 64.7 0.07 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.833 0.349 . . . . 0.0 110.934 -179.531 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.527 ' HD2' HD11 ' A' ' 195' ' ' LEU . 4.4 tptp -39.48 -46.23 4.13 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.382 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.461 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 72.6 Cg_exo -49.61 -36.78 41.72 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.006 1.804 . . . . 0.0 111.843 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.545 ' HA ' ' CD1' ' A' ' 203' ' ' ILE . 0.2 OUTLIER -65.62 -44.53 86.2 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 178.42 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.671 HG22 ' HE2' ' A' ' 223' ' ' PHE . 30.9 mm -60.9 -38.4 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.472 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.45 -43.63 93.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.229 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.545 ' CD1' ' HA ' ' A' ' 200' ' ' TYR . 4.6 mt -62.43 -50.95 77.83 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 CA-C-O 121.569 0.7 . . . . 0.0 109.635 178.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 208' ' ' MET . 78.5 m -53.66 -51.65 62.49 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.991 -178.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.531 ' O ' ' HE2' ' A' ' 209' ' ' LYS . 32.2 mt -65.31 -30.18 71.0 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.001 0.429 . . . . 0.0 111.534 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . 0.523 ' HA ' ' HE3' ' A' ' 209' ' ' LYS . 1.0 OUTLIER -77.5 -46.37 22.65 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.734 0.778 . . . . 0.0 109.77 179.007 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.548 HD21 ' HD2' ' A' ' 27' ' ' ARG . 2.6 tp -71.26 -30.02 65.8 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.24 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' MET . . . . . 0.809 ' HE2' ' O ' ' A' ' 177' ' ' LEU . 40.8 mtp -75.04 -35.63 61.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 12.8 mtmt -60.65 -37.71 82.43 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.046 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.427 HG21 ' N ' ' A' ' 211' ' ' PHE . 5.8 t -62.61 -28.88 70.2 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.718 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.55 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 42.7 m-85 -80.52 -6.98 59.01 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.579 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.99 7.65 24.9 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 115.98 1.152 . . . . 0.0 115.98 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.2 m -123.36 148.59 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 118.929 1.364 . . . . 0.0 112.794 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.489 ' HG2' ' HD3' ' A' ' 209' ' ' LYS . 18.0 mt-10 -130.84 136.21 48.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.811 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.586 HG22 ' HB ' ' A' ' 225' ' ' VAL . 16.8 mm -118.66 148.12 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 120.845 0.355 . . . . 0.0 110.565 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.525 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 2.6 tt0 -100.63 118.26 36.42 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.916 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -82.84 150.98 26.24 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.934 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . 0.484 ' CB ' ' HB3' ' A' ' 222' ' ' GLN . 3.5 tp60 -106.74 -138.26 0.37 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.114 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.467 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 0.1 OUTLIER -84.87 66.67 9.81 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.827 0.346 . . . . 0.0 111.008 -179.451 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 5.5 t80 60.07 33.04 21.24 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.82 0.819 . . . . 0.0 110.439 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.656 ' CB ' ' HB ' ' A' ' 191' ' ' ILE . 1.8 pt20 -166.39 -124.77 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.814 ' HG3' ' HG3' ' A' ' 190' ' ' ARG . 0.7 OUTLIER -5.43 130.09 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.671 ' HE2' HG22 ' A' ' 201' ' ' ILE . 1.2 m-85 -125.07 133.37 52.93 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 112.977 -1.92 . . . . 0.0 109.509 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.525 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 61.3 t -116.96 113.51 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-O 121.573 0.702 . . . . 0.0 109.206 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.586 ' HB ' HG22 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -120.22 122.29 67.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.152 -178.776 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.554 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 0.1 OUTLIER -76.84 123.43 26.24 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.806 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -75.54 -177.11 40.71 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.718 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 65.5 21.72 69.0 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 121.573 -0.346 . . . . 0.0 113.036 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . 0.554 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 15.7 mt-30 -77.41 179.58 6.36 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.298 0.57 . . . . 0.0 111.338 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 13.6 t -138.01 147.8 44.53 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.869 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' TYR . . . . . 0.648 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 1.1 m-30 -107.83 123.76 49.07 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.894 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.96 161.3 20.02 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.553 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.12 113.34 57.95 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-O 120.835 0.35 . . . . 0.0 111.43 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.65 1.98 3.88 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.656 2.237 . . . . 0.0 112.875 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 98.99 -100.5 2.29 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.344 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 92.2 m -119.35 133.15 55.87 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -129.74 133.21 46.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.873 0.368 . . . . 0.0 111.117 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.593 HD22 HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -97.18 110.52 23.05 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.201 0.524 . . . . 0.0 110.524 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.407 HG22 HD21 ' A' ' 44' ' ' LEU . 21.9 t -79.06 113.51 18.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.421 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.487 ' HG2' HD13 ' A' ' 238' ' ' LEU . 7.8 mt-10 . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.212 -0.899 . . . . 0.0 111.156 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.505 ' HB3' HD23 ' A' ' 44' ' ' LEU . 5.0 p . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.533 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 17.5 m120 -73.23 -65.63 0.78 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.837 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.535 HH21 ' HB3' ' A' ' 171' ' ' GLN . 0.5 OUTLIER -65.37 -57.99 7.0 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.345 0.593 . . . . 0.0 110.171 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.691 ' HB3' ' HG ' ' A' ' 41' ' ' LEU . . . -40.73 -44.39 2.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.958 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 25' ' ' SER . 14.2 mt -71.68 -37.47 70.74 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.918 0.39 . . . . 0.0 111.213 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.428 ' HB2' ' HE1' ' A' ' 53' ' ' MET . 56.9 tp -65.32 -49.95 67.48 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.917 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.544 ' HB2' ' CE2' ' A' ' 211' ' ' PHE . 20.1 mt -69.33 -26.17 64.57 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.456 ' HA ' ' CE1' ' A' ' 211' ' ' PHE . . . -63.79 -41.82 97.85 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.221 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.572 ' CB ' ' HG ' ' A' ' 57' ' ' LEU . . . -80.47 -40.17 26.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.73 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.623 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 9.1 mt -67.48 -3.4 8.43 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.451 178.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.549 ' HB1' ' HB3' ' A' ' 231' ' ' TYR . . . -99.84 177.26 5.17 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -177.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.525 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.3 OUTLIER -111.28 114.39 27.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.656 178.357 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 114.28 167.48 15.97 Favored Glycine 0 C--O 1.228 -0.28 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.202 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.515 ' CD ' ' HG2' ' A' ' 74' ' ' GLU . 0.6 OUTLIER -95.34 117.53 30.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 117.284 0.542 . . . . 0.0 111.55 -179.439 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.52 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 0.9 OUTLIER -118.8 147.03 44.34 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.242 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.531 HG23 ' HG3' ' A' ' 74' ' ' GLU . 96.6 t -105.91 141.25 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 CA-C-O 121.385 0.612 . . . . 0.0 112.437 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.691 ' HG ' ' HB3' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -116.02 116.32 27.69 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 174.733 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.565 HG23 HD21 ' A' ' 238' ' ' LEU . 0.5 OUTLIER -103.15 152.93 20.86 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.228 -177.75 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.4 t30 68.8 24.71 6.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.514 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.511 HD12 ' HB3' ' A' ' 73' ' ' CYS . 34.8 mt -53.86 -175.55 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.951 0.405 . . . . 0.0 110.151 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.533 ' HB3' HG21 ' A' ' 50' ' ' VAL . 28.3 tp -111.78 132.28 54.77 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.163 -0.472 . . . . 0.0 109.995 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -88.52 89.26 7.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.835 0.35 . . . . 0.0 110.896 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 50' ' ' VAL . 36.5 m -163.79 142.17 7.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.057 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.562 ' HA ' ' HB3' ' A' ' 51' ' ' ARG . 1.6 p30 -37.89 -31.25 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.662 0.268 . . . . 0.0 111.429 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.432 ' HA ' ' CB ' ' A' ' 95' ' ' ALA . 0.7 OUTLIER -57.29 -42.72 82.25 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.024 0.44 . . . . 0.0 110.435 179.308 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.533 HG21 ' HB3' ' A' ' 45' ' ' LEU . 98.0 t -81.66 -45.08 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.562 ' HB3' ' HA ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -49.62 -39.13 34.64 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 177.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.614 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 14.7 m-70 -78.64 -33.25 47.38 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.908 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.565 ' O ' HD13 ' A' ' 57' ' ' LEU . 9.4 tpt -55.5 -35.58 65.74 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 176.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.548 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -81.88 -44.43 16.85 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 114.162 -1.381 . . . . 0.0 108.522 176.598 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.803 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 0.3 OUTLIER -57.31 -38.59 74.27 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.354 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 52' ' ' HIS . . . -60.54 -44.79 95.73 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.779 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.2 OUTLIER -65.59 -38.83 90.6 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.1 -1.409 . . . . 0.0 107.752 176.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.803 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.2 m -63.02 -33.76 76.11 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.528 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 55' ' ' ASN . . . -74.22 -37.13 63.93 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.341 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.497 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -83.54 -13.92 53.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.171 0.51 . . . . 0.0 111.058 -179.464 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.07 35.01 4.65 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.42 -0.809 . . . . 0.0 114.123 178.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.779 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 38.2 t -90.69 122.13 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.742 ' O ' HG12 ' A' ' 76' ' ' ILE . 5.5 m -84.88 132.54 34.38 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 120.911 0.386 . . . . 0.0 111.711 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.586 ' CB ' HG12 ' A' ' 75' ' ' ILE . 41.4 p90 -158.03 167.93 28.51 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.378 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 74' ' ' GLU . 40.7 m -129.81 147.31 51.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.372 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.437 ' CD1' ' HB2' ' A' ' 73' ' ' CYS . 12.3 tp -115.59 132.4 56.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.235 0.541 . . . . 0.0 110.487 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.503 ' HB2' ' CB ' ' A' ' 72' ' ' ARG . 0.2 OUTLIER -59.22 -161.2 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.554 -179.451 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -95.56 -32.02 13.03 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.549 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -79.84 1.24 27.7 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.261 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 30.6 mtt-85 57.88 35.33 25.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.996 0.426 . . . . 0.0 110.888 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.444 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -134.21 -4.5 2.71 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.626 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.503 ' CB ' ' HB2' ' A' ' 67' ' ' SER . 3.4 mtp-105 -121.62 122.09 38.86 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.526 ' SG ' ' CD2' ' A' ' 54' ' ' LEU . 28.8 t -131.18 126.9 36.81 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 120.989 0.424 . . . . 0.0 112.069 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.531 ' HG3' HG23 ' A' ' 40' ' ' VAL . 58.6 tt0 -110.63 131.65 54.87 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 176.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.586 HG12 ' CB ' ' A' ' 64' ' ' TYR . 13.2 mt -126.42 121.81 59.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.742 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -67.23 98.4 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-O 121.486 0.66 . . . . 0.0 109.252 175.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -35.15 145.04 0.06 OUTLIER Glycine 0 C--N 1.32 -0.344 0 CA-C-N 114.56 -1.2 . . . . 0.0 114.125 -178.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.454 ' CB ' HD11 ' A' ' 82' ' ' LEU . 1.1 t-20 -90.74 -13.11 34.66 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.06 0.457 . . . . 0.0 110.789 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.525 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 91.81 1.78 70.25 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.697 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.536 ' O ' HD21 ' A' ' 34' ' ' LEU . . . 149.97 -147.61 18.01 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.035 -0.602 . . . . 0.0 111.742 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.414 ' HD2' ' HA3' ' A' ' 80' ' ' GLY . 5.7 Cg_endo -49.05 122.66 8.71 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.596 2.198 . . . . 0.0 112.524 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.497 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . 0.5 OUTLIER -73.33 110.75 7.86 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.27 179.653 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -82.24 130.31 35.06 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.425 ' CB ' HD11 ' A' ' 113' ' ' ILE . . . -94.46 122.79 37.39 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.672 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -71.19 123.74 22.89 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 176.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.86 174.54 1.2 Allowed Glycine 0 N--CA 1.439 -1.124 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 -175.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.95 144.8 47.14 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 118.705 1.253 . . . . 0.0 111.923 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.519 ' CB ' HG13 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -112.27 160.94 17.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.001 -0.999 . . . . 0.0 112.127 -178.622 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 18.8 mt-10 -140.21 101.3 4.11 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.022 177.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 114' ' ' VAL . 0.0 OUTLIER -100.79 120.1 39.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.872 0.368 . . . . 0.0 111.346 -178.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.402 ' CE1' ' HB ' ' A' ' 116' ' ' THR . 1.4 m-85 -95.27 96.45 9.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.823 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.499 ' HB3' ' HB2' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -103.54 52.89 0.76 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.351 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.496 ' HA3' ' H ' ' A' ' 118' ' ' GLU . . . -49.82 -75.13 0.22 Allowed Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.408 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -77.51 -0.68 27.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.501 0.191 . . . . 0.0 110.97 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.499 ' HB2' ' HB3' ' A' ' 92' ' ' LEU . . . -92.18 46.53 1.27 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.81 0.338 . . . . 0.0 111.336 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -52.74 -24.37 18.5 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.297 -0.954 . . . . 0.0 111.811 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.69 -19.69 27.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.471 0.177 . . . . 0.0 111.167 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.521 ' C ' ' HD2' ' A' ' 101' ' ' PRO . . . -94.18 -31.69 14.03 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.648 0.261 . . . . 0.0 111.452 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.56 ' SD ' ' HB3' ' A' ' 115' ' ' LEU . 5.3 tpp -64.57 -47.35 79.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.716 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.625 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -55.18 -56.35 29.33 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.625 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 18.7 Cg_exo -64.73 -30.49 59.43 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.126 1.884 . . . . 0.0 112.63 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.535 HD21 ' HA ' ' A' ' 102' ' ' LEU . 0.1 OUTLIER -72.57 -53.16 12.72 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.193 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.546 ' HA ' HD13 ' A' ' 153' ' ' LEU . . . -52.89 -27.08 16.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.33 0.586 . . . . 0.0 110.509 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.511 ' C ' ' OG1' ' A' ' 179' ' ' THR . . . -86.62 -53.92 4.68 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.131 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.401 ' HB1' HD12 ' A' ' 34' ' ' LEU . . . -60.57 -36.51 78.67 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -177.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.461 HD23 HD12 ' A' ' 60' ' ' LEU . 27.4 mt -76.28 -12.88 60.15 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.569 ' HB3' ' HB2' ' A' ' 138' ' ' ALA . 69.3 m -86.73 20.12 2.67 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.25 0.548 . . . . 0.0 110.427 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.492 ' HG ' HG22 ' A' ' 179' ' ' THR . 2.4 mt -85.93 -75.02 0.39 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.019 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -69.7 -117.07 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.487 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.35 96.4 1.92 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.045 0.45 . . . . 0.0 110.123 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.699 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 8.8 m120 -148.51 143.99 27.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.116 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.838 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 13.4 m-20 -95.99 99.98 11.7 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.303 0.573 . . . . 0.0 110.149 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.519 HG13 ' CB ' ' A' ' 88' ' ' LEU . 1.9 mp -118.15 146.08 23.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.941 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.783 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 48.5 t -115.49 112.86 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 176.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.56 ' HB3' ' SD ' ' A' ' 99' ' ' MET . 31.0 mt -102.03 106.52 17.43 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.497 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.435 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -118.88 -170.83 1.98 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.037 -179.044 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.478 ' HA3' ' HG2' ' A' ' 121' ' ' MET . . . -170.08 179.13 42.53 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.968 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.672 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 2.9 mt-10 -72.32 169.72 15.61 Favored Pre-proline 0 C--N 1.332 -0.188 0 C-N-CA 123.573 0.749 . . . . 0.0 111.248 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.672 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 2.5 Cg_endo -43.56 -39.78 9.98 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.096 2.531 . . . . 0.0 113.193 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.8 mtm-85 -67.63 -24.4 65.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.667 0.27 . . . . 0.0 110.838 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.607 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 9.2 tpt -61.1 -34.94 75.75 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.414 ' HE3' ' HG2' ' A' ' 149' ' ' PRO . 0.0 OUTLIER -61.92 -16.69 52.81 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.463 179.139 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -87.59 4.17 44.76 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.934 0.397 . . . . 0.0 109.986 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 34.1 mtt85 -127.12 83.77 65.15 Favored Pre-proline 0 N--CA 1.454 -0.242 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.866 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.5 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 19.7 Cg_endo -58.02 148.76 75.12 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.675 2.25 . . . . 0.0 111.501 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.545 HG12 HD11 ' A' ' 151' ' ' LEU . 0.6 OUTLIER -125.48 -2.49 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -179.262 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.541 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -54.03 -34.7 52.73 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.713 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.493 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 13.3 m80 -58.53 -40.14 82.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.146 0.473 . . . . 0.0 110.142 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.589 ' HG ' ' CD1' ' A' ' 133' ' ' LEU . 16.4 tp -76.12 -40.59 52.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.705 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.732 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 46.1 t -56.0 -47.42 80.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.262 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.777 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 3.3 m-20 -71.27 -35.93 71.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.019 0.437 . . . . 0.0 110.025 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.419 ' CB ' HD22 ' A' ' 176' ' ' LEU . . . -60.84 -44.55 96.81 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.578 178.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.589 ' CD1' ' HG ' ' A' ' 129' ' ' LEU . 6.2 mt -77.08 -50.32 13.32 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.315 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.732 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -56.75 -27.94 60.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.759 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.777 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 5.6 tp -69.45 -31.76 70.27 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.779 178.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.483 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -83.09 13.52 44.13 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.038 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.78 3.15 58.3 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.941 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.569 ' HB2' ' HB3' ' A' ' 107' ' ' CYS . . . -71.53 152.12 43.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.737 0.304 . . . . 0.0 111.568 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 0.6 OUTLIER -101.74 101.44 11.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.76 178.418 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.685 ' HB ' ' HG3' ' A' ' 134' ' ' ARG . 19.8 mt -133.39 126.91 53.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.369 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.578 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -124.05 139.56 53.82 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 116.262 -0.427 . . . . 0.0 109.938 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.438 ' HH ' ' HB ' ' A' ' 130' ' ' VAL . 31.3 m-85 -80.58 132.81 35.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.652 0.263 . . . . 0.0 111.278 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.644 ' HB2' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -92.57 -91.33 0.17 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.698 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.55 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 40.6 mt-10 -57.18 -81.87 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.649 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.407 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 23.2 mt-30 -113.61 151.05 32.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.788 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 0.8 OUTLIER -67.91 130.98 44.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.839 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.541 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 1.9 m-20 71.82 17.75 5.29 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.04 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.567 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 18.7 m-85 -111.14 168.25 7.85 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-O 121.294 0.569 . . . . 0.0 112.352 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.861 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 1.4 Cg_exo -29.59 -63.12 0.09 OUTLIER 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 124.796 3.664 . . . . 0.0 116.779 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.861 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 58.5 Cg_exo -54.37 147.18 47.7 Favored 'Trans proline' 0 C--N 1.356 0.954 0 CA-C-N 121.301 1.501 . . . . 0.0 112.94 -178.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.783 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 7.8 mt -156.81 136.57 12.44 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.938 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.578 ' HB2' HG22 ' A' ' 141' ' ' THR . 6.8 mtp180 -106.99 102.75 12.08 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.838 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 6.6 mt -91.12 145.45 24.67 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.569 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.699 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 5.6 mt-30 -147.24 24.79 1.13 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.472 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 53.41 -173.38 0.46 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.894 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 118.35 -10.07 13.17 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.039 -1.076 . . . . 0.0 112.948 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.621 ' HE2' ' HA ' ' A' ' 180' ' ' ALA . 44.6 t80 -61.41 124.62 21.12 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 117.257 0.529 . . . . 0.0 110.441 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.664 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 66.4 p -118.32 -29.51 5.5 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 121.429 0.633 . . . . 0.0 111.411 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 133.13 -160.68 23.99 Favored Glycine 0 C--N 1.308 -1.02 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.416 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.456 ' O ' HG21 ' A' ' 162' ' ' VAL . . . 105.46 154.31 21.77 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.814 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -46.72 114.47 0.83 Allowed 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.407 -0.396 . . . . 0.0 111.019 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.765 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 69.1 t -107.9 121.66 61.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.317 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -91.6 119.69 31.73 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.682 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.516 HG13 ' HG ' ' A' ' 173' ' ' LEU . 1.2 t -132.27 122.29 47.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.437 ' HB3' ' CG2' ' A' ' 168' ' ' VAL . 0.6 OUTLIER -56.72 139.43 50.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.059 0.456 . . . . 0.0 111.638 -179.153 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.484 ' CA ' HG21 ' A' ' 191' ' ' ILE . . . -61.0 -51.03 61.08 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.657 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.9 m -85.0 90.47 7.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.865 0.364 . . . . 0.0 110.642 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.621 ' H ' ' HB ' ' A' ' 196' ' ' VAL . 58.8 t -149.45 -92.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.246 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.414 ' HB3' ' HG2' ' A' ' 171' ' ' GLN . 0.6 OUTLIER -157.43 127.83 6.4 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.317 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.554 ' HB2' ' HB3' ' A' ' 200' ' ' TYR . 0.3 OUTLIER -55.9 -23.78 33.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.001 -178.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.59 ' O ' ' HB2' ' A' ' 175' ' ' ALA . 0.0 OUTLIER -81.71 -12.2 58.73 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.983 -179.692 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.551 ' CD2' ' HB2' ' A' ' 129' ' ' LEU . 6.2 m-85 -75.33 -56.67 4.49 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.538 HD21 ' CZ ' ' A' ' 223' ' ' PHE . 0.2 OUTLIER -62.26 -43.6 98.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.454 178.587 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.58 ' O ' ' HG3' ' A' ' 178' ' ' MET . 1.8 m -56.06 -41.11 74.58 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.902 178.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 171' ' ' GLN . . . -57.87 -37.79 74.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.52 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.419 HD22 ' CB ' ' A' ' 132' ' ' ALA . 0.7 OUTLIER -76.63 -37.04 57.03 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.383 0.611 . . . . 0.0 110.238 178.88 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.579 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 4.3 mp -59.61 -34.48 72.82 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.693 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.58 ' HG3' ' O ' ' A' ' 174' ' ' THR . 8.8 mtp -81.84 -42.38 19.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.373 0.606 . . . . 0.0 112.185 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.511 ' OG1' ' C ' ' A' ' 104' ' ' ALA . 88.3 m -75.04 -40.82 60.12 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.546 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.621 ' HA ' ' HE2' ' A' ' 157' ' ' PHE . . . -59.88 -39.74 72.61 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 -176.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.579 ' HD3' ' O ' ' A' ' 177' ' ' LEU . 31.2 Cg_endo -68.4 -27.4 33.86 Favored 'Trans proline' 0 CA--C 1.498 -1.305 0 CA-C-N 120.241 1.122 . . . . 0.0 111.949 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.468 ' HB2' ' CD2' ' A' ' 108' ' ' LEU . 9.6 mt -85.05 0.35 51.84 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . -81.79 137.43 47.26 Favored Pre-proline 0 C--O 1.224 -0.241 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.187 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.664 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 14.3 Cg_endo -52.27 -30.68 43.27 Favored 'Trans proline' 0 CA--C 1.519 -0.269 0 C-N-CA 122.483 2.122 . . . . 0.0 113.178 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.76 138.48 50.69 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.905 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -55.1 142.3 31.23 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.049 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.529 ' HB ' ' HB1' ' A' ' 180' ' ' ALA . 87.0 m -120.31 144.42 47.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.205 0.526 . . . . 0.0 112.21 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 18.0 t -125.73 118.03 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.187 177.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.765 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 2.7 mp -101.16 117.86 47.04 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.655 ' HG3' ' HG3' ' A' ' 222' ' ' GLN . 0.2 OUTLIER -99.78 123.66 44.26 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.585 ' HB ' ' HA ' ' A' ' 221' ' ' GLN . 1.7 mp -93.71 124.99 46.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.063 -175.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -83.05 96.92 8.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.064 -1.426 . . . . 0.0 110.502 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 100.98 -129.81 10.02 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.933 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.32 129.0 56.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.709 0.29 . . . . 0.0 111.577 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.577 HD11 HG13 ' A' ' 201' ' ' ILE . 1.9 mt -41.43 144.68 0.33 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.621 ' HB ' ' H ' ' A' ' 168' ' ' VAL . 8.6 p -71.56 -36.64 60.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.196 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.426 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 2.0 t -160.72 62.33 0.31 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.258 0.552 . . . . 0.0 109.977 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.659 ' N ' ' HD2' ' A' ' 199' ' ' PRO . 5.5 tmtt? -38.93 -47.68 3.72 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.829 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 5.0 Cg_endo -46.68 -33.71 14.09 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.178 1.919 . . . . 0.0 111.771 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.554 ' HB3' ' HB2' ' A' ' 170' ' ' SER . 0.2 OUTLIER -67.26 -44.36 79.59 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.577 HG13 HD11 ' A' ' 195' ' ' LEU . 14.7 mm -56.71 -39.79 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 CA-C-N 114.286 -1.324 . . . . 0.0 110.348 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -58.05 -45.15 87.51 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.044 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.533 ' CD1' ' HA ' ' A' ' 200' ' ' TYR . 4.8 mt -61.27 -50.4 80.6 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.022 0 CA-C-O 121.786 0.803 . . . . 0.0 109.068 178.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.491 HG21 ' HG3' ' A' ' 208' ' ' MET . 87.1 m -53.15 -51.6 61.46 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.971 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.523 ' O ' ' HE2' ' A' ' 209' ' ' LYS . 34.1 mt -67.99 -29.24 68.22 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 120.98 0.419 . . . . 0.0 111.663 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -78.07 -46.56 20.51 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.733 0.778 . . . . 0.0 109.664 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.526 ' HB3' ' O ' ' A' ' 203' ' ' ILE . 2.3 tp -69.7 -29.65 67.11 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.288 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' MET . . . . . 0.567 ' CE ' ' HA ' ' A' ' 178' ' ' MET . 3.9 mmm -75.98 -34.23 59.77 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.551 0.691 . . . . 0.0 109.624 178.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.627 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 7.4 mtmt -63.52 -35.97 82.22 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.439 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.459 ' O ' ' HB3' ' A' ' 234' ' ' PRO . 3.9 t -62.6 -27.29 69.09 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.629 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.544 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 27.5 m-85 -83.64 -6.81 59.54 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.019 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.63 7.29 26.05 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 115.782 1.073 . . . . 0.0 115.782 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 5.0 m -123.29 148.76 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 118.513 1.157 . . . . 0.0 112.049 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.454 ' CG ' ' HG2' ' A' ' 209' ' ' LYS . 13.2 mt-10 -130.09 134.33 47.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.403 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.564 HG22 ' HB ' ' A' ' 225' ' ' VAL . 8.9 mm -117.5 148.66 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 120.818 0.342 . . . . 0.0 110.247 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.591 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 19.9 tt0 -104.81 116.65 32.37 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.612 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.18 151.01 27.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.596 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . 0.671 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -109.08 -148.31 0.42 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.65 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.519 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 0.2 OUTLIER -72.38 66.91 0.69 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.847 0.356 . . . . 0.0 111.515 -179.491 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 1.7 t80 56.75 31.73 19.95 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.06 0.934 . . . . 0.0 110.625 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.585 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 0.4 OUTLIER -159.33 -129.27 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 178.779 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.741 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.1 OUTLIER -4.02 131.12 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 179.698 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.626 ' O ' ' HA ' ' A' ' 188' ' ' VAL . 1.1 m-85 -125.17 129.89 51.05 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 113.107 -1.86 . . . . 0.0 108.852 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.591 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 42.9 t -114.98 113.94 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-O 121.602 0.715 . . . . 0.0 109.62 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.564 ' HB ' HG22 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -120.35 124.3 72.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.121 -178.877 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.583 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 2.0 mptt -76.76 125.06 28.62 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -78.64 -178.31 50.01 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.393 -0.908 . . . . 0.0 113.23 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 64.81 21.26 67.26 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 121.346 -0.454 . . . . 0.0 112.935 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . 0.583 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 34.5 mt-30 -75.2 176.39 7.39 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.386 0.612 . . . . 0.0 111.649 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 5.4 p -136.09 147.88 48.03 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.323 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' TYR . . . . . 0.623 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 5.2 m-30 -107.75 132.07 53.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.759 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.63 147.92 48.23 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.505 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.38 111.46 14.11 Favored Pre-proline 0 N--CA 1.45 -0.435 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.657 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.459 ' HB3' ' O ' ' A' ' 210' ' ' THR . 56.2 Cg_endo -69.59 3.04 2.91 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.454 2.102 . . . . 0.0 112.622 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 95.84 -103.9 3.02 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.242 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 27.2 m -115.42 137.11 52.4 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 41' ' ' LEU . 7.5 t80 -132.72 126.7 33.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.955 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.565 HD21 HG23 ' A' ' 42' ' ' THR . 0.2 OUTLIER -94.53 111.03 22.79 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.099 0.476 . . . . 0.0 110.942 -179.685 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 43.1 t -81.02 113.36 20.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.95 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.534 ' HG3' HD12 ' A' ' 238' ' ' LEU . 6.1 mt-10 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.164 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.599 ' CB ' HD22 ' A' ' 44' ' ' LEU . 1.5 m . . . . . 0 N--CA 1.485 1.315 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.517 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 3.0 m120 -77.72 -71.56 0.41 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.912 0.387 . . . . 0.0 111.102 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.875 ' HD3' HG21 ' A' ' 174' ' ' THR . 66.4 mtm-85 -60.99 -57.7 11.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.52 0.676 . . . . 0.0 110.338 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.701 ' HB2' ' HG ' ' A' ' 41' ' ' LEU . . . -40.73 -45.89 2.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.633 -1.167 . . . . 0.0 112.077 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.535 HD21 HD12 ' A' ' 75' ' ' ILE . 12.6 mt -73.87 -34.57 64.52 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 120.92 0.39 . . . . 0.0 111.163 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.678 HD21 ' HB2' ' A' ' 101' ' ' PRO . 45.6 tp -68.58 -50.33 52.52 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.911 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.595 HD23 ' HE1' ' A' ' 178' ' ' MET . 50.7 mt -67.08 -27.15 67.12 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.416 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.447 ' HB2' HD12 ' A' ' 75' ' ' ILE . . . -66.14 -39.18 89.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.104 178.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.585 ' CB ' ' HG ' ' A' ' 57' ' ' LEU . . . -80.73 -40.79 24.64 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.013 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.744 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 14.0 mt -67.54 -3.61 9.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.102 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.644 ' HB2' ' HB3' ' A' ' 231' ' ' TYR . . . -99.72 -179.86 4.31 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -177.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.601 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.3 OUTLIER -113.89 111.52 21.84 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.526 178.165 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 116.72 166.15 14.2 Favored Glycine 0 C--N 1.32 -0.315 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -178.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.732 ' HG3' HD13 ' A' ' 76' ' ' ILE . 2.5 ttmt -95.81 118.66 32.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.992 0.396 . . . . 0.0 111.902 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.552 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.9 OUTLIER -117.47 145.08 44.41 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.249 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.51 HG22 ' CG ' ' A' ' 74' ' ' GLU . 97.1 t -102.66 141.34 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-O 121.581 0.705 . . . . 0.0 112.423 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.701 ' HG ' ' HB2' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -115.74 116.47 28.12 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 174.403 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.521 HG23 HD22 ' A' ' 238' ' ' LEU . 0.5 OUTLIER -103.93 148.11 26.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.868 0.365 . . . . 0.0 110.992 -177.601 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.431 ' HB2' HD21 ' A' ' 238' ' ' LEU . 2.0 t30 69.12 26.18 5.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.063 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.599 HD22 ' CB ' ' A' ' 25' ' ' SER . 79.6 mt -52.66 -178.21 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.153 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 34.7 tp -109.79 131.21 55.27 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.205 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -86.78 87.14 7.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.008 0.433 . . . . 0.0 110.386 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.554 ' HB3' ' OD1' ' A' ' 49' ' ' ASP . 11.2 t -164.11 142.64 7.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.702 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.531 ' HB2' ' HB2' ' A' ' 94' ' ' ASN . 5.2 m-20 -37.09 -30.3 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.634 ' CB ' ' HA ' ' A' ' 95' ' ' ALA . 34.5 p-10 -56.85 -42.59 80.0 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.36 0.6 . . . . 0.0 110.208 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.519 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 64.6 t -83.44 -47.95 17.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.191 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.616 ' HA ' HD11 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -50.41 -37.97 40.59 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 178.72 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.649 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 7.4 m-70 -80.44 -32.69 37.26 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.842 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.601 ' O ' HD12 ' A' ' 57' ' ' LEU . 8.6 tpt -55.09 -35.27 64.41 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 176.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.616 HD11 ' HA ' ' A' ' 51' ' ' ARG . 0.5 OUTLIER -81.82 -42.49 19.6 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.398 176.328 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.769 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 24.6 t30 -60.77 -34.25 74.17 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.178 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.594 ' N ' ' O ' ' A' ' 52' ' ' HIS . . . -64.6 -46.95 80.46 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.857 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.2 OUTLIER -63.89 -39.61 94.58 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 113.914 -1.494 . . . . 0.0 107.807 177.103 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.769 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 2.6 m -59.96 -34.46 73.31 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.36 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.469 ' HB3' HD23 ' A' ' 88' ' ' LEU . . . -76.84 -36.91 56.51 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.485 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.445 HD11 ' HB2' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -82.74 -13.92 55.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.419 0.628 . . . . 0.0 110.719 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.14 35.02 5.18 Favored Glycine 0 C--N 1.32 -0.361 0 CA-C-N 115.228 -0.896 . . . . 0.0 114.174 177.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.857 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 38.6 t -90.27 118.53 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.817 ' O ' HG12 ' A' ' 76' ' ' ILE . 10.8 m -81.39 134.5 35.57 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.293 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.614 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 42.0 p90 -158.23 160.58 37.29 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.473 ' N ' ' O ' ' A' ' 74' ' ' GLU . 63.3 m -122.82 149.65 43.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.565 0.221 . . . . 0.0 110.993 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.783 HD21 ' HA ' ' A' ' 70' ' ' ARG . 4.0 tp -121.01 138.96 53.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.925 0.393 . . . . 0.0 110.636 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.461 ' HB2' ' CB ' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -69.66 -165.64 0.09 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.675 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.99 -23.43 22.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.171 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.412 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 0.1 OUTLIER -81.35 1.15 34.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.272 179.716 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.783 ' HA ' HD21 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 53.09 26.41 4.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.807 0.337 . . . . 0.0 111.286 179.773 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.412 ' OG1' ' HB3' ' A' ' 69' ' ' ASP . 1.3 p -127.93 -10.86 5.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.86 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.524 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 7.2 mtp180 -112.88 115.48 28.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.105 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.59 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -133.12 128.32 35.86 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -179.342 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.55 ' HA ' ' O ' ' A' ' 39' ' ' THR . 13.7 tt0 -107.73 133.78 51.65 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.613 178.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.593 ' HA ' ' CB ' ' A' ' 64' ' ' TYR . 8.2 mt -123.45 122.27 64.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.817 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -68.13 101.58 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-O 121.462 0.648 . . . . 0.0 109.516 175.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -39.61 143.2 0.46 Allowed Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 114.737 -1.12 . . . . 0.0 113.844 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.402 HD21 HD13 ' A' ' 82' ' ' LEU . 6.2 t-20 -87.89 -7.54 57.04 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 120.771 0.319 . . . . 0.0 110.82 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.601 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 88.38 2.66 79.48 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.278 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.46 ' C ' HD22 ' A' ' 34' ' ' LEU . . . 151.35 -147.43 17.35 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.005 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.639 ' HG3' ' HB3' ' A' ' 108' ' ' LEU . 77.0 Cg_exo -49.72 127.59 19.16 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.379 2.052 . . . . 0.0 112.727 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.628 HD22 HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -72.78 110.54 7.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.125 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.468 ' HA ' ' CG ' ' A' ' 111' ' ' ASN . 4.6 p80 -82.19 133.99 35.28 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.88 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.494 ' CB ' HD12 ' A' ' 113' ' ' ILE . . . -98.69 124.33 43.44 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.047 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -71.19 123.36 22.02 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 176.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.88 176.97 0.82 Allowed Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -175.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 112' ' ' ASP . . . -73.1 144.7 46.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 118.668 1.234 . . . . 0.0 111.11 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.551 ' CB ' HG13 ' A' ' 113' ' ' ILE . 0.4 OUTLIER -112.81 160.99 17.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.34 -178.532 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 7.3 mt-10 -141.53 102.91 4.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.43 177.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.664 ' HB2' HD21 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -102.25 115.5 30.68 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.657 -177.693 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.458 ' CD1' ' HB ' ' A' ' 116' ' ' THR . 0.9 OUTLIER -90.52 98.12 11.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.734 179.085 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.535 ' HB3' ' CB ' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -103.66 52.9 0.76 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.602 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.615 ' CA ' ' H ' ' A' ' 118' ' ' GLU . . . -59.86 -67.28 2.24 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.421 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.534 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 69.5 m-80 -75.43 15.26 0.48 Allowed 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.413 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.634 ' HA ' ' CB ' ' A' ' 49' ' ' ASP . . . -94.88 -70.15 0.72 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.56 -68.08 0.4 Allowed Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.923 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.417 ' O ' ' CD ' ' A' ' 101' ' ' PRO . 2.6 p -71.65 -8.42 53.98 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.528 ' O ' ' HB2' ' A' ' 102' ' ' LEU . . . -98.88 -30.1 12.58 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.655 0.264 . . . . 0.0 111.043 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -64.67 -42.75 95.15 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.551 ' CB ' ' HB3' ' A' ' 171' ' ' GLN . 1.4 mpt_? -55.84 -60.95 7.24 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.796 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.678 ' HB2' HD21 ' A' ' 30' ' ' LEU . 21.0 Cg_endo -60.78 -30.47 90.3 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.469 2.113 . . . . 0.0 112.488 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.528 ' HB2' ' O ' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -75.22 -52.5 10.77 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 120.335 -0.546 . . . . 0.0 109.998 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.626 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -51.6 -27.26 10.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.5 0.666 . . . . 0.0 110.509 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.633 ' CB ' HD22 ' A' ' 133' ' ' LEU . . . -86.55 -53.99 4.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.377 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.413 ' CB ' HD13 ' A' ' 34' ' ' LEU . . . -60.63 -33.61 73.02 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -177.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.52 ' HB2' ' CD1' ' A' ' 153' ' ' LEU . 26.9 mt -78.35 -20.76 50.67 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.55 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 0.0 OUTLIER -83.22 21.89 1.06 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.335 0.588 . . . . 0.0 110.87 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.639 ' HB3' ' HG3' ' A' ' 81' ' ' PRO . 0.5 OUTLIER -85.75 -76.05 0.35 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.74 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -70.28 -110.31 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.64 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.1 m -158.38 96.08 1.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.957 0.408 . . . . 0.0 110.595 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.641 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 13.7 m-80 -148.99 140.14 23.07 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.275 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.857 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 1.9 m-20 -92.95 98.59 11.46 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.171 0.51 . . . . 0.0 110.087 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.57 ' N ' HD11 ' A' ' 113' ' ' ILE . 1.5 mp -119.17 145.68 24.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.918 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.786 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 59.1 t -113.63 112.97 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 176.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.664 HD21 ' HB2' ' A' ' 90' ' ' LEU . 58.8 mt -102.63 110.99 23.1 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.903 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.458 ' HB ' ' CD1' ' A' ' 91' ' ' PHE . 0.2 OUTLIER -125.06 -171.97 2.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.253 -179.712 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -166.73 -173.12 34.77 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.514 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.661 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 1.3 mm-40 -76.83 172.49 9.54 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 123.245 0.618 . . . . 0.0 110.123 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.661 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 7.4 Cg_endo -47.97 -33.06 19.4 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.605 2.203 . . . . 0.0 112.744 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -67.62 -28.18 67.52 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.021 0.439 . . . . 0.0 110.219 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.577 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 9.8 tpt -61.19 -39.56 90.66 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.559 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.443 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 0.0 OUTLIER -63.01 -16.96 61.58 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.29 179.747 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.562 ' O ' ' HG3' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -85.68 -3.95 59.03 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.47 ' HB3' ' NH2' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -123.74 88.63 51.97 Favored Pre-proline 0 N--CA 1.452 -0.332 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.763 179.807 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.452 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 15.8 Cg_endo -56.67 149.09 61.04 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.651 2.234 . . . . 0.0 111.599 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.665 HG12 HD12 ' A' ' 151' ' ' LEU . 0.8 OUTLIER -119.88 8.98 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.946 0.403 . . . . 0.0 111.763 -179.121 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.435 ' HA3' ' OD1' ' A' ' 147' ' ' ASN . . . -57.19 -45.24 92.83 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.801 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.569 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 3.9 m80 -55.25 -38.62 68.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.013 0.406 . . . . 0.0 110.782 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.599 ' HG ' HD12 ' A' ' 133' ' ' LEU . 17.7 tp -74.8 -45.71 41.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.962 0.411 . . . . 0.0 110.372 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.76 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 49.9 t -56.58 -47.73 81.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.339 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.723 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 0.5 OUTLIER -71.88 -34.43 69.18 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.029 0.442 . . . . 0.0 110.297 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.527 ' HB2' HD22 ' A' ' 176' ' ' LEU . . . -62.42 -45.0 95.07 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.901 178.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.654 HD23 HD21 ' A' ' 176' ' ' LEU . 6.2 mt -77.27 -50.32 13.13 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.357 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.76 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -55.88 -27.59 52.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.764 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.723 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.6 OUTLIER -67.83 -33.02 73.96 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.586 178.616 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.53 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -82.55 13.63 40.25 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.015 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.07 2.45 60.83 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.329 -0.939 . . . . 0.0 112.833 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.65 ' HB1' ' HD1' ' A' ' 157' ' ' PHE . . . -70.74 152.42 43.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.895 0.379 . . . . 0.0 111.048 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 37.6 mttm -101.28 103.2 14.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.346 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.594 ' HB ' ' HG3' ' A' ' 134' ' ' ARG . 25.7 mt -134.4 126.48 48.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.367 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.726 HG23 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -121.72 139.37 53.66 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.718 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.433 ' HE1' HG21 ' A' ' 130' ' ' VAL . 47.5 m-85 -81.6 130.02 34.9 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.033 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.621 ' HB2' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -90.96 -91.59 0.15 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.473 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.59 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 17.7 mt-10 -56.1 -80.98 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.021 0.439 . . . . 0.0 110.439 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.508 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 31.6 mt-30 -115.67 151.32 35.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.426 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 31.2 mt-10 -67.9 137.54 55.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.117 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 146' ' ' GLU . 1.2 m-80 66.36 20.21 10.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.965 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.623 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 20.5 m-85 -113.79 170.04 5.82 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.93 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 27.6 Cg_exo -32.57 -63.39 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 124.345 3.363 . . . . 0.0 116.221 -177.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.93 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 77.8 Cg_exo -53.55 146.84 41.13 Favored 'Trans proline' 0 C--N 1.353 0.809 0 CA-C-N 120.706 1.288 . . . . 0.0 112.588 -178.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.786 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 9.7 mt -156.32 136.45 12.85 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.345 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.726 ' HB2' HG23 ' A' ' 141' ' ' THR . 0.0 OUTLIER -108.5 102.94 11.99 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.022 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.857 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 8.5 mt -91.29 146.81 23.51 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.738 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.641 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 2.8 mt-30 -148.83 25.74 0.92 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.368 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.55 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 54.88 -170.26 1.5 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.85 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 114.79 -15.43 19.26 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.119 -1.039 . . . . 0.0 113.389 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.702 ' HE2' ' HA ' ' A' ' 180' ' ' ALA . 55.4 t80 -58.33 123.69 16.98 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 117.258 0.529 . . . . 0.0 110.647 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.63 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 75.7 p -117.05 -33.55 4.68 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 121.382 0.61 . . . . 0.0 111.392 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.456 ' HA2' ' HG1' ' A' ' 187' ' ' THR . . . 138.56 -161.64 25.75 Favored Glycine 0 C--N 1.307 -1.083 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.987 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.451 ' O ' HG22 ' A' ' 162' ' ' VAL . . . 105.22 153.95 21.93 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.54 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -46.93 116.53 1.38 Allowed 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.321 -0.44 . . . . 0.0 111.093 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.767 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 73.4 t -109.59 130.62 62.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.829 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.16 120.38 39.41 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.522 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 191' ' ' ILE . 1.2 t -133.78 120.03 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 120.922 0.391 . . . . 0.0 110.12 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.526 ' O ' HG12 ' A' ' 168' ' ' VAL . 0.8 OUTLIER -52.44 141.83 18.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.657 -179.362 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.499 ' HA2' ' CG2' ' A' ' 191' ' ' ILE . . . -59.55 -51.26 60.12 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.076 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.406 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 0.2 OUTLIER -94.12 95.8 9.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.598 0.237 . . . . 0.0 111.368 179.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 165' ' ' ASP . 8.2 p -177.15 59.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.131 0.491 . . . . 0.0 110.755 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.533 ' HB2' ' CD1' ' A' ' 172' ' ' PHE . 20.2 m 63.88 130.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.2 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.429 ' N ' HG13 ' A' ' 196' ' ' VAL . 0.2 OUTLIER -70.9 -17.55 62.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.361 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.551 ' HB3' ' CB ' ' A' ' 100' ' ' ARG . 0.8 OUTLIER -76.53 -10.64 59.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.937 -179.092 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.569 ' CE2' ' HB2' ' A' ' 128' ' ' HIS . 8.4 m-85 -72.48 -50.43 26.09 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.581 0.705 . . . . 0.0 109.559 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.714 HD22 ' CZ ' ' A' ' 223' ' ' PHE . 0.2 OUTLIER -68.64 -43.5 76.15 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.16 178.693 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.875 HG21 ' HD3' ' A' ' 27' ' ' ARG . 2.1 m -54.03 -35.31 61.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.501 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.533 ' HB3' ' HB1' ' A' ' 104' ' ' ALA . . . -63.88 -45.23 90.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.495 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.654 HD21 HD23 ' A' ' 133' ' ' LEU . 0.1 OUTLIER -76.58 -33.07 58.49 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.054 -179.814 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.789 ' O ' ' HE1' ' A' ' 208' ' ' MET . 3.4 mp -59.97 -39.1 84.48 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.62 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.632 ' HE2' ' HA ' ' A' ' 27' ' ' ARG . 1.9 mtp -81.55 -44.35 17.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.407 0.622 . . . . 0.0 112.226 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.485 HG21 ' HG ' ' A' ' 108' ' ' LEU . 58.3 m -71.4 -41.0 70.17 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.796 -178.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.702 ' HA ' ' HE2' ' A' ' 157' ' ' PHE . . . -59.9 -39.84 73.36 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -176.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.551 ' HD3' HG21 ' A' ' 225' ' ' VAL . 28.2 Cg_endo -65.66 -28.59 52.29 Favored 'Trans proline' 0 CA--C 1.497 -1.354 0 CA-C-N 120.108 1.074 . . . . 0.0 111.657 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.538 ' HB2' ' CD2' ' A' ' 108' ' ' LEU . 4.7 mt -84.06 0.49 48.08 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.724 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.499 ' O ' ' HA3' ' A' ' 227' ' ' GLY . . . -83.19 136.57 43.37 Favored Pre-proline 0 C--O 1.224 -0.279 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.856 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.63 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 10.7 Cg_endo -50.18 -33.49 35.98 Favored 'Trans proline' 0 CA--C 1.518 -0.278 0 C-N-CA 122.597 2.198 . . . . 0.0 113.443 -179.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.79 139.54 48.32 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.731 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 187' ' ' THR . 10.1 t0 -55.33 143.89 26.95 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.835 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.67 ' O ' HG12 ' A' ' 225' ' ' VAL . 87.8 m -121.2 148.98 43.52 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.949 0.404 . . . . 0.0 111.606 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 44.0 t -130.38 117.75 40.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.795 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 4.6 mp -100.23 119.79 48.79 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.561 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 0.1 OUTLIER -100.78 125.57 47.28 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.558 ' HB ' ' HA ' ' A' ' 221' ' ' GLN . 1.6 mp -94.04 125.18 46.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.807 -176.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -77.91 96.86 5.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 113.948 -1.478 . . . . 0.0 110.458 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 96.58 -126.99 9.03 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.263 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -116.41 130.87 56.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.79 0.329 . . . . 0.0 111.582 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.608 HD13 HG13 ' A' ' 201' ' ' ILE . 1.5 mt -41.72 144.22 0.42 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.385 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.429 HG13 ' N ' ' A' ' 170' ' ' SER . 14.8 p -72.33 -28.28 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.039 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.447 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 0.1 OUTLIER -168.85 65.19 0.06 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.058 0.456 . . . . 0.0 110.49 -179.15 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.458 ' N ' ' CD ' ' A' ' 199' ' ' PRO . 0.0 OUTLIER -40.66 -46.72 6.44 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.498 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 198' ' ' LYS . 83.5 Cg_exo -47.49 -33.81 18.36 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 121.842 1.694 . . . . 0.0 111.411 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.537 ' HA ' ' CD1' ' A' ' 203' ' ' ILE . 0.2 OUTLIER -69.16 -41.94 76.57 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.373 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.608 HG13 HD13 ' A' ' 195' ' ' LEU . 18.5 mm -64.64 -38.69 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.917 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.15 -44.14 83.14 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.256 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.537 ' CD1' ' HA ' ' A' ' 200' ' ' TYR . 4.1 mt -62.79 -48.82 86.27 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.918 0 CA-C-O 121.739 0.781 . . . . 0.0 109.358 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.503 ' O ' ' HG3' ' A' ' 208' ' ' MET . 87.6 m -54.12 -51.26 64.79 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.121 -178.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.614 ' O ' ' HE3' ' A' ' 209' ' ' LYS . 32.5 mt -65.77 -31.15 71.96 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 120.922 0.392 . . . . 0.0 111.517 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -77.48 -46.07 23.62 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.901 0.858 . . . . 0.0 109.51 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.817 ' O ' HG22 ' A' ' 210' ' ' THR . 6.4 tp -69.91 -30.46 67.88 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.526 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' MET . . . . . 0.789 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 37.9 mtp -76.38 -34.2 58.88 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.584 0.707 . . . . 0.0 109.231 177.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.689 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 2.6 mtmt -60.95 -38.3 85.37 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.346 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.817 HG22 ' O ' ' A' ' 207' ' ' LEU . 4.7 t -60.92 -33.37 73.05 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.161 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.534 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 50.0 m-85 -76.1 -5.94 48.9 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.801 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 109.51 7.33 28.16 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 115.671 1.028 . . . . 0.0 115.671 177.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.8 m -123.62 148.58 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 118.549 1.174 . . . . 0.0 112.799 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.446 ' HG2' ' CG ' ' A' ' 209' ' ' LYS . 6.0 mt-10 -129.9 138.61 51.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.659 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.581 HG23 ' HB ' ' A' ' 225' ' ' VAL . 17.1 mm -122.04 148.64 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.671 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 1.6 tp10 -103.89 117.76 35.09 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.983 0.421 . . . . 0.0 111.905 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -83.02 151.11 25.96 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.525 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . 0.673 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 5.4 mm-40 -109.43 -144.1 0.39 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.72 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.567 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 7.8 t-80 -73.9 65.88 1.1 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.813 0.34 . . . . 0.0 111.492 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 4.1 t80 56.01 35.12 25.0 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.931 0.872 . . . . 0.0 110.785 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.598 ' O ' ' CD1' ' A' ' 223' ' ' PHE . 1.7 pt20 -163.92 -127.45 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.795 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -8.04 134.43 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.714 ' CZ ' HD22 ' A' ' 173' ' ' LEU . 0.6 OUTLIER -125.35 137.32 54.04 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 113.038 -1.892 . . . . 0.0 109.654 -179.234 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.671 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 23.7 t -117.39 114.27 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 187' ' ' THR . 0.5 OUTLIER -122.25 120.71 61.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.804 -179.393 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.488 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -74.59 127.37 32.92 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -80.03 -171.29 42.47 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.236 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 61.51 21.16 59.91 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 121.398 -0.43 . . . . 0.0 113.006 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 23.9 mt-30 -80.63 -173.45 4.15 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.257 0.551 . . . . 0.0 111.158 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 17.2 t -151.94 147.64 26.81 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.934 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' TYR . . . . . 0.744 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 4.7 m-85 -100.74 130.23 46.75 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.452 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.99 146.77 46.34 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.55 111.04 8.88 Favored Pre-proline 0 N--CA 1.447 -0.59 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.383 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.552 ' HD2' ' OG1' ' A' ' 39' ' ' THR . 54.6 Cg_endo -69.6 -0.32 6.61 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 121.942 1.762 . . . . 0.0 112.076 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 99.6 -101.18 2.34 Favored Glycine 0 C--O 1.226 -0.349 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.772 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 90.3 m -119.03 135.55 54.57 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.521 ' CD2' HG23 ' A' ' 210' ' ' THR . 1.5 t80 -131.21 129.73 42.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.906 0.384 . . . . 0.0 111.046 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.53 HD11 ' HG2' ' A' ' 240' ' ' GLU . 0.1 OUTLIER -95.0 110.96 22.81 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.382 179.242 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 21.7 t -82.57 111.91 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.092 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.53 ' HG2' HD11 ' A' ' 238' ' ' LEU . 3.3 mt-10 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.975 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.431 ' CB ' HG22 ' A' ' 50' ' ' VAL . 2.9 m . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.765 0.317 . . . . 0.0 111.383 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 26' ' ' ASN . 2.2 p-10 -38.14 -74.35 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.977 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.728 ' HA ' ' HE1' ' A' ' 178' ' ' MET . 0.0 OUTLIER -63.81 -56.23 17.06 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.277 0.561 . . . . 0.0 110.754 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.613 ' CB ' ' HG ' ' A' ' 41' ' ' LEU . . . -40.5 -47.53 2.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.004 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.54 HD13 ' CD2' ' A' ' 54' ' ' LEU . 12.9 mt -75.76 -35.36 60.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.846 0.355 . . . . 0.0 111.882 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.515 ' HB2' ' HE2' ' A' ' 53' ' ' MET . 50.7 tp -68.92 -49.8 54.94 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.186 0.517 . . . . 0.0 110.674 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.695 ' HB2' ' CE2' ' A' ' 211' ' ' PHE . 27.5 mt -67.91 -27.02 66.28 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.395 179.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.3 -40.27 89.87 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.092 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.556 ' CB ' ' HG ' ' A' ' 57' ' ' LEU . . . -81.1 -41.31 22.71 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.253 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.62 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 16.1 mt -67.94 -4.15 12.14 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.066 178.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.563 ' HB1' ' HB3' ' A' ' 231' ' ' TYR . . . -96.9 176.56 5.93 Favored 'General case' 0 CA--C 1.523 -0.089 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -177.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.547 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.3 OUTLIER -109.84 112.65 24.81 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.636 -1.166 . . . . 0.0 108.941 178.367 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 116.78 166.68 14.35 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.595 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.62 ' HG2' ' HG2' ' A' ' 74' ' ' GLU . 10.6 tttt -95.09 117.81 30.83 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.809 0.304 . . . . 0.0 111.174 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.691 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 0.8 OUTLIER -119.2 148.24 43.32 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-O 120.644 0.259 . . . . 0.0 111.559 -179.462 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.525 HG21 ' CG ' ' A' ' 74' ' ' GLU . 56.8 t -103.67 135.63 40.4 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.668 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.613 ' HG ' ' CB ' ' A' ' 28' ' ' ALA . 0.3 OUTLIER -111.23 115.97 30.25 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 174.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.551 HG21 HD22 ' A' ' 238' ' ' LEU . 0.6 OUTLIER -104.23 149.89 24.89 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.232 -177.93 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.421 ' HB2' HD21 ' A' ' 238' ' ' LEU . 10.4 t-20 69.18 26.01 5.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.268 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.543 HD13 ' HB3' ' A' ' 73' ' ' CYS . 67.5 mt -55.59 -174.87 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.402 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 41.6 tp -111.42 131.68 55.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.594 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -88.83 89.36 7.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.96 0.41 . . . . 0.0 110.312 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -164.02 142.72 7.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.062 -179.104 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.407 ' HA ' ' HB3' ' A' ' 51' ' ' ARG . 0.6 OUTLIER -36.6 -31.25 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.57 0.224 . . . . 0.0 111.342 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.493 ' HB3' ' O ' ' A' ' 94' ' ' ASN . 1.6 p30 -58.7 -42.64 89.07 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.906 0.384 . . . . 0.0 110.712 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.454 ' N ' ' O ' ' A' ' 47' ' ' SER . 82.0 t -81.85 -44.18 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.66 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.543 ' HA ' HD13 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -49.5 -40.07 36.27 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.525 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.658 ' HA ' ' HB2' ' A' ' 55' ' ' ASN . 19.9 m-70 -79.62 -32.29 41.72 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.978 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.515 ' HE2' ' HB2' ' A' ' 30' ' ' LEU . 7.3 tpt -53.74 -35.61 61.41 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 176.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.543 HD13 ' HA ' ' A' ' 51' ' ' ARG . 0.3 OUTLIER -84.03 -45.76 12.74 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 114.317 -1.31 . . . . 0.0 109.028 176.482 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.724 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -57.77 -36.38 72.06 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.776 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 52' ' ' HIS . . . -65.81 -43.05 89.82 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.755 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -65.34 -38.43 90.11 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 176.84 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.724 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.1 m -61.81 -39.67 92.57 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 113.875 -1.511 . . . . 0.0 111.813 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.572 ' CB ' HD12 ' A' ' 90' ' ' LEU . . . -71.07 -37.24 72.46 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.392 -178.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.07 -16.25 55.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.345 0.593 . . . . 0.0 110.429 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.88 35.57 3.96 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.142 -0.935 . . . . 0.0 114.194 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.755 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 25.4 t -90.6 122.37 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.752 ' O ' HG12 ' A' ' 76' ' ' ILE . 12.9 m -85.02 131.88 34.41 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.887 0.375 . . . . 0.0 111.523 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.572 ' HB3' ' CG2' ' A' ' 75' ' ' ILE . 40.1 p90 -158.69 172.23 18.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.535 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 86.5 m -131.59 148.38 52.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.785 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.436 ' CD1' ' HB2' ' A' ' 73' ' ' CYS . 14.6 tp -119.68 134.78 55.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.162 0.506 . . . . 0.0 111.114 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.401 ' CB ' ' HB2' ' A' ' 72' ' ' ARG . 88.1 p -61.71 -169.26 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.001 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.91 -41.7 18.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.311 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.36 1.98 17.25 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.634 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 59.81 30.01 19.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.733 0.302 . . . . 0.0 111.262 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.437 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 2.0 p -119.6 -14.73 9.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.911 0.386 . . . . 0.0 111.217 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 14.7 mtp180 -113.43 119.23 36.88 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.4 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.543 ' HB3' HD13 ' A' ' 44' ' ' LEU . 42.5 t -131.12 126.9 36.94 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.691 ' HA ' ' O ' ' A' ' 39' ' ' THR . 35.9 tt0 -110.98 129.06 56.0 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.6 HG22 ' O ' ' A' ' 63' ' ' SER . 10.7 mt -126.59 123.56 63.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -177.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.752 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -67.69 99.27 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-O 121.571 0.701 . . . . 0.0 109.256 175.672 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -37.77 146.41 0.12 Allowed Glycine 0 C--N 1.32 -0.343 0 CA-C-N 114.53 -1.214 . . . . 0.0 114.05 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.87 -11.21 39.9 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.959 0.409 . . . . 0.0 111.046 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.547 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 89.86 -0.57 79.65 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.258 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.515 ' O ' HD22 ' A' ' 34' ' ' LEU . . . 152.81 -148.36 19.11 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.902 -0.665 . . . . 0.0 112.143 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.54 ' HG3' ' HB3' ' A' ' 108' ' ' LEU . 77.7 Cg_exo -49.36 127.98 19.23 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.788 2.325 . . . . 0.0 112.704 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.456 HD21 HD22 ' A' ' 34' ' ' LEU . 0.9 OUTLIER -78.23 105.64 9.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.901 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -82.13 128.1 33.79 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.055 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.547 ' HB1' HD11 ' A' ' 113' ' ' ILE . . . -92.44 126.44 37.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.041 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.97 123.89 23.08 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 176.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.85 172.88 0.91 Allowed Glycine 0 N--CA 1.438 -1.185 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 -175.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.34 144.88 46.33 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 118.469 1.135 . . . . 0.0 111.762 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.51 HD22 ' CB ' ' A' ' 59' ' ' ALA . 1.2 tp -113.71 160.54 18.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.047 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 10.9 mt-10 -139.75 102.13 4.36 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.958 178.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.622 ' HB2' HD22 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -101.56 130.01 47.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.955 0.407 . . . . 0.0 111.346 -178.736 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.449 ' CE1' ' HB ' ' A' ' 116' ' ' THR . 16.5 m-85 -101.03 96.77 7.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.608 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 99' ' ' MET . 0.0 OUTLIER -110.34 51.22 0.77 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.814 -179.596 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.72 ' HA3' ' H ' ' A' ' 118' ' ' GLU . . . -58.26 -61.16 7.73 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.817 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.493 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 17.9 m-80 -76.97 -3.16 37.49 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.111 -0.235 . . . . 0.0 110.585 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.471 ' HB2' ' HB3' ' A' ' 92' ' ' LEU . . . -94.47 56.3 2.09 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.915 0.388 . . . . 0.0 111.338 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -56.75 -29.99 59.06 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.468 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.505 ' HA ' ' HG2' ' A' ' 171' ' ' GLN . 6.1 p -93.84 -6.54 45.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.682 -0.259 . . . . 0.0 111.421 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 102' ' ' LEU . . . -101.63 -37.85 8.18 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.836 0.351 . . . . 0.0 111.185 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.507 ' HB2' ' HB2' ' A' ' 92' ' ' LEU . 3.0 tpp -61.72 -45.58 93.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.339 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.465 ' NH2' ' HD3' ' A' ' 124' ' ' ARG . 0.1 OUTLIER -53.63 -60.5 6.99 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.227 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.479 ' HG3' ' O ' ' A' ' 97' ' ' THR . 18.5 Cg_endo -60.77 -33.16 93.33 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.477 2.118 . . . . 0.0 112.86 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.475 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 0.2 OUTLIER -71.56 -53.13 14.8 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.836 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.496 ' O ' HD12 ' A' ' 153' ' ' LEU . . . -51.38 -28.52 12.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.177 0.513 . . . . 0.0 110.311 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.496 ' HB2' ' HB1' ' A' ' 175' ' ' ALA . . . -86.6 -52.52 5.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.599 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.51 -34.09 73.59 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 102' ' ' LEU . 37.3 mt -78.68 -15.6 58.29 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -176.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.605 ' HB3' ' HB2' ' A' ' 138' ' ' ALA . 90.3 m -87.84 22.8 2.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.322 0.582 . . . . 0.0 110.433 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.54 ' HB3' ' HG3' ' A' ' 81' ' ' PRO . 2.0 mt -87.16 -75.04 0.42 Allowed 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.545 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.63 -113.6 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.235 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.07 96.4 2.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.049 0.452 . . . . 0.0 110.762 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.583 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 0.1 OUTLIER -148.25 140.91 24.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.53 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.862 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 3.4 m-20 -94.21 102.49 14.52 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.831 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.547 HD11 ' HB1' ' A' ' 84' ' ' ALA . 20.7 mm -121.35 140.92 43.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.556 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.868 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 61.8 t -111.71 112.37 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 175.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.622 HD22 ' HB2' ' A' ' 90' ' ' LEU . 74.6 mt -102.17 105.85 16.61 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.492 -178.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.449 ' HB ' ' CE1' ' A' ' 91' ' ' PHE . 0.2 OUTLIER -114.66 -170.48 1.75 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.322 -178.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.531 ' HA3' ' HG2' ' A' ' 121' ' ' MET . . . -171.4 175.15 45.01 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.629 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.723 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 36.6 mm-40 -68.9 169.41 11.31 Favored Pre-proline 0 CA--C 1.531 0.227 0 C-N-CA 123.214 0.605 . . . . 0.0 111.339 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.723 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 2.8 Cg_endo -44.35 -40.82 13.38 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.192 2.595 . . . . 0.0 113.196 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.44 -23.73 65.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.679 0.276 . . . . 0.0 110.722 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.569 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 9.1 tpt -62.2 -35.13 77.94 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -16.85 54.35 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.59 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.01 1.59 52.33 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.859 0.362 . . . . 0.0 110.333 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.465 ' HD3' ' NH2' ' A' ' 100' ' ' ARG . 55.6 mtt-85 -127.03 84.22 64.04 Favored Pre-proline 0 CA--C 1.529 0.161 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.57 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -56.49 148.57 62.31 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.715 2.277 . . . . 0.0 111.755 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.405 HG12 HD11 ' A' ' 151' ' ' LEU . 0.8 OUTLIER -124.17 8.43 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.27 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.559 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -61.61 -36.54 92.79 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.061 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.412 ' CD2' HG23 ' A' ' 168' ' ' VAL . 0.2 OUTLIER -57.19 -40.08 76.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.74 0.27 . . . . 0.0 110.67 -179.801 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.558 ' HG ' ' CD1' ' A' ' 133' ' ' LEU . 14.1 tp -75.37 -41.39 56.56 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.425 0.631 . . . . 0.0 110.023 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.87 HG22 HD21 ' A' ' 151' ' ' LEU . 39.8 t -56.42 -47.74 81.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.579 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.785 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 4.7 m-20 -72.08 -31.81 66.43 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.422 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.441 ' HB1' ' CG1' ' A' ' 162' ' ' VAL . . . -64.1 -49.81 70.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.449 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.558 ' CD1' ' HG ' ' A' ' 129' ' ' LEU . 7.7 mt -71.65 -48.93 44.45 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.845 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.783 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -57.85 -27.77 63.51 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.651 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.785 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 1.5 tp -67.19 -33.45 75.42 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.466 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.494 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -81.81 12.73 40.41 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.966 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.34 3.34 60.06 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.325 -0.941 . . . . 0.0 112.749 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.605 ' HB2' ' HB3' ' A' ' 107' ' ' CYS . . . -71.59 149.43 45.65 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.882 0.341 . . . . 0.0 111.234 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 21.6 mttm -97.78 103.24 15.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.149 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.504 ' HB ' ' HG3' ' A' ' 134' ' ' ARG . 21.0 mt -134.02 126.89 50.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.309 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.63 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -123.51 139.71 53.74 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.925 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.416 ' HE1' HG23 ' A' ' 130' ' ' VAL . 43.4 m-85 -81.41 132.62 35.33 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.409 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.708 ' HB2' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -90.17 -82.26 0.28 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.297 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.794 ' HG3' ' H ' ' A' ' 145' ' ' GLN . 11.2 pt-20 -63.5 -78.2 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.926 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.794 ' H ' ' HG3' ' A' ' 144' ' ' GLU . 1.5 mt-30 -121.38 154.19 36.81 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 6.8 mt-10 -64.48 135.6 56.22 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.074 0.464 . . . . 0.0 111.285 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.559 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 9.2 m-20 71.83 18.73 5.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.086 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.52 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 18.6 m-85 -107.77 167.12 9.79 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.863 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 51.3 Cg_exo -35.69 -63.3 0.2 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 124.159 3.239 . . . . 0.0 116.07 -177.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.863 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 71.5 Cg_exo -50.72 145.6 22.86 Favored 'Trans proline' 0 C--N 1.355 0.885 0 CA-C-N 120.773 1.312 . . . . 0.0 112.393 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.87 HD21 HG22 ' A' ' 130' ' ' VAL . 8.5 mt -155.89 137.04 13.76 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.846 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.694 ' HG3' HD12 ' A' ' 143' ' ' LEU . 0.2 OUTLIER -106.78 101.59 11.02 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 177.411 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.862 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 6.6 mt -91.46 145.61 24.48 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.023 -178.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.583 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 3.0 mt-30 -147.79 29.27 0.92 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.691 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 51.37 -170.3 0.34 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.222 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 114.83 -12.09 20.54 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.086 -1.054 . . . . 0.0 113.369 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.634 ' HE2' ' HA ' ' A' ' 180' ' ' ALA . 54.4 t80 -58.82 122.82 14.52 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 117.51 0.655 . . . . 0.0 110.595 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.751 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 43.3 p -113.12 -38.37 4.48 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 121.668 0.747 . . . . 0.0 111.243 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 139.04 -165.03 25.76 Favored Glycine 0 C--N 1.306 -1.089 0 CA-C-N 114.526 -1.216 . . . . 0.0 112.304 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.476 ' O ' HG22 ' A' ' 162' ' ' VAL . . . 109.48 155.59 16.2 Favored Glycine 0 N--CA 1.437 -1.298 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.882 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -46.94 115.48 1.08 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.216 -0.492 . . . . 0.0 111.333 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 72.1 t -108.02 137.71 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -107.09 119.77 40.29 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.256 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 191' ' ' ILE . 1.0 OUTLIER -132.09 120.43 43.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.113 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.644 ' HB3' ' CG2' ' A' ' 168' ' ' VAL . 23.0 t0 -55.58 138.51 46.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.933 0.396 . . . . 0.0 111.141 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.562 ' CA ' HG23 ' A' ' 191' ' ' ILE . . . -67.55 -31.03 75.53 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.204 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.2 t -97.81 64.29 1.74 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.98 0.419 . . . . 0.0 110.856 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.644 ' CG2' ' HB3' ' A' ' 165' ' ' ASP . 22.3 t -125.93 -111.75 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.78 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.486 ' HB2' ' CD1' ' A' ' 172' ' ' PHE . 0.5 OUTLIER -134.5 134.08 41.08 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.97 0.414 . . . . 0.0 109.985 179.521 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.587 ' HB2' ' HB3' ' A' ' 200' ' ' TYR . 0.1 OUTLIER -55.69 -17.28 5.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.762 -179.531 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.589 ' HA ' ' HB ' ' A' ' 174' ' ' THR . 0.5 OUTLIER -92.7 -13.85 28.83 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.443 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.486 ' CD1' ' HB2' ' A' ' 169' ' ' SER . 5.9 m-85 -66.73 -54.36 23.78 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.533 HD21 ' CE1' ' A' ' 223' ' ' PHE . 0.2 OUTLIER -64.95 -45.91 83.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.921 178.675 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.589 ' HB ' ' HA ' ' A' ' 171' ' ' GLN . 1.1 m -55.1 -33.01 62.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.969 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.496 ' HB1' ' HB2' ' A' ' 104' ' ' ALA . . . -66.39 -41.61 89.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.329 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.457 HD22 ' CD2' ' A' ' 133' ' ' LEU . 0.2 OUTLIER -76.71 -32.51 57.88 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.545 179.361 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.695 ' O ' ' HE1' ' A' ' 208' ' ' MET . 2.7 mp -59.89 -39.35 85.02 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.142 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.728 ' HE1' ' HA ' ' A' ' 27' ' ' ARG . 0.7 OUTLIER -82.16 -41.43 20.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.351 0.596 . . . . 0.0 111.912 179.751 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 100.0 m -71.06 -42.07 69.9 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.644 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.634 ' HA ' ' HE2' ' A' ' 157' ' ' PHE . . . -59.08 -40.37 80.93 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -176.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 38.1 Cg_endo -66.76 -28.78 43.34 Favored 'Trans proline' 0 CA--C 1.498 -1.292 0 C-N-CA 120.787 0.992 . . . . 0.0 112.06 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.501 ' HB2' ' CD2' ' A' ' 108' ' ' LEU . 5.3 mt -84.67 1.5 46.0 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.626 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . -82.86 139.46 43.19 Favored Pre-proline 0 C--O 1.223 -0.298 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.226 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.751 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 11.6 Cg_endo -52.03 -33.37 52.54 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.206 1.938 . . . . 0.0 112.782 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.53 143.05 45.6 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.582 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -58.54 145.27 39.81 Favored 'General case' 0 N--CA 1.46 0.074 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.453 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.615 ' HB ' ' HB2' ' A' ' 180' ' ' ALA . 65.9 m -122.14 144.42 48.95 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 25.2 t -122.45 117.81 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.069 176.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.7 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 2.7 mp -101.53 117.63 47.11 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.738 ' HG3' ' HG3' ' A' ' 222' ' ' GLN . 0.1 OUTLIER -99.4 122.49 42.58 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.4 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.562 HG23 ' CA ' ' A' ' 166' ' ' GLY . 1.6 mp -93.47 119.72 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.954 -175.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.429 ' HE3' ' CA ' ' A' ' 165' ' ' ASP . 0.7 OUTLIER -75.14 96.63 3.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.769 -179.468 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 95.47 -134.11 11.78 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.265 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -117.09 137.27 52.39 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.478 HD21 HG13 ' A' ' 201' ' ' ILE . 8.9 mt -40.81 147.03 0.13 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.184 0.516 . . . . 0.0 111.124 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.66 -21.07 25.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.896 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.821 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 26.7 t -138.55 -67.43 0.46 Allowed 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.249 178.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.553 ' HB3' ' O ' ' A' ' 197' ' ' SER . 8.0 tmtt? 96.82 -56.57 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 114.656 -1.157 . . . . 0.0 111.177 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.821 ' HD2' ' C ' ' A' ' 197' ' ' SER . 18.3 Cg_endo -62.71 -25.7 75.09 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 120.868 1.045 . . . . 0.0 110.021 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.587 ' HB3' ' HB2' ' A' ' 170' ' ' SER . 0.2 OUTLIER -67.48 -48.2 67.83 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.784 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.478 HG13 HD21 ' A' ' 195' ' ' LEU . 15.6 mm -63.28 -35.09 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.443 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.15 -42.86 99.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.102 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.571 ' CD1' ' HA ' ' A' ' 200' ' ' TYR . 4.5 mt -60.36 -50.78 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.493 ' O ' ' HG3' ' A' ' 208' ' ' MET . 45.8 m -53.47 -51.85 61.37 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.107 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.574 ' O ' ' HD3' ' A' ' 209' ' ' LYS . 36.8 mt -65.54 -30.62 71.39 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.38 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . 0.414 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 2.6 m-80 -77.86 -46.3 21.82 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.772 0.796 . . . . 0.0 109.956 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.568 ' HB3' ' O ' ' A' ' 203' ' ' ILE . 0.8 OUTLIER -68.76 -29.77 68.22 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.211 178.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' MET . . . . . 0.695 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 37.0 mtp -69.95 -33.23 71.84 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.655 178.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.598 ' HE2' ' HA ' ' A' ' 214' ' ' GLU . 6.7 mmtp -57.54 -38.6 74.98 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.813 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.407 HG21 ' HG3' ' A' ' 234' ' ' PRO . 1.0 OUTLIER -60.6 -27.25 67.59 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.645 -178.523 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.695 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 76.9 m-85 -85.19 -8.88 58.38 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.541 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.1 9.38 24.23 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 115.658 1.023 . . . . 0.0 115.658 177.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.479 HG22 ' HE2' ' A' ' 208' ' ' MET . 4.2 m -124.18 148.84 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 118.683 1.242 . . . . 0.0 112.133 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.598 ' HA ' ' HE2' ' A' ' 209' ' ' LYS . 22.5 mt-10 -129.74 141.75 50.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.149 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.533 HG22 ' HB ' ' A' ' 225' ' ' VAL . 24.7 mm -123.5 148.45 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-O 120.89 0.376 . . . . 0.0 110.552 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.58 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 40.2 tt0 -104.74 116.44 32.03 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.726 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -82.49 150.18 27.15 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . 0.617 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.2 OUTLIER -110.16 -148.05 0.42 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.606 0.241 . . . . 0.0 110.909 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.531 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 4.0 t-160 -67.83 63.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.453 ' CE1' ' HG3' ' A' ' 198' ' ' LYS . 6.3 t80 58.87 33.88 23.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.902 0.858 . . . . 0.0 110.867 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.621 ' O ' ' O ' ' A' ' 222' ' ' GLN . 12.2 pt20 -164.69 -124.63 0.02 OUTLIER 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.738 ' HG3' ' HG3' ' A' ' 190' ' ' ARG . 0.5 OUTLIER -3.97 132.37 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 179.495 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.647 ' O ' ' HA ' ' A' ' 188' ' ' VAL . 3.2 m-85 -126.55 129.89 49.48 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.432 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.58 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 41.6 t -114.17 113.68 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 121.588 0.708 . . . . 0.0 109.739 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.533 ' HB ' HG22 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -123.15 125.51 72.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.095 -179.028 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 181' ' ' PRO . 0.0 OUTLIER -76.62 141.52 41.02 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.838 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -91.18 -178.21 43.15 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.457 -178.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 66.47 20.22 69.53 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 121.54 -0.362 . . . . 0.0 113.081 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . 0.496 ' NE2' ' HB3' ' A' ' 181' ' ' PRO . 47.7 mt-30 -77.79 -173.77 3.2 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.19 0.519 . . . . 0.0 110.896 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.14 147.57 24.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.543 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' TYR . . . . . 0.62 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 5.5 m-85 -99.26 133.81 43.02 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.056 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -120.76 148.84 43.44 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.429 ' CA ' ' HG1' ' A' ' 39' ' ' THR . 84.1 p -76.54 111.43 15.72 Favored Pre-proline 0 N--CA 1.446 -0.636 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.834 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.41 ' HD2' ' HG1' ' A' ' 39' ' ' THR . 46.7 Cg_endo -68.3 -2.38 8.91 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.947 1.765 . . . . 0.0 112.422 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 96.34 -84.0 0.82 Allowed Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.29 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 93.5 m -130.56 127.13 38.45 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -130.33 134.47 47.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.995 0.426 . . . . 0.0 111.373 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.551 HD22 HG21 ' A' ' 42' ' ' THR . 0.1 OUTLIER -97.94 110.73 23.25 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.687 179.846 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 20.1 t -81.65 112.77 20.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.11 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.517 ' HG3' HD11 ' A' ' 238' ' ' LEU . 10.3 mt-10 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.347 -0.835 . . . . 0.0 111.129 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 58.7 p . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 120.823 0.344 . . . . 0.0 111.348 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.426 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 46.9 m-80 67.57 -79.0 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.545 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.59 ' HA ' ' HE1' ' A' ' 178' ' ' MET . 77.3 mtm-85 -70.17 -58.22 4.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.046 0.45 . . . . 0.0 110.879 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.576 ' CB ' ' HG ' ' A' ' 41' ' ' LEU . . . -46.07 -42.38 13.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.763 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.498 HD13 ' CD2' ' A' ' 54' ' ' LEU . 10.6 mt -71.1 -34.56 71.22 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 120.983 0.42 . . . . 0.0 110.833 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.415 ' CD2' ' HB2' ' A' ' 101' ' ' PRO . 53.3 tp -68.9 -49.74 55.63 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.377 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.566 ' HB2' ' CE2' ' A' ' 211' ' ' PHE . 34.1 mt -67.28 -27.13 66.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.521 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.77 -39.03 90.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.056 178.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.593 ' CB ' ' HG ' ' A' ' 57' ' ' LEU . . . -81.32 -41.39 22.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.615 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.501 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 21.9 mt -69.05 -3.36 12.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.286 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.562 ' HB1' ' HB3' ' A' ' 231' ' ' TYR . . . -96.81 176.1 6.11 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.504 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.1 OUTLIER -112.18 113.4 25.63 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.596 178.247 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 115.59 167.99 15.29 Favored Glycine 0 C--N 1.32 -0.323 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -178.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.496 ' HG3' HG22 ' A' ' 76' ' ' ILE . 1.0 OUTLIER -95.3 117.78 30.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 117.32 0.56 . . . . 0.0 111.443 -179.371 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.503 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.9 OUTLIER -119.6 145.84 46.06 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.22 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.566 HG22 ' CG ' ' A' ' 74' ' ' GLU . 96.6 t -104.91 139.08 26.96 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.584 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 0.4 OUTLIER -114.77 116.1 28.1 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 174.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.622 HG23 HD21 ' A' ' 238' ' ' LEU . 0.6 OUTLIER -105.06 152.3 22.92 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.078 -178.29 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 36.9 t30 68.99 25.44 5.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.724 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.455 HD12 ' HB3' ' A' ' 73' ' ' CYS . 16.0 mt -55.32 -169.97 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.407 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 32.9 tp -112.46 131.9 55.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.596 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -89.05 85.92 6.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.021 0.439 . . . . 0.0 110.55 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.46 ' O ' ' N ' ' A' ' 50' ' ' VAL . 1.0 OUTLIER -164.25 142.88 7.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.926 -179.479 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 47' ' ' SER . 0.5 OUTLIER -33.07 -34.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.764 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.491 ' CB ' ' HA ' ' A' ' 95' ' ' ALA . 3.1 p30 -55.33 -42.59 73.97 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.043 0.449 . . . . 0.0 110.836 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.46 ' N ' ' O ' ' A' ' 47' ' ' SER . 78.5 t -84.63 -44.51 17.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.013 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.613 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -50.68 -39.77 51.93 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.653 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.656 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 18.9 m-70 -80.9 -32.42 34.79 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.888 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.556 ' O ' HD13 ' A' ' 57' ' ' LEU . 9.0 tpt -53.5 -34.74 59.17 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 176.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.636 ' HB3' ' CE2' ' A' ' 64' ' ' TYR . 0.4 OUTLIER -83.49 -43.04 16.21 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.648 176.465 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.742 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 67.0 t30 -56.73 -42.11 78.67 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-O 121.05 0.452 . . . . 0.0 110.131 179.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.474 ' HB1' HD13 ' A' ' 102' ' ' LEU . . . -57.11 -49.06 77.07 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.812 0.815 . . . . 0.0 108.956 178.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.757 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -61.8 -37.83 85.87 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.006 -1.452 . . . . 0.0 107.871 177.066 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.742 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -63.8 -35.02 79.24 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.877 179.271 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.436 ' O ' HD22 ' A' ' 88' ' ' LEU . . . -73.52 -37.59 65.6 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.356 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -82.24 -13.13 57.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.255 0.55 . . . . 0.0 110.893 -179.622 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.58 35.76 4.81 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.38 -0.827 . . . . 0.0 114.137 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.757 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 37.2 t -90.51 124.34 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.78 ' O ' HG12 ' A' ' 76' ' ' ILE . 4.3 m -85.96 130.8 34.43 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.499 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.636 ' CE2' ' HB3' ' A' ' 54' ' ' LEU . 38.4 p90 -157.64 171.68 19.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.84 0.352 . . . . 0.0 110.622 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 74' ' ' GLU . 99.7 m -138.1 149.16 45.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.305 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.472 ' CD1' ' HB2' ' A' ' 73' ' ' CYS . 7.3 tp -117.76 137.34 52.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.968 0.413 . . . . 0.0 110.756 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.7 p -59.93 179.91 0.12 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.989 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.79 -28.32 40.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.88 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -80.29 -0.11 35.16 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.247 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 55.89 48.73 17.4 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.797 0.332 . . . . 0.0 111.197 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -153.4 0.63 0.25 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.277 -0.419 . . . . 0.0 112.081 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.584 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.5 OUTLIER -129.48 110.97 12.3 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.472 ' HB2' ' CD1' ' A' ' 66' ' ' LEU . 42.9 t -118.37 132.34 56.27 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.566 ' CG ' HG22 ' A' ' 40' ' ' VAL . 43.4 tt0 -111.76 133.13 54.19 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.572 HG12 ' CB ' ' A' ' 64' ' ' TYR . 11.3 mt -130.46 122.97 54.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -178.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.78 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -67.75 100.93 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.763 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -39.27 144.17 0.33 Allowed Glycine 0 C--N 1.319 -0.39 0 CA-C-N 114.717 -1.128 . . . . 0.0 113.844 -178.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -88.86 -11.36 44.91 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.003 0.43 . . . . 0.0 110.861 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.504 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 85.86 15.61 65.03 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.217 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.436 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 139.55 -150.34 21.31 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.326 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.507 ' HB3' ' CB ' ' A' ' 108' ' ' LEU . 4.2 Cg_endo -49.2 123.55 10.27 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.71 2.274 . . . . 0.0 113.13 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.456 ' HB2' HD11 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -72.24 108.54 5.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.139 179.198 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.404 ' HA ' ' CG ' ' A' ' 111' ' ' ASN . 4.4 p80 -81.87 131.88 35.26 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.413 ' HB2' ' CD2' ' A' ' 88' ' ' LEU . . . -96.0 120.45 36.3 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.669 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -70.96 123.94 23.2 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.46 173.87 1.39 Allowed Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 -175.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.03 144.75 47.04 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 118.616 1.208 . . . . 0.0 111.816 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.551 ' CB ' HG13 ' A' ' 113' ' ' ILE . 0.7 OUTLIER -112.52 161.03 17.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.198 -178.536 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 32.6 mt-10 -142.05 101.39 3.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.136 177.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.47 ' N ' ' O ' ' A' ' 114' ' ' VAL . 0.0 OUTLIER -100.2 125.79 46.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.314 -178.622 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -98.37 96.44 8.03 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.688 HD21 HD23 ' A' ' 115' ' ' LEU . 0.1 OUTLIER -105.18 48.25 0.84 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.472 -179.479 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.58 ' HA3' ' H ' ' A' ' 118' ' ' GLU . . . -53.6 -66.0 3.04 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.65 -0.705 . . . . 0.0 113.247 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.462 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 23.0 m-80 -76.27 -0.98 24.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.559 0.218 . . . . 0.0 110.913 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.491 ' HA ' ' CB ' ' A' ' 49' ' ' ASP . . . -91.86 68.73 5.45 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.989 0.423 . . . . 0.0 111.307 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.07 -24.38 71.74 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.76 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.409 ' O ' ' HG3' ' A' ' 101' ' ' PRO . 0.6 OUTLIER -106.54 4.79 28.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.463 0.173 . . . . 0.0 111.167 179.595 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.411 ' O ' ' HG2' ' A' ' 101' ' ' PRO . . . -107.26 -40.82 5.29 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.875 0.369 . . . . 0.0 111.503 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.44 ' HB2' ' HB2' ' A' ' 92' ' ' LEU . 6.3 tpp -59.96 -46.31 89.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.609 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.486 ' HB2' ' HB2' ' A' ' 171' ' ' GLN . 5.3 mpt_? -53.72 -60.24 7.69 Favored Pre-proline 0 C--N 1.323 -0.571 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.006 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 100' ' ' ARG . 11.7 Cg_endo -59.24 -34.38 98.14 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 121.958 1.772 . . . . 0.0 112.409 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.479 ' HA ' HD23 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -71.31 -53.25 14.88 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.025 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.514 ' HA ' HD12 ' A' ' 115' ' ' LEU . . . -51.29 -28.34 11.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.534 178.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.498 ' CB ' HD21 ' A' ' 133' ' ' LEU . . . -86.75 -53.65 4.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.357 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.32 -37.47 80.69 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -177.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 102' ' ' LEU . 25.8 mt -75.24 -11.62 60.11 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.215 -177.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.578 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 21.9 m -83.23 17.76 1.95 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.185 0.517 . . . . 0.0 110.247 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.507 ' CB ' ' HB3' ' A' ' 81' ' ' PRO . 2.6 mt -95.92 -68.36 0.8 Allowed 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.365 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.07 151.96 27.83 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.669 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 m -66.54 98.29 0.49 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.982 0.42 . . . . 0.0 110.855 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.673 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 5.8 m-80 -148.53 137.44 21.62 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.103 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.798 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 1.7 m-20 -95.29 100.28 12.09 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.191 0.52 . . . . 0.0 109.926 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.551 HG13 ' CB ' ' A' ' 88' ' ' LEU . 1.6 mp -118.38 148.37 21.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.903 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.767 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 43.9 t -118.0 112.58 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 176.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.688 HD23 HD21 ' A' ' 92' ' ' LEU . 24.0 mt -102.36 105.58 16.22 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.905 -178.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.42 -170.39 1.8 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.802 0.334 . . . . 0.0 111.206 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.556 ' HA3' ' HG2' ' A' ' 121' ' ' MET . . . -168.32 172.58 42.94 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.006 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.596 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 18.1 mt-10 -68.85 176.36 1.55 Allowed Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 122.639 0.375 . . . . 0.0 110.903 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.596 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 81.7 Cg_exo -47.78 -41.06 31.89 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.759 2.306 . . . . 0.0 113.581 -179.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -67.37 -23.15 65.56 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.661 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.556 ' HG2' ' HA3' ' A' ' 117' ' ' GLY . 10.5 tpt -61.84 -35.19 77.55 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.462 ' HA ' ' HG2' ' A' ' 149' ' ' PRO . 3.4 mmtp -61.64 -16.78 51.56 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.673 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -86.34 3.48 43.28 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 120.827 0.346 . . . . 0.0 110.289 178.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.419 ' HB3' ' NH2' ' A' ' 100' ' ' ARG . 3.5 mtt180 -127.3 81.18 70.5 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.075 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.408 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 14.8 Cg_endo -56.9 149.21 62.56 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.937 2.425 . . . . 0.0 112.032 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.441 HG12 HD11 ' A' ' 151' ' ' LEU . 0.7 OUTLIER -124.14 17.67 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.349 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.415 ' HA3' ' CB ' ' A' ' 147' ' ' ASN . . . -61.29 -46.16 95.0 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.927 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.604 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 37.6 m80 -56.87 -35.53 69.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.982 0.391 . . . . 0.0 111.322 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.572 ' HG ' ' CD1' ' A' ' 133' ' ' LEU . 15.4 tp -75.79 -47.71 24.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.927 0.394 . . . . 0.0 111.318 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.694 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 51.9 t -56.25 -47.43 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.395 -178.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.657 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 82.8 m-20 -68.81 -39.8 79.86 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.031 0.443 . . . . 0.0 110.12 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.426 ' HB2' ' CG1' ' A' ' 162' ' ' VAL . . . -59.4 -45.24 92.06 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.012 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.572 ' CD1' ' HG ' ' A' ' 129' ' ' LEU . 10.7 mt -75.15 -48.42 23.74 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.446 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.694 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -58.65 -28.37 65.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.959 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.657 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 5.8 tp -68.3 -32.57 72.81 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.278 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 159' ' ' GLY . . . -79.35 9.96 38.5 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.153 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.39 6.64 57.48 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.329 -0.939 . . . . 0.0 112.755 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.48 151.97 39.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.882 0.372 . . . . 0.0 111.146 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.433 ' CB ' ' HB2' ' A' ' 154' ' ' GLN . 9.9 mmmt -99.22 100.14 11.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.687 178.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.656 ' HB ' ' HG3' ' A' ' 134' ' ' ARG . 28.5 mt -131.68 127.44 59.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.477 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.734 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -125.14 139.03 54.12 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.004 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -78.54 133.48 37.36 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.847 0.356 . . . . 0.0 110.955 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.818 ' HB2' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -94.02 -87.84 0.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.734 -179.55 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.491 ' HB2' ' CG ' ' A' ' 150' ' ' PRO . 2.5 mm-40 -59.36 -81.99 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.34 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.42 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 35.0 mt-30 -115.14 154.45 28.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.112 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 5.0 mt-10 -67.66 131.96 46.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.31 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 146' ' ' GLU . 1.1 m-20 70.57 19.41 6.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.954 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.548 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 13.2 m-85 -109.72 168.63 7.41 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.61 ' HB2' ' CD ' ' A' ' 150' ' ' PRO . 10.5 Cg_exo -30.91 -62.1 0.12 Allowed 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 125.264 3.976 . . . . 0.0 117.477 -177.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.818 ' HB2' ' HB2' ' A' ' 143' ' ' LEU . 26.3 Cg_endo -62.24 150.17 87.93 Favored 'Trans proline' 0 C--N 1.351 0.677 0 CA-C-N 120.655 1.27 . . . . 0.0 112.117 -177.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.767 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 7.6 mt -155.64 138.63 15.43 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.866 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.734 ' HB2' HG22 ' A' ' 141' ' ' THR . 0.7 OUTLIER -104.71 104.31 14.09 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 176.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.798 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 4.1 mt -95.6 141.54 28.99 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.817 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.673 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 2.8 mt-30 -145.47 31.1 1.09 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.665 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 48.18 -158.02 0.84 Allowed Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.323 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.44 -11.08 46.95 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.264 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.442 ' CB ' ' O ' ' A' ' 107' ' ' CYS . 31.6 t80 -59.77 122.93 15.41 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 117.467 0.634 . . . . 0.0 110.367 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.719 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 70.0 p -115.96 -35.53 4.41 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 121.54 0.686 . . . . 0.0 111.182 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.435 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 140.21 -160.76 26.4 Favored Glycine 0 C--N 1.307 -1.049 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.085 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 105.88 152.64 20.43 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.545 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -47.02 123.03 4.85 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.084 -0.558 . . . . 0.0 110.597 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 42.7 t -116.06 146.39 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.123 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -113.27 120.16 40.22 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.117 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 191' ' ' ILE . 1.0 OUTLIER -133.95 119.92 33.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.465 ' HB2' ' HD2' ' A' ' 128' ' ' HIS . 0.8 OUTLIER -56.47 141.18 43.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.929 0.395 . . . . 0.0 111.041 -179.223 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.513 ' CA ' HG21 ' A' ' 191' ' ' ILE . . . -57.32 -51.36 58.1 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.595 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 18.6 p -97.56 111.32 23.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.615 0.245 . . . . 0.0 111.268 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.451 HG21 ' CG ' ' A' ' 128' ' ' HIS . 14.2 p -175.21 -35.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 179.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.506 ' HB2' ' CD1' ' A' ' 172' ' ' PHE . 0.4 OUTLIER 162.69 128.5 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.245 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.61 -17.4 64.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.572 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.486 ' HB2' ' HB2' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -86.26 -11.86 51.16 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.005 -179.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.604 ' CE2' ' HB2' ' A' ' 128' ' ' HIS . 5.9 m-85 -71.3 -56.77 5.35 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.635 HD13 ' CG1' ' A' ' 191' ' ' ILE . 0.5 OUTLIER -62.81 -44.43 96.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.39 178.741 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.47 ' HB ' ' HA ' ' A' ' 171' ' ' GLN . 2.5 m -54.82 -33.19 61.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.826 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.423 ' CB ' ' HB3' ' A' ' 104' ' ' ALA . . . -68.32 -39.3 82.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.242 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.402 HD21 HD22 ' A' ' 133' ' ' LEU . 0.7 OUTLIER -76.58 -35.45 58.16 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.839 179.753 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.76 ' O ' ' HE1' ' A' ' 208' ' ' MET . 3.8 mp -59.82 -37.85 80.37 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.191 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.59 ' HE1' ' HA ' ' A' ' 27' ' ' ARG . 2.6 mtp -81.68 -43.15 18.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.338 0.59 . . . . 0.0 112.086 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 95.9 m -72.01 -42.4 66.43 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.105 -178.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.611 ' HB3' ' HB ' ' A' ' 187' ' ' THR . . . -58.71 -41.44 88.86 Favored Pre-proline 0 C--N 1.32 -0.716 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -176.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 28.5 Cg_endo -64.43 -28.54 62.53 Favored 'Trans proline' 0 CA--C 1.501 -1.167 0 C-N-CA 120.831 1.02 . . . . 0.0 112.128 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.433 ' HB2' ' CD2' ' A' ' 108' ' ' LEU . 5.6 mt -84.26 0.83 47.43 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.51 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 228' ' ' GLY . . . -83.51 137.71 41.71 Favored Pre-proline 0 C--O 1.224 -0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.396 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.719 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 11.4 Cg_endo -51.34 -34.31 49.47 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.688 2.258 . . . . 0.0 113.404 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.81 140.2 46.66 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.733 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -55.16 143.69 26.62 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.046 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.611 ' HB ' ' HB3' ' A' ' 180' ' ' ALA . 92.0 m -123.6 148.23 46.6 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.687 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 40.3 t -128.7 118.27 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.878 177.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.696 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 5.0 mp -99.09 119.09 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.568 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 2.4 ttt180 -100.74 125.46 47.2 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.635 ' CG1' HD13 ' A' ' 173' ' ' LEU . 1.5 mp -93.37 127.33 45.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.867 -176.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -82.65 96.67 8.19 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.231 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 98.66 -127.55 9.28 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.708 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -116.66 133.54 55.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.708 0.29 . . . . 0.0 111.471 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.466 HD13 HG13 ' A' ' 201' ' ' ILE . 1.1 mt -41.62 144.13 0.42 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.166 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.446 ' HB ' ' O ' ' A' ' 166' ' ' GLY . 12.4 p -72.87 -25.03 21.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.637 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.542 ' C ' ' CD ' ' A' ' 199' ' ' PRO . 0.4 OUTLIER -170.78 68.63 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.096 0.474 . . . . 0.0 110.235 -179.575 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.723 ' HG3' ' HD3' ' A' ' 199' ' ' PRO . 0.0 OUTLIER -48.17 -29.37 1.4 Allowed Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.344 179.712 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.723 ' HD3' ' HG3' ' A' ' 198' ' ' LYS . 23.3 Cg_exo -64.78 -28.9 59.41 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 121.094 1.196 . . . . 0.0 110.724 178.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.543 ' HA ' ' CD1' ' A' ' 203' ' ' ILE . 0.1 OUTLIER -69.79 -42.3 73.93 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 177.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.466 HG13 HD13 ' A' ' 195' ' ' LEU . 11.9 mm -60.15 -39.61 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.255 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -58.07 -44.86 87.74 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.327 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.543 ' CD1' ' HA ' ' A' ' 200' ' ' TYR . 4.0 mt -62.66 -50.42 79.83 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 CA-C-O 121.569 0.699 . . . . 0.0 109.551 178.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.468 ' O ' ' HG3' ' A' ' 208' ' ' MET . 97.4 m -53.43 -51.54 62.31 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.843 -178.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.481 ' CD2' ' HB ' ' A' ' 215' ' ' ILE . 29.8 mt -67.01 -29.22 68.99 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.028 0.442 . . . . 0.0 111.369 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . 0.419 ' HA ' ' HE3' ' A' ' 209' ' ' LYS . 5.1 t-20 -77.63 -46.47 21.96 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.633 0.73 . . . . 0.0 109.876 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.442 ' O ' ' CG2' ' A' ' 210' ' ' THR . 4.4 tp -71.75 -29.7 64.79 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.574 -1.193 . . . . 0.0 109.404 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' MET . . . . . 0.76 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 43.0 mtp -76.13 -35.31 59.3 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 14.4 mtmt -61.43 -38.71 88.14 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.654 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.449 ' O ' ' HB3' ' A' ' 234' ' ' PRO . 6.6 t -61.04 -26.85 67.92 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.3 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.566 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 27.6 m-85 -83.88 -7.31 59.47 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.903 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.89 7.43 25.37 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 116.31 1.284 . . . . 0.0 116.31 177.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.2 m -123.55 148.54 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 118.983 1.392 . . . . 0.0 112.604 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.478 ' HG2' ' HD3' ' A' ' 209' ' ' LYS . 12.0 mt-10 -130.35 139.41 50.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.008 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.537 HG23 ' HB ' ' A' ' 225' ' ' VAL . 18.4 mm -122.46 148.78 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 120.836 0.351 . . . . 0.0 110.744 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.572 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 1.3 tp10 -104.67 122.4 45.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.032 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.84 151.01 23.72 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.182 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . 0.523 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 2.8 mm-40 -111.12 -141.57 0.38 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.14 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.513 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 28.3 m170 -73.92 65.03 1.03 Allowed 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 2.0 t80 57.24 36.3 27.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.706 0.765 . . . . 0.0 110.944 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.628 ' O ' ' CD1' ' A' ' 223' ' ' PHE . 4.5 pt20 -168.73 -124.5 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.696 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -8.61 130.88 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.687 ' O ' ' HA ' ' A' ' 188' ' ' VAL . 0.7 OUTLIER -121.87 140.23 52.65 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.119 -1.855 . . . . 0.0 109.625 -179.163 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.572 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 40.1 t -120.84 114.25 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-O 121.297 0.57 . . . . 0.0 109.696 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.537 ' HB ' HG23 ' A' ' 215' ' ' ILE . 0.2 OUTLIER -122.29 125.87 73.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.087 -179.017 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.454 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -77.88 127.55 32.56 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -80.52 -178.51 52.11 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.351 -178.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 67.5 21.01 72.29 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 121.623 -0.322 . . . . 0.0 113.285 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 46.5 mt-30 -78.32 -173.43 3.27 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.268 0.556 . . . . 0.0 111.214 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.09 147.8 26.25 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.365 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' TYR . . . . . 0.562 ' HB3' ' HB1' ' A' ' 35' ' ' ALA . 7.2 m-85 -102.89 130.35 49.9 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.886 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.04 151.78 37.62 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.48 111.09 12.45 Favored Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.97 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.503 ' HD2' ' OG1' ' A' ' 39' ' ' THR . 52.0 Cg_endo -69.37 1.11 4.46 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.249 1.966 . . . . 0.0 112.27 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 98.68 -101.04 2.4 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.303 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 49.2 m -118.42 136.97 53.46 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.465 ' N ' ' O ' ' A' ' 40' ' ' VAL . 9.3 t80 -133.23 124.2 26.95 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.989 0.423 . . . . 0.0 111.362 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.671 HD13 ' HG2' ' A' ' 240' ' ' GLU . 0.2 OUTLIER -94.99 110.83 22.69 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.8 179.866 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 21.5 t -77.93 112.52 16.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.474 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.671 ' HG2' HD13 ' A' ' 238' ' ' LEU . 2.7 mt-10 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.296 -0.859 . . . . 0.0 111.018 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.556 ' HA ' ' HE1' ' A' ' 178' ' ' MET . 37.7 mtm-85 . . . . . 0 CA--C 1.52 -0.193 0 N-CA-C 112.094 0.405 . . . . 2.3300000000000001 112.094 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.73 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -35.76 -42.75 0.27 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.584 -0.735 . . . . 0.17999999999999999 112.601 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.01 HD22 HD11 ' A' ' 75' ' ' ILE . 12.4 mt -75.9 -39.55 56.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.896 0.379 . . . . 0.14000000000000001 111.587 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.782 HD22 ' HB2' ' A' ' 101' ' ' PRO . 31.7 tp -64.91 -50.85 64.88 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.034 -0.53 . . . . 0.23999999999999999 110.873 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.549 HD21 ' CE ' ' A' ' 178' ' ' MET . 31.4 mt -64.78 -28.06 69.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.992 -0.549 . . . . 0.38 109.684 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.785 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -64.75 -40.03 94.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.523 -0.762 . . . . 0.20000000000000001 110.238 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.601 ' CB ' HG11 ' A' ' 62' ' ' VAL . . . -77.82 -39.46 43.64 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.046 -0.525 . . . . 0.14000000000000001 111.273 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.589 HD11 ' HB1' ' A' ' 105' ' ' ALA . 20.7 mt -70.69 -3.0 16.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.95 -0.568 . . . . 0.25 110.534 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.444 ' HA ' ' CB ' ' A' ' 231' ' ' TYR . . . -96.39 172.9 7.65 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 113.144 0.794 . . . . 0.33000000000000002 113.144 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.461 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.2 OUTLIER -110.11 108.76 19.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.845 -1.07 . . . . 1.03 108.593 178.001 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 120.57 170.1 14.09 Favored Glycine 0 C--N 1.319 -0.38 0 C-N-CA 120.822 -0.704 . . . . 0.56000000000000005 111.375 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.825 ' HG3' HG23 ' A' ' 76' ' ' ILE . 0.1 OUTLIER -94.48 119.3 32.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.227 0.514 . . . . 1.72 111.609 -179.228 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.533 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 1.0 OUTLIER -120.3 142.13 49.38 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 120.715 0.293 . . . . 0.52000000000000002 110.401 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.416 ' C ' HD13 ' A' ' 41' ' ' LEU . 69.5 t -102.08 139.21 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-O 121.324 0.583 . . . . 0.25 111.937 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.855 HD23 HD23 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -113.21 114.96 27.48 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 107.217 -1.401 . . . . 0.23999999999999999 107.217 175.759 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.8 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.6 OUTLIER -102.81 149.34 24.58 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.487 -0.485 . . . . 0.33000000000000002 111.04 -178.317 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 69.4 24.5 5.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.03 -0.532 . . . . 1.1899999999999999 111.756 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.787 HD21 ' HB3' ' A' ' 41' ' ' LEU . 86.8 mt -52.92 -177.47 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.832 0.349 . . . . 0.28000000000000003 110.138 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.494 ' O ' HG21 ' A' ' 50' ' ' VAL . 48.4 tp -108.75 131.39 54.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.439 -0.346 . . . . 0.44 110.369 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -89.17 88.87 7.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.855 0.359 . . . . 1.6399999999999999 110.247 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 49' ' ' ASP . 0.6 OUTLIER -165.48 144.64 6.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.97999999999999998 110.073 -179.154 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -36.1 -32.31 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.638 0.256 . . . . 1.6100000000000001 111.449 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.635 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 4.6 p30 -56.13 -42.2 76.55 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.899 0.381 . . . . 1.5600000000000001 110.841 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.534 HG12 HD11 ' A' ' 54' ' ' LEU . 84.1 t -84.4 -45.82 17.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.036 -0.529 . . . . 0.23000000000000001 110.531 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.892 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -48.73 -38.65 22.17 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.989 -0.285 . . . . 2.04 110.615 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.564 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 36.4 m170 -79.88 -36.22 36.88 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 109.634 -0.506 . . . . 0.26000000000000001 109.634 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.484 ' O ' HD13 ' A' ' 57' ' ' LEU . 8.5 tpt -53.36 -31.55 45.14 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 106.086 -1.82 . . . . 0.16 106.086 176.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.892 HD12 ' HA ' ' A' ' 51' ' ' ARG . 2.2 mt -83.42 -45.41 13.69 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 113.914 -1.494 . . . . 0.20999999999999999 108.645 176.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.596 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 18.2 t-20 -58.94 -39.75 82.59 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 115.82 -0.627 . . . . 1.24 111.002 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.824 ' CB ' HD11 ' A' ' 102' ' ' LEU . . . -62.37 -49.96 73.45 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.69 0.757 . . . . 0.14000000000000001 109.249 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.646 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.5 OUTLIER -57.95 -37.66 74.55 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.246 -1.39 . . . . 0.22 107.246 176.984 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.596 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -62.59 -44.43 96.34 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.005 -1.452 . . . . 0.27000000000000002 112.021 179.227 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.655 ' C ' HD21 ' A' ' 88' ' ' LEU . . . -67.78 -39.13 84.13 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.712 0.634 . . . . 0.23999999999999999 112.712 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.636 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.7 OUTLIER -75.26 -17.13 60.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.426 0.631 . . . . 0.26000000000000001 110.28 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.81 37.16 3.75 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 114.894 -1.048 . . . . 0.31 113.935 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.646 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 22.0 t -90.3 125.57 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 109.09 -0.707 . . . . 0.25 109.09 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.716 ' O ' HG12 ' A' ' 76' ' ' ILE . 12.5 m -86.55 130.61 34.43 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 120.469 -0.492 . . . . 1.0 111.13 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.813 ' HB3' HG23 ' A' ' 75' ' ' ILE . 32.4 p90 -159.78 168.87 24.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.18 -0.464 . . . . 0.20000000000000001 110.291 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 99.0 m -134.76 148.65 50.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.284 -0.416 . . . . 0.20999999999999999 110.561 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.417 HD12 ' HB2' ' A' ' 73' ' ' CYS . 14.4 tp -117.19 136.79 52.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.09 0.472 . . . . 0.42999999999999999 110.776 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.514 ' HB2' ' CB ' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -63.94 -158.99 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.612 -0.722 . . . . 1.7 111.281 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -95.7 -31.98 12.97 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.413 -0.358 . . . . 1.78 111.178 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.53 1.09 30.95 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.413 -0.358 . . . . 1.8899999999999999 111.375 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 59.79 24.72 13.7 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.48 -0.327 . . . . 1.8600000000000001 111.67 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.644 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -122.4 -11.23 8.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.823 0.344 . . . . 0.38 111.406 179.573 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.514 ' CB ' ' HB2' ' A' ' 67' ' ' SER . 2.0 mtt180 -112.56 117.96 33.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.439 -0.346 . . . . 3.0099999999999998 110.275 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.766 ' HB3' HD11 ' A' ' 44' ' ' LEU . 43.4 t -131.11 127.52 38.27 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 120.958 0.408 . . . . 0.17999999999999999 111.735 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.535 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 51.3 tt0 -112.24 133.1 54.55 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 109.04 -0.726 . . . . 1.49 109.04 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 1.01 HD11 HD22 ' A' ' 29' ' ' LEU . 11.8 mt -128.7 123.86 60.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 113.948 1.092 . . . . 0.17999999999999999 113.948 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.825 HG23 ' HG3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -67.73 98.86 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 109.157 -0.683 . . . . 0.94999999999999996 109.157 175.764 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -37.23 142.91 0.2 Allowed Glycine 0 C--N 1.321 -0.262 0 CA-C-N 115.138 -0.937 . . . . 0.22 113.579 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.31 -13.32 35.45 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.917 0.389 . . . . 1.21 111.113 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.461 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 86.24 14.51 66.34 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.037 -0.601 . . . . 0.28999999999999998 112.606 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.585 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 145.36 -155.58 26.55 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.792 -0.718 . . . . 0.14999999999999999 112.581 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.516 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 5.8 Cg_endo -49.3 127.41 17.76 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.682 2.255 . . . . 0.51000000000000001 112.436 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.653 ' H ' HD22 ' A' ' 82' ' ' LEU . 0.3 OUTLIER -74.88 109.25 8.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.124 -0.489 . . . . 0.23000000000000001 109.935 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.411 ' HA ' HD22 ' A' ' 111' ' ' ASN . 3.9 p80 -80.42 124.12 28.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.2 0.524 . . . . 0.59999999999999998 112.111 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.667 ' CB ' HD11 ' A' ' 113' ' ' ILE . . . -89.34 124.2 34.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.505 -0.77 . . . . 0.19 111.275 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.51 122.92 20.0 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 105.621 -1.992 . . . . 1.95 105.621 176.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.24 -175.39 5.5 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 108.559 -1.816 . . . . 0.20000000000000001 108.559 -175.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.38 145.03 30.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 118.787 1.294 . . . . 0.17999999999999999 111.832 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.655 HD21 ' C ' ' A' ' 59' ' ' ALA . 0.8 OUTLIER -114.16 161.78 17.35 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.003 -0.998 . . . . 0.20999999999999999 112.278 -178.656 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -139.63 102.89 4.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.612 -1.176 . . . . 1.8700000000000001 108.707 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.699 ' HB3' HD11 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -99.2 127.54 45.19 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 120.99 0.424 . . . . 0.16 111.276 -178.601 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.609 ' C ' HD13 ' A' ' 92' ' ' LEU . 0.9 OUTLIER -99.09 95.51 7.16 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.86 -0.609 . . . . 1.48 109.679 179.185 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.746 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -104.03 54.82 0.73 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.846 -0.615 . . . . 0.62 110.085 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -56.63 -68.5 1.66 Allowed Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.71 -0.677 . . . . 0.72999999999999998 112.984 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.507 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 33.2 m-20 -79.12 -1.76 37.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.575 0.226 . . . . 2.04 110.801 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.959 ' HB1' ' HB3' ' A' ' 98' ' ' ALA . . . -92.76 45.58 1.19 Allowed 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 116.475 -0.33 . . . . 0.93000000000000005 110.919 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -50.42 -27.58 12.17 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.429 -0.891 . . . . 0.47999999999999998 112.032 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.795 HG22 ' CD ' ' A' ' 171' ' ' GLN . 1.1 p -88.83 -14.94 35.77 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.529 0.196 . . . . 0.79000000000000004 111.529 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.959 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -93.46 -37.19 12.07 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.074 0.398 . . . . 0.33000000000000002 112.074 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.1 tpp -59.17 -46.37 88.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.693 -0.23 . . . . 0.39000000000000001 110.737 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.509 ' HB3' ' O ' ' A' ' 171' ' ' GLN . 2.2 mpt_? -52.89 -60.68 6.08 Favored Pre-proline 0 C--N 1.324 -0.537 0 C-N-CA 120.755 -0.378 . . . . 1.3799999999999999 110.056 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.782 ' HB2' HD22 ' A' ' 30' ' ' LEU . 18.1 Cg_endo -60.31 -31.63 93.11 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.422 2.082 . . . . 0.39000000000000001 112.773 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.824 HD11 ' CB ' ' A' ' 56' ' ' ALA . 2.1 mt -73.76 -54.03 8.98 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 120.403 -0.519 . . . . 0.20000000000000001 109.945 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.855 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -47.42 -29.6 2.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.673 -0.694 . . . . 0.17000000000000001 110.543 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.733 ' CB ' ' HB1' ' A' ' 175' ' ' ALA . . . -88.08 -52.11 5.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.872 -0.604 . . . . 0.17000000000000001 112.226 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.67 ' CB ' HD11 ' A' ' 30' ' ' LEU . . . -59.89 -35.42 74.8 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.193 0.812 . . . . 0.17000000000000001 113.193 -177.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.729 ' HB2' HD12 ' A' ' 153' ' ' LEU . 28.3 mt -78.74 -10.98 59.96 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 112.705 0.631 . . . . 0.23000000000000001 112.705 -177.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.754 ' SG ' HD13 ' A' ' 153' ' ' LEU . 99.0 m -93.07 24.86 3.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.287 0.565 . . . . 1.48 110.067 178.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.829 HD21 ' HB2' ' A' ' 182' ' ' LEU . 0.5 OUTLIER -85.51 -75.95 0.35 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.335 -0.848 . . . . 0.40999999999999998 111.213 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -76.76 -105.61 0.14 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.581 -0.819 . . . . 1.1399999999999999 112.141 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.63 96.33 1.5 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.057 0.456 . . . . 0.82999999999999996 110.523 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.69 ' HB2' HD13 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -141.39 140.1 33.61 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.76 -0.654 . . . . 1.96 110.799 -178.949 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.795 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 5.6 m-20 -95.44 99.25 11.18 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 109.087 -0.708 . . . . 1.1200000000000001 109.087 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.69 HD13 ' HB2' ' A' ' 111' ' ' ASN . 1.3 mp -123.28 144.11 33.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.553 -0.749 . . . . 0.52000000000000002 111.663 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.89 HG13 ' CD2' ' A' ' 143' ' ' LEU . 48.0 t -113.9 113.22 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 107.922 -1.14 . . . . 0.17000000000000001 107.922 176.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' A' ' 90' ' ' LEU . 25.7 mt -101.23 105.67 16.81 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 119.869 -0.733 . . . . 0.16 110.346 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.699 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -117.48 -171.61 2.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.573 -0.285 . . . . 0.23999999999999999 111.315 -179.364 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -167.27 -166.22 25.98 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.547 -0.835 . . . . 0.28999999999999998 113.278 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.578 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 40.2 mt-10 -85.85 166.82 27.42 Favored Pre-proline 0 C--N 1.33 -0.273 0 C-N-CA 122.606 0.363 . . . . 1.79 110.678 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.578 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 2.1 Cg_endo -44.83 -37.25 11.74 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.725 2.283 . . . . 0.41999999999999998 112.696 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -67.62 -26.55 66.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.807 0.337 . . . . 2.25 110.381 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.517 ' O ' ' HG3' ' A' ' 149' ' ' PRO . 7.3 tpt -62.5 -31.81 72.62 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.532 -0.544 . . . . 0.28999999999999998 109.532 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 119' ' ' PRO . 0.1 OUTLIER -61.7 -18.08 58.22 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 115.923 -0.58 . . . . 1.51 110.257 179.067 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -85.25 4.9 32.64 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.957 0.408 . . . . 2.3199999999999998 110.086 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 124' ' ' ARG . 5.9 mtt-85 -127.16 80.58 71.38 Favored Pre-proline 0 N--CA 1.455 -0.197 0 CA-C-N 116.013 -0.54 . . . . 2.1099999999999999 110.51 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.83 148.89 63.8 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.583 2.188 . . . . 0.47999999999999998 111.712 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 148' ' ' TYR . 1.2 tt -126.13 10.4 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 112.386 0.513 . . . . 0.23000000000000001 112.386 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.526 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -59.99 -39.83 96.16 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.559 -0.829 . . . . 0.23000000000000001 113.107 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.415 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 14.4 m-70 -57.41 -37.02 72.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.747 0.308 . . . . 1.5600000000000001 111.03 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.749 ' HG ' HD11 ' A' ' 133' ' ' LEU . 12.5 tp -75.65 -44.49 42.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.273 0.559 . . . . 0.29999999999999999 110.514 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.76 HG13 ' CG2' ' A' ' 140' ' ' ILE . 47.8 t -55.48 -48.13 77.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.367 -0.833 . . . . 0.22 111.275 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.662 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 4.1 m-20 -67.77 -41.45 83.25 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 120.993 0.425 . . . . 1.3200000000000001 110.562 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.617 ' HB2' HG23 ' A' ' 164' ' ' VAL . . . -56.84 -44.06 81.72 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.553 -0.749 . . . . 0.16 110.003 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.749 HD11 ' HG ' ' A' ' 129' ' ' LEU . 6.5 mt -77.4 -51.32 11.0 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.596 -0.729 . . . . 0.19 110.769 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.658 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -55.16 -26.41 38.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.598 -0.728 . . . . 2.8700000000000001 109.912 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.662 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 3.4 tp -69.51 -32.5 71.4 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.175 -0.466 . . . . 0.44 110.556 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.47 12.06 41.76 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.646 -0.788 . . . . 0.20000000000000001 112.049 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.91 5.57 58.41 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.25 -0.976 . . . . 0.25 112.689 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.655 ' HB1' ' HB3' ' A' ' 107' ' ' CYS . . . -75.77 149.66 37.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.029 0.442 . . . . 0.22 111.305 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.0 mttp -97.0 109.22 22.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.948 -0.569 . . . . 2.1000000000000001 110.277 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.76 ' CG2' HG13 ' A' ' 130' ' ' VAL . 28.1 mt -140.6 126.9 21.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.838 0.351 . . . . 0.20000000000000001 111.638 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.655 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -124.2 139.96 53.43 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.124 -0.489 . . . . 0.27000000000000002 110.258 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.403 ' HE1' HG21 ' A' ' 130' ' ' VAL . 32.5 m-85 -80.56 130.14 34.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.837 0.351 . . . . 0.33000000000000002 110.867 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.89 ' CD2' HG13 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -88.5 -85.03 0.19 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.136 -0.484 . . . . 0.29999999999999999 112.076 -178.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.444 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 1.2 mt-10 -66.28 -83.87 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.838 -0.345 . . . . 1.77 110.586 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.481 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 75.5 mt-30 -109.49 153.95 23.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.407 -0.36 . . . . 1.76 110.139 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -69.1 131.74 45.47 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.874 0.368 . . . . 1.6599999999999999 110.865 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.526 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 0.9 OUTLIER 71.43 19.93 5.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.934 -0.575 . . . . 0.77000000000000002 111.155 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.56 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 14.6 m-85 -106.8 169.12 7.15 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 112.277 0.473 . . . . 0.45000000000000001 112.277 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.755 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 65.4 Cg_exo -36.09 -57.26 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.86 3.04 . . . . 0.26000000000000001 115.481 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.755 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 52.3 Cg_exo -56.79 144.97 85.72 Favored 'Trans proline' 0 C--N 1.353 0.806 0 CA-C-N 120.432 1.19 . . . . 0.20000000000000001 112.05 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.679 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 12.2 mt -156.81 134.98 11.2 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.841 -1.072 . . . . 0.23999999999999999 109.894 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.655 ' HB2' HG22 ' A' ' 141' ' ' THR . 3.7 mtt180 -105.33 105.43 15.47 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.009 -1.108 . . . . 2.0800000000000001 108.009 176.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.855 HD11 ' HA ' ' A' ' 103' ' ' ALA . 3.4 mt -94.35 144.62 25.39 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.865 -1.061 . . . . 0.19 110.904 -177.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.681 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 1.5 mt-30 -145.87 27.23 1.2 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.508 -0.769 . . . . 1.1799999999999999 110.72 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 51.06 179.05 0.03 OUTLIER Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.015 -0.612 . . . . 0.40000000000000002 112.622 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 158' ' ' THR . . . 125.68 -10.27 7.58 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.143 -1.027 . . . . 0.25 113.405 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.577 ' CD1' ' HB2' ' A' ' 183' ' ' ALA . 21.4 t80 -58.87 122.64 14.12 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 117.381 0.591 . . . . 0.53000000000000003 110.482 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.687 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 73.1 p -117.53 -38.29 3.33 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.334 0.588 . . . . 0.25 111.625 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.553 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 144.64 -170.92 26.11 Favored Glycine 0 C--N 1.308 -1.022 0 C-N-CA 120.239 -0.981 . . . . 0.25 112.583 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.573 ' O ' HG23 ' A' ' 187' ' ' THR . . . 112.58 155.06 12.19 Favored Glycine 0 N--CA 1.436 -1.323 0 N-CA-C 111.189 -0.764 . . . . 0.62 111.189 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -47.76 125.67 9.04 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 120.833 0.349 . . . . 1.9299999999999999 110.68 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 132' ' ' ALA . 74.7 t -117.11 144.42 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.66 -0.496 . . . . 0.27000000000000002 109.66 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -113.26 119.39 37.57 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.865 -0.334 . . . . 1.1200000000000001 110.794 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.846 HG21 HD11 ' A' ' 176' ' ' LEU . 1.1 t -131.83 119.17 40.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 120.598 -0.441 . . . . 0.31 109.851 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.44 138.39 46.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 1.48 111.288 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.709 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . . . . . . 0 N--CA 1.446 -0.658 0 C-N-CA 120.588 -0.815 . . . . 0.52000000000000002 112.431 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.463 ' HB2' ' HB3' ' A' ' 200' ' ' TYR . 71.9 p . . . . . 0 C--O 1.231 0.13 0 N-CA-C 111.993 0.368 . . . . 1.25 111.993 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.795 ' CD ' HG22 ' A' ' 97' ' ' THR . 8.7 mp0 -85.5 -11.01 55.25 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.815 -0.354 . . . . 2.3700000000000001 111.111 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.486 ' CD2' ' HB2' ' A' ' 129' ' ' LEU . 10.8 m-85 -75.07 -59.19 2.85 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.317 -0.623 . . . . 0.39000000000000001 109.317 178.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.841 HD11 ' CG1' ' A' ' 191' ' ' ILE . 0.3 OUTLIER -60.7 -39.14 87.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.475 -0.784 . . . . 0.57999999999999996 109.18 178.42 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.463 HG23 HG21 ' A' ' 204' ' ' THR . 1.7 m -59.84 -38.96 83.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.922 -1.036 . . . . 0.31 109.62 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.733 ' HB1' ' CB ' ' A' ' 104' ' ' ALA . . . -60.65 -41.5 95.08 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.815 -0.629 . . . . 0.19 110.911 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.846 HD11 HG21 ' A' ' 164' ' ' VAL . 0.3 OUTLIER -77.37 -32.16 54.78 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.473 -0.785 . . . . 0.63 110.891 179.657 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.687 ' CD2' HD21 ' A' ' 205' ' ' LEU . 3.5 mp -61.51 -38.44 87.36 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.342 -0.845 . . . . 0.34999999999999998 110.759 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.667 ' HA ' ' HE1' ' A' ' 208' ' ' MET . 1.5 mtp -82.65 -40.6 20.49 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.51 0.559 . . . . 0.68000000000000005 112.51 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.498 HG23 ' HG ' ' A' ' 108' ' ' LEU . 50.3 m -77.1 -39.43 49.56 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.343 -0.844 . . . . 0.27000000000000002 113.071 -178.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.53 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . -58.7 -42.52 94.72 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 114.428 1.27 . . . . 0.37 114.428 -177.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 27.0 Cg_endo -64.82 -27.56 59.42 Favored 'Trans proline' 0 CA--C 1.501 -1.154 0 CA-C-N 119.795 0.962 . . . . 0.52000000000000002 112.387 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.829 ' HB2' HD21 ' A' ' 108' ' ' LEU . 4.0 mt -83.26 -2.36 55.42 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 109.31 -0.626 . . . . 0.51000000000000001 109.31 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.68 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -78.17 135.8 61.9 Favored Pre-proline 0 C--O 1.224 -0.274 0 CA-C-N 116.049 -0.523 . . . . 0.25 110.122 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.687 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 11.3 Cg_endo -51.14 -34.4 47.77 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.378 2.052 . . . . 0.25 113.11 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -112.4 143.64 43.18 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.697 -0.683 . . . . 2.0899999999999999 111.112 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -58.07 153.43 14.67 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.285 -0.416 . . . . 2.2400000000000002 110.286 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.574 HG23 HG23 ' A' ' 162' ' ' VAL . 56.4 m -133.75 145.65 50.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.077 0.465 . . . . 0.27000000000000002 112.223 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.573 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 54.6 t -124.48 117.58 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.584 -0.735 . . . . 0.25 110.197 178.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.687 HG12 HD13 ' A' ' 176' ' ' LEU . 3.4 mp -100.13 117.9 45.99 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 N-CA-C 108.731 -0.84 . . . . 0.23000000000000001 108.731 177.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 7.7 ttt180 -100.66 124.71 46.64 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.322 -0.992 . . . . 2.4300000000000002 108.322 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.841 ' CG1' HD11 ' A' ' 173' ' ' LEU . 1.6 mp -92.27 122.37 43.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.933 -1.03 . . . . 0.31 111.746 -176.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -80.46 96.87 6.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.072 -1.422 . . . . 0.98999999999999999 110.595 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 101.56 -132.39 10.94 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.747 -0.74 . . . . 0.46999999999999997 111.884 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -116.74 127.51 54.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.711 0.291 . . . . 1.1000000000000001 111.628 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.556 HD11 ' HZ ' ' A' ' 223' ' ' PHE . 1.1 mt -40.42 144.87 0.2 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.157 -0.474 . . . . 0.44 111.269 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.402 HG11 ' N ' ' A' ' 170' ' ' SER . 10.5 p -72.52 -30.74 35.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.995 -0.548 . . . . 0.60999999999999999 112.2 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.478 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 0.2 OUTLIER -165.23 63.61 0.12 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.977 0.417 . . . . 0.88 110.734 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.51 ' HA ' HD13 ' A' ' 195' ' ' LEU . 6.1 tttm -40.25 -46.21 5.41 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 115.851 -0.613 . . . . 2.02 111.355 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' PRO . . . . . 0.478 ' HD2' ' C ' ' A' ' 197' ' ' SER . 87.6 Cg_exo -47.37 -34.09 18.22 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.027 1.818 . . . . 0.62 111.798 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.958 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.3 OUTLIER -70.34 -42.06 72.39 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.804 -0.813 . . . . 1.4099999999999999 108.804 178.056 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.442 HG21 ' HE2' ' A' ' 223' ' ' PHE . 26.4 mm -63.21 -33.8 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 114.819 -1.082 . . . . 0.41999999999999998 110.44 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.7 -45.28 94.8 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.121 0.486 . . . . 1.1399999999999999 109.914 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.958 HD12 ' HA ' ' A' ' 200' ' ' TYR . 3.8 mt -62.14 -50.95 77.95 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 CA-C-O 121.633 0.73 . . . . 0.62 110.163 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.463 HG21 HG23 ' A' ' 174' ' ' THR . 74.9 m -51.63 -51.11 58.29 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.478 -1.237 . . . . 0.46999999999999997 111.449 -178.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.692 HD22 ' HB ' ' A' ' 215' ' ' ILE . 21.3 mt -66.84 -28.59 68.47 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 120.892 0.377 . . . . 0.26000000000000001 111.661 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ASN . . . . . 0.415 ' HA ' ' HE3' ' A' ' 209' ' ' LYS . 1.9 t30 -78.48 -46.64 19.18 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.588 0.708 . . . . 1.6000000000000001 109.827 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.979 ' O ' HG22 ' A' ' 210' ' ' THR . 0.2 OUTLIER -71.11 -30.31 66.36 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.687 -1.142 . . . . 0.52000000000000002 109.192 178.883 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 208' ' ' MET . . . . . 0.667 ' HE1' ' HA ' ' A' ' 178' ' ' MET . 35.5 mtp -72.76 -35.03 67.37 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.848 -0.615 . . . . 0.38 109.534 177.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 10.4 mtmt -60.97 -36.39 79.3 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 115.092 -0.958 . . . . 0.98999999999999999 110.856 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.979 HG22 ' O ' ' A' ' 207' ' ' LEU . 4.8 t -62.04 -22.98 66.19 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.633 -0.712 . . . . 0.96999999999999997 109.33 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.536 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 61.3 m-85 -85.76 -9.07 57.68 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.749 -0.66 . . . . 1.51 111.587 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 111.54 5.33 26.17 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 116.006 1.162 . . . . 2.9300000000000002 116.006 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.5 m -123.54 148.96 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 118.969 1.385 . . . . 1.6899999999999999 112.81 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.476 ' HG2' ' CG ' ' A' ' 209' ' ' LYS . 8.5 mt-10 -131.01 135.88 48.0 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.341 -0.845 . . . . 2.6699999999999999 111.291 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.988 HD12 ' HB ' ' A' ' 225' ' ' VAL . 20.0 mm -118.26 148.59 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 120.772 0.32 . . . . 1.0800000000000001 110.225 178.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.542 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 9.2 tt0 -104.86 116.56 32.2 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.302 -0.408 . . . . 1.54 112.004 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -84.94 151.25 24.37 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.091 -0.504 . . . . 2.2400000000000002 110.396 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 5.0 tp60 -108.18 -143.23 0.38 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.477 0.179 . . . . 1.97 110.785 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.409 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 4.5 m-70 -73.3 66.51 0.92 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.886 0.374 . . . . 2.4199999999999999 111.491 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.41 ' CE1' ' HD2' ' A' ' 198' ' ' LYS . 6.4 t80 58.43 33.65 23.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.788 0.804 . . . . 0.97999999999999998 111.11 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.636 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 5.1 pt20 -165.74 -129.99 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 106.69 -1.596 . . . . 1.5600000000000001 106.69 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.617 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -3.06 128.7 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 114.36 1.244 . . . . 1.3500000000000001 114.36 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.597 ' CD1' ' O ' ' A' ' 221' ' ' GLN . 5.1 m-85 -123.02 140.93 52.52 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.262 -1.79 . . . . 0.63 110.042 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.542 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 42.3 t -123.03 112.78 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 121.329 0.585 . . . . 0.33000000000000002 109.841 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.988 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -119.44 135.27 60.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.222 -0.899 . . . . 0.44 111.49 -178.945 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.431 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 3.7 mptt -83.76 127.8 34.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.038 -0.528 . . . . 2.71 109.823 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.428 ' CA ' ' O ' ' A' ' 183' ' ' ALA . . . -83.03 167.99 46.41 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.442 -0.885 . . . . 0.38 113.347 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 77.73 19.81 75.02 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 121.703 -0.284 . . . . 0.28999999999999998 113.412 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 19.6 mt-30 -77.22 -176.22 4.0 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.39 0.614 . . . . 1.8400000000000001 111.728 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.6 147.67 30.3 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.116 -0.947 . . . . 1.21 110.636 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' TYR . . . . . 0.495 ' CE2' HD22 ' A' ' 31' ' ' LEU . 6.3 m-30 -103.19 132.06 49.74 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.975 -0.557 . . . . 0.76000000000000001 110.995 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -119.74 155.14 33.04 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.697 -0.483 . . . . 2.5299999999999998 109.697 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.484 ' HB2' ' OG1' ' A' ' 39' ' ' THR . 51.8 p -82.42 109.71 17.57 Favored Pre-proline 0 N--CA 1.451 -0.411 0 C-N-CA 121.077 -0.249 . . . . 1.3500000000000001 110.56 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.533 ' HD2' ' OG1' ' A' ' 39' ' ' THR . 54.9 Cg_endo -68.45 -2.34 8.97 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.089 1.859 . . . . 0.33000000000000002 112.233 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 102.21 -94.7 1.21 Allowed Glycine 0 C--O 1.227 -0.313 0 C-N-CA 120.629 -0.796 . . . . 0.28000000000000003 111.666 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 95.9 m -121.51 135.41 55.03 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.344 -0.613 . . . . 0.29999999999999999 109.344 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' TYR . . . . . 0.739 ' CD2' HG21 ' A' ' 210' ' ' THR . 12.3 t80 -133.58 134.74 43.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.93 0.395 . . . . 0.55000000000000004 111.516 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.8 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -98.91 113.05 25.01 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.981 -0.554 . . . . 0.40999999999999998 111.529 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.744 ' N ' HD22 ' A' ' 238' ' ' LEU . 25.1 t -84.59 112.75 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.731 -0.668 . . . . 0.40999999999999998 110.908 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.251 -0.881 . . . . 1.6899999999999999 111.124 -179.699 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.782 HH12 ' HB ' ' A' ' 203' ' ' ILE . 29.1 mtm180 . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.876 0.37 . . . . 0.0 110.985 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.748 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -39.32 -48.42 1.86 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.667 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.08 HD22 HD11 ' A' ' 75' ' ' ILE . 11.0 mt -72.31 -36.42 68.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.905 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.79 HD22 ' HB2' ' A' ' 101' ' ' PRO . 35.9 tp -65.86 -50.19 65.44 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.719 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.712 HD22 ' CZ ' ' A' ' 231' ' ' TYR . 60.0 mt -67.0 -27.64 67.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.728 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.754 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -65.91 -39.18 90.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.14 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.813 ' CB ' HG11 ' A' ' 62' ' ' VAL . . . -81.73 -41.07 21.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.212 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.727 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 14.4 mt -68.33 -4.01 12.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.227 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.534 ' HB2' ' HB3' ' A' ' 231' ' ' TYR . . . -97.6 179.19 4.93 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -177.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.58 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.4 OUTLIER -112.19 113.5 25.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.931 178.543 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 114.12 169.08 16.52 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.608 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.568 ' HG2' ' HG2' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -95.06 117.57 30.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 117.154 0.477 . . . . 0.0 111.475 -179.223 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 235' ' ' GLY . 0.9 OUTLIER -119.58 145.71 46.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.445 -179.697 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.51 HG22 ' HB2' ' A' ' 74' ' ' GLU . 75.8 t -104.37 142.31 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 CA-C-O 121.344 0.592 . . . . 0.0 112.548 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.874 HD23 HD23 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -116.51 116.36 27.49 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 174.632 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.931 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.5 OUTLIER -102.96 151.35 22.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.108 -177.909 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.7 t30 66.08 27.26 10.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.179 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.717 HD21 ' CB ' ' A' ' 41' ' ' LEU . 86.2 mt -54.68 -172.94 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.562 ' HB3' HG21 ' A' ' 50' ' ' VAL . 29.7 tp -114.03 131.38 56.38 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -88.46 88.45 7.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.149 0.5 . . . . 0.0 110.565 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 49' ' ' ASP . 1.7 m -164.31 142.91 7.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.1 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.421 ' HA ' ' HB3' ' A' ' 51' ' ' ARG . 0.6 OUTLIER -36.42 -30.45 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.602 0.239 . . . . 0.0 111.455 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.939 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 1.5 p30 -58.19 -42.77 86.82 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 121.028 0.442 . . . . 0.0 110.905 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.797 HG23 ' OD1' ' A' ' 49' ' ' ASP . 88.8 t -84.24 -44.66 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.57 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.943 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -50.89 -39.01 53.11 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.017 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.668 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 55.3 m170 -80.31 -32.58 37.96 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.595 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.574 ' O ' HD13 ' A' ' 57' ' ' LEU . 9.5 tpt -55.0 -34.62 63.6 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.943 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.5 OUTLIER -82.42 -41.54 19.75 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 114.22 -1.354 . . . . 0.0 108.58 176.346 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.675 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 34.4 t30 -59.13 -41.56 88.52 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-O 120.922 0.391 . . . . 0.0 110.749 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 1.029 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -59.24 -46.76 87.62 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 121.702 0.763 . . . . 0.0 108.96 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.851 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.4 OUTLIER -63.41 -41.11 98.71 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.245 -1.343 . . . . 0.0 107.745 177.243 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.675 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -59.78 -32.9 71.03 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 114.187 -1.369 . . . . 0.0 111.564 179.044 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.748 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -77.66 -38.33 47.91 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.073 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.698 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.5 OUTLIER -79.89 -12.91 59.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.407 0.622 . . . . 0.0 110.566 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.43 33.33 5.42 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 114.967 -1.015 . . . . 0.0 114.244 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.851 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 40.5 t -90.55 117.67 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.791 ' O ' HG12 ' A' ' 76' ' ' ILE . 26.0 m -82.98 132.89 35.13 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 121.078 0.466 . . . . 0.0 112.167 -178.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.723 ' HB3' HG23 ' A' ' 75' ' ' ILE . 41.1 p90 -158.31 171.87 19.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.463 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 62.1 m -131.37 148.51 52.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.182 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.415 ' CD1' ' HB2' ' A' ' 73' ' ' CYS . 12.5 tp -115.04 133.7 55.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.177 0.513 . . . . 0.0 110.685 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.527 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 0.6 OUTLIER -61.21 -167.22 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.378 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.75 -44.47 14.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.553 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.33 1.79 10.79 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.596 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 58.81 39.83 23.62 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.868 0.366 . . . . 0.0 111.54 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -133.95 -10.46 2.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.225 179.292 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.572 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 14.8 mtp180 -114.92 120.59 40.45 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.676 ' HB3' HD11 ' A' ' 44' ' ' LEU . 34.2 t -129.53 125.62 36.72 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.568 ' HG2' ' HG2' ' A' ' 38' ' ' LYS . 56.8 tt0 -106.98 130.62 54.6 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 176.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 1.08 HD11 HD22 ' A' ' 29' ' ' LEU . 10.4 mt -127.72 124.49 63.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -177.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.791 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -68.51 99.62 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-O 121.104 0.478 . . . . 0.0 109.712 175.813 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' A' ' 35' ' ' ALA . . . -38.77 143.71 0.29 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.843 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.31 -10.71 45.75 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.093 0.473 . . . . 0.0 110.921 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.58 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 90.14 3.11 73.32 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.14 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.505 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 150.07 -148.49 19.8 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.012 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.579 ' CG ' ' HB3' ' A' ' 108' ' ' LEU . 88.1 Cg_exo -49.09 125.14 12.73 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.783 2.322 . . . . 0.0 112.973 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.707 ' H ' HD22 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -74.58 110.52 8.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.792 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.405 ' HA ' ' CG ' ' A' ' 111' ' ' ASN . 4.4 p80 -82.08 135.06 35.37 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.072 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.639 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -98.03 123.78 42.22 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.061 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -71.04 123.67 22.61 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.61 175.71 0.96 Allowed Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -175.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.65 144.8 47.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 118.735 1.268 . . . . 0.0 111.411 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.748 HD21 ' HB1' ' A' ' 59' ' ' ALA . 1.3 tp -116.26 160.54 20.31 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.393 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 22.4 mt-10 -139.22 104.23 4.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.288 178.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.686 ' HB2' HD23 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -100.63 118.83 37.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.143 -178.699 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.424 ' C ' HD13 ' A' ' 92' ' ' LEU . 4.3 m-85 -92.99 96.26 9.98 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.906 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.923 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -104.89 47.31 0.88 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.089 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.782 ' HA3' ' H ' ' A' ' 118' ' ' GLU . . . -54.4 -44.66 76.78 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.848 -0.692 . . . . 0.0 113.281 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.625 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 74.2 m-20 -94.43 -6.89 42.99 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.666 0.27 . . . . 0.0 110.733 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 1.005 ' HB1' ' HB3' ' A' ' 98' ' ' ALA . . . -98.16 61.7 1.49 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.011 0.434 . . . . 0.0 111.311 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.617 ' O ' ' HD3' ' A' ' 100' ' ' ARG . . . -63.82 -25.2 68.94 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.068 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.434 ' HA ' ' HG2' ' A' ' 171' ' ' GLN . 0.9 OUTLIER -88.19 -17.11 31.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.707 0.289 . . . . 0.0 110.882 179.497 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 1.005 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -95.27 -29.21 14.61 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.925 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.668 ' SD ' ' HB3' ' A' ' 115' ' ' LEU . 5.6 tpp -64.3 -47.4 79.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.168 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.671 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 1.9 mpt_? -54.34 -58.87 11.9 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.79 ' HB2' HD22 ' A' ' 30' ' ' LEU . 18.1 Cg_endo -59.71 -33.04 96.57 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.286 1.991 . . . . 0.0 112.635 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 1.029 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.4 OUTLIER -74.16 -53.43 9.88 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.056 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.884 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -50.04 -28.09 6.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.429 0.633 . . . . 0.0 110.279 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.858 ' HB2' ' HB1' ' A' ' 175' ' ' ALA . . . -86.96 -54.44 4.34 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.316 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.67 ' HB1' HD11 ' A' ' 34' ' ' LEU . . . -59.93 -32.76 71.09 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -176.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.739 ' HB2' HD12 ' A' ' 153' ' ' LEU . 20.2 mt -78.99 -12.89 60.05 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.046 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.559 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 20.2 m -81.23 15.32 1.99 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.219 0.533 . . . . 0.0 110.936 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.691 HD21 ' HB2' ' A' ' 182' ' ' LEU . 2.3 mt -91.91 -71.02 0.66 Allowed 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.267 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.86 146.19 22.06 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.707 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.2 p -58.16 98.84 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.803 0.335 . . . . 0.0 111.141 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.616 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 16.8 m-80 -148.28 135.51 20.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.874 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.881 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 5.0 m-20 -91.66 101.05 13.67 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.252 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.639 HD11 ' HB2' ' A' ' 84' ' ' ALA . 31.5 mm -118.89 137.48 52.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.161 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.815 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 62.9 t -110.17 112.39 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 176.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.686 HD23 ' HB2' ' A' ' 90' ' ' LEU . 63.9 mt -102.21 105.83 16.56 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.327 -178.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.776 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -119.37 -175.37 2.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.844 0.354 . . . . 0.0 111.624 -178.921 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.602 ' H ' HG22 ' A' ' 116' ' ' THR . . . -166.17 178.07 40.91 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.994 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.782 ' H ' ' HA3' ' A' ' 93' ' ' GLY . 3.9 mt-10 -70.79 172.63 5.97 Favored Pre-proline 0 C--N 1.328 -0.333 0 C-N-CA 123.096 0.558 . . . . 0.0 110.793 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.645 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 81.5 Cg_exo -46.65 -39.57 23.34 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.682 2.254 . . . . 0.0 113.105 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.419 ' O ' ' HB3' ' A' ' 123' ' ' GLU . 2.1 mpp_? -67.8 -23.57 65.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.681 0.277 . . . . 0.0 110.961 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.664 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 10.8 tpt -60.92 -35.65 77.25 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.42 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 3.5 mptp? -62.78 -16.86 59.79 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.149 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.651 ' O ' ' HG3' ' A' ' 123' ' ' GLU . 1.0 OUTLIER -80.92 -0.17 38.05 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.307 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.442 ' HB3' HH22 ' A' ' 100' ' ' ARG . 6.5 mtt180 -126.31 83.71 63.45 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.71 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.532 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 15.8 Cg_endo -56.86 148.75 65.03 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.646 2.231 . . . . 0.0 111.538 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 148' ' ' TYR . 0.7 OUTLIER -123.48 -0.76 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.012 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.573 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -53.69 -39.01 60.16 Favored Glycine 0 CA--C 1.516 0.138 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.707 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.581 ' CD2' ' HB2' ' A' ' 165' ' ' ASP . 1.4 m80 -55.58 -39.29 70.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.023 0.412 . . . . 0.0 110.735 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.747 ' HG ' HD11 ' A' ' 133' ' ' LEU . 14.4 tp -75.36 -40.86 57.7 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.347 0.594 . . . . 0.0 110.141 178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.762 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 55.1 t -56.19 -48.17 79.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.562 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.738 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 75.2 m-20 -69.5 -37.26 77.12 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.133 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.639 ' HB2' HG23 ' A' ' 164' ' ' VAL . . . -58.99 -49.62 77.2 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.936 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.747 HD11 ' HG ' ' A' ' 129' ' ' LEU . 6.6 mt -73.6 -47.44 40.36 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.591 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.762 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -59.53 -27.47 66.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.702 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.738 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 5.6 tp -70.89 -28.69 64.73 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.998 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 159' ' ' GLY . . . -85.55 15.26 47.27 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.709 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.91 4.73 61.45 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.522 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.512 ' HB3' ' C ' ' A' ' 133' ' ' LEU . . . -73.95 152.99 39.96 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 120.865 0.364 . . . . 0.0 111.417 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.446 ' CB ' ' HB2' ' A' ' 154' ' ' GLN . 13.5 mmtm -102.29 103.43 13.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.249 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.681 ' CG2' HD22 ' A' ' 151' ' ' LEU . 14.7 mt -134.86 127.35 48.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.431 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.714 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -124.62 139.23 54.06 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.101 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.494 ' HE1' HG21 ' A' ' 130' ' ' VAL . 36.3 m-85 -78.08 130.35 36.31 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.125 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.759 ' CD2' HG13 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -91.09 -90.26 0.16 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.57 -179.723 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.834 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 2.6 mt-10 -58.99 -81.51 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 122.083 -0.386 . . . . 0.0 110.903 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.428 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 14.2 mt-30 -114.73 151.86 33.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.505 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -66.93 135.2 53.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.919 0.39 . . . . 0.0 110.68 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.573 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 4.3 m-20 66.91 19.73 10.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.196 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.568 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 10.9 m-85 -110.28 169.64 6.15 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 121.085 0.469 . . . . 0.0 112.128 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.914 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 36.5 Cg_exo -33.23 -62.32 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 124.547 3.498 . . . . 0.0 116.252 -177.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.914 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 52.4 Cg_exo -53.56 145.73 46.28 Favored 'Trans proline' 0 C--N 1.352 0.746 0 CA-C-N 120.723 1.294 . . . . 0.0 112.678 -178.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.815 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 6.5 mt -156.3 136.31 12.76 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.62 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.714 ' HB2' HG22 ' A' ' 141' ' ' THR . 11.7 mtt180 -106.42 103.18 12.58 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.884 HD11 ' HA ' ' A' ' 103' ' ' ALA . 6.6 mt -93.6 145.39 24.57 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.797 -178.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.616 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 2.6 mp0 -147.35 26.93 1.04 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.43 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 52.14 -158.59 3.11 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.027 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.39 -12.86 43.69 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 119.922 -1.132 . . . . 0.0 112.917 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.538 ' HE1' ' HA ' ' A' ' 180' ' ' ALA . 51.6 t80 -60.29 122.75 15.27 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 117.14 0.47 . . . . 0.0 110.852 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.689 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 54.3 p -115.31 -33.12 5.41 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.575 0.703 . . . . 0.0 111.206 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.414 ' O ' ' HA2' ' A' ' 136' ' ' GLY . . . 136.46 -160.39 24.74 Favored Glycine 0 C--N 1.305 -1.148 0 CA-C-N 114.667 -1.151 . . . . 0.0 112.247 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.612 ' O ' HG23 ' A' ' 187' ' ' THR . . . 105.97 154.85 21.35 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 120.625 -0.797 . . . . 0.0 111.35 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -47.04 119.22 2.44 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 120.869 0.366 . . . . 0.0 110.944 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.745 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 75.3 t -110.36 129.87 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.929 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.11 119.41 37.79 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.521 -0.472 . . . . 0.0 109.74 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.872 HG21 HD11 ' A' ' 176' ' ' LEU . 1.0 OUTLIER -132.32 120.19 42.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.581 ' HB2' ' CD2' ' A' ' 128' ' ' HIS . 0.6 OUTLIER -53.32 141.89 22.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.246 -179.228 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.899 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . . . . . . 0 N--CA 1.448 -0.527 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.653 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.466 ' HB3' ' CB ' ' A' ' 197' ' ' SER . 2.8 p . . . . . 0 N--CA 1.462 0.17 0 CA-C-O 120.847 0.356 . . . . 0.0 111.056 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.671 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 1.5 mp0 -81.62 -11.66 59.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.361 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.532 ' HZ ' ' O ' ' A' ' 125' ' ' PRO . 5.3 m-85 -69.53 -51.84 31.96 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.718 0.77 . . . . 0.0 109.272 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.916 HD21 HD11 ' A' ' 191' ' ' ILE . 0.4 OUTLIER -67.48 -43.21 81.51 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.513 -1.222 . . . . 0.0 109.106 178.71 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.615 ' O ' ' HG3' ' A' ' 178' ' ' MET . 5.1 m -55.01 -33.52 62.69 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.55 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.858 ' HB1' ' HB2' ' A' ' 104' ' ' ALA . . . -66.92 -41.05 87.74 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.874 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.872 HD11 HG21 ' A' ' 164' ' ' VAL . 1.1 mt -76.17 -34.89 59.36 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.404 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.81 HD11 ' CD2' ' A' ' 223' ' ' PHE . 3.8 mp -60.37 -36.95 79.24 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.336 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.624 ' HA ' ' HE1' ' A' ' 208' ' ' MET . 6.0 mtp -81.6 -43.68 18.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.558 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 88.2 m -72.16 -42.48 65.86 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.988 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.542 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . -59.28 -38.93 68.57 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -176.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.652 ' HA ' ' O ' ' A' ' 226' ' ' LYS . 27.0 Cg_endo -65.79 -29.67 50.42 Favored 'Trans proline' 0 CA--C 1.499 -1.236 0 CA-C-N 120.163 1.094 . . . . 0.0 111.699 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.691 ' HB2' HD21 ' A' ' 108' ' ' LEU . 5.6 mt -83.8 2.0 40.28 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.765 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.689 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -84.7 138.29 38.05 Favored Pre-proline 0 C--O 1.224 -0.285 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.201 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.676 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 12.1 Cg_endo -51.47 -31.19 38.01 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.444 2.096 . . . . 0.0 113.028 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.45 140.89 48.87 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.522 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -57.07 147.77 23.51 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.197 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 160' ' ' GLY . 78.8 m -122.99 147.29 46.8 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 36.0 t -126.24 117.9 49.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.745 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 2.6 mp -103.83 117.35 49.19 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.954 0 C-N-CA 120.029 -0.669 . . . . 0.0 109.368 178.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.644 ' HG3' ' HG3' ' A' ' 222' ' ' GLN . 1.3 ttt85 -99.85 124.68 45.41 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.916 HD11 HD21 ' A' ' 173' ' ' LEU . 1.5 mp -94.08 123.48 46.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.976 -176.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -76.21 96.33 3.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.835 -1.529 . . . . 0.0 110.47 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 97.75 -126.72 8.98 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.972 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.59 132.72 56.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.845 0.355 . . . . 0.0 111.633 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.837 HD21 HD13 ' A' ' 173' ' ' LEU . 0.9 OUTLIER -42.07 144.42 0.46 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.044 179.267 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 12.5 p -73.87 -26.52 21.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.165 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.466 ' CB ' ' HB3' ' A' ' 170' ' ' SER . 0.3 OUTLIER -168.51 65.05 0.07 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.176 0.513 . . . . 0.0 109.741 -179.663 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.49 ' HA ' HD13 ' A' ' 195' ' ' LEU . 0.0 OUTLIER -42.93 -46.02 12.55 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.096 -179.812 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 199' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 198' ' ' LYS . 79.8 Cg_exo -48.27 -34.83 25.65 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.903 1.735 . . . . 0.0 111.638 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.927 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.3 OUTLIER -67.91 -42.45 81.12 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.401 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.453 HG21 ' CE2' ' A' ' 223' ' ' PHE . 20.0 mm -60.12 -39.49 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.026 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -57.15 -47.2 81.76 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.224 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.927 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.9 mt -60.55 -50.38 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 CA-C-O 121.486 0.66 . . . . 0.0 109.457 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.579 ' CG2' HG23 ' A' ' 174' ' ' THR . 89.7 m -52.83 -52.01 58.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.756 -177.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.889 HD22 ' HB ' ' A' ' 215' ' ' ILE . 45.2 mt -65.02 -31.36 72.55 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 120.985 0.422 . . . . 0.0 111.415 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -76.86 -44.89 30.35 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.751 0.786 . . . . 0.0 109.743 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.889 ' O ' HG22 ' A' ' 210' ' ' THR . 8.0 tp -71.8 -29.6 64.63 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.301 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' MET . . . . . 0.726 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 41.7 mtp -75.99 -35.42 59.6 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.677 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 3.5 mtmt -61.54 -38.66 88.25 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 114.438 -1.255 . . . . 0.0 111.001 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.889 HG22 ' O ' ' A' ' 207' ' ' LEU . 6.1 t -61.54 -31.64 71.67 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.388 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.598 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 40.6 m-85 -78.74 -5.26 52.74 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.83 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.29 5.62 28.22 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 115.891 1.116 . . . . 0.0 115.891 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.3 m -123.53 148.69 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 118.878 1.339 . . . . 0.0 112.78 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.617 ' O ' HD13 ' A' ' 215' ' ' ILE . 20.4 mt-10 -129.18 140.14 51.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.893 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.889 ' HB ' HD22 ' A' ' 205' ' ' LEU . 16.3 mm -122.76 148.3 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 120.699 0.285 . . . . 0.0 110.314 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.738 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 38.8 tt0 -101.21 115.09 29.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.656 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -81.51 150.78 28.08 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.302 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 222' ' ' GLN . 5.5 tp60 -108.3 -136.7 0.36 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.759 -0.2 . . . . 0.0 111.321 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.403 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 61.0 m80 -84.6 69.53 10.63 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 120.832 0.349 . . . . 0.0 110.307 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.408 ' CE1' ' HG3' ' A' ' 198' ' ' LYS . 4.0 t80 54.16 31.28 13.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 122.11 0.957 . . . . 0.0 109.967 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.676 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -160.69 -128.32 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 113.632 -1.622 . . . . 0.0 106.838 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.735 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -4.53 129.24 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -179.446 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.81 ' CD2' HD11 ' A' ' 177' ' ' LEU . 0.7 OUTLIER -124.44 128.33 48.85 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.104 -1.862 . . . . 0.0 109.091 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.738 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 46.2 t -111.24 114.06 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 121.544 0.688 . . . . 0.0 109.393 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.74 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.4 OUTLIER -124.35 119.91 57.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.181 -178.651 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.652 ' O ' ' HA ' ' A' ' 181' ' ' PRO . 4.0 pttt -74.17 143.41 45.25 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -92.93 -173.15 40.82 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.678 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 62.72 21.13 62.64 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 121.49 -0.386 . . . . 0.0 113.253 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' GLN . . . . . 0.56 ' NE2' ' HB3' ' A' ' 181' ' ' PRO . 47.4 mt-30 -80.68 -172.94 3.88 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.272 0.558 . . . . 0.0 111.361 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 2.3 t -158.18 147.95 19.86 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.625 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' TYR . . . . . 0.727 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 7.8 m-85 -99.04 136.02 39.61 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.149 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' GLN . . . . . 0.401 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 0.1 OUTLIER -123.09 148.02 46.11 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.697 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.502 ' HB2' ' OG1' ' A' ' 39' ' ' THR . 19.5 p -72.47 110.93 9.2 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.575 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.441 ' HD2' ' OG1' ' A' ' 39' ' ' THR . 55.7 Cg_endo -69.95 1.1 4.87 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.195 1.93 . . . . 0.0 112.141 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 100.28 -99.61 2.05 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 93.0 m -120.03 136.82 54.42 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' TYR . . . . . 0.674 ' CD2' HG21 ' A' ' 210' ' ' THR . 10.9 t80 -132.96 128.07 35.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.974 0.416 . . . . 0.0 111.707 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.931 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -92.97 111.87 23.64 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.587 179.526 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.67 ' N ' HD22 ' A' ' 238' ' ' LEU . 21.7 t -85.87 111.68 21.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.143 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.404 ' HG3' HD13 ' A' ' 238' ' ' LEU . 1.6 mt-10 . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.15 -0.928 . . . . 0.0 111.083 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.871 ' HE ' HD23 ' A' ' 207' ' ' LEU . 78.6 mtm-85 . . . . . 0 N--CA 1.452 -0.339 0 CA-C-O 120.982 0.42 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.849 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -43.21 -45.16 5.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.139 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.053 HD22 HD11 ' A' ' 75' ' ' ILE . 9.8 mt -75.54 -33.42 60.68 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.043 0.449 . . . . 0.0 111.154 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.733 HD11 ' CB ' ' A' ' 105' ' ' ALA . 66.1 tp -69.55 -50.11 48.04 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.115 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.889 HD22 ' CZ ' ' A' ' 231' ' ' TYR . 21.4 mt -68.61 -26.8 65.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.94 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.799 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -65.22 -39.35 92.63 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.645 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.856 ' CB ' HG11 ' A' ' 62' ' ' VAL . . . -81.35 -41.32 22.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.071 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.719 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 14.2 mt -67.32 -3.4 7.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.0 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.56 ' HB2' ' HB3' ' A' ' 231' ' ' TYR . . . -98.51 177.89 5.19 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -177.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.548 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.7 OUTLIER -110.87 112.29 24.02 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.787 178.281 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 114.83 167.11 15.46 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.787 ' HE3' HD12 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -94.89 117.83 30.79 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 117.144 0.472 . . . . 0.0 111.55 -179.097 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 235' ' ' GLY . 0.8 OUTLIER -119.61 146.84 45.17 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.94 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.544 HG22 ' HB2' ' A' ' 74' ' ' GLU . 91.8 t -103.55 142.14 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 CA-C-O 121.77 0.795 . . . . 0.0 112.653 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.986 HD23 HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -117.25 116.3 26.99 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 174.437 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.967 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.6 OUTLIER -105.06 152.41 22.79 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.437 -177.32 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.2 t30 66.57 26.67 9.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.098 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.817 HD21 ' HB3' ' A' ' 41' ' ' LEU . 65.1 mt -55.05 -170.82 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.653 ' HB3' HG21 ' A' ' 50' ' ' VAL . 48.9 tp -114.15 131.71 56.34 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.816 0.341 . . . . 0.0 110.245 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -88.98 87.06 7.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.097 0.475 . . . . 0.0 110.738 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.468 ' HB3' ' OD1' ' A' ' 49' ' ' ASP . 27.8 t -164.14 142.61 7.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.06 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.452 ' OD2' ' HB2' ' A' ' 94' ' ' ASN . 33.9 p-10 -36.71 -29.14 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.946 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 37.6 p-10 -60.58 -42.48 96.77 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.187 0.518 . . . . 0.0 110.365 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.653 HG21 ' HB3' ' A' ' 45' ' ' LEU . 99.3 t -82.13 -46.02 19.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.701 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.92 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -49.28 -39.34 30.45 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.465 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.682 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 11.3 m-70 -78.86 -32.33 45.96 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.197 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.611 ' O ' HD13 ' A' ' 57' ' ' LEU . 8.0 tpt -54.2 -37.43 64.53 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 176.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.92 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.3 OUTLIER -80.58 -43.94 19.79 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.666 176.105 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.718 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 2.0 t30 -58.41 -36.41 73.54 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.01 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 1.002 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -63.52 -44.61 93.78 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 122.034 0.921 . . . . 0.0 108.88 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.876 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -64.95 -40.97 95.82 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.558 -1.655 . . . . 0.0 107.011 177.164 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.718 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.2 m -60.19 -31.69 70.38 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 113.757 -1.565 . . . . 0.0 111.233 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.724 ' C ' HD21 ' A' ' 88' ' ' LEU . . . -79.55 -37.53 36.26 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.024 -179.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.709 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.5 OUTLIER -81.73 -14.45 56.5 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.375 0.607 . . . . 0.0 110.765 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.87 33.32 5.04 Favored Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.292 -0.867 . . . . 0.0 114.47 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.876 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 21.6 t -90.44 118.71 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.844 ' O ' HG12 ' A' ' 76' ' ' ILE . 7.5 t -84.03 136.02 34.2 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 120.944 0.402 . . . . 0.0 110.799 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.926 ' HB3' HG23 ' A' ' 75' ' ' ILE . 35.3 p90 -160.71 170.39 20.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.542 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.411 ' N ' ' O ' ' A' ' 74' ' ' GLU . 83.5 m -133.65 147.89 51.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.491 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.519 HD12 ' HB2' ' A' ' 73' ' ' CYS . 10.5 tp -116.56 136.22 53.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.182 0.515 . . . . 0.0 110.956 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.578 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 1.6 m -61.43 -167.44 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.912 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.42 -31.76 18.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.811 0.339 . . . . 0.0 110.926 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.44 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 0.2 OUTLIER -76.64 1.26 17.44 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.266 179.765 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 56.86 27.84 13.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.752 0.31 . . . . 0.0 111.515 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.44 ' OG1' ' HB3' ' A' ' 69' ' ' ASP . 0.9 OUTLIER -127.25 -11.26 5.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.293 179.716 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.578 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 2.1 mtt85 -111.06 121.42 45.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.325 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.626 ' HB3' HD11 ' A' ' 44' ' ' LEU . 40.4 t -130.8 125.14 32.94 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 112.386 0.514 . . . . 0.0 112.386 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.544 ' HB2' HG22 ' A' ' 40' ' ' VAL . 29.7 tt0 -107.72 131.3 54.57 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 176.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 1.053 HD11 HD22 ' A' ' 29' ' ' LEU . 7.8 mt -127.57 123.22 60.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.844 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -68.53 100.93 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 121.682 0.753 . . . . 0.0 109.16 176.027 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -38.88 144.79 0.23 Allowed Glycine 0 C--N 1.32 -0.351 0 CA-C-N 114.415 -1.266 . . . . 0.0 114.16 -178.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.49 ' CB ' HD12 ' A' ' 82' ' ' LEU . 33.6 t30 -90.45 -11.2 41.06 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 120.962 0.41 . . . . 0.0 110.612 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.548 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 86.56 9.18 75.86 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.435 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.402 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 146.51 -151.12 23.42 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.888 -0.673 . . . . 0.0 111.976 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.548 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 9.3 Cg_endo -50.75 128.67 24.87 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.511 2.141 . . . . 0.0 111.805 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.709 ' HB2' HD13 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -77.68 115.04 17.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.304 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.469 ' HA ' ' CG ' ' A' ' 111' ' ' ASN . 4.5 p80 -83.22 134.83 34.94 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.127 0.489 . . . . 0.0 112.022 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.519 ' CB ' HD11 ' A' ' 113' ' ' ILE . . . -96.48 123.57 40.18 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.863 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -71.71 123.65 23.04 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 176.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.93 178.17 1.01 Allowed Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 -175.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 112' ' ' ASP . . . -73.41 144.87 46.19 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 118.601 1.2 . . . . 0.0 111.342 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.751 ' CB ' HG13 ' A' ' 113' ' ' ILE . 0.9 OUTLIER -112.94 161.08 17.41 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.064 -178.491 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 4.1 mt-10 -143.0 102.8 4.07 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.108 177.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.828 ' HB2' HD23 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -98.29 122.08 41.01 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.779 -178.696 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.641 ' C ' HD13 ' A' ' 92' ' ' LEU . 18.3 m-85 -96.07 96.58 8.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.694 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 1.026 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -114.29 57.93 0.69 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.193 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.827 ' HA3' ' H ' ' A' ' 118' ' ' GLU . . . -59.64 -48.42 86.12 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.145 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.452 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 0.1 OUTLIER -94.87 -2.18 51.23 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.642 0.258 . . . . 0.0 110.687 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 1.026 ' HB3' ' HB3' ' A' ' 92' ' ' LEU . . . -92.63 45.53 1.2 Allowed 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.803 0.335 . . . . 0.0 110.989 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.664 ' O ' ' HD3' ' A' ' 100' ' ' ARG . . . -53.14 -23.26 16.2 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.352 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.751 HG22 ' OE1' ' A' ' 171' ' ' GLN . 15.9 p -88.7 -19.02 26.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.414 0.149 . . . . 0.0 111.037 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.875 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -98.12 -26.83 14.45 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.627 ' SD ' ' HB3' ' A' ' 115' ' ' LEU . 9.8 tpp -63.92 -44.03 94.13 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.712 0.291 . . . . 0.0 111.016 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.784 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 1.1 mpt_? -60.72 -55.74 41.9 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.784 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 23.7 Cg_exo -61.16 -32.14 90.77 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 121.633 1.555 . . . . 0.0 111.411 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 1.002 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -74.62 -53.31 9.59 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.804 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.86 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -51.58 -28.57 14.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.523 0.678 . . . . 0.0 110.236 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.72 ' HB2' ' HB1' ' A' ' 175' ' ' ALA . . . -86.76 -53.85 4.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.807 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.733 ' CB ' HD11 ' A' ' 30' ' ' LEU . . . -59.82 -28.06 67.14 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -176.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.627 ' HB2' HD12 ' A' ' 153' ' ' LEU . 35.2 mt -81.62 -28.16 33.82 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.139 -177.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.754 ' HB2' ' HB1' ' A' ' 138' ' ' ALA . 12.4 p -72.95 12.26 0.55 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.189 0.519 . . . . 0.0 111.085 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.713 ' HG ' HG23 ' A' ' 179' ' ' THR . 1.4 mt -79.81 -76.6 0.21 Allowed 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.083 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.505 ' O ' ' HA3' ' A' ' 155' ' ' GLY . . . -71.78 -117.54 0.05 OUTLIER Glycine 0 N--CA 1.454 -0.146 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.884 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -150.9 96.85 2.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.964 0.411 . . . . 0.0 110.884 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.684 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 18.6 m-80 -149.06 139.37 22.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.273 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.872 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 1.9 m-20 -94.34 96.32 9.46 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.046 0.45 . . . . 0.0 110.126 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.751 HG13 ' CB ' ' A' ' 88' ' ' LEU . 1.4 mp -118.99 144.21 27.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.48 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.814 HG13 HD23 ' A' ' 143' ' ' LEU . 47.8 t -110.05 112.95 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.828 HD23 ' HB2' ' A' ' 90' ' ' LEU . 59.7 mt -101.98 106.67 17.62 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.02 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.838 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.7 OUTLIER -122.66 -172.15 2.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.165 -178.709 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.684 ' H ' HG22 ' A' ' 116' ' ' THR . . . -167.07 179.05 41.01 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.832 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.827 ' H ' ' HA3' ' A' ' 93' ' ' GLY . 8.4 pt-20 -71.16 173.51 4.87 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 123.277 0.631 . . . . 0.0 110.549 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.789 ' HD2' ' HB2' ' A' ' 118' ' ' GLU . 7.6 Cg_endo -47.47 -36.61 24.28 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.699 2.266 . . . . 0.0 113.606 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.479 ' CG ' ' HG3' ' A' ' 118' ' ' GLU . 0.4 OUTLIER -67.37 -25.06 65.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.905 0.383 . . . . 0.0 110.443 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.651 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 8.1 tpt -60.55 -35.53 76.26 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.629 ' HE3' ' HG2' ' A' ' 149' ' ' PRO . 0.1 OUTLIER -62.51 -16.84 57.88 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.995 179.266 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.668 ' O ' ' HG3' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -85.06 -1.85 57.31 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.186 0.517 . . . . 0.0 109.645 178.944 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.662 ' HB3' HH22 ' A' ' 100' ' ' ARG . 1.3 mpt_? -126.12 86.35 58.08 Favored Pre-proline 0 CA--C 1.531 0.25 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.746 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.557 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 17.9 Cg_endo -58.7 148.71 81.32 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.677 2.251 . . . . 0.0 111.696 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.483 ' O ' HG13 ' A' ' 126' ' ' ILE . 0.7 OUTLIER -123.01 -0.13 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.194 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.632 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -53.98 -34.7 52.47 Favored Glycine 0 CA--C 1.516 0.12 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.513 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.503 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 57.4 m80 -58.5 -40.01 81.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.163 0.506 . . . . 0.0 110.851 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.847 ' HG ' HD11 ' A' ' 133' ' ' LEU . 34.0 tp -75.33 -39.28 59.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.202 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.72 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 54.8 t -56.91 -47.78 82.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.555 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.764 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 77.7 m-20 -71.23 -38.5 71.96 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.472 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.448 ' HA ' HG13 ' A' ' 162' ' ' VAL . . . -60.15 -44.66 94.81 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.534 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.847 HD11 ' HG ' ' A' ' 129' ' ' LEU . 5.7 mt -75.73 -50.27 15.79 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 121.086 0.47 . . . . 0.0 110.66 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.72 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -57.81 -28.3 63.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.055 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.764 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 5.5 tp -67.63 -30.97 70.68 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-O 121.004 0.431 . . . . 0.0 110.312 178.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 159' ' ' GLY . . . -81.4 12.75 37.64 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.892 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.16 3.74 63.33 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.459 -0.876 . . . . 0.0 112.429 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.754 ' HB1' ' HB2' ' A' ' 107' ' ' CYS . . . -73.88 153.87 39.67 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.837 0.351 . . . . 0.0 111.654 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 9.4 mttp -100.85 104.58 15.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.643 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.641 ' CG2' HG13 ' A' ' 130' ' ' VAL . 30.3 mt -136.27 125.23 37.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.954 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.914 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -124.15 139.99 53.4 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.005 0.431 . . . . 0.0 110.554 -179.483 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.52 ' CE1' HG21 ' A' ' 130' ' ' VAL . 43.7 m-85 -79.6 132.07 36.17 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.358 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.814 HD23 HG13 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -96.46 -88.5 0.28 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.795 -179.578 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.722 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 36.0 mt-10 -57.38 -80.98 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.546 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.567 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 15.0 mt-30 -117.77 148.95 41.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.991 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.64 135.22 56.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.951 0.405 . . . . 0.0 110.154 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.632 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 5.6 m-20 65.93 20.05 11.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.293 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.598 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 14.5 m-85 -111.72 169.25 6.53 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 121.202 0.525 . . . . 0.0 111.838 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.96 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 21.8 Cg_exo -31.19 -65.36 0.09 OUTLIER 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 124.385 3.39 . . . . 0.0 116.271 -178.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.96 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 72.3 Cg_exo -50.84 145.95 22.53 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 121.186 1.257 . . . . 0.0 113.305 -178.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.786 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 7.3 mt -156.49 136.64 12.82 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.422 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.914 ' HB2' HG22 ' A' ' 141' ' ' THR . 4.3 mtt180 -106.81 102.25 11.63 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.872 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 9.8 mt -92.53 145.53 24.37 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.909 -178.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.684 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 6.8 mt-30 -148.33 24.98 1.0 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.455 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 55.19 -166.99 2.79 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.53 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.425 ' O ' HG23 ' A' ' 158' ' ' THR . . . 112.6 -14.44 24.84 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.16 -1.019 . . . . 0.0 113.387 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.647 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 4.3 t80 -58.69 122.6 13.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.434 0.617 . . . . 0.0 110.395 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.691 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 82.0 p -115.86 -26.75 7.25 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 121.375 0.607 . . . . 0.0 111.39 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.458 ' O ' ' HA2' ' A' ' 136' ' ' GLY . . . 132.66 -159.62 23.51 Favored Glycine 0 N--CA 1.438 -1.189 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.346 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.559 ' O ' HG23 ' A' ' 187' ' ' THR . . . 104.77 151.99 21.49 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.729 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -46.29 116.36 1.25 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.01 -0.595 . . . . 0.0 110.66 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.76 ' HB ' HG13 ' A' ' 189' ' ' ILE . 79.2 t -108.81 137.94 38.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.693 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.41 119.67 39.49 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.629 -0.429 . . . . 0.0 110.796 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 1.077 HG21 HD11 ' A' ' 176' ' ' LEU . 1.7 t -130.25 119.96 47.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.418 ' HA ' ' CG ' ' A' ' 192' ' ' LYS . 4.1 t70 -59.56 141.71 54.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.942 0.401 . . . . 0.0 110.797 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.846 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.373 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.219 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.117 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.771 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 0.1 OUTLIER -88.17 -14.72 37.94 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.399 -178.998 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.813 ' HA ' HD13 ' A' ' 129' ' ' LEU . 8.4 m-85 -72.54 -49.8 30.14 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.472 0.653 . . . . 0.0 109.545 178.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.786 ' HG ' HG11 ' A' ' 164' ' ' VAL . 0.5 OUTLIER -70.46 -43.7 69.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.39 178.926 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.606 HG21 ' HD3' ' A' ' 27' ' ' ARG . 1.5 m -56.79 -34.58 67.79 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.458 178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.755 ' HB3' HD11 ' A' ' 129' ' ' LEU . . . -63.98 -39.78 94.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.493 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 1.077 HD11 HG21 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -77.01 -33.82 57.48 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.496 179.4 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.863 ' O ' ' HE1' ' A' ' 208' ' ' MET . 3.0 mp -59.56 -37.96 79.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.384 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.735 ' HE1' ' HG2' ' A' ' 27' ' ' ARG . 1.9 mtp -82.02 -43.12 18.38 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.47 0.652 . . . . 0.0 112.498 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.713 HG23 ' HG ' ' A' ' 108' ' ' LEU . 100.0 m -72.94 -43.25 62.56 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.792 -1.094 . . . . 0.0 113.077 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.603 ' HB1' ' HB ' ' A' ' 187' ' ' THR . . . -59.33 -38.98 68.87 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -177.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.561 ' HD3' HG21 ' A' ' 225' ' ' VAL . 33.6 Cg_endo -66.29 -28.34 47.42 Favored 'Trans proline' 0 CA--C 1.501 -1.129 0 C-N-CA 120.904 1.069 . . . . 0.0 111.37 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.66 ' HB2' HD21 ' A' ' 108' ' ' LEU . 7.3 mt -84.72 1.82 44.78 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.913 -1.039 . . . . 0.0 109.206 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.612 ' HB1' ' C ' ' A' ' 158' ' ' THR . . . -83.15 135.2 44.86 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.03 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.691 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 10.8 Cg_endo -49.23 -32.12 24.17 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.54 2.16 . . . . 0.0 113.015 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -115.03 140.16 49.28 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.586 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -55.61 145.65 22.85 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.301 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.603 ' HB ' ' HB1' ' A' ' 180' ' ' ALA . 86.3 m -122.39 144.0 49.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.231 0.539 . . . . 0.0 112.335 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.698 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 50.3 t -125.11 118.18 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 176.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.841 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 4.9 mp -101.56 117.47 46.9 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.93 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.596 ' HB2' ' HG3' ' A' ' 222' ' ' GLN . 0.2 OUTLIER -100.43 124.19 45.61 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.103 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.846 HG23 ' HA2' ' A' ' 166' ' ' GLY . 1.6 mp -93.52 123.33 45.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.96 -176.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.418 ' CG ' ' HA ' ' A' ' 165' ' ' ASP . 38.0 mttt -80.08 97.23 6.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.002 -1.454 . . . . 0.0 110.47 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 98.39 -133.92 11.51 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.171 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.07 125.73 52.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.225 0.536 . . . . 0.0 111.719 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.634 HD11 ' HZ ' ' A' ' 223' ' ' PHE . 1.9 mt -41.84 145.66 0.31 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.55 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 8.0 p -70.57 -29.12 37.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.725 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.465 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 28.6 t -168.16 65.49 0.07 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.98 0.419 . . . . 0.0 110.737 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.678 ' N ' ' HD2' ' A' ' 199' ' ' PRO . 2.5 tmpt? -37.26 -47.46 2.07 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.806 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' PRO . . . . . 0.678 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 4.8 Cg_endo -47.31 -34.06 17.78 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.376 2.051 . . . . 0.0 111.434 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.955 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.2 OUTLIER -67.11 -43.49 82.34 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.685 0.755 . . . . 0.0 109.065 178.072 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.752 HG21 ' HE2' ' A' ' 223' ' ' PHE . 27.8 mm -64.44 -32.46 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.921 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.74 -41.94 95.56 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.796 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.955 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.4 mt -61.47 -50.14 81.57 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 CA-C-O 121.701 0.762 . . . . 0.0 109.41 178.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.633 HG22 ' SD ' ' A' ' 208' ' ' MET . 100.0 m -53.71 -52.32 60.45 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.119 -178.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.938 HD22 ' HB ' ' A' ' 215' ' ' ILE . 44.6 mt -65.99 -30.79 71.4 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.109 0.481 . . . . 0.0 111.56 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -77.2 -46.71 22.4 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.772 0.796 . . . . 0.0 109.715 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.871 HD23 ' HE ' ' A' ' 27' ' ' ARG . 3.3 tp -70.34 -29.55 66.28 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.242 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' MET . . . . . 0.863 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 49.8 mtp -73.85 -34.14 64.39 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.591 0.71 . . . . 0.0 109.194 177.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.76 ' HE2' ' O ' ' A' ' 205' ' ' LEU . 5.1 mtmm -61.59 -40.17 93.82 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.236 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.866 HG22 ' O ' ' A' ' 207' ' ' LEU . 4.7 t -60.52 -28.35 68.33 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.069 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.716 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 49.5 m-85 -80.25 -7.67 59.11 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.519 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.7 7.64 25.47 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 115.503 0.961 . . . . 0.0 115.503 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.696 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 5.3 m -123.42 148.83 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 118.775 1.287 . . . . 0.0 112.811 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.589 ' HG2' ' CG ' ' A' ' 209' ' ' LYS . 4.7 mt-10 -130.22 138.19 50.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.818 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.976 HD12 ' HB ' ' A' ' 225' ' ' VAL . 22.1 mm -122.41 147.74 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-O 120.836 0.35 . . . . 0.0 110.236 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.708 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 20.5 tt0 -103.63 115.86 31.29 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.774 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.51 149.44 27.54 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.588 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' GLN . . . . . 0.744 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -108.07 -144.86 0.39 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.597 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 8.1 m-70 -72.66 65.3 0.68 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.917 0.389 . . . . 0.0 111.523 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 1.7 t80 56.52 32.73 21.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.838 0.827 . . . . 0.0 110.609 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.662 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 9.1 pt20 -159.78 -126.22 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.841 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.4 OUTLIER -10.11 134.98 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 115.024 1.491 . . . . 0.0 115.024 -179.671 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.752 ' HE2' HG21 ' A' ' 201' ' ' ILE . 0.9 OUTLIER -126.31 138.24 53.57 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 113.032 -1.894 . . . . 0.0 110.139 -179.518 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.708 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 36.9 t -118.24 114.19 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.976 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.5 OUTLIER -122.4 120.39 60.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.806 -178.945 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.611 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -74.65 122.74 23.66 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.517 179.232 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -74.39 -173.39 29.78 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.251 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 62.23 19.65 59.78 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 121.401 -0.428 . . . . 0.0 113.158 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' GLN . . . . . 0.611 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 47.1 mt-30 -75.52 -171.96 1.67 Allowed 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.347 0.594 . . . . 0.0 111.006 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 23.3 t -155.55 147.45 23.32 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.133 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' TYR . . . . . 0.889 ' CZ ' HD22 ' A' ' 31' ' ' LEU . 2.2 m-30 -102.01 134.97 44.38 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.7 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' GLN . . . . . 0.427 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 2.6 mt-30 -126.21 145.55 50.34 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.428 ' HB2' ' OG1' ' A' ' 39' ' ' THR . 25.0 p -72.39 109.42 5.88 Favored Pre-proline 0 N--CA 1.445 -0.685 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.7 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.515 ' HG3' HG23 ' A' ' 210' ' ' THR . 43.5 Cg_endo -66.75 0.1 3.98 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.865 1.71 . . . . 0.0 112.185 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 101.38 -102.55 2.41 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.498 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 90.0 m -117.3 132.86 56.52 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' TYR . . . . . 0.637 ' CD2' HG21 ' A' ' 210' ' ' THR . 6.5 t80 -132.64 127.42 34.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.129 0.49 . . . . 0.0 111.696 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.967 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -90.16 113.0 24.69 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.396 179.391 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.672 ' N ' HD22 ' A' ' 238' ' ' LEU . 21.2 t -85.78 111.38 20.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.622 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.447 ' HG2' HD11 ' A' ' 238' ' ' LEU . 32.5 mt-10 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.235 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.577 ' HE ' HD23 ' A' ' 207' ' ' LEU . 16.4 mtm-85 . . . . . 0 N--CA 1.455 -0.203 0 CA-C-O 120.823 0.344 . . . . 0.0 110.989 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.761 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -35.55 -47.97 0.48 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.643 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.031 HD22 HD11 ' A' ' 75' ' ' ILE . 9.8 mt -73.48 -34.44 65.33 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.872 0.368 . . . . 0.0 111.433 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.819 HD22 ' HB2' ' A' ' 101' ' ' PRO . 54.3 tp -68.46 -50.1 54.98 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.732 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.713 HD13 ' HA ' ' A' ' 208' ' ' MET . 49.0 mt -68.23 -26.71 65.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.583 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.779 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -65.63 -38.27 88.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.552 178.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.714 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . . . -81.26 -41.53 22.05 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.996 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.803 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 9.9 mt -68.93 -2.91 10.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.279 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.538 ' HA ' ' CB ' ' A' ' 231' ' ' TYR . . . -100.13 179.26 4.54 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -176.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.582 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.3 OUTLIER -112.59 113.83 26.17 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.012 178.615 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.11 166.85 16.68 Favored Glycine 0 C--N 1.322 -0.243 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.321 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.616 ' HG3' HD13 ' A' ' 76' ' ' ILE . 1.1 ttmt -95.37 117.68 30.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 117.155 0.478 . . . . 0.0 111.59 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.585 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 0.8 OUTLIER -117.73 148.59 41.87 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.387 179.59 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.515 HG22 ' HB2' ' A' ' 74' ' ' GLU . 92.4 t -105.47 141.27 21.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.144 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.931 HD23 HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -114.8 116.27 28.34 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 174.855 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.984 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.5 OUTLIER -102.84 151.67 22.16 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.869 0.366 . . . . 0.0 111.437 -177.48 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 64.97 28.29 12.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.844 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.778 HD11 ' HB3' ' A' ' 73' ' ' CYS . 91.4 mt -53.55 -174.26 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.195 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.528 ' HB3' HG21 ' A' ' 50' ' ' VAL . 56.6 tp -113.19 131.42 55.88 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -88.89 88.76 7.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.98 0.419 . . . . 0.0 110.323 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 50' ' ' VAL . 6.2 m -164.76 143.15 6.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.116 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.406 ' HA ' ' HB3' ' A' ' 51' ' ' ARG . 1.2 m-20 -36.34 -30.95 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 O-C-N 123.046 0.216 . . . . 0.0 111.575 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.858 ' OD1' HG23 ' A' ' 50' ' ' VAL . 1.4 p30 -57.78 -42.57 84.39 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-O 121.103 0.478 . . . . 0.0 110.617 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.858 HG23 ' OD1' ' A' ' 49' ' ' ASP . 74.6 t -83.91 -44.44 18.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.115 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.876 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -50.21 -39.18 43.44 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.803 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.618 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 9.6 m-70 -80.39 -32.43 37.58 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.771 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.526 ' O ' HD13 ' A' ' 57' ' ' LEU . 8.4 tpt -54.79 -34.64 62.92 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 176.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.876 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -83.49 -44.06 15.12 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.902 176.34 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.686 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 1.7 t30 -59.23 -37.8 78.43 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.816 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 1.054 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -62.15 -47.78 83.03 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.868 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.2 OUTLIER -61.42 -40.95 96.32 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.161 -1.382 . . . . 0.0 107.556 177.001 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.686 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.1 m -59.31 -33.93 71.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.056 -1.429 . . . . 0.0 111.417 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.734 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -78.34 -38.39 42.19 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.318 -178.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.714 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.6 OUTLIER -79.49 -14.37 58.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.42 0.629 . . . . 0.0 110.531 -179.626 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.77 35.78 4.48 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 114.938 -1.028 . . . . 0.0 113.854 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.868 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 25.0 t -90.41 121.29 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.782 ' O ' HG12 ' A' ' 76' ' ' ILE . 6.8 t -86.06 135.67 33.53 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.143 0.497 . . . . 0.0 111.148 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.8 ' HB3' HG23 ' A' ' 75' ' ' ILE . 36.0 p90 -161.99 172.29 16.22 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.324 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.9 m -134.66 147.32 50.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.321 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.552 HD21 ' HA ' ' A' ' 70' ' ' ARG . 5.5 tp -117.79 138.28 52.17 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.163 0.506 . . . . 0.0 110.852 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.525 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 1.1 m -63.88 -164.51 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.94 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -93.18 -34.04 13.76 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.438 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.52 1.06 15.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.661 0.267 . . . . 0.0 111.276 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.552 ' HA ' HD21 ' A' ' 66' ' ' LEU . 0.3 OUTLIER 57.6 39.86 27.25 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.943 0.402 . . . . 0.0 111.059 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.502 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 1.1 p -139.18 -10.52 1.27 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.441 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.525 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 7.6 mtt180 -114.16 117.67 31.85 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.778 ' HB3' HD11 ' A' ' 44' ' ' LEU . 13.9 t -130.08 128.91 42.86 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.585 ' HA ' ' O ' ' A' ' 39' ' ' THR . 29.0 tt0 -112.11 128.95 56.36 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 176.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 1.031 HD11 HD22 ' A' ' 29' ' ' LEU . 16.2 mt -124.22 123.35 66.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -178.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.782 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -68.73 97.92 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-O 121.427 0.632 . . . . 0.0 109.664 175.833 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 35' ' ' ALA . . . -37.82 144.25 0.19 Allowed Glycine 0 C--N 1.322 -0.237 0 CA-C-N 114.804 -1.089 . . . . 0.0 113.974 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.17 -10.87 42.89 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.957 0.408 . . . . 0.0 110.91 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.582 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 93.36 -1.35 69.49 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.921 -0.582 . . . . 0.0 112.6 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.551 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 154.69 -145.96 13.58 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.172 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.599 ' HG3' ' HB3' ' A' ' 108' ' ' LEU . 53.7 Cg_exo -49.8 124.84 13.12 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.74 2.293 . . . . 0.0 112.718 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.714 ' HB2' HD13 ' A' ' 60' ' ' LEU . 0.9 OUTLIER -77.25 106.38 8.94 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.637 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -81.92 138.77 34.94 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.519 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.617 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -100.38 126.96 46.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.955 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.77 123.69 22.53 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 176.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.62 174.2 0.76 Allowed Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 -175.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.84 144.69 47.37 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 118.588 1.194 . . . . 0.0 111.556 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.734 HD21 ' HB1' ' A' ' 59' ' ' ALA . 1.2 tp -116.43 160.43 20.57 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.224 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 2.3 mt-10 -138.77 102.99 4.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.078 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.665 ' HB2' HD23 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -98.77 120.85 39.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.152 -178.716 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.451 ' CE1' ' HB ' ' A' ' 116' ' ' THR . 0.2 OUTLIER -94.1 96.67 9.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.572 179.217 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.613 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -104.35 56.7 0.71 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.952 -179.822 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.629 ' CA ' ' H ' ' A' ' 118' ' ' GLU . . . -62.92 -70.01 1.16 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.017 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 3.3 m-80 -76.04 18.47 0.27 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.356 -0.238 . . . . 0.0 110.356 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.732 ' HA ' ' HB3' ' A' ' 49' ' ' ASP . . . -93.59 -70.62 0.69 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.38 -66.82 0.25 Allowed Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.093 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.483 ' HA ' ' HG2' ' A' ' 171' ' ' GLN . 8.4 p -71.88 -8.15 52.66 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.728 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -99.65 -34.46 10.2 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.577 0.227 . . . . 0.0 111.468 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.7 -45.58 89.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.755 0.312 . . . . 0.0 110.193 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.838 ' HE ' HD12 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -52.73 -60.88 5.55 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.142 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.819 ' HB2' HD22 ' A' ' 30' ' ' LEU . 19.5 Cg_endo -60.13 -30.61 91.78 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.342 2.028 . . . . 0.0 112.646 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 1.054 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -75.91 -53.31 8.61 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.159 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.9 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -49.45 -27.98 4.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.227 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.934 ' HB2' ' HB1' ' A' ' 175' ' ' ALA . . . -87.1 -54.1 4.5 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.787 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.636 ' HB1' HD11 ' A' ' 34' ' ' LEU . . . -60.6 -31.19 70.37 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -177.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.717 HD13 HG13 ' A' ' 113' ' ' ILE . 30.3 mt -79.27 -21.61 45.85 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.509 -177.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.752 ' SG ' HD22 ' A' ' 153' ' ' LEU . 89.8 m -82.18 17.94 1.52 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.198 0.523 . . . . 0.0 111.186 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.761 HD21 ' HB2' ' A' ' 182' ' ' LEU . 2.8 mt -81.23 -77.0 0.22 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.275 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.14 -109.0 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.392 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 m -156.79 96.69 1.64 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.08 0.467 . . . . 0.0 111.108 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.518 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 37.8 p-10 -147.0 139.19 24.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.174 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.886 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 2.5 m-20 -90.87 101.0 13.76 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.771 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.717 HG13 HD13 ' A' ' 106' ' ' LEU . 28.7 mm -120.81 137.59 54.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.574 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.813 HG13 ' CD2' ' A' ' 143' ' ' LEU . 58.0 t -110.22 112.29 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 175.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.665 HD23 ' HB2' ' A' ' 90' ' ' LEU . 24.9 mt -102.27 107.09 18.01 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.608 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.764 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.7 OUTLIER -117.38 -173.91 2.51 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.087 -179.085 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.661 ' H ' HG22 ' A' ' 116' ' ' THR . . . -163.14 -174.54 33.16 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.921 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.629 ' H ' ' CA ' ' A' ' 93' ' ' GLY . 15.1 mt-10 -76.77 172.7 8.95 Favored Pre-proline 0 C--N 1.328 -0.352 0 C-N-CA 122.853 0.461 . . . . 0.0 110.582 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.576 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 87.4 Cg_exo -47.52 -38.6 28.2 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.448 2.099 . . . . 0.0 112.488 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 38.8 mtm180 -69.25 -23.19 63.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.962 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.714 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 11.0 tpt -60.69 -31.86 71.11 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -16.88 63.27 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.768 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 120' ' ' ARG . 3.4 mm-40 -82.56 -0.54 47.3 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.775 0.321 . . . . 0.0 110.534 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.416 ' O ' ' NH2' ' A' ' 100' ' ' ARG . 3.5 mtp85 -127.44 87.1 57.03 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.892 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.465 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 18.4 Cg_endo -59.51 148.81 85.5 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.519 2.146 . . . . 0.0 111.399 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.838 HD12 ' HE ' ' A' ' 100' ' ' ARG . 0.6 OUTLIER -120.48 6.08 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.908 0.385 . . . . 0.0 111.947 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.636 ' HA3' ' OD1' ' A' ' 147' ' ' ASN . . . -55.55 -44.14 85.74 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.94 -0.648 . . . . 0.0 114.179 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.482 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 60.0 m-70 -55.63 -36.26 66.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 117.442 0.621 . . . . 0.0 110.06 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.806 HD11 ' HB3' ' A' ' 175' ' ' ALA . 21.5 tp -75.85 -43.27 46.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.143 0.497 . . . . 0.0 110.162 178.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.779 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 40.5 t -56.4 -47.78 80.94 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.385 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.725 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 0.1 OUTLIER -70.95 -36.23 72.49 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.405 -179.702 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.548 ' HB1' ' CG1' ' A' ' 162' ' ' VAL . . . -61.65 -50.27 73.21 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.803 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.728 HD11 ' HG ' ' A' ' 129' ' ' LEU . 9.7 mt -70.74 -48.0 56.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.933 178.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.779 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -59.22 -27.38 65.69 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.72 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.725 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.5 OUTLIER -68.47 -31.72 71.22 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.966 0.412 . . . . 0.0 110.759 178.873 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.559 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -83.84 14.71 41.24 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.894 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.69 3.87 62.3 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.589 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.667 ' HB1' ' HB3' ' A' ' 107' ' ' CYS . . . -71.9 150.45 44.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.884 0.373 . . . . 0.0 111.298 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 0.5 OUTLIER -98.88 102.97 14.87 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.122 178.906 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.596 HG21 HG22 ' A' ' 130' ' ' VAL . 8.8 mt -134.77 126.93 48.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.264 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.729 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -124.35 139.44 53.9 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.204 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.588 ' CE1' HG11 ' A' ' 130' ' ' VAL . 33.6 m-85 -79.03 130.04 35.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.121 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.883 HD11 ' HG3' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -91.72 -89.04 0.18 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.542 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.636 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 6.3 mm-40 -59.67 -81.19 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.529 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.452 ' O ' ' HB2' ' A' ' 148' ' ' TYR . 18.5 mt-30 -113.91 151.49 32.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.128 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -67.25 137.52 56.21 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.636 ' OD1' ' HA3' ' A' ' 127' ' ' GLY . 7.9 m-80 65.55 19.13 11.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.138 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.522 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 8.2 m-85 -110.14 168.88 7.0 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-O 121.105 0.479 . . . . 0.0 112.167 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.915 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 37.8 Cg_exo -32.49 -62.27 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 124.409 3.406 . . . . 0.0 116.087 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.915 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 66.6 Cg_exo -54.86 145.26 62.71 Favored 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-N 120.515 1.219 . . . . 0.0 112.747 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.797 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 12.3 mt -156.17 133.97 11.1 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.602 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.883 ' HG3' HD11 ' A' ' 143' ' ' LEU . 3.2 mtt180 -105.74 102.68 12.11 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 176.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.9 HD11 ' HA ' ' A' ' 103' ' ' ALA . 10.0 mt -91.73 147.97 22.59 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.941 -178.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.579 ' HG3' ' O ' ' A' ' 153' ' ' LEU . 3.5 mt-30 -148.73 27.48 0.89 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.352 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 51.73 -175.61 0.12 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.162 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.426 ' O ' HG23 ' A' ' 158' ' ' THR . . . 121.46 -11.81 9.65 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.182 -1.009 . . . . 0.0 112.817 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.823 ' HE2' ' HA ' ' A' ' 180' ' ' ALA . 50.8 t80 -59.78 123.14 16.05 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.006 0.403 . . . . 0.0 110.832 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.697 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 81.4 p -118.38 -28.43 5.75 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.301 0.572 . . . . 0.0 111.682 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.493 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 134.35 -161.73 24.47 Favored Glycine 0 C--N 1.308 -1.02 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.503 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.59 ' O ' HG23 ' A' ' 187' ' ' THR . . . 105.21 153.3 21.68 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.351 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -47.09 119.39 2.54 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.292 -0.454 . . . . 0.0 111.077 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.662 ' HB ' HG13 ' A' ' 189' ' ' ILE . 78.7 t -111.28 134.96 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.48 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.44 119.65 39.46 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.269 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.789 HG21 HD11 ' A' ' 176' ' ' LEU . 1.0 OUTLIER -131.14 120.13 46.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.05 0.453 . . . . 0.0 110.424 179.453 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.413 ' CG ' ' HD2' ' A' ' 192' ' ' LYS . 1.9 m-20 -52.18 137.43 28.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.466 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.854 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.962 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.75 ' HB3' ' HB3' ' A' ' 197' ' ' SER . 53.3 p . . . . . 0 CA--C 1.521 -0.137 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.688 ' HB3' ' CB ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -86.53 -10.15 54.66 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.28 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.654 ' HA ' HD13 ' A' ' 129' ' ' LEU . 3.6 m-85 -75.02 -53.0 9.68 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.861 HD11 ' CG1' ' A' ' 191' ' ' ILE . 0.9 OUTLIER -65.9 -39.97 91.09 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.112 178.409 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.509 HG23 ' CG2' ' A' ' 204' ' ' THR . 1.8 m -60.15 -32.24 70.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.354 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.934 ' HB1' ' HB2' ' A' ' 104' ' ' ALA . . . -66.81 -41.48 87.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.44 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.795 HD12 ' HA ' ' A' ' 173' ' ' LEU . 0.2 OUTLIER -76.31 -35.42 58.83 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.794 -179.809 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.824 HD11 ' CD2' ' A' ' 223' ' ' PHE . 4.1 mp -59.59 -36.82 77.01 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.514 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.566 ' HA ' ' HE1' ' A' ' 208' ' ' MET . 2.6 mtp -81.88 -45.35 15.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.559 0.695 . . . . 0.0 112.219 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.67 HG23 ' HG ' ' A' ' 108' ' ' LEU . 93.0 m -70.9 -42.04 70.5 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.739 -1.119 . . . . 0.0 112.596 -178.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.823 ' HA ' ' HE2' ' A' ' 157' ' ' PHE . . . -59.86 -41.62 86.43 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.577 ' HD3' ' O ' ' A' ' 177' ' ' LEU . 17.9 Cg_endo -63.88 -30.07 67.65 Favored 'Trans proline' 0 CA--C 1.502 -1.122 0 C-N-CA 120.822 1.015 . . . . 0.0 111.321 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.761 ' HB2' HD21 ' A' ' 108' ' ' LEU . 10.8 mt -84.5 2.9 38.91 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.701 178.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.645 ' HB1' ' C ' ' A' ' 158' ' ' THR . . . -84.74 135.94 39.78 Favored Pre-proline 0 N--CA 1.454 -0.237 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.697 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 14.2 Cg_endo -52.51 -29.7 41.33 Favored 'Trans proline' 0 CA--C 1.518 -0.316 0 C-N-CA 122.523 2.149 . . . . 0.0 112.95 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.5 138.37 50.69 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.587 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -55.94 142.9 33.91 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.353 -0.385 . . . . 0.0 109.99 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 160' ' ' GLY . 88.8 m -120.89 147.45 45.4 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.871 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.671 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 55.1 t -128.26 117.84 46.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 176.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.819 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 5.2 mp -99.82 117.7 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.906 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.586 ' HB2' ' HG3' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -100.63 123.63 45.1 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.861 ' CG1' HD11 ' A' ' 173' ' ' LEU . 1.5 mp -93.77 121.16 44.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.454 -176.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.413 ' HD2' ' CG ' ' A' ' 165' ' ' ASP . 58.4 mttt -79.08 96.95 5.95 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.824 -1.534 . . . . 0.0 110.648 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 100.24 -132.73 11.04 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.958 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -114.09 127.52 55.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.051 0.453 . . . . 0.0 111.267 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.862 HD11 ' HZ ' ' A' ' 223' ' ' PHE . 1.1 mt -42.33 145.22 0.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.917 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 12.9 p -71.61 -29.92 36.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.346 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.75 ' HB3' ' HB3' ' A' ' 170' ' ' SER . 5.9 t -164.92 62.15 0.13 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.84 0.352 . . . . 0.0 111.174 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.651 ' N ' ' HD2' ' A' ' 199' ' ' PRO . 13.5 tptp -36.45 -49.08 1.8 Allowed Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.571 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' PRO . . . . . 0.651 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 6.3 Cg_endo -48.0 -34.69 23.56 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.097 1.864 . . . . 0.0 112.178 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.981 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.2 OUTLIER -68.34 -44.82 74.46 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.551 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.537 HG21 ' HE2' ' A' ' 223' ' ' PHE . 19.2 mm -59.84 -35.68 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.194 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.6 -41.53 97.58 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.014 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.981 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.1 mt -63.98 -49.27 82.38 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.915 0 CA-C-O 121.711 0.767 . . . . 0.0 109.233 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.52 HG22 ' SD ' ' A' ' 208' ' ' MET . 88.5 m -53.6 -51.19 63.82 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.933 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.902 HD22 ' HB ' ' A' ' 215' ' ' ILE . 33.4 mt -65.24 -32.7 74.5 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 120.541 -0.464 . . . . 0.0 111.465 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -76.89 -46.04 25.9 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.717 0.77 . . . . 0.0 109.414 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.938 ' O ' HG22 ' A' ' 210' ' ' THR . 4.4 tp -67.41 -33.28 74.84 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.595 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' MET . . . . . 0.754 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 42.9 mtp -74.99 -33.89 61.91 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.62 0.724 . . . . 0.0 109.232 177.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.654 ' HE2' ' O ' ' A' ' 205' ' ' LEU . 4.5 mtmt -61.35 -39.05 89.16 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.667 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.938 HG22 ' O ' ' A' ' 207' ' ' LEU . 5.8 t -61.93 -27.21 68.66 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.422 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.653 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 57.0 m-85 -84.07 -6.74 59.46 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.627 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.97 6.87 25.87 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 116.282 1.273 . . . . 0.0 116.282 177.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.597 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.6 m -123.17 148.41 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 118.973 1.387 . . . . 0.0 112.198 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.557 ' O ' HD13 ' A' ' 215' ' ' ILE . 10.9 mt-10 -130.06 141.69 50.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.972 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.919 HD12 ' HB ' ' A' ' 225' ' ' VAL . 21.1 mm -123.7 148.33 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-O 120.851 0.358 . . . . 0.0 110.502 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.66 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 1.5 tt0 -102.87 118.52 37.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.918 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.01 150.8 26.13 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.601 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' GLN . . . . . 0.66 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 9.8 mm-40 -109.48 -142.44 0.38 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 121.203 -0.199 . . . . 0.0 110.615 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.577 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 0.3 OUTLIER -75.02 65.91 1.52 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.88 0.371 . . . . 0.0 111.632 -179.023 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 4.0 t80 55.56 37.53 29.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.929 0.871 . . . . 0.0 110.598 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.67 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 12.6 pt20 -167.1 -125.29 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.819 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -9.0 133.62 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 179.783 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.862 ' HZ ' HD11 ' A' ' 195' ' ' LEU . 0.6 OUTLIER -124.84 138.55 54.26 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 112.975 -1.921 . . . . 0.0 109.853 -179.082 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.66 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 27.0 t -119.47 113.9 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-O 121.319 0.58 . . . . 0.0 109.506 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.919 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.5 OUTLIER -120.94 121.12 64.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.034 -179.197 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.558 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 2.7 mptp? -75.63 118.99 19.06 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -69.1 -174.58 10.37 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.046 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 62.36 21.31 62.03 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 121.226 -0.511 . . . . 0.0 113.076 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' GLN . . . . . 0.558 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 8.1 mm100 -68.11 -166.2 0.06 Allowed 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.434 0.635 . . . . 0.0 111.157 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 75.0 m -158.02 147.28 19.57 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.602 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' TYR . . . . . 0.803 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 3.8 m-30 -111.09 127.97 55.73 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.59 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.97 150.78 41.56 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 60.4 p -76.33 110.91 12.66 Favored Pre-proline 0 N--CA 1.442 -0.835 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.822 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.459 ' HB3' ' O ' ' A' ' 210' ' ' THR . 36.5 Cg_endo -65.94 -2.75 7.14 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.044 1.829 . . . . 0.0 112.29 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 99.81 -103.13 2.63 Favored Glycine 0 C--O 1.225 -0.442 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 73.0 m -115.46 133.93 55.57 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' TYR . . . . . 0.678 ' CD2' HG21 ' A' ' 210' ' ' THR . 8.3 t80 -132.62 126.95 33.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.959 0.409 . . . . 0.0 111.405 -178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.984 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -90.82 110.53 21.74 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.597 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.566 ' N ' HD22 ' A' ' 238' ' ' LEU . 21.8 t -83.63 113.0 21.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.094 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.409 ' HG2' ' CD1' ' A' ' 238' ' ' LEU . 11.3 mt-10 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.253 -0.879 . . . . 0.0 111.245 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.761 ' HD3' HG21 ' A' ' 174' ' ' THR . 78.1 mtm180 . . . . . 0 N--CA 1.454 -0.225 0 CA-C-O 120.91 0.386 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.777 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -43.12 -48.54 6.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.737 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.053 HD22 HD11 ' A' ' 75' ' ' ILE . 11.3 mt -72.09 -32.42 67.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.898 0.38 . . . . 0.0 111.371 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.877 HD22 ' HB2' ' A' ' 101' ' ' PRO . 53.2 tp -68.66 -50.18 53.17 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.355 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.768 HD22 ' CZ ' ' A' ' 231' ' ' TYR . 33.4 mt -68.16 -26.43 65.75 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.77 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.752 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -65.84 -39.52 90.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.302 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.804 ' CB ' HG11 ' A' ' 62' ' ' VAL . . . -81.44 -41.24 22.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.269 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.659 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 13.3 mt -67.72 -4.57 12.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.245 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.535 ' HA ' ' CB ' ' A' ' 231' ' ' TYR . . . -94.58 177.51 5.9 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.651 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.1 OUTLIER -117.48 114.89 24.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.623 178.975 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.626 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 128.51 -142.84 13.91 Favored Glycine 0 C--O 1.224 -0.508 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.025 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.678 ' HG3' HG23 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -136.66 117.47 14.1 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.186 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 235' ' ' GLY . 0.8 OUTLIER -128.68 145.79 51.06 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.541 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.637 HG22 ' HB2' ' A' ' 74' ' ' GLU . 78.3 t -109.3 143.58 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 CA-C-O 121.51 0.671 . . . . 0.0 112.312 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.881 ' HB3' HD21 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -115.84 116.3 27.77 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 174.704 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.898 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.5 OUTLIER -103.53 151.57 22.72 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.863 0.364 . . . . 0.0 111.277 -177.812 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.426 ' HB2' HD23 ' A' ' 238' ' ' LEU . 7.2 t30 65.78 26.37 11.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.044 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.881 HD21 ' HB3' ' A' ' 41' ' ' LEU . 84.6 mt -54.6 -172.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.832 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.554 ' HB3' HG21 ' A' ' 50' ' ' VAL . 61.9 tp -112.94 131.59 55.68 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.384 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -89.39 86.96 6.92 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.965 0.412 . . . . 0.0 110.153 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 49' ' ' ASP . 4.0 m -165.09 143.37 6.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.462 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 47' ' ' SER . 34.6 m-20 -34.71 -31.64 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.714 0.292 . . . . 0.0 111.721 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.868 ' OD1' HG23 ' A' ' 50' ' ' VAL . 2.0 p30 -57.91 -42.2 84.26 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.066 0.46 . . . . 0.0 110.848 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.868 HG23 ' OD1' ' A' ' 49' ' ' ASP . 92.9 t -84.47 -45.1 17.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.859 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -48.34 -39.67 22.79 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.636 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.636 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 33.9 m170 -80.15 -32.17 38.9 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.021 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.586 ' O ' HD13 ' A' ' 57' ' ' LEU . 9.4 tpt -55.55 -35.31 65.58 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.859 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -81.93 -44.2 17.08 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.102 -1.408 . . . . 0.0 108.694 176.149 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.722 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 4.7 t-20 -58.8 -35.59 73.09 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.742 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 1.024 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -63.04 -46.8 85.84 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.833 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.4 OUTLIER -63.96 -39.37 93.99 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.758 -1.565 . . . . 0.0 107.752 177.276 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.722 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -59.27 -41.0 87.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.154 178.793 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.632 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -71.21 -38.51 72.04 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.139 -178.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.673 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.6 OUTLIER -78.83 -16.23 57.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.241 0.543 . . . . 0.0 110.834 -179.69 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.82 35.22 4.37 Favored Glycine 0 C--N 1.319 -0.369 0 CA-C-N 115.272 -0.876 . . . . 0.0 114.372 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.833 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 39.7 t -90.56 120.5 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.813 ' O ' HG12 ' A' ' 76' ' ' ILE . 27.1 m -83.26 127.43 33.64 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.538 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.912 ' HB3' HG23 ' A' ' 75' ' ' ILE . 42.7 p90 -155.84 172.17 18.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.848 0.356 . . . . 0.0 110.266 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 87.0 m -133.94 148.91 51.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.221 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.419 HD12 ' HB2' ' A' ' 73' ' ' CYS . 14.0 tp -117.05 135.85 53.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.969 0.414 . . . . 0.0 110.4 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.467 ' HB3' ' CB ' ' A' ' 72' ' ' ARG . 33.8 p -61.71 -172.19 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.382 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.89 -43.53 19.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.189 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.36 0.54 11.86 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.555 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.1 mtp85 59.54 46.74 11.7 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.069 0.462 . . . . 0.0 110.956 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.521 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -141.24 -14.91 0.87 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.973 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 8.6 mtp180 -113.94 116.74 29.73 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.643 ' HB3' HD11 ' A' ' 44' ' ' LEU . 28.9 t -124.89 123.18 39.36 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.637 ' HB2' HG22 ' A' ' 40' ' ' VAL . 34.3 tt0 -104.37 134.36 47.71 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 176.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 1.053 HD11 HD22 ' A' ' 29' ' ' LEU . 8.1 mt -131.32 122.21 50.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -177.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.813 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -67.89 98.63 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.695 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -35.68 140.81 0.18 Allowed Glycine 0 CA--C 1.518 0.219 0 CA-C-N 115.232 -0.895 . . . . 0.0 114.02 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.82 -11.43 50.91 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.101 0.477 . . . . 0.0 110.786 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.651 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 90.73 -1.01 77.8 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.205 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.578 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 154.34 -150.02 21.52 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.542 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 87.3 Cg_exo -49.32 121.54 7.16 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.759 2.306 . . . . 0.0 112.639 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.673 ' HB2' HD13 ' A' ' 60' ' ' LEU . 0.7 OUTLIER -70.71 112.12 6.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.726 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.506 ' HA ' ' ND2' ' A' ' 111' ' ' ASN . 4.9 p80 -82.93 136.14 34.66 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.705 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -97.9 123.64 41.97 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.762 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -70.92 123.44 22.01 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 176.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.27 177.14 1.01 Allowed Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 108.692 -1.763 . . . . 0.0 108.692 -175.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.97 144.3 47.31 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 118.738 1.269 . . . . 0.0 111.085 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.632 HD21 ' HB1' ' A' ' 59' ' ' ALA . 1.0 OUTLIER -115.77 160.41 20.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.179 -178.829 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 9.9 mt-10 -139.71 103.85 4.77 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.86 178.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.734 ' HB2' HD23 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -97.19 122.73 40.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.884 0.373 . . . . 0.0 110.928 -178.531 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -95.47 96.31 9.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.817 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.968 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.2 OUTLIER -107.29 46.28 0.94 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.538 -179.392 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.616 ' CA ' ' H ' ' A' ' 118' ' ' GLU . . . -56.38 -27.74 53.95 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.721 -0.672 . . . . 0.0 113.152 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.531 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 1.0 OUTLIER -106.65 -21.14 13.14 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.586 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.975 ' HB1' ' HB3' ' A' ' 98' ' ' ALA . . . -86.02 57.84 4.71 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.057 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.581 ' O ' ' HD3' ' A' ' 100' ' ' ARG . . . -59.82 -38.04 93.4 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.051 -1.071 . . . . 0.0 111.146 178.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.45 HG22 ' HG3' ' A' ' 171' ' ' GLN . 0.6 OUTLIER -78.46 -15.67 58.38 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.506 0.188 . . . . 0.0 111.506 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.975 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -96.91 -27.33 14.71 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.716 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.689 ' SD ' ' HB3' ' A' ' 115' ' ' LEU . 4.3 tpp -62.07 -41.2 97.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.903 0.382 . . . . 0.0 110.156 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.62 ' O ' HD21 ' A' ' 129' ' ' LEU . 1.6 mpt_? -59.52 -60.11 11.65 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.877 ' HB2' HD22 ' A' ' 30' ' ' LEU . 18.6 Cg_endo -58.87 -31.11 94.72 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.057 1.838 . . . . 0.0 112.029 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 1.024 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -74.84 -53.34 9.28 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.055 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.835 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -50.35 -28.56 8.2 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.475 0.655 . . . . 0.0 110.503 178.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.722 ' HB2' ' HB1' ' A' ' 175' ' ' ALA . . . -87.19 -52.99 5.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.214 -0.903 . . . . 0.0 113.065 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.771 ' CB ' HD11 ' A' ' 30' ' ' LEU . . . -60.39 -27.83 67.75 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.713 0.635 . . . . 0.0 112.713 -177.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.709 HD13 HG13 ' A' ' 113' ' ' ILE . 33.6 mt -82.23 -27.08 32.7 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.737 ' HB2' ' HB1' ' A' ' 138' ' ' ALA . 11.1 p -74.38 12.33 0.79 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.18 0.514 . . . . 0.0 111.422 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.673 ' HG ' HG23 ' A' ' 179' ' ' THR . 1.3 mt -78.14 -76.57 0.18 Allowed 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.433 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.418 ' O ' ' HA3' ' A' ' 155' ' ' GLY . . . -71.79 -115.57 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.64 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.9 p -150.88 95.49 2.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.97 0.414 . . . . 0.0 110.245 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.597 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 23.6 m-80 -148.47 138.36 22.31 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.51 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.92 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 0.7 OUTLIER -90.35 100.01 12.92 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.15 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.709 HG13 HD13 ' A' ' 106' ' ' LEU . 24.7 mm -119.27 136.54 56.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.496 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.851 HG13 ' CD2' ' A' ' 143' ' ' LEU . 60.9 t -108.33 111.98 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 176.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.734 HD23 ' HB2' ' A' ' 90' ' ' LEU . 52.7 mt -102.25 107.96 19.18 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.53 -178.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.929 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -124.2 -170.41 2.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.89 0.376 . . . . 0.0 111.675 -179.04 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.599 ' H ' HG22 ' A' ' 116' ' ' THR . . . -168.59 -169.05 31.54 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.144 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.743 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 50.7 mt-10 -81.24 172.73 9.04 Favored Pre-proline 0 N--CA 1.455 -0.223 0 C-N-CA 123.213 0.605 . . . . 0.0 110.254 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.743 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 8.0 Cg_endo -48.1 -39.62 33.64 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.666 2.244 . . . . 0.0 112.336 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 120' ' ' ARG . 10.2 ttp180 -67.97 -23.95 65.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.702 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.611 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 9.7 tpt -61.14 -31.87 71.58 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.415 ' HD3' ' HG2' ' A' ' 149' ' ' PRO . 12.0 mmtt -63.63 -17.14 62.59 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.559 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -79.57 0.65 29.02 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.845 0.355 . . . . 0.0 110.621 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.565 ' HB3' ' NH2' ' A' ' 100' ' ' ARG . 0.8 OUTLIER -126.98 83.03 66.96 Favored Pre-proline 0 N--CA 1.454 -0.262 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.235 179.546 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.513 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 43.6 Cg_exo -56.29 148.68 59.6 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.577 2.184 . . . . 0.0 111.618 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.701 HD11 HD23 ' A' ' 129' ' ' LEU . 1.3 tt -128.84 22.56 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.525 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -69.2 -46.4 57.93 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.183 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.68 ' CE1' ' HB2' ' A' ' 165' ' ' ASP . 1.7 m-70 -55.68 -37.58 68.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.832 0.349 . . . . 0.0 110.929 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.791 ' HG ' HD11 ' A' ' 133' ' ' LEU . 16.9 tp -70.19 -44.32 68.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.353 0.597 . . . . 0.0 109.527 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.874 HG21 HD21 ' A' ' 151' ' ' LEU . 36.2 t -56.85 -47.31 83.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.16 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.77 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 2.8 m-20 -71.04 -38.29 72.54 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 120.881 0.372 . . . . 0.0 110.704 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.516 ' HA ' HG13 ' A' ' 162' ' ' VAL . . . -57.96 -46.97 84.28 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.537 0.684 . . . . 0.0 109.87 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.791 HD11 ' HG ' ' A' ' 129' ' ' LEU . 5.8 mt -76.02 -50.18 15.54 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.798 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.722 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -57.17 -27.7 62.15 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.01 179.704 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.77 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 5.0 tp -70.55 -30.09 66.72 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.941 0.4 . . . . 0.0 110.915 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 159' ' ' GLY . . . -84.22 14.42 44.92 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.838 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.63 4.48 60.58 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.892 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.738 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . . . -75.2 155.75 36.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.985 0.421 . . . . 0.0 111.533 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.451 ' CB ' ' HB2' ' A' ' 154' ' ' GLN . 3.7 mttm -102.58 105.55 16.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.303 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.747 HG21 HG22 ' A' ' 130' ' ' VAL . 13.6 mt -138.68 127.57 30.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.542 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.809 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -126.38 139.83 52.97 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.594 -179.544 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -78.07 132.37 37.7 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.382 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.851 ' CD2' HG13 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -95.16 -90.97 0.22 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.909 -179.568 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.793 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 16.0 mm-40 -59.15 -81.05 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.025 0.44 . . . . 0.0 110.692 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.504 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 31.6 mt-30 -113.09 148.86 34.38 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.788 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 4.7 mt-10 -65.5 132.54 49.17 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.428 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.525 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 2.1 m-20 67.85 17.82 9.67 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.124 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.598 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 16.8 m-85 -108.75 169.17 6.8 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.035 0.445 . . . . 0.0 111.603 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.918 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 8.2 Cg_exo -32.23 -62.73 0.14 Allowed 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 124.164 3.243 . . . . 0.0 116.656 -177.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.929 ' HG3' HG23 ' A' ' 116' ' ' THR . 59.2 Cg_exo -53.05 143.89 48.51 Favored 'Trans proline' 0 C--N 1.351 0.68 0 CA-C-N 120.982 1.387 . . . . 0.0 112.892 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.874 HD21 HG21 ' A' ' 130' ' ' VAL . 10.4 mt -155.58 133.23 11.15 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.67 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.837 ' HG3' HD11 ' A' ' 143' ' ' LEU . 2.8 mtt85 -103.29 100.76 10.66 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.92 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 10.0 mt -90.62 148.54 22.59 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.987 -178.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.597 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 3.6 mt-30 -149.64 23.79 0.88 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.048 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.595 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 54.52 -168.57 1.78 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.226 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 158' ' ' THR . . . 114.89 -14.57 19.45 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.243 -0.98 . . . . 0.0 113.216 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.738 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 45.4 t80 -58.18 122.75 13.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 117.396 0.598 . . . . 0.0 110.742 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.708 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 76.6 p -114.87 -29.88 6.59 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.375 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.492 ' O ' ' HA2' ' A' ' 136' ' ' GLY . . . 133.73 -157.99 23.06 Favored Glycine 0 C--N 1.305 -1.153 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.115 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.596 ' O ' HG23 ' A' ' 187' ' ' THR . . . 103.06 153.57 24.26 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.289 -0.958 . . . . 0.0 111.347 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -47.16 115.84 1.21 Allowed 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.296 -0.452 . . . . 0.0 111.081 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 60.9 t -107.85 140.28 26.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.64 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.96 119.79 40.1 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.057 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.945 HG11 ' HG ' ' A' ' 173' ' ' LEU . 1.6 t -129.27 120.56 51.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.68 ' HB2' ' CE1' ' A' ' 128' ' ' HIS . 7.8 t0 -55.04 139.62 40.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.234 0.54 . . . . 0.0 112.066 -178.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.91 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . . . . . . 0 N--CA 1.446 -0.682 0 CA-C-N 115.47 -0.787 . . . . 0.0 112.68 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.571 ' HB3' ' HB2' ' A' ' 197' ' ' SER . 46.2 p . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.597 0.237 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.576 ' HA ' ' HB ' ' A' ' 174' ' ' THR . 8.3 mm-40 -89.6 -12.09 40.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.579 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.589 ' CZ ' ' HA ' ' A' ' 126' ' ' ILE . 3.1 m-85 -69.26 -54.36 15.08 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.945 ' HG ' HG11 ' A' ' 164' ' ' VAL . 1.0 OUTLIER -64.84 -46.69 80.84 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.793 178.468 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.761 HG21 ' HD3' ' A' ' 27' ' ' ARG . 4.1 m -54.41 -35.0 62.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.172 178.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.722 ' HB1' ' HB2' ' A' ' 104' ' ' ALA . . . -64.13 -46.77 82.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.497 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.941 HD11 HG21 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -76.52 -31.75 57.86 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.315 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.853 HD11 ' CD2' ' A' ' 223' ' ' PHE . 1.6 mp -58.99 -39.18 81.02 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.181 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.693 ' HE1' ' HA ' ' A' ' 27' ' ' ARG . 2.0 mtp -81.08 -40.71 23.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.892 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.673 HG23 ' HG ' ' A' ' 108' ' ' LEU . 66.4 m -71.28 -41.85 69.48 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.949 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.552 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . -59.63 -40.51 79.95 Favored Pre-proline 0 C--N 1.321 -0.674 0 N-CA-C 115.132 1.531 . . . . 0.0 115.132 -176.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.577 ' HD3' ' O ' ' A' ' 177' ' ' LEU . 27.9 Cg_endo -64.93 -28.82 58.11 Favored 'Trans proline' 0 CA--C 1.502 -1.112 0 CA-C-N 120.081 1.064 . . . . 0.0 111.511 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.587 ' HB2' HD21 ' A' ' 108' ' ' LEU . 8.1 mt -83.58 0.81 45.07 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.485 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.623 ' HB1' ' C ' ' A' ' 158' ' ' THR . . . -83.36 136.89 42.58 Favored Pre-proline 0 C--O 1.223 -0.304 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.287 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.708 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 11.1 Cg_endo -50.53 -32.53 35.25 Favored 'Trans proline' 0 CA--C 1.516 -0.415 0 C-N-CA 122.715 2.277 . . . . 0.0 113.363 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -114.96 141.35 48.09 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.717 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -56.1 141.88 38.74 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.124 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.596 HG23 ' O ' ' A' ' 160' ' ' GLY . 91.5 m -119.97 143.41 48.04 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 50.8 t -123.69 118.15 53.37 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 176.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.816 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 2.7 mp -102.55 117.85 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.596 ' HB2' ' HG3' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -100.65 123.66 45.16 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.241 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.91 HG23 ' HA2' ' A' ' 166' ' ' GLY . 1.6 mp -93.69 119.59 41.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.605 -1.179 . . . . 0.0 111.142 -176.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.5 ' HE2' ' N ' ' A' ' 165' ' ' ASP . 1.7 mtmt -75.26 97.06 3.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.834 -178.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 99.64 -133.06 11.16 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.693 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -112.66 131.09 55.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.855 0.36 . . . . 0.0 111.135 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.753 HD11 ' HZ ' ' A' ' 223' ' ' PHE . 1.5 mt -41.77 144.48 0.4 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.836 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.41 ' N ' ' O ' ' A' ' 166' ' ' GLY . 14.2 p -73.75 -27.72 23.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.184 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.571 ' HB2' ' HB3' ' A' ' 170' ' ' SER . 0.3 OUTLIER -165.51 63.01 0.11 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.184 0.516 . . . . 0.0 110.25 -179.19 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.686 ' N ' ' HD2' ' A' ' 199' ' ' PRO . 0.0 OUTLIER -42.07 -46.63 10.44 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.5 179.7 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 199' ' ' PRO . . . . . 0.686 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 9.5 Cg_endo -49.31 -33.09 27.67 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 121.944 1.763 . . . . 0.0 111.39 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.991 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.1 OUTLIER -69.1 -43.82 73.7 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.785 0.803 . . . . 0.0 108.87 178.242 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.606 HG21 ' HE2' ' A' ' 223' ' ' PHE . 27.5 mm -62.69 -35.79 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.452 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.29 -44.13 95.65 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.695 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.991 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.0 mt -63.12 -49.76 82.04 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.927 0 CA-C-O 121.66 0.743 . . . . 0.0 108.996 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.537 ' CG2' HG23 ' A' ' 174' ' ' THR . 90.8 m -53.02 -51.48 61.54 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.893 -178.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.877 HD22 ' HB ' ' A' ' 215' ' ' ILE . 29.3 mt -66.13 -30.48 70.97 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.437 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ASN . . . . . 0.464 ' HA ' ' HE3' ' A' ' 209' ' ' LYS . 29.8 m-20 -77.02 -46.13 24.84 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.837 0.827 . . . . 0.0 109.527 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.801 ' O ' HG22 ' A' ' 210' ' ' THR . 5.1 tp -70.55 -29.47 65.93 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.09 -1.413 . . . . 0.0 109.618 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' MET . . . . . 0.72 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 52.2 mtp -77.13 -34.09 56.66 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.714 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 9.4 mtmt -62.04 -40.59 96.26 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.015 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.801 HG22 ' O ' ' A' ' 207' ' ' LEU . 5.0 t -60.5 -31.25 70.31 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.583 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.598 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 56.1 m-85 -78.61 -5.94 54.27 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.871 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.6 7.95 25.27 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.166 -1.016 . . . . 0.0 115.638 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.714 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 5.1 m -124.0 148.07 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 118.768 1.284 . . . . 0.0 112.829 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.467 ' CG ' ' HG2' ' A' ' 209' ' ' LYS . 16.2 mt-10 -130.02 137.72 50.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.126 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.877 ' HB ' HD22 ' A' ' 205' ' ' LEU . 18.0 mm -120.56 148.38 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-O 120.875 0.369 . . . . 0.0 110.557 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.665 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 2.4 tt0 -103.01 116.22 32.1 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.864 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -82.79 151.21 26.2 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.969 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' GLN . . . . . 0.633 ' HG3' ' HB3' ' A' ' 222' ' ' GLN . 10.2 mm100 -109.47 -139.12 0.38 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 121.146 -0.222 . . . . 0.0 110.821 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.642 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 5.5 t-80 -78.82 66.6 4.34 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 3.7 t80 57.25 33.38 23.22 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.974 0.893 . . . . 0.0 110.234 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.685 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 3.3 pt20 -163.92 -126.63 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.816 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -8.56 132.66 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.853 ' CD2' HD11 ' A' ' 177' ' ' LEU . 0.9 OUTLIER -124.76 138.69 54.27 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 112.867 -1.97 . . . . 0.0 110.181 -179.295 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.665 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 38.7 t -118.37 114.44 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.784 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.4 OUTLIER -121.78 125.66 73.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.443 -178.952 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.547 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -79.79 127.65 32.48 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.206 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.554 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -79.46 -173.84 45.24 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.404 -178.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 62.75 21.0 62.57 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 121.61 -0.329 . . . . 0.0 113.193 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' GLN . . . . . 0.571 ' NE2' ' HB3' ' A' ' 181' ' ' PRO . 42.4 mt-30 -76.78 -175.39 3.41 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.364 0.602 . . . . 0.0 111.557 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.22 147.81 28.84 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.654 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' TYR . . . . . 0.768 ' CZ ' HD22 ' A' ' 31' ' ' LEU . 1.9 m-30 -104.47 131.71 51.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.109 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.42 144.83 48.79 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.435 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 50.1 m -69.99 110.81 7.34 Favored Pre-proline 0 N--CA 1.45 -0.453 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.259 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.503 ' HG3' HG23 ' A' ' 210' ' ' THR . 40.5 Cg_endo -66.44 -1.0 4.91 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.017 1.811 . . . . 0.0 112.41 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' GLY . . . . . 0.579 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 99.45 -96.41 1.66 Allowed Glycine 0 C--O 1.226 -0.383 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.631 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 30.7 m -119.91 134.4 55.25 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' TYR . . . . . 0.563 ' CD2' HG21 ' A' ' 210' ' ' THR . 12.8 t80 -132.97 126.76 32.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.997 0.427 . . . . 0.0 111.314 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.898 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -93.25 112.2 24.06 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.033 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.693 ' N ' HD22 ' A' ' 238' ' ' LEU . 25.0 t -86.74 111.83 22.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.789 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.211 -179.667 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.874 HH11 HD23 ' A' ' 207' ' ' LEU . 6.6 mtm105 . . . . . 0 CA--C 1.521 -0.171 0 CA-C-O 120.877 0.37 . . . . 0.0 111.316 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.751 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -35.21 -45.41 0.3 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.378 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.054 HD22 HD11 ' A' ' 75' ' ' ILE . 11.4 mt -75.65 -38.93 58.46 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.977 0.418 . . . . 0.0 111.608 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.839 HD22 ' HB2' ' A' ' 101' ' ' PRO . 51.5 tp -65.22 -49.67 68.8 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.435 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.585 HD13 ' HA ' ' A' ' 208' ' ' MET . 45.3 mt -67.09 -26.9 66.94 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.657 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.847 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -66.28 -40.05 89.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.044 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.776 ' CB ' HG11 ' A' ' 62' ' ' VAL . . . -81.21 -41.21 22.66 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.793 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.671 HD11 ' HB1' ' A' ' 105' ' ' ALA . 13.3 mt -67.95 -3.69 10.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.246 178.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.493 ' HB2' ' HB3' ' A' ' 231' ' ' TYR . . . -100.22 178.34 4.8 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.565 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.1 OUTLIER -113.04 113.6 25.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.8 178.186 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.412 ' HA3' ' OG ' ' A' ' 233' ' ' SER . . . 116.75 167.91 14.73 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.357 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.819 ' HG3' HG23 ' A' ' 76' ' ' ILE . 1.1 ttmt -95.45 117.95 31.3 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 117.127 0.463 . . . . 0.0 111.692 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 0.9 OUTLIER -120.19 148.12 44.06 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.321 179.753 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.669 HG22 ' HB2' ' A' ' 74' ' ' GLU . 98.8 t -107.41 141.64 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.767 ' CB ' HD21 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -116.1 116.0 27.07 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 174.877 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.892 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.6 OUTLIER -103.92 152.83 21.51 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.93 -178.314 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.69 26.81 11.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.469 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.767 HD21 ' CB ' ' A' ' 41' ' ' LEU . 76.2 mt -54.14 -173.31 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.789 0.328 . . . . 0.0 110.127 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.525 ' HB3' HG21 ' A' ' 50' ' ' VAL . 56.8 tp -111.69 131.31 55.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.469 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -87.78 88.79 7.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.992 0.425 . . . . 0.0 110.11 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 50' ' ' VAL . 74.6 m -163.97 142.66 7.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.994 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.437 ' HA ' ' HB3' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -37.44 -29.92 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.736 0.303 . . . . 0.0 111.374 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.761 ' OD1' HG23 ' A' ' 50' ' ' VAL . 1.2 p30 -58.3 -42.51 86.8 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 121.043 0.449 . . . . 0.0 110.631 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.761 HG23 ' OD1' ' A' ' 49' ' ' ASP . 93.0 t -84.12 -44.55 18.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.672 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.782 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -49.32 -39.72 32.4 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.447 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.58 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 22.6 m-70 -81.04 -32.67 33.97 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.081 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.628 ' O ' HD13 ' A' ' 57' ' ' LEU . 7.5 tpt -53.69 -34.64 59.44 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 176.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.782 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.7 OUTLIER -82.52 -44.46 15.89 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 113.892 -1.503 . . . . 0.0 108.837 176.698 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.729 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 24.8 t-20 -57.97 -42.28 84.68 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-O 120.882 0.372 . . . . 0.0 110.655 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 1.024 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -57.27 -46.8 82.74 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.875 0.845 . . . . 0.0 109.012 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.777 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -64.33 -37.61 88.1 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.134 -1.394 . . . . 0.0 107.779 177.21 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.729 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -64.14 -33.13 75.07 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.179 -1.373 . . . . 0.0 111.933 179.411 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.789 ' CB ' HD11 ' A' ' 90' ' ' LEU . . . -76.21 -37.55 57.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.221 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.641 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -81.4 -12.5 58.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.289 0.566 . . . . 0.0 110.686 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.06 35.54 5.02 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.262 -0.881 . . . . 0.0 114.293 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.777 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 39.8 t -90.45 123.24 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.788 ' O ' HG12 ' A' ' 76' ' ' ILE . 7.2 m -85.32 131.44 34.41 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.0 0.428 . . . . 0.0 111.723 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.824 ' HB3' HG23 ' A' ' 75' ' ' ILE . 40.6 p90 -158.7 171.08 20.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.685 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 98.1 m -135.19 149.03 49.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.301 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.626 HD12 ' HB2' ' A' ' 73' ' ' CYS . 11.7 tp -120.25 138.69 53.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.028 0.442 . . . . 0.0 110.874 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 87.1 p -57.71 -175.31 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.339 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.1 -42.24 23.96 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.197 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -76.41 0.67 18.79 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.398 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.9 mtt-85 59.36 53.56 5.19 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.873 0.368 . . . . 0.0 111.176 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.445 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -149.19 4.16 0.61 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.76 179.657 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.612 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 9.5 ttm180 -136.97 110.78 8.14 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.626 ' HB2' HD12 ' A' ' 66' ' ' LEU . 36.9 t -121.61 134.48 55.0 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.669 ' HB2' HG22 ' A' ' 40' ' ' VAL . 24.6 tt0 -115.45 132.61 56.57 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.245 -0.888 . . . . 0.0 108.728 177.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 1.054 HD11 HD22 ' A' ' 29' ' ' LEU . 12.2 mt -127.79 123.45 61.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -177.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.819 HG23 ' HG3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -67.72 100.13 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 175.178 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 35' ' ' ALA . . . -39.19 144.73 0.27 Allowed Glycine 0 C--N 1.323 -0.189 0 CA-C-N 115.145 -0.934 . . . . 0.0 113.483 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -90.02 -12.41 38.69 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.947 0.404 . . . . 0.0 111.038 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.565 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 95.19 1.63 62.65 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.94 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.553 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 150.88 -148.96 20.69 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.683 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.52 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 77.3 Cg_exo -49.63 123.52 10.63 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.712 2.274 . . . . 0.0 112.218 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.641 ' HB2' HD13 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -74.27 106.33 5.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.225 -179.5 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -83.66 132.42 34.88 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.573 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.578 ' CB ' HD11 ' A' ' 113' ' ' ILE . . . -96.86 126.81 42.28 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.065 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.19 123.93 23.32 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.31 175.3 1.15 Allowed Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 -175.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 112' ' ' ASP . . . -74.04 144.98 44.85 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 118.559 1.179 . . . . 0.0 112.215 -178.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.661 HD21 ' C ' ' A' ' 59' ' ' ALA . 0.9 OUTLIER -115.26 161.12 18.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.649 -1.16 . . . . 0.0 112.557 -178.273 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.449 ' HG3' ' HB ' ' A' ' 114' ' ' VAL . 1.6 tt0 -140.26 112.26 7.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.758 177.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.789 HD11 ' CB ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -108.64 117.87 35.3 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.505 -178.427 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.632 ' C ' HD13 ' A' ' 92' ' ' LEU . 0.1 OUTLIER -88.97 96.67 10.82 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.508 179.042 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.808 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -105.37 53.04 0.72 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.267 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.459 ' CA ' ' H ' ' A' ' 118' ' ' GLU . . . -53.13 -75.11 0.24 Allowed Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.711 -0.677 . . . . 0.0 113.022 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.503 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 3.1 m120 -75.49 -1.06 22.4 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.768 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 1.05 ' HB1' ' HB3' ' A' ' 98' ' ' ALA . . . -87.96 47.66 1.53 Allowed 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.363 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.401 ' O ' ' HD2' ' A' ' 100' ' ' ARG . . . -56.37 -23.59 42.23 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.173 -1.013 . . . . 0.0 111.458 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.462 HG22 ' HG2' ' A' ' 171' ' ' GLN . 2.1 p -92.91 -16.69 24.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.464 0.173 . . . . 0.0 111.176 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 1.05 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -95.5 -37.17 11.01 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.469 ' HB2' ' HB2' ' A' ' 92' ' ' LEU . 2.2 tpp -59.3 -44.52 92.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.594 0.235 . . . . 0.0 110.524 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.7 ' HE ' HD12 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -54.13 -60.22 8.03 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.284 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.839 ' HB2' HD22 ' A' ' 30' ' ' LEU . 18.3 Cg_endo -62.0 -32.89 84.32 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.396 2.064 . . . . 0.0 112.831 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 1.024 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -70.86 -52.84 17.78 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.052 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.896 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -51.72 -28.72 15.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.26 0.552 . . . . 0.0 110.53 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.874 ' CB ' ' HB1' ' A' ' 175' ' ' ALA . . . -86.06 -52.97 5.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.428 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.702 ' CB ' HD11 ' A' ' 30' ' ' LEU . . . -60.57 -34.27 73.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.643 ' HB2' HD12 ' A' ' 153' ' ' LEU . 31.6 mt -78.52 -17.82 55.65 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.587 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 9.6 p -84.68 22.6 1.29 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.245 0.545 . . . . 0.0 110.598 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.771 HD21 ' HB2' ' A' ' 182' ' ' LEU . 0.4 OUTLIER -90.04 -73.86 0.51 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.427 -179.71 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -73.19 -116.31 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.699 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.24 94.15 2.09 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.141 0.496 . . . . 0.0 110.58 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.643 ' OD1' HD13 ' A' ' 113' ' ' ILE . 22.7 p30 -146.44 138.32 24.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.467 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.886 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 0.9 OUTLIER -95.21 100.65 12.42 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.656 179.122 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.644 HD12 ' C ' ' A' ' 112' ' ' ASP . 1.1 mp -120.66 147.68 24.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.494 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.865 HG13 ' CD2' ' A' ' 143' ' ' LEU . 58.0 t -117.53 113.22 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 176.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.679 HD23 ' HB2' ' A' ' 90' ' ' LEU . 33.9 mt -102.12 105.41 16.11 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.296 -0.561 . . . . 0.0 111.324 -177.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.813 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -118.14 -172.12 2.2 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.768 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.572 ' H ' HG22 ' A' ' 116' ' ' THR . . . -164.93 -167.97 26.34 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.206 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.609 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 16.9 mt-10 -78.31 171.86 11.38 Favored Pre-proline 0 C--N 1.332 -0.158 0 C-N-CA 122.661 0.384 . . . . 0.0 110.356 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 71.0 Cg_exo -49.5 -39.57 45.33 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.377 2.052 . . . . 0.0 112.77 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -68.23 -23.4 64.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.619 0.247 . . . . 0.0 110.971 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.557 ' O ' ' HG3' ' A' ' 149' ' ' PRO . 9.8 tpt -60.81 -34.45 74.55 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.474 ' HA ' ' HG2' ' A' ' 149' ' ' PRO . 0.0 OUTLIER -61.62 -16.77 51.33 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.614 179.166 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.3 3.19 32.47 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.837 0.351 . . . . 0.0 110.209 178.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.412 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 12.3 mtm180 -127.3 84.79 62.51 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.149 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 124' ' ' ARG . 16.2 Cg_endo -57.13 148.64 68.21 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.867 2.378 . . . . 0.0 112.068 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.7 HD12 ' HE ' ' A' ' 100' ' ' ARG . 0.9 OUTLIER -122.53 0.93 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -179.355 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.511 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -53.36 -39.43 59.19 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.219 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 42.5 m-70 -56.01 -41.61 75.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.783 0.325 . . . . 0.0 110.381 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.742 ' HG ' HD11 ' A' ' 133' ' ' LEU . 12.6 tp -75.48 -43.98 46.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.284 0.564 . . . . 0.0 110.055 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.842 HG13 ' CG2' ' A' ' 140' ' ' ILE . 69.5 t -56.41 -47.36 81.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.593 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.73 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 0.7 OUTLIER -69.2 -38.95 78.88 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.696 -179.603 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.617 ' HB2' HG23 ' A' ' 164' ' ' VAL . . . -58.39 -49.13 78.34 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.596 178.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.742 HD11 ' HG ' ' A' ' 129' ' ' LEU . 7.2 mt -69.92 -50.37 42.8 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.323 178.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.747 ' HG3' ' HB ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -58.14 -27.88 64.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.798 179.56 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.73 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 1.0 OUTLIER -69.79 -30.85 68.5 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.912 178.853 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -83.36 14.79 38.18 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.966 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 93.69 7.97 61.15 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.593 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.708 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . . . -78.21 152.03 32.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.834 0.349 . . . . 0.0 111.035 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 19.9 mtpt -100.73 103.96 15.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.126 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.842 ' CG2' HG13 ' A' ' 130' ' ' VAL . 34.7 mt -135.65 124.16 38.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.195 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.75 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -120.54 139.51 52.82 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.938 -179.589 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.559 ' CE1' HG11 ' A' ' 130' ' ' VAL . 42.1 m-85 -81.04 132.43 35.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.847 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.865 ' CD2' HG13 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -92.52 -87.16 0.23 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.775 -179.217 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.679 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 2.7 mt-10 -57.38 -82.46 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.397 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.401 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 44.8 mt-30 -116.69 154.3 30.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.341 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 6.0 mt-10 -66.88 132.82 48.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.373 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.511 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 2.7 m120 71.44 17.08 5.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.442 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.534 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 14.8 m-85 -107.0 168.22 8.36 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.813 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 75.0 Cg_exo -35.96 -60.33 0.35 Allowed 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.991 3.127 . . . . 0.0 115.921 -177.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.813 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 77.8 Cg_exo -52.35 145.5 35.79 Favored 'Trans proline' 0 C--N 1.352 0.736 0 CA-C-N 120.61 1.253 . . . . 0.0 112.118 -178.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.849 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 8.4 mt -156.41 137.59 13.73 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.808 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.75 ' HB2' HG22 ' A' ' 141' ' ' THR . 7.6 mtt85 -109.24 101.6 10.61 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.896 HD11 ' HA ' ' A' ' 103' ' ' ALA . 7.9 mt -90.35 148.01 23.11 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.283 -177.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.598 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 5.7 mt-30 -149.87 24.81 0.85 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.365 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.587 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 56.99 -162.04 7.52 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.322 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.421 ' O ' HG23 ' A' ' 158' ' ' THR . . . 107.35 -16.13 38.39 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.365 -0.922 . . . . 0.0 113.619 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.708 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 11.2 t80 -58.66 122.38 13.34 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 117.858 0.829 . . . . 0.0 110.155 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.738 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 56.9 p -114.76 -31.84 6.01 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 121.594 0.711 . . . . 0.0 111.171 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.442 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 137.19 -160.09 24.9 Favored Glycine 0 C--N 1.307 -1.068 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.049 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.566 ' O ' HG23 ' A' ' 187' ' ' THR . . . 105.5 152.95 21.14 Favored Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.008 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -47.01 116.47 1.37 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.98 -0.61 . . . . 0.0 110.83 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.569 ' CG1' ' HB1' ' A' ' 132' ' ' ALA . 68.6 t -109.49 144.88 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.48 119.97 39.4 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.477 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.893 HG21 HD11 ' A' ' 176' ' ' LEU . 1.0 OUTLIER -131.86 121.37 47.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.695 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.89 137.94 37.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.954 0.407 . . . . 0.0 111.191 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.802 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.43 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.75 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.497 ' HB2' ' HB3' ' A' ' 200' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.116 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.584 ' O ' ' HB3' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -82.24 -11.08 58.88 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.811 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.499 ' CD1' ' HG2' ' A' ' 100' ' ' ARG . 6.4 m-85 -74.13 -54.88 6.86 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.882 HD11 ' CG1' ' A' ' 191' ' ' ILE . 0.5 OUTLIER -65.62 -37.78 87.54 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.436 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.489 ' HB ' ' HA ' ' A' ' 171' ' ' GLN . 4.4 m -58.26 -34.57 70.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.063 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.874 ' HB1' ' CB ' ' A' ' 104' ' ' ALA . . . -68.28 -39.05 82.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.843 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.893 HD11 HG21 ' A' ' 164' ' ' VAL . 0.3 OUTLIER -76.78 -34.26 58.0 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.275 0.559 . . . . 0.0 110.899 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.817 HD11 ' CD2' ' A' ' 223' ' ' PHE . 2.4 mp -59.68 -38.41 81.47 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.529 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.742 ' HE1' ' HA ' ' A' ' 27' ' ' ARG . 3.8 mtp -81.76 -43.61 18.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.389 0.614 . . . . 0.0 112.509 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.594 HG23 ' HG ' ' A' ' 108' ' ' LEU . 48.5 m -73.11 -39.88 65.42 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.684 -178.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.576 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . -59.49 -41.55 87.34 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -177.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 30.3 Cg_endo -65.59 -28.32 52.97 Favored 'Trans proline' 0 CA--C 1.501 -1.161 0 C-N-CA 121.046 1.164 . . . . 0.0 111.723 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.771 ' HB2' HD21 ' A' ' 108' ' ' LEU . 5.4 mt -83.15 -0.19 48.1 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.079 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.738 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -82.19 137.29 46.0 Favored Pre-proline 0 N--CA 1.455 -0.209 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.183 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.697 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 11.7 Cg_endo -50.94 -33.18 40.94 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.685 2.257 . . . . 0.0 113.357 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -113.28 139.52 48.76 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.842 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' A' ' 186' ' ' ASP . 0.8 OUTLIER -53.68 144.59 17.44 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.15 179.227 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.574 ' HB ' ' HB1' ' A' ' 180' ' ' ALA . 94.1 m -123.83 145.88 48.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.258 0.552 . . . . 0.0 112.441 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.673 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 40.2 t -126.63 117.83 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.366 177.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.744 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 3.5 mp -101.12 118.08 47.32 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.579 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 3.6 ttt180 -100.93 124.82 47.2 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.882 ' CG1' HD11 ' A' ' 173' ' ' LEU . 1.5 mp -93.61 123.41 45.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.952 -175.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -83.03 96.88 8.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.11 -1.405 . . . . 0.0 110.361 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 102.06 -134.28 11.7 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.804 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -116.43 127.32 54.5 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.727 HD11 ' HZ ' ' A' ' 223' ' ' PHE . 1.0 OUTLIER -41.37 144.72 0.31 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.486 179.447 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.415 ' N ' ' O ' ' A' ' 166' ' ' GLY . 11.1 p -72.92 -30.53 32.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.999 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.496 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 0.2 OUTLIER -162.09 62.43 0.23 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.024 0.44 . . . . 0.0 110.611 -179.412 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.578 ' HA ' HD13 ' A' ' 195' ' ' LEU . 3.1 tttp -39.68 -45.92 4.31 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.175 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' PRO . . . . . 0.496 ' HD2' ' C ' ' A' ' 197' ' ' SER . 88.6 Cg_exo -47.8 -37.35 28.18 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 121.99 1.794 . . . . 0.0 111.622 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.954 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.3 OUTLIER -64.18 -45.79 86.83 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.984 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.637 HG21 ' HE2' ' A' ' 223' ' ' PHE . 12.5 mm -60.76 -37.33 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.584 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.442 ' OD2' ' HE3' ' A' ' 198' ' ' LYS . 83.8 m-20 -59.06 -46.78 87.39 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.857 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.954 HD12 ' HA ' ' A' ' 200' ' ' TYR . 3.1 mt -61.17 -46.26 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.977 0 CA-C-O 121.719 0.771 . . . . 0.0 108.986 178.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.55 HG22 ' SD ' ' A' ' 208' ' ' MET . 92.5 m -54.13 -51.44 64.23 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.699 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.874 HD22 ' HB ' ' A' ' 215' ' ' ILE . 26.8 mt -68.53 -28.37 66.93 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 120.531 -0.467 . . . . 0.0 111.246 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ASN . . . . . 0.496 ' HA ' ' HE3' ' A' ' 209' ' ' LYS . 15.0 t30 -77.84 -46.09 22.48 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.793 0.806 . . . . 0.0 109.577 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.99 ' O ' HG22 ' A' ' 210' ' ' THR . 3.1 tp -69.57 -34.46 74.21 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.188 -1.369 . . . . 0.0 109.297 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' MET . . . . . 0.79 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 50.1 mtp -72.57 -33.82 67.03 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.467 0.651 . . . . 0.0 109.328 177.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.623 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 15.5 mtmt -62.57 -37.57 86.69 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.862 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.99 HG22 ' O ' ' A' ' 207' ' ' LEU . 5.8 t -62.86 -28.45 70.03 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.409 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.569 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 39.3 m-85 -82.82 -6.04 59.24 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.913 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.99 6.9 25.81 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 116.226 1.25 . . . . 0.0 116.226 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.623 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.2 m -123.66 148.7 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 119.101 1.451 . . . . 0.0 112.729 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.571 ' O ' HD13 ' A' ' 215' ' ' ILE . 18.9 mt-10 -129.63 140.66 51.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.821 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.874 ' HB ' HD22 ' A' ' 205' ' ' LEU . 15.9 mm -123.29 148.31 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-O 120.871 0.367 . . . . 0.0 110.691 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.64 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 31.0 tt0 -103.45 119.19 38.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.603 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -82.85 151.17 26.15 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.541 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' GLN . . . . . 0.745 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -112.58 -146.09 0.4 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 121.182 -0.207 . . . . 0.0 110.49 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.425 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 7.0 m80 -68.01 66.23 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.416 ' CE1' ' HD2' ' A' ' 198' ' ' LYS . 3.4 t80 52.93 34.6 17.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.887 0.851 . . . . 0.0 110.266 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.648 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -164.35 -124.09 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 179.652 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.745 ' O ' ' HB2' ' A' ' 218' ' ' GLN . 0.0 OUTLIER -8.36 133.59 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.817 ' CD2' HD11 ' A' ' 177' ' ' LEU . 0.8 OUTLIER -124.75 139.26 54.01 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.269 -1.787 . . . . 0.0 109.79 -179.218 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.64 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 40.1 t -120.96 113.87 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.871 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -122.16 126.05 73.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.531 -178.935 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.527 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -74.4 126.76 31.4 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.608 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -81.92 -178.97 52.71 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.268 -0.968 . . . . 0.0 113.021 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 66.01 21.25 69.57 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 121.375 -0.44 . . . . 0.0 112.872 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' GLN . . . . . 0.571 ' NE2' ' HB3' ' A' ' 181' ' ' PRO . 48.3 mt-30 -78.72 -176.04 4.71 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.213 0.53 . . . . 0.0 111.476 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.4 t -148.64 147.77 29.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.043 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' TYR . . . . . 0.67 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 7.2 m-85 -103.32 129.95 50.47 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.87 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -121.53 148.07 44.97 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.756 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.439 ' HB2' ' OG1' ' A' ' 39' ' ' THR . 10.9 p -71.52 110.99 8.68 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 120.981 -0.287 . . . . 0.0 110.516 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.493 ' HB3' ' O ' ' A' ' 210' ' ' THR . 55.7 Cg_endo -70.08 1.66 4.44 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.199 1.933 . . . . 0.0 112.213 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 98.59 -101.75 2.51 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 56.1 m -117.39 137.78 52.25 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' TYR . . . . . 0.609 ' CD2' HG21 ' A' ' 210' ' ' THR . 10.6 t80 -134.32 125.49 27.74 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.928 0.394 . . . . 0.0 111.314 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.892 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -94.78 110.91 22.72 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.105 0.479 . . . . 0.0 111.017 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.606 ' N ' HD22 ' A' ' 238' ' ' LEU . 21.7 t -81.61 111.11 17.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.212 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.533 ' HG3' HD13 ' A' ' 238' ' ' LEU . 6.3 mt-10 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.078 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.691 ' HB2' HD21 ' A' ' 207' ' ' LEU . 1.0 OUTLIER . . . . . 0 CA--C 1.516 -0.351 0 CA-C-O 121.277 0.56 . . . . 0.0 110.69 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.863 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -37.23 -46.83 0.75 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.001 -0.999 . . . . 0.0 112.321 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.043 HD22 HD11 ' A' ' 75' ' ' ILE . 11.0 mt -75.51 -33.14 60.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.937 0.399 . . . . 0.0 111.256 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.895 HD22 ' HB2' ' A' ' 101' ' ' PRO . 46.4 tp -68.6 -49.71 57.15 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.489 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.628 HD22 ' CZ ' ' A' ' 231' ' ' TYR . 39.5 mt -68.71 -26.99 65.55 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.451 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.825 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -65.29 -37.46 87.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.084 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.81 ' CB ' HG11 ' A' ' 62' ' ' VAL . . . -80.83 -41.12 23.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.234 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.689 HD23 ' O ' ' A' ' 80' ' ' GLY . 32.4 mt -67.52 -3.78 9.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.368 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.427 ' O ' ' HA3' ' A' ' 77' ' ' GLY . . . -83.57 171.95 12.83 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -112.31 34.67 4.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.984 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -168.81 175.43 43.31 Favored Glycine 0 C--N 1.309 -0.936 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.74 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.759 ' HE2' HD12 ' A' ' 76' ' ' ILE . 10.6 ttmt -95.39 117.83 31.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.642 0.721 . . . . 0.0 111.373 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 235' ' ' GLY . 0.9 OUTLIER -123.14 148.28 45.89 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.615 -179.291 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.708 HG22 ' HB2' ' A' ' 74' ' ' GLU . 76.1 t -104.78 141.42 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 CA-C-O 121.393 0.616 . . . . 0.0 112.474 -179.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.896 HD23 HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -114.51 116.2 28.45 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 175.034 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.907 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.5 OUTLIER -102.99 151.68 22.2 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.149 -178.364 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.447 ' HB2' HD23 ' A' ' 238' ' ' LEU . 1.8 t-20 68.15 25.64 7.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.419 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.807 HD21 ' CB ' ' A' ' 41' ' ' LEU . 70.9 mt -53.4 -175.6 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.552 ' HB3' HG21 ' A' ' 50' ' ' VAL . 54.1 tp -113.0 130.91 55.97 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.509 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.417 ' O ' ' CG ' ' A' ' 46' ' ' ASP . 10.1 p-10 -85.45 87.41 7.39 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.302 0.573 . . . . 0.0 110.619 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.447 ' HB2' ' OD1' ' A' ' 49' ' ' ASP . 4.4 m -164.02 142.91 7.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.306 -178.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -36.27 -32.08 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.689 0.281 . . . . 0.0 111.578 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 1.065 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 29.4 p-10 -57.74 -42.62 84.3 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.055 0.455 . . . . 0.0 110.66 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.552 HG21 ' HB3' ' A' ' 45' ' ' LEU . 98.5 t -82.73 -45.78 19.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.788 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.912 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -48.65 -40.08 26.59 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.292 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.644 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 13.8 m-70 -78.62 -33.2 47.56 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.017 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.558 ' O ' HD13 ' A' ' 57' ' ' LEU . 7.8 tpt -54.36 -32.41 56.86 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 176.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.912 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.6 OUTLIER -84.08 -42.48 16.05 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.53 176.411 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.701 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 25.2 t-20 -60.25 -42.62 95.68 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.538 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 1.081 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -57.66 -47.23 82.87 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.752 0.787 . . . . 0.0 109.207 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.815 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -64.23 -39.71 94.54 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.253 -1.34 . . . . 0.0 107.775 177.147 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.701 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.1 m -61.44 -35.4 77.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.802 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.637 ' CB ' HD11 ' A' ' 90' ' ' LEU . . . -75.97 -38.04 57.91 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.267 -178.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.705 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -80.59 -14.01 58.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.287 0.565 . . . . 0.0 110.657 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.94 34.97 4.99 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.217 -0.901 . . . . 0.0 114.259 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.815 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 35.6 t -90.5 121.71 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.775 ' O ' HG12 ' A' ' 76' ' ' ILE . 2.7 t -85.68 135.06 33.92 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.462 -178.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.787 ' HB3' HG23 ' A' ' 75' ' ' ILE . 40.1 p90 -161.33 172.07 17.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.577 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 74' ' ' GLU . 85.9 m -135.68 146.41 47.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.462 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.652 HD12 ' HB2' ' A' ' 73' ' ' CYS . 9.3 tp -117.78 136.53 53.34 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.088 0.47 . . . . 0.0 110.716 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.432 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 1.2 t -59.95 -162.7 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.133 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -95.01 -29.4 14.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.157 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.03 1.88 25.94 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.181 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.493 ' HA ' HD21 ' A' ' 66' ' ' LEU . 1.3 mtt180 56.42 33.51 22.57 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.38 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.411 HG22 ' O ' ' A' ' 44' ' ' LEU . 1.1 p -130.95 -9.25 3.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.575 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -117.61 121.48 41.03 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.191 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.652 ' HB2' HD12 ' A' ' 66' ' ' LEU . 37.9 t -132.07 129.1 39.54 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.245 0.545 . . . . 0.0 112.041 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.708 ' HB2' HG22 ' A' ' 40' ' ' VAL . 64.2 tt0 -112.22 130.29 55.97 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 177.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 1.043 HD11 HD22 ' A' ' 29' ' ' LEU . 17.9 mt -126.35 122.17 60.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 -177.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.775 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -67.67 103.72 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-O 121.343 0.592 . . . . 0.0 109.508 175.78 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' A' ' 35' ' ' ALA . . . -43.44 151.44 0.45 Allowed Glycine 0 C--N 1.32 -0.324 0 CA-C-N 115.219 -0.9 . . . . 0.0 113.847 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 35' ' ' ALA . 5.8 t30 -97.34 -17.25 19.86 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.795 0.331 . . . . 0.0 111.347 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.11 -0.48 56.12 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.159 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.689 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 154.8 -150.71 22.32 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.167 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.598 ' CG ' ' HB3' ' A' ' 108' ' ' LEU . 73.1 Cg_exo -50.15 125.26 14.48 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.992 2.462 . . . . 0.0 112.98 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.705 ' HB2' HD13 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -74.21 106.27 5.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.901 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -81.67 133.77 35.4 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.333 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.607 ' CB ' HD11 ' A' ' 113' ' ' ILE . . . -97.05 129.8 44.44 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.25 123.97 23.45 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 176.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.59 -178.81 2.2 Favored Glycine 0 N--CA 1.44 -1.049 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 -175.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 112' ' ' ASP . . . -80.06 144.5 33.1 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 118.725 1.262 . . . . 0.0 112.025 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.636 HD21 ' C ' ' A' ' 59' ' ' ALA . 0.5 OUTLIER -114.63 161.06 18.59 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.089 -178.833 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.481 ' HG3' ' HB ' ' A' ' 114' ' ' VAL . 28.9 mp0 -139.31 105.28 5.19 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.099 178.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.748 ' HB3' HD11 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -105.11 116.92 32.76 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.886 -178.476 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.565 ' C ' HD13 ' A' ' 92' ' ' LEU . 7.6 m-85 -96.59 96.8 8.9 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.914 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -103.88 57.57 0.73 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.275 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.646 ' HA3' ' H ' ' A' ' 118' ' ' GLU . . . -50.35 -68.04 1.61 Allowed Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.592 -0.731 . . . . 0.0 113.499 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.526 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 83.5 m-20 -76.49 1.07 17.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.554 0.216 . . . . 0.0 111.299 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 1.065 ' HB2' ' HA ' ' A' ' 49' ' ' ASP . . . -99.87 54.12 0.92 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.948 0.404 . . . . 0.0 111.656 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -56.85 -25.39 52.41 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.31 -0.947 . . . . 0.0 111.339 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.478 HG23 ' OE1' ' A' ' 171' ' ' GLN . 0.1 OUTLIER -89.05 -14.36 36.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.685 -0.257 . . . . 0.0 111.656 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.863 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -96.83 -32.56 12.04 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.603 ' CG ' HD13 ' A' ' 126' ' ' ILE . 0.9 OUTLIER -61.73 -43.25 99.22 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.766 ' HD2' HD12 ' A' ' 126' ' ' ILE . 6.7 mpt_? -56.81 -60.5 9.24 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.895 ' HB2' HD22 ' A' ' 30' ' ' LEU . 14.1 Cg_endo -58.57 -34.73 99.05 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.513 2.142 . . . . 0.0 112.446 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 1.081 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -72.07 -52.49 16.6 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.145 179.703 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 1.018 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -53.13 -27.83 22.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.483 0.659 . . . . 0.0 110.311 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.858 ' CB ' ' HB1' ' A' ' 175' ' ' ALA . . . -86.5 -54.5 4.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.343 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.721 ' CB ' HD11 ' A' ' 30' ' ' LEU . . . -60.65 -34.44 74.29 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -177.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.704 ' HB2' HD12 ' A' ' 153' ' ' LEU . 31.2 mt -78.54 -23.06 46.41 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -176.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.558 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 13.7 p -78.42 16.1 0.87 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.161 0.505 . . . . 0.0 110.791 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.695 HD21 ' HB2' ' A' ' 182' ' ' LEU . 0.3 OUTLIER -82.98 -75.81 0.3 Allowed 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.032 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -70.69 -113.77 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.134 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.57 94.44 1.9 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.206 0.527 . . . . 0.0 110.793 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.657 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 17.3 p30 -145.27 139.12 26.88 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.378 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.877 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 1.2 m-20 -97.74 98.26 9.7 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.647 HD13 ' OD1' ' A' ' 111' ' ' ASN . 1.6 mp -120.35 147.92 23.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.253 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.859 HG13 ' CD2' ' A' ' 143' ' ' LEU . 47.1 t -115.34 113.76 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 176.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.617 HD23 ' HB2' ' A' ' 90' ' ' LEU . 77.6 mt -101.72 106.36 17.37 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.518 -178.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.663 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -119.04 -169.36 1.72 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.318 -179.232 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.479 ' HA3' ' HA2' ' A' ' 93' ' ' GLY . . . -171.35 -179.64 42.57 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.524 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.646 ' H ' ' HA3' ' A' ' 93' ' ' GLY . 39.0 mt-10 -70.15 169.61 12.86 Favored Pre-proline 0 C--N 1.331 -0.211 0 C-N-CA 123.207 0.603 . . . . 0.0 111.08 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.63 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 4.1 Cg_endo -45.08 -40.04 15.34 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.082 2.521 . . . . 0.0 113.077 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.3 mtm180 -67.84 -23.93 65.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.73 0.3 . . . . 0.0 110.716 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.633 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 10.5 tpt -60.96 -36.21 78.78 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.455 ' HA ' ' HG2' ' A' ' 149' ' ' PRO . 0.0 OUTLIER -61.47 -16.5 47.76 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.665 179.249 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -83.99 3.18 35.46 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.573 ' HB3' HH22 ' A' ' 100' ' ' ARG . 66.0 mtt-85 -127.62 83.26 66.55 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.352 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.466 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 38.1 Cg_exo -56.79 149.28 61.08 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.761 2.307 . . . . 0.0 111.701 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.766 HD12 ' HD2' ' A' ' 100' ' ' ARG . 1.0 OUTLIER -129.07 8.66 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.377 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.553 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -59.88 -39.84 96.02 Favored Glycine 0 CA--C 1.517 0.193 0 C-N-CA 120.749 -0.739 . . . . 0.0 113.764 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.591 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 26.0 m80 -55.71 -37.97 69.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.902 0.351 . . . . 0.0 110.54 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.772 ' HG ' HD11 ' A' ' 133' ' ' LEU . 29.3 tp -75.42 -40.46 57.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.241 0.544 . . . . 0.0 109.804 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.881 HG21 HD21 ' A' ' 151' ' ' LEU . 40.3 t -56.54 -47.98 81.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.331 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.692 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 0.1 OUTLIER -72.18 -35.94 69.13 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 121.298 0.571 . . . . 0.0 109.58 179.272 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.669 ' O ' HG13 ' A' ' 162' ' ' VAL . . . -57.31 -47.73 80.76 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.75 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.772 HD11 ' HG ' ' A' ' 129' ' ' LEU . 3.5 mt -75.94 -50.32 15.27 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.06 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.745 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.1 OUTLIER -54.71 -28.32 47.13 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.107 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.692 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 8.1 tp -69.01 -31.82 70.91 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 120.958 0.408 . . . . 0.0 110.902 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.464 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -81.86 11.64 46.45 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.787 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.49 6.54 56.44 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.764 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.673 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . . . -76.36 153.59 35.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.973 0.416 . . . . 0.0 111.481 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 0.4 OUTLIER -102.83 106.35 16.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.646 178.996 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.767 ' CG2' HG13 ' A' ' 130' ' ' VAL . 23.1 mt -137.91 125.88 30.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.485 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.781 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -123.56 139.48 53.96 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.519 -179.541 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.41 ' CE1' HG21 ' A' ' 130' ' ' VAL . 40.3 m-85 -79.71 131.05 35.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.469 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.859 ' CD2' HG13 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -91.52 -91.04 0.16 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.62 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.6 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 7.6 mm-40 -58.56 -81.68 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.676 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.512 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 0.2 OUTLIER -112.76 151.21 30.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.914 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 12.8 mt-10 -67.41 129.75 40.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.827 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.553 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 2.8 m120 71.04 17.91 6.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.068 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.62 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 16.8 m-85 -108.59 169.48 6.49 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 121.046 0.45 . . . . 0.0 111.992 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.918 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 48.9 Cg_exo -31.43 -62.67 0.12 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 124.384 3.389 . . . . 0.0 116.061 -177.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.918 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 65.3 Cg_exo -52.5 144.79 39.83 Favored 'Trans proline' 0 C--N 1.354 0.827 0 CA-C-N 120.626 1.259 . . . . 0.0 112.683 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.881 HD21 HG21 ' A' ' 130' ' ' VAL . 7.4 mt -155.9 136.85 13.59 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.023 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.781 ' HB2' HG22 ' A' ' 141' ' ' THR . 5.8 mtt180 -108.08 102.77 11.9 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 1.018 HD11 ' HA ' ' A' ' 103' ' ' ALA . 7.0 mt -90.73 145.83 24.49 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.861 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.657 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 6.5 mt-30 -149.3 26.19 0.87 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.164 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 53.78 -163.22 2.98 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.421 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.436 ' O ' HG23 ' A' ' 158' ' ' THR . . . 108.38 -16.27 35.06 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.005 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.73 ' HE2' ' HA ' ' A' ' 180' ' ' ALA . 67.0 t80 -58.55 122.97 14.71 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 117.081 0.44 . . . . 0.0 110.693 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.709 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 60.7 p -116.9 -28.84 6.18 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.495 0.664 . . . . 0.0 111.431 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 120.95 -169.47 14.27 Favored Glycine 0 C--N 1.306 -1.092 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.215 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.616 ' O ' ' HA ' ' A' ' 187' ' ' THR . . . 128.39 -126.13 5.26 Favored Glycine 0 N--CA 1.434 -1.468 0 N-CA-C 111.126 -0.789 . . . . 0.0 111.126 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.41 130.34 55.73 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.779 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 82.0 t -130.21 123.54 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 121.004 0.431 . . . . 0.0 110.687 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.17 119.99 38.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.665 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.714 HG11 ' HG ' ' A' ' 173' ' ' LEU . 1.0 OUTLIER -130.14 120.51 49.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.953 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.683 ' HA ' ' HG3' ' A' ' 192' ' ' LYS . 0.1 OUTLIER -51.94 137.89 25.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.298 0.571 . . . . 0.0 111.649 -179.737 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.881 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . . . . . . 0 N--CA 1.441 -0.968 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.603 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.496 ' N ' HG11 ' A' ' 196' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.462 0.127 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.54 ' O ' ' HB3' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -74.37 -6.01 45.64 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.122 -179.74 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.598 ' HA ' HD13 ' A' ' 129' ' ' LEU . 5.5 m-85 -76.27 -55.96 5.08 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.898 HD11 ' CG1' ' A' ' 191' ' ' ILE . 0.4 OUTLIER -61.74 -40.95 96.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.606 0.717 . . . . 0.0 109.084 178.057 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.482 ' HB ' ' HA ' ' A' ' 171' ' ' GLN . 5.5 m -55.82 -36.49 67.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.528 -1.214 . . . . 0.0 110.01 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.858 ' HB1' ' CB ' ' A' ' 104' ' ' ALA . . . -69.17 -40.29 78.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.563 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.695 HD11 HG21 ' A' ' 164' ' ' VAL . 0.4 OUTLIER -76.64 -33.32 58.34 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.149 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.783 HD11 ' CD2' ' A' ' 223' ' ' PHE . 5.1 mp -59.76 -38.13 80.94 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.908 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.649 ' HE1' ' HA ' ' A' ' 27' ' ' ARG . 0.4 OUTLIER -82.07 -43.03 18.4 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.469 0.652 . . . . 0.0 112.112 -179.66 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.619 HG23 ' HG ' ' A' ' 108' ' ' LEU . 54.4 m -71.41 -41.13 69.97 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.471 -178.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.73 ' HA ' ' HE2' ' A' ' 157' ' ' PHE . . . -59.72 -42.15 89.78 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -177.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.589 ' HB3' ' NE2' ' A' ' 229' ' ' GLN . 29.8 Cg_endo -64.77 -29.04 59.45 Favored 'Trans proline' 0 CA--C 1.5 -1.205 0 C-N-CA 120.956 1.104 . . . . 0.0 111.637 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.695 ' HB2' HD21 ' A' ' 108' ' ' LEU . 6.9 mt -83.73 1.56 42.12 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.358 178.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.66 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -83.59 138.53 41.12 Favored Pre-proline 0 C--O 1.224 -0.289 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.709 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 12.9 Cg_endo -51.84 -31.86 44.26 Favored 'Trans proline' 0 CA--C 1.518 -0.28 0 C-N-CA 122.45 2.1 . . . . 0.0 113.117 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -114.89 143.6 44.88 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.892 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -57.8 141.01 50.36 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.076 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 160' ' ' GLY . 70.7 m -119.01 145.85 45.51 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.652 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 35.3 t -125.63 118.94 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.438 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.779 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 4.1 mp -104.03 117.09 48.99 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.655 0 C-N-CA 120.079 -0.648 . . . . 0.0 109.276 178.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.888 ' HG3' ' HG3' ' A' ' 222' ' ' GLN . 1.7 ttt180 -99.88 123.57 44.27 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.898 ' CG1' HD11 ' A' ' 173' ' ' LEU . 1.3 mp -93.11 121.88 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.088 -176.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.683 ' HG3' ' HA ' ' A' ' 165' ' ' ASP . 0.5 OUTLIER -74.87 96.62 3.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.346 -178.594 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 97.36 -126.9 9.03 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.793 -0.717 . . . . 0.0 111.702 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -116.85 133.54 55.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.769 0.318 . . . . 0.0 111.321 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.721 HD11 ' HZ ' ' A' ' 223' ' ' PHE . 0.8 OUTLIER -41.91 144.68 0.4 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.211 0.529 . . . . 0.0 111.902 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.496 HG11 ' N ' ' A' ' 170' ' ' SER . 13.9 p -74.48 -25.38 19.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.975 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.475 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 0.3 OUTLIER -168.48 64.7 0.07 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.833 0.349 . . . . 0.0 110.934 -179.531 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.56 ' HA ' HD13 ' A' ' 195' ' ' LEU . 4.4 tptp -39.48 -46.23 4.13 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.382 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 72.6 Cg_exo -49.61 -36.78 41.72 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.006 1.804 . . . . 0.0 111.843 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.943 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.2 OUTLIER -65.62 -44.53 86.2 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 178.42 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.46 HG21 ' HE2' ' A' ' 223' ' ' PHE . 30.9 mm -60.9 -38.4 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.472 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.45 -43.63 93.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.229 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.943 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.6 mt -62.43 -50.95 77.83 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 CA-C-O 121.569 0.7 . . . . 0.0 109.635 178.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.544 HG22 ' SD ' ' A' ' 208' ' ' MET . 78.5 m -53.66 -51.65 62.49 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.991 -178.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.755 HD22 ' HB ' ' A' ' 215' ' ' ILE . 32.2 mt -65.31 -30.18 71.0 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.001 0.429 . . . . 0.0 111.534 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ASN . . . . . 0.559 ' HA ' ' HE3' ' A' ' 209' ' ' LYS . 1.0 OUTLIER -77.5 -46.37 22.65 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.734 0.778 . . . . 0.0 109.77 179.007 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.91 ' O ' HG22 ' A' ' 210' ' ' THR . 2.6 tp -71.26 -30.02 65.8 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.24 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' MET . . . . . 0.759 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 40.8 mtp -75.04 -35.63 61.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.647 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 12.8 mtmt -60.65 -37.71 82.43 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.046 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.91 HG22 ' O ' ' A' ' 207' ' ' LEU . 5.8 t -62.61 -28.88 70.2 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.718 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.574 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 42.7 m-85 -80.52 -6.98 59.01 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.579 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.99 7.65 24.9 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 115.98 1.152 . . . . 0.0 115.98 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.2 m -123.36 148.59 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 118.929 1.364 . . . . 0.0 112.794 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.509 ' O ' HD13 ' A' ' 215' ' ' ILE . 18.0 mt-10 -130.84 136.21 48.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.811 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.755 ' HB ' HD22 ' A' ' 205' ' ' LEU . 16.8 mm -118.66 148.12 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 120.845 0.355 . . . . 0.0 110.565 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.55 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 2.6 tt0 -100.63 118.26 36.42 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.916 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -82.84 150.98 26.24 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.934 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' GLN . . . . . 0.517 ' CB ' ' HB3' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -106.74 -138.26 0.37 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.114 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.493 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 0.1 OUTLIER -84.87 66.67 9.81 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.827 0.346 . . . . 0.0 111.008 -179.451 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 5.5 t80 60.07 33.04 21.24 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.82 0.819 . . . . 0.0 110.439 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.675 ' CB ' ' HB ' ' A' ' 191' ' ' ILE . 1.8 pt20 -166.39 -124.77 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.888 ' HG3' ' HG3' ' A' ' 190' ' ' ARG . 0.7 OUTLIER -5.43 130.09 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.783 ' CD2' HD11 ' A' ' 177' ' ' LEU . 1.2 m-85 -125.07 133.37 52.93 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 112.977 -1.92 . . . . 0.0 109.509 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 61.3 t -116.96 113.51 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-O 121.573 0.702 . . . . 0.0 109.206 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.739 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -120.22 122.29 67.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.152 -178.776 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.572 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 0.1 OUTLIER -76.84 123.43 26.24 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.806 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -75.54 -177.11 40.71 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.718 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 65.5 21.72 69.0 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 121.573 -0.346 . . . . 0.0 113.036 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' GLN . . . . . 0.589 ' NE2' ' HB3' ' A' ' 181' ' ' PRO . 43.9 mt-30 -77.41 179.58 6.36 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.298 0.57 . . . . 0.0 111.338 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 13.6 t -138.01 147.8 44.53 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.869 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' TYR . . . . . 0.681 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 1.1 m-30 -107.83 123.76 49.07 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.894 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.96 161.3 20.02 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.553 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.12 113.34 57.95 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-O 120.835 0.35 . . . . 0.0 111.43 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.517 ' HG3' HG23 ' A' ' 210' ' ' THR . 58.8 Cg_endo -69.65 1.98 3.88 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.656 2.237 . . . . 0.0 112.875 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 98.99 -100.5 2.29 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.344 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 92.2 m -119.35 133.15 55.87 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' TYR . . . . . 0.712 ' CD2' HG21 ' A' ' 210' ' ' THR . 4.4 t80 -129.74 133.21 46.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.873 0.368 . . . . 0.0 111.117 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.907 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -97.18 110.52 23.05 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.201 0.524 . . . . 0.0 110.524 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.621 ' N ' HD22 ' A' ' 238' ' ' LEU . 21.9 t -79.06 113.51 18.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.421 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.212 -0.899 . . . . 0.0 111.156 -179.984 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.596 ' HB2' HD21 ' A' ' 207' ' ' LEU . 0.5 OUTLIER . . . . . 0 CA--C 1.518 -0.274 0 CA-C-O 121.345 0.593 . . . . 0.0 110.171 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.692 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -40.73 -44.39 2.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.958 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.975 HD22 HD11 ' A' ' 75' ' ' ILE . 14.2 mt -71.68 -37.47 70.74 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.918 0.39 . . . . 0.0 111.213 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.681 HD11 ' CB ' ' A' ' 105' ' ' ALA . 56.9 tp -65.32 -49.95 67.48 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.917 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.692 HD11 ' HG2' ' A' ' 208' ' ' MET . 20.1 mt -69.33 -26.17 64.57 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.765 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -63.79 -41.82 97.85 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.221 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.83 ' CB ' HG11 ' A' ' 62' ' ' VAL . . . -80.47 -40.17 26.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.73 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.687 HD11 ' HB1' ' A' ' 105' ' ' ALA . 9.1 mt -67.48 -3.4 8.43 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.451 178.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.505 ' HA ' ' CB ' ' A' ' 231' ' ' TYR . . . -99.84 177.26 5.17 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -177.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.546 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.3 OUTLIER -111.28 114.39 27.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.656 178.357 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 114.28 167.48 15.97 Favored Glycine 0 C--O 1.228 -0.28 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.202 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.653 ' HG3' HG23 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -95.34 117.53 30.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 117.284 0.542 . . . . 0.0 111.55 -179.439 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 0.9 OUTLIER -118.8 147.03 44.34 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.242 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.672 HG22 ' HB2' ' A' ' 74' ' ' GLU . 96.6 t -105.91 141.25 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 CA-C-O 121.385 0.612 . . . . 0.0 112.437 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.923 HD23 HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -116.02 116.32 27.69 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 174.733 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.867 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.5 OUTLIER -103.15 152.93 20.86 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.228 -177.75 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.4 t30 68.8 24.71 6.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.514 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.813 HD21 ' CB ' ' A' ' 41' ' ' LEU . 34.8 mt -53.86 -175.55 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.951 0.405 . . . . 0.0 110.151 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.558 ' HB3' HG21 ' A' ' 50' ' ' VAL . 28.3 tp -111.78 132.28 54.77 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.163 -0.472 . . . . 0.0 109.995 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -88.52 89.26 7.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.835 0.35 . . . . 0.0 110.896 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 50' ' ' VAL . 36.5 m -163.79 142.17 7.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.057 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.583 ' HA ' ' HB3' ' A' ' 51' ' ' ARG . 1.6 p30 -37.89 -31.25 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.662 0.268 . . . . 0.0 111.429 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.875 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 0.7 OUTLIER -57.29 -42.72 82.25 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.024 0.44 . . . . 0.0 110.435 179.308 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.671 HG23 ' OD1' ' A' ' 49' ' ' ASP . 98.0 t -81.66 -45.08 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.873 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -49.62 -39.13 34.64 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 177.932 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.618 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 14.7 m-70 -78.64 -33.25 47.38 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.908 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.588 ' O ' HD13 ' A' ' 57' ' ' LEU . 9.4 tpt -55.5 -35.58 65.74 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 176.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.873 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.5 OUTLIER -81.88 -44.43 16.85 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 114.162 -1.381 . . . . 0.0 108.522 176.598 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.732 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 0.3 OUTLIER -57.31 -38.59 74.27 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.354 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 1.036 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -60.54 -44.79 95.73 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.801 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.2 OUTLIER -65.59 -38.83 90.6 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.1 -1.409 . . . . 0.0 107.752 176.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.732 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.2 m -63.02 -33.76 76.11 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.528 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.782 ' CB ' HD11 ' A' ' 90' ' ' LEU . . . -74.22 -37.13 63.93 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.341 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.714 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -83.54 -13.92 53.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.171 0.51 . . . . 0.0 111.058 -179.464 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.07 35.01 4.65 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.42 -0.809 . . . . 0.0 114.123 178.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.83 HG11 ' CB ' ' A' ' 33' ' ' ALA . 38.2 t -90.69 122.13 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.756 ' O ' HG12 ' A' ' 76' ' ' ILE . 5.5 m -84.88 132.54 34.38 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 120.911 0.386 . . . . 0.0 111.711 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.755 ' HB3' HG23 ' A' ' 75' ' ' ILE . 41.4 p90 -158.03 167.93 28.51 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.378 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 74' ' ' GLU . 40.7 m -129.81 147.31 51.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.372 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.45 HD12 ' HB2' ' A' ' 73' ' ' CYS . 12.3 tp -115.59 132.4 56.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.235 0.541 . . . . 0.0 110.487 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 0.2 OUTLIER -59.22 -161.2 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.554 -179.451 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -95.56 -32.02 13.03 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.549 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -79.84 1.24 27.7 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.261 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 30.6 mtt-85 57.88 35.33 25.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.996 0.426 . . . . 0.0 110.888 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -134.21 -4.5 2.71 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.626 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.545 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 3.4 mtp-105 -121.62 122.09 38.86 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.622 ' HB3' HD11 ' A' ' 44' ' ' LEU . 28.8 t -131.18 126.9 36.81 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 120.989 0.424 . . . . 0.0 112.069 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.672 ' HB2' HG22 ' A' ' 40' ' ' VAL . 58.6 tt0 -110.63 131.65 54.87 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 176.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.975 HD11 HD22 ' A' ' 29' ' ' LEU . 13.2 mt -126.42 121.81 59.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.756 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -67.23 98.4 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-O 121.486 0.66 . . . . 0.0 109.252 175.864 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -35.15 145.04 0.06 OUTLIER Glycine 0 C--N 1.32 -0.344 0 CA-C-N 114.56 -1.2 . . . . 0.0 114.125 -178.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.47 ' CB ' HD12 ' A' ' 82' ' ' LEU . 1.1 t-20 -90.74 -13.11 34.66 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.06 0.457 . . . . 0.0 110.789 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.546 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 91.81 1.78 70.25 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.697 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.637 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 149.97 -147.61 18.01 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.035 -0.602 . . . . 0.0 111.742 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.429 ' HD2' ' HA3' ' A' ' 80' ' ' GLY . 5.7 Cg_endo -49.05 122.66 8.71 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.596 2.198 . . . . 0.0 112.524 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.714 ' HB2' HD13 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -73.33 110.75 7.86 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.27 179.653 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.408 ' HA ' ' ND2' ' A' ' 111' ' ' ASN . 4.5 p80 -82.24 130.31 35.06 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.592 ' CB ' HD22 ' A' ' 88' ' ' LEU . . . -94.46 122.79 37.39 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.672 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -71.19 123.74 22.89 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 176.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.86 174.54 1.2 Allowed Glycine 0 N--CA 1.439 -1.124 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 -175.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 112' ' ' ASP . . . -72.95 144.8 47.14 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 118.705 1.253 . . . . 0.0 111.923 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.666 HD21 ' C ' ' A' ' 59' ' ' ALA . 0.5 OUTLIER -112.27 160.94 17.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.001 -0.999 . . . . 0.0 112.127 -178.622 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 18.8 mt-10 -140.21 101.3 4.11 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.022 177.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.782 HD11 ' CB ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -100.79 120.1 39.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.872 0.368 . . . . 0.0 111.346 -178.58 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.46 ' C ' HD13 ' A' ' 92' ' ' LEU . 1.4 m-85 -95.27 96.45 9.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.823 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.807 HD23 ' SD ' ' A' ' 99' ' ' MET . 0.1 OUTLIER -103.54 52.89 0.76 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.351 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.572 ' HA3' ' H ' ' A' ' 118' ' ' GLU . . . -49.82 -75.13 0.22 Allowed Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.408 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 50.0 m-80 -77.51 -0.68 27.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.501 0.191 . . . . 0.0 110.97 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.894 ' HB1' ' HB3' ' A' ' 98' ' ' ALA . . . -92.18 46.53 1.27 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.81 0.338 . . . . 0.0 111.336 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -52.74 -24.37 18.5 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.297 -0.954 . . . . 0.0 111.811 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.504 HG22 ' OE1' ' A' ' 171' ' ' GLN . 0.9 OUTLIER -87.69 -19.69 27.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.471 0.177 . . . . 0.0 111.167 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.894 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -94.18 -31.69 14.03 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.648 0.261 . . . . 0.0 111.452 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.807 ' SD ' HD23 ' A' ' 92' ' ' LEU . 5.3 tpp -64.57 -47.35 79.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.716 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.67 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -55.18 -56.35 29.33 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.67 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 18.7 Cg_exo -64.73 -30.49 59.43 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.126 1.884 . . . . 0.0 112.63 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 1.036 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -72.57 -53.16 12.72 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.193 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.898 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -52.89 -27.08 16.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.33 0.586 . . . . 0.0 110.509 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.695 ' HB2' ' HB1' ' A' ' 175' ' ' ALA . . . -86.62 -53.92 4.68 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.131 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.687 ' HB1' HD11 ' A' ' 34' ' ' LEU . . . -60.57 -36.51 78.67 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -177.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.644 ' HB2' HD12 ' A' ' 153' ' ' LEU . 27.4 mt -76.28 -12.88 60.15 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.593 ' SG ' HD22 ' A' ' 153' ' ' LEU . 69.3 m -86.73 20.12 2.67 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.25 0.548 . . . . 0.0 110.427 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.722 HD21 ' HB2' ' A' ' 182' ' ' LEU . 2.4 mt -85.93 -75.02 0.39 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.019 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -69.7 -117.07 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.487 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.35 96.4 1.92 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.045 0.45 . . . . 0.0 110.123 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.703 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 10.5 m-80 -148.51 143.99 27.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.116 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.837 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 13.4 m-20 -95.99 99.98 11.7 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.303 0.573 . . . . 0.0 110.149 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.53 HG13 ' CB ' ' A' ' 88' ' ' LEU . 1.9 mp -118.15 146.08 23.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.941 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.785 HG13 ' CD2' ' A' ' 143' ' ' LEU . 48.5 t -115.49 112.86 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 176.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.673 HD23 ' HB2' ' A' ' 90' ' ' LEU . 31.0 mt -102.03 106.52 17.43 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.497 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.767 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -118.88 -170.83 1.98 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.037 -179.044 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.476 ' HA3' ' HG2' ' A' ' 121' ' ' MET . . . -170.08 179.13 42.53 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.968 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.661 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 2.9 mt-10 -72.32 169.72 15.61 Favored Pre-proline 0 C--N 1.332 -0.188 0 C-N-CA 123.573 0.749 . . . . 0.0 111.248 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.661 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 2.5 Cg_endo -43.56 -39.78 9.98 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.096 2.531 . . . . 0.0 113.193 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.8 mtm-85 -67.63 -24.4 65.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.667 0.27 . . . . 0.0 110.838 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.631 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 9.2 tpt -61.1 -34.94 75.75 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.424 ' HA ' ' HG2' ' A' ' 149' ' ' PRO . 0.0 OUTLIER -61.92 -16.69 52.81 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.463 179.139 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -87.59 4.17 44.76 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.934 0.397 . . . . 0.0 109.986 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 34.1 mtt85 -127.12 83.77 65.15 Favored Pre-proline 0 N--CA 1.454 -0.242 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.866 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.505 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 19.7 Cg_endo -58.02 148.76 75.12 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.675 2.25 . . . . 0.0 111.501 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.471 ' O ' HG13 ' A' ' 126' ' ' ILE . 0.6 OUTLIER -125.48 -2.49 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -179.262 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.547 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -54.03 -34.7 52.73 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.713 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.508 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 13.3 m80 -58.53 -40.14 82.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.146 0.473 . . . . 0.0 110.142 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.786 ' HG ' HD11 ' A' ' 133' ' ' LEU . 16.4 tp -76.12 -40.59 52.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.705 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.733 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 46.1 t -56.0 -47.42 80.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.262 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.792 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 3.3 m-20 -71.27 -35.93 71.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.019 0.437 . . . . 0.0 110.025 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.62 ' HB2' HG23 ' A' ' 164' ' ' VAL . . . -60.84 -44.55 96.81 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.578 178.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.786 HD11 ' HG ' ' A' ' 129' ' ' LEU . 6.2 mt -77.08 -50.32 13.32 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.315 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.733 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -56.75 -27.94 60.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.759 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.792 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 5.6 tp -69.45 -31.76 70.27 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.779 178.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.48 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -83.09 13.52 44.13 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.038 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.78 3.15 58.3 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.941 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.513 ' HB2' ' HD1' ' A' ' 157' ' ' PHE . . . -71.53 152.12 43.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.737 0.304 . . . . 0.0 111.568 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 0.6 OUTLIER -101.74 101.44 11.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.76 178.418 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.716 ' HB ' ' HG3' ' A' ' 134' ' ' ARG . 19.8 mt -133.39 126.91 53.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.369 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.671 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -124.05 139.56 53.82 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 116.262 -0.427 . . . . 0.0 109.938 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.515 ' HE1' HG21 ' A' ' 130' ' ' VAL . 31.3 m-85 -80.58 132.81 35.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.652 0.263 . . . . 0.0 111.278 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.785 ' CD2' HG13 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -92.57 -91.33 0.17 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.698 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.556 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 40.6 mt-10 -57.18 -81.87 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.649 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.428 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 23.2 mt-30 -113.61 151.05 32.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.788 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 0.8 OUTLIER -67.91 130.98 44.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.839 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.547 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 1.9 m-20 71.82 17.75 5.29 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.04 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.571 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 18.7 m-85 -111.14 168.25 7.85 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-O 121.294 0.569 . . . . 0.0 112.352 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.894 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 1.4 Cg_exo -29.59 -63.12 0.09 OUTLIER 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 124.796 3.664 . . . . 0.0 116.779 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.894 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 58.5 Cg_exo -54.37 147.18 47.7 Favored 'Trans proline' 0 C--N 1.356 0.954 0 CA-C-N 121.301 1.501 . . . . 0.0 112.94 -178.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.78 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 7.8 mt -156.81 136.57 12.44 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.938 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.671 ' HB2' HG22 ' A' ' 141' ' ' THR . 6.8 mtp180 -106.99 102.75 12.08 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.898 HD11 ' HA ' ' A' ' 103' ' ' ALA . 6.6 mt -91.12 145.45 24.67 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.569 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.703 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 5.6 mt-30 -147.24 24.79 1.13 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.472 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 53.41 -173.38 0.46 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.894 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 118.35 -10.07 13.17 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.039 -1.076 . . . . 0.0 112.948 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.638 ' HE2' ' HA ' ' A' ' 180' ' ' ALA . 44.6 t80 -61.41 124.62 21.12 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 117.257 0.529 . . . . 0.0 110.441 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.671 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 66.4 p -118.32 -29.51 5.5 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 121.429 0.633 . . . . 0.0 111.411 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.407 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 133.13 -160.68 23.99 Favored Glycine 0 C--N 1.308 -1.02 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.416 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.6 ' O ' HG23 ' A' ' 187' ' ' THR . . . 105.46 154.31 21.77 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.814 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -46.72 114.47 0.83 Allowed 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.407 -0.396 . . . . 0.0 111.019 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.754 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 69.1 t -107.9 121.66 61.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.317 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -91.6 119.69 31.73 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.682 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.78 HG11 ' HG ' ' A' ' 173' ' ' LEU . 1.2 t -132.27 122.29 47.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.72 139.43 50.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.059 0.456 . . . . 0.0 111.638 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.678 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . . . . . . 0 N--CA 1.449 -0.485 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.657 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.597 ' HB2' ' HB3' ' A' ' 200' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.155 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.562 ' HB3' HH21 ' A' ' 27' ' ' ARG . 0.0 OUTLIER -81.71 -12.2 58.73 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.983 -179.692 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.563 ' CD2' ' HB2' ' A' ' 129' ' ' LEU . 6.2 m-85 -75.33 -56.67 4.49 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.959 HD13 HD21 ' A' ' 195' ' ' LEU . 0.2 OUTLIER -62.26 -43.6 98.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.454 178.587 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.706 HG23 ' CG2' ' A' ' 204' ' ' THR . 1.8 m -56.06 -41.11 74.58 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.902 178.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.695 ' HB1' ' HB2' ' A' ' 104' ' ' ALA . . . -57.87 -37.79 74.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.52 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.756 HD13 HG12 ' A' ' 189' ' ' ILE . 0.7 OUTLIER -76.63 -37.04 57.03 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.383 0.611 . . . . 0.0 110.238 178.88 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.699 HD11 ' CD2' ' A' ' 223' ' ' PHE . 4.3 mp -59.61 -34.48 72.82 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.693 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.621 ' CE ' HD21 ' A' ' 31' ' ' LEU . 8.8 mtp -81.84 -42.38 19.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.373 0.606 . . . . 0.0 112.185 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.527 HG23 ' HG ' ' A' ' 108' ' ' LEU . 88.3 m -75.04 -40.82 60.12 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.546 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.638 ' HA ' ' HE2' ' A' ' 157' ' ' PHE . . . -59.88 -39.74 72.61 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 -176.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.596 ' HD3' ' O ' ' A' ' 177' ' ' LEU . 31.2 Cg_endo -68.4 -27.4 33.86 Favored 'Trans proline' 0 CA--C 1.498 -1.305 0 CA-C-N 120.241 1.122 . . . . 0.0 111.949 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.722 ' HB2' HD21 ' A' ' 108' ' ' LEU . 9.6 mt -85.05 0.35 51.84 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.643 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -81.79 137.43 47.26 Favored Pre-proline 0 C--O 1.224 -0.241 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.187 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.671 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 14.3 Cg_endo -52.27 -30.68 43.27 Favored 'Trans proline' 0 CA--C 1.519 -0.269 0 C-N-CA 122.483 2.122 . . . . 0.0 113.178 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.76 138.48 50.69 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.905 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -55.1 142.3 31.23 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.049 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 160' ' ' GLY . 87.0 m -120.31 144.42 47.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.205 0.526 . . . . 0.0 112.21 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 18.0 t -125.73 118.03 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.187 177.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.766 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 2.7 mp -101.16 117.86 47.04 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.722 ' HG3' ' HG3' ' A' ' 222' ' ' GLN . 0.2 OUTLIER -99.78 123.66 44.26 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.848 ' CG1' HD11 ' A' ' 173' ' ' LEU . 1.7 mp -93.71 124.99 46.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.063 -175.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -83.05 96.92 8.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.064 -1.426 . . . . 0.0 110.502 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 100.98 -129.81 10.02 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.933 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.32 129.0 56.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.709 0.29 . . . . 0.0 111.577 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.959 HD21 HD13 ' A' ' 173' ' ' LEU . 1.9 mt -41.43 144.68 0.33 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.419 HG11 ' N ' ' A' ' 170' ' ' SER . 8.6 p -71.56 -36.64 60.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.196 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.425 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 2.0 t -160.72 62.33 0.31 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.258 0.552 . . . . 0.0 109.977 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.699 ' HA ' HD13 ' A' ' 195' ' ' LEU . 5.5 tmtt? -38.93 -47.68 3.72 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.829 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' PRO . . . . . 0.671 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 5.0 Cg_endo -46.68 -33.71 14.09 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.178 1.919 . . . . 0.0 111.771 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.955 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.2 OUTLIER -67.26 -44.36 79.59 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.931 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.502 HG21 ' HE2' ' A' ' 223' ' ' PHE . 14.7 mm -56.71 -39.79 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 CA-C-N 114.286 -1.324 . . . . 0.0 110.348 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -58.05 -45.15 87.51 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.044 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.955 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.8 mt -61.27 -50.4 80.6 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.022 0 CA-C-O 121.786 0.803 . . . . 0.0 109.068 178.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.706 ' CG2' HG23 ' A' ' 174' ' ' THR . 87.1 m -53.15 -51.6 61.46 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.971 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.903 HD22 ' HB ' ' A' ' 215' ' ' ILE . 34.1 mt -67.99 -29.24 68.22 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 120.98 0.419 . . . . 0.0 111.663 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -78.07 -46.56 20.51 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.733 0.778 . . . . 0.0 109.664 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.961 ' O ' HG22 ' A' ' 210' ' ' THR . 2.3 tp -69.7 -29.65 67.11 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.288 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' MET . . . . . 0.692 ' HG2' HD11 ' A' ' 31' ' ' LEU . 3.9 mmm -75.98 -34.23 59.77 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.551 0.691 . . . . 0.0 109.624 178.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.652 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 7.4 mtmt -63.52 -35.97 82.22 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.439 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.961 HG22 ' O ' ' A' ' 207' ' ' LEU . 3.9 t -62.6 -27.29 69.09 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.629 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.563 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 27.5 m-85 -83.64 -6.81 59.54 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.019 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.63 7.29 26.05 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 115.782 1.073 . . . . 0.0 115.782 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 5.0 m -123.29 148.76 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 118.513 1.157 . . . . 0.0 112.049 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.471 ' CG ' ' HG2' ' A' ' 209' ' ' LYS . 13.2 mt-10 -130.09 134.33 47.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.403 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.903 ' HB ' HD22 ' A' ' 205' ' ' LEU . 8.9 mm -117.5 148.66 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 120.818 0.342 . . . . 0.0 110.247 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.618 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 19.9 tt0 -104.81 116.65 32.37 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.612 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.18 151.01 27.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.596 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' GLN . . . . . 0.694 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -109.08 -148.31 0.42 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.65 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.55 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 0.2 OUTLIER -72.38 66.91 0.69 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.847 0.356 . . . . 0.0 111.515 -179.491 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 1.7 t80 56.75 31.73 19.95 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.06 0.934 . . . . 0.0 110.625 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.689 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 4.2 pt20 -159.33 -129.27 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.766 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.1 OUTLIER -4.02 131.12 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 179.698 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.83 ' HZ ' HD11 ' A' ' 195' ' ' LEU . 1.1 m-85 -125.17 129.89 51.05 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 113.107 -1.86 . . . . 0.0 108.852 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.618 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 42.9 t -114.98 113.94 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-O 121.602 0.715 . . . . 0.0 109.62 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.674 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -120.35 124.3 72.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.121 -178.877 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.605 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 2.0 mptt -76.76 125.06 28.62 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -78.64 -178.31 50.01 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.393 -0.908 . . . . 0.0 113.23 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 64.81 21.26 67.26 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 121.346 -0.454 . . . . 0.0 112.935 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' GLN . . . . . 0.605 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 34.5 mt-30 -75.2 176.39 7.39 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.386 0.612 . . . . 0.0 111.649 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 5.4 p -136.09 147.88 48.03 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.323 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' TYR . . . . . 0.653 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 5.2 m-30 -107.75 132.07 53.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.759 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.63 147.92 48.23 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.505 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.38 111.46 14.11 Favored Pre-proline 0 N--CA 1.45 -0.435 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.657 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.475 ' HG3' HG23 ' A' ' 210' ' ' THR . 56.2 Cg_endo -69.59 3.04 2.91 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.454 2.102 . . . . 0.0 112.622 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 95.84 -103.9 3.02 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.242 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.495 HG23 ' HB ' ' A' ' 40' ' ' VAL . 27.2 m -115.42 137.11 52.4 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' TYR . . . . . 0.719 ' CD2' HG21 ' A' ' 210' ' ' THR . 7.5 t80 -132.72 126.7 33.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.955 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.867 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -94.53 111.03 22.79 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.099 0.476 . . . . 0.0 110.942 -179.685 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.618 ' N ' HD22 ' A' ' 238' ' ' LEU . 43.1 t -81.02 113.36 20.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.95 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.164 -179.75 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.641 ' HA ' ' HE1' ' A' ' 178' ' ' MET . 66.4 mtm-85 . . . . . 0 CA--C 1.518 -0.28 0 CA-C-O 121.52 0.676 . . . . 0.0 110.338 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.577 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -40.73 -45.89 2.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.633 -1.167 . . . . 0.0 112.077 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.095 HD22 HD11 ' A' ' 75' ' ' ILE . 12.6 mt -73.87 -34.57 64.52 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 120.92 0.39 . . . . 0.0 111.163 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.785 HD22 ' HB2' ' A' ' 101' ' ' PRO . 45.6 tp -68.58 -50.33 52.52 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.911 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.78 HD22 ' CZ ' ' A' ' 231' ' ' TYR . 50.7 mt -67.08 -27.15 67.12 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.416 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.82 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -66.14 -39.18 89.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.104 178.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.782 ' CB ' HG11 ' A' ' 62' ' ' VAL . . . -80.73 -40.79 24.64 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.013 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.782 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 14.0 mt -67.54 -3.61 9.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.102 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.637 ' HB2' ' HB3' ' A' ' 231' ' ' TYR . . . -99.72 -179.86 4.31 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -177.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.627 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.3 OUTLIER -113.89 111.52 21.84 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.526 178.165 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.72 166.15 14.2 Favored Glycine 0 C--N 1.32 -0.315 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -178.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.604 ' HE2' HG23 ' A' ' 76' ' ' ILE . 2.5 ttmt -95.81 118.66 32.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.992 0.396 . . . . 0.0 111.902 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.577 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 0.9 OUTLIER -117.47 145.08 44.41 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.249 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.502 ' C ' HD13 ' A' ' 41' ' ' LEU . 97.1 t -102.66 141.34 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-O 121.581 0.705 . . . . 0.0 112.423 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.826 HD23 HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -115.74 116.47 28.12 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 174.403 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.971 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.5 OUTLIER -103.93 148.11 26.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.868 0.365 . . . . 0.0 110.992 -177.601 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.461 ' HB2' HD23 ' A' ' 238' ' ' LEU . 2.0 t30 69.12 26.18 5.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.063 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.783 HD21 ' CB ' ' A' ' 41' ' ' LEU . 79.6 mt -52.66 -178.21 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.153 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.577 HD23 ' OD2' ' A' ' 49' ' ' ASP . 34.7 tp -109.79 131.21 55.27 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.205 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -86.78 87.14 7.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.008 0.433 . . . . 0.0 110.386 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.562 ' HB3' ' OD1' ' A' ' 49' ' ' ASP . 11.2 t -164.11 142.64 7.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.702 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.577 ' HB2' ' HB2' ' A' ' 94' ' ' ASN . 5.2 m-20 -37.09 -30.3 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.648 ' CB ' ' HA ' ' A' ' 95' ' ' ALA . 34.5 p-10 -56.85 -42.59 80.0 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.36 0.6 . . . . 0.0 110.208 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.521 HG21 ' HB3' ' A' ' 45' ' ' LEU . 64.6 t -83.44 -47.95 17.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.191 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.905 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -50.41 -37.97 40.59 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 178.72 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.659 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 7.4 m-70 -80.44 -32.69 37.26 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.842 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.504 ' O ' HD13 ' A' ' 57' ' ' LEU . 8.6 tpt -55.09 -35.27 64.41 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 176.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.905 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.5 OUTLIER -81.82 -42.49 19.6 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.398 176.328 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.694 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 24.6 t30 -60.77 -34.25 74.17 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.178 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 1.026 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -64.6 -46.95 80.46 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.877 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.2 OUTLIER -63.89 -39.61 94.58 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 113.914 -1.494 . . . . 0.0 107.807 177.103 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.694 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 2.6 m -59.96 -34.46 73.31 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.36 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.838 ' CB ' HD11 ' A' ' 90' ' ' LEU . . . -76.84 -36.91 56.51 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.485 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.663 HD13 ' CB ' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -82.74 -13.92 55.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.419 0.628 . . . . 0.0 110.719 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.14 35.02 5.18 Favored Glycine 0 C--N 1.32 -0.361 0 CA-C-N 115.228 -0.896 . . . . 0.0 114.174 177.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.877 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 38.6 t -90.27 118.53 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.823 ' O ' HG12 ' A' ' 76' ' ' ILE . 10.8 m -81.39 134.5 35.57 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.293 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.872 ' HB3' HG23 ' A' ' 75' ' ' ILE . 42.0 p90 -158.23 160.58 37.29 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 74' ' ' GLU . 63.3 m -122.82 149.65 43.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.565 0.221 . . . . 0.0 110.993 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.73 HD21 ' HA ' ' A' ' 70' ' ' ARG . 4.0 tp -121.01 138.96 53.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.925 0.393 . . . . 0.0 110.636 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.481 ' HB2' ' CB ' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -69.66 -165.64 0.09 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.675 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.99 -23.43 22.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.171 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.427 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 0.1 OUTLIER -81.35 1.15 34.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.272 179.716 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.73 ' HA ' HD21 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 53.09 26.41 4.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.807 0.337 . . . . 0.0 111.286 179.773 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.463 HG22 ' O ' ' A' ' 44' ' ' LEU . 1.3 p -127.93 -10.86 5.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.86 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.54 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 7.2 mtp180 -112.88 115.48 28.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.105 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.621 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -133.12 128.32 35.86 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -179.342 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 39' ' ' THR . 13.7 tt0 -107.73 133.78 51.65 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.613 178.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 1.095 HD11 HD22 ' A' ' 29' ' ' LEU . 8.2 mt -123.45 122.27 64.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.823 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -68.13 101.58 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-O 121.462 0.648 . . . . 0.0 109.516 175.685 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 35' ' ' ALA . . . -39.61 143.2 0.46 Allowed Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 114.737 -1.12 . . . . 0.0 113.844 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.434 HD21 ' HA ' ' A' ' 78' ' ' ASN . 0.2 OUTLIER -87.89 -7.54 57.04 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 120.771 0.319 . . . . 0.0 110.82 179.381 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.627 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 88.38 2.66 79.48 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.278 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.487 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 151.35 -147.43 17.35 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.005 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.678 ' HG3' ' HB3' ' A' ' 108' ' ' LEU . 77.0 Cg_exo -49.72 127.59 19.16 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.379 2.052 . . . . 0.0 112.727 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.663 ' CB ' HD13 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -72.78 110.54 7.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.125 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.495 ' HA ' ' CG ' ' A' ' 111' ' ' ASN . 4.6 p80 -82.19 133.99 35.28 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.88 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.567 ' CB ' HD22 ' A' ' 88' ' ' LEU . . . -98.69 124.33 43.44 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.047 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -71.19 123.36 22.02 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 176.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.88 176.97 0.82 Allowed Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -175.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 112' ' ' ASP . . . -73.1 144.7 46.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 118.668 1.234 . . . . 0.0 111.11 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.723 HD21 ' C ' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -112.81 160.99 17.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.34 -178.532 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 7.3 mt-10 -141.53 102.91 4.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.43 177.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.838 HD11 ' CB ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -102.25 115.5 30.68 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.657 -177.693 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.472 ' CD1' ' HB ' ' A' ' 116' ' ' THR . 0.9 OUTLIER -90.52 98.12 11.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.734 179.085 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.616 HD11 ' HB3' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -103.66 52.9 0.76 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.602 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.625 ' CA ' ' H ' ' A' ' 118' ' ' GLU . . . -59.86 -67.28 2.24 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.421 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.577 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 69.5 m-80 -75.43 15.26 0.48 Allowed 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.413 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.752 ' HB1' ' HB3' ' A' ' 98' ' ' ALA . . . -94.88 -70.15 0.72 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.56 -68.08 0.4 Allowed Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.923 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.417 ' O ' ' CD ' ' A' ' 101' ' ' PRO . 2.6 p -71.65 -8.42 53.98 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.752 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -98.88 -30.1 12.58 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.655 0.264 . . . . 0.0 111.043 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.433 ' CG ' HD13 ' A' ' 126' ' ' ILE . 1.0 OUTLIER -64.67 -42.75 95.15 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.043 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.69 ' O ' HD21 ' A' ' 129' ' ' LEU . 1.4 mpt_? -55.84 -60.95 7.24 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.796 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.785 ' HB2' HD22 ' A' ' 30' ' ' LEU . 21.0 Cg_endo -60.78 -30.47 90.3 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.469 2.113 . . . . 0.0 112.488 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 1.026 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -75.22 -52.5 10.77 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 120.335 -0.546 . . . . 0.0 109.998 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.894 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -51.6 -27.26 10.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.5 0.666 . . . . 0.0 110.509 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.948 ' HB2' ' HB1' ' A' ' 175' ' ' ALA . . . -86.55 -53.99 4.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.377 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.712 ' CB ' HD11 ' A' ' 30' ' ' LEU . . . -60.63 -33.61 73.02 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -177.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.688 ' HB2' HD12 ' A' ' 153' ' ' LEU . 26.9 mt -78.35 -20.76 50.67 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.704 ' SG ' ' HB1' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -83.22 21.89 1.06 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.335 0.588 . . . . 0.0 110.87 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.855 HD21 ' HB2' ' A' ' 182' ' ' LEU . 0.5 OUTLIER -85.75 -76.05 0.35 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.74 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -70.28 -110.31 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.64 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.1 m -158.38 96.08 1.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.957 0.408 . . . . 0.0 110.595 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.646 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 13.7 m-80 -148.99 140.14 23.07 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.275 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.857 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 1.9 m-20 -92.95 98.59 11.46 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.171 0.51 . . . . 0.0 110.087 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.566 HG13 ' CB ' ' A' ' 88' ' ' LEU . 1.5 mp -119.17 145.68 24.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.918 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.782 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 59.1 t -113.63 112.97 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 176.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.791 HD23 ' HB2' ' A' ' 90' ' ' LEU . 58.8 mt -102.63 110.99 23.1 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.903 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.743 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -125.06 -171.97 2.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.253 -179.712 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.494 ' H ' HG22 ' A' ' 116' ' ' THR . . . -166.73 -173.12 34.77 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.514 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.646 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 1.3 mm-40 -76.83 172.49 9.54 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 123.245 0.618 . . . . 0.0 110.123 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.646 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 7.4 Cg_endo -47.97 -33.06 19.4 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.605 2.203 . . . . 0.0 112.744 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -67.62 -28.18 67.52 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.021 0.439 . . . . 0.0 110.219 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.578 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 9.8 tpt -61.19 -39.56 90.66 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.559 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.449 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 0.0 OUTLIER -63.01 -16.96 61.58 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.29 179.747 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.568 ' O ' ' HG3' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -85.68 -3.95 59.03 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.977 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.486 ' HB3' ' NH2' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -123.74 88.63 51.97 Favored Pre-proline 0 N--CA 1.452 -0.332 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.763 179.807 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.457 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 15.8 Cg_endo -56.67 149.09 61.04 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.651 2.234 . . . . 0.0 111.599 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.49 HG22 ' O ' ' A' ' 148' ' ' TYR . 0.8 OUTLIER -119.88 8.98 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.946 0.403 . . . . 0.0 111.763 -179.121 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.596 ' HA3' ' ND2' ' A' ' 147' ' ' ASN . . . -57.19 -45.24 92.83 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.801 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.591 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 12.2 m-70 -55.25 -38.62 68.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.013 0.406 . . . . 0.0 110.782 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.929 HD11 ' HB3' ' A' ' 175' ' ' ALA . 17.7 tp -74.8 -45.71 41.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.962 0.411 . . . . 0.0 110.372 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.922 HG21 HD21 ' A' ' 151' ' ' LEU . 49.9 t -56.58 -47.73 81.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.339 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.731 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 0.5 OUTLIER -71.88 -34.43 69.18 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.029 0.442 . . . . 0.0 110.297 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.64 ' HB2' HG23 ' A' ' 164' ' ' VAL . . . -62.42 -45.0 95.07 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.901 178.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.756 HD11 ' HG ' ' A' ' 129' ' ' LEU . 6.2 mt -77.27 -50.32 13.13 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.357 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.754 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -55.88 -27.59 52.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.764 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.731 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.6 OUTLIER -67.83 -33.02 73.96 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.586 178.616 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.526 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -82.55 13.63 40.25 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.015 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.07 2.45 60.83 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.329 -0.939 . . . . 0.0 112.833 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.704 ' HB1' ' SG ' ' A' ' 107' ' ' CYS . . . -70.74 152.42 43.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.895 0.379 . . . . 0.0 111.048 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 37.6 mttm -101.28 103.2 14.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.346 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.627 ' HB ' ' HG3' ' A' ' 134' ' ' ARG . 25.7 mt -134.4 126.48 48.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.367 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.818 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -121.72 139.37 53.66 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.718 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.549 ' CZ ' HG11 ' A' ' 130' ' ' VAL . 47.5 m-85 -81.6 130.02 34.9 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.033 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.942 HD11 ' HG3' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -90.96 -91.59 0.15 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.473 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.599 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 17.7 mt-10 -56.1 -80.98 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.021 0.439 . . . . 0.0 110.439 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.533 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 46.0 mt-30 -115.67 151.32 35.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.426 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 31.2 mt-10 -67.9 137.54 55.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.117 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.596 ' ND2' ' HA3' ' A' ' 127' ' ' GLY . 3.7 m120 66.36 20.21 10.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.965 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.616 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 20.5 m-85 -113.79 170.04 5.82 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.948 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 27.6 Cg_exo -32.57 -63.39 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 124.345 3.363 . . . . 0.0 116.221 -177.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.948 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 77.8 Cg_exo -53.55 146.84 41.13 Favored 'Trans proline' 0 C--N 1.353 0.809 0 CA-C-N 120.706 1.288 . . . . 0.0 112.588 -178.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.922 HD21 HG21 ' A' ' 130' ' ' VAL . 9.7 mt -156.32 136.45 12.85 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.345 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.942 ' HG3' HD11 ' A' ' 143' ' ' LEU . 0.0 OUTLIER -108.5 102.94 11.99 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.022 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.894 HD11 ' HA ' ' A' ' 103' ' ' ALA . 8.5 mt -91.29 146.81 23.51 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.738 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.646 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 1.1 mt-30 -148.83 25.74 0.92 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.368 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.566 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 54.88 -170.26 1.5 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.85 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 158' ' ' THR . . . 114.79 -15.43 19.26 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.119 -1.039 . . . . 0.0 113.389 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.713 ' HE2' ' HA ' ' A' ' 180' ' ' ALA . 55.4 t80 -58.33 123.69 16.98 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 117.258 0.529 . . . . 0.0 110.647 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.697 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 75.7 p -117.05 -33.55 4.68 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 121.382 0.61 . . . . 0.0 111.392 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.446 ' O ' ' HA2' ' A' ' 136' ' ' GLY . . . 138.56 -161.64 25.75 Favored Glycine 0 C--N 1.307 -1.083 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.987 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.584 ' O ' HG23 ' A' ' 187' ' ' THR . . . 105.22 153.95 21.93 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.54 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -46.93 116.53 1.38 Allowed 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.321 -0.44 . . . . 0.0 111.093 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.755 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 73.4 t -109.59 130.62 62.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.829 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.16 120.38 39.41 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.522 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.808 HG21 HD11 ' A' ' 176' ' ' LEU . 1.2 t -133.78 120.03 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 120.922 0.391 . . . . 0.0 110.12 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.44 141.83 18.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.657 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.876 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . . . . . . 0 N--CA 1.446 -0.671 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.076 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.452 ' N ' HG11 ' A' ' 196' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.718 0.294 . . . . 0.0 111.361 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.562 ' HB3' ' CB ' ' A' ' 100' ' ' ARG . 0.8 OUTLIER -76.53 -10.64 59.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.937 -179.092 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.734 ' HA ' HD13 ' A' ' 129' ' ' LEU . 8.4 m-85 -72.48 -50.43 26.09 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.581 0.705 . . . . 0.0 109.559 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 1.002 HD21 HD11 ' A' ' 191' ' ' ILE . 0.2 OUTLIER -68.64 -43.5 76.15 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.16 178.693 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.588 HG21 HH11 ' A' ' 27' ' ' ARG . 2.1 m -54.03 -35.31 61.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.501 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.948 ' HB1' ' HB2' ' A' ' 104' ' ' ALA . . . -63.88 -45.23 90.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.495 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.808 HD11 HG21 ' A' ' 164' ' ' VAL . 0.1 OUTLIER -76.58 -33.07 58.49 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.054 -179.814 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.821 HD11 ' CD2' ' A' ' 223' ' ' PHE . 3.4 mp -59.97 -39.1 84.48 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.62 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.641 ' HE1' ' HA ' ' A' ' 27' ' ' ARG . 1.9 mtp -81.55 -44.35 17.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.407 0.622 . . . . 0.0 112.226 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.623 HG23 ' HG ' ' A' ' 108' ' ' LEU . 58.3 m -71.4 -41.0 70.17 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.796 -178.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.713 ' HA ' ' HE2' ' A' ' 157' ' ' PHE . . . -59.9 -39.84 73.36 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -176.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.557 ' HD3' ' O ' ' A' ' 177' ' ' LEU . 28.2 Cg_endo -65.66 -28.59 52.29 Favored 'Trans proline' 0 CA--C 1.497 -1.354 0 CA-C-N 120.108 1.074 . . . . 0.0 111.657 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.855 ' HB2' HD21 ' A' ' 108' ' ' LEU . 4.7 mt -84.06 0.49 48.08 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.724 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.697 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -83.19 136.57 43.37 Favored Pre-proline 0 C--O 1.224 -0.279 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.856 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.641 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 10.7 Cg_endo -50.18 -33.49 35.98 Favored 'Trans proline' 0 CA--C 1.518 -0.278 0 C-N-CA 122.597 2.198 . . . . 0.0 113.443 -179.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.79 139.54 48.32 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.731 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 187' ' ' THR . 10.1 t0 -55.33 143.89 26.95 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.835 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 160' ' ' GLY . 87.8 m -121.2 148.98 43.52 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.949 0.404 . . . . 0.0 111.606 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.622 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 44.0 t -130.38 117.75 40.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.819 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 4.6 mp -100.23 119.79 48.79 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 0.1 OUTLIER -100.78 125.57 47.28 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 1.002 HD11 HD21 ' A' ' 173' ' ' LEU . 1.6 mp -94.04 125.18 46.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.807 -176.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -77.91 96.86 5.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 113.948 -1.478 . . . . 0.0 110.458 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 96.58 -126.99 9.03 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.263 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -116.41 130.87 56.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.79 0.329 . . . . 0.0 111.582 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.84 HD21 HD13 ' A' ' 173' ' ' LEU . 1.5 mt -41.72 144.22 0.42 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.385 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.452 HG11 ' N ' ' A' ' 170' ' ' SER . 14.8 p -72.33 -28.28 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.039 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.461 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 0.1 OUTLIER -168.85 65.19 0.06 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.058 0.456 . . . . 0.0 110.49 -179.15 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.682 ' HA ' HD13 ' A' ' 195' ' ' LEU . 0.0 OUTLIER -40.66 -46.72 6.44 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.498 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 199' ' ' PRO . . . . . 0.462 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 83.5 Cg_exo -47.49 -33.81 18.36 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 121.842 1.694 . . . . 0.0 111.411 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.956 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.2 OUTLIER -69.16 -41.94 76.57 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.373 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.566 HG21 ' HE2' ' A' ' 223' ' ' PHE . 18.5 mm -64.64 -38.69 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.917 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.15 -44.14 83.14 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.256 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.956 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.1 mt -62.79 -48.82 86.27 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.918 0 CA-C-O 121.739 0.781 . . . . 0.0 109.358 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.563 HG22 ' SD ' ' A' ' 208' ' ' MET . 87.6 m -54.12 -51.26 64.79 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.121 -178.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.903 HD22 ' HB ' ' A' ' 215' ' ' ILE . 32.5 mt -65.77 -31.15 71.96 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 120.922 0.392 . . . . 0.0 111.517 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -77.48 -46.07 23.62 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.901 0.858 . . . . 0.0 109.51 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.857 ' O ' HG22 ' A' ' 210' ' ' THR . 6.4 tp -69.91 -30.46 67.88 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.526 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' MET . . . . . 0.81 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 37.9 mtp -76.38 -34.2 58.88 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.584 0.707 . . . . 0.0 109.231 177.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.716 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 2.6 mtmt -60.95 -38.3 85.37 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.346 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.857 HG22 ' O ' ' A' ' 207' ' ' LEU . 4.7 t -60.92 -33.37 73.05 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.161 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.558 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 50.0 m-85 -76.1 -5.94 48.9 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.801 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 109.51 7.33 28.16 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 115.671 1.028 . . . . 0.0 115.671 177.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.716 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.8 m -123.62 148.58 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 118.549 1.174 . . . . 0.0 112.799 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.595 ' O ' HD13 ' A' ' 215' ' ' ILE . 6.0 mt-10 -129.9 138.61 51.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.659 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.903 ' HB ' HD22 ' A' ' 205' ' ' LEU . 17.1 mm -122.04 148.64 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.694 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 1.6 tp10 -103.89 117.76 35.09 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.983 0.421 . . . . 0.0 111.905 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -83.02 151.11 25.96 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.525 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' GLN . . . . . 0.676 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 5.4 mm-40 -109.43 -144.1 0.39 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.72 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.598 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 7.8 t-80 -73.9 65.88 1.1 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.813 0.34 . . . . 0.0 111.492 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 4.1 t80 56.01 35.12 25.0 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.931 0.872 . . . . 0.0 110.785 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.658 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 1.7 pt20 -163.92 -127.45 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.819 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -8.04 134.43 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.821 ' CD2' HD11 ' A' ' 177' ' ' LEU . 0.6 OUTLIER -125.35 137.32 54.04 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 113.038 -1.892 . . . . 0.0 109.654 -179.234 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.694 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 23.7 t -117.39 114.27 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.801 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.5 OUTLIER -122.25 120.71 61.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.804 -179.393 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.498 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -74.59 127.37 32.92 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -80.03 -171.29 42.47 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.236 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 61.51 21.16 59.91 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 121.398 -0.43 . . . . 0.0 113.006 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' GLN . . . . . 0.548 ' NE2' ' HB3' ' A' ' 181' ' ' PRO . 55.1 mt-30 -80.63 -173.45 4.15 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.257 0.551 . . . . 0.0 111.158 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 17.2 t -151.94 147.64 26.81 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.934 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' TYR . . . . . 0.782 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 4.7 m-85 -100.74 130.23 46.75 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.452 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' GLN . . . . . 0.408 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -120.99 146.77 46.34 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.06 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.55 111.04 8.88 Favored Pre-proline 0 N--CA 1.447 -0.59 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.383 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.542 ' HD2' ' OG1' ' A' ' 39' ' ' THR . 54.6 Cg_endo -69.6 -0.32 6.61 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 121.942 1.762 . . . . 0.0 112.076 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 99.6 -101.18 2.34 Favored Glycine 0 C--O 1.226 -0.349 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.772 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.417 HG23 ' HB ' ' A' ' 40' ' ' VAL . 90.3 m -119.03 135.55 54.57 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' TYR . . . . . 0.545 ' CD2' HG21 ' A' ' 210' ' ' THR . 1.5 t80 -131.21 129.73 42.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.906 0.384 . . . . 0.0 111.046 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.971 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.1 OUTLIER -95.0 110.96 22.81 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.382 179.242 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.669 ' N ' HD22 ' A' ' 238' ' ' LEU . 21.7 t -82.57 111.91 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.092 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.975 -179.98 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.746 ' HA ' ' HE1' ' A' ' 178' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.515 -0.396 0 CA-C-O 121.277 0.561 . . . . 0.0 110.754 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.871 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -40.5 -47.53 2.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.004 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.06 HD22 HD11 ' A' ' 75' ' ' ILE . 12.9 mt -75.76 -35.36 60.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.846 0.355 . . . . 0.0 111.882 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.798 HD22 ' HB2' ' A' ' 101' ' ' PRO . 50.7 tp -68.92 -49.8 54.94 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.186 0.517 . . . . 0.0 110.674 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.728 ' HB2' ' CE2' ' A' ' 211' ' ' PHE . 27.5 mt -67.91 -27.02 66.28 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.395 179.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.728 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -66.3 -40.27 89.87 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.092 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.751 ' CB ' HG11 ' A' ' 62' ' ' VAL . . . -81.1 -41.31 22.71 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.253 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.663 HD11 ' HB1' ' A' ' 105' ' ' ALA . 16.1 mt -67.94 -4.15 12.14 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.066 178.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.5 ' HB2' ' HB3' ' A' ' 231' ' ' TYR . . . -96.9 176.56 5.93 Favored 'General case' 0 CA--C 1.523 -0.089 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -177.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.571 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.3 OUTLIER -109.84 112.65 24.81 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.636 -1.166 . . . . 0.0 108.941 178.367 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 116.78 166.68 14.35 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.595 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.631 ' HG2' ' HG2' ' A' ' 74' ' ' GLU . 10.6 tttt -95.09 117.81 30.83 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.809 0.304 . . . . 0.0 111.174 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.715 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 0.8 OUTLIER -119.2 148.24 43.32 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-O 120.644 0.259 . . . . 0.0 111.559 -179.462 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.616 HG22 ' HB2' ' A' ' 74' ' ' GLU . 56.8 t -103.67 135.63 40.4 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.668 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.871 ' HG ' ' HB1' ' A' ' 28' ' ' ALA . 0.3 OUTLIER -111.23 115.97 30.25 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 174.91 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.859 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.6 OUTLIER -104.23 149.89 24.89 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.232 -177.93 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 69.18 26.01 5.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.268 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.74 HD21 ' HB3' ' A' ' 41' ' ' LEU . 67.5 mt -55.59 -174.87 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.524 ' HB3' HG21 ' A' ' 50' ' ' VAL . 41.6 tp -111.42 131.68 55.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.594 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -88.83 89.36 7.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.96 0.41 . . . . 0.0 110.312 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -164.02 142.72 7.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.062 -179.104 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.421 ' HA ' ' HB3' ' A' ' 51' ' ' ARG . 0.6 OUTLIER -36.6 -31.25 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.57 0.224 . . . . 0.0 111.342 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.725 ' OD1' HG23 ' A' ' 50' ' ' VAL . 1.6 p30 -58.7 -42.64 89.07 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.906 0.384 . . . . 0.0 110.712 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.725 HG23 ' OD1' ' A' ' 49' ' ' ASP . 82.0 t -81.85 -44.18 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.66 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.827 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -49.5 -40.07 36.27 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.525 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.682 ' HA ' ' HB2' ' A' ' 55' ' ' ASN . 19.9 m-70 -79.62 -32.29 41.72 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.978 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.624 ' O ' HD13 ' A' ' 57' ' ' LEU . 7.3 tpt -53.74 -35.61 61.41 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 176.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.827 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.3 OUTLIER -84.03 -45.76 12.74 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 114.317 -1.31 . . . . 0.0 109.028 176.482 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.682 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -57.77 -36.38 72.06 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.776 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 1.129 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -65.81 -43.05 89.82 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.774 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -65.34 -38.43 90.11 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 176.84 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.682 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.1 m -61.81 -39.67 92.57 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 113.875 -1.511 . . . . 0.0 111.813 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.709 ' CB ' HD11 ' A' ' 90' ' ' LEU . . . -71.07 -37.24 72.46 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.392 -178.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.561 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.6 OUTLIER -80.07 -16.25 55.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.345 0.593 . . . . 0.0 110.429 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.88 35.57 3.96 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.142 -0.935 . . . . 0.0 114.194 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.774 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 25.4 t -90.6 122.37 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.76 ' O ' HG12 ' A' ' 76' ' ' ILE . 12.9 m -85.02 131.88 34.41 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.887 0.375 . . . . 0.0 111.523 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.815 ' HB3' HG23 ' A' ' 75' ' ' ILE . 40.1 p90 -158.69 172.23 18.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.535 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.401 ' N ' ' O ' ' A' ' 74' ' ' GLU . 86.5 m -131.59 148.38 52.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.785 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.442 ' CD1' ' HB2' ' A' ' 73' ' ' CYS . 14.6 tp -119.68 134.78 55.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.162 0.506 . . . . 0.0 111.114 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.426 ' CB ' ' HB2' ' A' ' 72' ' ' ARG . 88.1 p -61.71 -169.26 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.001 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.91 -41.7 18.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.311 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.36 1.98 17.25 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.634 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 59.81 30.01 19.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.733 0.302 . . . . 0.0 111.262 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.458 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 2.0 p -119.6 -14.73 9.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.911 0.386 . . . . 0.0 111.217 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.591 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 14.7 mtp180 -113.43 119.23 36.88 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.4 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.62 ' HB3' HD11 ' A' ' 44' ' ' LEU . 42.5 t -131.12 126.9 36.94 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.715 ' HA ' ' O ' ' A' ' 39' ' ' THR . 35.9 tt0 -110.98 129.06 56.0 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 1.06 HD11 HD22 ' A' ' 29' ' ' LEU . 10.7 mt -126.59 123.56 63.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -177.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.76 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -67.69 99.27 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-O 121.571 0.701 . . . . 0.0 109.256 175.672 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -37.77 146.41 0.12 Allowed Glycine 0 C--N 1.32 -0.343 0 CA-C-N 114.53 -1.214 . . . . 0.0 114.05 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.87 -11.21 39.9 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.959 0.409 . . . . 0.0 111.046 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.571 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 89.86 -0.57 79.65 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.258 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.534 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 152.81 -148.36 19.11 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.902 -0.665 . . . . 0.0 112.143 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.578 ' HG3' ' HB3' ' A' ' 108' ' ' LEU . 77.7 Cg_exo -49.36 127.98 19.23 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.788 2.325 . . . . 0.0 112.704 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.561 ' HB2' HD13 ' A' ' 60' ' ' LEU . 0.9 OUTLIER -78.23 105.64 9.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.901 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -82.13 128.1 33.79 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.055 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.486 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -92.44 126.44 37.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.041 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.97 123.89 23.08 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 176.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.85 172.88 0.91 Allowed Glycine 0 N--CA 1.438 -1.185 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 -175.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.34 144.88 46.33 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 118.469 1.135 . . . . 0.0 111.762 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.622 HD21 ' C ' ' A' ' 59' ' ' ALA . 1.2 tp -113.71 160.54 18.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.047 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 10.9 mt-10 -139.75 102.13 4.36 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.958 178.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.709 HD11 ' CB ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -101.56 130.01 47.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.955 0.407 . . . . 0.0 111.346 -178.736 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.591 ' C ' HD13 ' A' ' 92' ' ' LEU . 16.5 m-85 -101.03 96.77 7.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.608 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.817 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -110.34 51.22 0.77 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.814 -179.596 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.798 ' HA3' ' H ' ' A' ' 118' ' ' GLU . . . -58.26 -61.16 7.73 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.817 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.509 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 17.9 m-80 -76.97 -3.16 37.49 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.111 -0.235 . . . . 0.0 110.585 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 1.01 ' HB1' ' HB3' ' A' ' 98' ' ' ALA . . . -94.47 56.3 2.09 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.915 0.388 . . . . 0.0 111.338 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -56.75 -29.99 59.06 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.468 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.501 ' O ' ' HG3' ' A' ' 101' ' ' PRO . 6.1 p -93.84 -6.54 45.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.682 -0.259 . . . . 0.0 111.421 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 1.01 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -101.63 -37.85 8.18 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.836 0.351 . . . . 0.0 111.185 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.537 ' HB2' ' HB2' ' A' ' 92' ' ' LEU . 3.0 tpp -61.72 -45.58 93.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.339 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.531 ' HD2' HD12 ' A' ' 126' ' ' ILE . 0.1 OUTLIER -53.63 -60.5 6.99 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.227 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.798 ' HB2' HD22 ' A' ' 30' ' ' LEU . 18.5 Cg_endo -60.77 -33.16 93.33 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.477 2.118 . . . . 0.0 112.86 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 1.129 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -71.56 -53.13 14.8 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.836 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.873 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -51.38 -28.52 12.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.177 0.513 . . . . 0.0 110.311 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.895 ' CB ' ' HB1' ' A' ' 175' ' ' ALA . . . -86.6 -52.52 5.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.599 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.706 ' CB ' HD11 ' A' ' 30' ' ' LEU . . . -60.51 -34.09 73.59 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.678 ' HB2' HD12 ' A' ' 153' ' ' LEU . 37.3 mt -78.68 -15.6 58.29 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -176.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.656 ' HB3' ' HB1' ' A' ' 138' ' ' ALA . 90.3 m -87.84 22.8 2.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.322 0.582 . . . . 0.0 110.433 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.786 HD21 ' HB2' ' A' ' 182' ' ' LEU . 2.0 mt -87.16 -75.04 0.42 Allowed 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.545 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.63 -113.6 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.235 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.07 96.4 2.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.049 0.452 . . . . 0.0 110.762 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.589 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 0.1 OUTLIER -148.25 140.91 24.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.53 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.865 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 3.4 m-20 -94.21 102.49 14.52 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.831 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.646 HG13 HD13 ' A' ' 106' ' ' LEU . 20.7 mm -121.35 140.92 43.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.556 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.856 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 61.8 t -111.71 112.37 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 175.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.67 HD23 ' HB2' ' A' ' 90' ' ' LEU . 74.6 mt -102.17 105.85 16.61 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.492 -178.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.787 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -114.66 -170.48 1.75 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.322 -178.876 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.526 ' HA3' ' HG2' ' A' ' 121' ' ' MET . . . -171.4 175.15 45.01 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.629 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.798 ' H ' ' HA3' ' A' ' 93' ' ' GLY . 36.6 mm-40 -68.9 169.41 11.31 Favored Pre-proline 0 CA--C 1.531 0.227 0 C-N-CA 123.214 0.605 . . . . 0.0 111.339 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.716 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 2.8 Cg_endo -44.35 -40.82 13.38 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.192 2.595 . . . . 0.0 113.196 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.44 -23.73 65.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.679 0.276 . . . . 0.0 110.722 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.57 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 9.1 tpt -62.2 -35.13 77.94 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -16.85 54.35 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.59 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.01 1.59 52.33 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.859 0.362 . . . . 0.0 110.333 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.472 ' HD3' ' NH2' ' A' ' 100' ' ' ARG . 55.6 mtt-85 -127.03 84.22 64.04 Favored Pre-proline 0 CA--C 1.529 0.161 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.57 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -56.49 148.57 62.31 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.715 2.277 . . . . 0.0 111.755 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.531 HD12 ' HD2' ' A' ' 100' ' ' ARG . 0.8 OUTLIER -124.17 8.43 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.27 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.559 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -61.61 -36.54 92.79 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.061 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.19 -40.08 76.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.74 0.27 . . . . 0.0 110.67 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.715 ' HG ' HD11 ' A' ' 133' ' ' LEU . 14.1 tp -75.37 -41.39 56.56 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.425 0.631 . . . . 0.0 110.023 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.791 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 39.8 t -56.42 -47.74 81.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.579 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.795 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 4.7 m-20 -72.08 -31.81 66.43 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.422 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.545 ' HB1' ' CG1' ' A' ' 162' ' ' VAL . . . -64.1 -49.81 70.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.449 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.715 HD11 ' HG ' ' A' ' 129' ' ' LEU . 7.7 mt -71.65 -48.93 44.45 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.845 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.791 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -57.85 -27.77 63.51 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.651 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.795 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 1.5 tp -67.19 -33.45 75.42 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.466 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.49 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -81.81 12.73 40.41 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.966 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.34 3.34 60.06 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.325 -0.941 . . . . 0.0 112.749 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.656 ' HB1' ' HB3' ' A' ' 107' ' ' CYS . . . -71.59 149.43 45.65 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.882 0.341 . . . . 0.0 111.234 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 21.6 mttm -97.78 103.24 15.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.149 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.733 HG21 HG22 ' A' ' 130' ' ' VAL . 21.0 mt -134.02 126.89 50.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.309 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.737 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -123.51 139.71 53.74 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.925 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.523 ' CZ ' HG11 ' A' ' 130' ' ' VAL . 43.4 m-85 -81.41 132.62 35.33 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.409 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.801 ' CD2' HG13 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -90.17 -82.26 0.28 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.297 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.845 ' HG3' ' H ' ' A' ' 145' ' ' GLN . 11.2 pt-20 -63.5 -78.2 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.926 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.845 ' H ' ' HG3' ' A' ' 144' ' ' GLU . 1.5 mt-30 -121.38 154.19 36.81 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 6.8 mt-10 -64.48 135.6 56.22 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.074 0.464 . . . . 0.0 111.285 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.559 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 9.2 m-20 71.83 18.73 5.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.086 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.516 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 18.6 m-85 -107.77 167.12 9.79 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.898 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 51.3 Cg_exo -35.69 -63.3 0.2 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 124.159 3.239 . . . . 0.0 116.07 -177.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.898 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 71.5 Cg_exo -50.72 145.6 22.86 Favored 'Trans proline' 0 C--N 1.355 0.885 0 CA-C-N 120.773 1.312 . . . . 0.0 112.393 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.856 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 8.5 mt -155.89 137.04 13.76 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.846 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.737 ' HB2' HG22 ' A' ' 141' ' ' THR . 0.2 OUTLIER -106.78 101.59 11.02 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 177.411 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.873 HD11 ' HA ' ' A' ' 103' ' ' ALA . 6.6 mt -91.46 145.61 24.48 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.023 -178.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.589 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 3.0 mt-30 -147.79 29.27 0.92 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.691 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 51.37 -170.3 0.34 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.222 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 114.83 -12.09 20.54 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.086 -1.054 . . . . 0.0 113.369 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.661 ' HE2' ' HA ' ' A' ' 180' ' ' ALA . 54.4 t80 -58.82 122.82 14.52 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 117.51 0.655 . . . . 0.0 110.595 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.817 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 43.3 p -113.12 -38.37 4.48 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 121.668 0.747 . . . . 0.0 111.243 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.42 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 139.04 -165.03 25.76 Favored Glycine 0 C--N 1.306 -1.089 0 CA-C-N 114.526 -1.216 . . . . 0.0 112.304 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.591 ' O ' HG23 ' A' ' 187' ' ' THR . . . 109.48 155.59 16.2 Favored Glycine 0 N--CA 1.437 -1.298 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.882 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -46.94 115.48 1.08 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.216 -0.492 . . . . 0.0 111.333 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 72.1 t -108.02 137.71 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -107.09 119.77 40.29 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.256 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.824 HG21 HD11 ' A' ' 176' ' ' LEU . 1.0 OUTLIER -132.09 120.43 43.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.113 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.432 ' CA ' ' HE3' ' A' ' 192' ' ' LYS . 23.0 t0 -55.58 138.51 46.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.933 0.396 . . . . 0.0 111.141 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.667 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.427 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.204 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.625 ' HB2' ' HB3' ' A' ' 200' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.101 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.586 ' HA ' ' HB ' ' A' ' 174' ' ' THR . 9.4 mp0 -92.7 -13.85 28.83 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.443 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.448 ' HE1' ' CZ ' ' A' ' 100' ' ' ARG . 5.9 m-85 -66.73 -54.36 23.78 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 1.115 HD13 HD21 ' A' ' 195' ' ' LEU . 0.2 OUTLIER -64.95 -45.91 83.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.921 178.675 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.586 ' HB ' ' HA ' ' A' ' 171' ' ' GLN . 1.1 m -55.1 -33.01 62.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.969 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.895 ' HB1' ' CB ' ' A' ' 104' ' ' ALA . . . -66.39 -41.61 89.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.329 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.824 HD11 HG21 ' A' ' 164' ' ' VAL . 0.2 OUTLIER -76.71 -32.51 57.88 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.545 179.361 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.72 ' HG ' HD21 ' A' ' 205' ' ' LEU . 2.7 mp -59.89 -39.35 85.02 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.142 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.746 ' HE1' ' HA ' ' A' ' 27' ' ' ARG . 0.7 OUTLIER -82.16 -41.43 20.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.351 0.596 . . . . 0.0 111.912 179.751 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.437 HG23 ' HG ' ' A' ' 108' ' ' LEU . 100.0 m -71.06 -42.07 69.9 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.644 -178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.661 ' HA ' ' HE2' ' A' ' 157' ' ' PHE . . . -59.08 -40.37 80.93 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -176.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.567 ' HD3' ' O ' ' A' ' 177' ' ' LEU . 38.1 Cg_endo -66.76 -28.78 43.34 Favored 'Trans proline' 0 CA--C 1.498 -1.292 0 C-N-CA 120.787 0.992 . . . . 0.0 112.06 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.786 ' HB2' HD21 ' A' ' 108' ' ' LEU . 5.3 mt -84.67 1.5 46.0 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.626 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.817 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -82.86 139.46 43.19 Favored Pre-proline 0 C--O 1.223 -0.298 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.226 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.752 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 11.6 Cg_endo -52.03 -33.37 52.54 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.206 1.938 . . . . 0.0 112.782 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.53 143.05 45.6 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.582 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -58.54 145.27 39.81 Favored 'General case' 0 N--CA 1.46 0.074 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.453 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.611 ' HB ' ' HB1' ' A' ' 180' ' ' ALA . 65.9 m -122.14 144.42 48.95 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.644 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 25.2 t -122.45 117.81 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.069 176.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.738 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 2.7 mp -101.53 117.63 47.11 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.801 ' HG3' ' HG3' ' A' ' 222' ' ' GLN . 0.1 OUTLIER -99.4 122.49 42.58 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.4 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.965 HD11 HD21 ' A' ' 173' ' ' LEU . 1.6 mp -93.47 119.72 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.954 -175.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.432 ' HE3' ' CA ' ' A' ' 165' ' ' ASP . 0.7 OUTLIER -75.14 96.63 3.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.769 -179.468 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 95.47 -134.11 11.78 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.265 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -117.09 137.27 52.39 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 1.115 HD21 HD13 ' A' ' 173' ' ' LEU . 8.9 mt -40.81 147.03 0.13 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.184 0.516 . . . . 0.0 111.124 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.433 HG11 ' N ' ' A' ' 170' ' ' SER . 7.2 p -68.66 -21.07 25.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.896 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.864 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 26.7 t -138.55 -67.43 0.46 Allowed 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.249 178.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.812 ' HA ' HD13 ' A' ' 195' ' ' LEU . 8.0 tmtt? 96.82 -56.57 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 114.656 -1.157 . . . . 0.0 111.177 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' PRO . . . . . 0.864 ' HD2' ' C ' ' A' ' 197' ' ' SER . 18.3 Cg_endo -62.71 -25.7 75.09 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 120.868 1.045 . . . . 0.0 110.021 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.971 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.2 OUTLIER -67.48 -48.2 67.83 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.784 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.625 HG21 ' HE2' ' A' ' 223' ' ' PHE . 15.6 mm -63.28 -35.09 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.443 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.15 -42.86 99.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.102 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.971 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.5 mt -60.36 -50.78 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.488 ' O ' ' HG3' ' A' ' 208' ' ' MET . 45.8 m -53.47 -51.85 61.37 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.107 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.863 HD22 ' HB ' ' A' ' 215' ' ' ILE . 36.8 mt -65.54 -30.62 71.39 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.38 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ASN . . . . . 0.416 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 2.6 m-80 -77.86 -46.3 21.82 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.772 0.796 . . . . 0.0 109.956 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.84 ' O ' HG22 ' A' ' 210' ' ' THR . 0.8 OUTLIER -68.76 -29.77 68.22 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.211 178.938 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 208' ' ' MET . . . . . 0.703 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 37.0 mtp -69.95 -33.23 71.84 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.655 178.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.604 ' HE2' ' HA ' ' A' ' 214' ' ' GLU . 6.7 mmtp -57.54 -38.6 74.98 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.813 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.84 HG22 ' O ' ' A' ' 207' ' ' LEU . 1.0 OUTLIER -60.6 -27.25 67.59 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.645 -178.523 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.728 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 76.9 m-85 -85.19 -8.88 58.38 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.541 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.1 9.38 24.23 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 115.658 1.023 . . . . 0.0 115.658 177.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.545 HG21 ' HE3' ' A' ' 208' ' ' MET . 4.2 m -124.18 148.84 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 118.683 1.242 . . . . 0.0 112.133 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.604 ' HA ' ' HE2' ' A' ' 209' ' ' LYS . 22.5 mt-10 -129.74 141.75 50.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.149 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 1.03 HD12 ' HB ' ' A' ' 225' ' ' VAL . 24.7 mm -123.5 148.45 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-O 120.89 0.376 . . . . 0.0 110.552 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.603 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 40.2 tt0 -104.74 116.44 32.03 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.726 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -82.49 150.18 27.15 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' GLN . . . . . 0.63 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.2 OUTLIER -110.16 -148.05 0.42 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.606 0.241 . . . . 0.0 110.909 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.547 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 1.8 t-80 -67.83 63.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.457 ' CE1' ' HG3' ' A' ' 198' ' ' LYS . 6.3 t80 58.87 33.88 23.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.902 0.858 . . . . 0.0 110.867 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.639 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 12.2 pt20 -164.69 -124.63 0.02 OUTLIER 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.801 ' HG3' ' HG3' ' A' ' 190' ' ' ARG . 0.5 OUTLIER -3.97 132.37 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 179.495 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.644 ' O ' ' HA ' ' A' ' 188' ' ' VAL . 3.2 m-85 -126.55 129.89 49.48 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.432 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.603 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 41.6 t -114.17 113.68 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 121.588 0.708 . . . . 0.0 109.739 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 1.03 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -123.15 125.51 72.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.095 -179.028 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 181' ' ' PRO . 0.0 OUTLIER -76.62 141.52 41.02 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.838 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -91.18 -178.21 43.15 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.457 -178.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 66.47 20.22 69.53 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 121.54 -0.362 . . . . 0.0 113.081 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' GLN . . . . . 0.513 ' NE2' ' HB3' ' A' ' 181' ' ' PRO . 47.7 mt-30 -77.79 -173.77 3.2 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.19 0.519 . . . . 0.0 110.896 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.14 147.57 24.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.543 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' TYR . . . . . 0.653 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 5.5 m-85 -99.26 133.81 43.02 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.056 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -120.76 148.84 43.44 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 84.1 p -76.54 111.43 15.72 Favored Pre-proline 0 N--CA 1.446 -0.636 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.834 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.557 ' HG3' HG23 ' A' ' 210' ' ' THR . 46.7 Cg_endo -68.3 -2.38 8.91 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.947 1.765 . . . . 0.0 112.422 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 96.34 -84.0 0.82 Allowed Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.29 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 93.5 m -130.56 127.13 38.45 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' TYR . . . . . 0.705 ' CD2' HG21 ' A' ' 210' ' ' THR . 24.8 t80 -130.33 134.47 47.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.995 0.426 . . . . 0.0 111.373 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.859 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.1 OUTLIER -97.94 110.73 23.25 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.687 179.846 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.648 ' N ' HD22 ' A' ' 238' ' ' LEU . 20.1 t -81.65 112.77 20.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.11 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.347 -0.835 . . . . 0.0 111.129 -179.948 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.733 ' HE ' HD23 ' A' ' 207' ' ' LEU . 77.3 mtm-85 . . . . . 0 CA--C 1.52 -0.206 0 CA-C-O 121.046 0.45 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.617 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -46.07 -42.38 13.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.763 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.055 HD22 HD11 ' A' ' 75' ' ' ILE . 10.6 mt -71.1 -34.56 71.22 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 120.983 0.42 . . . . 0.0 110.833 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.921 HD22 ' HB2' ' A' ' 101' ' ' PRO . 53.3 tp -68.9 -49.74 55.63 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.377 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.59 ' HB2' ' CE2' ' A' ' 211' ' ' PHE . 34.1 mt -67.28 -27.13 66.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.521 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.774 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -65.77 -39.03 90.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.056 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.655 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . . . -81.32 -41.39 22.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.615 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.745 HD11 ' HB1' ' A' ' 105' ' ' ALA . 21.9 mt -69.05 -3.36 12.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.286 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.482 ' HB2' ' HB3' ' A' ' 231' ' ' TYR . . . -96.81 176.1 6.11 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.524 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.1 OUTLIER -112.18 113.4 25.63 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.596 178.247 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.59 167.99 15.29 Favored Glycine 0 C--N 1.32 -0.323 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.635 ' HG3' HG23 ' A' ' 76' ' ' ILE . 1.0 OUTLIER -95.3 117.78 30.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 117.32 0.56 . . . . 0.0 111.443 -179.371 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.495 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.9 OUTLIER -119.6 145.84 46.06 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.22 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.55 HG22 ' HB2' ' A' ' 74' ' ' GLU . 96.6 t -104.91 139.08 26.96 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 1.003 HD23 HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -114.77 116.1 28.1 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 174.986 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.922 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.6 OUTLIER -105.06 152.3 22.92 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.078 -178.29 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 36.9 t30 68.99 25.44 5.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.724 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.691 HD21 ' CB ' ' A' ' 41' ' ' LEU . 16.0 mt -55.32 -169.97 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.501 ' HB3' HG21 ' A' ' 50' ' ' VAL . 32.9 tp -112.46 131.9 55.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.596 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -89.05 85.92 6.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.021 0.439 . . . . 0.0 110.55 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.46 ' O ' ' N ' ' A' ' 50' ' ' VAL . 1.0 OUTLIER -164.25 142.88 7.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.926 -179.479 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 47' ' ' SER . 0.5 OUTLIER -33.07 -34.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.764 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.803 ' OD1' HG23 ' A' ' 50' ' ' VAL . 3.1 p30 -55.33 -42.59 73.97 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.043 0.449 . . . . 0.0 110.836 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.803 HG23 ' OD1' ' A' ' 49' ' ' ASP . 78.5 t -84.63 -44.51 17.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.013 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.815 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -50.68 -39.77 51.93 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.653 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.696 ' HA ' ' HB3' ' A' ' 55' ' ' ASN . 18.9 m-70 -80.9 -32.42 34.79 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.888 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.508 ' O ' HD13 ' A' ' 57' ' ' LEU . 9.0 tpt -53.5 -34.74 59.17 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 176.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.815 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -83.49 -43.04 16.21 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.648 176.465 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.696 ' HB3' ' HA ' ' A' ' 52' ' ' HIS . 67.0 t30 -56.73 -42.11 78.67 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-O 121.05 0.452 . . . . 0.0 110.131 179.056 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 1.055 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -57.11 -49.06 77.07 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.812 0.815 . . . . 0.0 108.956 178.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.778 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -61.8 -37.83 85.87 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.006 -1.452 . . . . 0.0 107.871 177.066 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.679 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -63.8 -35.02 79.24 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.877 179.271 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.85 ' CB ' HD11 ' A' ' 90' ' ' LEU . . . -73.52 -37.59 65.6 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.356 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.684 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -82.24 -13.13 57.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.255 0.55 . . . . 0.0 110.893 -179.622 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.58 35.76 4.81 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.38 -0.827 . . . . 0.0 114.137 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.778 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 37.2 t -90.51 124.34 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.789 ' O ' HG12 ' A' ' 76' ' ' ILE . 4.3 m -85.96 130.8 34.43 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.499 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.826 ' HB3' HG23 ' A' ' 75' ' ' ILE . 38.4 p90 -157.64 171.68 19.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.84 0.352 . . . . 0.0 110.622 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.43 ' N ' ' O ' ' A' ' 74' ' ' GLU . 99.7 m -138.1 149.16 45.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.305 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.732 HD12 ' HB2' ' A' ' 73' ' ' CYS . 7.3 tp -117.76 137.34 52.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.968 0.413 . . . . 0.0 110.756 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.7 p -59.93 179.91 0.12 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.989 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.79 -28.32 40.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.88 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -80.29 -0.11 35.16 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.247 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 55.89 48.73 17.4 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.797 0.332 . . . . 0.0 111.197 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.423 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -153.4 0.63 0.25 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.277 -0.419 . . . . 0.0 112.081 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.5 OUTLIER -129.48 110.97 12.3 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.939 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.732 ' HB2' HD12 ' A' ' 66' ' ' LEU . 42.9 t -118.37 132.34 56.27 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.55 ' HB2' HG22 ' A' ' 40' ' ' VAL . 43.4 tt0 -111.76 133.13 54.19 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 1.055 HD11 HD22 ' A' ' 29' ' ' LEU . 11.3 mt -130.46 122.97 54.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -178.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.789 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -67.75 100.93 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.763 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 35' ' ' ALA . . . -39.27 144.17 0.33 Allowed Glycine 0 C--N 1.319 -0.39 0 CA-C-N 114.717 -1.128 . . . . 0.0 113.844 -178.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.41 ' CB ' HD12 ' A' ' 82' ' ' LEU . 14.2 t-20 -88.86 -11.36 44.91 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.003 0.43 . . . . 0.0 110.861 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.524 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 85.86 15.61 65.03 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.217 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.527 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 139.55 -150.34 21.31 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.326 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.521 ' HB3' ' CB ' ' A' ' 108' ' ' LEU . 4.2 Cg_endo -49.2 123.55 10.27 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.71 2.274 . . . . 0.0 113.13 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.684 ' HB2' HD13 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -72.24 108.54 5.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.139 179.198 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.429 ' HA ' ' CG ' ' A' ' 111' ' ' ASN . 4.4 p80 -81.87 131.88 35.26 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.564 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -96.0 120.45 36.3 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.669 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -70.96 123.94 23.2 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.46 173.87 1.39 Allowed Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 -175.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 112' ' ' ASP . . . -73.03 144.75 47.04 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 118.616 1.208 . . . . 0.0 111.816 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.747 HD21 ' C ' ' A' ' 59' ' ' ALA . 0.7 OUTLIER -112.52 161.03 17.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.198 -178.536 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.419 ' HG2' ' HB ' ' A' ' 114' ' ' VAL . 32.6 mt-10 -142.05 101.39 3.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.136 177.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.85 HD11 ' CB ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -100.2 125.79 46.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.314 -178.622 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.52 ' C ' HD13 ' A' ' 92' ' ' LEU . 1.2 m-85 -98.37 96.44 8.03 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.849 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -105.18 48.25 0.84 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.472 -179.479 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.646 ' HA3' ' H ' ' A' ' 118' ' ' GLU . . . -53.6 -66.0 3.04 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.65 -0.705 . . . . 0.0 113.247 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.485 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 23.0 m-80 -76.27 -0.98 24.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.559 0.218 . . . . 0.0 110.913 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.975 ' HB1' ' HB3' ' A' ' 98' ' ' ALA . . . -91.86 68.73 5.45 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.989 0.423 . . . . 0.0 111.307 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.07 -24.38 71.74 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.76 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.49 HG22 ' OE1' ' A' ' 171' ' ' GLN . 0.6 OUTLIER -106.54 4.79 28.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.463 0.173 . . . . 0.0 111.167 179.595 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.975 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -107.26 -40.82 5.29 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.875 0.369 . . . . 0.0 111.503 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.466 ' HB2' ' HB2' ' A' ' 92' ' ' LEU . 6.3 tpp -59.96 -46.31 89.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.609 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.548 ' O ' HD21 ' A' ' 129' ' ' LEU . 5.3 mpt_? -53.72 -60.24 7.69 Favored Pre-proline 0 C--N 1.323 -0.571 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.006 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.921 ' HB2' HD22 ' A' ' 30' ' ' LEU . 11.7 Cg_endo -59.24 -34.38 98.14 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 121.958 1.772 . . . . 0.0 112.409 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 1.055 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -71.31 -53.25 14.88 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.025 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.897 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -51.29 -28.34 11.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.534 178.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.901 ' CB ' ' HB1' ' A' ' 175' ' ' ALA . . . -86.75 -53.65 4.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.357 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.752 ' CB ' HD11 ' A' ' 30' ' ' LEU . . . -60.32 -37.47 80.69 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -177.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.734 ' HB2' HD12 ' A' ' 153' ' ' LEU . 25.8 mt -75.24 -11.62 60.11 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.215 -177.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.59 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 21.9 m -83.23 17.76 1.95 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.185 0.517 . . . . 0.0 110.247 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.648 HD21 ' HB2' ' A' ' 182' ' ' LEU . 2.6 mt -95.92 -68.36 0.8 Allowed 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.365 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.07 151.96 27.83 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.669 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 m -66.54 98.29 0.49 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.982 0.42 . . . . 0.0 110.855 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.672 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 5.8 m-80 -148.53 137.44 21.62 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.103 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.8 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 1.7 m-20 -95.29 100.28 12.09 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.191 0.52 . . . . 0.0 109.926 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.569 HG12 HD13 ' A' ' 106' ' ' LEU . 1.6 mp -118.38 148.37 21.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.903 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.821 HG13 ' CD2' ' A' ' 143' ' ' LEU . 43.9 t -118.0 112.58 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 176.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.722 ' O ' ' HA ' ' A' ' 150' ' ' PRO . 24.0 mt -102.36 105.58 16.22 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.905 -178.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.526 HG23 ' HB3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -116.42 -170.39 1.8 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.802 0.334 . . . . 0.0 111.206 -179.736 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.551 ' HA3' ' HG2' ' A' ' 121' ' ' MET . . . -168.32 172.58 42.94 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.006 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.651 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 18.1 mt-10 -68.85 176.36 1.55 Allowed Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 122.639 0.375 . . . . 0.0 110.903 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.651 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 81.7 Cg_exo -47.78 -41.06 31.89 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.759 2.306 . . . . 0.0 113.581 -179.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -67.37 -23.15 65.56 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.661 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.575 ' O ' ' HG3' ' A' ' 149' ' ' PRO . 10.5 tpt -61.84 -35.19 77.55 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.489 ' HA ' ' HG2' ' A' ' 149' ' ' PRO . 3.4 mmtp -61.64 -16.78 51.56 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.673 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -86.34 3.48 43.28 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 120.827 0.346 . . . . 0.0 110.289 178.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.436 ' HB3' ' NH2' ' A' ' 100' ' ' ARG . 3.5 mtt180 -127.3 81.18 70.5 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.075 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.413 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 14.8 Cg_endo -56.9 149.21 62.56 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.937 2.425 . . . . 0.0 112.032 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.508 HD11 HD23 ' A' ' 129' ' ' LEU . 0.7 OUTLIER -124.14 17.67 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.349 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.43 ' HA3' ' CB ' ' A' ' 147' ' ' ASN . . . -61.29 -46.16 95.0 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.927 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.626 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 27.2 m-70 -56.87 -35.53 69.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.982 0.391 . . . . 0.0 111.322 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.763 HD11 ' HB3' ' A' ' 175' ' ' ALA . 15.4 tp -75.79 -47.71 24.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.927 0.394 . . . . 0.0 111.318 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.826 HG13 ' CG2' ' A' ' 140' ' ' ILE . 51.9 t -56.25 -47.43 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.395 -178.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.67 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 82.8 m-20 -68.81 -39.8 79.86 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.031 0.443 . . . . 0.0 110.12 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.568 ' HB2' HG23 ' A' ' 164' ' ' VAL . . . -59.4 -45.24 92.06 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.012 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.728 HD11 ' HG ' ' A' ' 129' ' ' LEU . 10.7 mt -75.15 -48.42 23.74 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.446 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.696 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -58.65 -28.37 65.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.959 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.67 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 5.8 tp -68.3 -32.57 72.81 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.278 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 159' ' ' GLY . . . -79.35 9.96 38.5 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.153 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.39 6.64 57.48 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.329 -0.939 . . . . 0.0 112.755 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.415 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . . . -74.48 151.97 39.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.882 0.372 . . . . 0.0 111.146 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.446 ' CB ' ' HB2' ' A' ' 154' ' ' GLN . 9.9 mmmt -99.22 100.14 11.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.687 178.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.826 ' CG2' HG13 ' A' ' 130' ' ' VAL . 28.5 mt -131.68 127.44 59.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.477 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.765 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -125.14 139.03 54.12 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.004 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.469 ' CE1' HG11 ' A' ' 130' ' ' VAL . 29.1 m-85 -78.54 133.48 37.36 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.847 0.356 . . . . 0.0 110.955 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.899 HD11 ' HG3' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -94.02 -87.84 0.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.734 -179.55 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.509 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 2.5 mm-40 -59.36 -81.99 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.34 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.441 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 35.0 mt-30 -115.14 154.45 28.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.112 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 5.0 mt-10 -67.66 131.96 46.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.31 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.43 ' CB ' ' HA3' ' A' ' 127' ' ' GLY . 1.1 m-20 70.57 19.41 6.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.954 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.558 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 13.2 m-85 -109.72 168.63 7.41 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.634 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 10.5 Cg_exo -30.91 -62.1 0.12 Allowed 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 125.264 3.976 . . . . 0.0 117.477 -177.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.86 ' HB2' ' HB2' ' A' ' 143' ' ' LEU . 26.3 Cg_endo -62.24 150.17 87.93 Favored 'Trans proline' 0 C--N 1.351 0.677 0 CA-C-N 120.655 1.27 . . . . 0.0 112.117 -177.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.763 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 7.6 mt -155.64 138.63 15.43 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.866 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.899 ' HG3' HD11 ' A' ' 143' ' ' LEU . 0.7 OUTLIER -104.71 104.31 14.09 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 176.986 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.897 HD11 ' HA ' ' A' ' 103' ' ' ALA . 4.1 mt -95.6 141.54 28.99 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.817 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.672 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 2.8 mt-30 -145.47 31.1 1.09 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.665 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.59 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 48.18 -158.02 0.84 Allowed Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.323 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.44 -11.08 46.95 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.264 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.547 ' CD1' ' HB2' ' A' ' 183' ' ' ALA . 31.6 t80 -59.77 122.93 15.41 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 117.467 0.634 . . . . 0.0 110.367 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.736 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 70.0 p -115.96 -35.53 4.41 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 121.54 0.686 . . . . 0.0 111.182 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.457 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 140.21 -160.76 26.4 Favored Glycine 0 C--N 1.307 -1.049 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.085 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.57 ' O ' HG23 ' A' ' 187' ' ' THR . . . 105.88 152.64 20.43 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.545 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -47.02 123.03 4.85 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.084 -0.558 . . . . 0.0 110.597 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 160' ' ' GLY . 42.7 t -116.06 146.39 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.123 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -113.27 120.16 40.22 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.117 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.836 HG21 HD11 ' A' ' 176' ' ' LEU . 1.0 OUTLIER -133.95 119.92 33.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.966 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.47 141.18 43.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.929 0.395 . . . . 0.0 111.041 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.677 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . . . . . . 0 N--CA 1.447 -0.618 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.595 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.084 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.507 ' HB2' ' HB2' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -86.26 -11.86 51.16 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.005 -179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.682 ' HA ' HD13 ' A' ' 129' ' ' LEU . 5.9 m-85 -71.3 -56.77 5.35 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.746 ' HG ' HG11 ' A' ' 164' ' ' VAL . 0.5 OUTLIER -62.81 -44.43 96.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.39 178.741 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.703 HG21 ' HD3' ' A' ' 27' ' ' ARG . 2.5 m -54.82 -33.19 61.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.826 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.901 ' HB1' ' CB ' ' A' ' 104' ' ' ALA . . . -68.32 -39.3 82.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.242 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.836 HD11 HG21 ' A' ' 164' ' ' VAL . 0.7 OUTLIER -76.58 -35.45 58.16 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.839 179.753 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.78 ' O ' ' HE1' ' A' ' 208' ' ' MET . 3.8 mp -59.82 -37.85 80.37 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.191 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.62 ' HE1' ' HA ' ' A' ' 27' ' ' ARG . 2.6 mtp -81.68 -43.15 18.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.338 0.59 . . . . 0.0 112.086 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 95.9 m -72.01 -42.4 66.43 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.105 -178.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.573 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . -58.71 -41.44 88.86 Favored Pre-proline 0 C--N 1.32 -0.716 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -176.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 28.5 Cg_endo -64.43 -28.54 62.53 Favored 'Trans proline' 0 CA--C 1.501 -1.167 0 C-N-CA 120.831 1.02 . . . . 0.0 112.128 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.648 ' HB2' HD21 ' A' ' 108' ' ' LEU . 5.6 mt -84.26 0.83 47.43 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.51 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.736 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -83.51 137.71 41.71 Favored Pre-proline 0 C--O 1.224 -0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.396 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.721 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 11.4 Cg_endo -51.34 -34.31 49.47 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.688 2.258 . . . . 0.0 113.404 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.81 140.2 46.66 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.733 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -55.16 143.69 26.62 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.046 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 160' ' ' GLY . 92.0 m -123.6 148.23 46.6 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.687 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 40.3 t -128.7 118.27 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.878 177.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.733 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 5.0 mp -99.09 119.09 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.548 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 2.4 ttt180 -100.74 125.46 47.2 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.677 HG23 ' HA2' ' A' ' 166' ' ' GLY . 1.5 mp -93.37 127.33 45.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.867 -176.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -82.65 96.67 8.19 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.231 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 98.66 -127.55 9.28 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.708 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -116.66 133.54 55.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.708 0.29 . . . . 0.0 111.471 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.672 HD11 ' HZ ' ' A' ' 223' ' ' PHE . 1.1 mt -41.62 144.13 0.42 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.166 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.447 ' HB ' ' O ' ' A' ' 166' ' ' GLY . 12.4 p -72.87 -25.03 21.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.637 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.572 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 0.4 OUTLIER -170.78 68.63 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.096 0.474 . . . . 0.0 110.235 -179.575 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.733 ' HG3' ' HD3' ' A' ' 199' ' ' PRO . 0.0 OUTLIER -48.17 -29.37 1.4 Allowed Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.344 179.712 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 199' ' ' PRO . . . . . 0.733 ' HD3' ' HG3' ' A' ' 198' ' ' LYS . 23.3 Cg_exo -64.78 -28.9 59.41 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 121.094 1.196 . . . . 0.0 110.724 178.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.936 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.1 OUTLIER -69.79 -42.3 73.93 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 177.991 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 11.9 mm -60.15 -39.61 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.255 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -58.07 -44.86 87.74 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.327 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.936 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.0 mt -62.66 -50.42 79.83 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 CA-C-O 121.569 0.699 . . . . 0.0 109.551 178.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.579 HG22 ' SD ' ' A' ' 208' ' ' MET . 97.4 m -53.43 -51.54 62.31 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.843 -178.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.762 HD22 ' HB ' ' A' ' 215' ' ' ILE . 29.8 mt -67.01 -29.22 68.99 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.028 0.442 . . . . 0.0 111.369 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' ASN . . . . . 0.443 ' HA ' ' HE3' ' A' ' 209' ' ' LYS . 5.1 t-20 -77.63 -46.47 21.96 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.633 0.73 . . . . 0.0 109.876 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.953 ' O ' HG22 ' A' ' 210' ' ' THR . 4.4 tp -71.75 -29.7 64.79 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.574 -1.193 . . . . 0.0 109.404 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' MET . . . . . 0.78 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 43.0 mtp -76.13 -35.31 59.3 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 14.4 mtmt -61.43 -38.71 88.14 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.654 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.953 HG22 ' O ' ' A' ' 207' ' ' LEU . 6.6 t -61.04 -26.85 67.92 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.3 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.59 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 27.6 m-85 -83.88 -7.31 59.47 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.903 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.89 7.43 25.37 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 116.31 1.284 . . . . 0.0 116.31 177.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.2 m -123.55 148.54 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 118.983 1.392 . . . . 0.0 112.604 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.538 ' O ' HD13 ' A' ' 215' ' ' ILE . 12.0 mt-10 -130.35 139.41 50.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.008 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.9 HD12 ' HB ' ' A' ' 225' ' ' VAL . 18.4 mm -122.46 148.78 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 120.836 0.351 . . . . 0.0 110.744 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.589 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 1.3 tp10 -104.67 122.4 45.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.032 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -86.84 151.01 23.72 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.182 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' GLN . . . . . 0.521 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 2.8 mm-40 -111.12 -141.57 0.38 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.14 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.535 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 28.3 m170 -73.92 65.03 1.03 Allowed 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 2.0 t80 57.24 36.3 27.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.706 0.765 . . . . 0.0 110.944 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.651 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 4.5 pt20 -168.73 -124.5 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.733 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -8.61 130.88 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.687 ' O ' ' HA ' ' A' ' 188' ' ' VAL . 0.7 OUTLIER -121.87 140.23 52.65 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.119 -1.855 . . . . 0.0 109.625 -179.163 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 40.1 t -120.84 114.25 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-O 121.297 0.57 . . . . 0.0 109.696 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.9 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.2 OUTLIER -122.29 125.87 73.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.087 -179.017 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -77.88 127.55 32.56 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.955 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -80.52 -178.51 52.11 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.351 -178.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 67.5 21.01 72.29 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 121.623 -0.322 . . . . 0.0 113.285 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' GLN . . . . . 0.468 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 46.5 mt-30 -78.32 -173.43 3.27 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.268 0.556 . . . . 0.0 111.214 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.09 147.8 26.25 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.365 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' TYR . . . . . 0.536 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 7.2 m-85 -102.89 130.35 49.9 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.886 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.04 151.78 37.62 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.48 111.09 12.45 Favored Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.97 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.495 ' HD2' ' OG1' ' A' ' 39' ' ' THR . 52.0 Cg_endo -69.37 1.11 4.46 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.249 1.966 . . . . 0.0 112.27 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 98.68 -101.04 2.4 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.303 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 49.2 m -118.42 136.97 53.46 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' TYR . . . . . 0.685 ' CE2' HG21 ' A' ' 210' ' ' THR . 9.3 t80 -133.23 124.2 26.95 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.989 0.423 . . . . 0.0 111.362 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.922 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -94.99 110.83 22.69 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.8 179.866 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.631 ' N ' HD22 ' A' ' 238' ' ' LEU . 21.5 t -77.93 112.52 16.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.474 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.413 ' HG2' HD13 ' A' ' 238' ' ' LEU . 2.7 mt-10 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.296 -0.859 . . . . 0.0 111.018 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.784 ' HB3' HG22 ' A' ' 50' ' ' VAL . 22.7 t . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.328 0.109 . . . . 2.0 110.933 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 56.7 m-20 63.84 -81.91 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.682 0.277 . . . . 1.4299999999999999 111.713 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.556 ' HA ' ' HE1' ' A' ' 178' ' ' MET . 37.7 mtm-85 -76.94 -61.51 1.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.094 0.405 . . . . 2.3300000000000001 112.094 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.73 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -35.76 -42.75 0.27 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.584 -0.735 . . . . 0.17999999999999999 112.601 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.01 HD22 HD11 ' A' ' 75' ' ' ILE . 12.4 mt -75.9 -39.55 56.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.896 0.379 . . . . 0.14000000000000001 111.587 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.782 HD22 ' HB2' ' A' ' 101' ' ' PRO . 31.7 tp -64.91 -50.85 64.88 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.034 -0.53 . . . . 0.23999999999999999 110.873 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.549 HD21 ' CE ' ' A' ' 178' ' ' MET . 31.4 mt -64.78 -28.06 69.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.992 -0.549 . . . . 0.38 109.684 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.785 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -64.75 -40.03 94.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.523 -0.762 . . . . 0.20000000000000001 110.238 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.601 ' CB ' HG11 ' A' ' 62' ' ' VAL . . . -77.82 -39.46 43.64 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.046 -0.525 . . . . 0.14000000000000001 111.273 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.589 HD11 ' HB1' ' A' ' 105' ' ' ALA . 20.7 mt -70.69 -3.0 16.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.95 -0.568 . . . . 0.25 110.534 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.444 ' HA ' ' CB ' ' A' ' 231' ' ' TYR . . . -96.39 172.9 7.65 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 113.144 0.794 . . . . 0.33000000000000002 113.144 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.461 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.2 OUTLIER -110.11 108.76 19.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.845 -1.07 . . . . 1.03 108.593 178.001 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 120.57 170.1 14.09 Favored Glycine 0 C--N 1.319 -0.38 0 C-N-CA 120.822 -0.704 . . . . 0.56000000000000005 111.375 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.825 ' HG3' HG23 ' A' ' 76' ' ' ILE . 0.1 OUTLIER -94.48 119.3 32.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.227 0.514 . . . . 1.72 111.609 -179.228 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.533 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 1.0 OUTLIER -120.3 142.13 49.38 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 120.715 0.293 . . . . 0.52000000000000002 110.401 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.416 ' C ' HD13 ' A' ' 41' ' ' LEU . 69.5 t -102.08 139.21 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-O 121.324 0.583 . . . . 0.25 111.937 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.855 HD23 HD23 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -113.21 114.96 27.48 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 107.217 -1.401 . . . . 0.23999999999999999 107.217 175.759 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.8 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.6 OUTLIER -102.81 149.34 24.58 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.487 -0.485 . . . . 0.33000000000000002 111.04 -178.317 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 69.4 24.5 5.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.03 -0.532 . . . . 1.1899999999999999 111.756 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.787 HD21 ' HB3' ' A' ' 41' ' ' LEU . 86.8 mt -52.92 -177.47 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.832 0.349 . . . . 0.28000000000000003 110.138 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.494 ' O ' HG21 ' A' ' 50' ' ' VAL . 48.4 tp -108.75 131.39 54.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.439 -0.346 . . . . 0.44 110.369 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -89.17 88.87 7.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.855 0.359 . . . . 1.6399999999999999 110.247 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 49' ' ' ASP . 0.6 OUTLIER -165.48 144.64 6.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.97999999999999998 110.073 -179.154 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -36.1 -32.31 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.638 0.256 . . . . 1.6100000000000001 111.449 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.635 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 4.6 p30 -56.13 -42.2 76.55 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.899 0.381 . . . . 1.5600000000000001 110.841 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.784 HG22 ' HB3' ' A' ' 25' ' ' SER . 84.1 t -84.4 -45.82 17.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.036 -0.529 . . . . 0.23000000000000001 110.531 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.892 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -48.73 -38.65 22.17 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.989 -0.285 . . . . 2.04 110.615 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.564 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 36.4 m170 -79.88 -36.22 36.88 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 109.634 -0.506 . . . . 0.26000000000000001 109.634 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.484 ' O ' HD13 ' A' ' 57' ' ' LEU . 8.5 tpt -53.36 -31.55 45.14 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 106.086 -1.82 . . . . 0.16 106.086 176.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.892 HD12 ' HA ' ' A' ' 51' ' ' ARG . 2.2 mt -83.42 -45.41 13.69 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 113.914 -1.494 . . . . 0.20999999999999999 108.645 176.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.596 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 18.2 t-20 -58.94 -39.75 82.59 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 115.82 -0.627 . . . . 1.24 111.002 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.824 ' CB ' HD11 ' A' ' 102' ' ' LEU . . . -62.37 -49.96 73.45 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.69 0.757 . . . . 0.14000000000000001 109.249 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.646 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.5 OUTLIER -57.95 -37.66 74.55 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.246 -1.39 . . . . 0.22 107.246 176.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.596 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -62.59 -44.43 96.34 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.005 -1.452 . . . . 0.27000000000000002 112.021 179.227 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.655 ' C ' HD21 ' A' ' 88' ' ' LEU . . . -67.78 -39.13 84.13 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.712 0.634 . . . . 0.23999999999999999 112.712 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.636 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.7 OUTLIER -75.26 -17.13 60.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.426 0.631 . . . . 0.26000000000000001 110.28 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.81 37.16 3.75 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 114.894 -1.048 . . . . 0.31 113.935 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.646 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 22.0 t -90.3 125.57 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 109.09 -0.707 . . . . 0.25 109.09 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.716 ' O ' HG12 ' A' ' 76' ' ' ILE . 12.5 m -86.55 130.61 34.43 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 120.469 -0.492 . . . . 1.0 111.13 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.813 ' HB3' HG23 ' A' ' 75' ' ' ILE . 32.4 p90 -159.78 168.87 24.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.18 -0.464 . . . . 0.20000000000000001 110.291 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 99.0 m -134.76 148.65 50.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.284 -0.416 . . . . 0.20999999999999999 110.561 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.417 HD12 ' HB2' ' A' ' 73' ' ' CYS . 14.4 tp -117.19 136.79 52.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.09 0.472 . . . . 0.42999999999999999 110.776 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.514 ' HB2' ' CB ' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -63.94 -158.99 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.612 -0.722 . . . . 1.7 111.281 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -95.7 -31.98 12.97 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.413 -0.358 . . . . 1.78 111.178 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.53 1.09 30.95 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.413 -0.358 . . . . 1.8899999999999999 111.375 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 59.79 24.72 13.7 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.48 -0.327 . . . . 1.8600000000000001 111.67 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.644 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -122.4 -11.23 8.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.823 0.344 . . . . 0.38 111.406 179.573 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.514 ' CB ' ' HB2' ' A' ' 67' ' ' SER . 2.0 mtt180 -112.56 117.96 33.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.439 -0.346 . . . . 3.0099999999999998 110.275 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.766 ' HB3' HD11 ' A' ' 44' ' ' LEU . 43.4 t -131.11 127.52 38.27 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 120.958 0.408 . . . . 0.17999999999999999 111.735 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.535 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 51.3 tt0 -112.24 133.1 54.55 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 109.04 -0.726 . . . . 1.49 109.04 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 1.01 HD11 HD22 ' A' ' 29' ' ' LEU . 11.8 mt -128.7 123.86 60.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 113.948 1.092 . . . . 0.17999999999999999 113.948 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.825 HG23 ' HG3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -67.73 98.86 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 109.157 -0.683 . . . . 0.94999999999999996 109.157 175.764 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -37.23 142.91 0.2 Allowed Glycine 0 C--N 1.321 -0.262 0 CA-C-N 115.138 -0.937 . . . . 0.22 113.579 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.31 -13.32 35.45 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.917 0.389 . . . . 1.21 111.113 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.461 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 86.24 14.51 66.34 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.037 -0.601 . . . . 0.28999999999999998 112.606 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.585 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 145.36 -155.58 26.55 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.792 -0.718 . . . . 0.14999999999999999 112.581 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.516 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 5.8 Cg_endo -49.3 127.41 17.76 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.682 2.255 . . . . 0.51000000000000001 112.436 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.653 ' H ' HD22 ' A' ' 82' ' ' LEU . 0.3 OUTLIER -74.88 109.25 8.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.124 -0.489 . . . . 0.23000000000000001 109.935 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.411 ' HA ' HD22 ' A' ' 111' ' ' ASN . 3.9 p80 -80.42 124.12 28.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.2 0.524 . . . . 0.59999999999999998 112.111 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.667 ' CB ' HD11 ' A' ' 113' ' ' ILE . . . -89.34 124.2 34.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.505 -0.77 . . . . 0.19 111.275 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.51 122.92 20.0 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 105.621 -1.992 . . . . 1.95 105.621 176.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.24 -175.39 5.5 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 108.559 -1.816 . . . . 0.20000000000000001 108.559 -175.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.38 145.03 30.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 118.787 1.294 . . . . 0.17999999999999999 111.832 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.655 HD21 ' C ' ' A' ' 59' ' ' ALA . 0.8 OUTLIER -114.16 161.78 17.35 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.003 -0.998 . . . . 0.20999999999999999 112.278 -178.656 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -139.63 102.89 4.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.612 -1.176 . . . . 1.8700000000000001 108.707 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.699 ' HB3' HD11 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -99.2 127.54 45.19 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 120.99 0.424 . . . . 0.16 111.276 -178.601 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.609 ' C ' HD13 ' A' ' 92' ' ' LEU . 0.9 OUTLIER -99.09 95.51 7.16 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.86 -0.609 . . . . 1.48 109.679 179.185 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.746 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -104.03 54.82 0.73 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.846 -0.615 . . . . 0.62 110.085 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -56.63 -68.5 1.66 Allowed Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.71 -0.677 . . . . 0.72999999999999998 112.984 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.507 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 33.2 m-20 -79.12 -1.76 37.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.575 0.226 . . . . 2.04 110.801 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.959 ' HB1' ' HB3' ' A' ' 98' ' ' ALA . . . -92.76 45.58 1.19 Allowed 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 116.475 -0.33 . . . . 0.93000000000000005 110.919 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -50.42 -27.58 12.17 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.429 -0.891 . . . . 0.47999999999999998 112.032 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.795 HG22 ' CD ' ' A' ' 171' ' ' GLN . 1.1 p -88.83 -14.94 35.77 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.529 0.196 . . . . 0.79000000000000004 111.529 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.959 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -93.46 -37.19 12.07 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.074 0.398 . . . . 0.33000000000000002 112.074 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.1 tpp -59.17 -46.37 88.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.693 -0.23 . . . . 0.39000000000000001 110.737 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.509 ' HB3' ' O ' ' A' ' 171' ' ' GLN . 2.2 mpt_? -52.89 -60.68 6.08 Favored Pre-proline 0 C--N 1.324 -0.537 0 C-N-CA 120.755 -0.378 . . . . 1.3799999999999999 110.056 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.782 ' HB2' HD22 ' A' ' 30' ' ' LEU . 18.1 Cg_endo -60.31 -31.63 93.11 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.422 2.082 . . . . 0.39000000000000001 112.773 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.824 HD11 ' CB ' ' A' ' 56' ' ' ALA . 2.1 mt -73.76 -54.03 8.98 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 120.403 -0.519 . . . . 0.20000000000000001 109.945 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.855 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -47.42 -29.6 2.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.673 -0.694 . . . . 0.17000000000000001 110.543 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.733 ' CB ' ' HB1' ' A' ' 175' ' ' ALA . . . -88.08 -52.11 5.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.872 -0.604 . . . . 0.17000000000000001 112.226 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.67 ' CB ' HD11 ' A' ' 30' ' ' LEU . . . -59.89 -35.42 74.8 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.193 0.812 . . . . 0.17000000000000001 113.193 -177.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.729 ' HB2' HD12 ' A' ' 153' ' ' LEU . 28.3 mt -78.74 -10.98 59.96 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 112.705 0.631 . . . . 0.23000000000000001 112.705 -177.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.754 ' SG ' HD13 ' A' ' 153' ' ' LEU . 99.0 m -93.07 24.86 3.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.287 0.565 . . . . 1.48 110.067 178.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.829 HD21 ' HB2' ' A' ' 182' ' ' LEU . 0.5 OUTLIER -85.51 -75.95 0.35 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.335 -0.848 . . . . 0.40999999999999998 111.213 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -76.76 -105.61 0.14 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.581 -0.819 . . . . 1.1399999999999999 112.141 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.63 96.33 1.5 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.057 0.456 . . . . 0.82999999999999996 110.523 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.69 ' HB2' HD13 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -141.39 140.1 33.61 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.76 -0.654 . . . . 1.96 110.799 -178.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.795 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 5.6 m-20 -95.44 99.25 11.18 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 109.087 -0.708 . . . . 1.1200000000000001 109.087 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.69 HD13 ' HB2' ' A' ' 111' ' ' ASN . 1.3 mp -123.28 144.11 33.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.553 -0.749 . . . . 0.52000000000000002 111.663 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.89 HG13 ' CD2' ' A' ' 143' ' ' LEU . 48.0 t -113.9 113.22 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 107.922 -1.14 . . . . 0.17000000000000001 107.922 176.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' A' ' 90' ' ' LEU . 25.7 mt -101.23 105.67 16.81 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 119.869 -0.733 . . . . 0.16 110.346 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.699 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -117.48 -171.61 2.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.573 -0.285 . . . . 0.23999999999999999 111.315 -179.364 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -167.27 -166.22 25.98 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.547 -0.835 . . . . 0.28999999999999998 113.278 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.578 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 40.2 mt-10 -85.85 166.82 27.42 Favored Pre-proline 0 C--N 1.33 -0.273 0 C-N-CA 122.606 0.363 . . . . 1.79 110.678 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.578 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 2.1 Cg_endo -44.83 -37.25 11.74 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.725 2.283 . . . . 0.41999999999999998 112.696 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -67.62 -26.55 66.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.807 0.337 . . . . 2.25 110.381 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.517 ' O ' ' HG3' ' A' ' 149' ' ' PRO . 7.3 tpt -62.5 -31.81 72.62 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.532 -0.544 . . . . 0.28999999999999998 109.532 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 119' ' ' PRO . 0.1 OUTLIER -61.7 -18.08 58.22 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 115.923 -0.58 . . . . 1.51 110.257 179.067 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -85.25 4.9 32.64 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.957 0.408 . . . . 2.3199999999999998 110.086 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 124' ' ' ARG . 5.9 mtt-85 -127.16 80.58 71.38 Favored Pre-proline 0 N--CA 1.455 -0.197 0 CA-C-N 116.013 -0.54 . . . . 2.1099999999999999 110.51 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.83 148.89 63.8 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.583 2.188 . . . . 0.47999999999999998 111.712 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 148' ' ' TYR . 1.2 tt -126.13 10.4 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 112.386 0.513 . . . . 0.23000000000000001 112.386 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.526 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -59.99 -39.83 96.16 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.559 -0.829 . . . . 0.23000000000000001 113.107 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.415 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 14.4 m-70 -57.41 -37.02 72.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.747 0.308 . . . . 1.5600000000000001 111.03 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.749 ' HG ' HD11 ' A' ' 133' ' ' LEU . 12.5 tp -75.65 -44.49 42.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.273 0.559 . . . . 0.29999999999999999 110.514 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.76 HG13 ' CG2' ' A' ' 140' ' ' ILE . 47.8 t -55.48 -48.13 77.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.367 -0.833 . . . . 0.22 111.275 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.662 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 4.1 m-20 -67.77 -41.45 83.25 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 120.993 0.425 . . . . 1.3200000000000001 110.562 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.617 ' HB2' HG23 ' A' ' 164' ' ' VAL . . . -56.84 -44.06 81.72 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.553 -0.749 . . . . 0.16 110.003 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.749 HD11 ' HG ' ' A' ' 129' ' ' LEU . 6.5 mt -77.4 -51.32 11.0 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.596 -0.729 . . . . 0.19 110.769 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.658 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -55.16 -26.41 38.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.598 -0.728 . . . . 2.8700000000000001 109.912 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.662 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 3.4 tp -69.51 -32.5 71.4 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.175 -0.466 . . . . 0.44 110.556 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.47 12.06 41.76 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.646 -0.788 . . . . 0.20000000000000001 112.049 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.91 5.57 58.41 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.25 -0.976 . . . . 0.25 112.689 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.655 ' HB1' ' HB3' ' A' ' 107' ' ' CYS . . . -75.77 149.66 37.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.029 0.442 . . . . 0.22 111.305 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.0 mttp -97.0 109.22 22.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.948 -0.569 . . . . 2.1000000000000001 110.277 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.76 ' CG2' HG13 ' A' ' 130' ' ' VAL . 28.1 mt -140.6 126.9 21.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.838 0.351 . . . . 0.20000000000000001 111.638 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.655 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -124.2 139.96 53.43 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.124 -0.489 . . . . 0.27000000000000002 110.258 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.403 ' HE1' HG21 ' A' ' 130' ' ' VAL . 32.5 m-85 -80.56 130.14 34.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.837 0.351 . . . . 0.33000000000000002 110.867 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.89 ' CD2' HG13 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -88.5 -85.03 0.19 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.136 -0.484 . . . . 0.29999999999999999 112.076 -178.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.444 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 1.2 mt-10 -66.28 -83.87 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.838 -0.345 . . . . 1.77 110.586 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.481 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 75.5 mt-30 -109.49 153.95 23.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.407 -0.36 . . . . 1.76 110.139 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -69.1 131.74 45.47 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.874 0.368 . . . . 1.6599999999999999 110.865 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.526 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 0.9 OUTLIER 71.43 19.93 5.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.934 -0.575 . . . . 0.77000000000000002 111.155 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.56 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 14.6 m-85 -106.8 169.12 7.15 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 112.277 0.473 . . . . 0.45000000000000001 112.277 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.755 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 65.4 Cg_exo -36.09 -57.26 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.86 3.04 . . . . 0.26000000000000001 115.481 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.755 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 52.3 Cg_exo -56.79 144.97 85.72 Favored 'Trans proline' 0 C--N 1.353 0.806 0 CA-C-N 120.432 1.19 . . . . 0.20000000000000001 112.05 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.679 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 12.2 mt -156.81 134.98 11.2 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.841 -1.072 . . . . 0.23999999999999999 109.894 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.655 ' HB2' HG22 ' A' ' 141' ' ' THR . 3.7 mtt180 -105.33 105.43 15.47 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.009 -1.108 . . . . 2.0800000000000001 108.009 176.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.855 HD11 ' HA ' ' A' ' 103' ' ' ALA . 3.4 mt -94.35 144.62 25.39 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.865 -1.061 . . . . 0.19 110.904 -177.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.681 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 1.5 mt-30 -145.87 27.23 1.2 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.508 -0.769 . . . . 1.1799999999999999 110.72 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 51.06 179.05 0.03 OUTLIER Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.015 -0.612 . . . . 0.40000000000000002 112.622 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 158' ' ' THR . . . 125.68 -10.27 7.58 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.143 -1.027 . . . . 0.25 113.405 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.577 ' CD1' ' HB2' ' A' ' 183' ' ' ALA . 21.4 t80 -58.87 122.64 14.12 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 117.381 0.591 . . . . 0.53000000000000003 110.482 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.687 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 73.1 p -117.53 -38.29 3.33 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.334 0.588 . . . . 0.25 111.625 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.553 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 144.64 -170.92 26.11 Favored Glycine 0 C--N 1.308 -1.022 0 C-N-CA 120.239 -0.981 . . . . 0.25 112.583 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.573 ' O ' HG23 ' A' ' 187' ' ' THR . . . 112.58 155.06 12.19 Favored Glycine 0 N--CA 1.436 -1.323 0 N-CA-C 111.189 -0.764 . . . . 0.62 111.189 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -47.76 125.67 9.04 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 120.833 0.349 . . . . 1.9299999999999999 110.68 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 132' ' ' ALA . 74.7 t -117.11 144.42 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.66 -0.496 . . . . 0.27000000000000002 109.66 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -113.26 119.39 37.57 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.865 -0.334 . . . . 1.1200000000000001 110.794 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.846 HG21 HD11 ' A' ' 176' ' ' LEU . 1.1 t -131.83 119.17 40.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 120.598 -0.441 . . . . 0.31 109.851 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.493 ' HB3' HG23 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -55.44 138.39 46.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 1.48 111.288 -178.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.709 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . -60.8 -46.17 95.02 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.588 -0.815 . . . . 0.52000000000000002 112.431 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.3 m -91.5 87.36 6.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.729 0.3 . . . . 1.3600000000000001 111.432 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.493 HG23 ' HB3' ' A' ' 165' ' ' ASP . 72.4 t -146.22 -79.86 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.248 0.547 . . . . 1.8700000000000001 110.674 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.58 ' CA ' HG11 ' A' ' 196' ' ' VAL . 0.6 OUTLIER -169.99 132.8 1.13 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.362 -0.835 . . . . 1.1699999999999999 110.685 179.868 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.463 ' HB2' ' HB3' ' A' ' 200' ' ' TYR . 71.9 p -58.22 -16.96 15.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.919 -0.582 . . . . 1.25 111.993 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.795 ' CD ' HG22 ' A' ' 97' ' ' THR . 8.7 mp0 -85.5 -11.01 55.25 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.815 -0.354 . . . . 2.3700000000000001 111.111 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.486 ' CD2' ' HB2' ' A' ' 129' ' ' LEU . 10.8 m-85 -75.07 -59.19 2.85 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.317 -0.623 . . . . 0.39000000000000001 109.317 178.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.841 HD11 ' CG1' ' A' ' 191' ' ' ILE . 0.3 OUTLIER -60.7 -39.14 87.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.475 -0.784 . . . . 0.57999999999999996 109.18 178.42 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.463 HG23 HG21 ' A' ' 204' ' ' THR . 1.7 m -59.84 -38.96 83.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.922 -1.036 . . . . 0.31 109.62 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.733 ' HB1' ' CB ' ' A' ' 104' ' ' ALA . . . -60.65 -41.5 95.08 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.815 -0.629 . . . . 0.19 110.911 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.846 HD11 HG21 ' A' ' 164' ' ' VAL . 0.3 OUTLIER -77.37 -32.16 54.78 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.473 -0.785 . . . . 0.63 110.891 179.657 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.687 ' CD2' HD21 ' A' ' 205' ' ' LEU . 3.5 mp -61.51 -38.44 87.36 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.342 -0.845 . . . . 0.34999999999999998 110.759 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.667 ' HA ' ' HE1' ' A' ' 208' ' ' MET . 1.5 mtp -82.65 -40.6 20.49 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.51 0.559 . . . . 0.68000000000000005 112.51 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.498 HG23 ' HG ' ' A' ' 108' ' ' LEU . 50.3 m -77.1 -39.43 49.56 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.343 -0.844 . . . . 0.27000000000000002 113.071 -178.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.53 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . -58.7 -42.52 94.72 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 114.428 1.27 . . . . 0.37 114.428 -177.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 27.0 Cg_endo -64.82 -27.56 59.42 Favored 'Trans proline' 0 CA--C 1.501 -1.154 0 CA-C-N 119.795 0.962 . . . . 0.52000000000000002 112.387 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.829 ' HB2' HD21 ' A' ' 108' ' ' LEU . 4.0 mt -83.26 -2.36 55.42 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 109.31 -0.626 . . . . 0.51000000000000001 109.31 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.68 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -78.17 135.8 61.9 Favored Pre-proline 0 C--O 1.224 -0.274 0 CA-C-N 116.049 -0.523 . . . . 0.25 110.122 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.687 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 11.3 Cg_endo -51.14 -34.4 47.77 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.378 2.052 . . . . 0.25 113.11 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -112.4 143.64 43.18 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.697 -0.683 . . . . 2.0899999999999999 111.112 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -58.07 153.43 14.67 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.285 -0.416 . . . . 2.2400000000000002 110.286 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.574 HG23 HG23 ' A' ' 162' ' ' VAL . 56.4 m -133.75 145.65 50.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.077 0.465 . . . . 0.27000000000000002 112.223 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.573 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 54.6 t -124.48 117.58 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.584 -0.735 . . . . 0.25 110.197 178.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.687 HG12 HD13 ' A' ' 176' ' ' LEU . 3.4 mp -100.13 117.9 45.99 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 N-CA-C 108.731 -0.84 . . . . 0.23000000000000001 108.731 177.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 7.7 ttt180 -100.66 124.71 46.64 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.322 -0.992 . . . . 2.4300000000000002 108.322 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.841 ' CG1' HD11 ' A' ' 173' ' ' LEU . 1.6 mp -92.27 122.37 43.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.933 -1.03 . . . . 0.31 111.746 -176.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -80.46 96.87 6.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.072 -1.422 . . . . 0.98999999999999999 110.595 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 101.56 -132.39 10.94 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.747 -0.74 . . . . 0.46999999999999997 111.884 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -116.74 127.51 54.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.711 0.291 . . . . 1.1000000000000001 111.628 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.556 HD11 ' HZ ' ' A' ' 223' ' ' PHE . 1.1 mt -40.42 144.87 0.2 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.157 -0.474 . . . . 0.44 111.269 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.58 HG11 ' CA ' ' A' ' 169' ' ' SER . 10.5 p -72.52 -30.74 35.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.995 -0.548 . . . . 0.60999999999999999 112.2 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.478 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 0.2 OUTLIER -165.23 63.61 0.12 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.977 0.417 . . . . 0.88 110.734 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.51 ' HA ' HD13 ' A' ' 195' ' ' LEU . 6.1 tttm -40.25 -46.21 5.41 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 115.851 -0.613 . . . . 2.02 111.355 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.478 ' HD2' ' C ' ' A' ' 197' ' ' SER . 87.6 Cg_exo -47.37 -34.09 18.22 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.027 1.818 . . . . 0.62 111.798 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.958 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.3 OUTLIER -70.34 -42.06 72.39 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.804 -0.813 . . . . 1.4099999999999999 108.804 178.056 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.442 HG21 ' HE2' ' A' ' 223' ' ' PHE . 26.4 mm -63.21 -33.8 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 114.819 -1.082 . . . . 0.41999999999999998 110.44 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.7 -45.28 94.8 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.121 0.486 . . . . 1.1399999999999999 109.914 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.958 HD12 ' HA ' ' A' ' 200' ' ' TYR . 3.8 mt -62.14 -50.95 77.95 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 CA-C-O 121.633 0.73 . . . . 0.62 110.163 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.463 HG21 HG23 ' A' ' 174' ' ' THR . 74.9 m -51.63 -51.11 58.29 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.478 -1.237 . . . . 0.46999999999999997 111.449 -178.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.692 HD22 ' HB ' ' A' ' 215' ' ' ILE . 21.3 mt -66.84 -28.59 68.47 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 120.892 0.377 . . . . 0.26000000000000001 111.661 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ASN . . . . . 0.415 ' HA ' ' HE3' ' A' ' 209' ' ' LYS . 1.9 t30 -78.48 -46.64 19.18 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.588 0.708 . . . . 1.6000000000000001 109.827 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.979 ' O ' HG22 ' A' ' 210' ' ' THR . 0.2 OUTLIER -71.11 -30.31 66.36 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.687 -1.142 . . . . 0.52000000000000002 109.192 178.883 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 208' ' ' MET . . . . . 0.667 ' HE1' ' HA ' ' A' ' 178' ' ' MET . 35.5 mtp -72.76 -35.03 67.37 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.848 -0.615 . . . . 0.38 109.534 177.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 10.4 mtmt -60.97 -36.39 79.3 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 115.092 -0.958 . . . . 0.98999999999999999 110.856 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.979 HG22 ' O ' ' A' ' 207' ' ' LEU . 4.8 t -62.04 -22.98 66.19 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.633 -0.712 . . . . 0.96999999999999997 109.33 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.536 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 61.3 m-85 -85.76 -9.07 57.68 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.749 -0.66 . . . . 1.51 111.587 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 111.54 5.33 26.17 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 116.006 1.162 . . . . 2.9300000000000002 116.006 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.5 m -123.54 148.96 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 118.969 1.385 . . . . 1.6899999999999999 112.81 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.476 ' HG2' ' CG ' ' A' ' 209' ' ' LYS . 8.5 mt-10 -131.01 135.88 48.0 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.341 -0.845 . . . . 2.6699999999999999 111.291 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.988 HD12 ' HB ' ' A' ' 225' ' ' VAL . 20.0 mm -118.26 148.59 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 120.772 0.32 . . . . 1.0800000000000001 110.225 178.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.542 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 9.2 tt0 -104.86 116.56 32.2 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.302 -0.408 . . . . 1.54 112.004 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -84.94 151.25 24.37 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.091 -0.504 . . . . 2.2400000000000002 110.396 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 5.0 tp60 -108.18 -143.23 0.38 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.477 0.179 . . . . 1.97 110.785 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.409 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 4.5 m-70 -73.3 66.51 0.92 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.886 0.374 . . . . 2.4199999999999999 111.491 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.41 ' CE1' ' HD2' ' A' ' 198' ' ' LYS . 6.4 t80 58.43 33.65 23.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.788 0.804 . . . . 0.97999999999999998 111.11 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.636 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 5.1 pt20 -165.74 -129.99 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 106.69 -1.596 . . . . 1.5600000000000001 106.69 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.617 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -3.06 128.7 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 114.36 1.244 . . . . 1.3500000000000001 114.36 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.597 ' CD1' ' O ' ' A' ' 221' ' ' GLN . 5.1 m-85 -123.02 140.93 52.52 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.262 -1.79 . . . . 0.63 110.042 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.542 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 42.3 t -123.03 112.78 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 121.329 0.585 . . . . 0.33000000000000002 109.841 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.988 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -119.44 135.27 60.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.222 -0.899 . . . . 0.44 111.49 -178.945 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.431 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 3.7 mptt -83.76 127.8 34.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.038 -0.528 . . . . 2.71 109.823 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.428 ' CA ' ' O ' ' A' ' 183' ' ' ALA . . . -83.03 167.99 46.41 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.442 -0.885 . . . . 0.38 113.347 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 77.73 19.81 75.02 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 121.703 -0.284 . . . . 0.28999999999999998 113.412 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 19.6 mt-30 -77.22 -176.22 4.0 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.39 0.614 . . . . 1.8400000000000001 111.728 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.6 147.67 30.3 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.116 -0.947 . . . . 1.21 110.636 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' TYR . . . . . 0.495 ' CE2' HD22 ' A' ' 31' ' ' LEU . 6.3 m-30 -103.19 132.06 49.74 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.975 -0.557 . . . . 0.76000000000000001 110.995 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -119.74 155.14 33.04 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.697 -0.483 . . . . 2.5299999999999998 109.697 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.484 ' HB2' ' OG1' ' A' ' 39' ' ' THR . 51.8 p -82.42 109.71 17.57 Favored Pre-proline 0 N--CA 1.451 -0.411 0 C-N-CA 121.077 -0.249 . . . . 1.3500000000000001 110.56 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.533 ' HD2' ' OG1' ' A' ' 39' ' ' THR . 54.9 Cg_endo -68.45 -2.34 8.97 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.089 1.859 . . . . 0.33000000000000002 112.233 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 102.21 -94.7 1.21 Allowed Glycine 0 C--O 1.227 -0.313 0 C-N-CA 120.629 -0.796 . . . . 0.28000000000000003 111.666 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 95.9 m -121.51 135.41 55.03 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.344 -0.613 . . . . 0.29999999999999999 109.344 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.739 ' CD2' HG21 ' A' ' 210' ' ' THR . 12.3 t80 -133.58 134.74 43.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.93 0.395 . . . . 0.55000000000000004 111.516 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.8 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -98.91 113.05 25.01 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.981 -0.554 . . . . 0.40999999999999998 111.529 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.744 ' N ' HD22 ' A' ' 238' ' ' LEU . 25.1 t -84.59 112.75 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.731 -0.668 . . . . 0.40999999999999998 110.908 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.251 -0.881 . . . . 1.6899999999999999 111.124 -179.699 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.907 ' HB3' HD22 ' A' ' 44' ' ' LEU . 65.4 p . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.795 0.331 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.474 HD22 ' HB2' ' A' ' 98' ' ' ALA . 19.8 m120 56.93 -87.43 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.514 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.782 HH12 ' HB ' ' A' ' 203' ' ' ILE . 29.1 mtm180 -74.69 -58.41 3.31 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.876 0.37 . . . . 0.0 110.985 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.748 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -39.32 -48.42 1.86 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.667 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.08 HD22 HD11 ' A' ' 75' ' ' ILE . 11.0 mt -72.31 -36.42 68.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.905 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.79 HD22 ' HB2' ' A' ' 101' ' ' PRO . 35.9 tp -65.86 -50.19 65.44 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.719 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.712 HD22 ' CZ ' ' A' ' 231' ' ' TYR . 60.0 mt -67.0 -27.64 67.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.728 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.754 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -65.91 -39.18 90.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.14 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.813 ' CB ' HG11 ' A' ' 62' ' ' VAL . . . -81.73 -41.07 21.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.212 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.727 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 14.4 mt -68.33 -4.01 12.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.227 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.534 ' HB2' ' HB3' ' A' ' 231' ' ' TYR . . . -97.6 179.19 4.93 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -177.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.58 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.4 OUTLIER -112.19 113.5 25.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.931 178.543 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 114.12 169.08 16.52 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.608 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.568 ' HG2' ' HG2' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -95.06 117.57 30.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 117.154 0.477 . . . . 0.0 111.475 -179.223 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 235' ' ' GLY . 0.9 OUTLIER -119.58 145.71 46.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.445 -179.697 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.51 HG22 ' HB2' ' A' ' 74' ' ' GLU . 75.8 t -104.37 142.31 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 CA-C-O 121.344 0.592 . . . . 0.0 112.548 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.874 HD23 HD23 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -116.51 116.36 27.49 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 174.632 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.931 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.5 OUTLIER -102.96 151.35 22.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.108 -177.909 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.7 t30 66.08 27.26 10.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.179 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.907 HD22 ' HB3' ' A' ' 25' ' ' SER . 86.2 mt -54.68 -172.94 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.562 ' HB3' HG21 ' A' ' 50' ' ' VAL . 29.7 tp -114.03 131.38 56.38 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -88.46 88.45 7.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.149 0.5 . . . . 0.0 110.565 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 49' ' ' ASP . 1.7 m -164.31 142.91 7.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.1 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.421 ' HA ' ' HB3' ' A' ' 51' ' ' ARG . 0.6 OUTLIER -36.42 -30.45 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.602 0.239 . . . . 0.0 111.455 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.939 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 1.5 p30 -58.19 -42.77 86.82 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 121.028 0.442 . . . . 0.0 110.905 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.797 HG23 ' OD1' ' A' ' 49' ' ' ASP . 88.8 t -84.24 -44.66 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.57 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.943 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -50.89 -39.01 53.11 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.017 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.668 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 55.3 m170 -80.31 -32.58 37.96 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.595 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.574 ' O ' HD13 ' A' ' 57' ' ' LEU . 9.5 tpt -55.0 -34.62 63.6 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.943 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.5 OUTLIER -82.42 -41.54 19.75 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 114.22 -1.354 . . . . 0.0 108.58 176.346 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.675 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 34.4 t30 -59.13 -41.56 88.52 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-O 120.922 0.391 . . . . 0.0 110.749 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 1.029 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -59.24 -46.76 87.62 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 121.702 0.763 . . . . 0.0 108.96 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.851 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.4 OUTLIER -63.41 -41.11 98.71 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.245 -1.343 . . . . 0.0 107.745 177.243 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.675 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -59.78 -32.9 71.03 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 114.187 -1.369 . . . . 0.0 111.564 179.044 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.748 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -77.66 -38.33 47.91 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.073 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.698 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.5 OUTLIER -79.89 -12.91 59.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.407 0.622 . . . . 0.0 110.566 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.43 33.33 5.42 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 114.967 -1.015 . . . . 0.0 114.244 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.851 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 40.5 t -90.55 117.67 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.791 ' O ' HG12 ' A' ' 76' ' ' ILE . 26.0 m -82.98 132.89 35.13 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 121.078 0.466 . . . . 0.0 112.167 -178.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.723 ' HB3' HG23 ' A' ' 75' ' ' ILE . 41.1 p90 -158.31 171.87 19.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.463 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 62.1 m -131.37 148.51 52.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.182 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.415 ' CD1' ' HB2' ' A' ' 73' ' ' CYS . 12.5 tp -115.04 133.7 55.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.177 0.513 . . . . 0.0 110.685 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.527 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 0.6 OUTLIER -61.21 -167.22 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.378 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.75 -44.47 14.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.553 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.33 1.79 10.79 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.596 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 58.81 39.83 23.62 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.868 0.366 . . . . 0.0 111.54 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -133.95 -10.46 2.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.225 179.292 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.572 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 14.8 mtp180 -114.92 120.59 40.45 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.676 ' HB3' HD11 ' A' ' 44' ' ' LEU . 34.2 t -129.53 125.62 36.72 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.568 ' HG2' ' HG2' ' A' ' 38' ' ' LYS . 56.8 tt0 -106.98 130.62 54.6 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 176.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 1.08 HD11 HD22 ' A' ' 29' ' ' LEU . 10.4 mt -127.72 124.49 63.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -177.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.791 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -68.51 99.62 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-O 121.104 0.478 . . . . 0.0 109.712 175.813 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' A' ' 35' ' ' ALA . . . -38.77 143.71 0.29 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.843 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.31 -10.71 45.75 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.093 0.473 . . . . 0.0 110.921 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.58 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 90.14 3.11 73.32 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.14 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.505 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 150.07 -148.49 19.8 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.012 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.579 ' CG ' ' HB3' ' A' ' 108' ' ' LEU . 88.1 Cg_exo -49.09 125.14 12.73 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.783 2.322 . . . . 0.0 112.973 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.707 ' H ' HD22 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -74.58 110.52 8.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.792 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.405 ' HA ' ' CG ' ' A' ' 111' ' ' ASN . 4.4 p80 -82.08 135.06 35.37 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.072 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.639 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -98.03 123.78 42.22 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.061 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -71.04 123.67 22.61 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.61 175.71 0.96 Allowed Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -175.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.65 144.8 47.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 118.735 1.268 . . . . 0.0 111.411 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.748 HD21 ' HB1' ' A' ' 59' ' ' ALA . 1.3 tp -116.26 160.54 20.31 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.393 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 22.4 mt-10 -139.22 104.23 4.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.288 178.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.686 ' HB2' HD23 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -100.63 118.83 37.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.143 -178.699 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.424 ' C ' HD13 ' A' ' 92' ' ' LEU . 4.3 m-85 -92.99 96.26 9.98 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.906 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.923 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -104.89 47.31 0.88 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.089 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.782 ' HA3' ' H ' ' A' ' 118' ' ' GLU . . . -54.4 -44.66 76.78 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.848 -0.692 . . . . 0.0 113.281 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.625 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 74.2 m-20 -94.43 -6.89 42.99 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.666 0.27 . . . . 0.0 110.733 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 1.005 ' HB1' ' HB3' ' A' ' 98' ' ' ALA . . . -98.16 61.7 1.49 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.011 0.434 . . . . 0.0 111.311 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.617 ' O ' ' HD3' ' A' ' 100' ' ' ARG . . . -63.82 -25.2 68.94 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.068 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.434 ' HA ' ' HG2' ' A' ' 171' ' ' GLN . 0.9 OUTLIER -88.19 -17.11 31.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.707 0.289 . . . . 0.0 110.882 179.497 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 1.005 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -95.27 -29.21 14.61 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.925 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.668 ' SD ' ' HB3' ' A' ' 115' ' ' LEU . 5.6 tpp -64.3 -47.4 79.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.168 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.671 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 1.9 mpt_? -54.34 -58.87 11.9 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.79 ' HB2' HD22 ' A' ' 30' ' ' LEU . 18.1 Cg_endo -59.71 -33.04 96.57 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.286 1.991 . . . . 0.0 112.635 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 1.029 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.4 OUTLIER -74.16 -53.43 9.88 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.056 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.884 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -50.04 -28.09 6.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.429 0.633 . . . . 0.0 110.279 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.858 ' HB2' ' HB1' ' A' ' 175' ' ' ALA . . . -86.96 -54.44 4.34 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.316 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.67 ' HB1' HD11 ' A' ' 34' ' ' LEU . . . -59.93 -32.76 71.09 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -176.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.739 ' HB2' HD12 ' A' ' 153' ' ' LEU . 20.2 mt -78.99 -12.89 60.05 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.046 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.559 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 20.2 m -81.23 15.32 1.99 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.219 0.533 . . . . 0.0 110.936 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.691 HD21 ' HB2' ' A' ' 182' ' ' LEU . 2.3 mt -91.91 -71.02 0.66 Allowed 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.267 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.86 146.19 22.06 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.707 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.2 p -58.16 98.84 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.803 0.335 . . . . 0.0 111.141 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.616 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 16.8 m-80 -148.28 135.51 20.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.874 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.881 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 5.0 m-20 -91.66 101.05 13.67 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.252 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.639 HD11 ' HB2' ' A' ' 84' ' ' ALA . 31.5 mm -118.89 137.48 52.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.161 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.815 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 62.9 t -110.17 112.39 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 176.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.686 HD23 ' HB2' ' A' ' 90' ' ' LEU . 63.9 mt -102.21 105.83 16.56 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.327 -178.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.776 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -119.37 -175.37 2.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.844 0.354 . . . . 0.0 111.624 -178.921 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.602 ' H ' HG22 ' A' ' 116' ' ' THR . . . -166.17 178.07 40.91 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.994 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.782 ' H ' ' HA3' ' A' ' 93' ' ' GLY . 3.9 mt-10 -70.79 172.63 5.97 Favored Pre-proline 0 C--N 1.328 -0.333 0 C-N-CA 123.096 0.558 . . . . 0.0 110.793 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.645 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 81.5 Cg_exo -46.65 -39.57 23.34 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.682 2.254 . . . . 0.0 113.105 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.419 ' O ' ' HB3' ' A' ' 123' ' ' GLU . 2.1 mpp_? -67.8 -23.57 65.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.681 0.277 . . . . 0.0 110.961 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.664 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 10.8 tpt -60.92 -35.65 77.25 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.42 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 3.5 mptp? -62.78 -16.86 59.79 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.149 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.651 ' O ' ' HG3' ' A' ' 123' ' ' GLU . 1.0 OUTLIER -80.92 -0.17 38.05 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.307 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.442 ' HB3' HH22 ' A' ' 100' ' ' ARG . 6.5 mtt180 -126.31 83.71 63.45 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.71 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.532 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 15.8 Cg_endo -56.86 148.75 65.03 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.646 2.231 . . . . 0.0 111.538 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 148' ' ' TYR . 0.7 OUTLIER -123.48 -0.76 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.012 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.573 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -53.69 -39.01 60.16 Favored Glycine 0 CA--C 1.516 0.138 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.707 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.745 ' CG ' HG21 ' A' ' 168' ' ' VAL . 1.8 m-70 -55.58 -39.29 70.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.023 0.412 . . . . 0.0 110.735 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.747 ' HG ' HD11 ' A' ' 133' ' ' LEU . 14.4 tp -75.36 -40.86 57.7 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.347 0.594 . . . . 0.0 110.141 178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.762 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 55.1 t -56.19 -48.17 79.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.562 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.738 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 75.2 m-20 -69.5 -37.26 77.12 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.133 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.639 ' HB2' HG23 ' A' ' 164' ' ' VAL . . . -58.99 -49.62 77.2 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.936 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.747 HD11 ' HG ' ' A' ' 129' ' ' LEU . 6.6 mt -73.6 -47.44 40.36 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.591 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.762 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -59.53 -27.47 66.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.702 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.738 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 5.6 tp -70.89 -28.69 64.73 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.998 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 159' ' ' GLY . . . -85.55 15.26 47.27 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.709 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.91 4.73 61.45 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.522 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.512 ' HB3' ' C ' ' A' ' 133' ' ' LEU . . . -73.95 152.99 39.96 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 120.865 0.364 . . . . 0.0 111.417 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.446 ' CB ' ' HB2' ' A' ' 154' ' ' GLN . 13.5 mmtm -102.29 103.43 13.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.249 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.681 ' CG2' HD22 ' A' ' 151' ' ' LEU . 14.7 mt -134.86 127.35 48.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.431 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.714 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -124.62 139.23 54.06 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.101 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.494 ' HE1' HG21 ' A' ' 130' ' ' VAL . 36.3 m-85 -78.08 130.35 36.31 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.125 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.759 ' CD2' HG13 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -91.09 -90.26 0.16 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.57 -179.723 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.834 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 2.6 mt-10 -58.99 -81.51 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 122.083 -0.386 . . . . 0.0 110.903 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.428 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 14.2 mt-30 -114.73 151.86 33.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.505 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -66.93 135.2 53.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.919 0.39 . . . . 0.0 110.68 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.573 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 4.3 m-20 66.91 19.73 10.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.196 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.568 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 10.9 m-85 -110.28 169.64 6.15 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 121.085 0.469 . . . . 0.0 112.128 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.914 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 36.5 Cg_exo -33.23 -62.32 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 124.547 3.498 . . . . 0.0 116.252 -177.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.914 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 52.4 Cg_exo -53.56 145.73 46.28 Favored 'Trans proline' 0 C--N 1.352 0.746 0 CA-C-N 120.723 1.294 . . . . 0.0 112.678 -178.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.815 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 6.5 mt -156.3 136.31 12.76 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.62 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.714 ' HB2' HG22 ' A' ' 141' ' ' THR . 11.7 mtt180 -106.42 103.18 12.58 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.884 HD11 ' HA ' ' A' ' 103' ' ' ALA . 6.6 mt -93.6 145.39 24.57 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.797 -178.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.616 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 2.6 mp0 -147.35 26.93 1.04 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.43 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 52.14 -158.59 3.11 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.027 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.39 -12.86 43.69 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 119.922 -1.132 . . . . 0.0 112.917 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.538 ' HE1' ' HA ' ' A' ' 180' ' ' ALA . 51.6 t80 -60.29 122.75 15.27 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 117.14 0.47 . . . . 0.0 110.852 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.689 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 54.3 p -115.31 -33.12 5.41 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.575 0.703 . . . . 0.0 111.206 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.414 ' O ' ' HA2' ' A' ' 136' ' ' GLY . . . 136.46 -160.39 24.74 Favored Glycine 0 C--N 1.305 -1.148 0 CA-C-N 114.667 -1.151 . . . . 0.0 112.247 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.612 ' O ' HG23 ' A' ' 187' ' ' THR . . . 105.97 154.85 21.35 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 120.625 -0.797 . . . . 0.0 111.35 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -47.04 119.22 2.44 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 120.869 0.366 . . . . 0.0 110.944 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.745 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 75.3 t -110.36 129.87 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.929 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.11 119.41 37.79 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.521 -0.472 . . . . 0.0 109.74 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.872 HG21 HD11 ' A' ' 176' ' ' LEU . 1.0 OUTLIER -132.32 120.19 42.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.507 ' O ' HG12 ' A' ' 168' ' ' VAL . 0.6 OUTLIER -53.32 141.89 22.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.246 -179.228 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.899 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . -60.38 -51.69 57.21 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.653 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.427 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 88.8 p -92.93 95.41 9.48 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.454 0.169 . . . . 0.0 111.188 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.745 HG21 ' CG ' ' A' ' 128' ' ' HIS . 8.5 p -179.31 67.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 120.997 0.427 . . . . 0.0 111.539 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.612 ' C ' HG11 ' A' ' 196' ' ' VAL . 0.4 OUTLIER 64.53 126.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.599 179.292 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.466 ' HB3' ' CB ' ' A' ' 197' ' ' SER . 2.8 p -72.29 -16.98 61.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.056 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.671 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 1.5 mp0 -81.62 -11.66 59.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.361 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.532 ' HZ ' ' O ' ' A' ' 125' ' ' PRO . 5.3 m-85 -69.53 -51.84 31.96 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.718 0.77 . . . . 0.0 109.272 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.916 HD21 HD11 ' A' ' 191' ' ' ILE . 0.4 OUTLIER -67.48 -43.21 81.51 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.513 -1.222 . . . . 0.0 109.106 178.71 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.615 ' O ' ' HG3' ' A' ' 178' ' ' MET . 5.1 m -55.01 -33.52 62.69 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.55 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.858 ' HB1' ' HB2' ' A' ' 104' ' ' ALA . . . -66.92 -41.05 87.74 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.874 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.872 HD11 HG21 ' A' ' 164' ' ' VAL . 1.1 mt -76.17 -34.89 59.36 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.404 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.81 HD11 ' CD2' ' A' ' 223' ' ' PHE . 3.8 mp -60.37 -36.95 79.24 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.336 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.624 ' HA ' ' HE1' ' A' ' 208' ' ' MET . 6.0 mtp -81.6 -43.68 18.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.558 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 88.2 m -72.16 -42.48 65.86 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.988 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.542 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . -59.28 -38.93 68.57 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -176.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.652 ' HA ' ' O ' ' A' ' 226' ' ' LYS . 27.0 Cg_endo -65.79 -29.67 50.42 Favored 'Trans proline' 0 CA--C 1.499 -1.236 0 CA-C-N 120.163 1.094 . . . . 0.0 111.699 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.691 ' HB2' HD21 ' A' ' 108' ' ' LEU . 5.6 mt -83.8 2.0 40.28 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.765 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.689 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -84.7 138.29 38.05 Favored Pre-proline 0 C--O 1.224 -0.285 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.201 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.676 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 12.1 Cg_endo -51.47 -31.19 38.01 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.444 2.096 . . . . 0.0 113.028 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.45 140.89 48.87 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.522 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -57.07 147.77 23.51 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.197 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 160' ' ' GLY . 78.8 m -122.99 147.29 46.8 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 36.0 t -126.24 117.9 49.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.745 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 2.6 mp -103.83 117.35 49.19 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.954 0 C-N-CA 120.029 -0.669 . . . . 0.0 109.368 178.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.644 ' HG3' ' HG3' ' A' ' 222' ' ' GLN . 1.3 ttt85 -99.85 124.68 45.41 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.916 HD11 HD21 ' A' ' 173' ' ' LEU . 1.5 mp -94.08 123.48 46.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.976 -176.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -76.21 96.33 3.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.835 -1.529 . . . . 0.0 110.47 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 97.75 -126.72 8.98 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.972 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.59 132.72 56.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.845 0.355 . . . . 0.0 111.633 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.837 HD21 HD13 ' A' ' 173' ' ' LEU . 0.9 OUTLIER -42.07 144.42 0.46 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.044 179.267 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.612 HG11 ' C ' ' A' ' 169' ' ' SER . 12.5 p -73.87 -26.52 21.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.165 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.466 ' CB ' ' HB3' ' A' ' 170' ' ' SER . 0.3 OUTLIER -168.51 65.05 0.07 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.176 0.513 . . . . 0.0 109.741 -179.663 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.49 ' HA ' HD13 ' A' ' 195' ' ' LEU . 0.0 OUTLIER -42.93 -46.02 12.55 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.096 -179.812 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 198' ' ' LYS . 79.8 Cg_exo -48.27 -34.83 25.65 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.903 1.735 . . . . 0.0 111.638 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.927 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.3 OUTLIER -67.91 -42.45 81.12 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.401 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.453 HG21 ' CE2' ' A' ' 223' ' ' PHE . 20.0 mm -60.12 -39.49 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.026 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -57.15 -47.2 81.76 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.224 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.927 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.9 mt -60.55 -50.38 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 CA-C-O 121.486 0.66 . . . . 0.0 109.457 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.579 ' CG2' HG23 ' A' ' 174' ' ' THR . 89.7 m -52.83 -52.01 58.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.756 -177.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.889 HD22 ' HB ' ' A' ' 215' ' ' ILE . 45.2 mt -65.02 -31.36 72.55 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 120.985 0.422 . . . . 0.0 111.415 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -76.86 -44.89 30.35 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.751 0.786 . . . . 0.0 109.743 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.889 ' O ' HG22 ' A' ' 210' ' ' THR . 8.0 tp -71.8 -29.6 64.63 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.301 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' MET . . . . . 0.726 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 41.7 mtp -75.99 -35.42 59.6 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.677 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 3.5 mtmt -61.54 -38.66 88.25 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 114.438 -1.255 . . . . 0.0 111.001 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.889 HG22 ' O ' ' A' ' 207' ' ' LEU . 6.1 t -61.54 -31.64 71.67 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.388 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.598 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 40.6 m-85 -78.74 -5.26 52.74 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.83 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.29 5.62 28.22 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 115.891 1.116 . . . . 0.0 115.891 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.3 m -123.53 148.69 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 118.878 1.339 . . . . 0.0 112.78 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.617 ' O ' HD13 ' A' ' 215' ' ' ILE . 20.4 mt-10 -129.18 140.14 51.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.893 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.889 ' HB ' HD22 ' A' ' 205' ' ' LEU . 16.3 mm -122.76 148.3 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 120.699 0.285 . . . . 0.0 110.314 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.738 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 38.8 tt0 -101.21 115.09 29.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.656 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -81.51 150.78 28.08 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.302 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 222' ' ' GLN . 5.5 tp60 -108.3 -136.7 0.36 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.759 -0.2 . . . . 0.0 111.321 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.403 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 61.0 m80 -84.6 69.53 10.63 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 120.832 0.349 . . . . 0.0 110.307 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.408 ' CE1' ' HG3' ' A' ' 198' ' ' LYS . 4.0 t80 54.16 31.28 13.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 122.11 0.957 . . . . 0.0 109.967 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.676 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -160.69 -128.32 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 113.632 -1.622 . . . . 0.0 106.838 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.735 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -4.53 129.24 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -179.446 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.81 ' CD2' HD11 ' A' ' 177' ' ' LEU . 0.7 OUTLIER -124.44 128.33 48.85 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.104 -1.862 . . . . 0.0 109.091 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.738 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 46.2 t -111.24 114.06 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 121.544 0.688 . . . . 0.0 109.393 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.74 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.4 OUTLIER -124.35 119.91 57.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.181 -178.651 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.652 ' O ' ' HA ' ' A' ' 181' ' ' PRO . 4.0 pttt -74.17 143.41 45.25 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -92.93 -173.15 40.82 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.678 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 62.72 21.13 62.64 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 121.49 -0.386 . . . . 0.0 113.253 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' GLN . . . . . 0.56 ' NE2' ' HB3' ' A' ' 181' ' ' PRO . 47.4 mt-30 -80.68 -172.94 3.88 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.272 0.558 . . . . 0.0 111.361 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 2.3 t -158.18 147.95 19.86 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.625 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' TYR . . . . . 0.727 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 7.8 m-85 -99.04 136.02 39.61 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.149 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.401 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 0.1 OUTLIER -123.09 148.02 46.11 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.697 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.502 ' HB2' ' OG1' ' A' ' 39' ' ' THR . 19.5 p -72.47 110.93 9.2 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.575 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.441 ' HD2' ' OG1' ' A' ' 39' ' ' THR . 55.7 Cg_endo -69.95 1.1 4.87 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.195 1.93 . . . . 0.0 112.141 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 100.28 -99.61 2.05 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 93.0 m -120.03 136.82 54.42 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.674 ' CD2' HG21 ' A' ' 210' ' ' THR . 10.9 t80 -132.96 128.07 35.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.974 0.416 . . . . 0.0 111.707 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.931 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -92.97 111.87 23.64 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.587 179.526 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.67 ' N ' HD22 ' A' ' 238' ' ' LEU . 21.7 t -85.87 111.68 21.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.143 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.404 ' HG3' HD13 ' A' ' 238' ' ' LEU . 1.6 mt-10 . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.15 -0.928 . . . . 0.0 111.083 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.732 ' HB2' HD22 ' A' ' 44' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 120.843 0.354 . . . . 0.0 111.601 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.402 ' OD1' ' OG1' ' A' ' 97' ' ' THR . 70.0 m-80 62.99 -81.2 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.191 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.871 ' HE ' HD23 ' A' ' 207' ' ' LEU . 78.6 mtm-85 -74.15 -57.48 3.93 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.849 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -43.21 -45.16 5.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.139 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.053 HD22 HD11 ' A' ' 75' ' ' ILE . 9.8 mt -75.54 -33.42 60.68 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.043 0.449 . . . . 0.0 111.154 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.733 HD11 ' CB ' ' A' ' 105' ' ' ALA . 66.1 tp -69.55 -50.11 48.04 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.115 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.889 HD22 ' CZ ' ' A' ' 231' ' ' TYR . 21.4 mt -68.61 -26.8 65.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.94 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.799 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -65.22 -39.35 92.63 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.645 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.856 ' CB ' HG11 ' A' ' 62' ' ' VAL . . . -81.35 -41.32 22.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.071 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.719 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 14.2 mt -67.32 -3.4 7.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.0 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.56 ' HB2' ' HB3' ' A' ' 231' ' ' TYR . . . -98.51 177.89 5.19 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -177.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.548 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.7 OUTLIER -110.87 112.29 24.02 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.787 178.281 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 114.83 167.11 15.46 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.787 ' HE3' HD12 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -94.89 117.83 30.79 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 117.144 0.472 . . . . 0.0 111.55 -179.097 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 235' ' ' GLY . 0.8 OUTLIER -119.61 146.84 45.17 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.94 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.544 HG22 ' HB2' ' A' ' 74' ' ' GLU . 91.8 t -103.55 142.14 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 CA-C-O 121.77 0.795 . . . . 0.0 112.653 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.986 HD23 HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -117.25 116.3 26.99 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 174.437 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.967 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.6 OUTLIER -105.06 152.41 22.79 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.437 -177.32 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.2 t30 66.57 26.67 9.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.098 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.817 HD21 ' HB3' ' A' ' 41' ' ' LEU . 65.1 mt -55.05 -170.82 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.653 ' HB3' HG21 ' A' ' 50' ' ' VAL . 48.9 tp -114.15 131.71 56.34 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.816 0.341 . . . . 0.0 110.245 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -88.98 87.06 7.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.097 0.475 . . . . 0.0 110.738 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.468 ' HB3' ' OD1' ' A' ' 49' ' ' ASP . 27.8 t -164.14 142.61 7.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.06 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.452 ' OD2' ' HB2' ' A' ' 94' ' ' ASN . 33.9 p-10 -36.71 -29.14 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.946 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 37.6 p-10 -60.58 -42.48 96.77 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.187 0.518 . . . . 0.0 110.365 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.653 HG21 ' HB3' ' A' ' 45' ' ' LEU . 99.3 t -82.13 -46.02 19.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.701 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.92 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -49.28 -39.34 30.45 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.465 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.682 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 11.3 m-70 -78.86 -32.33 45.96 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.197 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.611 ' O ' HD13 ' A' ' 57' ' ' LEU . 8.0 tpt -54.2 -37.43 64.53 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 176.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.92 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.3 OUTLIER -80.58 -43.94 19.79 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.666 176.105 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.718 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 2.0 t30 -58.41 -36.41 73.54 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.01 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 1.002 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -63.52 -44.61 93.78 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 122.034 0.921 . . . . 0.0 108.88 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.876 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -64.95 -40.97 95.82 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.558 -1.655 . . . . 0.0 107.011 177.164 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.718 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.2 m -60.19 -31.69 70.38 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 113.757 -1.565 . . . . 0.0 111.233 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.724 ' C ' HD21 ' A' ' 88' ' ' LEU . . . -79.55 -37.53 36.26 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.024 -179.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.709 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.5 OUTLIER -81.73 -14.45 56.5 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.375 0.607 . . . . 0.0 110.765 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.87 33.32 5.04 Favored Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.292 -0.867 . . . . 0.0 114.47 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.876 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 21.6 t -90.44 118.71 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.844 ' O ' HG12 ' A' ' 76' ' ' ILE . 7.5 t -84.03 136.02 34.2 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 120.944 0.402 . . . . 0.0 110.799 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.926 ' HB3' HG23 ' A' ' 75' ' ' ILE . 35.3 p90 -160.71 170.39 20.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.542 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.411 ' N ' ' O ' ' A' ' 74' ' ' GLU . 83.5 m -133.65 147.89 51.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.491 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.519 HD12 ' HB2' ' A' ' 73' ' ' CYS . 10.5 tp -116.56 136.22 53.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.182 0.515 . . . . 0.0 110.956 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.578 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 1.6 m -61.43 -167.44 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.912 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.42 -31.76 18.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.811 0.339 . . . . 0.0 110.926 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.44 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 0.2 OUTLIER -76.64 1.26 17.44 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.266 179.765 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 56.86 27.84 13.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.752 0.31 . . . . 0.0 111.515 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.44 ' OG1' ' HB3' ' A' ' 69' ' ' ASP . 0.9 OUTLIER -127.25 -11.26 5.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.293 179.716 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.578 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 2.1 mtt85 -111.06 121.42 45.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.325 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.626 ' HB3' HD11 ' A' ' 44' ' ' LEU . 40.4 t -130.8 125.14 32.94 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 112.386 0.514 . . . . 0.0 112.386 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.544 ' HB2' HG22 ' A' ' 40' ' ' VAL . 29.7 tt0 -107.72 131.3 54.57 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 176.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 1.053 HD11 HD22 ' A' ' 29' ' ' LEU . 7.8 mt -127.57 123.22 60.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.844 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -68.53 100.93 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 121.682 0.753 . . . . 0.0 109.16 176.027 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -38.88 144.79 0.23 Allowed Glycine 0 C--N 1.32 -0.351 0 CA-C-N 114.415 -1.266 . . . . 0.0 114.16 -178.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.49 ' CB ' HD12 ' A' ' 82' ' ' LEU . 33.6 t30 -90.45 -11.2 41.06 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 120.962 0.41 . . . . 0.0 110.612 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.548 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 86.56 9.18 75.86 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.435 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.402 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 146.51 -151.12 23.42 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.888 -0.673 . . . . 0.0 111.976 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.548 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 9.3 Cg_endo -50.75 128.67 24.87 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.511 2.141 . . . . 0.0 111.805 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.709 ' HB2' HD13 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -77.68 115.04 17.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.304 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.469 ' HA ' ' CG ' ' A' ' 111' ' ' ASN . 4.5 p80 -83.22 134.83 34.94 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.127 0.489 . . . . 0.0 112.022 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.519 ' CB ' HD11 ' A' ' 113' ' ' ILE . . . -96.48 123.57 40.18 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.863 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -71.71 123.65 23.04 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 176.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.93 178.17 1.01 Allowed Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 -175.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 112' ' ' ASP . . . -73.41 144.87 46.19 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 118.601 1.2 . . . . 0.0 111.342 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.751 ' CB ' HG13 ' A' ' 113' ' ' ILE . 0.9 OUTLIER -112.94 161.08 17.41 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.064 -178.491 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 4.1 mt-10 -143.0 102.8 4.07 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.108 177.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.828 ' HB2' HD23 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -98.29 122.08 41.01 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.779 -178.696 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.641 ' C ' HD13 ' A' ' 92' ' ' LEU . 18.3 m-85 -96.07 96.58 8.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.694 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 1.026 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -114.29 57.93 0.69 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.193 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.827 ' HA3' ' H ' ' A' ' 118' ' ' GLU . . . -59.64 -48.42 86.12 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.145 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.452 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 0.1 OUTLIER -94.87 -2.18 51.23 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.642 0.258 . . . . 0.0 110.687 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 1.026 ' HB3' ' HB3' ' A' ' 92' ' ' LEU . . . -92.63 45.53 1.2 Allowed 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.803 0.335 . . . . 0.0 110.989 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.664 ' O ' ' HD3' ' A' ' 100' ' ' ARG . . . -53.14 -23.26 16.2 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.352 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.751 HG22 ' OE1' ' A' ' 171' ' ' GLN . 15.9 p -88.7 -19.02 26.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.414 0.149 . . . . 0.0 111.037 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.875 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -98.12 -26.83 14.45 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.627 ' SD ' ' HB3' ' A' ' 115' ' ' LEU . 9.8 tpp -63.92 -44.03 94.13 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.712 0.291 . . . . 0.0 111.016 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.784 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 1.1 mpt_? -60.72 -55.74 41.9 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.784 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 23.7 Cg_exo -61.16 -32.14 90.77 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 121.633 1.555 . . . . 0.0 111.411 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 1.002 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -74.62 -53.31 9.59 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.804 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.86 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -51.58 -28.57 14.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.523 0.678 . . . . 0.0 110.236 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.72 ' HB2' ' HB1' ' A' ' 175' ' ' ALA . . . -86.76 -53.85 4.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.807 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.733 ' CB ' HD11 ' A' ' 30' ' ' LEU . . . -59.82 -28.06 67.14 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -176.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.627 ' HB2' HD12 ' A' ' 153' ' ' LEU . 35.2 mt -81.62 -28.16 33.82 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.139 -177.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.754 ' HB2' ' HB1' ' A' ' 138' ' ' ALA . 12.4 p -72.95 12.26 0.55 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.189 0.519 . . . . 0.0 111.085 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.713 ' HG ' HG23 ' A' ' 179' ' ' THR . 1.4 mt -79.81 -76.6 0.21 Allowed 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.083 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.505 ' O ' ' HA3' ' A' ' 155' ' ' GLY . . . -71.78 -117.54 0.05 OUTLIER Glycine 0 N--CA 1.454 -0.146 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.884 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -150.9 96.85 2.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.964 0.411 . . . . 0.0 110.884 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.684 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 18.6 m-80 -149.06 139.37 22.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.273 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.872 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 1.9 m-20 -94.34 96.32 9.46 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.046 0.45 . . . . 0.0 110.126 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.751 HG13 ' CB ' ' A' ' 88' ' ' LEU . 1.4 mp -118.99 144.21 27.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.48 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.814 HG13 HD23 ' A' ' 143' ' ' LEU . 47.8 t -110.05 112.95 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.828 HD23 ' HB2' ' A' ' 90' ' ' LEU . 59.7 mt -101.98 106.67 17.62 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.02 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.838 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.7 OUTLIER -122.66 -172.15 2.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.165 -178.709 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.684 ' H ' HG22 ' A' ' 116' ' ' THR . . . -167.07 179.05 41.01 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.832 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.827 ' H ' ' HA3' ' A' ' 93' ' ' GLY . 8.4 pt-20 -71.16 173.51 4.87 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 123.277 0.631 . . . . 0.0 110.549 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.789 ' HD2' ' HB2' ' A' ' 118' ' ' GLU . 7.6 Cg_endo -47.47 -36.61 24.28 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.699 2.266 . . . . 0.0 113.606 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.479 ' CG ' ' HG3' ' A' ' 118' ' ' GLU . 0.4 OUTLIER -67.37 -25.06 65.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.905 0.383 . . . . 0.0 110.443 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.651 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 8.1 tpt -60.55 -35.53 76.26 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.629 ' HE3' ' HG2' ' A' ' 149' ' ' PRO . 0.1 OUTLIER -62.51 -16.84 57.88 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.995 179.266 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.668 ' O ' ' HG3' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -85.06 -1.85 57.31 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.186 0.517 . . . . 0.0 109.645 178.944 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.662 ' HB3' HH22 ' A' ' 100' ' ' ARG . 1.3 mpt_? -126.12 86.35 58.08 Favored Pre-proline 0 CA--C 1.531 0.25 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.746 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.557 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 17.9 Cg_endo -58.7 148.71 81.32 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.677 2.251 . . . . 0.0 111.696 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.483 ' O ' HG13 ' A' ' 126' ' ' ILE . 0.7 OUTLIER -123.01 -0.13 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.194 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.632 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -53.98 -34.7 52.47 Favored Glycine 0 CA--C 1.516 0.12 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.513 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.503 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 41.6 m-70 -58.5 -40.01 81.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.163 0.506 . . . . 0.0 110.851 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.847 ' HG ' HD11 ' A' ' 133' ' ' LEU . 34.0 tp -75.33 -39.28 59.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.202 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.72 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 54.8 t -56.91 -47.78 82.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.555 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.764 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 77.7 m-20 -71.23 -38.5 71.96 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.472 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.448 ' HA ' HG13 ' A' ' 162' ' ' VAL . . . -60.15 -44.66 94.81 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.534 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.847 HD11 ' HG ' ' A' ' 129' ' ' LEU . 5.7 mt -75.73 -50.27 15.79 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 121.086 0.47 . . . . 0.0 110.66 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.72 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -57.81 -28.3 63.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.055 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.764 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 5.5 tp -67.63 -30.97 70.68 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-O 121.004 0.431 . . . . 0.0 110.312 178.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 159' ' ' GLY . . . -81.4 12.75 37.64 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.892 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.16 3.74 63.33 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.459 -0.876 . . . . 0.0 112.429 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.754 ' HB1' ' HB2' ' A' ' 107' ' ' CYS . . . -73.88 153.87 39.67 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.837 0.351 . . . . 0.0 111.654 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 9.4 mttp -100.85 104.58 15.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.643 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.641 ' CG2' HG13 ' A' ' 130' ' ' VAL . 30.3 mt -136.27 125.23 37.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.954 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.914 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -124.15 139.99 53.4 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.005 0.431 . . . . 0.0 110.554 -179.483 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.52 ' CE1' HG21 ' A' ' 130' ' ' VAL . 43.7 m-85 -79.6 132.07 36.17 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.358 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.814 HD23 HG13 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -96.46 -88.5 0.28 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.795 -179.578 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.722 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 36.0 mt-10 -57.38 -80.98 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.546 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.567 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 15.0 mt-30 -117.77 148.95 41.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.991 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.64 135.22 56.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.951 0.405 . . . . 0.0 110.154 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.632 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 5.6 m-20 65.93 20.05 11.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.293 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.598 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 14.5 m-85 -111.72 169.25 6.53 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 121.202 0.525 . . . . 0.0 111.838 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.96 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 21.8 Cg_exo -31.19 -65.36 0.09 OUTLIER 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 124.385 3.39 . . . . 0.0 116.271 -178.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.96 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 72.3 Cg_exo -50.84 145.95 22.53 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 121.186 1.257 . . . . 0.0 113.305 -178.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.786 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 7.3 mt -156.49 136.64 12.82 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.422 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.914 ' HB2' HG22 ' A' ' 141' ' ' THR . 4.3 mtt180 -106.81 102.25 11.63 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.872 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 9.8 mt -92.53 145.53 24.37 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.909 -178.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.684 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 6.8 mt-30 -148.33 24.98 1.0 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.455 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 55.19 -166.99 2.79 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.53 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.425 ' O ' HG23 ' A' ' 158' ' ' THR . . . 112.6 -14.44 24.84 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.16 -1.019 . . . . 0.0 113.387 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.647 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 4.3 t80 -58.69 122.6 13.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.434 0.617 . . . . 0.0 110.395 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.691 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 82.0 p -115.86 -26.75 7.25 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 121.375 0.607 . . . . 0.0 111.39 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.458 ' O ' ' HA2' ' A' ' 136' ' ' GLY . . . 132.66 -159.62 23.51 Favored Glycine 0 N--CA 1.438 -1.189 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.346 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.559 ' O ' HG23 ' A' ' 187' ' ' THR . . . 104.77 151.99 21.49 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.729 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -46.29 116.36 1.25 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.01 -0.595 . . . . 0.0 110.66 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.76 ' HB ' HG13 ' A' ' 189' ' ' ILE . 79.2 t -108.81 137.94 38.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.693 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.41 119.67 39.49 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.629 -0.429 . . . . 0.0 110.796 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 1.077 HG21 HD11 ' A' ' 176' ' ' LEU . 1.7 t -130.25 119.96 47.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.784 ' HB3' HG23 ' A' ' 168' ' ' VAL . 4.1 t70 -59.56 141.71 54.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.942 0.401 . . . . 0.0 110.797 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.846 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . -63.4 -26.23 69.32 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.219 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.4 t -82.66 -10.86 58.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.673 0.273 . . . . 0.0 111.313 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.784 HG23 ' HB3' ' A' ' 165' ' ' ASP . 26.8 t -61.34 150.98 7.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.287 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.606 ' HB3' ' CD1' ' A' ' 172' ' ' PHE . 2.5 t -50.34 159.26 0.49 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.071 0.463 . . . . 0.0 111.134 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.11 -17.37 60.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.865 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.771 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 0.1 OUTLIER -88.17 -14.72 37.94 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.399 -178.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.813 ' HA ' HD13 ' A' ' 129' ' ' LEU . 8.4 m-85 -72.54 -49.8 30.14 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.472 0.653 . . . . 0.0 109.545 178.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.786 ' HG ' HG11 ' A' ' 164' ' ' VAL . 0.5 OUTLIER -70.46 -43.7 69.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.39 178.926 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.606 HG21 ' HD3' ' A' ' 27' ' ' ARG . 1.5 m -56.79 -34.58 67.79 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.458 178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.755 ' HB3' HD11 ' A' ' 129' ' ' LEU . . . -63.98 -39.78 94.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.493 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 1.077 HD11 HG21 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -77.01 -33.82 57.48 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.496 179.4 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.863 ' O ' ' HE1' ' A' ' 208' ' ' MET . 3.0 mp -59.56 -37.96 79.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.384 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.735 ' HE1' ' HG2' ' A' ' 27' ' ' ARG . 1.9 mtp -82.02 -43.12 18.38 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.47 0.652 . . . . 0.0 112.498 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.713 HG23 ' HG ' ' A' ' 108' ' ' LEU . 100.0 m -72.94 -43.25 62.56 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.792 -1.094 . . . . 0.0 113.077 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.603 ' HB1' ' HB ' ' A' ' 187' ' ' THR . . . -59.33 -38.98 68.87 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -177.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.561 ' HD3' HG21 ' A' ' 225' ' ' VAL . 33.6 Cg_endo -66.29 -28.34 47.42 Favored 'Trans proline' 0 CA--C 1.501 -1.129 0 C-N-CA 120.904 1.069 . . . . 0.0 111.37 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.66 ' HB2' HD21 ' A' ' 108' ' ' LEU . 7.3 mt -84.72 1.82 44.78 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.913 -1.039 . . . . 0.0 109.206 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.612 ' HB1' ' C ' ' A' ' 158' ' ' THR . . . -83.15 135.2 44.86 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.03 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.691 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 10.8 Cg_endo -49.23 -32.12 24.17 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.54 2.16 . . . . 0.0 113.015 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -115.03 140.16 49.28 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.586 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -55.61 145.65 22.85 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.301 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.603 ' HB ' ' HB1' ' A' ' 180' ' ' ALA . 86.3 m -122.39 144.0 49.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.231 0.539 . . . . 0.0 112.335 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.698 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 50.3 t -125.11 118.18 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 176.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.841 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 4.9 mp -101.56 117.47 46.9 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.93 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.596 ' HB2' ' HG3' ' A' ' 222' ' ' GLN . 0.2 OUTLIER -100.43 124.19 45.61 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.103 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.846 HG23 ' HA2' ' A' ' 166' ' ' GLY . 1.6 mp -93.52 123.33 45.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.96 -176.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.418 ' CG ' ' HA ' ' A' ' 165' ' ' ASP . 38.0 mttt -80.08 97.23 6.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.002 -1.454 . . . . 0.0 110.47 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 98.39 -133.92 11.51 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.171 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.07 125.73 52.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.225 0.536 . . . . 0.0 111.719 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.634 HD11 ' HZ ' ' A' ' 223' ' ' PHE . 1.9 mt -41.84 145.66 0.31 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.55 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 8.0 p -70.57 -29.12 37.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.725 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.465 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 28.6 t -168.16 65.49 0.07 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.98 0.419 . . . . 0.0 110.737 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.678 ' N ' ' HD2' ' A' ' 199' ' ' PRO . 2.5 tmpt? -37.26 -47.46 2.07 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.806 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.678 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 4.8 Cg_endo -47.31 -34.06 17.78 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.376 2.051 . . . . 0.0 111.434 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.955 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.2 OUTLIER -67.11 -43.49 82.34 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.685 0.755 . . . . 0.0 109.065 178.072 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.752 HG21 ' HE2' ' A' ' 223' ' ' PHE . 27.8 mm -64.44 -32.46 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.921 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.74 -41.94 95.56 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.796 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.955 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.4 mt -61.47 -50.14 81.57 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 CA-C-O 121.701 0.762 . . . . 0.0 109.41 178.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.633 HG22 ' SD ' ' A' ' 208' ' ' MET . 100.0 m -53.71 -52.32 60.45 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.119 -178.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.938 HD22 ' HB ' ' A' ' 215' ' ' ILE . 44.6 mt -65.99 -30.79 71.4 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.109 0.481 . . . . 0.0 111.56 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -77.2 -46.71 22.4 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.772 0.796 . . . . 0.0 109.715 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.871 HD23 ' HE ' ' A' ' 27' ' ' ARG . 3.3 tp -70.34 -29.55 66.28 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.242 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' MET . . . . . 0.863 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 49.8 mtp -73.85 -34.14 64.39 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.591 0.71 . . . . 0.0 109.194 177.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.76 ' HE2' ' O ' ' A' ' 205' ' ' LEU . 5.1 mtmm -61.59 -40.17 93.82 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.236 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.866 HG22 ' O ' ' A' ' 207' ' ' LEU . 4.7 t -60.52 -28.35 68.33 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.069 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.716 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 49.5 m-85 -80.25 -7.67 59.11 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.519 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.7 7.64 25.47 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 115.503 0.961 . . . . 0.0 115.503 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.696 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 5.3 m -123.42 148.83 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 118.775 1.287 . . . . 0.0 112.811 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.589 ' HG2' ' CG ' ' A' ' 209' ' ' LYS . 4.7 mt-10 -130.22 138.19 50.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.818 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.976 HD12 ' HB ' ' A' ' 225' ' ' VAL . 22.1 mm -122.41 147.74 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-O 120.836 0.35 . . . . 0.0 110.236 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.708 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 20.5 tt0 -103.63 115.86 31.29 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.774 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.51 149.44 27.54 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.588 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' GLN . . . . . 0.744 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -108.07 -144.86 0.39 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.597 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 8.1 m-70 -72.66 65.3 0.68 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.917 0.389 . . . . 0.0 111.523 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 1.7 t80 56.52 32.73 21.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.838 0.827 . . . . 0.0 110.609 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.662 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 9.1 pt20 -159.78 -126.22 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.841 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.4 OUTLIER -10.11 134.98 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 115.024 1.491 . . . . 0.0 115.024 -179.671 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.752 ' HE2' HG21 ' A' ' 201' ' ' ILE . 0.9 OUTLIER -126.31 138.24 53.57 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 113.032 -1.894 . . . . 0.0 110.139 -179.518 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.708 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 36.9 t -118.24 114.19 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.976 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.5 OUTLIER -122.4 120.39 60.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.806 -178.945 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.611 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -74.65 122.74 23.66 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.517 179.232 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -74.39 -173.39 29.78 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.251 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 62.23 19.65 59.78 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 121.401 -0.428 . . . . 0.0 113.158 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' GLN . . . . . 0.611 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 47.1 mt-30 -75.52 -171.96 1.67 Allowed 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.347 0.594 . . . . 0.0 111.006 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 23.3 t -155.55 147.45 23.32 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.133 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' TYR . . . . . 0.889 ' CZ ' HD22 ' A' ' 31' ' ' LEU . 2.2 m-30 -102.01 134.97 44.38 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.7 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.427 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 2.6 mt-30 -126.21 145.55 50.34 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.428 ' HB2' ' OG1' ' A' ' 39' ' ' THR . 25.0 p -72.39 109.42 5.88 Favored Pre-proline 0 N--CA 1.445 -0.685 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.7 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.515 ' HG3' HG23 ' A' ' 210' ' ' THR . 43.5 Cg_endo -66.75 0.1 3.98 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.865 1.71 . . . . 0.0 112.185 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 101.38 -102.55 2.41 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.498 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 90.0 m -117.3 132.86 56.52 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.637 ' CD2' HG21 ' A' ' 210' ' ' THR . 6.5 t80 -132.64 127.42 34.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.129 0.49 . . . . 0.0 111.696 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.967 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -90.16 113.0 24.69 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.396 179.391 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.672 ' N ' HD22 ' A' ' 238' ' ' LEU . 21.2 t -85.78 111.38 20.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.622 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.447 ' HG2' HD11 ' A' ' 238' ' ' LEU . 32.5 mt-10 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.235 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.9 ' HB3' HD22 ' A' ' 44' ' ' LEU . 88.4 p . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.726 0.298 . . . . 0.0 111.222 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 59.63 -95.21 0.05 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.816 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.577 ' HE ' HD23 ' A' ' 207' ' ' LEU . 16.4 mtm-85 -76.43 -56.05 4.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.823 0.344 . . . . 0.0 110.989 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.761 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -35.55 -47.97 0.48 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.643 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.031 HD22 HD11 ' A' ' 75' ' ' ILE . 9.8 mt -73.48 -34.44 65.33 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.872 0.368 . . . . 0.0 111.433 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.819 HD22 ' HB2' ' A' ' 101' ' ' PRO . 54.3 tp -68.46 -50.1 54.98 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.732 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.713 HD13 ' HA ' ' A' ' 208' ' ' MET . 49.0 mt -68.23 -26.71 65.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.583 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.779 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -65.63 -38.27 88.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.552 178.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.714 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . . . -81.26 -41.53 22.05 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.996 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.803 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 9.9 mt -68.93 -2.91 10.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.279 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.538 ' HA ' ' CB ' ' A' ' 231' ' ' TYR . . . -100.13 179.26 4.54 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -176.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.582 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.3 OUTLIER -112.59 113.83 26.17 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.012 178.615 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.11 166.85 16.68 Favored Glycine 0 C--N 1.322 -0.243 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.321 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.616 ' HG3' HD13 ' A' ' 76' ' ' ILE . 1.1 ttmt -95.37 117.68 30.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 117.155 0.478 . . . . 0.0 111.59 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.585 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 0.8 OUTLIER -117.73 148.59 41.87 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.387 179.59 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.515 HG22 ' HB2' ' A' ' 74' ' ' GLU . 92.4 t -105.47 141.27 21.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.144 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.931 HD23 HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -114.8 116.27 28.34 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 174.855 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.984 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.5 OUTLIER -102.84 151.67 22.16 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.869 0.366 . . . . 0.0 111.437 -177.48 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 64.97 28.29 12.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.844 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.9 HD22 ' HB3' ' A' ' 25' ' ' SER . 91.4 mt -53.55 -174.26 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.195 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.528 ' HB3' HG21 ' A' ' 50' ' ' VAL . 56.6 tp -113.19 131.42 55.88 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -88.89 88.76 7.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.98 0.419 . . . . 0.0 110.323 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 50' ' ' VAL . 6.2 m -164.76 143.15 6.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.116 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.406 ' HA ' ' HB3' ' A' ' 51' ' ' ARG . 1.2 m-20 -36.34 -30.95 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 O-C-N 123.046 0.216 . . . . 0.0 111.575 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.858 ' OD1' HG23 ' A' ' 50' ' ' VAL . 1.4 p30 -57.78 -42.57 84.39 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-O 121.103 0.478 . . . . 0.0 110.617 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.858 HG23 ' OD1' ' A' ' 49' ' ' ASP . 74.6 t -83.91 -44.44 18.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.115 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.876 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -50.21 -39.18 43.44 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.803 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.618 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 9.6 m-70 -80.39 -32.43 37.58 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.771 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.526 ' O ' HD13 ' A' ' 57' ' ' LEU . 8.4 tpt -54.79 -34.64 62.92 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 176.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.876 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -83.49 -44.06 15.12 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.902 176.34 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.686 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 1.7 t30 -59.23 -37.8 78.43 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.816 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 1.054 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -62.15 -47.78 83.03 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.868 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.2 OUTLIER -61.42 -40.95 96.32 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.161 -1.382 . . . . 0.0 107.556 177.001 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.686 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.1 m -59.31 -33.93 71.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.056 -1.429 . . . . 0.0 111.417 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.734 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -78.34 -38.39 42.19 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.318 -178.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.714 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.6 OUTLIER -79.49 -14.37 58.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.42 0.629 . . . . 0.0 110.531 -179.626 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.77 35.78 4.48 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 114.938 -1.028 . . . . 0.0 113.854 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.868 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 25.0 t -90.41 121.29 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.782 ' O ' HG12 ' A' ' 76' ' ' ILE . 6.8 t -86.06 135.67 33.53 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.143 0.497 . . . . 0.0 111.148 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.8 ' HB3' HG23 ' A' ' 75' ' ' ILE . 36.0 p90 -161.99 172.29 16.22 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.324 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.9 m -134.66 147.32 50.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.321 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.552 HD21 ' HA ' ' A' ' 70' ' ' ARG . 5.5 tp -117.79 138.28 52.17 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.163 0.506 . . . . 0.0 110.852 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.525 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 1.1 m -63.88 -164.51 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.94 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -93.18 -34.04 13.76 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.438 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.52 1.06 15.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.661 0.267 . . . . 0.0 111.276 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.552 ' HA ' HD21 ' A' ' 66' ' ' LEU . 0.3 OUTLIER 57.6 39.86 27.25 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.943 0.402 . . . . 0.0 111.059 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.502 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 1.1 p -139.18 -10.52 1.27 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.441 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.525 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 7.6 mtt180 -114.16 117.67 31.85 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.778 ' HB3' HD11 ' A' ' 44' ' ' LEU . 13.9 t -130.08 128.91 42.86 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.585 ' HA ' ' O ' ' A' ' 39' ' ' THR . 29.0 tt0 -112.11 128.95 56.36 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 176.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 1.031 HD11 HD22 ' A' ' 29' ' ' LEU . 16.2 mt -124.22 123.35 66.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -178.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.782 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -68.73 97.92 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-O 121.427 0.632 . . . . 0.0 109.664 175.833 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 35' ' ' ALA . . . -37.82 144.25 0.19 Allowed Glycine 0 C--N 1.322 -0.237 0 CA-C-N 114.804 -1.089 . . . . 0.0 113.974 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.17 -10.87 42.89 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.957 0.408 . . . . 0.0 110.91 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.582 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 93.36 -1.35 69.49 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.921 -0.582 . . . . 0.0 112.6 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.551 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 154.69 -145.96 13.58 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.172 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.599 ' HG3' ' HB3' ' A' ' 108' ' ' LEU . 53.7 Cg_exo -49.8 124.84 13.12 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.74 2.293 . . . . 0.0 112.718 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.714 ' HB2' HD13 ' A' ' 60' ' ' LEU . 0.9 OUTLIER -77.25 106.38 8.94 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.637 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -81.92 138.77 34.94 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.519 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.617 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -100.38 126.96 46.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.955 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.77 123.69 22.53 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 176.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.62 174.2 0.76 Allowed Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 -175.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.84 144.69 47.37 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 118.588 1.194 . . . . 0.0 111.556 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.734 HD21 ' HB1' ' A' ' 59' ' ' ALA . 1.2 tp -116.43 160.43 20.57 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.224 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 2.3 mt-10 -138.77 102.99 4.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.078 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.665 ' HB2' HD23 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -98.77 120.85 39.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.152 -178.716 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.451 ' CE1' ' HB ' ' A' ' 116' ' ' THR . 0.2 OUTLIER -94.1 96.67 9.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.572 179.217 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.613 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -104.35 56.7 0.71 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.952 -179.822 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.629 ' CA ' ' H ' ' A' ' 118' ' ' GLU . . . -62.92 -70.01 1.16 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.017 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 3.3 m-80 -76.04 18.47 0.27 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.356 -0.238 . . . . 0.0 110.356 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.732 ' HA ' ' HB3' ' A' ' 49' ' ' ASP . . . -93.59 -70.62 0.69 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.38 -66.82 0.25 Allowed Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.093 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.483 ' HA ' ' HG2' ' A' ' 171' ' ' GLN . 8.4 p -71.88 -8.15 52.66 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.728 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -99.65 -34.46 10.2 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.577 0.227 . . . . 0.0 111.468 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.7 -45.58 89.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.755 0.312 . . . . 0.0 110.193 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.838 ' HE ' HD12 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -52.73 -60.88 5.55 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.142 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.819 ' HB2' HD22 ' A' ' 30' ' ' LEU . 19.5 Cg_endo -60.13 -30.61 91.78 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.342 2.028 . . . . 0.0 112.646 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 1.054 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -75.91 -53.31 8.61 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.159 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.9 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -49.45 -27.98 4.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.227 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.934 ' HB2' ' HB1' ' A' ' 175' ' ' ALA . . . -87.1 -54.1 4.5 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.787 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.636 ' HB1' HD11 ' A' ' 34' ' ' LEU . . . -60.6 -31.19 70.37 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -177.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.717 HD13 HG13 ' A' ' 113' ' ' ILE . 30.3 mt -79.27 -21.61 45.85 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.509 -177.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.752 ' SG ' HD22 ' A' ' 153' ' ' LEU . 89.8 m -82.18 17.94 1.52 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.198 0.523 . . . . 0.0 111.186 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.761 HD21 ' HB2' ' A' ' 182' ' ' LEU . 2.8 mt -81.23 -77.0 0.22 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.275 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.14 -109.0 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.392 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 m -156.79 96.69 1.64 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.08 0.467 . . . . 0.0 111.108 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.518 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 37.8 p-10 -147.0 139.19 24.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.174 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.886 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 2.5 m-20 -90.87 101.0 13.76 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.771 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.717 HG13 HD13 ' A' ' 106' ' ' LEU . 28.7 mm -120.81 137.59 54.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.574 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.813 HG13 ' CD2' ' A' ' 143' ' ' LEU . 58.0 t -110.22 112.29 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 175.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.665 HD23 ' HB2' ' A' ' 90' ' ' LEU . 24.9 mt -102.27 107.09 18.01 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.608 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.764 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.7 OUTLIER -117.38 -173.91 2.51 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.087 -179.085 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.661 ' H ' HG22 ' A' ' 116' ' ' THR . . . -163.14 -174.54 33.16 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.921 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.629 ' H ' ' CA ' ' A' ' 93' ' ' GLY . 15.1 mt-10 -76.77 172.7 8.95 Favored Pre-proline 0 C--N 1.328 -0.352 0 C-N-CA 122.853 0.461 . . . . 0.0 110.582 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.576 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 87.4 Cg_exo -47.52 -38.6 28.2 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.448 2.099 . . . . 0.0 112.488 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 38.8 mtm180 -69.25 -23.19 63.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.962 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.714 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 11.0 tpt -60.69 -31.86 71.11 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -16.88 63.27 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.768 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 120' ' ' ARG . 3.4 mm-40 -82.56 -0.54 47.3 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.775 0.321 . . . . 0.0 110.534 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.416 ' O ' ' NH2' ' A' ' 100' ' ' ARG . 3.5 mtp85 -127.44 87.1 57.03 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.892 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.465 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 18.4 Cg_endo -59.51 148.81 85.5 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.519 2.146 . . . . 0.0 111.399 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.838 HD12 ' HE ' ' A' ' 100' ' ' ARG . 0.6 OUTLIER -120.48 6.08 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.908 0.385 . . . . 0.0 111.947 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.636 ' HA3' ' OD1' ' A' ' 147' ' ' ASN . . . -55.55 -44.14 85.74 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.94 -0.648 . . . . 0.0 114.179 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.482 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 60.0 m-70 -55.63 -36.26 66.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 117.442 0.621 . . . . 0.0 110.06 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.806 HD11 ' HB3' ' A' ' 175' ' ' ALA . 21.5 tp -75.85 -43.27 46.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.143 0.497 . . . . 0.0 110.162 178.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.779 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 40.5 t -56.4 -47.78 80.94 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.385 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.725 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 0.1 OUTLIER -70.95 -36.23 72.49 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.405 -179.702 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.548 ' HB1' ' CG1' ' A' ' 162' ' ' VAL . . . -61.65 -50.27 73.21 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.803 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.728 HD11 ' HG ' ' A' ' 129' ' ' LEU . 9.7 mt -70.74 -48.0 56.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.933 178.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.779 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -59.22 -27.38 65.69 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.72 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.725 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.5 OUTLIER -68.47 -31.72 71.22 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.966 0.412 . . . . 0.0 110.759 178.873 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.559 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -83.84 14.71 41.24 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.894 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.69 3.87 62.3 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.589 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.667 ' HB1' ' HB3' ' A' ' 107' ' ' CYS . . . -71.9 150.45 44.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.884 0.373 . . . . 0.0 111.298 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 0.5 OUTLIER -98.88 102.97 14.87 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.122 178.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.596 HG21 HG22 ' A' ' 130' ' ' VAL . 8.8 mt -134.77 126.93 48.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.264 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.729 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -124.35 139.44 53.9 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.204 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.588 ' CE1' HG11 ' A' ' 130' ' ' VAL . 33.6 m-85 -79.03 130.04 35.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.121 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.883 HD11 ' HG3' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -91.72 -89.04 0.18 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.542 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.636 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 6.3 mm-40 -59.67 -81.19 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.529 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.452 ' O ' ' HB2' ' A' ' 148' ' ' TYR . 18.5 mt-30 -113.91 151.49 32.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.128 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -67.25 137.52 56.21 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.636 ' OD1' ' HA3' ' A' ' 127' ' ' GLY . 7.9 m-80 65.55 19.13 11.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.138 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.522 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 8.2 m-85 -110.14 168.88 7.0 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-O 121.105 0.479 . . . . 0.0 112.167 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.915 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 37.8 Cg_exo -32.49 -62.27 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 124.409 3.406 . . . . 0.0 116.087 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.915 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 66.6 Cg_exo -54.86 145.26 62.71 Favored 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-N 120.515 1.219 . . . . 0.0 112.747 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.797 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 12.3 mt -156.17 133.97 11.1 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.602 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.883 ' HG3' HD11 ' A' ' 143' ' ' LEU . 3.2 mtt180 -105.74 102.68 12.11 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 176.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.9 HD11 ' HA ' ' A' ' 103' ' ' ALA . 10.0 mt -91.73 147.97 22.59 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.941 -178.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.579 ' HG3' ' O ' ' A' ' 153' ' ' LEU . 3.5 mt-30 -148.73 27.48 0.89 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.352 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 51.73 -175.61 0.12 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.162 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.426 ' O ' HG23 ' A' ' 158' ' ' THR . . . 121.46 -11.81 9.65 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.182 -1.009 . . . . 0.0 112.817 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.823 ' HE2' ' HA ' ' A' ' 180' ' ' ALA . 50.8 t80 -59.78 123.14 16.05 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.006 0.403 . . . . 0.0 110.832 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.697 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 81.4 p -118.38 -28.43 5.75 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.301 0.572 . . . . 0.0 111.682 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.493 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 134.35 -161.73 24.47 Favored Glycine 0 C--N 1.308 -1.02 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.503 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.59 ' O ' HG23 ' A' ' 187' ' ' THR . . . 105.21 153.3 21.68 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.351 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -47.09 119.39 2.54 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.292 -0.454 . . . . 0.0 111.077 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.662 ' HB ' HG13 ' A' ' 189' ' ' ILE . 78.7 t -111.28 134.96 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.48 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.44 119.65 39.46 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.269 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.789 HG21 HD11 ' A' ' 176' ' ' LEU . 1.0 OUTLIER -131.14 120.13 46.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.05 0.453 . . . . 0.0 110.424 179.453 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.482 ' HB2' HG21 ' A' ' 168' ' ' VAL . 1.9 m-20 -52.18 137.43 28.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.466 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.854 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . -61.83 -48.47 83.66 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.962 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.3 m -88.64 87.97 7.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.968 0.413 . . . . 0.0 110.365 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.617 ' H ' ' HB ' ' A' ' 196' ' ' VAL . 46.5 t -147.41 -105.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.964 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.709 ' HB2' ' CD1' ' A' ' 172' ' ' PHE . 40.7 m -141.98 128.41 20.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.942 0.401 . . . . 0.0 110.076 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.75 ' HB3' ' HB3' ' A' ' 197' ' ' SER . 53.3 p -55.5 -19.21 8.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.245 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.688 ' HB3' ' CB ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -86.53 -10.15 54.66 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.28 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.709 ' CD1' ' HB2' ' A' ' 169' ' ' SER . 3.6 m-85 -75.02 -53.0 9.68 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.861 HD11 ' CG1' ' A' ' 191' ' ' ILE . 0.9 OUTLIER -65.9 -39.97 91.09 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.112 178.409 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.509 HG23 ' CG2' ' A' ' 204' ' ' THR . 1.8 m -60.15 -32.24 70.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.354 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.934 ' HB1' ' HB2' ' A' ' 104' ' ' ALA . . . -66.81 -41.48 87.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.44 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.795 HD12 ' HA ' ' A' ' 173' ' ' LEU . 0.2 OUTLIER -76.31 -35.42 58.83 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.794 -179.809 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.824 HD11 ' CD2' ' A' ' 223' ' ' PHE . 4.1 mp -59.59 -36.82 77.01 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.514 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.566 ' HA ' ' HE1' ' A' ' 208' ' ' MET . 2.6 mtp -81.88 -45.35 15.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.559 0.695 . . . . 0.0 112.219 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.67 HG23 ' HG ' ' A' ' 108' ' ' LEU . 93.0 m -70.9 -42.04 70.5 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.739 -1.119 . . . . 0.0 112.596 -178.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.823 ' HA ' ' HE2' ' A' ' 157' ' ' PHE . . . -59.86 -41.62 86.43 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.577 ' HD3' ' O ' ' A' ' 177' ' ' LEU . 17.9 Cg_endo -63.88 -30.07 67.65 Favored 'Trans proline' 0 CA--C 1.502 -1.122 0 C-N-CA 120.822 1.015 . . . . 0.0 111.321 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.761 ' HB2' HD21 ' A' ' 108' ' ' LEU . 10.8 mt -84.5 2.9 38.91 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.701 178.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.645 ' HB1' ' C ' ' A' ' 158' ' ' THR . . . -84.74 135.94 39.78 Favored Pre-proline 0 N--CA 1.454 -0.237 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.697 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 14.2 Cg_endo -52.51 -29.7 41.33 Favored 'Trans proline' 0 CA--C 1.518 -0.316 0 C-N-CA 122.523 2.149 . . . . 0.0 112.95 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.5 138.37 50.69 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.587 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -55.94 142.9 33.91 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.353 -0.385 . . . . 0.0 109.99 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 160' ' ' GLY . 88.8 m -120.89 147.45 45.4 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.871 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.671 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 55.1 t -128.26 117.84 46.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 176.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.819 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 5.2 mp -99.82 117.7 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.906 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.586 ' HB2' ' HG3' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -100.63 123.63 45.1 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.861 ' CG1' HD11 ' A' ' 173' ' ' LEU . 1.5 mp -93.77 121.16 44.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.454 -176.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.413 ' HD2' ' CG ' ' A' ' 165' ' ' ASP . 58.4 mttt -79.08 96.95 5.95 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.824 -1.534 . . . . 0.0 110.648 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 100.24 -132.73 11.04 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.958 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -114.09 127.52 55.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.051 0.453 . . . . 0.0 111.267 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.862 HD11 ' HZ ' ' A' ' 223' ' ' PHE . 1.1 mt -42.33 145.22 0.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.917 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.617 ' HB ' ' H ' ' A' ' 168' ' ' VAL . 12.9 p -71.61 -29.92 36.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.346 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.75 ' HB3' ' HB3' ' A' ' 170' ' ' SER . 5.9 t -164.92 62.15 0.13 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.84 0.352 . . . . 0.0 111.174 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.651 ' N ' ' HD2' ' A' ' 199' ' ' PRO . 13.5 tptp -36.45 -49.08 1.8 Allowed Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.571 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.651 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 6.3 Cg_endo -48.0 -34.69 23.56 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.097 1.864 . . . . 0.0 112.178 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.981 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.2 OUTLIER -68.34 -44.82 74.46 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.551 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.537 HG21 ' HE2' ' A' ' 223' ' ' PHE . 19.2 mm -59.84 -35.68 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.194 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.6 -41.53 97.58 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.014 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.981 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.1 mt -63.98 -49.27 82.38 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.915 0 CA-C-O 121.711 0.767 . . . . 0.0 109.233 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.52 HG22 ' SD ' ' A' ' 208' ' ' MET . 88.5 m -53.6 -51.19 63.82 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.933 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.902 HD22 ' HB ' ' A' ' 215' ' ' ILE . 33.4 mt -65.24 -32.7 74.5 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 120.541 -0.464 . . . . 0.0 111.465 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -76.89 -46.04 25.9 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.717 0.77 . . . . 0.0 109.414 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.938 ' O ' HG22 ' A' ' 210' ' ' THR . 4.4 tp -67.41 -33.28 74.84 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.595 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' MET . . . . . 0.754 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 42.9 mtp -74.99 -33.89 61.91 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.62 0.724 . . . . 0.0 109.232 177.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.654 ' HE2' ' O ' ' A' ' 205' ' ' LEU . 4.5 mtmt -61.35 -39.05 89.16 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.667 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.938 HG22 ' O ' ' A' ' 207' ' ' LEU . 5.8 t -61.93 -27.21 68.66 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.422 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.653 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 57.0 m-85 -84.07 -6.74 59.46 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.627 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.97 6.87 25.87 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 116.282 1.273 . . . . 0.0 116.282 177.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.597 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.6 m -123.17 148.41 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 118.973 1.387 . . . . 0.0 112.198 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.557 ' O ' HD13 ' A' ' 215' ' ' ILE . 10.9 mt-10 -130.06 141.69 50.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.972 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.919 HD12 ' HB ' ' A' ' 225' ' ' VAL . 21.1 mm -123.7 148.33 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-O 120.851 0.358 . . . . 0.0 110.502 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.66 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 1.5 tt0 -102.87 118.52 37.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.918 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.01 150.8 26.13 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.601 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' GLN . . . . . 0.66 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 9.8 mm-40 -109.48 -142.44 0.38 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 121.203 -0.199 . . . . 0.0 110.615 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.577 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 0.3 OUTLIER -75.02 65.91 1.52 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.88 0.371 . . . . 0.0 111.632 -179.023 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 4.0 t80 55.56 37.53 29.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.929 0.871 . . . . 0.0 110.598 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.67 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 12.6 pt20 -167.1 -125.29 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.819 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -9.0 133.62 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 179.783 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.862 ' HZ ' HD11 ' A' ' 195' ' ' LEU . 0.6 OUTLIER -124.84 138.55 54.26 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 112.975 -1.921 . . . . 0.0 109.853 -179.082 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.66 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 27.0 t -119.47 113.9 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-O 121.319 0.58 . . . . 0.0 109.506 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.919 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.5 OUTLIER -120.94 121.12 64.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.034 -179.197 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.558 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 2.7 mptp? -75.63 118.99 19.06 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -69.1 -174.58 10.37 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.046 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 62.36 21.31 62.03 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 121.226 -0.511 . . . . 0.0 113.076 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' GLN . . . . . 0.558 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 8.1 mm100 -68.11 -166.2 0.06 Allowed 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.434 0.635 . . . . 0.0 111.157 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 75.0 m -158.02 147.28 19.57 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.602 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' TYR . . . . . 0.803 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 3.8 m-30 -111.09 127.97 55.73 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.59 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.97 150.78 41.56 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 60.4 p -76.33 110.91 12.66 Favored Pre-proline 0 N--CA 1.442 -0.835 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.822 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.459 ' HB3' ' O ' ' A' ' 210' ' ' THR . 36.5 Cg_endo -65.94 -2.75 7.14 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.044 1.829 . . . . 0.0 112.29 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 99.81 -103.13 2.63 Favored Glycine 0 C--O 1.225 -0.442 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 73.0 m -115.46 133.93 55.57 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.678 ' CD2' HG21 ' A' ' 210' ' ' THR . 8.3 t80 -132.62 126.95 33.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.959 0.409 . . . . 0.0 111.405 -178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.984 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -90.82 110.53 21.74 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.597 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.566 ' N ' HD22 ' A' ' 238' ' ' LEU . 21.8 t -83.63 113.0 21.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.094 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.409 ' HG2' ' CD1' ' A' ' 238' ' ' LEU . 11.3 mt-10 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.253 -0.879 . . . . 0.0 111.245 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.866 ' HB2' HD22 ' A' ' 44' ' ' LEU . 7.6 t . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 120.868 0.366 . . . . 0.0 111.282 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 63.07 -80.87 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.303 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.761 ' HD3' HG21 ' A' ' 174' ' ' THR . 78.1 mtm180 -74.37 -57.99 3.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.095 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.777 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -43.12 -48.54 6.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.737 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.053 HD22 HD11 ' A' ' 75' ' ' ILE . 11.3 mt -72.09 -32.42 67.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.898 0.38 . . . . 0.0 111.371 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.877 HD22 ' HB2' ' A' ' 101' ' ' PRO . 53.2 tp -68.66 -50.18 53.17 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.355 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.768 HD22 ' CZ ' ' A' ' 231' ' ' TYR . 33.4 mt -68.16 -26.43 65.75 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.77 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.752 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -65.84 -39.52 90.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.302 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.804 ' CB ' HG11 ' A' ' 62' ' ' VAL . . . -81.44 -41.24 22.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.269 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.659 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 13.3 mt -67.72 -4.57 12.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.245 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.535 ' HA ' ' CB ' ' A' ' 231' ' ' TYR . . . -94.58 177.51 5.9 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.651 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.1 OUTLIER -117.48 114.89 24.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.623 178.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.626 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 128.51 -142.84 13.91 Favored Glycine 0 C--O 1.224 -0.508 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.025 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.678 ' HG3' HG23 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -136.66 117.47 14.1 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.186 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 235' ' ' GLY . 0.8 OUTLIER -128.68 145.79 51.06 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.541 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.637 HG22 ' HB2' ' A' ' 74' ' ' GLU . 78.3 t -109.3 143.58 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 CA-C-O 121.51 0.671 . . . . 0.0 112.312 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.881 ' HB3' HD21 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -115.84 116.3 27.77 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 174.704 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.898 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.5 OUTLIER -103.53 151.57 22.72 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.863 0.364 . . . . 0.0 111.277 -177.812 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.426 ' HB2' HD23 ' A' ' 238' ' ' LEU . 7.2 t30 65.78 26.37 11.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.044 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.881 HD21 ' HB3' ' A' ' 41' ' ' LEU . 84.6 mt -54.6 -172.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.832 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.554 ' HB3' HG21 ' A' ' 50' ' ' VAL . 61.9 tp -112.94 131.59 55.68 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.384 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -89.39 86.96 6.92 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.965 0.412 . . . . 0.0 110.153 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 49' ' ' ASP . 4.0 m -165.09 143.37 6.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.462 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 47' ' ' SER . 34.6 m-20 -34.71 -31.64 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.714 0.292 . . . . 0.0 111.721 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.868 ' OD1' HG23 ' A' ' 50' ' ' VAL . 2.0 p30 -57.91 -42.2 84.26 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.066 0.46 . . . . 0.0 110.848 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.868 HG23 ' OD1' ' A' ' 49' ' ' ASP . 92.9 t -84.47 -45.1 17.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.859 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -48.34 -39.67 22.79 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.636 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.636 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 33.9 m170 -80.15 -32.17 38.9 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.021 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.586 ' O ' HD13 ' A' ' 57' ' ' LEU . 9.4 tpt -55.55 -35.31 65.58 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.859 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -81.93 -44.2 17.08 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.102 -1.408 . . . . 0.0 108.694 176.149 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.722 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 4.7 t-20 -58.8 -35.59 73.09 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.742 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 1.024 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -63.04 -46.8 85.84 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.833 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.4 OUTLIER -63.96 -39.37 93.99 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.758 -1.565 . . . . 0.0 107.752 177.276 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.722 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -59.27 -41.0 87.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.154 178.793 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.632 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -71.21 -38.51 72.04 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.139 -178.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.673 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.6 OUTLIER -78.83 -16.23 57.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.241 0.543 . . . . 0.0 110.834 -179.69 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.82 35.22 4.37 Favored Glycine 0 C--N 1.319 -0.369 0 CA-C-N 115.272 -0.876 . . . . 0.0 114.372 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.833 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 39.7 t -90.56 120.5 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.813 ' O ' HG12 ' A' ' 76' ' ' ILE . 27.1 m -83.26 127.43 33.64 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.538 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.912 ' HB3' HG23 ' A' ' 75' ' ' ILE . 42.7 p90 -155.84 172.17 18.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.848 0.356 . . . . 0.0 110.266 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 87.0 m -133.94 148.91 51.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.221 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.419 HD12 ' HB2' ' A' ' 73' ' ' CYS . 14.0 tp -117.05 135.85 53.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.969 0.414 . . . . 0.0 110.4 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.467 ' HB3' ' CB ' ' A' ' 72' ' ' ARG . 33.8 p -61.71 -172.19 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.382 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.89 -43.53 19.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.189 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.36 0.54 11.86 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.555 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.1 mtp85 59.54 46.74 11.7 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.069 0.462 . . . . 0.0 110.956 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.521 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -141.24 -14.91 0.87 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.973 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 8.6 mtp180 -113.94 116.74 29.73 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.643 ' HB3' HD11 ' A' ' 44' ' ' LEU . 28.9 t -124.89 123.18 39.36 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.637 ' HB2' HG22 ' A' ' 40' ' ' VAL . 34.3 tt0 -104.37 134.36 47.71 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 176.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 1.053 HD11 HD22 ' A' ' 29' ' ' LEU . 8.1 mt -131.32 122.21 50.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -177.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.813 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -67.89 98.63 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.695 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -35.68 140.81 0.18 Allowed Glycine 0 CA--C 1.518 0.219 0 CA-C-N 115.232 -0.895 . . . . 0.0 114.02 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.82 -11.43 50.91 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.101 0.477 . . . . 0.0 110.786 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.651 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 90.73 -1.01 77.8 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.205 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.578 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 154.34 -150.02 21.52 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.542 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 87.3 Cg_exo -49.32 121.54 7.16 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.759 2.306 . . . . 0.0 112.639 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.673 ' HB2' HD13 ' A' ' 60' ' ' LEU . 0.7 OUTLIER -70.71 112.12 6.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.726 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.506 ' HA ' ' ND2' ' A' ' 111' ' ' ASN . 4.9 p80 -82.93 136.14 34.66 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.705 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -97.9 123.64 41.97 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.762 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -70.92 123.44 22.01 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 176.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.27 177.14 1.01 Allowed Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 108.692 -1.763 . . . . 0.0 108.692 -175.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.97 144.3 47.31 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 118.738 1.269 . . . . 0.0 111.085 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.632 HD21 ' HB1' ' A' ' 59' ' ' ALA . 1.0 OUTLIER -115.77 160.41 20.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.179 -178.829 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 9.9 mt-10 -139.71 103.85 4.77 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.86 178.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.734 ' HB2' HD23 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -97.19 122.73 40.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.884 0.373 . . . . 0.0 110.928 -178.531 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -95.47 96.31 9.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.817 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.968 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.2 OUTLIER -107.29 46.28 0.94 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.538 -179.392 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.616 ' CA ' ' H ' ' A' ' 118' ' ' GLU . . . -56.38 -27.74 53.95 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.721 -0.672 . . . . 0.0 113.152 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.531 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 1.0 OUTLIER -106.65 -21.14 13.14 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.586 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.975 ' HB1' ' HB3' ' A' ' 98' ' ' ALA . . . -86.02 57.84 4.71 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.057 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.581 ' O ' ' HD3' ' A' ' 100' ' ' ARG . . . -59.82 -38.04 93.4 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.051 -1.071 . . . . 0.0 111.146 178.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.45 HG22 ' HG3' ' A' ' 171' ' ' GLN . 0.6 OUTLIER -78.46 -15.67 58.38 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.506 0.188 . . . . 0.0 111.506 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.975 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -96.91 -27.33 14.71 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.716 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.689 ' SD ' ' HB3' ' A' ' 115' ' ' LEU . 4.3 tpp -62.07 -41.2 97.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.903 0.382 . . . . 0.0 110.156 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.62 ' O ' HD21 ' A' ' 129' ' ' LEU . 1.6 mpt_? -59.52 -60.11 11.65 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.877 ' HB2' HD22 ' A' ' 30' ' ' LEU . 18.6 Cg_endo -58.87 -31.11 94.72 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.057 1.838 . . . . 0.0 112.029 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 1.024 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -74.84 -53.34 9.28 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.055 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.835 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -50.35 -28.56 8.2 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.475 0.655 . . . . 0.0 110.503 178.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.722 ' HB2' ' HB1' ' A' ' 175' ' ' ALA . . . -87.19 -52.99 5.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.214 -0.903 . . . . 0.0 113.065 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.771 ' CB ' HD11 ' A' ' 30' ' ' LEU . . . -60.39 -27.83 67.75 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.713 0.635 . . . . 0.0 112.713 -177.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.709 HD13 HG13 ' A' ' 113' ' ' ILE . 33.6 mt -82.23 -27.08 32.7 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.737 ' HB2' ' HB1' ' A' ' 138' ' ' ALA . 11.1 p -74.38 12.33 0.79 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.18 0.514 . . . . 0.0 111.422 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.673 ' HG ' HG23 ' A' ' 179' ' ' THR . 1.3 mt -78.14 -76.57 0.18 Allowed 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.433 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.418 ' O ' ' HA3' ' A' ' 155' ' ' GLY . . . -71.79 -115.57 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.64 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.9 p -150.88 95.49 2.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.97 0.414 . . . . 0.0 110.245 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.597 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 23.6 m-80 -148.47 138.36 22.31 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.51 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.92 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 0.7 OUTLIER -90.35 100.01 12.92 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.15 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.709 HG13 HD13 ' A' ' 106' ' ' LEU . 24.7 mm -119.27 136.54 56.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.496 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.851 HG13 ' CD2' ' A' ' 143' ' ' LEU . 60.9 t -108.33 111.98 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 176.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.734 HD23 ' HB2' ' A' ' 90' ' ' LEU . 52.7 mt -102.25 107.96 19.18 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.53 -178.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.929 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -124.2 -170.41 2.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.89 0.376 . . . . 0.0 111.675 -179.04 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.599 ' H ' HG22 ' A' ' 116' ' ' THR . . . -168.59 -169.05 31.54 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.144 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.743 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 50.7 mt-10 -81.24 172.73 9.04 Favored Pre-proline 0 N--CA 1.455 -0.223 0 C-N-CA 123.213 0.605 . . . . 0.0 110.254 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.743 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 8.0 Cg_endo -48.1 -39.62 33.64 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.666 2.244 . . . . 0.0 112.336 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 120' ' ' ARG . 10.2 ttp180 -67.97 -23.95 65.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.702 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.611 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 9.7 tpt -61.14 -31.87 71.58 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.415 ' HD3' ' HG2' ' A' ' 149' ' ' PRO . 12.0 mmtt -63.63 -17.14 62.59 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.559 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -79.57 0.65 29.02 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.845 0.355 . . . . 0.0 110.621 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.565 ' HB3' ' NH2' ' A' ' 100' ' ' ARG . 0.8 OUTLIER -126.98 83.03 66.96 Favored Pre-proline 0 N--CA 1.454 -0.262 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.235 179.546 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.513 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 43.6 Cg_exo -56.29 148.68 59.6 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.577 2.184 . . . . 0.0 111.618 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.701 HD11 HD23 ' A' ' 129' ' ' LEU . 1.3 tt -128.84 22.56 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.525 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -69.2 -46.4 57.93 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.183 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.626 ' CE1' ' HB2' ' A' ' 165' ' ' ASP . 0.4 OUTLIER -55.68 -37.58 68.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.832 0.349 . . . . 0.0 110.929 -179.567 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.791 ' HG ' HD11 ' A' ' 133' ' ' LEU . 16.9 tp -70.19 -44.32 68.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.353 0.597 . . . . 0.0 109.527 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.874 HG21 HD21 ' A' ' 151' ' ' LEU . 36.2 t -56.85 -47.31 83.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.16 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.77 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 2.8 m-20 -71.04 -38.29 72.54 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 120.881 0.372 . . . . 0.0 110.704 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.516 ' HA ' HG13 ' A' ' 162' ' ' VAL . . . -57.96 -46.97 84.28 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.537 0.684 . . . . 0.0 109.87 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.791 HD11 ' HG ' ' A' ' 129' ' ' LEU . 5.8 mt -76.02 -50.18 15.54 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.798 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.722 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -57.17 -27.7 62.15 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.01 179.704 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.77 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 5.0 tp -70.55 -30.09 66.72 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.941 0.4 . . . . 0.0 110.915 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 159' ' ' GLY . . . -84.22 14.42 44.92 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.838 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.63 4.48 60.58 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.892 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.738 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . . . -75.2 155.75 36.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.985 0.421 . . . . 0.0 111.533 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.451 ' CB ' ' HB2' ' A' ' 154' ' ' GLN . 3.7 mttm -102.58 105.55 16.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.303 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.747 HG21 HG22 ' A' ' 130' ' ' VAL . 13.6 mt -138.68 127.57 30.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.542 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.809 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -126.38 139.83 52.97 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.594 -179.544 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -78.07 132.37 37.7 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.382 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.851 ' CD2' HG13 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -95.16 -90.97 0.22 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.909 -179.568 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.793 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 16.0 mm-40 -59.15 -81.05 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.025 0.44 . . . . 0.0 110.692 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.504 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 31.6 mt-30 -113.09 148.86 34.38 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.788 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 4.7 mt-10 -65.5 132.54 49.17 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.428 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.525 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 2.1 m-20 67.85 17.82 9.67 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.124 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.598 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 16.8 m-85 -108.75 169.17 6.8 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.035 0.445 . . . . 0.0 111.603 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.918 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 8.2 Cg_exo -32.23 -62.73 0.14 Allowed 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 124.164 3.243 . . . . 0.0 116.656 -177.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.929 ' HG3' HG23 ' A' ' 116' ' ' THR . 59.2 Cg_exo -53.05 143.89 48.51 Favored 'Trans proline' 0 C--N 1.351 0.68 0 CA-C-N 120.982 1.387 . . . . 0.0 112.892 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.874 HD21 HG21 ' A' ' 130' ' ' VAL . 10.4 mt -155.58 133.23 11.15 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.67 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.837 ' HG3' HD11 ' A' ' 143' ' ' LEU . 2.8 mtt85 -103.29 100.76 10.66 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.92 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 10.0 mt -90.62 148.54 22.59 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.987 -178.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.597 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 3.6 mt-30 -149.64 23.79 0.88 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.048 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.595 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 54.52 -168.57 1.78 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.226 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 158' ' ' THR . . . 114.89 -14.57 19.45 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.243 -0.98 . . . . 0.0 113.216 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.738 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 45.4 t80 -58.18 122.75 13.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 117.396 0.598 . . . . 0.0 110.742 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.708 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 76.6 p -114.87 -29.88 6.59 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.375 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.492 ' O ' ' HA2' ' A' ' 136' ' ' GLY . . . 133.73 -157.99 23.06 Favored Glycine 0 C--N 1.305 -1.153 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.115 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.596 ' O ' HG23 ' A' ' 187' ' ' THR . . . 103.06 153.57 24.26 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.289 -0.958 . . . . 0.0 111.347 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -47.16 115.84 1.21 Allowed 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.296 -0.452 . . . . 0.0 111.081 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 60.9 t -107.85 140.28 26.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.64 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.96 119.79 40.1 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.057 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.945 HG11 ' HG ' ' A' ' 173' ' ' LEU . 1.6 t -129.27 120.56 51.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.626 ' HB2' ' CE1' ' A' ' 128' ' ' HIS . 7.8 t0 -55.04 139.62 40.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.234 0.54 . . . . 0.0 112.066 -178.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.91 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . -62.11 -12.73 38.58 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.47 -0.787 . . . . 0.0 112.68 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.612 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -145.06 98.85 3.23 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.028 0.442 . . . . 0.0 111.483 -179.462 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.573 HG21 ' HB2' ' A' ' 128' ' ' HIS . 10.5 p -160.82 -33.31 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.401 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.503 ' CB ' ' CD1' ' A' ' 172' ' ' PHE . 0.6 OUTLIER 167.26 126.91 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.976 179.455 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.571 ' HB3' ' HB2' ' A' ' 197' ' ' SER . 46.2 p -67.25 -17.49 64.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.249 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.576 ' HA ' ' HB ' ' A' ' 174' ' ' THR . 8.3 mm-40 -89.6 -12.09 40.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.579 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.589 ' CZ ' ' HA ' ' A' ' 126' ' ' ILE . 3.1 m-85 -69.26 -54.36 15.08 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.945 ' HG ' HG11 ' A' ' 164' ' ' VAL . 1.0 OUTLIER -64.84 -46.69 80.84 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.793 178.468 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.761 HG21 ' HD3' ' A' ' 27' ' ' ARG . 4.1 m -54.41 -35.0 62.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.172 178.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.722 ' HB1' ' HB2' ' A' ' 104' ' ' ALA . . . -64.13 -46.77 82.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.497 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.941 HD11 HG21 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -76.52 -31.75 57.86 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.315 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.853 HD11 ' CD2' ' A' ' 223' ' ' PHE . 1.6 mp -58.99 -39.18 81.02 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.181 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.693 ' HE1' ' HA ' ' A' ' 27' ' ' ARG . 2.0 mtp -81.08 -40.71 23.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.892 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.673 HG23 ' HG ' ' A' ' 108' ' ' LEU . 66.4 m -71.28 -41.85 69.48 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.949 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.552 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . -59.63 -40.51 79.95 Favored Pre-proline 0 C--N 1.321 -0.674 0 N-CA-C 115.132 1.531 . . . . 0.0 115.132 -176.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.577 ' HD3' ' O ' ' A' ' 177' ' ' LEU . 27.9 Cg_endo -64.93 -28.82 58.11 Favored 'Trans proline' 0 CA--C 1.502 -1.112 0 CA-C-N 120.081 1.064 . . . . 0.0 111.511 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.587 ' HB2' HD21 ' A' ' 108' ' ' LEU . 8.1 mt -83.58 0.81 45.07 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.485 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.623 ' HB1' ' C ' ' A' ' 158' ' ' THR . . . -83.36 136.89 42.58 Favored Pre-proline 0 C--O 1.223 -0.304 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.287 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.708 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 11.1 Cg_endo -50.53 -32.53 35.25 Favored 'Trans proline' 0 CA--C 1.516 -0.415 0 C-N-CA 122.715 2.277 . . . . 0.0 113.363 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -114.96 141.35 48.09 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.717 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -56.1 141.88 38.74 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.124 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.596 HG23 ' O ' ' A' ' 160' ' ' GLY . 91.5 m -119.97 143.41 48.04 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 50.8 t -123.69 118.15 53.37 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 176.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.816 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 2.7 mp -102.55 117.85 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.596 ' HB2' ' HG3' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -100.65 123.66 45.16 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.241 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.91 HG23 ' HA2' ' A' ' 166' ' ' GLY . 1.6 mp -93.69 119.59 41.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.605 -1.179 . . . . 0.0 111.142 -176.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.5 ' HE2' ' N ' ' A' ' 165' ' ' ASP . 1.7 mtmt -75.26 97.06 3.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.834 -178.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 99.64 -133.06 11.16 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.693 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -112.66 131.09 55.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.855 0.36 . . . . 0.0 111.135 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.753 HD11 ' HZ ' ' A' ' 223' ' ' PHE . 1.5 mt -41.77 144.48 0.4 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.836 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.612 ' HB ' ' HA ' ' A' ' 167' ' ' SER . 14.2 p -73.75 -27.72 23.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.184 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.571 ' HB2' ' HB3' ' A' ' 170' ' ' SER . 0.3 OUTLIER -165.51 63.01 0.11 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.184 0.516 . . . . 0.0 110.25 -179.19 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.686 ' N ' ' HD2' ' A' ' 199' ' ' PRO . 0.0 OUTLIER -42.07 -46.63 10.44 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.5 179.7 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.686 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 9.5 Cg_endo -49.31 -33.09 27.67 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 121.944 1.763 . . . . 0.0 111.39 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.991 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.1 OUTLIER -69.1 -43.82 73.7 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.785 0.803 . . . . 0.0 108.87 178.242 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.606 HG21 ' HE2' ' A' ' 223' ' ' PHE . 27.5 mm -62.69 -35.79 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.452 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.29 -44.13 95.65 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.695 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.991 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.0 mt -63.12 -49.76 82.04 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.927 0 CA-C-O 121.66 0.743 . . . . 0.0 108.996 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.537 ' CG2' HG23 ' A' ' 174' ' ' THR . 90.8 m -53.02 -51.48 61.54 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.893 -178.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.877 HD22 ' HB ' ' A' ' 215' ' ' ILE . 29.3 mt -66.13 -30.48 70.97 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.437 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ASN . . . . . 0.464 ' HA ' ' HE3' ' A' ' 209' ' ' LYS . 29.8 m-20 -77.02 -46.13 24.84 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.837 0.827 . . . . 0.0 109.527 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.801 ' O ' HG22 ' A' ' 210' ' ' THR . 5.1 tp -70.55 -29.47 65.93 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.09 -1.413 . . . . 0.0 109.618 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' MET . . . . . 0.72 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 52.2 mtp -77.13 -34.09 56.66 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.714 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 9.4 mtmt -62.04 -40.59 96.26 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.015 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.801 HG22 ' O ' ' A' ' 207' ' ' LEU . 5.0 t -60.5 -31.25 70.31 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.583 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.598 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 56.1 m-85 -78.61 -5.94 54.27 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.871 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.6 7.95 25.27 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.166 -1.016 . . . . 0.0 115.638 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.714 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 5.1 m -124.0 148.07 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 118.768 1.284 . . . . 0.0 112.829 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.467 ' CG ' ' HG2' ' A' ' 209' ' ' LYS . 16.2 mt-10 -130.02 137.72 50.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.126 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.877 ' HB ' HD22 ' A' ' 205' ' ' LEU . 18.0 mm -120.56 148.38 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-O 120.875 0.369 . . . . 0.0 110.557 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.665 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 2.4 tt0 -103.01 116.22 32.1 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.864 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -82.79 151.21 26.2 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.969 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' GLN . . . . . 0.633 ' HG3' ' HB3' ' A' ' 222' ' ' GLN . 10.2 mm100 -109.47 -139.12 0.38 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 121.146 -0.222 . . . . 0.0 110.821 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.642 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 5.5 t-80 -78.82 66.6 4.34 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 3.7 t80 57.25 33.38 23.22 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.974 0.893 . . . . 0.0 110.234 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.685 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 3.3 pt20 -163.92 -126.63 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.816 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -8.56 132.66 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.853 ' CD2' HD11 ' A' ' 177' ' ' LEU . 0.9 OUTLIER -124.76 138.69 54.27 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 112.867 -1.97 . . . . 0.0 110.181 -179.295 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.665 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 38.7 t -118.37 114.44 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.784 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.4 OUTLIER -121.78 125.66 73.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.443 -178.952 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.547 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -79.79 127.65 32.48 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.206 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.554 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -79.46 -173.84 45.24 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.404 -178.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 62.75 21.0 62.57 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 121.61 -0.329 . . . . 0.0 113.193 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' GLN . . . . . 0.571 ' NE2' ' HB3' ' A' ' 181' ' ' PRO . 42.4 mt-30 -76.78 -175.39 3.41 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.364 0.602 . . . . 0.0 111.557 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.22 147.81 28.84 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.654 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' TYR . . . . . 0.768 ' CZ ' HD22 ' A' ' 31' ' ' LEU . 1.9 m-30 -104.47 131.71 51.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.109 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.42 144.83 48.79 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.435 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 50.1 m -69.99 110.81 7.34 Favored Pre-proline 0 N--CA 1.45 -0.453 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.259 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.503 ' HG3' HG23 ' A' ' 210' ' ' THR . 40.5 Cg_endo -66.44 -1.0 4.91 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.017 1.811 . . . . 0.0 112.41 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' GLY . . . . . 0.579 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 99.45 -96.41 1.66 Allowed Glycine 0 C--O 1.226 -0.383 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.631 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 30.7 m -119.91 134.4 55.25 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.563 ' CD2' HG21 ' A' ' 210' ' ' THR . 12.8 t80 -132.97 126.76 32.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.997 0.427 . . . . 0.0 111.314 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.898 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -93.25 112.2 24.06 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.033 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.693 ' N ' HD22 ' A' ' 238' ' ' LEU . 25.0 t -86.74 111.83 22.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.789 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.211 -179.667 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.58 ' HB2' HD22 ' A' ' 44' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.845 0.355 . . . . 0.0 111.195 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 67.25 -82.34 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.97 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.874 HH11 HD23 ' A' ' 207' ' ' LEU . 6.6 mtm105 -76.01 -62.49 1.58 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.877 0.37 . . . . 0.0 111.316 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.751 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -35.21 -45.41 0.3 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.378 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.054 HD22 HD11 ' A' ' 75' ' ' ILE . 11.4 mt -75.65 -38.93 58.46 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.977 0.418 . . . . 0.0 111.608 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.839 HD22 ' HB2' ' A' ' 101' ' ' PRO . 51.5 tp -65.22 -49.67 68.8 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.435 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.585 HD13 ' HA ' ' A' ' 208' ' ' MET . 45.3 mt -67.09 -26.9 66.94 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.657 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.847 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -66.28 -40.05 89.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.044 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.776 ' CB ' HG11 ' A' ' 62' ' ' VAL . . . -81.21 -41.21 22.66 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.793 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.671 HD11 ' HB1' ' A' ' 105' ' ' ALA . 13.3 mt -67.95 -3.69 10.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.246 178.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.493 ' HB2' ' HB3' ' A' ' 231' ' ' TYR . . . -100.22 178.34 4.8 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.565 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.1 OUTLIER -113.04 113.6 25.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.8 178.186 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.412 ' HA3' ' OG ' ' A' ' 233' ' ' SER . . . 116.75 167.91 14.73 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.357 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.819 ' HG3' HG23 ' A' ' 76' ' ' ILE . 1.1 ttmt -95.45 117.95 31.3 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 117.127 0.463 . . . . 0.0 111.692 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 0.9 OUTLIER -120.19 148.12 44.06 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.321 179.753 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.669 HG22 ' HB2' ' A' ' 74' ' ' GLU . 98.8 t -107.41 141.64 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.767 ' CB ' HD21 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -116.1 116.0 27.07 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 174.877 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.892 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.6 OUTLIER -103.92 152.83 21.51 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.93 -178.314 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.69 26.81 11.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.469 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.767 HD21 ' CB ' ' A' ' 41' ' ' LEU . 76.2 mt -54.14 -173.31 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.789 0.328 . . . . 0.0 110.127 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.525 ' HB3' HG21 ' A' ' 50' ' ' VAL . 56.8 tp -111.69 131.31 55.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.469 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -87.78 88.79 7.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.992 0.425 . . . . 0.0 110.11 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 50' ' ' VAL . 74.6 m -163.97 142.66 7.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.994 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.437 ' HA ' ' HB3' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -37.44 -29.92 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.736 0.303 . . . . 0.0 111.374 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.761 ' OD1' HG23 ' A' ' 50' ' ' VAL . 1.2 p30 -58.3 -42.51 86.8 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 121.043 0.449 . . . . 0.0 110.631 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.761 HG23 ' OD1' ' A' ' 49' ' ' ASP . 93.0 t -84.12 -44.55 18.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.672 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.782 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -49.32 -39.72 32.4 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.447 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.58 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 22.6 m-70 -81.04 -32.67 33.97 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.081 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.628 ' O ' HD13 ' A' ' 57' ' ' LEU . 7.5 tpt -53.69 -34.64 59.44 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 176.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.782 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.7 OUTLIER -82.52 -44.46 15.89 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 113.892 -1.503 . . . . 0.0 108.837 176.698 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.729 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 24.8 t-20 -57.97 -42.28 84.68 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-O 120.882 0.372 . . . . 0.0 110.655 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 1.024 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -57.27 -46.8 82.74 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.875 0.845 . . . . 0.0 109.012 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.777 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -64.33 -37.61 88.1 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.134 -1.394 . . . . 0.0 107.779 177.21 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.729 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -64.14 -33.13 75.07 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.179 -1.373 . . . . 0.0 111.933 179.411 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.789 ' CB ' HD11 ' A' ' 90' ' ' LEU . . . -76.21 -37.55 57.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.221 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.641 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -81.4 -12.5 58.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.289 0.566 . . . . 0.0 110.686 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.06 35.54 5.02 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.262 -0.881 . . . . 0.0 114.293 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.777 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 39.8 t -90.45 123.24 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.788 ' O ' HG12 ' A' ' 76' ' ' ILE . 7.2 m -85.32 131.44 34.41 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.0 0.428 . . . . 0.0 111.723 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.824 ' HB3' HG23 ' A' ' 75' ' ' ILE . 40.6 p90 -158.7 171.08 20.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.685 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 98.1 m -135.19 149.03 49.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.301 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.626 HD12 ' HB2' ' A' ' 73' ' ' CYS . 11.7 tp -120.25 138.69 53.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.028 0.442 . . . . 0.0 110.874 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 87.1 p -57.71 -175.31 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.339 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.1 -42.24 23.96 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.197 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -76.41 0.67 18.79 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.398 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.9 mtt-85 59.36 53.56 5.19 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.873 0.368 . . . . 0.0 111.176 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.445 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -149.19 4.16 0.61 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.76 179.657 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.612 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 9.5 ttm180 -136.97 110.78 8.14 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.626 ' HB2' HD12 ' A' ' 66' ' ' LEU . 36.9 t -121.61 134.48 55.0 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.669 ' HB2' HG22 ' A' ' 40' ' ' VAL . 24.6 tt0 -115.45 132.61 56.57 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.245 -0.888 . . . . 0.0 108.728 177.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 1.054 HD11 HD22 ' A' ' 29' ' ' LEU . 12.2 mt -127.79 123.45 61.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -177.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.819 HG23 ' HG3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -67.72 100.13 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 175.178 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 35' ' ' ALA . . . -39.19 144.73 0.27 Allowed Glycine 0 C--N 1.323 -0.189 0 CA-C-N 115.145 -0.934 . . . . 0.0 113.483 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -90.02 -12.41 38.69 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.947 0.404 . . . . 0.0 111.038 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.565 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 95.19 1.63 62.65 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.94 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.553 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 150.88 -148.96 20.69 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.683 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.52 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 77.3 Cg_exo -49.63 123.52 10.63 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.712 2.274 . . . . 0.0 112.218 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.641 ' HB2' HD13 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -74.27 106.33 5.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.225 -179.5 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -83.66 132.42 34.88 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.573 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.578 ' CB ' HD11 ' A' ' 113' ' ' ILE . . . -96.86 126.81 42.28 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.065 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.19 123.93 23.32 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.31 175.3 1.15 Allowed Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 -175.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 112' ' ' ASP . . . -74.04 144.98 44.85 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 118.559 1.179 . . . . 0.0 112.215 -178.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.661 HD21 ' C ' ' A' ' 59' ' ' ALA . 0.9 OUTLIER -115.26 161.12 18.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.649 -1.16 . . . . 0.0 112.557 -178.273 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.449 ' HG3' ' HB ' ' A' ' 114' ' ' VAL . 1.6 tt0 -140.26 112.26 7.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.758 177.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.789 HD11 ' CB ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -108.64 117.87 35.3 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.505 -178.427 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.632 ' C ' HD13 ' A' ' 92' ' ' LEU . 0.1 OUTLIER -88.97 96.67 10.82 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.508 179.042 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.808 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -105.37 53.04 0.72 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.267 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.459 ' CA ' ' H ' ' A' ' 118' ' ' GLU . . . -53.13 -75.11 0.24 Allowed Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.711 -0.677 . . . . 0.0 113.022 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.503 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 3.1 m120 -75.49 -1.06 22.4 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.768 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 1.05 ' HB1' ' HB3' ' A' ' 98' ' ' ALA . . . -87.96 47.66 1.53 Allowed 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.363 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.401 ' O ' ' HD2' ' A' ' 100' ' ' ARG . . . -56.37 -23.59 42.23 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.173 -1.013 . . . . 0.0 111.458 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.462 HG22 ' HG2' ' A' ' 171' ' ' GLN . 2.1 p -92.91 -16.69 24.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.464 0.173 . . . . 0.0 111.176 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 1.05 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -95.5 -37.17 11.01 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.469 ' HB2' ' HB2' ' A' ' 92' ' ' LEU . 2.2 tpp -59.3 -44.52 92.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.594 0.235 . . . . 0.0 110.524 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.7 ' HE ' HD12 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -54.13 -60.22 8.03 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.284 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.839 ' HB2' HD22 ' A' ' 30' ' ' LEU . 18.3 Cg_endo -62.0 -32.89 84.32 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.396 2.064 . . . . 0.0 112.831 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 1.024 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -70.86 -52.84 17.78 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.052 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.896 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -51.72 -28.72 15.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.26 0.552 . . . . 0.0 110.53 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.874 ' CB ' ' HB1' ' A' ' 175' ' ' ALA . . . -86.06 -52.97 5.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.428 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.702 ' CB ' HD11 ' A' ' 30' ' ' LEU . . . -60.57 -34.27 73.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.643 ' HB2' HD12 ' A' ' 153' ' ' LEU . 31.6 mt -78.52 -17.82 55.65 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.587 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 9.6 p -84.68 22.6 1.29 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.245 0.545 . . . . 0.0 110.598 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.771 HD21 ' HB2' ' A' ' 182' ' ' LEU . 0.4 OUTLIER -90.04 -73.86 0.51 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.427 -179.71 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -73.19 -116.31 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.699 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.24 94.15 2.09 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.141 0.496 . . . . 0.0 110.58 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.643 ' OD1' HD13 ' A' ' 113' ' ' ILE . 22.7 p30 -146.44 138.32 24.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.467 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.886 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 0.9 OUTLIER -95.21 100.65 12.42 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.656 179.122 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.644 HD12 ' C ' ' A' ' 112' ' ' ASP . 1.1 mp -120.66 147.68 24.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.494 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.865 HG13 ' CD2' ' A' ' 143' ' ' LEU . 58.0 t -117.53 113.22 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 176.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.679 HD23 ' HB2' ' A' ' 90' ' ' LEU . 33.9 mt -102.12 105.41 16.11 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.296 -0.561 . . . . 0.0 111.324 -177.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.813 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -118.14 -172.12 2.2 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.768 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.572 ' H ' HG22 ' A' ' 116' ' ' THR . . . -164.93 -167.97 26.34 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.206 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.609 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 16.9 mt-10 -78.31 171.86 11.38 Favored Pre-proline 0 C--N 1.332 -0.158 0 C-N-CA 122.661 0.384 . . . . 0.0 110.356 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 71.0 Cg_exo -49.5 -39.57 45.33 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.377 2.052 . . . . 0.0 112.77 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -68.23 -23.4 64.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.619 0.247 . . . . 0.0 110.971 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.557 ' O ' ' HG3' ' A' ' 149' ' ' PRO . 9.8 tpt -60.81 -34.45 74.55 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.474 ' HA ' ' HG2' ' A' ' 149' ' ' PRO . 0.0 OUTLIER -61.62 -16.77 51.33 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.614 179.166 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.3 3.19 32.47 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.837 0.351 . . . . 0.0 110.209 178.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.412 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 12.3 mtm180 -127.3 84.79 62.51 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.149 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 124' ' ' ARG . 16.2 Cg_endo -57.13 148.64 68.21 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.867 2.378 . . . . 0.0 112.068 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.7 HD12 ' HE ' ' A' ' 100' ' ' ARG . 0.9 OUTLIER -122.53 0.93 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -179.355 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.511 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -53.36 -39.43 59.19 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.219 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 29.1 m170 -56.01 -41.61 75.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.783 0.325 . . . . 0.0 110.381 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.742 ' HG ' HD11 ' A' ' 133' ' ' LEU . 12.6 tp -75.48 -43.98 46.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.284 0.564 . . . . 0.0 110.055 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.842 HG13 ' CG2' ' A' ' 140' ' ' ILE . 69.5 t -56.41 -47.36 81.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.593 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.73 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 0.7 OUTLIER -69.2 -38.95 78.88 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.696 -179.603 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.617 ' HB2' HG23 ' A' ' 164' ' ' VAL . . . -58.39 -49.13 78.34 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.596 178.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.742 HD11 ' HG ' ' A' ' 129' ' ' LEU . 7.2 mt -69.92 -50.37 42.8 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.323 178.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.747 ' HG3' ' HB ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -58.14 -27.88 64.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.798 179.56 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.73 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 1.0 OUTLIER -69.79 -30.85 68.5 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.912 178.853 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -83.36 14.79 38.18 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.966 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 93.69 7.97 61.15 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.593 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.708 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . . . -78.21 152.03 32.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.834 0.349 . . . . 0.0 111.035 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 19.9 mtpt -100.73 103.96 15.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.126 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.842 ' CG2' HG13 ' A' ' 130' ' ' VAL . 34.7 mt -135.65 124.16 38.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.195 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.75 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -120.54 139.51 52.82 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.938 -179.589 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.559 ' CE1' HG11 ' A' ' 130' ' ' VAL . 42.1 m-85 -81.04 132.43 35.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.847 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.865 ' CD2' HG13 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -92.52 -87.16 0.23 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.775 -179.217 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.679 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 2.7 mt-10 -57.38 -82.46 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.397 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.401 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 44.8 mt-30 -116.69 154.3 30.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.341 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 6.0 mt-10 -66.88 132.82 48.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.373 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.511 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 2.7 m120 71.44 17.08 5.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.442 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.534 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 14.8 m-85 -107.0 168.22 8.36 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.813 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 75.0 Cg_exo -35.96 -60.33 0.35 Allowed 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.991 3.127 . . . . 0.0 115.921 -177.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.813 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 77.8 Cg_exo -52.35 145.5 35.79 Favored 'Trans proline' 0 C--N 1.352 0.736 0 CA-C-N 120.61 1.253 . . . . 0.0 112.118 -178.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.849 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 8.4 mt -156.41 137.59 13.73 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.808 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.75 ' HB2' HG22 ' A' ' 141' ' ' THR . 7.6 mtt85 -109.24 101.6 10.61 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.896 HD11 ' HA ' ' A' ' 103' ' ' ALA . 7.9 mt -90.35 148.01 23.11 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.283 -177.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.598 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 5.7 mt-30 -149.87 24.81 0.85 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.365 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.587 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 56.99 -162.04 7.52 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.322 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.421 ' O ' HG23 ' A' ' 158' ' ' THR . . . 107.35 -16.13 38.39 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.365 -0.922 . . . . 0.0 113.619 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.708 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 11.2 t80 -58.66 122.38 13.34 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 117.858 0.829 . . . . 0.0 110.155 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.738 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 56.9 p -114.76 -31.84 6.01 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 121.594 0.711 . . . . 0.0 111.171 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.442 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 137.19 -160.09 24.9 Favored Glycine 0 C--N 1.307 -1.068 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.049 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.566 ' O ' HG23 ' A' ' 187' ' ' THR . . . 105.5 152.95 21.14 Favored Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.008 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -47.01 116.47 1.37 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.98 -0.61 . . . . 0.0 110.83 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.569 ' CG1' ' HB1' ' A' ' 132' ' ' ALA . 68.6 t -109.49 144.88 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.48 119.97 39.4 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.477 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.893 HG21 HD11 ' A' ' 176' ' ' LEU . 1.0 OUTLIER -131.86 121.37 47.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.695 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.89 137.94 37.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.954 0.407 . . . . 0.0 111.191 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.802 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . -58.99 -22.84 56.09 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.75 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 13.2 m -84.6 -134.53 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.965 -0.384 . . . . 0.0 109.965 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.599 HG11 ' CD2' ' A' ' 172' ' ' PHE . 2.9 t 67.15 -124.8 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 O-C-N 122.341 -0.225 . . . . 0.0 111.018 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.491 ' C ' HG11 ' A' ' 196' ' ' VAL . 0.1 OUTLIER -136.92 145.24 44.03 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.901 0.382 . . . . 0.0 110.418 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.497 ' HB2' ' HB3' ' A' ' 200' ' ' TYR . 0.1 OUTLIER -60.73 -17.54 49.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.878 -179.581 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.584 ' O ' ' HB3' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -82.24 -11.08 58.88 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.811 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.599 ' CD2' HG11 ' A' ' 168' ' ' VAL . 6.4 m-85 -74.13 -54.88 6.86 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.882 HD11 ' CG1' ' A' ' 191' ' ' ILE . 0.5 OUTLIER -65.62 -37.78 87.54 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.436 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.489 ' HB ' ' HA ' ' A' ' 171' ' ' GLN . 4.4 m -58.26 -34.57 70.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.063 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.874 ' HB1' ' CB ' ' A' ' 104' ' ' ALA . . . -68.28 -39.05 82.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.843 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.893 HD11 HG21 ' A' ' 164' ' ' VAL . 0.3 OUTLIER -76.78 -34.26 58.0 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.275 0.559 . . . . 0.0 110.899 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.817 HD11 ' CD2' ' A' ' 223' ' ' PHE . 2.4 mp -59.68 -38.41 81.47 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.529 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.742 ' HE1' ' HA ' ' A' ' 27' ' ' ARG . 3.8 mtp -81.76 -43.61 18.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.389 0.614 . . . . 0.0 112.509 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.594 HG23 ' HG ' ' A' ' 108' ' ' LEU . 48.5 m -73.11 -39.88 65.42 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.684 -178.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.576 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . -59.49 -41.55 87.34 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -177.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 30.3 Cg_endo -65.59 -28.32 52.97 Favored 'Trans proline' 0 CA--C 1.501 -1.161 0 C-N-CA 121.046 1.164 . . . . 0.0 111.723 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.771 ' HB2' HD21 ' A' ' 108' ' ' LEU . 5.4 mt -83.15 -0.19 48.1 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.079 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.738 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -82.19 137.29 46.0 Favored Pre-proline 0 N--CA 1.455 -0.209 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.183 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.697 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 11.7 Cg_endo -50.94 -33.18 40.94 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.685 2.257 . . . . 0.0 113.357 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -113.28 139.52 48.76 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.842 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' A' ' 186' ' ' ASP . 0.8 OUTLIER -53.68 144.59 17.44 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.15 179.227 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.574 ' HB ' ' HB1' ' A' ' 180' ' ' ALA . 94.1 m -123.83 145.88 48.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.258 0.552 . . . . 0.0 112.441 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.673 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 40.2 t -126.63 117.83 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.366 177.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.744 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 3.5 mp -101.12 118.08 47.32 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.579 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 3.6 ttt180 -100.93 124.82 47.2 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.882 ' CG1' HD11 ' A' ' 173' ' ' LEU . 1.5 mp -93.61 123.41 45.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.952 -175.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -83.03 96.88 8.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.11 -1.405 . . . . 0.0 110.361 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 102.06 -134.28 11.7 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.804 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -116.43 127.32 54.5 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.727 HD11 ' HZ ' ' A' ' 223' ' ' PHE . 1.0 OUTLIER -41.37 144.72 0.31 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.486 179.447 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.491 HG11 ' C ' ' A' ' 169' ' ' SER . 11.1 p -72.92 -30.53 32.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.999 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.496 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 0.2 OUTLIER -162.09 62.43 0.23 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.024 0.44 . . . . 0.0 110.611 -179.412 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.578 ' HA ' HD13 ' A' ' 195' ' ' LEU . 3.1 tttp -39.68 -45.92 4.31 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.175 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.496 ' HD2' ' C ' ' A' ' 197' ' ' SER . 88.6 Cg_exo -47.8 -37.35 28.18 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 121.99 1.794 . . . . 0.0 111.622 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.954 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.3 OUTLIER -64.18 -45.79 86.83 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.637 HG21 ' HE2' ' A' ' 223' ' ' PHE . 12.5 mm -60.76 -37.33 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.584 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.442 ' OD2' ' HE3' ' A' ' 198' ' ' LYS . 83.8 m-20 -59.06 -46.78 87.39 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.857 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.954 HD12 ' HA ' ' A' ' 200' ' ' TYR . 3.1 mt -61.17 -46.26 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.977 0 CA-C-O 121.719 0.771 . . . . 0.0 108.986 178.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.55 HG22 ' SD ' ' A' ' 208' ' ' MET . 92.5 m -54.13 -51.44 64.23 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.699 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.874 HD22 ' HB ' ' A' ' 215' ' ' ILE . 26.8 mt -68.53 -28.37 66.93 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 120.531 -0.467 . . . . 0.0 111.246 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ASN . . . . . 0.496 ' HA ' ' HE3' ' A' ' 209' ' ' LYS . 15.0 t30 -77.84 -46.09 22.48 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.793 0.806 . . . . 0.0 109.577 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.99 ' O ' HG22 ' A' ' 210' ' ' THR . 3.1 tp -69.57 -34.46 74.21 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.188 -1.369 . . . . 0.0 109.297 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' MET . . . . . 0.79 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 50.1 mtp -72.57 -33.82 67.03 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.467 0.651 . . . . 0.0 109.328 177.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.623 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 15.5 mtmt -62.57 -37.57 86.69 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.862 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.99 HG22 ' O ' ' A' ' 207' ' ' LEU . 5.8 t -62.86 -28.45 70.03 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.409 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.569 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 39.3 m-85 -82.82 -6.04 59.24 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.913 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.99 6.9 25.81 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 116.226 1.25 . . . . 0.0 116.226 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.623 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.2 m -123.66 148.7 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 119.101 1.451 . . . . 0.0 112.729 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.571 ' O ' HD13 ' A' ' 215' ' ' ILE . 18.9 mt-10 -129.63 140.66 51.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.821 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.874 ' HB ' HD22 ' A' ' 205' ' ' LEU . 15.9 mm -123.29 148.31 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-O 120.871 0.367 . . . . 0.0 110.691 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.64 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 31.0 tt0 -103.45 119.19 38.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.603 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -82.85 151.17 26.15 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.541 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' GLN . . . . . 0.745 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -112.58 -146.09 0.4 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 121.182 -0.207 . . . . 0.0 110.49 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.425 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 7.0 m80 -68.01 66.23 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.416 ' CE1' ' HD2' ' A' ' 198' ' ' LYS . 3.4 t80 52.93 34.6 17.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.887 0.851 . . . . 0.0 110.266 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.648 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -164.35 -124.09 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 179.652 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.745 ' O ' ' HB2' ' A' ' 218' ' ' GLN . 0.0 OUTLIER -8.36 133.59 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.817 ' CD2' HD11 ' A' ' 177' ' ' LEU . 0.8 OUTLIER -124.75 139.26 54.01 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.269 -1.787 . . . . 0.0 109.79 -179.218 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.64 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 40.1 t -120.96 113.87 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.871 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -122.16 126.05 73.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.531 -178.935 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.527 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -74.4 126.76 31.4 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.608 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -81.92 -178.97 52.71 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.268 -0.968 . . . . 0.0 113.021 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 66.01 21.25 69.57 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 121.375 -0.44 . . . . 0.0 112.872 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' GLN . . . . . 0.571 ' NE2' ' HB3' ' A' ' 181' ' ' PRO . 48.3 mt-30 -78.72 -176.04 4.71 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.213 0.53 . . . . 0.0 111.476 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.4 t -148.64 147.77 29.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.043 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' TYR . . . . . 0.67 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 7.2 m-85 -103.32 129.95 50.47 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.87 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -121.53 148.07 44.97 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.756 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.439 ' HB2' ' OG1' ' A' ' 39' ' ' THR . 10.9 p -71.52 110.99 8.68 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 120.981 -0.287 . . . . 0.0 110.516 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.493 ' HB3' ' O ' ' A' ' 210' ' ' THR . 55.7 Cg_endo -70.08 1.66 4.44 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.199 1.933 . . . . 0.0 112.213 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 98.59 -101.75 2.51 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 56.1 m -117.39 137.78 52.25 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.609 ' CD2' HG21 ' A' ' 210' ' ' THR . 10.6 t80 -134.32 125.49 27.74 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.928 0.394 . . . . 0.0 111.314 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.892 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -94.78 110.91 22.72 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.105 0.479 . . . . 0.0 111.017 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.606 ' N ' HD22 ' A' ' 238' ' ' LEU . 21.7 t -81.61 111.11 17.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.212 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.533 ' HG3' HD13 ' A' ' 238' ' ' LEU . 6.3 mt-10 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.078 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.523 ' CB ' HD22 ' A' ' 44' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.88 0.371 . . . . 0.0 111.437 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 61.96 -78.41 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.946 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.691 ' HB2' HD21 ' A' ' 207' ' ' LEU . 1.0 OUTLIER -73.75 -63.2 1.26 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.277 0.56 . . . . 0.0 110.69 179.602 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.863 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -37.23 -46.83 0.75 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.001 -0.999 . . . . 0.0 112.321 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.043 HD22 HD11 ' A' ' 75' ' ' ILE . 11.0 mt -75.51 -33.14 60.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.937 0.399 . . . . 0.0 111.256 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.895 HD22 ' HB2' ' A' ' 101' ' ' PRO . 46.4 tp -68.6 -49.71 57.15 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.489 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.628 HD22 ' CZ ' ' A' ' 231' ' ' TYR . 39.5 mt -68.71 -26.99 65.55 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.451 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.825 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -65.29 -37.46 87.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.084 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.81 ' CB ' HG11 ' A' ' 62' ' ' VAL . . . -80.83 -41.12 23.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.234 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.689 HD23 ' O ' ' A' ' 80' ' ' GLY . 32.4 mt -67.52 -3.78 9.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.368 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.427 ' O ' ' HA3' ' A' ' 77' ' ' GLY . . . -83.57 171.95 12.83 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -112.31 34.67 4.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.984 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -168.81 175.43 43.31 Favored Glycine 0 C--N 1.309 -0.936 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.74 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.759 ' HE2' HD12 ' A' ' 76' ' ' ILE . 10.6 ttmt -95.39 117.83 31.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.642 0.721 . . . . 0.0 111.373 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 235' ' ' GLY . 0.9 OUTLIER -123.14 148.28 45.89 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.615 -179.291 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.708 HG22 ' HB2' ' A' ' 74' ' ' GLU . 76.1 t -104.78 141.42 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 CA-C-O 121.393 0.616 . . . . 0.0 112.474 -179.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.896 HD23 HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -114.51 116.2 28.45 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 175.034 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.907 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.5 OUTLIER -102.99 151.68 22.2 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.149 -178.364 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.447 ' HB2' HD23 ' A' ' 238' ' ' LEU . 1.8 t-20 68.15 25.64 7.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.419 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.807 HD21 ' CB ' ' A' ' 41' ' ' LEU . 70.9 mt -53.4 -175.6 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.552 ' HB3' HG21 ' A' ' 50' ' ' VAL . 54.1 tp -113.0 130.91 55.97 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.509 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.417 ' O ' ' CG ' ' A' ' 46' ' ' ASP . 10.1 p-10 -85.45 87.41 7.39 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.302 0.573 . . . . 0.0 110.619 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.447 ' HB2' ' OD1' ' A' ' 49' ' ' ASP . 4.4 m -164.02 142.91 7.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.306 -178.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -36.27 -32.08 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.689 0.281 . . . . 0.0 111.578 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 1.065 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 29.4 p-10 -57.74 -42.62 84.3 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.055 0.455 . . . . 0.0 110.66 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.552 HG21 ' HB3' ' A' ' 45' ' ' LEU . 98.5 t -82.73 -45.78 19.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.788 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.912 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -48.65 -40.08 26.59 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.292 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.644 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 13.8 m-70 -78.62 -33.2 47.56 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.017 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.558 ' O ' HD13 ' A' ' 57' ' ' LEU . 7.8 tpt -54.36 -32.41 56.86 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 176.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.912 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.6 OUTLIER -84.08 -42.48 16.05 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.53 176.411 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.701 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 25.2 t-20 -60.25 -42.62 95.68 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.538 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 1.081 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -57.66 -47.23 82.87 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.752 0.787 . . . . 0.0 109.207 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.815 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -64.23 -39.71 94.54 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.253 -1.34 . . . . 0.0 107.775 177.147 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.701 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.1 m -61.44 -35.4 77.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.802 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.637 ' CB ' HD11 ' A' ' 90' ' ' LEU . . . -75.97 -38.04 57.91 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.267 -178.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.705 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -80.59 -14.01 58.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.287 0.565 . . . . 0.0 110.657 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.94 34.97 4.99 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.217 -0.901 . . . . 0.0 114.259 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.815 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 35.6 t -90.5 121.71 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.775 ' O ' HG12 ' A' ' 76' ' ' ILE . 2.7 t -85.68 135.06 33.92 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.462 -178.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.787 ' HB3' HG23 ' A' ' 75' ' ' ILE . 40.1 p90 -161.33 172.07 17.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.577 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 74' ' ' GLU . 85.9 m -135.68 146.41 47.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.462 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.652 HD12 ' HB2' ' A' ' 73' ' ' CYS . 9.3 tp -117.78 136.53 53.34 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.088 0.47 . . . . 0.0 110.716 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.432 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 1.2 t -59.95 -162.7 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.133 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -95.01 -29.4 14.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.157 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.03 1.88 25.94 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.181 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.493 ' HA ' HD21 ' A' ' 66' ' ' LEU . 1.3 mtt180 56.42 33.51 22.57 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.38 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.411 HG22 ' O ' ' A' ' 44' ' ' LEU . 1.1 p -130.95 -9.25 3.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.575 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -117.61 121.48 41.03 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.191 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.652 ' HB2' HD12 ' A' ' 66' ' ' LEU . 37.9 t -132.07 129.1 39.54 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.245 0.545 . . . . 0.0 112.041 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.708 ' HB2' HG22 ' A' ' 40' ' ' VAL . 64.2 tt0 -112.22 130.29 55.97 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 177.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 1.043 HD11 HD22 ' A' ' 29' ' ' LEU . 17.9 mt -126.35 122.17 60.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 -177.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.775 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -67.67 103.72 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-O 121.343 0.592 . . . . 0.0 109.508 175.78 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' A' ' 35' ' ' ALA . . . -43.44 151.44 0.45 Allowed Glycine 0 C--N 1.32 -0.324 0 CA-C-N 115.219 -0.9 . . . . 0.0 113.847 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 35' ' ' ALA . 5.8 t30 -97.34 -17.25 19.86 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.795 0.331 . . . . 0.0 111.347 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.11 -0.48 56.12 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.159 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.689 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 154.8 -150.71 22.32 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.167 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.598 ' CG ' ' HB3' ' A' ' 108' ' ' LEU . 73.1 Cg_exo -50.15 125.26 14.48 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.992 2.462 . . . . 0.0 112.98 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.705 ' HB2' HD13 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -74.21 106.27 5.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.901 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -81.67 133.77 35.4 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.333 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.607 ' CB ' HD11 ' A' ' 113' ' ' ILE . . . -97.05 129.8 44.44 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.25 123.97 23.45 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 176.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.59 -178.81 2.2 Favored Glycine 0 N--CA 1.44 -1.049 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 -175.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 112' ' ' ASP . . . -80.06 144.5 33.1 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 118.725 1.262 . . . . 0.0 112.025 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.636 HD21 ' C ' ' A' ' 59' ' ' ALA . 0.5 OUTLIER -114.63 161.06 18.59 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.089 -178.833 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.481 ' HG3' ' HB ' ' A' ' 114' ' ' VAL . 28.9 mp0 -139.31 105.28 5.19 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.099 178.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.748 ' HB3' HD11 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -105.11 116.92 32.76 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.886 -178.476 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.565 ' C ' HD13 ' A' ' 92' ' ' LEU . 7.6 m-85 -96.59 96.8 8.9 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.914 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -103.88 57.57 0.73 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.275 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.646 ' HA3' ' H ' ' A' ' 118' ' ' GLU . . . -50.35 -68.04 1.61 Allowed Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.592 -0.731 . . . . 0.0 113.499 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.526 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 83.5 m-20 -76.49 1.07 17.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.554 0.216 . . . . 0.0 111.299 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 1.065 ' HB2' ' HA ' ' A' ' 49' ' ' ASP . . . -99.87 54.12 0.92 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.948 0.404 . . . . 0.0 111.656 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -56.85 -25.39 52.41 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.31 -0.947 . . . . 0.0 111.339 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.478 HG23 ' OE1' ' A' ' 171' ' ' GLN . 0.1 OUTLIER -89.05 -14.36 36.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.685 -0.257 . . . . 0.0 111.656 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.863 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -96.83 -32.56 12.04 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.603 ' CG ' HD13 ' A' ' 126' ' ' ILE . 0.9 OUTLIER -61.73 -43.25 99.22 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.766 ' HD2' HD12 ' A' ' 126' ' ' ILE . 6.7 mpt_? -56.81 -60.5 9.24 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.895 ' HB2' HD22 ' A' ' 30' ' ' LEU . 14.1 Cg_endo -58.57 -34.73 99.05 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.513 2.142 . . . . 0.0 112.446 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 1.081 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -72.07 -52.49 16.6 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.145 179.703 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 1.018 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -53.13 -27.83 22.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.483 0.659 . . . . 0.0 110.311 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.858 ' CB ' ' HB1' ' A' ' 175' ' ' ALA . . . -86.5 -54.5 4.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.343 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.721 ' CB ' HD11 ' A' ' 30' ' ' LEU . . . -60.65 -34.44 74.29 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -177.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.704 ' HB2' HD12 ' A' ' 153' ' ' LEU . 31.2 mt -78.54 -23.06 46.41 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -176.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.558 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 13.7 p -78.42 16.1 0.87 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.161 0.505 . . . . 0.0 110.791 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.695 HD21 ' HB2' ' A' ' 182' ' ' LEU . 0.3 OUTLIER -82.98 -75.81 0.3 Allowed 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.032 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -70.69 -113.77 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.134 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.57 94.44 1.9 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.206 0.527 . . . . 0.0 110.793 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.657 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 17.3 p30 -145.27 139.12 26.88 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.378 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.877 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 1.2 m-20 -97.74 98.26 9.7 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.647 HD13 ' OD1' ' A' ' 111' ' ' ASN . 1.6 mp -120.35 147.92 23.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.253 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.859 HG13 ' CD2' ' A' ' 143' ' ' LEU . 47.1 t -115.34 113.76 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 176.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.617 HD23 ' HB2' ' A' ' 90' ' ' LEU . 77.6 mt -101.72 106.36 17.37 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.518 -178.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.663 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -119.04 -169.36 1.72 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.318 -179.232 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.479 ' HA3' ' HA2' ' A' ' 93' ' ' GLY . . . -171.35 -179.64 42.57 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.524 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.646 ' H ' ' HA3' ' A' ' 93' ' ' GLY . 39.0 mt-10 -70.15 169.61 12.86 Favored Pre-proline 0 C--N 1.331 -0.211 0 C-N-CA 123.207 0.603 . . . . 0.0 111.08 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.63 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 4.1 Cg_endo -45.08 -40.04 15.34 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.082 2.521 . . . . 0.0 113.077 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.3 mtm180 -67.84 -23.93 65.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.73 0.3 . . . . 0.0 110.716 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.633 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 10.5 tpt -60.96 -36.21 78.78 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.455 ' HA ' ' HG2' ' A' ' 149' ' ' PRO . 0.0 OUTLIER -61.47 -16.5 47.76 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.665 179.249 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -83.99 3.18 35.46 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.573 ' HB3' HH22 ' A' ' 100' ' ' ARG . 66.0 mtt-85 -127.62 83.26 66.55 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.352 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.466 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 38.1 Cg_exo -56.79 149.28 61.08 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.761 2.307 . . . . 0.0 111.701 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.766 HD12 ' HD2' ' A' ' 100' ' ' ARG . 1.0 OUTLIER -129.07 8.66 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.377 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.553 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -59.88 -39.84 96.02 Favored Glycine 0 CA--C 1.517 0.193 0 C-N-CA 120.749 -0.739 . . . . 0.0 113.764 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.803 ' CG ' HG21 ' A' ' 168' ' ' VAL . 26.0 m80 -55.71 -37.97 69.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.902 0.351 . . . . 0.0 110.54 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.772 ' HG ' HD11 ' A' ' 133' ' ' LEU . 29.3 tp -75.42 -40.46 57.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.241 0.544 . . . . 0.0 109.804 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.881 HG21 HD21 ' A' ' 151' ' ' LEU . 40.3 t -56.54 -47.98 81.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.331 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.692 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 0.1 OUTLIER -72.18 -35.94 69.13 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 121.298 0.571 . . . . 0.0 109.58 179.272 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.669 ' O ' HG13 ' A' ' 162' ' ' VAL . . . -57.31 -47.73 80.76 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.75 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.772 HD11 ' HG ' ' A' ' 129' ' ' LEU . 3.5 mt -75.94 -50.32 15.27 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.06 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.745 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.1 OUTLIER -54.71 -28.32 47.13 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.107 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.692 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 8.1 tp -69.01 -31.82 70.91 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 120.958 0.408 . . . . 0.0 110.902 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.464 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -81.86 11.64 46.45 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.787 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.49 6.54 56.44 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.764 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.673 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . . . -76.36 153.59 35.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.973 0.416 . . . . 0.0 111.481 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 0.4 OUTLIER -102.83 106.35 16.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.646 178.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.767 ' CG2' HG13 ' A' ' 130' ' ' VAL . 23.1 mt -137.91 125.88 30.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.485 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.781 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -123.56 139.48 53.96 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.519 -179.541 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.41 ' CE1' HG21 ' A' ' 130' ' ' VAL . 40.3 m-85 -79.71 131.05 35.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.469 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.859 ' CD2' HG13 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -91.52 -91.04 0.16 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.62 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.6 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 7.6 mm-40 -58.56 -81.68 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.676 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.512 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 0.2 OUTLIER -112.76 151.21 30.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.914 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 12.8 mt-10 -67.41 129.75 40.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.827 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.553 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 2.8 m120 71.04 17.91 6.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.068 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.62 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 16.8 m-85 -108.59 169.48 6.49 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 121.046 0.45 . . . . 0.0 111.992 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.918 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 48.9 Cg_exo -31.43 -62.67 0.12 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 124.384 3.389 . . . . 0.0 116.061 -177.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.918 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 65.3 Cg_exo -52.5 144.79 39.83 Favored 'Trans proline' 0 C--N 1.354 0.827 0 CA-C-N 120.626 1.259 . . . . 0.0 112.683 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.881 HD21 HG21 ' A' ' 130' ' ' VAL . 7.4 mt -155.9 136.85 13.59 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.023 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.781 ' HB2' HG22 ' A' ' 141' ' ' THR . 5.8 mtt180 -108.08 102.77 11.9 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 1.018 HD11 ' HA ' ' A' ' 103' ' ' ALA . 7.0 mt -90.73 145.83 24.49 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.861 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.657 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 6.5 mt-30 -149.3 26.19 0.87 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.164 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 53.78 -163.22 2.98 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.421 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.436 ' O ' HG23 ' A' ' 158' ' ' THR . . . 108.38 -16.27 35.06 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.005 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.73 ' HE2' ' HA ' ' A' ' 180' ' ' ALA . 67.0 t80 -58.55 122.97 14.71 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 117.081 0.44 . . . . 0.0 110.693 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.709 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 60.7 p -116.9 -28.84 6.18 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.495 0.664 . . . . 0.0 111.431 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 120.95 -169.47 14.27 Favored Glycine 0 C--N 1.306 -1.092 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.215 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.616 ' O ' ' HA ' ' A' ' 187' ' ' THR . . . 128.39 -126.13 5.26 Favored Glycine 0 N--CA 1.434 -1.468 0 N-CA-C 111.126 -0.789 . . . . 0.0 111.126 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.41 130.34 55.73 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.779 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 82.0 t -130.21 123.54 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 121.004 0.431 . . . . 0.0 110.687 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.17 119.99 38.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.665 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.714 HG11 ' HG ' ' A' ' 173' ' ' LEU . 1.0 OUTLIER -130.14 120.51 49.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.953 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.683 ' HA ' ' HG3' ' A' ' 192' ' ' LYS . 0.1 OUTLIER -51.94 137.89 25.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.298 0.571 . . . . 0.0 111.649 -179.737 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.881 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . -59.63 -50.6 66.03 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.603 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 92.5 p -95.93 91.96 6.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.705 0.288 . . . . 0.0 111.04 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.803 HG21 ' CG ' ' A' ' 128' ' ' HIS . 8.7 p -175.58 58.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.008 0.432 . . . . 0.0 111.243 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.733 ' C ' HG11 ' A' ' 196' ' ' VAL . 2.0 m 67.99 128.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.959 0.409 . . . . 0.0 110.833 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.496 ' N ' HG11 ' A' ' 196' ' ' VAL . 0.3 OUTLIER -75.74 -17.4 59.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.698 -179.393 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.54 ' O ' ' HB3' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -74.37 -6.01 45.64 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.122 -179.74 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.663 ' CD1' ' HB2' ' A' ' 169' ' ' SER . 5.5 m-85 -76.27 -55.96 5.08 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.898 HD11 ' CG1' ' A' ' 191' ' ' ILE . 0.4 OUTLIER -61.74 -40.95 96.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.606 0.717 . . . . 0.0 109.084 178.057 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.482 ' HB ' ' HA ' ' A' ' 171' ' ' GLN . 5.5 m -55.82 -36.49 67.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.528 -1.214 . . . . 0.0 110.01 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.858 ' HB1' ' CB ' ' A' ' 104' ' ' ALA . . . -69.17 -40.29 78.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.563 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.695 HD11 HG21 ' A' ' 164' ' ' VAL . 0.4 OUTLIER -76.64 -33.32 58.34 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.149 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.783 HD11 ' CD2' ' A' ' 223' ' ' PHE . 5.1 mp -59.76 -38.13 80.94 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.908 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.649 ' HE1' ' HA ' ' A' ' 27' ' ' ARG . 0.4 OUTLIER -82.07 -43.03 18.4 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.469 0.652 . . . . 0.0 112.112 -179.66 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.619 HG23 ' HG ' ' A' ' 108' ' ' LEU . 54.4 m -71.41 -41.13 69.97 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.471 -178.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.73 ' HA ' ' HE2' ' A' ' 157' ' ' PHE . . . -59.72 -42.15 89.78 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -177.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.589 ' HB3' ' NE2' ' A' ' 229' ' ' GLN . 29.8 Cg_endo -64.77 -29.04 59.45 Favored 'Trans proline' 0 CA--C 1.5 -1.205 0 C-N-CA 120.956 1.104 . . . . 0.0 111.637 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.695 ' HB2' HD21 ' A' ' 108' ' ' LEU . 6.9 mt -83.73 1.56 42.12 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.358 178.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.66 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -83.59 138.53 41.12 Favored Pre-proline 0 C--O 1.224 -0.289 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.709 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 12.9 Cg_endo -51.84 -31.86 44.26 Favored 'Trans proline' 0 CA--C 1.518 -0.28 0 C-N-CA 122.45 2.1 . . . . 0.0 113.117 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -114.89 143.6 44.88 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.892 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -57.8 141.01 50.36 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.076 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 160' ' ' GLY . 70.7 m -119.01 145.85 45.51 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.652 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 35.3 t -125.63 118.94 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.438 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.779 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 4.1 mp -104.03 117.09 48.99 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.655 0 C-N-CA 120.079 -0.648 . . . . 0.0 109.276 178.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.888 ' HG3' ' HG3' ' A' ' 222' ' ' GLN . 1.7 ttt180 -99.88 123.57 44.27 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.898 ' CG1' HD11 ' A' ' 173' ' ' LEU . 1.3 mp -93.11 121.88 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.088 -176.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.683 ' HG3' ' HA ' ' A' ' 165' ' ' ASP . 0.5 OUTLIER -74.87 96.62 3.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.346 -178.594 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 97.36 -126.9 9.03 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.793 -0.717 . . . . 0.0 111.702 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -116.85 133.54 55.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.769 0.318 . . . . 0.0 111.321 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.721 HD11 ' HZ ' ' A' ' 223' ' ' PHE . 0.8 OUTLIER -41.91 144.68 0.4 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.211 0.529 . . . . 0.0 111.902 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.733 HG11 ' C ' ' A' ' 169' ' ' SER . 13.9 p -74.48 -25.38 19.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.975 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.475 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 0.3 OUTLIER -168.48 64.7 0.07 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.833 0.349 . . . . 0.0 110.934 -179.531 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.56 ' HA ' HD13 ' A' ' 195' ' ' LEU . 4.4 tptp -39.48 -46.23 4.13 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.382 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 72.6 Cg_exo -49.61 -36.78 41.72 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.006 1.804 . . . . 0.0 111.843 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.943 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.2 OUTLIER -65.62 -44.53 86.2 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 178.42 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.46 HG21 ' HE2' ' A' ' 223' ' ' PHE . 30.9 mm -60.9 -38.4 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.472 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.45 -43.63 93.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.229 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.943 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.6 mt -62.43 -50.95 77.83 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 CA-C-O 121.569 0.7 . . . . 0.0 109.635 178.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.544 HG22 ' SD ' ' A' ' 208' ' ' MET . 78.5 m -53.66 -51.65 62.49 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.991 -178.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.755 HD22 ' HB ' ' A' ' 215' ' ' ILE . 32.2 mt -65.31 -30.18 71.0 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.001 0.429 . . . . 0.0 111.534 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ASN . . . . . 0.559 ' HA ' ' HE3' ' A' ' 209' ' ' LYS . 1.0 OUTLIER -77.5 -46.37 22.65 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.734 0.778 . . . . 0.0 109.77 179.007 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.91 ' O ' HG22 ' A' ' 210' ' ' THR . 2.6 tp -71.26 -30.02 65.8 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.24 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' MET . . . . . 0.759 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 40.8 mtp -75.04 -35.63 61.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.647 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 12.8 mtmt -60.65 -37.71 82.43 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.046 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.91 HG22 ' O ' ' A' ' 207' ' ' LEU . 5.8 t -62.61 -28.88 70.2 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.718 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.574 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 42.7 m-85 -80.52 -6.98 59.01 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.579 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.99 7.65 24.9 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 115.98 1.152 . . . . 0.0 115.98 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.2 m -123.36 148.59 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 118.929 1.364 . . . . 0.0 112.794 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.509 ' O ' HD13 ' A' ' 215' ' ' ILE . 18.0 mt-10 -130.84 136.21 48.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.811 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.755 ' HB ' HD22 ' A' ' 205' ' ' LEU . 16.8 mm -118.66 148.12 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 120.845 0.355 . . . . 0.0 110.565 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.55 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 2.6 tt0 -100.63 118.26 36.42 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.916 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -82.84 150.98 26.24 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.934 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' GLN . . . . . 0.517 ' CB ' ' HB3' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -106.74 -138.26 0.37 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.114 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.493 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 0.1 OUTLIER -84.87 66.67 9.81 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.827 0.346 . . . . 0.0 111.008 -179.451 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 5.5 t80 60.07 33.04 21.24 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.82 0.819 . . . . 0.0 110.439 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.675 ' CB ' ' HB ' ' A' ' 191' ' ' ILE . 1.8 pt20 -166.39 -124.77 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.888 ' HG3' ' HG3' ' A' ' 190' ' ' ARG . 0.7 OUTLIER -5.43 130.09 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.783 ' CD2' HD11 ' A' ' 177' ' ' LEU . 1.2 m-85 -125.07 133.37 52.93 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 112.977 -1.92 . . . . 0.0 109.509 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 61.3 t -116.96 113.51 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-O 121.573 0.702 . . . . 0.0 109.206 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.739 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -120.22 122.29 67.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.152 -178.776 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.572 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 0.1 OUTLIER -76.84 123.43 26.24 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.806 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -75.54 -177.11 40.71 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.718 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 65.5 21.72 69.0 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 121.573 -0.346 . . . . 0.0 113.036 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' GLN . . . . . 0.589 ' NE2' ' HB3' ' A' ' 181' ' ' PRO . 43.9 mt-30 -77.41 179.58 6.36 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.298 0.57 . . . . 0.0 111.338 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 13.6 t -138.01 147.8 44.53 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.869 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' TYR . . . . . 0.681 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 1.1 m-30 -107.83 123.76 49.07 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.894 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.96 161.3 20.02 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.553 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.12 113.34 57.95 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-O 120.835 0.35 . . . . 0.0 111.43 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.517 ' HG3' HG23 ' A' ' 210' ' ' THR . 58.8 Cg_endo -69.65 1.98 3.88 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.656 2.237 . . . . 0.0 112.875 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 98.99 -100.5 2.29 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.344 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 92.2 m -119.35 133.15 55.87 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.712 ' CD2' HG21 ' A' ' 210' ' ' THR . 4.4 t80 -129.74 133.21 46.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.873 0.368 . . . . 0.0 111.117 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.907 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -97.18 110.52 23.05 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.201 0.524 . . . . 0.0 110.524 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.621 ' N ' HD22 ' A' ' 238' ' ' LEU . 21.9 t -79.06 113.51 18.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.421 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.212 -0.899 . . . . 0.0 111.156 -179.984 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.492 ' N ' HG11 ' A' ' 239' ' ' VAL . 5.0 p . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.536 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 17.5 m120 -73.23 -65.63 0.78 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.837 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.596 ' HB2' HD21 ' A' ' 207' ' ' LEU . 0.5 OUTLIER -65.37 -57.99 7.0 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.345 0.593 . . . . 0.0 110.171 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.692 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -40.73 -44.39 2.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.958 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.975 HD22 HD11 ' A' ' 75' ' ' ILE . 14.2 mt -71.68 -37.47 70.74 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.918 0.39 . . . . 0.0 111.213 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.681 HD11 ' CB ' ' A' ' 105' ' ' ALA . 56.9 tp -65.32 -49.95 67.48 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.917 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.692 HD11 ' HG2' ' A' ' 208' ' ' MET . 20.1 mt -69.33 -26.17 64.57 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.765 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -63.79 -41.82 97.85 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.221 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.83 ' CB ' HG11 ' A' ' 62' ' ' VAL . . . -80.47 -40.17 26.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.73 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.687 HD11 ' HB1' ' A' ' 105' ' ' ALA . 9.1 mt -67.48 -3.4 8.43 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.451 178.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.505 ' HA ' ' CB ' ' A' ' 231' ' ' TYR . . . -99.84 177.26 5.17 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -177.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.546 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.3 OUTLIER -111.28 114.39 27.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.656 178.357 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 114.28 167.48 15.97 Favored Glycine 0 C--O 1.228 -0.28 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.202 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.653 ' HG3' HG23 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -95.34 117.53 30.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 117.284 0.542 . . . . 0.0 111.55 -179.439 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 0.9 OUTLIER -118.8 147.03 44.34 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.242 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.672 HG22 ' HB2' ' A' ' 74' ' ' GLU . 96.6 t -105.91 141.25 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 CA-C-O 121.385 0.612 . . . . 0.0 112.437 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.923 HD23 HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -116.02 116.32 27.69 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 174.733 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.867 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.5 OUTLIER -103.15 152.93 20.86 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.228 -177.75 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.4 t30 68.8 24.71 6.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.514 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.813 HD21 ' CB ' ' A' ' 41' ' ' LEU . 34.8 mt -53.86 -175.55 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.951 0.405 . . . . 0.0 110.151 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.558 ' HB3' HG21 ' A' ' 50' ' ' VAL . 28.3 tp -111.78 132.28 54.77 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.163 -0.472 . . . . 0.0 109.995 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -88.52 89.26 7.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.835 0.35 . . . . 0.0 110.896 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 50' ' ' VAL . 36.5 m -163.79 142.17 7.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.057 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.583 ' HA ' ' HB3' ' A' ' 51' ' ' ARG . 1.6 p30 -37.89 -31.25 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.662 0.268 . . . . 0.0 111.429 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.875 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 0.7 OUTLIER -57.29 -42.72 82.25 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.024 0.44 . . . . 0.0 110.435 179.308 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.671 HG23 ' OD1' ' A' ' 49' ' ' ASP . 98.0 t -81.66 -45.08 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.873 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -49.62 -39.13 34.64 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 177.932 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.618 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 14.7 m-70 -78.64 -33.25 47.38 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.908 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.588 ' O ' HD13 ' A' ' 57' ' ' LEU . 9.4 tpt -55.5 -35.58 65.74 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 176.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.873 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.5 OUTLIER -81.88 -44.43 16.85 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 114.162 -1.381 . . . . 0.0 108.522 176.598 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.732 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 0.3 OUTLIER -57.31 -38.59 74.27 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.354 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 1.036 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -60.54 -44.79 95.73 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.801 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.2 OUTLIER -65.59 -38.83 90.6 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.1 -1.409 . . . . 0.0 107.752 176.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.732 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.2 m -63.02 -33.76 76.11 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.528 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.782 ' CB ' HD11 ' A' ' 90' ' ' LEU . . . -74.22 -37.13 63.93 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.341 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.714 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -83.54 -13.92 53.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.171 0.51 . . . . 0.0 111.058 -179.464 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.07 35.01 4.65 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.42 -0.809 . . . . 0.0 114.123 178.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.83 HG11 ' CB ' ' A' ' 33' ' ' ALA . 38.2 t -90.69 122.13 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.756 ' O ' HG12 ' A' ' 76' ' ' ILE . 5.5 m -84.88 132.54 34.38 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 120.911 0.386 . . . . 0.0 111.711 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.755 ' HB3' HG23 ' A' ' 75' ' ' ILE . 41.4 p90 -158.03 167.93 28.51 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.378 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 74' ' ' GLU . 40.7 m -129.81 147.31 51.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.372 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.45 HD12 ' HB2' ' A' ' 73' ' ' CYS . 12.3 tp -115.59 132.4 56.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.235 0.541 . . . . 0.0 110.487 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 0.2 OUTLIER -59.22 -161.2 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.554 -179.451 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -95.56 -32.02 13.03 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.549 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -79.84 1.24 27.7 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.261 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 30.6 mtt-85 57.88 35.33 25.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.996 0.426 . . . . 0.0 110.888 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -134.21 -4.5 2.71 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.626 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.545 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 3.4 mtp-105 -121.62 122.09 38.86 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.622 ' HB3' HD11 ' A' ' 44' ' ' LEU . 28.8 t -131.18 126.9 36.81 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 120.989 0.424 . . . . 0.0 112.069 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.672 ' HB2' HG22 ' A' ' 40' ' ' VAL . 58.6 tt0 -110.63 131.65 54.87 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 176.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.975 HD11 HD22 ' A' ' 29' ' ' LEU . 13.2 mt -126.42 121.81 59.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.756 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -67.23 98.4 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-O 121.486 0.66 . . . . 0.0 109.252 175.864 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -35.15 145.04 0.06 OUTLIER Glycine 0 C--N 1.32 -0.344 0 CA-C-N 114.56 -1.2 . . . . 0.0 114.125 -178.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.47 ' CB ' HD12 ' A' ' 82' ' ' LEU . 1.1 t-20 -90.74 -13.11 34.66 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.06 0.457 . . . . 0.0 110.789 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.546 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 91.81 1.78 70.25 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.697 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.637 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 149.97 -147.61 18.01 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.035 -0.602 . . . . 0.0 111.742 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.429 ' HD2' ' HA3' ' A' ' 80' ' ' GLY . 5.7 Cg_endo -49.05 122.66 8.71 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.596 2.198 . . . . 0.0 112.524 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.714 ' HB2' HD13 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -73.33 110.75 7.86 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.27 179.653 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.408 ' HA ' ' ND2' ' A' ' 111' ' ' ASN . 4.5 p80 -82.24 130.31 35.06 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.592 ' CB ' HD22 ' A' ' 88' ' ' LEU . . . -94.46 122.79 37.39 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.672 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -71.19 123.74 22.89 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 176.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.86 174.54 1.2 Allowed Glycine 0 N--CA 1.439 -1.124 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 -175.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 112' ' ' ASP . . . -72.95 144.8 47.14 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 118.705 1.253 . . . . 0.0 111.923 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.666 HD21 ' C ' ' A' ' 59' ' ' ALA . 0.5 OUTLIER -112.27 160.94 17.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.001 -0.999 . . . . 0.0 112.127 -178.622 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 18.8 mt-10 -140.21 101.3 4.11 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.022 177.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.782 HD11 ' CB ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -100.79 120.1 39.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.872 0.368 . . . . 0.0 111.346 -178.58 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.46 ' C ' HD13 ' A' ' 92' ' ' LEU . 1.4 m-85 -95.27 96.45 9.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.823 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.807 HD23 ' SD ' ' A' ' 99' ' ' MET . 0.1 OUTLIER -103.54 52.89 0.76 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.351 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.572 ' HA3' ' H ' ' A' ' 118' ' ' GLU . . . -49.82 -75.13 0.22 Allowed Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.408 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 50.0 m-80 -77.51 -0.68 27.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.501 0.191 . . . . 0.0 110.97 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.894 ' HB1' ' HB3' ' A' ' 98' ' ' ALA . . . -92.18 46.53 1.27 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.81 0.338 . . . . 0.0 111.336 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -52.74 -24.37 18.5 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.297 -0.954 . . . . 0.0 111.811 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.504 HG22 ' OE1' ' A' ' 171' ' ' GLN . 0.9 OUTLIER -87.69 -19.69 27.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.471 0.177 . . . . 0.0 111.167 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.894 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -94.18 -31.69 14.03 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.648 0.261 . . . . 0.0 111.452 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.807 ' SD ' HD23 ' A' ' 92' ' ' LEU . 5.3 tpp -64.57 -47.35 79.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.716 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.67 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -55.18 -56.35 29.33 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.67 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 18.7 Cg_exo -64.73 -30.49 59.43 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.126 1.884 . . . . 0.0 112.63 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 1.036 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -72.57 -53.16 12.72 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.193 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.898 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -52.89 -27.08 16.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.33 0.586 . . . . 0.0 110.509 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.695 ' HB2' ' HB1' ' A' ' 175' ' ' ALA . . . -86.62 -53.92 4.68 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.131 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.687 ' HB1' HD11 ' A' ' 34' ' ' LEU . . . -60.57 -36.51 78.67 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -177.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.644 ' HB2' HD12 ' A' ' 153' ' ' LEU . 27.4 mt -76.28 -12.88 60.15 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.593 ' SG ' HD22 ' A' ' 153' ' ' LEU . 69.3 m -86.73 20.12 2.67 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.25 0.548 . . . . 0.0 110.427 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.722 HD21 ' HB2' ' A' ' 182' ' ' LEU . 2.4 mt -85.93 -75.02 0.39 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.019 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -69.7 -117.07 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.487 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.35 96.4 1.92 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.045 0.45 . . . . 0.0 110.123 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.703 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 10.5 m-80 -148.51 143.99 27.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.116 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.837 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 13.4 m-20 -95.99 99.98 11.7 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.303 0.573 . . . . 0.0 110.149 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.53 HG13 ' CB ' ' A' ' 88' ' ' LEU . 1.9 mp -118.15 146.08 23.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.941 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.785 HG13 ' CD2' ' A' ' 143' ' ' LEU . 48.5 t -115.49 112.86 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 176.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.673 HD23 ' HB2' ' A' ' 90' ' ' LEU . 31.0 mt -102.03 106.52 17.43 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.497 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.767 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -118.88 -170.83 1.98 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.037 -179.044 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.476 ' HA3' ' HG2' ' A' ' 121' ' ' MET . . . -170.08 179.13 42.53 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.968 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.661 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 2.9 mt-10 -72.32 169.72 15.61 Favored Pre-proline 0 C--N 1.332 -0.188 0 C-N-CA 123.573 0.749 . . . . 0.0 111.248 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.661 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 2.5 Cg_endo -43.56 -39.78 9.98 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.096 2.531 . . . . 0.0 113.193 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.8 mtm-85 -67.63 -24.4 65.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.667 0.27 . . . . 0.0 110.838 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.631 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 9.2 tpt -61.1 -34.94 75.75 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.424 ' HA ' ' HG2' ' A' ' 149' ' ' PRO . 0.0 OUTLIER -61.92 -16.69 52.81 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.463 179.139 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -87.59 4.17 44.76 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.934 0.397 . . . . 0.0 109.986 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 34.1 mtt85 -127.12 83.77 65.15 Favored Pre-proline 0 N--CA 1.454 -0.242 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.866 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.505 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 19.7 Cg_endo -58.02 148.76 75.12 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.675 2.25 . . . . 0.0 111.501 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.471 ' O ' HG13 ' A' ' 126' ' ' ILE . 0.6 OUTLIER -125.48 -2.49 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -179.262 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.547 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -54.03 -34.7 52.73 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.713 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.508 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 13.3 m80 -58.53 -40.14 82.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.146 0.473 . . . . 0.0 110.142 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.786 ' HG ' HD11 ' A' ' 133' ' ' LEU . 16.4 tp -76.12 -40.59 52.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.705 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.733 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 46.1 t -56.0 -47.42 80.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.262 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.792 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 3.3 m-20 -71.27 -35.93 71.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.019 0.437 . . . . 0.0 110.025 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.62 ' HB2' HG23 ' A' ' 164' ' ' VAL . . . -60.84 -44.55 96.81 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.578 178.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.786 HD11 ' HG ' ' A' ' 129' ' ' LEU . 6.2 mt -77.08 -50.32 13.32 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.315 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.733 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -56.75 -27.94 60.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.759 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.792 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 5.6 tp -69.45 -31.76 70.27 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.779 178.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.48 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -83.09 13.52 44.13 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.038 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.78 3.15 58.3 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.941 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.513 ' HB2' ' HD1' ' A' ' 157' ' ' PHE . . . -71.53 152.12 43.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.737 0.304 . . . . 0.0 111.568 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 0.6 OUTLIER -101.74 101.44 11.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.76 178.418 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.716 ' HB ' ' HG3' ' A' ' 134' ' ' ARG . 19.8 mt -133.39 126.91 53.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.369 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.671 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -124.05 139.56 53.82 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 116.262 -0.427 . . . . 0.0 109.938 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.515 ' HE1' HG21 ' A' ' 130' ' ' VAL . 31.3 m-85 -80.58 132.81 35.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.652 0.263 . . . . 0.0 111.278 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.785 ' CD2' HG13 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -92.57 -91.33 0.17 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.698 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.556 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 40.6 mt-10 -57.18 -81.87 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.649 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.428 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 23.2 mt-30 -113.61 151.05 32.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.788 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 0.8 OUTLIER -67.91 130.98 44.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.839 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.547 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 1.9 m-20 71.82 17.75 5.29 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.04 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.571 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 18.7 m-85 -111.14 168.25 7.85 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-O 121.294 0.569 . . . . 0.0 112.352 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.894 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 1.4 Cg_exo -29.59 -63.12 0.09 OUTLIER 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 124.796 3.664 . . . . 0.0 116.779 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.894 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 58.5 Cg_exo -54.37 147.18 47.7 Favored 'Trans proline' 0 C--N 1.356 0.954 0 CA-C-N 121.301 1.501 . . . . 0.0 112.94 -178.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.78 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 7.8 mt -156.81 136.57 12.44 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.938 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.671 ' HB2' HG22 ' A' ' 141' ' ' THR . 6.8 mtp180 -106.99 102.75 12.08 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.898 HD11 ' HA ' ' A' ' 103' ' ' ALA . 6.6 mt -91.12 145.45 24.67 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.569 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.703 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 5.6 mt-30 -147.24 24.79 1.13 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.472 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 53.41 -173.38 0.46 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.894 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 118.35 -10.07 13.17 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.039 -1.076 . . . . 0.0 112.948 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.638 ' HE2' ' HA ' ' A' ' 180' ' ' ALA . 44.6 t80 -61.41 124.62 21.12 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 117.257 0.529 . . . . 0.0 110.441 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.671 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 66.4 p -118.32 -29.51 5.5 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 121.429 0.633 . . . . 0.0 111.411 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.407 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 133.13 -160.68 23.99 Favored Glycine 0 C--N 1.308 -1.02 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.416 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.6 ' O ' HG23 ' A' ' 187' ' ' THR . . . 105.46 154.31 21.77 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.814 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -46.72 114.47 0.83 Allowed 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.407 -0.396 . . . . 0.0 111.019 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.754 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 69.1 t -107.9 121.66 61.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.317 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -91.6 119.69 31.73 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.682 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.78 HG11 ' HG ' ' A' ' 173' ' ' LEU . 1.2 t -132.27 122.29 47.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.459 ' HB3' ' CG2' ' A' ' 168' ' ' VAL . 0.6 OUTLIER -56.72 139.43 50.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.059 0.456 . . . . 0.0 111.638 -179.153 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.678 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . -61.0 -51.03 61.08 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.657 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.9 m -85.0 90.47 7.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.865 0.364 . . . . 0.0 110.642 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.654 ' H ' ' HB ' ' A' ' 196' ' ' VAL . 58.8 t -149.45 -92.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.246 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.585 ' C ' HG11 ' A' ' 196' ' ' VAL . 0.6 OUTLIER -157.43 127.83 6.4 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.317 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.597 ' HB2' ' HB3' ' A' ' 200' ' ' TYR . 0.3 OUTLIER -55.9 -23.78 33.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.001 -178.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.562 ' HB3' HH21 ' A' ' 27' ' ' ARG . 0.0 OUTLIER -81.71 -12.2 58.73 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.983 -179.692 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.563 ' CD2' ' HB2' ' A' ' 129' ' ' LEU . 6.2 m-85 -75.33 -56.67 4.49 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.959 HD13 HD21 ' A' ' 195' ' ' LEU . 0.2 OUTLIER -62.26 -43.6 98.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.454 178.587 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.706 HG23 ' CG2' ' A' ' 204' ' ' THR . 1.8 m -56.06 -41.11 74.58 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.902 178.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.695 ' HB1' ' HB2' ' A' ' 104' ' ' ALA . . . -57.87 -37.79 74.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.52 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.756 HD13 HG12 ' A' ' 189' ' ' ILE . 0.7 OUTLIER -76.63 -37.04 57.03 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.383 0.611 . . . . 0.0 110.238 178.88 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.699 HD11 ' CD2' ' A' ' 223' ' ' PHE . 4.3 mp -59.61 -34.48 72.82 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.693 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.621 ' CE ' HD21 ' A' ' 31' ' ' LEU . 8.8 mtp -81.84 -42.38 19.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.373 0.606 . . . . 0.0 112.185 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.527 HG23 ' HG ' ' A' ' 108' ' ' LEU . 88.3 m -75.04 -40.82 60.12 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.546 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.638 ' HA ' ' HE2' ' A' ' 157' ' ' PHE . . . -59.88 -39.74 72.61 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 -176.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.596 ' HD3' ' O ' ' A' ' 177' ' ' LEU . 31.2 Cg_endo -68.4 -27.4 33.86 Favored 'Trans proline' 0 CA--C 1.498 -1.305 0 CA-C-N 120.241 1.122 . . . . 0.0 111.949 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.722 ' HB2' HD21 ' A' ' 108' ' ' LEU . 9.6 mt -85.05 0.35 51.84 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.643 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -81.79 137.43 47.26 Favored Pre-proline 0 C--O 1.224 -0.241 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.187 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.671 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 14.3 Cg_endo -52.27 -30.68 43.27 Favored 'Trans proline' 0 CA--C 1.519 -0.269 0 C-N-CA 122.483 2.122 . . . . 0.0 113.178 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.76 138.48 50.69 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.905 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -55.1 142.3 31.23 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.049 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 160' ' ' GLY . 87.0 m -120.31 144.42 47.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.205 0.526 . . . . 0.0 112.21 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 18.0 t -125.73 118.03 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.187 177.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.766 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 2.7 mp -101.16 117.86 47.04 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.722 ' HG3' ' HG3' ' A' ' 222' ' ' GLN . 0.2 OUTLIER -99.78 123.66 44.26 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.848 ' CG1' HD11 ' A' ' 173' ' ' LEU . 1.7 mp -93.71 124.99 46.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.063 -175.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -83.05 96.92 8.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.064 -1.426 . . . . 0.0 110.502 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 100.98 -129.81 10.02 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.933 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.32 129.0 56.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.709 0.29 . . . . 0.0 111.577 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.959 HD21 HD13 ' A' ' 173' ' ' LEU . 1.9 mt -41.43 144.68 0.33 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.654 ' HB ' ' H ' ' A' ' 168' ' ' VAL . 8.6 p -71.56 -36.64 60.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.196 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.425 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 2.0 t -160.72 62.33 0.31 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.258 0.552 . . . . 0.0 109.977 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.699 ' HA ' HD13 ' A' ' 195' ' ' LEU . 5.5 tmtt? -38.93 -47.68 3.72 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.829 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.671 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 5.0 Cg_endo -46.68 -33.71 14.09 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.178 1.919 . . . . 0.0 111.771 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.955 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.2 OUTLIER -67.26 -44.36 79.59 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.502 HG21 ' HE2' ' A' ' 223' ' ' PHE . 14.7 mm -56.71 -39.79 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 CA-C-N 114.286 -1.324 . . . . 0.0 110.348 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -58.05 -45.15 87.51 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.044 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.955 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.8 mt -61.27 -50.4 80.6 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.022 0 CA-C-O 121.786 0.803 . . . . 0.0 109.068 178.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.706 ' CG2' HG23 ' A' ' 174' ' ' THR . 87.1 m -53.15 -51.6 61.46 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.971 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.903 HD22 ' HB ' ' A' ' 215' ' ' ILE . 34.1 mt -67.99 -29.24 68.22 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 120.98 0.419 . . . . 0.0 111.663 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -78.07 -46.56 20.51 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.733 0.778 . . . . 0.0 109.664 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.961 ' O ' HG22 ' A' ' 210' ' ' THR . 2.3 tp -69.7 -29.65 67.11 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.288 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' MET . . . . . 0.692 ' HG2' HD11 ' A' ' 31' ' ' LEU . 3.9 mmm -75.98 -34.23 59.77 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.551 0.691 . . . . 0.0 109.624 178.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.652 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 7.4 mtmt -63.52 -35.97 82.22 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.439 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.961 HG22 ' O ' ' A' ' 207' ' ' LEU . 3.9 t -62.6 -27.29 69.09 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.629 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.563 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 27.5 m-85 -83.64 -6.81 59.54 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.019 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.63 7.29 26.05 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 115.782 1.073 . . . . 0.0 115.782 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 5.0 m -123.29 148.76 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 118.513 1.157 . . . . 0.0 112.049 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.471 ' CG ' ' HG2' ' A' ' 209' ' ' LYS . 13.2 mt-10 -130.09 134.33 47.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.403 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.903 ' HB ' HD22 ' A' ' 205' ' ' LEU . 8.9 mm -117.5 148.66 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 120.818 0.342 . . . . 0.0 110.247 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.618 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 19.9 tt0 -104.81 116.65 32.37 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.612 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.18 151.01 27.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.596 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' GLN . . . . . 0.694 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -109.08 -148.31 0.42 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.65 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.55 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 0.2 OUTLIER -72.38 66.91 0.69 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.847 0.356 . . . . 0.0 111.515 -179.491 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 1.7 t80 56.75 31.73 19.95 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.06 0.934 . . . . 0.0 110.625 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.689 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 4.2 pt20 -159.33 -129.27 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.766 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.1 OUTLIER -4.02 131.12 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 179.698 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.83 ' HZ ' HD11 ' A' ' 195' ' ' LEU . 1.1 m-85 -125.17 129.89 51.05 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 113.107 -1.86 . . . . 0.0 108.852 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.618 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 42.9 t -114.98 113.94 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-O 121.602 0.715 . . . . 0.0 109.62 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.674 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -120.35 124.3 72.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.121 -178.877 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.605 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 2.0 mptt -76.76 125.06 28.62 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -78.64 -178.31 50.01 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.393 -0.908 . . . . 0.0 113.23 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 64.81 21.26 67.26 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 121.346 -0.454 . . . . 0.0 112.935 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' GLN . . . . . 0.605 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 34.5 mt-30 -75.2 176.39 7.39 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.386 0.612 . . . . 0.0 111.649 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 5.4 p -136.09 147.88 48.03 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.323 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' TYR . . . . . 0.653 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 5.2 m-30 -107.75 132.07 53.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.759 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.63 147.92 48.23 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.505 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.38 111.46 14.11 Favored Pre-proline 0 N--CA 1.45 -0.435 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.657 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.475 ' HG3' HG23 ' A' ' 210' ' ' THR . 56.2 Cg_endo -69.59 3.04 2.91 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.454 2.102 . . . . 0.0 112.622 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 95.84 -103.9 3.02 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.242 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.495 HG23 ' HB ' ' A' ' 40' ' ' VAL . 27.2 m -115.42 137.11 52.4 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.719 ' CD2' HG21 ' A' ' 210' ' ' THR . 7.5 t80 -132.72 126.7 33.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.955 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.867 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -94.53 111.03 22.79 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.099 0.476 . . . . 0.0 110.942 -179.685 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.618 ' N ' HD22 ' A' ' 238' ' ' LEU . 43.1 t -81.02 113.36 20.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.95 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.164 -179.75 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.753 ' HB2' HG22 ' A' ' 50' ' ' VAL . 1.5 m . . . . . 0 N--CA 1.485 1.315 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.526 HD21 ' N ' ' A' ' 26' ' ' ASN . 0.8 OUTLIER -77.72 -71.56 0.41 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.912 0.387 . . . . 0.0 111.102 -179.573 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.641 ' HA ' ' HE1' ' A' ' 178' ' ' MET . 66.4 mtm-85 -60.99 -57.7 11.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.52 0.676 . . . . 0.0 110.338 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.577 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -40.73 -45.89 2.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.633 -1.167 . . . . 0.0 112.077 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.095 HD22 HD11 ' A' ' 75' ' ' ILE . 12.6 mt -73.87 -34.57 64.52 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 120.92 0.39 . . . . 0.0 111.163 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.785 HD22 ' HB2' ' A' ' 101' ' ' PRO . 45.6 tp -68.58 -50.33 52.52 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.911 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.78 HD22 ' CZ ' ' A' ' 231' ' ' TYR . 50.7 mt -67.08 -27.15 67.12 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.416 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.82 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -66.14 -39.18 89.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.104 178.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.782 ' CB ' HG11 ' A' ' 62' ' ' VAL . . . -80.73 -40.79 24.64 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.013 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.782 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 14.0 mt -67.54 -3.61 9.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.102 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.637 ' HB2' ' HB3' ' A' ' 231' ' ' TYR . . . -99.72 -179.86 4.31 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -177.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.627 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.3 OUTLIER -113.89 111.52 21.84 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.526 178.165 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.72 166.15 14.2 Favored Glycine 0 C--N 1.32 -0.315 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -178.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.604 ' HE2' HG23 ' A' ' 76' ' ' ILE . 2.5 ttmt -95.81 118.66 32.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.992 0.396 . . . . 0.0 111.902 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.577 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 0.9 OUTLIER -117.47 145.08 44.41 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.249 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.502 ' C ' HD13 ' A' ' 41' ' ' LEU . 97.1 t -102.66 141.34 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-O 121.581 0.705 . . . . 0.0 112.423 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.826 HD23 HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -115.74 116.47 28.12 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 174.403 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.971 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.5 OUTLIER -103.93 148.11 26.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.868 0.365 . . . . 0.0 110.992 -177.601 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.461 ' HB2' HD23 ' A' ' 238' ' ' LEU . 2.0 t30 69.12 26.18 5.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.063 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.783 HD21 ' CB ' ' A' ' 41' ' ' LEU . 79.6 mt -52.66 -178.21 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.153 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.577 HD23 ' OD2' ' A' ' 49' ' ' ASP . 34.7 tp -109.79 131.21 55.27 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.205 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -86.78 87.14 7.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.008 0.433 . . . . 0.0 110.386 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.562 ' HB3' ' OD1' ' A' ' 49' ' ' ASP . 11.2 t -164.11 142.64 7.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.702 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.577 ' HB2' ' HB2' ' A' ' 94' ' ' ASN . 5.2 m-20 -37.09 -30.3 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.648 ' CB ' ' HA ' ' A' ' 95' ' ' ALA . 34.5 p-10 -56.85 -42.59 80.0 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.36 0.6 . . . . 0.0 110.208 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.753 HG22 ' HB2' ' A' ' 25' ' ' SER . 64.6 t -83.44 -47.95 17.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.191 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.905 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -50.41 -37.97 40.59 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 178.72 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.659 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 7.4 m-70 -80.44 -32.69 37.26 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.842 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.574 ' HG2' ' O ' ' A' ' 25' ' ' SER . 8.6 tpt -55.09 -35.27 64.41 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 176.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.905 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.5 OUTLIER -81.82 -42.49 19.6 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.398 176.328 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.694 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 24.6 t30 -60.77 -34.25 74.17 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.178 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 1.026 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -64.6 -46.95 80.46 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.877 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.2 OUTLIER -63.89 -39.61 94.58 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 113.914 -1.494 . . . . 0.0 107.807 177.103 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.694 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 2.6 m -59.96 -34.46 73.31 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.36 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.838 ' CB ' HD11 ' A' ' 90' ' ' LEU . . . -76.84 -36.91 56.51 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.485 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.663 HD13 ' CB ' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -82.74 -13.92 55.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.419 0.628 . . . . 0.0 110.719 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.14 35.02 5.18 Favored Glycine 0 C--N 1.32 -0.361 0 CA-C-N 115.228 -0.896 . . . . 0.0 114.174 177.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.877 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 38.6 t -90.27 118.53 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.823 ' O ' HG12 ' A' ' 76' ' ' ILE . 10.8 m -81.39 134.5 35.57 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.293 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.872 ' HB3' HG23 ' A' ' 75' ' ' ILE . 42.0 p90 -158.23 160.58 37.29 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 74' ' ' GLU . 63.3 m -122.82 149.65 43.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.565 0.221 . . . . 0.0 110.993 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.73 HD21 ' HA ' ' A' ' 70' ' ' ARG . 4.0 tp -121.01 138.96 53.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.925 0.393 . . . . 0.0 110.636 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.481 ' HB2' ' CB ' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -69.66 -165.64 0.09 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.675 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.99 -23.43 22.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.171 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.427 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 0.1 OUTLIER -81.35 1.15 34.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.272 179.716 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.73 ' HA ' HD21 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 53.09 26.41 4.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.807 0.337 . . . . 0.0 111.286 179.773 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.463 HG22 ' O ' ' A' ' 44' ' ' LEU . 1.3 p -127.93 -10.86 5.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.86 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.54 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 7.2 mtp180 -112.88 115.48 28.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.105 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.621 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -133.12 128.32 35.86 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -179.342 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 39' ' ' THR . 13.7 tt0 -107.73 133.78 51.65 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.613 178.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 1.095 HD11 HD22 ' A' ' 29' ' ' LEU . 8.2 mt -123.45 122.27 64.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.823 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -68.13 101.58 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-O 121.462 0.648 . . . . 0.0 109.516 175.685 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 35' ' ' ALA . . . -39.61 143.2 0.46 Allowed Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 114.737 -1.12 . . . . 0.0 113.844 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.434 HD21 ' HA ' ' A' ' 78' ' ' ASN . 0.2 OUTLIER -87.89 -7.54 57.04 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 120.771 0.319 . . . . 0.0 110.82 179.381 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.627 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 88.38 2.66 79.48 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.278 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.487 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 151.35 -147.43 17.35 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.005 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.678 ' HG3' ' HB3' ' A' ' 108' ' ' LEU . 77.0 Cg_exo -49.72 127.59 19.16 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.379 2.052 . . . . 0.0 112.727 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.663 ' CB ' HD13 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -72.78 110.54 7.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.125 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.495 ' HA ' ' CG ' ' A' ' 111' ' ' ASN . 4.6 p80 -82.19 133.99 35.28 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.88 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.567 ' CB ' HD22 ' A' ' 88' ' ' LEU . . . -98.69 124.33 43.44 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.047 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -71.19 123.36 22.02 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 176.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.88 176.97 0.82 Allowed Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -175.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 112' ' ' ASP . . . -73.1 144.7 46.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 118.668 1.234 . . . . 0.0 111.11 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.723 HD21 ' C ' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -112.81 160.99 17.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.34 -178.532 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 7.3 mt-10 -141.53 102.91 4.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.43 177.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.838 HD11 ' CB ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -102.25 115.5 30.68 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.657 -177.693 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.472 ' CD1' ' HB ' ' A' ' 116' ' ' THR . 0.9 OUTLIER -90.52 98.12 11.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.734 179.085 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.616 HD11 ' HB3' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -103.66 52.9 0.76 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.602 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.625 ' CA ' ' H ' ' A' ' 118' ' ' GLU . . . -59.86 -67.28 2.24 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.421 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.577 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 69.5 m-80 -75.43 15.26 0.48 Allowed 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.413 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.752 ' HB1' ' HB3' ' A' ' 98' ' ' ALA . . . -94.88 -70.15 0.72 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.56 -68.08 0.4 Allowed Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.923 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.417 ' O ' ' CD ' ' A' ' 101' ' ' PRO . 2.6 p -71.65 -8.42 53.98 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.752 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -98.88 -30.1 12.58 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.655 0.264 . . . . 0.0 111.043 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.433 ' CG ' HD13 ' A' ' 126' ' ' ILE . 1.0 OUTLIER -64.67 -42.75 95.15 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.043 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.69 ' O ' HD21 ' A' ' 129' ' ' LEU . 1.4 mpt_? -55.84 -60.95 7.24 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.796 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.785 ' HB2' HD22 ' A' ' 30' ' ' LEU . 21.0 Cg_endo -60.78 -30.47 90.3 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.469 2.113 . . . . 0.0 112.488 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 1.026 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -75.22 -52.5 10.77 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 120.335 -0.546 . . . . 0.0 109.998 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.894 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -51.6 -27.26 10.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.5 0.666 . . . . 0.0 110.509 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.948 ' HB2' ' HB1' ' A' ' 175' ' ' ALA . . . -86.55 -53.99 4.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.377 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.712 ' CB ' HD11 ' A' ' 30' ' ' LEU . . . -60.63 -33.61 73.02 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -177.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.688 ' HB2' HD12 ' A' ' 153' ' ' LEU . 26.9 mt -78.35 -20.76 50.67 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.704 ' SG ' ' HB1' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -83.22 21.89 1.06 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.335 0.588 . . . . 0.0 110.87 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.855 HD21 ' HB2' ' A' ' 182' ' ' LEU . 0.5 OUTLIER -85.75 -76.05 0.35 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.74 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -70.28 -110.31 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.64 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.1 m -158.38 96.08 1.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.957 0.408 . . . . 0.0 110.595 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.646 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 13.7 m-80 -148.99 140.14 23.07 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.275 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.857 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 1.9 m-20 -92.95 98.59 11.46 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.171 0.51 . . . . 0.0 110.087 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.566 HG13 ' CB ' ' A' ' 88' ' ' LEU . 1.5 mp -119.17 145.68 24.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.918 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.782 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 59.1 t -113.63 112.97 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 176.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.791 HD23 ' HB2' ' A' ' 90' ' ' LEU . 58.8 mt -102.63 110.99 23.1 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.903 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.743 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -125.06 -171.97 2.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.253 -179.712 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.494 ' H ' HG22 ' A' ' 116' ' ' THR . . . -166.73 -173.12 34.77 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.514 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.646 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 1.3 mm-40 -76.83 172.49 9.54 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 123.245 0.618 . . . . 0.0 110.123 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.646 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 7.4 Cg_endo -47.97 -33.06 19.4 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.605 2.203 . . . . 0.0 112.744 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -67.62 -28.18 67.52 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.021 0.439 . . . . 0.0 110.219 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.578 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 9.8 tpt -61.19 -39.56 90.66 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.559 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.449 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 0.0 OUTLIER -63.01 -16.96 61.58 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.29 179.747 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.568 ' O ' ' HG3' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -85.68 -3.95 59.03 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.977 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.486 ' HB3' ' NH2' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -123.74 88.63 51.97 Favored Pre-proline 0 N--CA 1.452 -0.332 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.763 179.807 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.457 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 15.8 Cg_endo -56.67 149.09 61.04 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.651 2.234 . . . . 0.0 111.599 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.49 HG22 ' O ' ' A' ' 148' ' ' TYR . 0.8 OUTLIER -119.88 8.98 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.946 0.403 . . . . 0.0 111.763 -179.121 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.596 ' HA3' ' ND2' ' A' ' 147' ' ' ASN . . . -57.19 -45.24 92.83 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.801 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.661 ' CG ' HG21 ' A' ' 168' ' ' VAL . 12.2 m-70 -55.25 -38.62 68.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.013 0.406 . . . . 0.0 110.782 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.929 HD11 ' HB3' ' A' ' 175' ' ' ALA . 17.7 tp -74.8 -45.71 41.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.962 0.411 . . . . 0.0 110.372 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.922 HG21 HD21 ' A' ' 151' ' ' LEU . 49.9 t -56.58 -47.73 81.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.339 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.731 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 0.5 OUTLIER -71.88 -34.43 69.18 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.029 0.442 . . . . 0.0 110.297 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.64 ' HB2' HG23 ' A' ' 164' ' ' VAL . . . -62.42 -45.0 95.07 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.901 178.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.756 HD11 ' HG ' ' A' ' 129' ' ' LEU . 6.2 mt -77.27 -50.32 13.13 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.357 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.754 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -55.88 -27.59 52.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.764 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.731 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.6 OUTLIER -67.83 -33.02 73.96 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.586 178.616 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.526 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -82.55 13.63 40.25 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.015 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.07 2.45 60.83 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.329 -0.939 . . . . 0.0 112.833 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.704 ' HB1' ' SG ' ' A' ' 107' ' ' CYS . . . -70.74 152.42 43.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.895 0.379 . . . . 0.0 111.048 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 37.6 mttm -101.28 103.2 14.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.346 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.627 ' HB ' ' HG3' ' A' ' 134' ' ' ARG . 25.7 mt -134.4 126.48 48.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.367 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.818 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -121.72 139.37 53.66 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.718 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.549 ' CZ ' HG11 ' A' ' 130' ' ' VAL . 47.5 m-85 -81.6 130.02 34.9 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.033 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.942 HD11 ' HG3' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -90.96 -91.59 0.15 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.473 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.599 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 17.7 mt-10 -56.1 -80.98 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.021 0.439 . . . . 0.0 110.439 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.533 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 46.0 mt-30 -115.67 151.32 35.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.426 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 31.2 mt-10 -67.9 137.54 55.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.117 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.596 ' ND2' ' HA3' ' A' ' 127' ' ' GLY . 3.7 m120 66.36 20.21 10.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.965 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.616 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 20.5 m-85 -113.79 170.04 5.82 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.948 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 27.6 Cg_exo -32.57 -63.39 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 124.345 3.363 . . . . 0.0 116.221 -177.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.948 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 77.8 Cg_exo -53.55 146.84 41.13 Favored 'Trans proline' 0 C--N 1.353 0.809 0 CA-C-N 120.706 1.288 . . . . 0.0 112.588 -178.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.922 HD21 HG21 ' A' ' 130' ' ' VAL . 9.7 mt -156.32 136.45 12.85 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.345 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.942 ' HG3' HD11 ' A' ' 143' ' ' LEU . 0.0 OUTLIER -108.5 102.94 11.99 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.022 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.894 HD11 ' HA ' ' A' ' 103' ' ' ALA . 8.5 mt -91.29 146.81 23.51 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.738 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.646 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 1.1 mt-30 -148.83 25.74 0.92 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.368 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.566 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 54.88 -170.26 1.5 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.85 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 158' ' ' THR . . . 114.79 -15.43 19.26 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.119 -1.039 . . . . 0.0 113.389 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.713 ' HE2' ' HA ' ' A' ' 180' ' ' ALA . 55.4 t80 -58.33 123.69 16.98 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 117.258 0.529 . . . . 0.0 110.647 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.697 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 75.7 p -117.05 -33.55 4.68 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 121.382 0.61 . . . . 0.0 111.392 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.446 ' O ' ' HA2' ' A' ' 136' ' ' GLY . . . 138.56 -161.64 25.75 Favored Glycine 0 C--N 1.307 -1.083 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.987 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.584 ' O ' HG23 ' A' ' 187' ' ' THR . . . 105.22 153.95 21.93 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.54 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -46.93 116.53 1.38 Allowed 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.321 -0.44 . . . . 0.0 111.093 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.755 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 73.4 t -109.59 130.62 62.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.829 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.16 120.38 39.41 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.522 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.808 HG21 HD11 ' A' ' 176' ' ' LEU . 1.2 t -133.78 120.03 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 120.922 0.391 . . . . 0.0 110.12 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.508 ' O ' HG12 ' A' ' 168' ' ' VAL . 0.8 OUTLIER -52.44 141.83 18.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.657 -179.362 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.876 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . -59.55 -51.26 60.12 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.076 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.43 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 0.2 OUTLIER -94.12 95.8 9.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.598 0.237 . . . . 0.0 111.368 179.741 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.661 HG21 ' CG ' ' A' ' 128' ' ' HIS . 8.2 p -177.15 59.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.131 0.491 . . . . 0.0 110.755 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.722 ' C ' HG11 ' A' ' 196' ' ' VAL . 20.2 m 63.88 130.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.2 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.452 ' N ' HG11 ' A' ' 196' ' ' VAL . 0.2 OUTLIER -70.9 -17.55 62.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.361 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.562 ' HB3' ' CB ' ' A' ' 100' ' ' ARG . 0.8 OUTLIER -76.53 -10.64 59.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.937 -179.092 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.734 ' HA ' HD13 ' A' ' 129' ' ' LEU . 8.4 m-85 -72.48 -50.43 26.09 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.581 0.705 . . . . 0.0 109.559 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 1.002 HD21 HD11 ' A' ' 191' ' ' ILE . 0.2 OUTLIER -68.64 -43.5 76.15 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.16 178.693 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.588 HG21 HH11 ' A' ' 27' ' ' ARG . 2.1 m -54.03 -35.31 61.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.501 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.948 ' HB1' ' HB2' ' A' ' 104' ' ' ALA . . . -63.88 -45.23 90.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.495 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.808 HD11 HG21 ' A' ' 164' ' ' VAL . 0.1 OUTLIER -76.58 -33.07 58.49 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.054 -179.814 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.821 HD11 ' CD2' ' A' ' 223' ' ' PHE . 3.4 mp -59.97 -39.1 84.48 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.62 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.641 ' HE1' ' HA ' ' A' ' 27' ' ' ARG . 1.9 mtp -81.55 -44.35 17.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.407 0.622 . . . . 0.0 112.226 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.623 HG23 ' HG ' ' A' ' 108' ' ' LEU . 58.3 m -71.4 -41.0 70.17 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.796 -178.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.713 ' HA ' ' HE2' ' A' ' 157' ' ' PHE . . . -59.9 -39.84 73.36 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -176.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.557 ' HD3' ' O ' ' A' ' 177' ' ' LEU . 28.2 Cg_endo -65.66 -28.59 52.29 Favored 'Trans proline' 0 CA--C 1.497 -1.354 0 CA-C-N 120.108 1.074 . . . . 0.0 111.657 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.855 ' HB2' HD21 ' A' ' 108' ' ' LEU . 4.7 mt -84.06 0.49 48.08 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.724 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.697 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -83.19 136.57 43.37 Favored Pre-proline 0 C--O 1.224 -0.279 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.856 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.641 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 10.7 Cg_endo -50.18 -33.49 35.98 Favored 'Trans proline' 0 CA--C 1.518 -0.278 0 C-N-CA 122.597 2.198 . . . . 0.0 113.443 -179.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.79 139.54 48.32 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.731 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 187' ' ' THR . 10.1 t0 -55.33 143.89 26.95 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.835 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 160' ' ' GLY . 87.8 m -121.2 148.98 43.52 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.949 0.404 . . . . 0.0 111.606 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.622 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 44.0 t -130.38 117.75 40.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.819 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 4.6 mp -100.23 119.79 48.79 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 0.1 OUTLIER -100.78 125.57 47.28 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 1.002 HD11 HD21 ' A' ' 173' ' ' LEU . 1.6 mp -94.04 125.18 46.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.807 -176.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -77.91 96.86 5.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 113.948 -1.478 . . . . 0.0 110.458 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 96.58 -126.99 9.03 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.263 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -116.41 130.87 56.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.79 0.329 . . . . 0.0 111.582 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.84 HD21 HD13 ' A' ' 173' ' ' LEU . 1.5 mt -41.72 144.22 0.42 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.385 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.722 HG11 ' C ' ' A' ' 169' ' ' SER . 14.8 p -72.33 -28.28 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.039 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.461 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 0.1 OUTLIER -168.85 65.19 0.06 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.058 0.456 . . . . 0.0 110.49 -179.15 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.682 ' HA ' HD13 ' A' ' 195' ' ' LEU . 0.0 OUTLIER -40.66 -46.72 6.44 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.498 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.462 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 83.5 Cg_exo -47.49 -33.81 18.36 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 121.842 1.694 . . . . 0.0 111.411 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.956 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.2 OUTLIER -69.16 -41.94 76.57 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.373 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.566 HG21 ' HE2' ' A' ' 223' ' ' PHE . 18.5 mm -64.64 -38.69 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.917 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.15 -44.14 83.14 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.256 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.956 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.1 mt -62.79 -48.82 86.27 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.918 0 CA-C-O 121.739 0.781 . . . . 0.0 109.358 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.563 HG22 ' SD ' ' A' ' 208' ' ' MET . 87.6 m -54.12 -51.26 64.79 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.121 -178.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.903 HD22 ' HB ' ' A' ' 215' ' ' ILE . 32.5 mt -65.77 -31.15 71.96 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 120.922 0.392 . . . . 0.0 111.517 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -77.48 -46.07 23.62 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.901 0.858 . . . . 0.0 109.51 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.857 ' O ' HG22 ' A' ' 210' ' ' THR . 6.4 tp -69.91 -30.46 67.88 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.526 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' MET . . . . . 0.81 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 37.9 mtp -76.38 -34.2 58.88 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.584 0.707 . . . . 0.0 109.231 177.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.716 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 2.6 mtmt -60.95 -38.3 85.37 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.346 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.857 HG22 ' O ' ' A' ' 207' ' ' LEU . 4.7 t -60.92 -33.37 73.05 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.161 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.558 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 50.0 m-85 -76.1 -5.94 48.9 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.801 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 109.51 7.33 28.16 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 115.671 1.028 . . . . 0.0 115.671 177.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.716 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.8 m -123.62 148.58 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 118.549 1.174 . . . . 0.0 112.799 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.595 ' O ' HD13 ' A' ' 215' ' ' ILE . 6.0 mt-10 -129.9 138.61 51.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.659 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.903 ' HB ' HD22 ' A' ' 205' ' ' LEU . 17.1 mm -122.04 148.64 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.694 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 1.6 tp10 -103.89 117.76 35.09 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.983 0.421 . . . . 0.0 111.905 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -83.02 151.11 25.96 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.525 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' GLN . . . . . 0.676 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 5.4 mm-40 -109.43 -144.1 0.39 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.72 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.598 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 7.8 t-80 -73.9 65.88 1.1 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.813 0.34 . . . . 0.0 111.492 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 4.1 t80 56.01 35.12 25.0 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.931 0.872 . . . . 0.0 110.785 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.658 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 1.7 pt20 -163.92 -127.45 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.819 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -8.04 134.43 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.821 ' CD2' HD11 ' A' ' 177' ' ' LEU . 0.6 OUTLIER -125.35 137.32 54.04 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 113.038 -1.892 . . . . 0.0 109.654 -179.234 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.694 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 23.7 t -117.39 114.27 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.801 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.5 OUTLIER -122.25 120.71 61.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.804 -179.393 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.498 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -74.59 127.37 32.92 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -80.03 -171.29 42.47 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.236 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 61.51 21.16 59.91 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 121.398 -0.43 . . . . 0.0 113.006 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' GLN . . . . . 0.548 ' NE2' ' HB3' ' A' ' 181' ' ' PRO . 55.1 mt-30 -80.63 -173.45 4.15 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.257 0.551 . . . . 0.0 111.158 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 17.2 t -151.94 147.64 26.81 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.934 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' TYR . . . . . 0.782 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 4.7 m-85 -100.74 130.23 46.75 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.452 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.408 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -120.99 146.77 46.34 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.06 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.55 111.04 8.88 Favored Pre-proline 0 N--CA 1.447 -0.59 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.383 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.542 ' HD2' ' OG1' ' A' ' 39' ' ' THR . 54.6 Cg_endo -69.6 -0.32 6.61 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 121.942 1.762 . . . . 0.0 112.076 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 99.6 -101.18 2.34 Favored Glycine 0 C--O 1.226 -0.349 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.772 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.417 HG23 ' HB ' ' A' ' 40' ' ' VAL . 90.3 m -119.03 135.55 54.57 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.545 ' CD2' HG21 ' A' ' 210' ' ' THR . 1.5 t80 -131.21 129.73 42.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.906 0.384 . . . . 0.0 111.046 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.971 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.1 OUTLIER -95.0 110.96 22.81 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.382 179.242 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.669 ' N ' HD22 ' A' ' 238' ' ' LEU . 21.7 t -82.57 111.91 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.092 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.975 -179.98 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.676 ' HB2' HG22 ' A' ' 50' ' ' VAL . 2.9 m . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.765 0.317 . . . . 0.0 111.383 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 26' ' ' ASN . 2.2 p-10 -38.14 -74.35 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.977 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.746 ' HA ' ' HE1' ' A' ' 178' ' ' MET . 0.0 OUTLIER -63.81 -56.23 17.06 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.277 0.561 . . . . 0.0 110.754 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.871 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -40.5 -47.53 2.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.004 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.06 HD22 HD11 ' A' ' 75' ' ' ILE . 12.9 mt -75.76 -35.36 60.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.846 0.355 . . . . 0.0 111.882 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.798 HD22 ' HB2' ' A' ' 101' ' ' PRO . 50.7 tp -68.92 -49.8 54.94 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.186 0.517 . . . . 0.0 110.674 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.728 ' HB2' ' CE2' ' A' ' 211' ' ' PHE . 27.5 mt -67.91 -27.02 66.28 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.395 179.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.728 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -66.3 -40.27 89.87 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.092 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.751 ' CB ' HG11 ' A' ' 62' ' ' VAL . . . -81.1 -41.31 22.71 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.253 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.663 HD11 ' HB1' ' A' ' 105' ' ' ALA . 16.1 mt -67.94 -4.15 12.14 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.066 178.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.5 ' HB2' ' HB3' ' A' ' 231' ' ' TYR . . . -96.9 176.56 5.93 Favored 'General case' 0 CA--C 1.523 -0.089 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -177.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.571 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.3 OUTLIER -109.84 112.65 24.81 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.636 -1.166 . . . . 0.0 108.941 178.367 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 116.78 166.68 14.35 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.595 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.631 ' HG2' ' HG2' ' A' ' 74' ' ' GLU . 10.6 tttt -95.09 117.81 30.83 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.809 0.304 . . . . 0.0 111.174 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.715 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 0.8 OUTLIER -119.2 148.24 43.32 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-O 120.644 0.259 . . . . 0.0 111.559 -179.462 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.616 HG22 ' HB2' ' A' ' 74' ' ' GLU . 56.8 t -103.67 135.63 40.4 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.668 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.871 ' HG ' ' HB1' ' A' ' 28' ' ' ALA . 0.3 OUTLIER -111.23 115.97 30.25 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 174.91 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.859 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.6 OUTLIER -104.23 149.89 24.89 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.232 -177.93 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 69.18 26.01 5.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.268 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.74 HD21 ' HB3' ' A' ' 41' ' ' LEU . 67.5 mt -55.59 -174.87 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.524 ' HB3' HG21 ' A' ' 50' ' ' VAL . 41.6 tp -111.42 131.68 55.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.594 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -88.83 89.36 7.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.96 0.41 . . . . 0.0 110.312 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -164.02 142.72 7.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.062 -179.104 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.421 ' HA ' ' HB3' ' A' ' 51' ' ' ARG . 0.6 OUTLIER -36.6 -31.25 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.57 0.224 . . . . 0.0 111.342 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.725 ' OD1' HG23 ' A' ' 50' ' ' VAL . 1.6 p30 -58.7 -42.64 89.07 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.906 0.384 . . . . 0.0 110.712 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.725 HG23 ' OD1' ' A' ' 49' ' ' ASP . 82.0 t -81.85 -44.18 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.66 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.827 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -49.5 -40.07 36.27 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.525 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.682 ' HA ' ' HB2' ' A' ' 55' ' ' ASN . 19.9 m-70 -79.62 -32.29 41.72 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.978 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.624 ' O ' HD13 ' A' ' 57' ' ' LEU . 7.3 tpt -53.74 -35.61 61.41 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 176.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.827 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.3 OUTLIER -84.03 -45.76 12.74 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 114.317 -1.31 . . . . 0.0 109.028 176.482 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.682 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -57.77 -36.38 72.06 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.776 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 1.129 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -65.81 -43.05 89.82 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.774 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -65.34 -38.43 90.11 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 176.84 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.682 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.1 m -61.81 -39.67 92.57 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 113.875 -1.511 . . . . 0.0 111.813 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.709 ' CB ' HD11 ' A' ' 90' ' ' LEU . . . -71.07 -37.24 72.46 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.392 -178.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.561 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.6 OUTLIER -80.07 -16.25 55.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.345 0.593 . . . . 0.0 110.429 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.88 35.57 3.96 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.142 -0.935 . . . . 0.0 114.194 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.774 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 25.4 t -90.6 122.37 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.76 ' O ' HG12 ' A' ' 76' ' ' ILE . 12.9 m -85.02 131.88 34.41 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.887 0.375 . . . . 0.0 111.523 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.815 ' HB3' HG23 ' A' ' 75' ' ' ILE . 40.1 p90 -158.69 172.23 18.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.535 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.401 ' N ' ' O ' ' A' ' 74' ' ' GLU . 86.5 m -131.59 148.38 52.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.785 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.442 ' CD1' ' HB2' ' A' ' 73' ' ' CYS . 14.6 tp -119.68 134.78 55.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.162 0.506 . . . . 0.0 111.114 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.426 ' CB ' ' HB2' ' A' ' 72' ' ' ARG . 88.1 p -61.71 -169.26 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.001 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.91 -41.7 18.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.311 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.36 1.98 17.25 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.634 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 59.81 30.01 19.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.733 0.302 . . . . 0.0 111.262 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.458 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 2.0 p -119.6 -14.73 9.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.911 0.386 . . . . 0.0 111.217 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.591 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 14.7 mtp180 -113.43 119.23 36.88 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.4 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.62 ' HB3' HD11 ' A' ' 44' ' ' LEU . 42.5 t -131.12 126.9 36.94 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.715 ' HA ' ' O ' ' A' ' 39' ' ' THR . 35.9 tt0 -110.98 129.06 56.0 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 1.06 HD11 HD22 ' A' ' 29' ' ' LEU . 10.7 mt -126.59 123.56 63.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -177.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.76 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -67.69 99.27 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-O 121.571 0.701 . . . . 0.0 109.256 175.672 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -37.77 146.41 0.12 Allowed Glycine 0 C--N 1.32 -0.343 0 CA-C-N 114.53 -1.214 . . . . 0.0 114.05 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.87 -11.21 39.9 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.959 0.409 . . . . 0.0 111.046 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.571 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 89.86 -0.57 79.65 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.258 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.534 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 152.81 -148.36 19.11 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.902 -0.665 . . . . 0.0 112.143 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.578 ' HG3' ' HB3' ' A' ' 108' ' ' LEU . 77.7 Cg_exo -49.36 127.98 19.23 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.788 2.325 . . . . 0.0 112.704 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.561 ' HB2' HD13 ' A' ' 60' ' ' LEU . 0.9 OUTLIER -78.23 105.64 9.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.901 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -82.13 128.1 33.79 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.055 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.486 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -92.44 126.44 37.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.041 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.97 123.89 23.08 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 176.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.85 172.88 0.91 Allowed Glycine 0 N--CA 1.438 -1.185 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 -175.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.34 144.88 46.33 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 118.469 1.135 . . . . 0.0 111.762 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.622 HD21 ' C ' ' A' ' 59' ' ' ALA . 1.2 tp -113.71 160.54 18.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.047 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 10.9 mt-10 -139.75 102.13 4.36 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.958 178.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.709 HD11 ' CB ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -101.56 130.01 47.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.955 0.407 . . . . 0.0 111.346 -178.736 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.591 ' C ' HD13 ' A' ' 92' ' ' LEU . 16.5 m-85 -101.03 96.77 7.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.608 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.817 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -110.34 51.22 0.77 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.814 -179.596 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.798 ' HA3' ' H ' ' A' ' 118' ' ' GLU . . . -58.26 -61.16 7.73 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.817 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.509 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 17.9 m-80 -76.97 -3.16 37.49 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.111 -0.235 . . . . 0.0 110.585 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 1.01 ' HB1' ' HB3' ' A' ' 98' ' ' ALA . . . -94.47 56.3 2.09 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.915 0.388 . . . . 0.0 111.338 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -56.75 -29.99 59.06 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.468 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.501 ' O ' ' HG3' ' A' ' 101' ' ' PRO . 6.1 p -93.84 -6.54 45.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.682 -0.259 . . . . 0.0 111.421 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 1.01 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -101.63 -37.85 8.18 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.836 0.351 . . . . 0.0 111.185 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.537 ' HB2' ' HB2' ' A' ' 92' ' ' LEU . 3.0 tpp -61.72 -45.58 93.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.339 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.531 ' HD2' HD12 ' A' ' 126' ' ' ILE . 0.1 OUTLIER -53.63 -60.5 6.99 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.227 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.798 ' HB2' HD22 ' A' ' 30' ' ' LEU . 18.5 Cg_endo -60.77 -33.16 93.33 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.477 2.118 . . . . 0.0 112.86 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 1.129 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -71.56 -53.13 14.8 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.836 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.873 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -51.38 -28.52 12.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.177 0.513 . . . . 0.0 110.311 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.895 ' CB ' ' HB1' ' A' ' 175' ' ' ALA . . . -86.6 -52.52 5.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.599 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.706 ' CB ' HD11 ' A' ' 30' ' ' LEU . . . -60.51 -34.09 73.59 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.678 ' HB2' HD12 ' A' ' 153' ' ' LEU . 37.3 mt -78.68 -15.6 58.29 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -176.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.656 ' HB3' ' HB1' ' A' ' 138' ' ' ALA . 90.3 m -87.84 22.8 2.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.322 0.582 . . . . 0.0 110.433 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.786 HD21 ' HB2' ' A' ' 182' ' ' LEU . 2.0 mt -87.16 -75.04 0.42 Allowed 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.545 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.63 -113.6 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.235 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.07 96.4 2.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.049 0.452 . . . . 0.0 110.762 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.589 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 0.1 OUTLIER -148.25 140.91 24.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.53 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.865 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 3.4 m-20 -94.21 102.49 14.52 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.831 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.646 HG13 HD13 ' A' ' 106' ' ' LEU . 20.7 mm -121.35 140.92 43.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.556 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.856 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 61.8 t -111.71 112.37 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 175.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.67 HD23 ' HB2' ' A' ' 90' ' ' LEU . 74.6 mt -102.17 105.85 16.61 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.492 -178.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.787 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -114.66 -170.48 1.75 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.322 -178.876 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.526 ' HA3' ' HG2' ' A' ' 121' ' ' MET . . . -171.4 175.15 45.01 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.629 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.798 ' H ' ' HA3' ' A' ' 93' ' ' GLY . 36.6 mm-40 -68.9 169.41 11.31 Favored Pre-proline 0 CA--C 1.531 0.227 0 C-N-CA 123.214 0.605 . . . . 0.0 111.339 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.716 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 2.8 Cg_endo -44.35 -40.82 13.38 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.192 2.595 . . . . 0.0 113.196 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.44 -23.73 65.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.679 0.276 . . . . 0.0 110.722 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.57 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 9.1 tpt -62.2 -35.13 77.94 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -16.85 54.35 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.59 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.01 1.59 52.33 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.859 0.362 . . . . 0.0 110.333 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.472 ' HD3' ' NH2' ' A' ' 100' ' ' ARG . 55.6 mtt-85 -127.03 84.22 64.04 Favored Pre-proline 0 CA--C 1.529 0.161 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.57 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -56.49 148.57 62.31 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.715 2.277 . . . . 0.0 111.755 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.531 HD12 ' HD2' ' A' ' 100' ' ' ARG . 0.8 OUTLIER -124.17 8.43 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.27 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.559 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -61.61 -36.54 92.79 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.061 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.19 -40.08 76.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.74 0.27 . . . . 0.0 110.67 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.715 ' HG ' HD11 ' A' ' 133' ' ' LEU . 14.1 tp -75.37 -41.39 56.56 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.425 0.631 . . . . 0.0 110.023 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.791 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 39.8 t -56.42 -47.74 81.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.579 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.795 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 4.7 m-20 -72.08 -31.81 66.43 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.422 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.545 ' HB1' ' CG1' ' A' ' 162' ' ' VAL . . . -64.1 -49.81 70.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.449 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.715 HD11 ' HG ' ' A' ' 129' ' ' LEU . 7.7 mt -71.65 -48.93 44.45 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.845 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.791 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -57.85 -27.77 63.51 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.651 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.795 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 1.5 tp -67.19 -33.45 75.42 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.466 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.49 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -81.81 12.73 40.41 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.966 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.34 3.34 60.06 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.325 -0.941 . . . . 0.0 112.749 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.656 ' HB1' ' HB3' ' A' ' 107' ' ' CYS . . . -71.59 149.43 45.65 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.882 0.341 . . . . 0.0 111.234 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 21.6 mttm -97.78 103.24 15.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.149 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.733 HG21 HG22 ' A' ' 130' ' ' VAL . 21.0 mt -134.02 126.89 50.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.309 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.737 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -123.51 139.71 53.74 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.925 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.523 ' CZ ' HG11 ' A' ' 130' ' ' VAL . 43.4 m-85 -81.41 132.62 35.33 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.409 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.801 ' CD2' HG13 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -90.17 -82.26 0.28 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.297 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.845 ' HG3' ' H ' ' A' ' 145' ' ' GLN . 11.2 pt-20 -63.5 -78.2 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.926 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.845 ' H ' ' HG3' ' A' ' 144' ' ' GLU . 1.5 mt-30 -121.38 154.19 36.81 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 6.8 mt-10 -64.48 135.6 56.22 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.074 0.464 . . . . 0.0 111.285 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.559 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 9.2 m-20 71.83 18.73 5.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.086 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.516 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 18.6 m-85 -107.77 167.12 9.79 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.898 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 51.3 Cg_exo -35.69 -63.3 0.2 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 124.159 3.239 . . . . 0.0 116.07 -177.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.898 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 71.5 Cg_exo -50.72 145.6 22.86 Favored 'Trans proline' 0 C--N 1.355 0.885 0 CA-C-N 120.773 1.312 . . . . 0.0 112.393 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.856 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 8.5 mt -155.89 137.04 13.76 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.846 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.737 ' HB2' HG22 ' A' ' 141' ' ' THR . 0.2 OUTLIER -106.78 101.59 11.02 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 177.411 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.873 HD11 ' HA ' ' A' ' 103' ' ' ALA . 6.6 mt -91.46 145.61 24.48 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.023 -178.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.589 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 3.0 mt-30 -147.79 29.27 0.92 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.691 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 51.37 -170.3 0.34 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.222 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 114.83 -12.09 20.54 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.086 -1.054 . . . . 0.0 113.369 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.661 ' HE2' ' HA ' ' A' ' 180' ' ' ALA . 54.4 t80 -58.82 122.82 14.52 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 117.51 0.655 . . . . 0.0 110.595 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.817 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 43.3 p -113.12 -38.37 4.48 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 121.668 0.747 . . . . 0.0 111.243 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.42 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 139.04 -165.03 25.76 Favored Glycine 0 C--N 1.306 -1.089 0 CA-C-N 114.526 -1.216 . . . . 0.0 112.304 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.591 ' O ' HG23 ' A' ' 187' ' ' THR . . . 109.48 155.59 16.2 Favored Glycine 0 N--CA 1.437 -1.298 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.882 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -46.94 115.48 1.08 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.216 -0.492 . . . . 0.0 111.333 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 72.1 t -108.02 137.71 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -107.09 119.77 40.29 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.256 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.824 HG21 HD11 ' A' ' 176' ' ' LEU . 1.0 OUTLIER -132.09 120.43 43.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.113 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.65 ' HB3' ' CG2' ' A' ' 168' ' ' VAL . 23.0 t0 -55.58 138.51 46.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.933 0.396 . . . . 0.0 111.141 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.667 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . -67.55 -31.03 75.53 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.204 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.2 t -97.81 64.29 1.74 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.98 0.419 . . . . 0.0 110.856 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.65 ' CG2' ' HB3' ' A' ' 165' ' ' ASP . 22.3 t -125.93 -111.75 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.78 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.515 ' HB2' ' CD1' ' A' ' 172' ' ' PHE . 0.5 OUTLIER -134.5 134.08 41.08 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.97 0.414 . . . . 0.0 109.985 179.521 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.625 ' HB2' ' HB3' ' A' ' 200' ' ' TYR . 0.1 OUTLIER -55.69 -17.28 5.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.762 -179.531 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.586 ' HA ' ' HB ' ' A' ' 174' ' ' THR . 9.4 mp0 -92.7 -13.85 28.83 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.443 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.515 ' CD1' ' HB2' ' A' ' 169' ' ' SER . 5.9 m-85 -66.73 -54.36 23.78 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 1.115 HD13 HD21 ' A' ' 195' ' ' LEU . 0.2 OUTLIER -64.95 -45.91 83.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.921 178.675 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.586 ' HB ' ' HA ' ' A' ' 171' ' ' GLN . 1.1 m -55.1 -33.01 62.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.969 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.895 ' HB1' ' CB ' ' A' ' 104' ' ' ALA . . . -66.39 -41.61 89.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.329 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.824 HD11 HG21 ' A' ' 164' ' ' VAL . 0.2 OUTLIER -76.71 -32.51 57.88 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.545 179.361 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.72 ' HG ' HD21 ' A' ' 205' ' ' LEU . 2.7 mp -59.89 -39.35 85.02 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.142 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.746 ' HE1' ' HA ' ' A' ' 27' ' ' ARG . 0.7 OUTLIER -82.16 -41.43 20.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.351 0.596 . . . . 0.0 111.912 179.751 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.437 HG23 ' HG ' ' A' ' 108' ' ' LEU . 100.0 m -71.06 -42.07 69.9 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.644 -178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.661 ' HA ' ' HE2' ' A' ' 157' ' ' PHE . . . -59.08 -40.37 80.93 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -176.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.567 ' HD3' ' O ' ' A' ' 177' ' ' LEU . 38.1 Cg_endo -66.76 -28.78 43.34 Favored 'Trans proline' 0 CA--C 1.498 -1.292 0 C-N-CA 120.787 0.992 . . . . 0.0 112.06 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.786 ' HB2' HD21 ' A' ' 108' ' ' LEU . 5.3 mt -84.67 1.5 46.0 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.626 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.817 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -82.86 139.46 43.19 Favored Pre-proline 0 C--O 1.223 -0.298 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.226 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.752 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 11.6 Cg_endo -52.03 -33.37 52.54 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.206 1.938 . . . . 0.0 112.782 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.53 143.05 45.6 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.582 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -58.54 145.27 39.81 Favored 'General case' 0 N--CA 1.46 0.074 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.453 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.611 ' HB ' ' HB1' ' A' ' 180' ' ' ALA . 65.9 m -122.14 144.42 48.95 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.644 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 25.2 t -122.45 117.81 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.069 176.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.738 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 2.7 mp -101.53 117.63 47.11 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.801 ' HG3' ' HG3' ' A' ' 222' ' ' GLN . 0.1 OUTLIER -99.4 122.49 42.58 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.4 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.965 HD11 HD21 ' A' ' 173' ' ' LEU . 1.6 mp -93.47 119.72 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.954 -175.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.432 ' HE3' ' CA ' ' A' ' 165' ' ' ASP . 0.7 OUTLIER -75.14 96.63 3.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.769 -179.468 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 95.47 -134.11 11.78 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.265 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -117.09 137.27 52.39 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 1.115 HD21 HD13 ' A' ' 173' ' ' LEU . 8.9 mt -40.81 147.03 0.13 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.184 0.516 . . . . 0.0 111.124 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.499 HG21 ' O ' ' A' ' 168' ' ' VAL . 7.2 p -68.66 -21.07 25.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.896 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.864 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 26.7 t -138.55 -67.43 0.46 Allowed 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.249 178.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.812 ' HA ' HD13 ' A' ' 195' ' ' LEU . 8.0 tmtt? 96.82 -56.57 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 114.656 -1.157 . . . . 0.0 111.177 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.864 ' HD2' ' C ' ' A' ' 197' ' ' SER . 18.3 Cg_endo -62.71 -25.7 75.09 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 120.868 1.045 . . . . 0.0 110.021 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.971 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.2 OUTLIER -67.48 -48.2 67.83 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.784 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.625 HG21 ' HE2' ' A' ' 223' ' ' PHE . 15.6 mm -63.28 -35.09 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.443 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.15 -42.86 99.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.102 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.971 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.5 mt -60.36 -50.78 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.488 ' O ' ' HG3' ' A' ' 208' ' ' MET . 45.8 m -53.47 -51.85 61.37 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.107 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.863 HD22 ' HB ' ' A' ' 215' ' ' ILE . 36.8 mt -65.54 -30.62 71.39 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.38 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ASN . . . . . 0.416 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 2.6 m-80 -77.86 -46.3 21.82 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.772 0.796 . . . . 0.0 109.956 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.84 ' O ' HG22 ' A' ' 210' ' ' THR . 0.8 OUTLIER -68.76 -29.77 68.22 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.211 178.938 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 208' ' ' MET . . . . . 0.703 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 37.0 mtp -69.95 -33.23 71.84 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.655 178.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.604 ' HE2' ' HA ' ' A' ' 214' ' ' GLU . 6.7 mmtp -57.54 -38.6 74.98 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.813 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.84 HG22 ' O ' ' A' ' 207' ' ' LEU . 1.0 OUTLIER -60.6 -27.25 67.59 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.645 -178.523 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.728 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 76.9 m-85 -85.19 -8.88 58.38 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.541 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.1 9.38 24.23 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 115.658 1.023 . . . . 0.0 115.658 177.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.545 HG21 ' HE3' ' A' ' 208' ' ' MET . 4.2 m -124.18 148.84 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 118.683 1.242 . . . . 0.0 112.133 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.604 ' HA ' ' HE2' ' A' ' 209' ' ' LYS . 22.5 mt-10 -129.74 141.75 50.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.149 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 1.03 HD12 ' HB ' ' A' ' 225' ' ' VAL . 24.7 mm -123.5 148.45 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-O 120.89 0.376 . . . . 0.0 110.552 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.603 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 40.2 tt0 -104.74 116.44 32.03 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.726 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -82.49 150.18 27.15 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' GLN . . . . . 0.63 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.2 OUTLIER -110.16 -148.05 0.42 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.606 0.241 . . . . 0.0 110.909 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.547 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 1.8 t-80 -67.83 63.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.457 ' CE1' ' HG3' ' A' ' 198' ' ' LYS . 6.3 t80 58.87 33.88 23.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.902 0.858 . . . . 0.0 110.867 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.639 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 12.2 pt20 -164.69 -124.63 0.02 OUTLIER 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.801 ' HG3' ' HG3' ' A' ' 190' ' ' ARG . 0.5 OUTLIER -3.97 132.37 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 179.495 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.644 ' O ' ' HA ' ' A' ' 188' ' ' VAL . 3.2 m-85 -126.55 129.89 49.48 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.432 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.603 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 41.6 t -114.17 113.68 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 121.588 0.708 . . . . 0.0 109.739 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 1.03 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -123.15 125.51 72.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.095 -179.028 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 181' ' ' PRO . 0.0 OUTLIER -76.62 141.52 41.02 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.838 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -91.18 -178.21 43.15 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.457 -178.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 66.47 20.22 69.53 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 121.54 -0.362 . . . . 0.0 113.081 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' GLN . . . . . 0.513 ' NE2' ' HB3' ' A' ' 181' ' ' PRO . 47.7 mt-30 -77.79 -173.77 3.2 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.19 0.519 . . . . 0.0 110.896 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.14 147.57 24.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.543 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' TYR . . . . . 0.653 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 5.5 m-85 -99.26 133.81 43.02 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.056 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -120.76 148.84 43.44 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 84.1 p -76.54 111.43 15.72 Favored Pre-proline 0 N--CA 1.446 -0.636 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.834 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.557 ' HG3' HG23 ' A' ' 210' ' ' THR . 46.7 Cg_endo -68.3 -2.38 8.91 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.947 1.765 . . . . 0.0 112.422 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 96.34 -84.0 0.82 Allowed Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.29 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 93.5 m -130.56 127.13 38.45 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.705 ' CD2' HG21 ' A' ' 210' ' ' THR . 24.8 t80 -130.33 134.47 47.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.995 0.426 . . . . 0.0 111.373 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.859 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.1 OUTLIER -97.94 110.73 23.25 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.687 179.846 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.648 ' N ' HD22 ' A' ' 238' ' ' LEU . 20.1 t -81.65 112.77 20.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.11 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.347 -0.835 . . . . 0.0 111.129 -179.948 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.673 ' N ' HG11 ' A' ' 239' ' ' VAL . 58.7 p . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 120.823 0.344 . . . . 0.0 111.348 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.43 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 46.9 m-80 67.57 -79.0 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.545 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.733 ' HE ' HD23 ' A' ' 207' ' ' LEU . 77.3 mtm-85 -70.17 -58.22 4.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.046 0.45 . . . . 0.0 110.879 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.617 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -46.07 -42.38 13.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.763 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.055 HD22 HD11 ' A' ' 75' ' ' ILE . 10.6 mt -71.1 -34.56 71.22 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 120.983 0.42 . . . . 0.0 110.833 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.921 HD22 ' HB2' ' A' ' 101' ' ' PRO . 53.3 tp -68.9 -49.74 55.63 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.377 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.59 ' HB2' ' CE2' ' A' ' 211' ' ' PHE . 34.1 mt -67.28 -27.13 66.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.521 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.774 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -65.77 -39.03 90.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.056 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.655 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . . . -81.32 -41.39 22.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.615 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.745 HD11 ' HB1' ' A' ' 105' ' ' ALA . 21.9 mt -69.05 -3.36 12.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.286 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.482 ' HB2' ' HB3' ' A' ' 231' ' ' TYR . . . -96.81 176.1 6.11 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.524 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.1 OUTLIER -112.18 113.4 25.63 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.596 178.247 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.59 167.99 15.29 Favored Glycine 0 C--N 1.32 -0.323 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.635 ' HG3' HG23 ' A' ' 76' ' ' ILE . 1.0 OUTLIER -95.3 117.78 30.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 117.32 0.56 . . . . 0.0 111.443 -179.371 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.495 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.9 OUTLIER -119.6 145.84 46.06 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.22 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.55 HG22 ' HB2' ' A' ' 74' ' ' GLU . 96.6 t -104.91 139.08 26.96 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 1.003 HD23 HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -114.77 116.1 28.1 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 174.986 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.922 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.6 OUTLIER -105.06 152.3 22.92 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.078 -178.29 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 36.9 t30 68.99 25.44 5.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.724 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.691 HD21 ' CB ' ' A' ' 41' ' ' LEU . 16.0 mt -55.32 -169.97 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.501 ' HB3' HG21 ' A' ' 50' ' ' VAL . 32.9 tp -112.46 131.9 55.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.596 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -89.05 85.92 6.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.021 0.439 . . . . 0.0 110.55 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.46 ' O ' ' N ' ' A' ' 50' ' ' VAL . 1.0 OUTLIER -164.25 142.88 7.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.926 -179.479 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 47' ' ' SER . 0.5 OUTLIER -33.07 -34.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.764 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.803 ' OD1' HG23 ' A' ' 50' ' ' VAL . 3.1 p30 -55.33 -42.59 73.97 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.043 0.449 . . . . 0.0 110.836 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.803 HG23 ' OD1' ' A' ' 49' ' ' ASP . 78.5 t -84.63 -44.51 17.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.013 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.815 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -50.68 -39.77 51.93 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.653 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.696 ' HA ' ' HB3' ' A' ' 55' ' ' ASN . 18.9 m-70 -80.9 -32.42 34.79 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.888 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.508 ' O ' HD13 ' A' ' 57' ' ' LEU . 9.0 tpt -53.5 -34.74 59.17 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 176.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.815 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -83.49 -43.04 16.21 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.648 176.465 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.696 ' HB3' ' HA ' ' A' ' 52' ' ' HIS . 67.0 t30 -56.73 -42.11 78.67 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-O 121.05 0.452 . . . . 0.0 110.131 179.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 1.055 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -57.11 -49.06 77.07 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.812 0.815 . . . . 0.0 108.956 178.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.778 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -61.8 -37.83 85.87 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.006 -1.452 . . . . 0.0 107.871 177.066 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.679 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -63.8 -35.02 79.24 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.877 179.271 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.85 ' CB ' HD11 ' A' ' 90' ' ' LEU . . . -73.52 -37.59 65.6 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.356 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.684 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -82.24 -13.13 57.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.255 0.55 . . . . 0.0 110.893 -179.622 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.58 35.76 4.81 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.38 -0.827 . . . . 0.0 114.137 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.778 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 37.2 t -90.51 124.34 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.789 ' O ' HG12 ' A' ' 76' ' ' ILE . 4.3 m -85.96 130.8 34.43 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.499 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.826 ' HB3' HG23 ' A' ' 75' ' ' ILE . 38.4 p90 -157.64 171.68 19.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.84 0.352 . . . . 0.0 110.622 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.43 ' N ' ' O ' ' A' ' 74' ' ' GLU . 99.7 m -138.1 149.16 45.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.305 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.732 HD12 ' HB2' ' A' ' 73' ' ' CYS . 7.3 tp -117.76 137.34 52.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.968 0.413 . . . . 0.0 110.756 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.7 p -59.93 179.91 0.12 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.989 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.79 -28.32 40.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.88 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -80.29 -0.11 35.16 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.247 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 55.89 48.73 17.4 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.797 0.332 . . . . 0.0 111.197 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.423 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -153.4 0.63 0.25 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.277 -0.419 . . . . 0.0 112.081 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.5 OUTLIER -129.48 110.97 12.3 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.939 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.732 ' HB2' HD12 ' A' ' 66' ' ' LEU . 42.9 t -118.37 132.34 56.27 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.55 ' HB2' HG22 ' A' ' 40' ' ' VAL . 43.4 tt0 -111.76 133.13 54.19 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 1.055 HD11 HD22 ' A' ' 29' ' ' LEU . 11.3 mt -130.46 122.97 54.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -178.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.789 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -67.75 100.93 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.763 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 35' ' ' ALA . . . -39.27 144.17 0.33 Allowed Glycine 0 C--N 1.319 -0.39 0 CA-C-N 114.717 -1.128 . . . . 0.0 113.844 -178.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.41 ' CB ' HD12 ' A' ' 82' ' ' LEU . 14.2 t-20 -88.86 -11.36 44.91 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.003 0.43 . . . . 0.0 110.861 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.524 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 85.86 15.61 65.03 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.217 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.527 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 139.55 -150.34 21.31 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.326 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.521 ' HB3' ' CB ' ' A' ' 108' ' ' LEU . 4.2 Cg_endo -49.2 123.55 10.27 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.71 2.274 . . . . 0.0 113.13 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.684 ' HB2' HD13 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -72.24 108.54 5.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.139 179.198 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.429 ' HA ' ' CG ' ' A' ' 111' ' ' ASN . 4.4 p80 -81.87 131.88 35.26 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.564 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -96.0 120.45 36.3 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.669 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -70.96 123.94 23.2 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.46 173.87 1.39 Allowed Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 -175.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 112' ' ' ASP . . . -73.03 144.75 47.04 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 118.616 1.208 . . . . 0.0 111.816 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.747 HD21 ' C ' ' A' ' 59' ' ' ALA . 0.7 OUTLIER -112.52 161.03 17.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.198 -178.536 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.419 ' HG2' ' HB ' ' A' ' 114' ' ' VAL . 32.6 mt-10 -142.05 101.39 3.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.136 177.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.85 HD11 ' CB ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -100.2 125.79 46.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.314 -178.622 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.52 ' C ' HD13 ' A' ' 92' ' ' LEU . 1.2 m-85 -98.37 96.44 8.03 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.849 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -105.18 48.25 0.84 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.472 -179.479 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.646 ' HA3' ' H ' ' A' ' 118' ' ' GLU . . . -53.6 -66.0 3.04 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.65 -0.705 . . . . 0.0 113.247 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.485 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 23.0 m-80 -76.27 -0.98 24.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.559 0.218 . . . . 0.0 110.913 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.975 ' HB1' ' HB3' ' A' ' 98' ' ' ALA . . . -91.86 68.73 5.45 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.989 0.423 . . . . 0.0 111.307 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.07 -24.38 71.74 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.76 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.49 HG22 ' OE1' ' A' ' 171' ' ' GLN . 0.6 OUTLIER -106.54 4.79 28.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.463 0.173 . . . . 0.0 111.167 179.595 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.975 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -107.26 -40.82 5.29 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.875 0.369 . . . . 0.0 111.503 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.466 ' HB2' ' HB2' ' A' ' 92' ' ' LEU . 6.3 tpp -59.96 -46.31 89.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.609 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.548 ' O ' HD21 ' A' ' 129' ' ' LEU . 5.3 mpt_? -53.72 -60.24 7.69 Favored Pre-proline 0 C--N 1.323 -0.571 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.006 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.921 ' HB2' HD22 ' A' ' 30' ' ' LEU . 11.7 Cg_endo -59.24 -34.38 98.14 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 121.958 1.772 . . . . 0.0 112.409 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 1.055 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -71.31 -53.25 14.88 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.025 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.897 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -51.29 -28.34 11.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.534 178.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.901 ' CB ' ' HB1' ' A' ' 175' ' ' ALA . . . -86.75 -53.65 4.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.357 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.752 ' CB ' HD11 ' A' ' 30' ' ' LEU . . . -60.32 -37.47 80.69 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -177.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.734 ' HB2' HD12 ' A' ' 153' ' ' LEU . 25.8 mt -75.24 -11.62 60.11 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.215 -177.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.59 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 21.9 m -83.23 17.76 1.95 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.185 0.517 . . . . 0.0 110.247 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.648 HD21 ' HB2' ' A' ' 182' ' ' LEU . 2.6 mt -95.92 -68.36 0.8 Allowed 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.365 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.07 151.96 27.83 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.669 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 m -66.54 98.29 0.49 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.982 0.42 . . . . 0.0 110.855 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.672 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 5.8 m-80 -148.53 137.44 21.62 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.103 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.8 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 1.7 m-20 -95.29 100.28 12.09 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.191 0.52 . . . . 0.0 109.926 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.569 HG12 HD13 ' A' ' 106' ' ' LEU . 1.6 mp -118.38 148.37 21.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.903 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.821 HG13 ' CD2' ' A' ' 143' ' ' LEU . 43.9 t -118.0 112.58 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 176.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.722 ' O ' ' HA ' ' A' ' 150' ' ' PRO . 24.0 mt -102.36 105.58 16.22 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.905 -178.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.526 HG23 ' HB3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -116.42 -170.39 1.8 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.802 0.334 . . . . 0.0 111.206 -179.736 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.551 ' HA3' ' HG2' ' A' ' 121' ' ' MET . . . -168.32 172.58 42.94 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.006 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.651 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 18.1 mt-10 -68.85 176.36 1.55 Allowed Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 122.639 0.375 . . . . 0.0 110.903 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.651 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 81.7 Cg_exo -47.78 -41.06 31.89 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.759 2.306 . . . . 0.0 113.581 -179.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -67.37 -23.15 65.56 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.661 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.575 ' O ' ' HG3' ' A' ' 149' ' ' PRO . 10.5 tpt -61.84 -35.19 77.55 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.489 ' HA ' ' HG2' ' A' ' 149' ' ' PRO . 3.4 mmtp -61.64 -16.78 51.56 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.673 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -86.34 3.48 43.28 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 120.827 0.346 . . . . 0.0 110.289 178.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.436 ' HB3' ' NH2' ' A' ' 100' ' ' ARG . 3.5 mtt180 -127.3 81.18 70.5 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.075 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.413 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 14.8 Cg_endo -56.9 149.21 62.56 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.937 2.425 . . . . 0.0 112.032 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.508 HD11 HD23 ' A' ' 129' ' ' LEU . 0.7 OUTLIER -124.14 17.67 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.349 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.43 ' HA3' ' CB ' ' A' ' 147' ' ' ASN . . . -61.29 -46.16 95.0 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.927 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.626 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 27.2 m-70 -56.87 -35.53 69.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.982 0.391 . . . . 0.0 111.322 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.763 HD11 ' HB3' ' A' ' 175' ' ' ALA . 15.4 tp -75.79 -47.71 24.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.927 0.394 . . . . 0.0 111.318 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.826 HG13 ' CG2' ' A' ' 140' ' ' ILE . 51.9 t -56.25 -47.43 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.395 -178.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.67 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 82.8 m-20 -68.81 -39.8 79.86 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.031 0.443 . . . . 0.0 110.12 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.568 ' HB2' HG23 ' A' ' 164' ' ' VAL . . . -59.4 -45.24 92.06 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.012 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.728 HD11 ' HG ' ' A' ' 129' ' ' LEU . 10.7 mt -75.15 -48.42 23.74 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.446 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.696 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -58.65 -28.37 65.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.959 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.67 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 5.8 tp -68.3 -32.57 72.81 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.278 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 159' ' ' GLY . . . -79.35 9.96 38.5 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.153 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.39 6.64 57.48 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.329 -0.939 . . . . 0.0 112.755 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.415 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . . . -74.48 151.97 39.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.882 0.372 . . . . 0.0 111.146 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.446 ' CB ' ' HB2' ' A' ' 154' ' ' GLN . 9.9 mmmt -99.22 100.14 11.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.687 178.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.826 ' CG2' HG13 ' A' ' 130' ' ' VAL . 28.5 mt -131.68 127.44 59.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.477 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.765 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -125.14 139.03 54.12 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.004 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.469 ' CE1' HG11 ' A' ' 130' ' ' VAL . 29.1 m-85 -78.54 133.48 37.36 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.847 0.356 . . . . 0.0 110.955 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.899 HD11 ' HG3' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -94.02 -87.84 0.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.734 -179.55 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.509 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 2.5 mm-40 -59.36 -81.99 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.34 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.441 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 35.0 mt-30 -115.14 154.45 28.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.112 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 5.0 mt-10 -67.66 131.96 46.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.31 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.43 ' CB ' ' HA3' ' A' ' 127' ' ' GLY . 1.1 m-20 70.57 19.41 6.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.954 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.558 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 13.2 m-85 -109.72 168.63 7.41 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.634 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 10.5 Cg_exo -30.91 -62.1 0.12 Allowed 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 125.264 3.976 . . . . 0.0 117.477 -177.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.86 ' HB2' ' HB2' ' A' ' 143' ' ' LEU . 26.3 Cg_endo -62.24 150.17 87.93 Favored 'Trans proline' 0 C--N 1.351 0.677 0 CA-C-N 120.655 1.27 . . . . 0.0 112.117 -177.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.763 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 7.6 mt -155.64 138.63 15.43 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.866 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.899 ' HG3' HD11 ' A' ' 143' ' ' LEU . 0.7 OUTLIER -104.71 104.31 14.09 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 176.986 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.897 HD11 ' HA ' ' A' ' 103' ' ' ALA . 4.1 mt -95.6 141.54 28.99 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.817 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.672 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 2.8 mt-30 -145.47 31.1 1.09 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.665 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.59 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 48.18 -158.02 0.84 Allowed Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.323 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.44 -11.08 46.95 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.264 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.547 ' CD1' ' HB2' ' A' ' 183' ' ' ALA . 31.6 t80 -59.77 122.93 15.41 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 117.467 0.634 . . . . 0.0 110.367 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.736 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 70.0 p -115.96 -35.53 4.41 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 121.54 0.686 . . . . 0.0 111.182 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.457 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 140.21 -160.76 26.4 Favored Glycine 0 C--N 1.307 -1.049 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.085 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.57 ' O ' HG23 ' A' ' 187' ' ' THR . . . 105.88 152.64 20.43 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.545 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -47.02 123.03 4.85 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.084 -0.558 . . . . 0.0 110.597 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 160' ' ' GLY . 42.7 t -116.06 146.39 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.123 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -113.27 120.16 40.22 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.117 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.836 HG21 HD11 ' A' ' 176' ' ' LEU . 1.0 OUTLIER -133.95 119.92 33.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.966 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.47 141.18 43.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.929 0.395 . . . . 0.0 111.041 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.677 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . -57.32 -51.36 58.1 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.595 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.424 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 18.6 p -97.56 111.32 23.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.615 0.245 . . . . 0.0 111.268 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.496 HG21 ' CG ' ' A' ' 128' ' ' HIS . 14.2 p -175.21 -35.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.588 ' C ' HG11 ' A' ' 196' ' ' VAL . 0.4 OUTLIER 162.69 128.5 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.245 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.61 -17.4 64.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.572 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.507 ' HB2' ' HB2' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -86.26 -11.86 51.16 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.005 -179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.682 ' HA ' HD13 ' A' ' 129' ' ' LEU . 5.9 m-85 -71.3 -56.77 5.35 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.746 ' HG ' HG11 ' A' ' 164' ' ' VAL . 0.5 OUTLIER -62.81 -44.43 96.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.39 178.741 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.703 HG21 ' HD3' ' A' ' 27' ' ' ARG . 2.5 m -54.82 -33.19 61.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.826 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.901 ' HB1' ' CB ' ' A' ' 104' ' ' ALA . . . -68.32 -39.3 82.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.242 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.836 HD11 HG21 ' A' ' 164' ' ' VAL . 0.7 OUTLIER -76.58 -35.45 58.16 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.839 179.753 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.78 ' O ' ' HE1' ' A' ' 208' ' ' MET . 3.8 mp -59.82 -37.85 80.37 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.191 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.62 ' HE1' ' HA ' ' A' ' 27' ' ' ARG . 2.6 mtp -81.68 -43.15 18.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.338 0.59 . . . . 0.0 112.086 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 95.9 m -72.01 -42.4 66.43 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.105 -178.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.573 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . -58.71 -41.44 88.86 Favored Pre-proline 0 C--N 1.32 -0.716 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -176.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 28.5 Cg_endo -64.43 -28.54 62.53 Favored 'Trans proline' 0 CA--C 1.501 -1.167 0 C-N-CA 120.831 1.02 . . . . 0.0 112.128 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.648 ' HB2' HD21 ' A' ' 108' ' ' LEU . 5.6 mt -84.26 0.83 47.43 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.51 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.736 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -83.51 137.71 41.71 Favored Pre-proline 0 C--O 1.224 -0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.396 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.721 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 11.4 Cg_endo -51.34 -34.31 49.47 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.688 2.258 . . . . 0.0 113.404 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.81 140.2 46.66 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.733 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -55.16 143.69 26.62 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.046 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 160' ' ' GLY . 92.0 m -123.6 148.23 46.6 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.687 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 40.3 t -128.7 118.27 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.878 177.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.733 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 5.0 mp -99.09 119.09 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.548 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 2.4 ttt180 -100.74 125.46 47.2 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.677 HG23 ' HA2' ' A' ' 166' ' ' GLY . 1.5 mp -93.37 127.33 45.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.867 -176.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -82.65 96.67 8.19 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.231 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 98.66 -127.55 9.28 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.708 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -116.66 133.54 55.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.708 0.29 . . . . 0.0 111.471 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.672 HD11 ' HZ ' ' A' ' 223' ' ' PHE . 1.1 mt -41.62 144.13 0.42 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.166 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.588 HG11 ' C ' ' A' ' 169' ' ' SER . 12.4 p -72.87 -25.03 21.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.637 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.572 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 0.4 OUTLIER -170.78 68.63 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.096 0.474 . . . . 0.0 110.235 -179.575 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.733 ' HG3' ' HD3' ' A' ' 199' ' ' PRO . 0.0 OUTLIER -48.17 -29.37 1.4 Allowed Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.344 179.712 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.733 ' HD3' ' HG3' ' A' ' 198' ' ' LYS . 23.3 Cg_exo -64.78 -28.9 59.41 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 121.094 1.196 . . . . 0.0 110.724 178.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.936 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.1 OUTLIER -69.79 -42.3 73.93 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 177.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 11.9 mm -60.15 -39.61 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.255 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -58.07 -44.86 87.74 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.327 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.936 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.0 mt -62.66 -50.42 79.83 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 CA-C-O 121.569 0.699 . . . . 0.0 109.551 178.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.579 HG22 ' SD ' ' A' ' 208' ' ' MET . 97.4 m -53.43 -51.54 62.31 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.843 -178.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.762 HD22 ' HB ' ' A' ' 215' ' ' ILE . 29.8 mt -67.01 -29.22 68.99 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.028 0.442 . . . . 0.0 111.369 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' ASN . . . . . 0.443 ' HA ' ' HE3' ' A' ' 209' ' ' LYS . 5.1 t-20 -77.63 -46.47 21.96 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.633 0.73 . . . . 0.0 109.876 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.953 ' O ' HG22 ' A' ' 210' ' ' THR . 4.4 tp -71.75 -29.7 64.79 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.574 -1.193 . . . . 0.0 109.404 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' MET . . . . . 0.78 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 43.0 mtp -76.13 -35.31 59.3 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 14.4 mtmt -61.43 -38.71 88.14 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.654 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.953 HG22 ' O ' ' A' ' 207' ' ' LEU . 6.6 t -61.04 -26.85 67.92 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.3 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.59 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 27.6 m-85 -83.88 -7.31 59.47 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.903 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.89 7.43 25.37 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 116.31 1.284 . . . . 0.0 116.31 177.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.2 m -123.55 148.54 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 118.983 1.392 . . . . 0.0 112.604 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.538 ' O ' HD13 ' A' ' 215' ' ' ILE . 12.0 mt-10 -130.35 139.41 50.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.008 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.9 HD12 ' HB ' ' A' ' 225' ' ' VAL . 18.4 mm -122.46 148.78 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 120.836 0.351 . . . . 0.0 110.744 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.589 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 1.3 tp10 -104.67 122.4 45.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.032 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -86.84 151.01 23.72 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.182 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' GLN . . . . . 0.521 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 2.8 mm-40 -111.12 -141.57 0.38 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.14 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.535 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 28.3 m170 -73.92 65.03 1.03 Allowed 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 2.0 t80 57.24 36.3 27.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.706 0.765 . . . . 0.0 110.944 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.651 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 4.5 pt20 -168.73 -124.5 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.733 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -8.61 130.88 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.687 ' O ' ' HA ' ' A' ' 188' ' ' VAL . 0.7 OUTLIER -121.87 140.23 52.65 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.119 -1.855 . . . . 0.0 109.625 -179.163 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 40.1 t -120.84 114.25 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-O 121.297 0.57 . . . . 0.0 109.696 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.9 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.2 OUTLIER -122.29 125.87 73.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.087 -179.017 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -77.88 127.55 32.56 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.955 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -80.52 -178.51 52.11 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.351 -178.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 67.5 21.01 72.29 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 121.623 -0.322 . . . . 0.0 113.285 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' GLN . . . . . 0.468 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 46.5 mt-30 -78.32 -173.43 3.27 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.268 0.556 . . . . 0.0 111.214 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.09 147.8 26.25 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.365 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' TYR . . . . . 0.536 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 7.2 m-85 -102.89 130.35 49.9 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.886 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.04 151.78 37.62 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.48 111.09 12.45 Favored Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.97 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.495 ' HD2' ' OG1' ' A' ' 39' ' ' THR . 52.0 Cg_endo -69.37 1.11 4.46 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.249 1.966 . . . . 0.0 112.27 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 98.68 -101.04 2.4 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.303 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 49.2 m -118.42 136.97 53.46 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.685 ' CE2' HG21 ' A' ' 210' ' ' THR . 9.3 t80 -133.23 124.2 26.95 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.989 0.423 . . . . 0.0 111.362 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.922 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -94.99 110.83 22.69 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.8 179.866 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.673 HG11 ' N ' ' A' ' 25' ' ' SER . 21.5 t -77.93 112.52 16.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.474 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.413 ' HG2' HD13 ' A' ' 238' ' ' LEU . 2.7 mt-10 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.296 -0.859 . . . . 0.0 111.018 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.556 ' HA ' ' HE1' ' A' ' 178' ' ' MET . 37.7 mtm-85 . . . . . 0 CA--C 1.52 -0.193 0 N-CA-C 112.094 0.405 . . . . 2.3300000000000001 112.094 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.73 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -35.76 -42.75 0.27 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.584 -0.735 . . . . 0.17999999999999999 112.601 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.01 HD22 HD11 ' A' ' 75' ' ' ILE . 12.4 mt -75.9 -39.55 56.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.896 0.379 . . . . 0.14000000000000001 111.587 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.782 HD22 ' HB2' ' A' ' 101' ' ' PRO . 31.7 tp -64.91 -50.85 64.88 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.034 -0.53 . . . . 0.23999999999999999 110.873 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.549 HD21 ' CE ' ' A' ' 178' ' ' MET . 31.4 mt -64.78 -28.06 69.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.992 -0.549 . . . . 0.38 109.684 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.785 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -64.75 -40.03 94.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.523 -0.762 . . . . 0.20000000000000001 110.238 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.601 ' CB ' HG11 ' A' ' 62' ' ' VAL . . . -77.82 -39.46 43.64 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.046 -0.525 . . . . 0.14000000000000001 111.273 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.589 HD11 ' HB1' ' A' ' 105' ' ' ALA . 20.7 mt -70.69 -3.0 16.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.95 -0.568 . . . . 0.25 110.534 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.444 ' HA ' ' CB ' ' A' ' 231' ' ' TYR . . . -96.39 172.9 7.65 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 113.144 0.794 . . . . 0.33000000000000002 113.144 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.461 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.2 OUTLIER -110.11 108.76 19.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.845 -1.07 . . . . 1.03 108.593 178.001 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 120.57 170.1 14.09 Favored Glycine 0 C--N 1.319 -0.38 0 C-N-CA 120.822 -0.704 . . . . 0.56000000000000005 111.375 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.825 ' HG3' HG23 ' A' ' 76' ' ' ILE . 0.1 OUTLIER -94.48 119.3 32.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.227 0.514 . . . . 1.72 111.609 -179.228 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.533 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 1.0 OUTLIER -120.3 142.13 49.38 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 120.715 0.293 . . . . 0.52000000000000002 110.401 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.416 ' C ' HD13 ' A' ' 41' ' ' LEU . 69.5 t -102.08 139.21 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-O 121.324 0.583 . . . . 0.25 111.937 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.855 HD23 HD23 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -113.21 114.96 27.48 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 107.217 -1.401 . . . . 0.23999999999999999 107.217 175.759 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.8 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.6 OUTLIER -102.81 149.34 24.58 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.487 -0.485 . . . . 0.33000000000000002 111.04 -178.317 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 69.4 24.5 5.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.03 -0.532 . . . . 1.1899999999999999 111.756 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.787 HD21 ' HB3' ' A' ' 41' ' ' LEU . 86.8 mt -52.92 -177.47 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.832 0.349 . . . . 0.28000000000000003 110.138 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.494 ' O ' HG21 ' A' ' 50' ' ' VAL . 48.4 tp -108.75 131.39 54.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.439 -0.346 . . . . 0.44 110.369 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -89.17 88.87 7.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.855 0.359 . . . . 1.6399999999999999 110.247 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 49' ' ' ASP . 0.6 OUTLIER -165.48 144.64 6.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.97999999999999998 110.073 -179.154 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -36.1 -32.31 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.638 0.256 . . . . 1.6100000000000001 111.449 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.635 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 4.6 p30 -56.13 -42.2 76.55 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.899 0.381 . . . . 1.5600000000000001 110.841 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.534 HG12 HD11 ' A' ' 54' ' ' LEU . 84.1 t -84.4 -45.82 17.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.036 -0.529 . . . . 0.23000000000000001 110.531 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.892 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -48.73 -38.65 22.17 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.989 -0.285 . . . . 2.04 110.615 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.564 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 19.6 m-70 -79.88 -36.22 36.88 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 109.634 -0.506 . . . . 0.26000000000000001 109.634 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.484 ' O ' HD13 ' A' ' 57' ' ' LEU . 8.5 tpt -53.36 -31.55 45.14 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 106.086 -1.82 . . . . 0.16 106.086 176.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.892 HD12 ' HA ' ' A' ' 51' ' ' ARG . 2.2 mt -83.42 -45.41 13.69 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 113.914 -1.494 . . . . 0.20999999999999999 108.645 176.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.596 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 18.2 t-20 -58.94 -39.75 82.59 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 115.82 -0.627 . . . . 1.24 111.002 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.824 ' CB ' HD11 ' A' ' 102' ' ' LEU . . . -62.37 -49.96 73.45 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.69 0.757 . . . . 0.14000000000000001 109.249 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.646 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.5 OUTLIER -57.95 -37.66 74.55 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.246 -1.39 . . . . 0.22 107.246 176.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.596 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -62.59 -44.43 96.34 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.005 -1.452 . . . . 0.27000000000000002 112.021 179.227 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.655 ' C ' HD21 ' A' ' 88' ' ' LEU . . . -67.78 -39.13 84.13 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.712 0.634 . . . . 0.23999999999999999 112.712 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.636 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.7 OUTLIER -75.26 -17.13 60.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.426 0.631 . . . . 0.26000000000000001 110.28 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.81 37.16 3.75 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 114.894 -1.048 . . . . 0.31 113.935 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.646 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 22.0 t -90.3 125.57 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 109.09 -0.707 . . . . 0.25 109.09 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.716 ' O ' HG12 ' A' ' 76' ' ' ILE . 12.5 m -86.55 130.61 34.43 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 120.469 -0.492 . . . . 1.0 111.13 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.813 ' HB3' HG23 ' A' ' 75' ' ' ILE . 32.4 p90 -159.78 168.87 24.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.18 -0.464 . . . . 0.20000000000000001 110.291 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 99.0 m -134.76 148.65 50.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.284 -0.416 . . . . 0.20999999999999999 110.561 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.417 HD12 ' HB2' ' A' ' 73' ' ' CYS . 14.4 tp -117.19 136.79 52.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.09 0.472 . . . . 0.42999999999999999 110.776 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.514 ' HB2' ' CB ' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -63.94 -158.99 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.612 -0.722 . . . . 1.7 111.281 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -95.7 -31.98 12.97 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.413 -0.358 . . . . 1.78 111.178 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.53 1.09 30.95 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.413 -0.358 . . . . 1.8899999999999999 111.375 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 59.79 24.72 13.7 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.48 -0.327 . . . . 1.8600000000000001 111.67 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.644 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -122.4 -11.23 8.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.823 0.344 . . . . 0.38 111.406 179.573 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.514 ' CB ' ' HB2' ' A' ' 67' ' ' SER . 2.0 mtt180 -112.56 117.96 33.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.439 -0.346 . . . . 3.0099999999999998 110.275 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.766 ' HB3' HD11 ' A' ' 44' ' ' LEU . 43.4 t -131.11 127.52 38.27 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 120.958 0.408 . . . . 0.17999999999999999 111.735 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.535 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 51.3 tt0 -112.24 133.1 54.55 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 109.04 -0.726 . . . . 1.49 109.04 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 1.01 HD11 HD22 ' A' ' 29' ' ' LEU . 11.8 mt -128.7 123.86 60.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 113.948 1.092 . . . . 0.17999999999999999 113.948 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.825 HG23 ' HG3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -67.73 98.86 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 109.157 -0.683 . . . . 0.94999999999999996 109.157 175.764 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -37.23 142.91 0.2 Allowed Glycine 0 C--N 1.321 -0.262 0 CA-C-N 115.138 -0.937 . . . . 0.22 113.579 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -90.31 -13.32 35.45 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.917 0.389 . . . . 1.21 111.113 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.461 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 86.24 14.51 66.34 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.037 -0.601 . . . . 0.28999999999999998 112.606 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.585 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 145.36 -155.58 26.55 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.792 -0.718 . . . . 0.14999999999999999 112.581 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.516 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 5.8 Cg_endo -49.3 127.41 17.76 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.682 2.255 . . . . 0.51000000000000001 112.436 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.653 ' H ' HD22 ' A' ' 82' ' ' LEU . 0.3 OUTLIER -74.88 109.25 8.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.124 -0.489 . . . . 0.23000000000000001 109.935 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.411 ' HA ' HD22 ' A' ' 111' ' ' ASN . 3.9 p80 -80.42 124.12 28.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.2 0.524 . . . . 0.59999999999999998 112.111 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.667 ' CB ' HD11 ' A' ' 113' ' ' ILE . . . -89.34 124.2 34.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.505 -0.77 . . . . 0.19 111.275 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.51 122.92 20.0 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 105.621 -1.992 . . . . 1.95 105.621 176.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.24 -175.39 5.5 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 108.559 -1.816 . . . . 0.20000000000000001 108.559 -175.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.38 145.03 30.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 118.787 1.294 . . . . 0.17999999999999999 111.832 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.655 HD21 ' C ' ' A' ' 59' ' ' ALA . 0.8 OUTLIER -114.16 161.78 17.35 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.003 -0.998 . . . . 0.20999999999999999 112.278 -178.656 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -139.63 102.89 4.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.612 -1.176 . . . . 1.8700000000000001 108.707 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.699 ' HB3' HD11 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -99.2 127.54 45.19 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 120.99 0.424 . . . . 0.16 111.276 -178.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.609 ' C ' HD13 ' A' ' 92' ' ' LEU . 0.9 OUTLIER -99.09 95.51 7.16 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.86 -0.609 . . . . 1.48 109.679 179.185 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.746 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -104.03 54.82 0.73 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.846 -0.615 . . . . 0.62 110.085 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -56.63 -68.5 1.66 Allowed Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.71 -0.677 . . . . 0.72999999999999998 112.984 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.507 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 33.2 m-20 -79.12 -1.76 37.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.575 0.226 . . . . 2.04 110.801 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.959 ' HB1' ' HB3' ' A' ' 98' ' ' ALA . . . -92.76 45.58 1.19 Allowed 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 116.475 -0.33 . . . . 0.93000000000000005 110.919 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -50.42 -27.58 12.17 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.429 -0.891 . . . . 0.47999999999999998 112.032 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.795 HG22 ' CD ' ' A' ' 171' ' ' GLN . 1.1 p -88.83 -14.94 35.77 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.529 0.196 . . . . 0.79000000000000004 111.529 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.959 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -93.46 -37.19 12.07 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.074 0.398 . . . . 0.33000000000000002 112.074 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.1 tpp -59.17 -46.37 88.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.693 -0.23 . . . . 0.39000000000000001 110.737 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.509 ' HB3' ' O ' ' A' ' 171' ' ' GLN . 2.2 mpt_? -52.89 -60.68 6.08 Favored Pre-proline 0 C--N 1.324 -0.537 0 C-N-CA 120.755 -0.378 . . . . 1.3799999999999999 110.056 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.782 ' HB2' HD22 ' A' ' 30' ' ' LEU . 18.1 Cg_endo -60.31 -31.63 93.11 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.422 2.082 . . . . 0.39000000000000001 112.773 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.824 HD11 ' CB ' ' A' ' 56' ' ' ALA . 2.1 mt -73.76 -54.03 8.98 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 120.403 -0.519 . . . . 0.20000000000000001 109.945 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.855 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -47.42 -29.6 2.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.673 -0.694 . . . . 0.17000000000000001 110.543 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.733 ' CB ' ' HB1' ' A' ' 175' ' ' ALA . . . -88.08 -52.11 5.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.872 -0.604 . . . . 0.17000000000000001 112.226 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.67 ' CB ' HD11 ' A' ' 30' ' ' LEU . . . -59.89 -35.42 74.8 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.193 0.812 . . . . 0.17000000000000001 113.193 -177.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.729 ' HB2' HD12 ' A' ' 153' ' ' LEU . 28.3 mt -78.74 -10.98 59.96 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 112.705 0.631 . . . . 0.23000000000000001 112.705 -177.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.754 ' SG ' HD13 ' A' ' 153' ' ' LEU . 99.0 m -93.07 24.86 3.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.287 0.565 . . . . 1.48 110.067 178.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.829 HD21 ' HB2' ' A' ' 182' ' ' LEU . 0.5 OUTLIER -85.51 -75.95 0.35 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.335 -0.848 . . . . 0.40999999999999998 111.213 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -76.76 -105.61 0.14 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.581 -0.819 . . . . 1.1399999999999999 112.141 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.63 96.33 1.5 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.057 0.456 . . . . 0.82999999999999996 110.523 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.69 ' HB2' HD13 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -141.39 140.1 33.61 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.76 -0.654 . . . . 1.96 110.799 -178.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.795 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 5.6 m-20 -95.44 99.25 11.18 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 109.087 -0.708 . . . . 1.1200000000000001 109.087 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.69 HD13 ' HB2' ' A' ' 111' ' ' ASN . 1.3 mp -123.28 144.11 33.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.553 -0.749 . . . . 0.52000000000000002 111.663 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.89 HG13 ' CD2' ' A' ' 143' ' ' LEU . 48.0 t -113.9 113.22 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 107.922 -1.14 . . . . 0.17000000000000001 107.922 176.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' A' ' 90' ' ' LEU . 25.7 mt -101.23 105.67 16.81 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 119.869 -0.733 . . . . 0.16 110.346 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.699 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -117.48 -171.61 2.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.573 -0.285 . . . . 0.23999999999999999 111.315 -179.364 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -167.27 -166.22 25.98 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.547 -0.835 . . . . 0.28999999999999998 113.278 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.578 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 40.2 mt-10 -85.85 166.82 27.42 Favored Pre-proline 0 C--N 1.33 -0.273 0 C-N-CA 122.606 0.363 . . . . 1.79 110.678 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.578 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 2.1 Cg_endo -44.83 -37.25 11.74 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.725 2.283 . . . . 0.41999999999999998 112.696 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -67.62 -26.55 66.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.807 0.337 . . . . 2.25 110.381 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.517 ' O ' ' HG3' ' A' ' 149' ' ' PRO . 7.3 tpt -62.5 -31.81 72.62 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.532 -0.544 . . . . 0.28999999999999998 109.532 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 119' ' ' PRO . 0.1 OUTLIER -61.7 -18.08 58.22 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 115.923 -0.58 . . . . 1.51 110.257 179.067 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -85.25 4.9 32.64 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.957 0.408 . . . . 2.3199999999999998 110.086 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 124' ' ' ARG . 5.9 mtt-85 -127.16 80.58 71.38 Favored Pre-proline 0 N--CA 1.455 -0.197 0 CA-C-N 116.013 -0.54 . . . . 2.1099999999999999 110.51 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.83 148.89 63.8 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.583 2.188 . . . . 0.47999999999999998 111.712 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 148' ' ' TYR . 1.2 tt -126.13 10.4 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 112.386 0.513 . . . . 0.23000000000000001 112.386 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.526 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -59.99 -39.83 96.16 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.559 -0.829 . . . . 0.23000000000000001 113.107 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.415 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 14.4 m-70 -57.41 -37.02 72.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.747 0.308 . . . . 1.5600000000000001 111.03 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.749 ' HG ' HD11 ' A' ' 133' ' ' LEU . 12.5 tp -75.65 -44.49 42.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.273 0.559 . . . . 0.29999999999999999 110.514 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.76 HG13 ' CG2' ' A' ' 140' ' ' ILE . 47.8 t -55.48 -48.13 77.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.367 -0.833 . . . . 0.22 111.275 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.662 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 4.1 m-20 -67.77 -41.45 83.25 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 120.993 0.425 . . . . 1.3200000000000001 110.562 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.617 ' HB2' HG23 ' A' ' 164' ' ' VAL . . . -56.84 -44.06 81.72 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.553 -0.749 . . . . 0.16 110.003 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.749 HD11 ' HG ' ' A' ' 129' ' ' LEU . 6.5 mt -77.4 -51.32 11.0 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.596 -0.729 . . . . 0.19 110.769 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.658 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -55.16 -26.41 38.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.598 -0.728 . . . . 2.8700000000000001 109.912 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.662 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 3.4 tp -69.51 -32.5 71.4 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.175 -0.466 . . . . 0.44 110.556 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.47 12.06 41.76 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.646 -0.788 . . . . 0.20000000000000001 112.049 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.91 5.57 58.41 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.25 -0.976 . . . . 0.25 112.689 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.655 ' HB1' ' HB3' ' A' ' 107' ' ' CYS . . . -75.77 149.66 37.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.029 0.442 . . . . 0.22 111.305 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.0 mttp -97.0 109.22 22.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.948 -0.569 . . . . 2.1000000000000001 110.277 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.76 ' CG2' HG13 ' A' ' 130' ' ' VAL . 28.1 mt -140.6 126.9 21.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.838 0.351 . . . . 0.20000000000000001 111.638 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.655 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -124.2 139.96 53.43 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.124 -0.489 . . . . 0.27000000000000002 110.258 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.403 ' HE1' HG21 ' A' ' 130' ' ' VAL . 32.5 m-85 -80.56 130.14 34.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.837 0.351 . . . . 0.33000000000000002 110.867 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.89 ' CD2' HG13 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -88.5 -85.03 0.19 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.136 -0.484 . . . . 0.29999999999999999 112.076 -178.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.444 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 1.2 mt-10 -66.28 -83.87 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.838 -0.345 . . . . 1.77 110.586 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.481 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 75.5 mt-30 -109.49 153.95 23.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.407 -0.36 . . . . 1.76 110.139 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -69.1 131.74 45.47 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.874 0.368 . . . . 1.6599999999999999 110.865 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.526 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 0.9 OUTLIER 71.43 19.93 5.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.934 -0.575 . . . . 0.77000000000000002 111.155 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.56 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 14.6 m-85 -106.8 169.12 7.15 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 112.277 0.473 . . . . 0.45000000000000001 112.277 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.755 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 65.4 Cg_exo -36.09 -57.26 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.86 3.04 . . . . 0.26000000000000001 115.481 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.755 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 52.3 Cg_exo -56.79 144.97 85.72 Favored 'Trans proline' 0 C--N 1.353 0.806 0 CA-C-N 120.432 1.19 . . . . 0.20000000000000001 112.05 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.679 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 12.2 mt -156.81 134.98 11.2 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.841 -1.072 . . . . 0.23999999999999999 109.894 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.655 ' HB2' HG22 ' A' ' 141' ' ' THR . 3.7 mtt180 -105.33 105.43 15.47 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.009 -1.108 . . . . 2.0800000000000001 108.009 176.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.855 HD11 ' HA ' ' A' ' 103' ' ' ALA . 3.4 mt -94.35 144.62 25.39 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.865 -1.061 . . . . 0.19 110.904 -177.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.681 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 3.6 mt-30 -145.87 27.23 1.2 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.508 -0.769 . . . . 1.1799999999999999 110.72 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 51.06 179.05 0.03 OUTLIER Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.015 -0.612 . . . . 0.40000000000000002 112.622 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 158' ' ' THR . . . 125.68 -10.27 7.58 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.143 -1.027 . . . . 0.25 113.405 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.577 ' CD1' ' HB2' ' A' ' 183' ' ' ALA . 21.4 t80 -58.87 122.64 14.12 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 117.381 0.591 . . . . 0.53000000000000003 110.482 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.687 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 73.1 p -117.53 -38.29 3.33 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.334 0.588 . . . . 0.25 111.625 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.553 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 144.64 -170.92 26.11 Favored Glycine 0 C--N 1.308 -1.022 0 C-N-CA 120.239 -0.981 . . . . 0.25 112.583 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.573 ' O ' HG23 ' A' ' 187' ' ' THR . . . 112.58 155.06 12.19 Favored Glycine 0 N--CA 1.436 -1.323 0 N-CA-C 111.189 -0.764 . . . . 0.62 111.189 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -47.76 125.67 9.04 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 120.833 0.349 . . . . 1.9299999999999999 110.68 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 132' ' ' ALA . 74.7 t -117.11 144.42 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.66 -0.496 . . . . 0.27000000000000002 109.66 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -113.26 119.39 37.57 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.865 -0.334 . . . . 1.1200000000000001 110.794 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.846 HG21 HD11 ' A' ' 176' ' ' LEU . 1.1 t -131.83 119.17 40.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 120.598 -0.441 . . . . 0.31 109.851 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.44 138.39 46.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 1.48 111.288 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.709 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . . . . . . 0 N--CA 1.446 -0.658 0 C-N-CA 120.588 -0.815 . . . . 0.52000000000000002 112.431 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.463 ' HB2' ' HB3' ' A' ' 200' ' ' TYR . 71.9 p . . . . . 0 C--O 1.231 0.13 0 N-CA-C 111.993 0.368 . . . . 1.25 111.993 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.795 ' CD ' HG22 ' A' ' 97' ' ' THR . 8.7 mp0 -85.5 -11.01 55.25 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.815 -0.354 . . . . 2.3700000000000001 111.111 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.486 ' CD2' ' HB2' ' A' ' 129' ' ' LEU . 10.8 m-85 -75.07 -59.19 2.85 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.317 -0.623 . . . . 0.39000000000000001 109.317 178.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.841 HD11 ' CG1' ' A' ' 191' ' ' ILE . 0.3 OUTLIER -60.7 -39.14 87.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.475 -0.784 . . . . 0.57999999999999996 109.18 178.42 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.463 HG23 HG21 ' A' ' 204' ' ' THR . 1.7 m -59.84 -38.96 83.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.922 -1.036 . . . . 0.31 109.62 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.733 ' HB1' ' CB ' ' A' ' 104' ' ' ALA . . . -60.65 -41.5 95.08 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.815 -0.629 . . . . 0.19 110.911 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.846 HD11 HG21 ' A' ' 164' ' ' VAL . 0.3 OUTLIER -77.37 -32.16 54.78 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.473 -0.785 . . . . 0.63 110.891 179.657 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.687 ' CD2' HD21 ' A' ' 205' ' ' LEU . 3.5 mp -61.51 -38.44 87.36 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.342 -0.845 . . . . 0.34999999999999998 110.759 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.667 ' HA ' ' HE1' ' A' ' 208' ' ' MET . 1.5 mtp -82.65 -40.6 20.49 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.51 0.559 . . . . 0.68000000000000005 112.51 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.498 HG23 ' HG ' ' A' ' 108' ' ' LEU . 50.3 m -77.1 -39.43 49.56 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.343 -0.844 . . . . 0.27000000000000002 113.071 -178.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.53 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . -58.7 -42.52 94.72 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 114.428 1.27 . . . . 0.37 114.428 -177.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 27.0 Cg_endo -64.82 -27.56 59.42 Favored 'Trans proline' 0 CA--C 1.501 -1.154 0 CA-C-N 119.795 0.962 . . . . 0.52000000000000002 112.387 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.829 ' HB2' HD21 ' A' ' 108' ' ' LEU . 4.0 mt -83.26 -2.36 55.42 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 109.31 -0.626 . . . . 0.51000000000000001 109.31 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.68 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -78.17 135.8 61.9 Favored Pre-proline 0 C--O 1.224 -0.274 0 CA-C-N 116.049 -0.523 . . . . 0.25 110.122 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.687 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 11.3 Cg_endo -51.14 -34.4 47.77 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.378 2.052 . . . . 0.25 113.11 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -112.4 143.64 43.18 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.697 -0.683 . . . . 2.0899999999999999 111.112 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -58.07 153.43 14.67 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.285 -0.416 . . . . 2.2400000000000002 110.286 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.574 HG23 HG23 ' A' ' 162' ' ' VAL . 56.4 m -133.75 145.65 50.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.077 0.465 . . . . 0.27000000000000002 112.223 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.573 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 54.6 t -124.48 117.58 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.584 -0.735 . . . . 0.25 110.197 178.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.687 HG12 HD13 ' A' ' 176' ' ' LEU . 3.4 mp -100.13 117.9 45.99 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 N-CA-C 108.731 -0.84 . . . . 0.23000000000000001 108.731 177.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 7.7 ttt180 -100.66 124.71 46.64 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.322 -0.992 . . . . 2.4300000000000002 108.322 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.841 ' CG1' HD11 ' A' ' 173' ' ' LEU . 1.6 mp -92.27 122.37 43.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.933 -1.03 . . . . 0.31 111.746 -176.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -80.46 96.87 6.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.072 -1.422 . . . . 0.98999999999999999 110.595 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 101.56 -132.39 10.94 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.747 -0.74 . . . . 0.46999999999999997 111.884 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -116.74 127.51 54.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.711 0.291 . . . . 1.1000000000000001 111.628 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.556 HD11 ' HZ ' ' A' ' 223' ' ' PHE . 1.1 mt -40.42 144.87 0.2 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.157 -0.474 . . . . 0.44 111.269 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.402 HG11 ' N ' ' A' ' 170' ' ' SER . 10.5 p -72.52 -30.74 35.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.995 -0.548 . . . . 0.60999999999999999 112.2 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.478 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 0.2 OUTLIER -165.23 63.61 0.12 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.977 0.417 . . . . 0.88 110.734 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.51 ' HA ' HD13 ' A' ' 195' ' ' LEU . 6.1 tttm -40.25 -46.21 5.41 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 115.851 -0.613 . . . . 2.02 111.355 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . 0.478 ' HD2' ' C ' ' A' ' 197' ' ' SER . 87.6 Cg_exo -47.37 -34.09 18.22 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.027 1.818 . . . . 0.62 111.798 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.958 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.3 OUTLIER -70.34 -42.06 72.39 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.804 -0.813 . . . . 1.4099999999999999 108.804 178.056 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.442 HG21 ' HE2' ' A' ' 223' ' ' PHE . 26.4 mm -63.21 -33.8 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 114.819 -1.082 . . . . 0.41999999999999998 110.44 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.7 -45.28 94.8 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.121 0.486 . . . . 1.1399999999999999 109.914 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.958 HD12 ' HA ' ' A' ' 200' ' ' TYR . 3.8 mt -62.14 -50.95 77.95 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 CA-C-O 121.633 0.73 . . . . 0.62 110.163 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.463 HG21 HG23 ' A' ' 174' ' ' THR . 74.9 m -51.63 -51.11 58.29 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.478 -1.237 . . . . 0.46999999999999997 111.449 -178.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.692 HD22 ' HB ' ' A' ' 215' ' ' ILE . 21.3 mt -66.84 -28.59 68.47 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 120.892 0.377 . . . . 0.26000000000000001 111.661 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . 0.415 ' HA ' ' HE3' ' A' ' 209' ' ' LYS . 1.9 t30 -78.48 -46.64 19.18 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.588 0.708 . . . . 1.6000000000000001 109.827 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.979 ' O ' HG22 ' A' ' 210' ' ' THR . 0.2 OUTLIER -71.11 -30.31 66.36 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.687 -1.142 . . . . 0.52000000000000002 109.192 178.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' MET . . . . . 0.667 ' HE1' ' HA ' ' A' ' 178' ' ' MET . 35.5 mtp -72.76 -35.03 67.37 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.848 -0.615 . . . . 0.38 109.534 177.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 10.4 mtmt -60.97 -36.39 79.3 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 115.092 -0.958 . . . . 0.98999999999999999 110.856 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.979 HG22 ' O ' ' A' ' 207' ' ' LEU . 4.8 t -62.04 -22.98 66.19 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.633 -0.712 . . . . 0.96999999999999997 109.33 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.536 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 61.3 m-85 -85.76 -9.07 57.68 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.749 -0.66 . . . . 1.51 111.587 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 111.54 5.33 26.17 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 116.006 1.162 . . . . 2.9300000000000002 116.006 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.5 m -123.54 148.96 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 118.969 1.385 . . . . 1.6899999999999999 112.81 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.476 ' HG2' ' CG ' ' A' ' 209' ' ' LYS . 8.5 mt-10 -131.01 135.88 48.0 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.341 -0.845 . . . . 2.6699999999999999 111.291 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.988 HD12 ' HB ' ' A' ' 225' ' ' VAL . 20.0 mm -118.26 148.59 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 120.772 0.32 . . . . 1.0800000000000001 110.225 178.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.542 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 9.2 tt0 -104.86 116.56 32.2 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.302 -0.408 . . . . 1.54 112.004 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . 0.571 HD22 ' N ' ' A' ' 217' ' ' ASN . 0.0 OUTLIER -84.94 151.25 24.37 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.091 -0.504 . . . . 2.2400000000000002 110.396 179.223 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 5.0 tp60 -108.18 -143.23 0.38 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.477 0.179 . . . . 1.97 110.785 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.409 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 4.5 m-70 -73.3 66.51 0.92 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.886 0.374 . . . . 2.4199999999999999 111.491 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.41 ' CE1' ' HD2' ' A' ' 198' ' ' LYS . 6.4 t80 58.43 33.65 23.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.788 0.804 . . . . 0.97999999999999998 111.11 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.636 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 5.1 pt20 -165.74 -129.99 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 106.69 -1.596 . . . . 1.5600000000000001 106.69 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.617 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -3.06 128.7 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 114.36 1.244 . . . . 1.3500000000000001 114.36 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.597 ' CD1' ' O ' ' A' ' 221' ' ' GLN . 5.1 m-85 -123.02 140.93 52.52 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.262 -1.79 . . . . 0.63 110.042 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.542 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 42.3 t -123.03 112.78 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 121.329 0.585 . . . . 0.33000000000000002 109.841 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.988 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -119.44 135.27 60.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.222 -0.899 . . . . 0.44 111.49 -178.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.431 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 3.7 mptt -83.76 127.8 34.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.038 -0.528 . . . . 2.71 109.823 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.428 ' CA ' ' O ' ' A' ' 183' ' ' ALA . . . -83.03 167.99 46.41 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.442 -0.885 . . . . 0.38 113.347 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 77.73 19.81 75.02 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 121.703 -0.284 . . . . 0.28999999999999998 113.412 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 19.6 mt-30 -77.22 -176.22 4.0 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.39 0.614 . . . . 1.8400000000000001 111.728 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.6 147.67 30.3 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.116 -0.947 . . . . 1.21 110.636 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' TYR . . . . . 0.495 ' CE2' HD22 ' A' ' 31' ' ' LEU . 6.3 m-30 -103.19 132.06 49.74 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.975 -0.557 . . . . 0.76000000000000001 110.995 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -119.74 155.14 33.04 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.697 -0.483 . . . . 2.5299999999999998 109.697 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.484 ' HB2' ' OG1' ' A' ' 39' ' ' THR . 51.8 p -82.42 109.71 17.57 Favored Pre-proline 0 N--CA 1.451 -0.411 0 C-N-CA 121.077 -0.249 . . . . 1.3500000000000001 110.56 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.533 ' HD2' ' OG1' ' A' ' 39' ' ' THR . 54.9 Cg_endo -68.45 -2.34 8.97 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.089 1.859 . . . . 0.33000000000000002 112.233 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 102.21 -94.7 1.21 Allowed Glycine 0 C--O 1.227 -0.313 0 C-N-CA 120.629 -0.796 . . . . 0.28000000000000003 111.666 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 95.9 m -121.51 135.41 55.03 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.344 -0.613 . . . . 0.29999999999999999 109.344 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . 0.739 ' CD2' HG21 ' A' ' 210' ' ' THR . 12.3 t80 -133.58 134.74 43.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.93 0.395 . . . . 0.55000000000000004 111.516 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.8 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -98.91 113.05 25.01 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.981 -0.554 . . . . 0.40999999999999998 111.529 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.744 ' N ' HD22 ' A' ' 238' ' ' LEU . 25.1 t -84.59 112.75 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.731 -0.668 . . . . 0.40999999999999998 110.908 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.251 -0.881 . . . . 1.6899999999999999 111.124 -179.699 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.782 HH12 ' HB ' ' A' ' 203' ' ' ILE . 29.1 mtm180 . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.876 0.37 . . . . 0.0 110.985 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.748 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -39.32 -48.42 1.86 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.667 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.08 HD22 HD11 ' A' ' 75' ' ' ILE . 11.0 mt -72.31 -36.42 68.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.905 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.79 HD22 ' HB2' ' A' ' 101' ' ' PRO . 35.9 tp -65.86 -50.19 65.44 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.719 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.712 HD22 ' CZ ' ' A' ' 231' ' ' TYR . 60.0 mt -67.0 -27.64 67.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.728 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.754 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -65.91 -39.18 90.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.14 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.813 ' CB ' HG11 ' A' ' 62' ' ' VAL . . . -81.73 -41.07 21.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.212 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.727 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 14.4 mt -68.33 -4.01 12.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.227 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.534 ' HB2' ' HB3' ' A' ' 231' ' ' TYR . . . -97.6 179.19 4.93 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -177.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.58 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.4 OUTLIER -112.19 113.5 25.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.931 178.543 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 114.12 169.08 16.52 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.608 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.568 ' HG2' ' HG2' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -95.06 117.57 30.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 117.154 0.477 . . . . 0.0 111.475 -179.223 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 235' ' ' GLY . 0.9 OUTLIER -119.58 145.71 46.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.445 -179.697 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.51 HG22 ' HB2' ' A' ' 74' ' ' GLU . 75.8 t -104.37 142.31 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 CA-C-O 121.344 0.592 . . . . 0.0 112.548 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.874 HD23 HD23 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -116.51 116.36 27.49 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 174.632 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.931 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.5 OUTLIER -102.96 151.35 22.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.108 -177.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.7 t30 66.08 27.26 10.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.179 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.717 HD21 ' CB ' ' A' ' 41' ' ' LEU . 86.2 mt -54.68 -172.94 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.562 ' HB3' HG21 ' A' ' 50' ' ' VAL . 29.7 tp -114.03 131.38 56.38 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -88.46 88.45 7.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.149 0.5 . . . . 0.0 110.565 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 49' ' ' ASP . 1.7 m -164.31 142.91 7.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.1 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.421 ' HA ' ' HB3' ' A' ' 51' ' ' ARG . 0.6 OUTLIER -36.42 -30.45 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.602 0.239 . . . . 0.0 111.455 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.939 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 1.5 p30 -58.19 -42.77 86.82 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 121.028 0.442 . . . . 0.0 110.905 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.797 HG23 ' OD1' ' A' ' 49' ' ' ASP . 88.8 t -84.24 -44.66 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.57 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.943 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -50.89 -39.01 53.11 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.017 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.668 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 7.4 m-70 -80.31 -32.58 37.96 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.595 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.574 ' O ' HD13 ' A' ' 57' ' ' LEU . 9.5 tpt -55.0 -34.62 63.6 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.943 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.5 OUTLIER -82.42 -41.54 19.75 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 114.22 -1.354 . . . . 0.0 108.58 176.346 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.675 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 34.4 t30 -59.13 -41.56 88.52 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-O 120.922 0.391 . . . . 0.0 110.749 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 1.029 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -59.24 -46.76 87.62 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 121.702 0.763 . . . . 0.0 108.96 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.851 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.4 OUTLIER -63.41 -41.11 98.71 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.245 -1.343 . . . . 0.0 107.745 177.243 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.675 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -59.78 -32.9 71.03 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 114.187 -1.369 . . . . 0.0 111.564 179.044 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.748 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -77.66 -38.33 47.91 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.073 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.698 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.5 OUTLIER -79.89 -12.91 59.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.407 0.622 . . . . 0.0 110.566 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.43 33.33 5.42 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 114.967 -1.015 . . . . 0.0 114.244 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.851 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 40.5 t -90.55 117.67 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.791 ' O ' HG12 ' A' ' 76' ' ' ILE . 26.0 m -82.98 132.89 35.13 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 121.078 0.466 . . . . 0.0 112.167 -178.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.723 ' HB3' HG23 ' A' ' 75' ' ' ILE . 41.1 p90 -158.31 171.87 19.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.463 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 62.1 m -131.37 148.51 52.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.182 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.415 ' CD1' ' HB2' ' A' ' 73' ' ' CYS . 12.5 tp -115.04 133.7 55.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.177 0.513 . . . . 0.0 110.685 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.527 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 0.6 OUTLIER -61.21 -167.22 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.378 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.75 -44.47 14.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.553 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.33 1.79 10.79 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.596 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 58.81 39.83 23.62 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.868 0.366 . . . . 0.0 111.54 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -133.95 -10.46 2.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.225 179.292 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.572 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 14.8 mtp180 -114.92 120.59 40.45 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.676 ' HB3' HD11 ' A' ' 44' ' ' LEU . 34.2 t -129.53 125.62 36.72 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.568 ' HG2' ' HG2' ' A' ' 38' ' ' LYS . 56.8 tt0 -106.98 130.62 54.6 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 176.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 1.08 HD11 HD22 ' A' ' 29' ' ' LEU . 10.4 mt -127.72 124.49 63.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -177.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.791 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -68.51 99.62 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-O 121.104 0.478 . . . . 0.0 109.712 175.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' A' ' 35' ' ' ALA . . . -38.77 143.71 0.29 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.843 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -89.31 -10.71 45.75 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.093 0.473 . . . . 0.0 110.921 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.58 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 90.14 3.11 73.32 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.14 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.505 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 150.07 -148.49 19.8 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.012 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.579 ' CG ' ' HB3' ' A' ' 108' ' ' LEU . 88.1 Cg_exo -49.09 125.14 12.73 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.783 2.322 . . . . 0.0 112.973 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.707 ' H ' HD22 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -74.58 110.52 8.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.792 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.409 ' HA ' ' ND2' ' A' ' 111' ' ' ASN . 4.4 p80 -82.08 135.06 35.37 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.072 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.639 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -98.03 123.78 42.22 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.061 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -71.04 123.67 22.61 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.61 175.71 0.96 Allowed Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -175.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.65 144.8 47.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 118.735 1.268 . . . . 0.0 111.411 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.748 HD21 ' HB1' ' A' ' 59' ' ' ALA . 1.3 tp -116.26 160.54 20.31 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.393 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 22.4 mt-10 -139.22 104.23 4.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.288 178.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.686 ' HB2' HD23 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -100.63 118.83 37.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.143 -178.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.424 ' C ' HD13 ' A' ' 92' ' ' LEU . 4.3 m-85 -92.99 96.26 9.98 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.906 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.923 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -104.89 47.31 0.88 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.089 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.782 ' HA3' ' H ' ' A' ' 118' ' ' GLU . . . -54.4 -44.66 76.78 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.848 -0.692 . . . . 0.0 113.281 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.625 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 74.2 m-20 -94.43 -6.89 42.99 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.666 0.27 . . . . 0.0 110.733 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 1.005 ' HB1' ' HB3' ' A' ' 98' ' ' ALA . . . -98.16 61.7 1.49 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.011 0.434 . . . . 0.0 111.311 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.617 ' O ' ' HD3' ' A' ' 100' ' ' ARG . . . -63.82 -25.2 68.94 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.068 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.434 ' HA ' ' HG2' ' A' ' 171' ' ' GLN . 0.9 OUTLIER -88.19 -17.11 31.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.707 0.289 . . . . 0.0 110.882 179.497 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 1.005 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -95.27 -29.21 14.61 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.925 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.668 ' SD ' ' HB3' ' A' ' 115' ' ' LEU . 5.6 tpp -64.3 -47.4 79.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.168 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.671 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 1.9 mpt_? -54.34 -58.87 11.9 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.79 ' HB2' HD22 ' A' ' 30' ' ' LEU . 18.1 Cg_endo -59.71 -33.04 96.57 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.286 1.991 . . . . 0.0 112.635 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 1.029 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.4 OUTLIER -74.16 -53.43 9.88 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.056 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.884 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -50.04 -28.09 6.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.429 0.633 . . . . 0.0 110.279 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.858 ' HB2' ' HB1' ' A' ' 175' ' ' ALA . . . -86.96 -54.44 4.34 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.316 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.67 ' HB1' HD11 ' A' ' 34' ' ' LEU . . . -59.93 -32.76 71.09 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -176.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.739 ' HB2' HD12 ' A' ' 153' ' ' LEU . 20.2 mt -78.99 -12.89 60.05 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.046 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.559 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 20.2 m -81.23 15.32 1.99 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.219 0.533 . . . . 0.0 110.936 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.691 HD21 ' HB2' ' A' ' 182' ' ' LEU . 2.3 mt -91.91 -71.02 0.66 Allowed 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.267 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.86 146.19 22.06 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.707 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.426 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 3.2 p -58.16 98.84 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.803 0.335 . . . . 0.0 111.141 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.616 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 9.7 m120 -148.28 135.51 20.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.874 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.881 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 5.0 m-20 -91.66 101.05 13.67 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.252 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.639 HD11 ' HB2' ' A' ' 84' ' ' ALA . 31.5 mm -118.89 137.48 52.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.161 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.815 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 62.9 t -110.17 112.39 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 176.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.686 HD23 ' HB2' ' A' ' 90' ' ' LEU . 63.9 mt -102.21 105.83 16.56 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.327 -178.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.776 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -119.37 -175.37 2.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.844 0.354 . . . . 0.0 111.624 -178.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.602 ' H ' HG22 ' A' ' 116' ' ' THR . . . -166.17 178.07 40.91 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.994 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.782 ' H ' ' HA3' ' A' ' 93' ' ' GLY . 3.9 mt-10 -70.79 172.63 5.97 Favored Pre-proline 0 C--N 1.328 -0.333 0 C-N-CA 123.096 0.558 . . . . 0.0 110.793 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.645 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 81.5 Cg_exo -46.65 -39.57 23.34 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.682 2.254 . . . . 0.0 113.105 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.419 ' O ' ' HB3' ' A' ' 123' ' ' GLU . 2.1 mpp_? -67.8 -23.57 65.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.681 0.277 . . . . 0.0 110.961 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.664 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 10.8 tpt -60.92 -35.65 77.25 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.42 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 3.5 mptp? -62.78 -16.86 59.79 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.149 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.651 ' O ' ' HG3' ' A' ' 123' ' ' GLU . 1.0 OUTLIER -80.92 -0.17 38.05 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.307 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.442 ' HB3' HH22 ' A' ' 100' ' ' ARG . 6.5 mtt180 -126.31 83.71 63.45 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.71 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.532 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 15.8 Cg_endo -56.86 148.75 65.03 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.646 2.231 . . . . 0.0 111.538 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 148' ' ' TYR . 0.7 OUTLIER -123.48 -0.76 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.012 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.573 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -53.69 -39.01 60.16 Favored Glycine 0 CA--C 1.516 0.138 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.707 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.581 ' CD2' ' HB2' ' A' ' 165' ' ' ASP . 1.4 m80 -55.58 -39.29 70.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.023 0.412 . . . . 0.0 110.735 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.747 ' HG ' HD11 ' A' ' 133' ' ' LEU . 14.4 tp -75.36 -40.86 57.7 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.347 0.594 . . . . 0.0 110.141 178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.762 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 55.1 t -56.19 -48.17 79.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.562 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.738 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 75.2 m-20 -69.5 -37.26 77.12 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.133 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.639 ' HB2' HG23 ' A' ' 164' ' ' VAL . . . -58.99 -49.62 77.2 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.936 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.747 HD11 ' HG ' ' A' ' 129' ' ' LEU . 6.6 mt -73.6 -47.44 40.36 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.591 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.762 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -59.53 -27.47 66.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.702 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.738 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 5.6 tp -70.89 -28.69 64.73 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.998 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 159' ' ' GLY . . . -85.55 15.26 47.27 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.709 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.91 4.73 61.45 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.522 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.512 ' HB3' ' C ' ' A' ' 133' ' ' LEU . . . -73.95 152.99 39.96 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 120.865 0.364 . . . . 0.0 111.417 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.446 ' CB ' ' HB2' ' A' ' 154' ' ' GLN . 13.5 mmtm -102.29 103.43 13.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.249 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.681 ' CG2' HD22 ' A' ' 151' ' ' LEU . 14.7 mt -134.86 127.35 48.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.431 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.714 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -124.62 139.23 54.06 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.101 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.494 ' HE1' HG21 ' A' ' 130' ' ' VAL . 36.3 m-85 -78.08 130.35 36.31 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.125 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.759 ' CD2' HG13 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -91.09 -90.26 0.16 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.57 -179.723 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.834 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 2.6 mt-10 -58.99 -81.51 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 122.083 -0.386 . . . . 0.0 110.903 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.428 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 14.2 mt-30 -114.73 151.86 33.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.505 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -66.93 135.2 53.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.919 0.39 . . . . 0.0 110.68 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.573 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 4.3 m-20 66.91 19.73 10.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.196 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.568 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 10.9 m-85 -110.28 169.64 6.15 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 121.085 0.469 . . . . 0.0 112.128 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.914 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 36.5 Cg_exo -33.23 -62.32 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 124.547 3.498 . . . . 0.0 116.252 -177.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.914 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 52.4 Cg_exo -53.56 145.73 46.28 Favored 'Trans proline' 0 C--N 1.352 0.746 0 CA-C-N 120.723 1.294 . . . . 0.0 112.678 -178.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.815 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 6.5 mt -156.3 136.31 12.76 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.62 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.714 ' HB2' HG22 ' A' ' 141' ' ' THR . 11.7 mtt180 -106.42 103.18 12.58 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.884 HD11 ' HA ' ' A' ' 103' ' ' ALA . 6.6 mt -93.6 145.39 24.57 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.797 -178.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.616 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 2.6 mp0 -147.35 26.93 1.04 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.43 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 52.14 -158.59 3.11 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.027 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.39 -12.86 43.69 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 119.922 -1.132 . . . . 0.0 112.917 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.538 ' HE1' ' HA ' ' A' ' 180' ' ' ALA . 51.6 t80 -60.29 122.75 15.27 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 117.14 0.47 . . . . 0.0 110.852 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.689 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 54.3 p -115.31 -33.12 5.41 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.575 0.703 . . . . 0.0 111.206 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.414 ' O ' ' HA2' ' A' ' 136' ' ' GLY . . . 136.46 -160.39 24.74 Favored Glycine 0 C--N 1.305 -1.148 0 CA-C-N 114.667 -1.151 . . . . 0.0 112.247 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.612 ' O ' HG23 ' A' ' 187' ' ' THR . . . 105.97 154.85 21.35 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 120.625 -0.797 . . . . 0.0 111.35 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -47.04 119.22 2.44 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 120.869 0.366 . . . . 0.0 110.944 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.745 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 75.3 t -110.36 129.87 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.929 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.11 119.41 37.79 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.521 -0.472 . . . . 0.0 109.74 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.872 HG21 HD11 ' A' ' 176' ' ' LEU . 1.0 OUTLIER -132.32 120.19 42.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.581 ' HB2' ' CD2' ' A' ' 128' ' ' HIS . 0.6 OUTLIER -53.32 141.89 22.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.246 -179.228 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.899 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . . . . . . 0 N--CA 1.448 -0.527 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.653 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.466 ' HB3' ' CB ' ' A' ' 197' ' ' SER . 2.8 p . . . . . 0 N--CA 1.462 0.17 0 CA-C-O 120.847 0.356 . . . . 0.0 111.056 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.671 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 1.5 mp0 -81.62 -11.66 59.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.361 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.532 ' HZ ' ' O ' ' A' ' 125' ' ' PRO . 5.3 m-85 -69.53 -51.84 31.96 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.718 0.77 . . . . 0.0 109.272 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.916 HD21 HD11 ' A' ' 191' ' ' ILE . 0.4 OUTLIER -67.48 -43.21 81.51 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.513 -1.222 . . . . 0.0 109.106 178.71 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.615 ' O ' ' HG3' ' A' ' 178' ' ' MET . 5.1 m -55.01 -33.52 62.69 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.55 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.858 ' HB1' ' HB2' ' A' ' 104' ' ' ALA . . . -66.92 -41.05 87.74 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.874 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.872 HD11 HG21 ' A' ' 164' ' ' VAL . 1.1 mt -76.17 -34.89 59.36 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.404 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.81 HD11 ' CD2' ' A' ' 223' ' ' PHE . 3.8 mp -60.37 -36.95 79.24 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.336 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.624 ' HA ' ' HE1' ' A' ' 208' ' ' MET . 6.0 mtp -81.6 -43.68 18.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.558 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 88.2 m -72.16 -42.48 65.86 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.988 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.542 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . -59.28 -38.93 68.57 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -176.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.652 ' HA ' ' O ' ' A' ' 226' ' ' LYS . 27.0 Cg_endo -65.79 -29.67 50.42 Favored 'Trans proline' 0 CA--C 1.499 -1.236 0 CA-C-N 120.163 1.094 . . . . 0.0 111.699 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.691 ' HB2' HD21 ' A' ' 108' ' ' LEU . 5.6 mt -83.8 2.0 40.28 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.765 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.689 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -84.7 138.29 38.05 Favored Pre-proline 0 C--O 1.224 -0.285 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.201 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.676 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 12.1 Cg_endo -51.47 -31.19 38.01 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.444 2.096 . . . . 0.0 113.028 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.45 140.89 48.87 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.522 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -57.07 147.77 23.51 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.197 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 160' ' ' GLY . 78.8 m -122.99 147.29 46.8 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 36.0 t -126.24 117.9 49.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.745 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 2.6 mp -103.83 117.35 49.19 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.954 0 C-N-CA 120.029 -0.669 . . . . 0.0 109.368 178.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.644 ' HG3' ' HG3' ' A' ' 222' ' ' GLN . 1.3 ttt85 -99.85 124.68 45.41 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.916 HD11 HD21 ' A' ' 173' ' ' LEU . 1.5 mp -94.08 123.48 46.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.976 -176.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -76.21 96.33 3.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.835 -1.529 . . . . 0.0 110.47 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 97.75 -126.72 8.98 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.972 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.59 132.72 56.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.845 0.355 . . . . 0.0 111.633 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.837 HD21 HD13 ' A' ' 173' ' ' LEU . 0.9 OUTLIER -42.07 144.42 0.46 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.044 179.267 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 12.5 p -73.87 -26.52 21.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.165 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.466 ' CB ' ' HB3' ' A' ' 170' ' ' SER . 0.3 OUTLIER -168.51 65.05 0.07 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.176 0.513 . . . . 0.0 109.741 -179.663 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.49 ' HA ' HD13 ' A' ' 195' ' ' LEU . 0.0 OUTLIER -42.93 -46.02 12.55 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.096 -179.812 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 198' ' ' LYS . 79.8 Cg_exo -48.27 -34.83 25.65 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.903 1.735 . . . . 0.0 111.638 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.927 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.3 OUTLIER -67.91 -42.45 81.12 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.401 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.453 HG21 ' CE2' ' A' ' 223' ' ' PHE . 20.0 mm -60.12 -39.49 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.026 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -57.15 -47.2 81.76 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.224 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.927 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.9 mt -60.55 -50.38 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 CA-C-O 121.486 0.66 . . . . 0.0 109.457 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.579 ' CG2' HG23 ' A' ' 174' ' ' THR . 89.7 m -52.83 -52.01 58.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.756 -177.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.889 HD22 ' HB ' ' A' ' 215' ' ' ILE . 45.2 mt -65.02 -31.36 72.55 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 120.985 0.422 . . . . 0.0 111.415 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -76.86 -44.89 30.35 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.751 0.786 . . . . 0.0 109.743 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.889 ' O ' HG22 ' A' ' 210' ' ' THR . 8.0 tp -71.8 -29.6 64.63 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.301 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' MET . . . . . 0.726 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 41.7 mtp -75.99 -35.42 59.6 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.677 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 3.5 mtmt -61.54 -38.66 88.25 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 114.438 -1.255 . . . . 0.0 111.001 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.889 HG22 ' O ' ' A' ' 207' ' ' LEU . 6.1 t -61.54 -31.64 71.67 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.388 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.598 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 40.6 m-85 -78.74 -5.26 52.74 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.83 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.29 5.62 28.22 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 115.891 1.116 . . . . 0.0 115.891 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.3 m -123.53 148.69 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 118.878 1.339 . . . . 0.0 112.78 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.617 ' O ' HD13 ' A' ' 215' ' ' ILE . 20.4 mt-10 -129.18 140.14 51.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.893 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.889 ' HB ' HD22 ' A' ' 205' ' ' LEU . 16.3 mm -122.76 148.3 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 120.699 0.285 . . . . 0.0 110.314 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.738 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 38.8 tt0 -101.21 115.09 29.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.656 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -81.51 150.78 28.08 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.302 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 222' ' ' GLN . 5.5 tp60 -108.3 -136.7 0.36 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.759 -0.2 . . . . 0.0 111.321 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.423 ' CD2' ' HG3' ' A' ' 218' ' ' GLN . 77.3 m-70 -84.6 69.53 10.63 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 120.832 0.349 . . . . 0.0 110.307 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.408 ' CE1' ' HG3' ' A' ' 198' ' ' LYS . 4.0 t80 54.16 31.28 13.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 122.11 0.957 . . . . 0.0 109.967 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.676 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -160.69 -128.32 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 113.632 -1.622 . . . . 0.0 106.838 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.735 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -4.53 129.24 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -179.446 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.81 ' CD2' HD11 ' A' ' 177' ' ' LEU . 0.7 OUTLIER -124.44 128.33 48.85 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.104 -1.862 . . . . 0.0 109.091 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.738 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 46.2 t -111.24 114.06 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 121.544 0.688 . . . . 0.0 109.393 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.74 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.4 OUTLIER -124.35 119.91 57.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.181 -178.651 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.652 ' O ' ' HA ' ' A' ' 181' ' ' PRO . 4.0 pttt -74.17 143.41 45.25 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -92.93 -173.15 40.82 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.678 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 62.72 21.13 62.64 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 121.49 -0.386 . . . . 0.0 113.253 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' GLN . . . . . 0.411 ' HB2' ' HB2' ' A' ' 181' ' ' PRO . 17.9 mt-30 -80.68 -172.94 3.88 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.272 0.558 . . . . 0.0 111.361 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 2.3 t -158.18 147.95 19.86 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.625 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' TYR . . . . . 0.727 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 7.8 m-85 -99.04 136.02 39.61 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.149 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . 0.401 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 0.1 OUTLIER -123.09 148.02 46.11 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.697 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.502 ' HB2' ' OG1' ' A' ' 39' ' ' THR . 19.5 p -72.47 110.93 9.2 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.575 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.441 ' HD2' ' OG1' ' A' ' 39' ' ' THR . 55.7 Cg_endo -69.95 1.1 4.87 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.195 1.93 . . . . 0.0 112.141 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 100.28 -99.61 2.05 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 93.0 m -120.03 136.82 54.42 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . 0.674 ' CD2' HG21 ' A' ' 210' ' ' THR . 10.9 t80 -132.96 128.07 35.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.974 0.416 . . . . 0.0 111.707 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.931 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -92.97 111.87 23.64 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.587 179.526 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.67 ' N ' HD22 ' A' ' 238' ' ' LEU . 21.7 t -85.87 111.68 21.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.143 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.404 ' HG3' HD13 ' A' ' 238' ' ' LEU . 1.6 mt-10 . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.15 -0.928 . . . . 0.0 111.083 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.871 ' HE ' HD23 ' A' ' 207' ' ' LEU . 78.6 mtm-85 . . . . . 0 N--CA 1.452 -0.339 0 CA-C-O 120.982 0.42 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.849 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -43.21 -45.16 5.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.139 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.053 HD22 HD11 ' A' ' 75' ' ' ILE . 9.8 mt -75.54 -33.42 60.68 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.043 0.449 . . . . 0.0 111.154 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.733 HD11 ' CB ' ' A' ' 105' ' ' ALA . 66.1 tp -69.55 -50.11 48.04 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.115 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.889 HD22 ' CZ ' ' A' ' 231' ' ' TYR . 21.4 mt -68.61 -26.8 65.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.94 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.799 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -65.22 -39.35 92.63 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.645 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.856 ' CB ' HG11 ' A' ' 62' ' ' VAL . . . -81.35 -41.32 22.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.071 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.719 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 14.2 mt -67.32 -3.4 7.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.0 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.56 ' HB2' ' HB3' ' A' ' 231' ' ' TYR . . . -98.51 177.89 5.19 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -177.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.548 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.7 OUTLIER -110.87 112.29 24.02 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.787 178.281 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 114.83 167.11 15.46 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.787 ' HE3' HD12 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -94.89 117.83 30.79 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 117.144 0.472 . . . . 0.0 111.55 -179.097 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 235' ' ' GLY . 0.8 OUTLIER -119.61 146.84 45.17 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.94 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.544 HG22 ' HB2' ' A' ' 74' ' ' GLU . 91.8 t -103.55 142.14 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 CA-C-O 121.77 0.795 . . . . 0.0 112.653 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.986 HD23 HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -117.25 116.3 26.99 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 174.437 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.967 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.6 OUTLIER -105.06 152.41 22.79 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.437 -177.32 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.2 t30 66.57 26.67 9.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.098 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.817 HD21 ' HB3' ' A' ' 41' ' ' LEU . 65.1 mt -55.05 -170.82 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.653 ' HB3' HG21 ' A' ' 50' ' ' VAL . 48.9 tp -114.15 131.71 56.34 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.816 0.341 . . . . 0.0 110.245 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -88.98 87.06 7.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.097 0.475 . . . . 0.0 110.738 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.468 ' HB3' ' OD1' ' A' ' 49' ' ' ASP . 27.8 t -164.14 142.61 7.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.06 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.452 ' OD2' ' HB2' ' A' ' 94' ' ' ASN . 33.9 p-10 -36.71 -29.14 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.946 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 37.6 p-10 -60.58 -42.48 96.77 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.187 0.518 . . . . 0.0 110.365 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.653 HG21 ' HB3' ' A' ' 45' ' ' LEU . 99.3 t -82.13 -46.02 19.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.701 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.92 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -49.28 -39.34 30.45 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.465 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.682 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 11.3 m-70 -78.86 -32.33 45.96 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.197 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.611 ' O ' HD13 ' A' ' 57' ' ' LEU . 8.0 tpt -54.2 -37.43 64.53 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 176.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.92 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.3 OUTLIER -80.58 -43.94 19.79 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.666 176.105 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.718 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 2.0 t30 -58.41 -36.41 73.54 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.01 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 1.002 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -63.52 -44.61 93.78 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 122.034 0.921 . . . . 0.0 108.88 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.876 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -64.95 -40.97 95.82 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.558 -1.655 . . . . 0.0 107.011 177.164 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.718 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.2 m -60.19 -31.69 70.38 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 113.757 -1.565 . . . . 0.0 111.233 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.724 ' C ' HD21 ' A' ' 88' ' ' LEU . . . -79.55 -37.53 36.26 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.024 -179.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.709 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.5 OUTLIER -81.73 -14.45 56.5 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.375 0.607 . . . . 0.0 110.765 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.87 33.32 5.04 Favored Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.292 -0.867 . . . . 0.0 114.47 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.876 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 21.6 t -90.44 118.71 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.844 ' O ' HG12 ' A' ' 76' ' ' ILE . 7.5 t -84.03 136.02 34.2 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 120.944 0.402 . . . . 0.0 110.799 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.926 ' HB3' HG23 ' A' ' 75' ' ' ILE . 35.3 p90 -160.71 170.39 20.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.542 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.411 ' N ' ' O ' ' A' ' 74' ' ' GLU . 83.5 m -133.65 147.89 51.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.491 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.519 HD12 ' HB2' ' A' ' 73' ' ' CYS . 10.5 tp -116.56 136.22 53.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.182 0.515 . . . . 0.0 110.956 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.578 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 1.6 m -61.43 -167.44 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.912 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.42 -31.76 18.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.811 0.339 . . . . 0.0 110.926 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.44 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 0.2 OUTLIER -76.64 1.26 17.44 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.266 179.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 56.86 27.84 13.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.752 0.31 . . . . 0.0 111.515 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.44 ' OG1' ' HB3' ' A' ' 69' ' ' ASP . 0.9 OUTLIER -127.25 -11.26 5.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.293 179.716 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.578 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 2.1 mtt85 -111.06 121.42 45.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.325 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.626 ' HB3' HD11 ' A' ' 44' ' ' LEU . 40.4 t -130.8 125.14 32.94 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 112.386 0.514 . . . . 0.0 112.386 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.544 ' HB2' HG22 ' A' ' 40' ' ' VAL . 29.7 tt0 -107.72 131.3 54.57 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 176.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 1.053 HD11 HD22 ' A' ' 29' ' ' LEU . 7.8 mt -127.57 123.22 60.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.844 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -68.53 100.93 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 121.682 0.753 . . . . 0.0 109.16 176.027 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -38.88 144.79 0.23 Allowed Glycine 0 C--N 1.32 -0.351 0 CA-C-N 114.415 -1.266 . . . . 0.0 114.16 -178.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.49 ' CB ' HD12 ' A' ' 82' ' ' LEU . 33.6 t30 -90.45 -11.2 41.06 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 120.962 0.41 . . . . 0.0 110.612 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.548 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 86.56 9.18 75.86 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.435 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.402 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 146.51 -151.12 23.42 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.888 -0.673 . . . . 0.0 111.976 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.548 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 9.3 Cg_endo -50.75 128.67 24.87 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.511 2.141 . . . . 0.0 111.805 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.709 ' HB2' HD13 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -77.68 115.04 17.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.304 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.469 ' HA ' ' CG ' ' A' ' 111' ' ' ASN . 4.5 p80 -83.22 134.83 34.94 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.127 0.489 . . . . 0.0 112.022 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.519 ' CB ' HD11 ' A' ' 113' ' ' ILE . . . -96.48 123.57 40.18 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.863 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -71.71 123.65 23.04 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 176.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.93 178.17 1.01 Allowed Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 -175.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 112' ' ' ASP . . . -73.41 144.87 46.19 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 118.601 1.2 . . . . 0.0 111.342 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.751 ' CB ' HG13 ' A' ' 113' ' ' ILE . 0.9 OUTLIER -112.94 161.08 17.41 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.064 -178.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 4.1 mt-10 -143.0 102.8 4.07 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.108 177.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.828 ' HB2' HD23 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -98.29 122.08 41.01 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.779 -178.696 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.641 ' C ' HD13 ' A' ' 92' ' ' LEU . 18.3 m-85 -96.07 96.58 8.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.694 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 1.026 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -114.29 57.93 0.69 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.193 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.827 ' HA3' ' H ' ' A' ' 118' ' ' GLU . . . -59.64 -48.42 86.12 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.145 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.452 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 0.7 OUTLIER -94.87 -2.18 51.23 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.642 0.258 . . . . 0.0 110.687 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 1.026 ' HB3' ' HB3' ' A' ' 92' ' ' LEU . . . -92.63 45.53 1.2 Allowed 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.803 0.335 . . . . 0.0 110.989 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.664 ' O ' ' HD3' ' A' ' 100' ' ' ARG . . . -53.14 -23.26 16.2 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.352 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.751 HG22 ' OE1' ' A' ' 171' ' ' GLN . 15.9 p -88.7 -19.02 26.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.414 0.149 . . . . 0.0 111.037 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.875 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -98.12 -26.83 14.45 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.627 ' SD ' ' HB3' ' A' ' 115' ' ' LEU . 9.8 tpp -63.92 -44.03 94.13 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.712 0.291 . . . . 0.0 111.016 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.784 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 1.1 mpt_? -60.72 -55.74 41.9 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.784 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 23.7 Cg_exo -61.16 -32.14 90.77 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 121.633 1.555 . . . . 0.0 111.411 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 1.002 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -74.62 -53.31 9.59 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.804 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.86 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -51.58 -28.57 14.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.523 0.678 . . . . 0.0 110.236 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.72 ' HB2' ' HB1' ' A' ' 175' ' ' ALA . . . -86.76 -53.85 4.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.807 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.733 ' CB ' HD11 ' A' ' 30' ' ' LEU . . . -59.82 -28.06 67.14 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -176.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.627 ' HB2' HD12 ' A' ' 153' ' ' LEU . 35.2 mt -81.62 -28.16 33.82 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.139 -177.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.754 ' HB2' ' HB1' ' A' ' 138' ' ' ALA . 12.4 p -72.95 12.26 0.55 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.189 0.519 . . . . 0.0 111.085 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.713 ' HG ' HG23 ' A' ' 179' ' ' THR . 1.4 mt -79.81 -76.6 0.21 Allowed 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.083 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.505 ' O ' ' HA3' ' A' ' 155' ' ' GLY . . . -71.78 -117.54 0.05 OUTLIER Glycine 0 N--CA 1.454 -0.146 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.884 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -150.9 96.85 2.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.964 0.411 . . . . 0.0 110.884 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.684 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 18.6 m-80 -149.06 139.37 22.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.273 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.872 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 1.9 m-20 -94.34 96.32 9.46 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.046 0.45 . . . . 0.0 110.126 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.751 HG13 ' CB ' ' A' ' 88' ' ' LEU . 1.4 mp -118.99 144.21 27.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.48 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.814 HG13 HD23 ' A' ' 143' ' ' LEU . 47.8 t -110.05 112.95 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.828 HD23 ' HB2' ' A' ' 90' ' ' LEU . 59.7 mt -101.98 106.67 17.62 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.02 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.838 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.7 OUTLIER -122.66 -172.15 2.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.165 -178.709 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.684 ' H ' HG22 ' A' ' 116' ' ' THR . . . -167.07 179.05 41.01 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.832 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.827 ' H ' ' HA3' ' A' ' 93' ' ' GLY . 8.4 pt-20 -71.16 173.51 4.87 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 123.277 0.631 . . . . 0.0 110.549 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.789 ' HD2' ' HB2' ' A' ' 118' ' ' GLU . 7.6 Cg_endo -47.47 -36.61 24.28 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.699 2.266 . . . . 0.0 113.606 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.479 ' CG ' ' HG3' ' A' ' 118' ' ' GLU . 0.4 OUTLIER -67.37 -25.06 65.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.905 0.383 . . . . 0.0 110.443 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.651 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 8.1 tpt -60.55 -35.53 76.26 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.629 ' HE3' ' HG2' ' A' ' 149' ' ' PRO . 0.1 OUTLIER -62.51 -16.84 57.88 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.995 179.266 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.668 ' O ' ' HG3' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -85.06 -1.85 57.31 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.186 0.517 . . . . 0.0 109.645 178.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.662 ' HB3' HH22 ' A' ' 100' ' ' ARG . 1.3 mpt_? -126.12 86.35 58.08 Favored Pre-proline 0 CA--C 1.531 0.25 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.746 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.557 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 17.9 Cg_endo -58.7 148.71 81.32 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.677 2.251 . . . . 0.0 111.696 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.483 ' O ' HG13 ' A' ' 126' ' ' ILE . 0.7 OUTLIER -123.01 -0.13 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.194 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.632 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -53.98 -34.7 52.47 Favored Glycine 0 CA--C 1.516 0.12 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.513 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.503 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 57.4 m80 -58.5 -40.01 81.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.163 0.506 . . . . 0.0 110.851 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.847 ' HG ' HD11 ' A' ' 133' ' ' LEU . 34.0 tp -75.33 -39.28 59.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.202 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.72 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 54.8 t -56.91 -47.78 82.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.555 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.764 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 77.7 m-20 -71.23 -38.5 71.96 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.472 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.448 ' HA ' HG13 ' A' ' 162' ' ' VAL . . . -60.15 -44.66 94.81 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.534 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.847 HD11 ' HG ' ' A' ' 129' ' ' LEU . 5.7 mt -75.73 -50.27 15.79 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 121.086 0.47 . . . . 0.0 110.66 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.72 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -57.81 -28.3 63.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.055 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.764 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 5.5 tp -67.63 -30.97 70.68 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-O 121.004 0.431 . . . . 0.0 110.312 178.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 159' ' ' GLY . . . -81.4 12.75 37.64 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.892 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.16 3.74 63.33 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.459 -0.876 . . . . 0.0 112.429 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.754 ' HB1' ' HB2' ' A' ' 107' ' ' CYS . . . -73.88 153.87 39.67 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.837 0.351 . . . . 0.0 111.654 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 9.4 mttp -100.85 104.58 15.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.643 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.641 ' CG2' HG13 ' A' ' 130' ' ' VAL . 30.3 mt -136.27 125.23 37.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.954 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.914 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -124.15 139.99 53.4 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.005 0.431 . . . . 0.0 110.554 -179.483 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.52 ' CE1' HG21 ' A' ' 130' ' ' VAL . 43.7 m-85 -79.6 132.07 36.17 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.358 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.814 HD23 HG13 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -96.46 -88.5 0.28 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.795 -179.578 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.722 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 36.0 mt-10 -57.38 -80.98 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.546 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.567 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 15.0 mt-30 -117.77 148.95 41.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.991 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.64 135.22 56.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.951 0.405 . . . . 0.0 110.154 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.632 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 5.6 m-20 65.93 20.05 11.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.293 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.598 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 14.5 m-85 -111.72 169.25 6.53 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 121.202 0.525 . . . . 0.0 111.838 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.96 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 21.8 Cg_exo -31.19 -65.36 0.09 OUTLIER 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 124.385 3.39 . . . . 0.0 116.271 -178.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.96 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 72.3 Cg_exo -50.84 145.95 22.53 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 121.186 1.257 . . . . 0.0 113.305 -178.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.786 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 7.3 mt -156.49 136.64 12.82 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.422 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.914 ' HB2' HG22 ' A' ' 141' ' ' THR . 4.3 mtt180 -106.81 102.25 11.63 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.872 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 9.8 mt -92.53 145.53 24.37 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.909 -178.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.684 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 6.8 mt-30 -148.33 24.98 1.0 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.455 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 55.19 -166.99 2.79 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.53 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.425 ' O ' HG23 ' A' ' 158' ' ' THR . . . 112.6 -14.44 24.84 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.16 -1.019 . . . . 0.0 113.387 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.647 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 4.3 t80 -58.69 122.6 13.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.434 0.617 . . . . 0.0 110.395 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.691 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 82.0 p -115.86 -26.75 7.25 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 121.375 0.607 . . . . 0.0 111.39 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.458 ' O ' ' HA2' ' A' ' 136' ' ' GLY . . . 132.66 -159.62 23.51 Favored Glycine 0 N--CA 1.438 -1.189 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.346 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.559 ' O ' HG23 ' A' ' 187' ' ' THR . . . 104.77 151.99 21.49 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.729 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -46.29 116.36 1.25 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.01 -0.595 . . . . 0.0 110.66 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.76 ' HB ' HG13 ' A' ' 189' ' ' ILE . 79.2 t -108.81 137.94 38.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.693 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.41 119.67 39.49 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.629 -0.429 . . . . 0.0 110.796 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 1.077 HG21 HD11 ' A' ' 176' ' ' LEU . 1.7 t -130.25 119.96 47.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.418 ' HA ' ' CG ' ' A' ' 192' ' ' LYS . 4.1 t70 -59.56 141.71 54.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.942 0.401 . . . . 0.0 110.797 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.846 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.373 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.219 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.117 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.771 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 0.1 OUTLIER -88.17 -14.72 37.94 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.399 -178.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.813 ' HA ' HD13 ' A' ' 129' ' ' LEU . 8.4 m-85 -72.54 -49.8 30.14 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.472 0.653 . . . . 0.0 109.545 178.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.786 ' HG ' HG11 ' A' ' 164' ' ' VAL . 0.5 OUTLIER -70.46 -43.7 69.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.39 178.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.606 HG21 ' HD3' ' A' ' 27' ' ' ARG . 1.5 m -56.79 -34.58 67.79 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.458 178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.755 ' HB3' HD11 ' A' ' 129' ' ' LEU . . . -63.98 -39.78 94.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.493 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 1.077 HD11 HG21 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -77.01 -33.82 57.48 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.496 179.4 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.863 ' O ' ' HE1' ' A' ' 208' ' ' MET . 3.0 mp -59.56 -37.96 79.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.384 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.735 ' HE1' ' HG2' ' A' ' 27' ' ' ARG . 1.9 mtp -82.02 -43.12 18.38 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.47 0.652 . . . . 0.0 112.498 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.713 HG23 ' HG ' ' A' ' 108' ' ' LEU . 100.0 m -72.94 -43.25 62.56 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.792 -1.094 . . . . 0.0 113.077 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.603 ' HB1' ' HB ' ' A' ' 187' ' ' THR . . . -59.33 -38.98 68.87 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -177.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.561 ' HD3' HG21 ' A' ' 225' ' ' VAL . 33.6 Cg_endo -66.29 -28.34 47.42 Favored 'Trans proline' 0 CA--C 1.501 -1.129 0 C-N-CA 120.904 1.069 . . . . 0.0 111.37 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.66 ' HB2' HD21 ' A' ' 108' ' ' LEU . 7.3 mt -84.72 1.82 44.78 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.913 -1.039 . . . . 0.0 109.206 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.612 ' HB1' ' C ' ' A' ' 158' ' ' THR . . . -83.15 135.2 44.86 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.03 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.691 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 10.8 Cg_endo -49.23 -32.12 24.17 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.54 2.16 . . . . 0.0 113.015 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -115.03 140.16 49.28 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.586 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -55.61 145.65 22.85 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.301 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.603 ' HB ' ' HB1' ' A' ' 180' ' ' ALA . 86.3 m -122.39 144.0 49.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.231 0.539 . . . . 0.0 112.335 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.698 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 50.3 t -125.11 118.18 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 176.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.841 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 4.9 mp -101.56 117.47 46.9 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.93 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.596 ' HB2' ' HG3' ' A' ' 222' ' ' GLN . 0.2 OUTLIER -100.43 124.19 45.61 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.103 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.846 HG23 ' HA2' ' A' ' 166' ' ' GLY . 1.6 mp -93.52 123.33 45.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.96 -176.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.418 ' CG ' ' HA ' ' A' ' 165' ' ' ASP . 38.0 mttt -80.08 97.23 6.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.002 -1.454 . . . . 0.0 110.47 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 98.39 -133.92 11.51 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.171 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.07 125.73 52.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.225 0.536 . . . . 0.0 111.719 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.634 HD11 ' HZ ' ' A' ' 223' ' ' PHE . 1.9 mt -41.84 145.66 0.31 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.55 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 8.0 p -70.57 -29.12 37.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.725 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.465 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 28.6 t -168.16 65.49 0.07 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.98 0.419 . . . . 0.0 110.737 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.678 ' N ' ' HD2' ' A' ' 199' ' ' PRO . 2.5 tmpt? -37.26 -47.46 2.07 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.806 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . 0.678 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 4.8 Cg_endo -47.31 -34.06 17.78 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.376 2.051 . . . . 0.0 111.434 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.955 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.2 OUTLIER -67.11 -43.49 82.34 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.685 0.755 . . . . 0.0 109.065 178.072 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.752 HG21 ' HE2' ' A' ' 223' ' ' PHE . 27.8 mm -64.44 -32.46 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.921 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.74 -41.94 95.56 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.796 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.955 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.4 mt -61.47 -50.14 81.57 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 CA-C-O 121.701 0.762 . . . . 0.0 109.41 178.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.633 HG22 ' SD ' ' A' ' 208' ' ' MET . 100.0 m -53.71 -52.32 60.45 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.119 -178.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.938 HD22 ' HB ' ' A' ' 215' ' ' ILE . 44.6 mt -65.99 -30.79 71.4 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.109 0.481 . . . . 0.0 111.56 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -77.2 -46.71 22.4 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.772 0.796 . . . . 0.0 109.715 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.871 HD23 ' HE ' ' A' ' 27' ' ' ARG . 3.3 tp -70.34 -29.55 66.28 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.242 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' MET . . . . . 0.863 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 49.8 mtp -73.85 -34.14 64.39 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.591 0.71 . . . . 0.0 109.194 177.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.76 ' HE2' ' O ' ' A' ' 205' ' ' LEU . 5.1 mtmm -61.59 -40.17 93.82 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.236 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.866 HG22 ' O ' ' A' ' 207' ' ' LEU . 4.7 t -60.52 -28.35 68.33 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.069 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.716 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 49.5 m-85 -80.25 -7.67 59.11 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.519 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.7 7.64 25.47 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 115.503 0.961 . . . . 0.0 115.503 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.696 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 5.3 m -123.42 148.83 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 118.775 1.287 . . . . 0.0 112.811 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.589 ' HG2' ' CG ' ' A' ' 209' ' ' LYS . 4.7 mt-10 -130.22 138.19 50.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.818 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.976 HD12 ' HB ' ' A' ' 225' ' ' VAL . 22.1 mm -122.41 147.74 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-O 120.836 0.35 . . . . 0.0 110.236 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.708 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 20.5 tt0 -103.63 115.86 31.29 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.774 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.51 149.44 27.54 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.588 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . 0.744 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -108.07 -144.86 0.39 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.597 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 8.1 m-70 -72.66 65.3 0.68 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.917 0.389 . . . . 0.0 111.523 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 1.7 t80 56.52 32.73 21.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.838 0.827 . . . . 0.0 110.609 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.662 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 9.1 pt20 -159.78 -126.22 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.841 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.4 OUTLIER -10.11 134.98 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 115.024 1.491 . . . . 0.0 115.024 -179.671 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.752 ' HE2' HG21 ' A' ' 201' ' ' ILE . 0.9 OUTLIER -126.31 138.24 53.57 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 113.032 -1.894 . . . . 0.0 110.139 -179.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.708 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 36.9 t -118.24 114.19 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.976 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.5 OUTLIER -122.4 120.39 60.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.806 -178.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.611 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -74.65 122.74 23.66 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.517 179.232 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -74.39 -173.39 29.78 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.251 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 62.23 19.65 59.78 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 121.401 -0.428 . . . . 0.0 113.158 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' GLN . . . . . 0.611 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 47.1 mt-30 -75.52 -171.96 1.67 Allowed 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.347 0.594 . . . . 0.0 111.006 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 23.3 t -155.55 147.45 23.32 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.133 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' TYR . . . . . 0.889 ' CZ ' HD22 ' A' ' 31' ' ' LEU . 2.2 m-30 -102.01 134.97 44.38 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.7 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . 0.427 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 2.6 mt-30 -126.21 145.55 50.34 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.428 ' HB2' ' OG1' ' A' ' 39' ' ' THR . 25.0 p -72.39 109.42 5.88 Favored Pre-proline 0 N--CA 1.445 -0.685 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.7 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.515 ' HG3' HG23 ' A' ' 210' ' ' THR . 43.5 Cg_endo -66.75 0.1 3.98 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.865 1.71 . . . . 0.0 112.185 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 101.38 -102.55 2.41 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.498 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 90.0 m -117.3 132.86 56.52 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . 0.637 ' CD2' HG21 ' A' ' 210' ' ' THR . 6.5 t80 -132.64 127.42 34.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.129 0.49 . . . . 0.0 111.696 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.967 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -90.16 113.0 24.69 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.396 179.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.672 ' N ' HD22 ' A' ' 238' ' ' LEU . 21.2 t -85.78 111.38 20.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.622 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.447 ' HG2' HD11 ' A' ' 238' ' ' LEU . 32.5 mt-10 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.235 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.577 ' HE ' HD23 ' A' ' 207' ' ' LEU . 16.4 mtm-85 . . . . . 0 N--CA 1.455 -0.203 0 CA-C-O 120.823 0.344 . . . . 0.0 110.989 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.761 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -35.55 -47.97 0.48 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.643 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.031 HD22 HD11 ' A' ' 75' ' ' ILE . 9.8 mt -73.48 -34.44 65.33 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.872 0.368 . . . . 0.0 111.433 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.819 HD22 ' HB2' ' A' ' 101' ' ' PRO . 54.3 tp -68.46 -50.1 54.98 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.732 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.713 HD13 ' HA ' ' A' ' 208' ' ' MET . 49.0 mt -68.23 -26.71 65.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.583 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.779 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -65.63 -38.27 88.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.552 178.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.714 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . . . -81.26 -41.53 22.05 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.996 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.803 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 9.9 mt -68.93 -2.91 10.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.279 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.538 ' HA ' ' CB ' ' A' ' 231' ' ' TYR . . . -100.13 179.26 4.54 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -176.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.582 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.3 OUTLIER -112.59 113.83 26.17 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.012 178.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.11 166.85 16.68 Favored Glycine 0 C--N 1.322 -0.243 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.321 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.616 ' HG3' HD13 ' A' ' 76' ' ' ILE . 1.1 ttmt -95.37 117.68 30.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 117.155 0.478 . . . . 0.0 111.59 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.585 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 0.8 OUTLIER -117.73 148.59 41.87 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.387 179.59 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.515 HG22 ' HB2' ' A' ' 74' ' ' GLU . 92.4 t -105.47 141.27 21.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.144 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.931 HD23 HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -114.8 116.27 28.34 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 174.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.984 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.5 OUTLIER -102.84 151.67 22.16 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.869 0.366 . . . . 0.0 111.437 -177.48 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 64.97 28.29 12.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.844 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.778 HD11 ' HB3' ' A' ' 73' ' ' CYS . 91.4 mt -53.55 -174.26 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.195 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.528 ' HB3' HG21 ' A' ' 50' ' ' VAL . 56.6 tp -113.19 131.42 55.88 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -88.89 88.76 7.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.98 0.419 . . . . 0.0 110.323 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 50' ' ' VAL . 6.2 m -164.76 143.15 6.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.116 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.406 ' HA ' ' HB3' ' A' ' 51' ' ' ARG . 1.2 m-20 -36.34 -30.95 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 O-C-N 123.046 0.216 . . . . 0.0 111.575 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.858 ' OD1' HG23 ' A' ' 50' ' ' VAL . 1.4 p30 -57.78 -42.57 84.39 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-O 121.103 0.478 . . . . 0.0 110.617 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.858 HG23 ' OD1' ' A' ' 49' ' ' ASP . 74.6 t -83.91 -44.44 18.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.115 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.876 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -50.21 -39.18 43.44 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.618 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 9.6 m-70 -80.39 -32.43 37.58 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.771 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.526 ' O ' HD13 ' A' ' 57' ' ' LEU . 8.4 tpt -54.79 -34.64 62.92 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 176.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.876 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -83.49 -44.06 15.12 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.902 176.34 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.686 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 1.7 t30 -59.23 -37.8 78.43 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.816 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 1.054 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -62.15 -47.78 83.03 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.868 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.2 OUTLIER -61.42 -40.95 96.32 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.161 -1.382 . . . . 0.0 107.556 177.001 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.686 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.1 m -59.31 -33.93 71.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.056 -1.429 . . . . 0.0 111.417 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.734 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -78.34 -38.39 42.19 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.318 -178.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.714 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.6 OUTLIER -79.49 -14.37 58.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.42 0.629 . . . . 0.0 110.531 -179.626 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.77 35.78 4.48 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 114.938 -1.028 . . . . 0.0 113.854 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.868 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 25.0 t -90.41 121.29 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.782 ' O ' HG12 ' A' ' 76' ' ' ILE . 6.8 t -86.06 135.67 33.53 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.143 0.497 . . . . 0.0 111.148 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.8 ' HB3' HG23 ' A' ' 75' ' ' ILE . 36.0 p90 -161.99 172.29 16.22 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.324 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.9 m -134.66 147.32 50.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.321 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.552 HD21 ' HA ' ' A' ' 70' ' ' ARG . 5.5 tp -117.79 138.28 52.17 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.163 0.506 . . . . 0.0 110.852 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.525 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 1.1 m -63.88 -164.51 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.94 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -93.18 -34.04 13.76 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.438 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.52 1.06 15.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.661 0.267 . . . . 0.0 111.276 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.552 ' HA ' HD21 ' A' ' 66' ' ' LEU . 0.3 OUTLIER 57.6 39.86 27.25 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.943 0.402 . . . . 0.0 111.059 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.502 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 1.1 p -139.18 -10.52 1.27 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.441 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.525 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 7.6 mtt180 -114.16 117.67 31.85 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.778 ' HB3' HD11 ' A' ' 44' ' ' LEU . 13.9 t -130.08 128.91 42.86 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.585 ' HA ' ' O ' ' A' ' 39' ' ' THR . 29.0 tt0 -112.11 128.95 56.36 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 176.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 1.031 HD11 HD22 ' A' ' 29' ' ' LEU . 16.2 mt -124.22 123.35 66.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -178.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.782 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -68.73 97.92 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-O 121.427 0.632 . . . . 0.0 109.664 175.833 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 35' ' ' ALA . . . -37.82 144.25 0.19 Allowed Glycine 0 C--N 1.322 -0.237 0 CA-C-N 114.804 -1.089 . . . . 0.0 113.974 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.665 HD22 HD12 ' A' ' 82' ' ' LEU . 2.6 t-20 -90.17 -10.87 42.89 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.957 0.408 . . . . 0.0 110.91 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.582 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 93.36 -1.35 69.49 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.921 -0.582 . . . . 0.0 112.6 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.551 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 154.69 -145.96 13.58 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.172 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.599 ' HG3' ' HB3' ' A' ' 108' ' ' LEU . 53.7 Cg_exo -49.8 124.84 13.12 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.74 2.293 . . . . 0.0 112.718 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.714 ' HB2' HD13 ' A' ' 60' ' ' LEU . 0.9 OUTLIER -77.25 106.38 8.94 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.637 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -81.92 138.77 34.94 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.519 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.617 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -100.38 126.96 46.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.955 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.77 123.69 22.53 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 176.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.62 174.2 0.76 Allowed Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 -175.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.84 144.69 47.37 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 118.588 1.194 . . . . 0.0 111.556 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.734 HD21 ' HB1' ' A' ' 59' ' ' ALA . 1.2 tp -116.43 160.43 20.57 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.224 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 2.3 mt-10 -138.77 102.99 4.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.078 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.665 ' HB2' HD23 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -98.77 120.85 39.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.152 -178.716 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.451 ' CE1' ' HB ' ' A' ' 116' ' ' THR . 0.2 OUTLIER -94.1 96.67 9.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.572 179.217 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.613 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -104.35 56.7 0.71 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.952 -179.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.629 ' CA ' ' H ' ' A' ' 118' ' ' GLU . . . -62.92 -70.01 1.16 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.017 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 3.3 m-80 -76.04 18.47 0.27 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.356 -0.238 . . . . 0.0 110.356 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.732 ' HA ' ' HB3' ' A' ' 49' ' ' ASP . . . -93.59 -70.62 0.69 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.38 -66.82 0.25 Allowed Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.093 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.483 ' HA ' ' HG2' ' A' ' 171' ' ' GLN . 8.4 p -71.88 -8.15 52.66 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.728 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -99.65 -34.46 10.2 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.577 0.227 . . . . 0.0 111.468 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.7 -45.58 89.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.755 0.312 . . . . 0.0 110.193 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.838 ' HE ' HD12 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -52.73 -60.88 5.55 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.142 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.819 ' HB2' HD22 ' A' ' 30' ' ' LEU . 19.5 Cg_endo -60.13 -30.61 91.78 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.342 2.028 . . . . 0.0 112.646 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 1.054 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -75.91 -53.31 8.61 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.159 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.9 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -49.45 -27.98 4.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.227 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.934 ' HB2' ' HB1' ' A' ' 175' ' ' ALA . . . -87.1 -54.1 4.5 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.787 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.636 ' HB1' HD11 ' A' ' 34' ' ' LEU . . . -60.6 -31.19 70.37 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -177.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.717 HD13 HG13 ' A' ' 113' ' ' ILE . 30.3 mt -79.27 -21.61 45.85 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.509 -177.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.752 ' SG ' HD22 ' A' ' 153' ' ' LEU . 89.8 m -82.18 17.94 1.52 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.198 0.523 . . . . 0.0 111.186 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.761 HD21 ' HB2' ' A' ' 182' ' ' LEU . 2.8 mt -81.23 -77.0 0.22 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.275 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.14 -109.0 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.392 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 m -156.79 96.69 1.64 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.08 0.467 . . . . 0.0 111.108 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.518 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 37.8 p-10 -147.0 139.19 24.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.174 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.886 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 2.5 m-20 -90.87 101.0 13.76 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.771 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.717 HG13 HD13 ' A' ' 106' ' ' LEU . 28.7 mm -120.81 137.59 54.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.574 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.813 HG13 ' CD2' ' A' ' 143' ' ' LEU . 58.0 t -110.22 112.29 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 175.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.665 HD23 ' HB2' ' A' ' 90' ' ' LEU . 24.9 mt -102.27 107.09 18.01 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.608 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.764 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.7 OUTLIER -117.38 -173.91 2.51 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.087 -179.085 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.661 ' H ' HG22 ' A' ' 116' ' ' THR . . . -163.14 -174.54 33.16 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.921 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.629 ' H ' ' CA ' ' A' ' 93' ' ' GLY . 15.1 mt-10 -76.77 172.7 8.95 Favored Pre-proline 0 C--N 1.328 -0.352 0 C-N-CA 122.853 0.461 . . . . 0.0 110.582 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.576 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 87.4 Cg_exo -47.52 -38.6 28.2 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.448 2.099 . . . . 0.0 112.488 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 38.8 mtm180 -69.25 -23.19 63.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.962 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.714 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 11.0 tpt -60.69 -31.86 71.11 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -16.88 63.27 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.768 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 120' ' ' ARG . 3.4 mm-40 -82.56 -0.54 47.3 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.775 0.321 . . . . 0.0 110.534 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.416 ' O ' ' NH2' ' A' ' 100' ' ' ARG . 3.5 mtp85 -127.44 87.1 57.03 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.892 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.465 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 18.4 Cg_endo -59.51 148.81 85.5 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.519 2.146 . . . . 0.0 111.399 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.838 HD12 ' HE ' ' A' ' 100' ' ' ARG . 0.6 OUTLIER -120.48 6.08 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.908 0.385 . . . . 0.0 111.947 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.636 ' HA3' ' OD1' ' A' ' 147' ' ' ASN . . . -55.55 -44.14 85.74 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.94 -0.648 . . . . 0.0 114.179 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.482 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 60.0 m-70 -55.63 -36.26 66.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 117.442 0.621 . . . . 0.0 110.06 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.806 HD11 ' HB3' ' A' ' 175' ' ' ALA . 21.5 tp -75.85 -43.27 46.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.143 0.497 . . . . 0.0 110.162 178.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.779 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 40.5 t -56.4 -47.78 80.94 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.385 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.725 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 0.1 OUTLIER -70.95 -36.23 72.49 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.405 -179.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.548 ' HB1' ' CG1' ' A' ' 162' ' ' VAL . . . -61.65 -50.27 73.21 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.803 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.728 HD11 ' HG ' ' A' ' 129' ' ' LEU . 9.7 mt -70.74 -48.0 56.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.933 178.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.779 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -59.22 -27.38 65.69 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.72 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.725 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.5 OUTLIER -68.47 -31.72 71.22 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.966 0.412 . . . . 0.0 110.759 178.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.559 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -83.84 14.71 41.24 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.894 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.69 3.87 62.3 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.589 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.667 ' HB1' ' HB3' ' A' ' 107' ' ' CYS . . . -71.9 150.45 44.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.884 0.373 . . . . 0.0 111.298 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 0.5 OUTLIER -98.88 102.97 14.87 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.122 178.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.596 HG21 HG22 ' A' ' 130' ' ' VAL . 8.8 mt -134.77 126.93 48.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.264 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.729 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -124.35 139.44 53.9 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.204 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.588 ' CE1' HG11 ' A' ' 130' ' ' VAL . 33.6 m-85 -79.03 130.04 35.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.121 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.883 HD11 ' HG3' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -91.72 -89.04 0.18 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.542 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.636 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 6.3 mm-40 -59.67 -81.19 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.529 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.452 ' O ' ' HB2' ' A' ' 148' ' ' TYR . 18.5 mt-30 -113.91 151.49 32.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.128 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -67.25 137.52 56.21 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.636 ' OD1' ' HA3' ' A' ' 127' ' ' GLY . 7.9 m-80 65.55 19.13 11.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.138 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.522 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 8.2 m-85 -110.14 168.88 7.0 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-O 121.105 0.479 . . . . 0.0 112.167 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.915 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 37.8 Cg_exo -32.49 -62.27 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 124.409 3.406 . . . . 0.0 116.087 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.915 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 66.6 Cg_exo -54.86 145.26 62.71 Favored 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-N 120.515 1.219 . . . . 0.0 112.747 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.797 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 12.3 mt -156.17 133.97 11.1 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.602 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.883 ' HG3' HD11 ' A' ' 143' ' ' LEU . 3.2 mtt180 -105.74 102.68 12.11 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 176.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.9 HD11 ' HA ' ' A' ' 103' ' ' ALA . 10.0 mt -91.73 147.97 22.59 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.941 -178.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.579 ' HG3' ' O ' ' A' ' 153' ' ' LEU . 3.5 mt-30 -148.73 27.48 0.89 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.352 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 51.73 -175.61 0.12 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.162 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.426 ' O ' HG23 ' A' ' 158' ' ' THR . . . 121.46 -11.81 9.65 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.182 -1.009 . . . . 0.0 112.817 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.823 ' HE2' ' HA ' ' A' ' 180' ' ' ALA . 50.8 t80 -59.78 123.14 16.05 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.006 0.403 . . . . 0.0 110.832 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.697 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 81.4 p -118.38 -28.43 5.75 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.301 0.572 . . . . 0.0 111.682 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.493 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 134.35 -161.73 24.47 Favored Glycine 0 C--N 1.308 -1.02 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.503 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.59 ' O ' HG23 ' A' ' 187' ' ' THR . . . 105.21 153.3 21.68 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.351 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -47.09 119.39 2.54 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.292 -0.454 . . . . 0.0 111.077 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.662 ' HB ' HG13 ' A' ' 189' ' ' ILE . 78.7 t -111.28 134.96 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.48 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.44 119.65 39.46 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.269 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.789 HG21 HD11 ' A' ' 176' ' ' LEU . 1.0 OUTLIER -131.14 120.13 46.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.05 0.453 . . . . 0.0 110.424 179.453 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.413 ' CG ' ' HD2' ' A' ' 192' ' ' LYS . 1.9 m-20 -52.18 137.43 28.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.466 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.854 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.962 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.75 ' HB3' ' HB3' ' A' ' 197' ' ' SER . 53.3 p . . . . . 0 CA--C 1.521 -0.137 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.688 ' HB3' ' CB ' ' A' ' 100' ' ' ARG . 1.2 mp0 -86.53 -10.15 54.66 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.28 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.654 ' HA ' HD13 ' A' ' 129' ' ' LEU . 3.6 m-85 -75.02 -53.0 9.68 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.861 HD11 ' CG1' ' A' ' 191' ' ' ILE . 0.9 OUTLIER -65.9 -39.97 91.09 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.112 178.409 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.509 HG23 ' CG2' ' A' ' 204' ' ' THR . 1.8 m -60.15 -32.24 70.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.354 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.934 ' HB1' ' HB2' ' A' ' 104' ' ' ALA . . . -66.81 -41.48 87.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.44 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.795 HD12 ' HA ' ' A' ' 173' ' ' LEU . 0.2 OUTLIER -76.31 -35.42 58.83 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.794 -179.809 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.824 HD11 ' CD2' ' A' ' 223' ' ' PHE . 4.1 mp -59.59 -36.82 77.01 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.514 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.566 ' HA ' ' HE1' ' A' ' 208' ' ' MET . 2.6 mtp -81.88 -45.35 15.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.559 0.695 . . . . 0.0 112.219 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.67 HG23 ' HG ' ' A' ' 108' ' ' LEU . 93.0 m -70.9 -42.04 70.5 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.739 -1.119 . . . . 0.0 112.596 -178.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.823 ' HA ' ' HE2' ' A' ' 157' ' ' PHE . . . -59.86 -41.62 86.43 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.577 ' HD3' ' O ' ' A' ' 177' ' ' LEU . 17.9 Cg_endo -63.88 -30.07 67.65 Favored 'Trans proline' 0 CA--C 1.502 -1.122 0 C-N-CA 120.822 1.015 . . . . 0.0 111.321 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.761 ' HB2' HD21 ' A' ' 108' ' ' LEU . 10.8 mt -84.5 2.9 38.91 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.701 178.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.645 ' HB1' ' C ' ' A' ' 158' ' ' THR . . . -84.74 135.94 39.78 Favored Pre-proline 0 N--CA 1.454 -0.237 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.697 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 14.2 Cg_endo -52.51 -29.7 41.33 Favored 'Trans proline' 0 CA--C 1.518 -0.316 0 C-N-CA 122.523 2.149 . . . . 0.0 112.95 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.5 138.37 50.69 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.587 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -55.94 142.9 33.91 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.353 -0.385 . . . . 0.0 109.99 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 160' ' ' GLY . 88.8 m -120.89 147.45 45.4 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.871 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.671 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 55.1 t -128.26 117.84 46.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 176.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.819 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 5.2 mp -99.82 117.7 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.906 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.586 ' HB2' ' HG3' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -100.63 123.63 45.1 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.861 ' CG1' HD11 ' A' ' 173' ' ' LEU . 1.5 mp -93.77 121.16 44.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.454 -176.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.413 ' HD2' ' CG ' ' A' ' 165' ' ' ASP . 58.4 mttt -79.08 96.95 5.95 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.824 -1.534 . . . . 0.0 110.648 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 100.24 -132.73 11.04 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.958 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -114.09 127.52 55.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.051 0.453 . . . . 0.0 111.267 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.862 HD11 ' HZ ' ' A' ' 223' ' ' PHE . 1.1 mt -42.33 145.22 0.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.917 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 12.9 p -71.61 -29.92 36.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.346 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.75 ' HB3' ' HB3' ' A' ' 170' ' ' SER . 5.9 t -164.92 62.15 0.13 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.84 0.352 . . . . 0.0 111.174 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.651 ' N ' ' HD2' ' A' ' 199' ' ' PRO . 13.5 tptp -36.45 -49.08 1.8 Allowed Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.571 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . 0.651 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 6.3 Cg_endo -48.0 -34.69 23.56 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.097 1.864 . . . . 0.0 112.178 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.981 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.2 OUTLIER -68.34 -44.82 74.46 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.537 HG21 ' HE2' ' A' ' 223' ' ' PHE . 19.2 mm -59.84 -35.68 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.194 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.6 -41.53 97.58 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.014 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.981 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.1 mt -63.98 -49.27 82.38 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.915 0 CA-C-O 121.711 0.767 . . . . 0.0 109.233 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.52 HG22 ' SD ' ' A' ' 208' ' ' MET . 88.5 m -53.6 -51.19 63.82 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.933 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.902 HD22 ' HB ' ' A' ' 215' ' ' ILE . 33.4 mt -65.24 -32.7 74.5 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 120.541 -0.464 . . . . 0.0 111.465 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -76.89 -46.04 25.9 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.717 0.77 . . . . 0.0 109.414 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.938 ' O ' HG22 ' A' ' 210' ' ' THR . 4.4 tp -67.41 -33.28 74.84 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.595 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' MET . . . . . 0.754 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 42.9 mtp -74.99 -33.89 61.91 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.62 0.724 . . . . 0.0 109.232 177.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.654 ' HE2' ' O ' ' A' ' 205' ' ' LEU . 4.5 mtmt -61.35 -39.05 89.16 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.667 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.938 HG22 ' O ' ' A' ' 207' ' ' LEU . 5.8 t -61.93 -27.21 68.66 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.422 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.653 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 57.0 m-85 -84.07 -6.74 59.46 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.627 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.97 6.87 25.87 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 116.282 1.273 . . . . 0.0 116.282 177.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.597 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.6 m -123.17 148.41 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 118.973 1.387 . . . . 0.0 112.198 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.557 ' O ' HD13 ' A' ' 215' ' ' ILE . 10.9 mt-10 -130.06 141.69 50.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.972 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.919 HD12 ' HB ' ' A' ' 225' ' ' VAL . 21.1 mm -123.7 148.33 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-O 120.851 0.358 . . . . 0.0 110.502 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.66 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 1.5 tt0 -102.87 118.52 37.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.918 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . 0.476 ' ND2' ' HE2' ' A' ' 198' ' ' LYS . 1.5 t30 -83.01 150.8 26.13 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.601 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . 0.66 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 9.8 mm-40 -109.48 -142.44 0.38 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 121.203 -0.199 . . . . 0.0 110.615 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.577 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 0.3 OUTLIER -75.02 65.91 1.52 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.88 0.371 . . . . 0.0 111.632 -179.023 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 4.0 t80 55.56 37.53 29.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.929 0.871 . . . . 0.0 110.598 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.67 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 12.6 pt20 -167.1 -125.29 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.819 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -9.0 133.62 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 179.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.862 ' HZ ' HD11 ' A' ' 195' ' ' LEU . 0.6 OUTLIER -124.84 138.55 54.26 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 112.975 -1.921 . . . . 0.0 109.853 -179.082 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.66 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 27.0 t -119.47 113.9 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-O 121.319 0.58 . . . . 0.0 109.506 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.919 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.5 OUTLIER -120.94 121.12 64.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.034 -179.197 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.558 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 2.7 mptp? -75.63 118.99 19.06 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -69.1 -174.58 10.37 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.046 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 62.36 21.31 62.03 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 121.226 -0.511 . . . . 0.0 113.076 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' GLN . . . . . 0.558 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 8.1 mm100 -68.11 -166.2 0.06 Allowed 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.434 0.635 . . . . 0.0 111.157 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 75.0 m -158.02 147.28 19.57 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.602 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' TYR . . . . . 0.803 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 3.8 m-30 -111.09 127.97 55.73 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.59 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.97 150.78 41.56 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 60.4 p -76.33 110.91 12.66 Favored Pre-proline 0 N--CA 1.442 -0.835 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.822 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.459 ' HB3' ' O ' ' A' ' 210' ' ' THR . 36.5 Cg_endo -65.94 -2.75 7.14 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.044 1.829 . . . . 0.0 112.29 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 99.81 -103.13 2.63 Favored Glycine 0 C--O 1.225 -0.442 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 73.0 m -115.46 133.93 55.57 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . 0.678 ' CD2' HG21 ' A' ' 210' ' ' THR . 8.3 t80 -132.62 126.95 33.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.959 0.409 . . . . 0.0 111.405 -178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.984 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -90.82 110.53 21.74 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.597 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.566 ' N ' HD22 ' A' ' 238' ' ' LEU . 21.8 t -83.63 113.0 21.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.094 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.409 ' HG2' ' CD1' ' A' ' 238' ' ' LEU . 11.3 mt-10 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.253 -0.879 . . . . 0.0 111.245 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.761 ' HD3' HG21 ' A' ' 174' ' ' THR . 78.1 mtm180 . . . . . 0 N--CA 1.454 -0.225 0 CA-C-O 120.91 0.386 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.777 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -43.12 -48.54 6.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.737 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.053 HD22 HD11 ' A' ' 75' ' ' ILE . 11.3 mt -72.09 -32.42 67.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.898 0.38 . . . . 0.0 111.371 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.877 HD22 ' HB2' ' A' ' 101' ' ' PRO . 53.2 tp -68.66 -50.18 53.17 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.355 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.768 HD22 ' CZ ' ' A' ' 231' ' ' TYR . 33.4 mt -68.16 -26.43 65.75 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.77 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.752 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -65.84 -39.52 90.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.302 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.804 ' CB ' HG11 ' A' ' 62' ' ' VAL . . . -81.44 -41.24 22.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.269 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.659 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 13.3 mt -67.72 -4.57 12.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.245 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.535 ' HA ' ' CB ' ' A' ' 231' ' ' TYR . . . -94.58 177.51 5.9 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.651 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.1 OUTLIER -117.48 114.89 24.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.623 178.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.626 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 128.51 -142.84 13.91 Favored Glycine 0 C--O 1.224 -0.508 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.025 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.678 ' HG3' HG23 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -136.66 117.47 14.1 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.186 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 235' ' ' GLY . 0.8 OUTLIER -128.68 145.79 51.06 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.541 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.637 HG22 ' HB2' ' A' ' 74' ' ' GLU . 78.3 t -109.3 143.58 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 CA-C-O 121.51 0.671 . . . . 0.0 112.312 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.881 ' HB3' HD21 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -115.84 116.3 27.77 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 174.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.898 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.5 OUTLIER -103.53 151.57 22.72 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.863 0.364 . . . . 0.0 111.277 -177.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.426 ' HB2' HD23 ' A' ' 238' ' ' LEU . 7.2 t30 65.78 26.37 11.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.044 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.881 HD21 ' HB3' ' A' ' 41' ' ' LEU . 84.6 mt -54.6 -172.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.832 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.554 ' HB3' HG21 ' A' ' 50' ' ' VAL . 61.9 tp -112.94 131.59 55.68 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.384 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -89.39 86.96 6.92 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.965 0.412 . . . . 0.0 110.153 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 49' ' ' ASP . 4.0 m -165.09 143.37 6.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.462 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 47' ' ' SER . 34.6 m-20 -34.71 -31.64 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.714 0.292 . . . . 0.0 111.721 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.868 ' OD1' HG23 ' A' ' 50' ' ' VAL . 2.0 p30 -57.91 -42.2 84.26 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.066 0.46 . . . . 0.0 110.848 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.868 HG23 ' OD1' ' A' ' 49' ' ' ASP . 92.9 t -84.47 -45.1 17.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.859 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -48.34 -39.67 22.79 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.636 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 23.2 m-70 -80.15 -32.17 38.9 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.021 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.586 ' O ' HD13 ' A' ' 57' ' ' LEU . 9.4 tpt -55.55 -35.31 65.58 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.859 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -81.93 -44.2 17.08 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.102 -1.408 . . . . 0.0 108.694 176.149 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.722 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 4.7 t-20 -58.8 -35.59 73.09 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.742 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 1.024 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -63.04 -46.8 85.84 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.833 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.4 OUTLIER -63.96 -39.37 93.99 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.758 -1.565 . . . . 0.0 107.752 177.276 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.722 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -59.27 -41.0 87.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.154 178.793 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.632 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -71.21 -38.51 72.04 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.139 -178.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.673 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.6 OUTLIER -78.83 -16.23 57.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.241 0.543 . . . . 0.0 110.834 -179.69 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.82 35.22 4.37 Favored Glycine 0 C--N 1.319 -0.369 0 CA-C-N 115.272 -0.876 . . . . 0.0 114.372 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.833 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 39.7 t -90.56 120.5 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.813 ' O ' HG12 ' A' ' 76' ' ' ILE . 27.1 m -83.26 127.43 33.64 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.538 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.912 ' HB3' HG23 ' A' ' 75' ' ' ILE . 42.7 p90 -155.84 172.17 18.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.848 0.356 . . . . 0.0 110.266 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 87.0 m -133.94 148.91 51.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.221 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.419 HD12 ' HB2' ' A' ' 73' ' ' CYS . 14.0 tp -117.05 135.85 53.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.969 0.414 . . . . 0.0 110.4 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.467 ' HB3' ' CB ' ' A' ' 72' ' ' ARG . 33.8 p -61.71 -172.19 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.382 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.89 -43.53 19.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.189 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.36 0.54 11.86 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.555 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.1 mtp85 59.54 46.74 11.7 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.069 0.462 . . . . 0.0 110.956 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.521 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -141.24 -14.91 0.87 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.973 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 8.6 mtp180 -113.94 116.74 29.73 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.643 ' HB3' HD11 ' A' ' 44' ' ' LEU . 28.9 t -124.89 123.18 39.36 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.637 ' HB2' HG22 ' A' ' 40' ' ' VAL . 34.3 tt0 -104.37 134.36 47.71 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 176.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 1.053 HD11 HD22 ' A' ' 29' ' ' LEU . 8.1 mt -131.32 122.21 50.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -177.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.813 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -67.89 98.63 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.695 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -35.68 140.81 0.18 Allowed Glycine 0 CA--C 1.518 0.219 0 CA-C-N 115.232 -0.895 . . . . 0.0 114.02 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -86.82 -11.43 50.91 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.101 0.477 . . . . 0.0 110.786 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.651 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 90.73 -1.01 77.8 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.205 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.578 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 154.34 -150.02 21.52 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.542 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 87.3 Cg_exo -49.32 121.54 7.16 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.759 2.306 . . . . 0.0 112.639 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.673 ' HB2' HD13 ' A' ' 60' ' ' LEU . 0.7 OUTLIER -70.71 112.12 6.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.726 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.448 ' HA ' ' CG ' ' A' ' 111' ' ' ASN . 4.9 p80 -82.93 136.14 34.66 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.705 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -97.9 123.64 41.97 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.762 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -70.92 123.44 22.01 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 176.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.27 177.14 1.01 Allowed Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 108.692 -1.763 . . . . 0.0 108.692 -175.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.97 144.3 47.31 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 118.738 1.269 . . . . 0.0 111.085 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.632 HD21 ' HB1' ' A' ' 59' ' ' ALA . 1.0 OUTLIER -115.77 160.41 20.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.179 -178.829 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 9.9 mt-10 -139.71 103.85 4.77 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.86 178.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.734 ' HB2' HD23 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -97.19 122.73 40.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.884 0.373 . . . . 0.0 110.928 -178.531 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -95.47 96.31 9.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.817 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.968 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.2 OUTLIER -107.29 46.28 0.94 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.538 -179.392 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.616 ' CA ' ' H ' ' A' ' 118' ' ' GLU . . . -56.38 -27.74 53.95 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.721 -0.672 . . . . 0.0 113.152 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.531 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 1.0 OUTLIER -106.65 -21.14 13.14 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.586 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.975 ' HB1' ' HB3' ' A' ' 98' ' ' ALA . . . -86.02 57.84 4.71 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.057 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.581 ' O ' ' HD3' ' A' ' 100' ' ' ARG . . . -59.82 -38.04 93.4 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.051 -1.071 . . . . 0.0 111.146 178.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.45 HG22 ' HG3' ' A' ' 171' ' ' GLN . 0.6 OUTLIER -78.46 -15.67 58.38 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.506 0.188 . . . . 0.0 111.506 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.975 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -96.91 -27.33 14.71 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.716 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.689 ' SD ' ' HB3' ' A' ' 115' ' ' LEU . 4.3 tpp -62.07 -41.2 97.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.903 0.382 . . . . 0.0 110.156 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.62 ' O ' HD21 ' A' ' 129' ' ' LEU . 1.6 mpt_? -59.52 -60.11 11.65 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.877 ' HB2' HD22 ' A' ' 30' ' ' LEU . 18.6 Cg_endo -58.87 -31.11 94.72 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.057 1.838 . . . . 0.0 112.029 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 1.024 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -74.84 -53.34 9.28 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.055 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.835 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -50.35 -28.56 8.2 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.475 0.655 . . . . 0.0 110.503 178.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.722 ' HB2' ' HB1' ' A' ' 175' ' ' ALA . . . -87.19 -52.99 5.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.214 -0.903 . . . . 0.0 113.065 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.771 ' CB ' HD11 ' A' ' 30' ' ' LEU . . . -60.39 -27.83 67.75 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.713 0.635 . . . . 0.0 112.713 -177.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.709 HD13 HG13 ' A' ' 113' ' ' ILE . 33.6 mt -82.23 -27.08 32.7 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.737 ' HB2' ' HB1' ' A' ' 138' ' ' ALA . 11.1 p -74.38 12.33 0.79 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.18 0.514 . . . . 0.0 111.422 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.673 ' HG ' HG23 ' A' ' 179' ' ' THR . 1.3 mt -78.14 -76.57 0.18 Allowed 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.433 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.418 ' O ' ' HA3' ' A' ' 155' ' ' GLY . . . -71.79 -115.57 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.64 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.9 p -150.88 95.49 2.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.97 0.414 . . . . 0.0 110.245 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.597 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 14.8 m120 -148.47 138.36 22.31 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.51 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.92 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 0.7 OUTLIER -90.35 100.01 12.92 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.15 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.709 HG13 HD13 ' A' ' 106' ' ' LEU . 24.7 mm -119.27 136.54 56.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.496 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.851 HG13 ' CD2' ' A' ' 143' ' ' LEU . 60.9 t -108.33 111.98 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 176.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.734 HD23 ' HB2' ' A' ' 90' ' ' LEU . 52.7 mt -102.25 107.96 19.18 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.53 -178.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.929 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -124.2 -170.41 2.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.89 0.376 . . . . 0.0 111.675 -179.04 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.599 ' H ' HG22 ' A' ' 116' ' ' THR . . . -168.59 -169.05 31.54 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.144 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.743 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 50.7 mt-10 -81.24 172.73 9.04 Favored Pre-proline 0 N--CA 1.455 -0.223 0 C-N-CA 123.213 0.605 . . . . 0.0 110.254 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.743 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 8.0 Cg_endo -48.1 -39.62 33.64 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.666 2.244 . . . . 0.0 112.336 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 120' ' ' ARG . 10.2 ttp180 -67.97 -23.95 65.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.702 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.611 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 9.7 tpt -61.14 -31.87 71.58 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.415 ' HD3' ' HG2' ' A' ' 149' ' ' PRO . 12.0 mmtt -63.63 -17.14 62.59 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.559 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -79.57 0.65 29.02 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.845 0.355 . . . . 0.0 110.621 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.565 ' HB3' ' NH2' ' A' ' 100' ' ' ARG . 0.8 OUTLIER -126.98 83.03 66.96 Favored Pre-proline 0 N--CA 1.454 -0.262 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.235 179.546 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.513 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 43.6 Cg_exo -56.29 148.68 59.6 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.577 2.184 . . . . 0.0 111.618 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.701 HD11 HD23 ' A' ' 129' ' ' LEU . 1.3 tt -128.84 22.56 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.525 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -69.2 -46.4 57.93 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.183 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.68 ' CE1' ' HB2' ' A' ' 165' ' ' ASP . 1.7 m-70 -55.68 -37.58 68.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.832 0.349 . . . . 0.0 110.929 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.791 ' HG ' HD11 ' A' ' 133' ' ' LEU . 16.9 tp -70.19 -44.32 68.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.353 0.597 . . . . 0.0 109.527 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.874 HG21 HD21 ' A' ' 151' ' ' LEU . 36.2 t -56.85 -47.31 83.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.16 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.77 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 2.8 m-20 -71.04 -38.29 72.54 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 120.881 0.372 . . . . 0.0 110.704 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.516 ' HA ' HG13 ' A' ' 162' ' ' VAL . . . -57.96 -46.97 84.28 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.537 0.684 . . . . 0.0 109.87 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.791 HD11 ' HG ' ' A' ' 129' ' ' LEU . 5.8 mt -76.02 -50.18 15.54 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.798 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.722 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -57.17 -27.7 62.15 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.01 179.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.77 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 5.0 tp -70.55 -30.09 66.72 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.941 0.4 . . . . 0.0 110.915 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 159' ' ' GLY . . . -84.22 14.42 44.92 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.838 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.63 4.48 60.58 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.892 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.738 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . . . -75.2 155.75 36.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.985 0.421 . . . . 0.0 111.533 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.451 ' CB ' ' HB2' ' A' ' 154' ' ' GLN . 3.7 mttm -102.58 105.55 16.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.303 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.747 HG21 HG22 ' A' ' 130' ' ' VAL . 13.6 mt -138.68 127.57 30.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.542 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.809 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -126.38 139.83 52.97 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.594 -179.544 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -78.07 132.37 37.7 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.382 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.851 ' CD2' HG13 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -95.16 -90.97 0.22 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.909 -179.568 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.793 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 16.0 mm-40 -59.15 -81.05 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.025 0.44 . . . . 0.0 110.692 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.504 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 31.6 mt-30 -113.09 148.86 34.38 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.788 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 4.7 mt-10 -65.5 132.54 49.17 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.428 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.525 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 2.1 m-20 67.85 17.82 9.67 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.124 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.598 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 16.8 m-85 -108.75 169.17 6.8 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.035 0.445 . . . . 0.0 111.603 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.918 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 8.2 Cg_exo -32.23 -62.73 0.14 Allowed 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 124.164 3.243 . . . . 0.0 116.656 -177.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.929 ' HG3' HG23 ' A' ' 116' ' ' THR . 59.2 Cg_exo -53.05 143.89 48.51 Favored 'Trans proline' 0 C--N 1.351 0.68 0 CA-C-N 120.982 1.387 . . . . 0.0 112.892 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.874 HD21 HG21 ' A' ' 130' ' ' VAL . 10.4 mt -155.58 133.23 11.15 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.67 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.837 ' HG3' HD11 ' A' ' 143' ' ' LEU . 2.8 mtt85 -103.29 100.76 10.66 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.92 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 10.0 mt -90.62 148.54 22.59 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.987 -178.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.597 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 3.6 mt-30 -149.64 23.79 0.88 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.048 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.595 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 54.52 -168.57 1.78 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.226 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 158' ' ' THR . . . 114.89 -14.57 19.45 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.243 -0.98 . . . . 0.0 113.216 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.738 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 45.4 t80 -58.18 122.75 13.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 117.396 0.598 . . . . 0.0 110.742 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.708 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 76.6 p -114.87 -29.88 6.59 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.375 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.492 ' O ' ' HA2' ' A' ' 136' ' ' GLY . . . 133.73 -157.99 23.06 Favored Glycine 0 C--N 1.305 -1.153 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.115 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.596 ' O ' HG23 ' A' ' 187' ' ' THR . . . 103.06 153.57 24.26 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.289 -0.958 . . . . 0.0 111.347 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -47.16 115.84 1.21 Allowed 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.296 -0.452 . . . . 0.0 111.081 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 60.9 t -107.85 140.28 26.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.64 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.96 119.79 40.1 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.057 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.945 HG11 ' HG ' ' A' ' 173' ' ' LEU . 1.6 t -129.27 120.56 51.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.68 ' HB2' ' CE1' ' A' ' 128' ' ' HIS . 7.8 t0 -55.04 139.62 40.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.234 0.54 . . . . 0.0 112.066 -178.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.91 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . . . . . . 0 N--CA 1.446 -0.682 0 CA-C-N 115.47 -0.787 . . . . 0.0 112.68 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.571 ' HB3' ' HB2' ' A' ' 197' ' ' SER . 46.2 p . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.597 0.237 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.576 ' HA ' ' HB ' ' A' ' 174' ' ' THR . 8.3 mm-40 -89.6 -12.09 40.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.579 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.589 ' CZ ' ' HA ' ' A' ' 126' ' ' ILE . 3.1 m-85 -69.26 -54.36 15.08 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.945 ' HG ' HG11 ' A' ' 164' ' ' VAL . 1.0 OUTLIER -64.84 -46.69 80.84 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.793 178.468 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.761 HG21 ' HD3' ' A' ' 27' ' ' ARG . 4.1 m -54.41 -35.0 62.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.172 178.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.722 ' HB1' ' HB2' ' A' ' 104' ' ' ALA . . . -64.13 -46.77 82.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.497 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.941 HD11 HG21 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -76.52 -31.75 57.86 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.315 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.853 HD11 ' CD2' ' A' ' 223' ' ' PHE . 1.6 mp -58.99 -39.18 81.02 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.181 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.693 ' HE1' ' HA ' ' A' ' 27' ' ' ARG . 2.0 mtp -81.08 -40.71 23.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.892 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.673 HG23 ' HG ' ' A' ' 108' ' ' LEU . 66.4 m -71.28 -41.85 69.48 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.949 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.552 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . -59.63 -40.51 79.95 Favored Pre-proline 0 C--N 1.321 -0.674 0 N-CA-C 115.132 1.531 . . . . 0.0 115.132 -176.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.577 ' HD3' ' O ' ' A' ' 177' ' ' LEU . 27.9 Cg_endo -64.93 -28.82 58.11 Favored 'Trans proline' 0 CA--C 1.502 -1.112 0 CA-C-N 120.081 1.064 . . . . 0.0 111.511 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.587 ' HB2' HD21 ' A' ' 108' ' ' LEU . 8.1 mt -83.58 0.81 45.07 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.485 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.623 ' HB1' ' C ' ' A' ' 158' ' ' THR . . . -83.36 136.89 42.58 Favored Pre-proline 0 C--O 1.223 -0.304 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.287 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.708 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 11.1 Cg_endo -50.53 -32.53 35.25 Favored 'Trans proline' 0 CA--C 1.516 -0.415 0 C-N-CA 122.715 2.277 . . . . 0.0 113.363 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -114.96 141.35 48.09 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.717 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -56.1 141.88 38.74 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.124 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.596 HG23 ' O ' ' A' ' 160' ' ' GLY . 91.5 m -119.97 143.41 48.04 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 50.8 t -123.69 118.15 53.37 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 176.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.816 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 2.7 mp -102.55 117.85 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.596 ' HB2' ' HG3' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -100.65 123.66 45.16 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.241 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.91 HG23 ' HA2' ' A' ' 166' ' ' GLY . 1.6 mp -93.69 119.59 41.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.605 -1.179 . . . . 0.0 111.142 -176.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.5 ' HE2' ' N ' ' A' ' 165' ' ' ASP . 1.7 mtmt -75.26 97.06 3.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.834 -178.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 99.64 -133.06 11.16 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.693 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -112.66 131.09 55.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.855 0.36 . . . . 0.0 111.135 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.753 HD11 ' HZ ' ' A' ' 223' ' ' PHE . 1.5 mt -41.77 144.48 0.4 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.836 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.41 ' N ' ' O ' ' A' ' 166' ' ' GLY . 14.2 p -73.75 -27.72 23.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.184 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.571 ' HB2' ' HB3' ' A' ' 170' ' ' SER . 0.3 OUTLIER -165.51 63.01 0.11 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.184 0.516 . . . . 0.0 110.25 -179.19 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.686 ' N ' ' HD2' ' A' ' 199' ' ' PRO . 0.0 OUTLIER -42.07 -46.63 10.44 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.5 179.7 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . 0.686 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 9.5 Cg_endo -49.31 -33.09 27.67 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 121.944 1.763 . . . . 0.0 111.39 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.991 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.1 OUTLIER -69.1 -43.82 73.7 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.785 0.803 . . . . 0.0 108.87 178.242 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.606 HG21 ' HE2' ' A' ' 223' ' ' PHE . 27.5 mm -62.69 -35.79 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.452 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.29 -44.13 95.65 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.695 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.991 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.0 mt -63.12 -49.76 82.04 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.927 0 CA-C-O 121.66 0.743 . . . . 0.0 108.996 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.537 ' CG2' HG23 ' A' ' 174' ' ' THR . 90.8 m -53.02 -51.48 61.54 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.893 -178.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.877 HD22 ' HB ' ' A' ' 215' ' ' ILE . 29.3 mt -66.13 -30.48 70.97 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.437 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . 0.464 ' HA ' ' HE3' ' A' ' 209' ' ' LYS . 29.8 m-20 -77.02 -46.13 24.84 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.837 0.827 . . . . 0.0 109.527 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.801 ' O ' HG22 ' A' ' 210' ' ' THR . 5.1 tp -70.55 -29.47 65.93 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.09 -1.413 . . . . 0.0 109.618 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' MET . . . . . 0.72 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 52.2 mtp -77.13 -34.09 56.66 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.714 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 9.4 mtmt -62.04 -40.59 96.26 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.015 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.801 HG22 ' O ' ' A' ' 207' ' ' LEU . 5.0 t -60.5 -31.25 70.31 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.583 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.598 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 56.1 m-85 -78.61 -5.94 54.27 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.871 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.6 7.95 25.27 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.166 -1.016 . . . . 0.0 115.638 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.714 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 5.1 m -124.0 148.07 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 118.768 1.284 . . . . 0.0 112.829 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.467 ' CG ' ' HG2' ' A' ' 209' ' ' LYS . 16.2 mt-10 -130.02 137.72 50.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.126 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.877 ' HB ' HD22 ' A' ' 205' ' ' LEU . 18.0 mm -120.56 148.38 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-O 120.875 0.369 . . . . 0.0 110.557 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.665 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 2.4 tt0 -103.01 116.22 32.1 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.864 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . 0.601 ' H ' ' ND2' ' A' ' 217' ' ' ASN . 0.9 OUTLIER -82.79 151.21 26.2 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.969 179.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . 0.633 ' HG3' ' HB3' ' A' ' 222' ' ' GLN . 10.2 mm100 -109.47 -139.12 0.38 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 121.146 -0.222 . . . . 0.0 110.821 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.642 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 5.5 t-80 -78.82 66.6 4.34 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 3.7 t80 57.25 33.38 23.22 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.974 0.893 . . . . 0.0 110.234 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.685 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 3.3 pt20 -163.92 -126.63 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.816 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -8.56 132.66 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.853 ' CD2' HD11 ' A' ' 177' ' ' LEU . 0.9 OUTLIER -124.76 138.69 54.27 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 112.867 -1.97 . . . . 0.0 110.181 -179.295 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.665 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 38.7 t -118.37 114.44 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.784 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.4 OUTLIER -121.78 125.66 73.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.443 -178.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.547 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -79.79 127.65 32.48 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.206 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.554 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -79.46 -173.84 45.24 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.404 -178.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 62.75 21.0 62.57 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 121.61 -0.329 . . . . 0.0 113.193 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 12.5 mt-30 -76.78 -175.39 3.41 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.364 0.602 . . . . 0.0 111.557 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.22 147.81 28.84 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.654 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' TYR . . . . . 0.768 ' CZ ' HD22 ' A' ' 31' ' ' LEU . 1.9 m-30 -104.47 131.71 51.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.109 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.42 144.83 48.79 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.435 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 50.1 m -69.99 110.81 7.34 Favored Pre-proline 0 N--CA 1.45 -0.453 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.259 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.503 ' HG3' HG23 ' A' ' 210' ' ' THR . 40.5 Cg_endo -66.44 -1.0 4.91 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.017 1.811 . . . . 0.0 112.41 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . 0.579 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 99.45 -96.41 1.66 Allowed Glycine 0 C--O 1.226 -0.383 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.631 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 30.7 m -119.91 134.4 55.25 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . 0.563 ' CD2' HG21 ' A' ' 210' ' ' THR . 12.8 t80 -132.97 126.76 32.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.997 0.427 . . . . 0.0 111.314 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.898 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -93.25 112.2 24.06 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.033 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.693 ' N ' HD22 ' A' ' 238' ' ' LEU . 25.0 t -86.74 111.83 22.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.789 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.211 -179.667 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.874 HH11 HD23 ' A' ' 207' ' ' LEU . 6.6 mtm105 . . . . . 0 CA--C 1.521 -0.171 0 CA-C-O 120.877 0.37 . . . . 0.0 111.316 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.751 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -35.21 -45.41 0.3 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.378 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.054 HD22 HD11 ' A' ' 75' ' ' ILE . 11.4 mt -75.65 -38.93 58.46 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.977 0.418 . . . . 0.0 111.608 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.839 HD22 ' HB2' ' A' ' 101' ' ' PRO . 51.5 tp -65.22 -49.67 68.8 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.435 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.585 HD13 ' HA ' ' A' ' 208' ' ' MET . 45.3 mt -67.09 -26.9 66.94 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.657 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.847 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -66.28 -40.05 89.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.044 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.776 ' CB ' HG11 ' A' ' 62' ' ' VAL . . . -81.21 -41.21 22.66 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.793 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.671 HD11 ' HB1' ' A' ' 105' ' ' ALA . 13.3 mt -67.95 -3.69 10.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.246 178.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.493 ' HB2' ' HB3' ' A' ' 231' ' ' TYR . . . -100.22 178.34 4.8 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.565 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.1 OUTLIER -113.04 113.6 25.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.8 178.186 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.412 ' HA3' ' OG ' ' A' ' 233' ' ' SER . . . 116.75 167.91 14.73 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.357 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.819 ' HG3' HG23 ' A' ' 76' ' ' ILE . 1.1 ttmt -95.45 117.95 31.3 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 117.127 0.463 . . . . 0.0 111.692 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 0.9 OUTLIER -120.19 148.12 44.06 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.321 179.753 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.669 HG22 ' HB2' ' A' ' 74' ' ' GLU . 98.8 t -107.41 141.64 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.767 ' CB ' HD21 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -116.1 116.0 27.07 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 174.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.892 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.6 OUTLIER -103.92 152.83 21.51 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.93 -178.314 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 65.69 26.81 11.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.469 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.767 HD21 ' CB ' ' A' ' 41' ' ' LEU . 76.2 mt -54.14 -173.31 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.789 0.328 . . . . 0.0 110.127 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.525 ' HB3' HG21 ' A' ' 50' ' ' VAL . 56.8 tp -111.69 131.31 55.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.469 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -87.78 88.79 7.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.992 0.425 . . . . 0.0 110.11 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 50' ' ' VAL . 74.6 m -163.97 142.66 7.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.994 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.437 ' HA ' ' HB3' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -37.44 -29.92 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.736 0.303 . . . . 0.0 111.374 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.761 ' OD1' HG23 ' A' ' 50' ' ' VAL . 1.2 p30 -58.3 -42.51 86.8 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 121.043 0.449 . . . . 0.0 110.631 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.761 HG23 ' OD1' ' A' ' 49' ' ' ASP . 93.0 t -84.12 -44.55 18.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.672 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.782 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -49.32 -39.72 32.4 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.447 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.58 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 22.6 m-70 -81.04 -32.67 33.97 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.081 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.628 ' O ' HD13 ' A' ' 57' ' ' LEU . 7.5 tpt -53.69 -34.64 59.44 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 176.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.782 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.7 OUTLIER -82.52 -44.46 15.89 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 113.892 -1.503 . . . . 0.0 108.837 176.698 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.729 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 24.8 t-20 -57.97 -42.28 84.68 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-O 120.882 0.372 . . . . 0.0 110.655 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 1.024 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -57.27 -46.8 82.74 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.875 0.845 . . . . 0.0 109.012 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.777 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -64.33 -37.61 88.1 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.134 -1.394 . . . . 0.0 107.779 177.21 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.729 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -64.14 -33.13 75.07 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.179 -1.373 . . . . 0.0 111.933 179.411 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.789 ' CB ' HD11 ' A' ' 90' ' ' LEU . . . -76.21 -37.55 57.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.221 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.641 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -81.4 -12.5 58.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.289 0.566 . . . . 0.0 110.686 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.06 35.54 5.02 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.262 -0.881 . . . . 0.0 114.293 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.777 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 39.8 t -90.45 123.24 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.788 ' O ' HG12 ' A' ' 76' ' ' ILE . 7.2 m -85.32 131.44 34.41 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.0 0.428 . . . . 0.0 111.723 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.824 ' HB3' HG23 ' A' ' 75' ' ' ILE . 40.6 p90 -158.7 171.08 20.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.685 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 98.1 m -135.19 149.03 49.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.301 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.626 HD12 ' HB2' ' A' ' 73' ' ' CYS . 11.7 tp -120.25 138.69 53.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.028 0.442 . . . . 0.0 110.874 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 87.1 p -57.71 -175.31 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.339 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.1 -42.24 23.96 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.197 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -76.41 0.67 18.79 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.398 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.9 mtt-85 59.36 53.56 5.19 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.873 0.368 . . . . 0.0 111.176 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.445 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -149.19 4.16 0.61 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.76 179.657 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.612 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 9.5 ttm180 -136.97 110.78 8.14 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.626 ' HB2' HD12 ' A' ' 66' ' ' LEU . 36.9 t -121.61 134.48 55.0 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.669 ' HB2' HG22 ' A' ' 40' ' ' VAL . 24.6 tt0 -115.45 132.61 56.57 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.245 -0.888 . . . . 0.0 108.728 177.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 1.054 HD11 HD22 ' A' ' 29' ' ' LEU . 12.2 mt -127.79 123.45 61.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -177.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.819 HG23 ' HG3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -67.72 100.13 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 175.178 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 35' ' ' ALA . . . -39.19 144.73 0.27 Allowed Glycine 0 C--N 1.323 -0.189 0 CA-C-N 115.145 -0.934 . . . . 0.0 113.483 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -90.02 -12.41 38.69 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.947 0.404 . . . . 0.0 111.038 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.565 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 95.19 1.63 62.65 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.94 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.553 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 150.88 -148.96 20.69 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.683 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.52 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 77.3 Cg_exo -49.63 123.52 10.63 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.712 2.274 . . . . 0.0 112.218 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.641 ' HB2' HD13 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -74.27 106.33 5.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.225 -179.5 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -83.66 132.42 34.88 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.573 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.578 ' CB ' HD11 ' A' ' 113' ' ' ILE . . . -96.86 126.81 42.28 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.065 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.19 123.93 23.32 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.31 175.3 1.15 Allowed Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 -175.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 112' ' ' ASP . . . -74.04 144.98 44.85 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 118.559 1.179 . . . . 0.0 112.215 -178.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.661 HD21 ' C ' ' A' ' 59' ' ' ALA . 0.9 OUTLIER -115.26 161.12 18.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.649 -1.16 . . . . 0.0 112.557 -178.273 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.449 ' HG3' ' HB ' ' A' ' 114' ' ' VAL . 1.6 tt0 -140.26 112.26 7.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.758 177.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.789 HD11 ' CB ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -108.64 117.87 35.3 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.505 -178.427 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.632 ' C ' HD13 ' A' ' 92' ' ' LEU . 0.1 OUTLIER -88.97 96.67 10.82 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.508 179.042 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.808 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -105.37 53.04 0.72 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.267 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.459 ' CA ' ' H ' ' A' ' 118' ' ' GLU . . . -53.13 -75.11 0.24 Allowed Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.711 -0.677 . . . . 0.0 113.022 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.503 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 3.1 m120 -75.49 -1.06 22.4 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.768 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 1.05 ' HB1' ' HB3' ' A' ' 98' ' ' ALA . . . -87.96 47.66 1.53 Allowed 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.363 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.401 ' O ' ' HD2' ' A' ' 100' ' ' ARG . . . -56.37 -23.59 42.23 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.173 -1.013 . . . . 0.0 111.458 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.462 HG22 ' HG2' ' A' ' 171' ' ' GLN . 2.1 p -92.91 -16.69 24.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.464 0.173 . . . . 0.0 111.176 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 1.05 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -95.5 -37.17 11.01 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.469 ' HB2' ' HB2' ' A' ' 92' ' ' LEU . 2.2 tpp -59.3 -44.52 92.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.594 0.235 . . . . 0.0 110.524 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.7 ' HE ' HD12 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -54.13 -60.22 8.03 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.284 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.839 ' HB2' HD22 ' A' ' 30' ' ' LEU . 18.3 Cg_endo -62.0 -32.89 84.32 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.396 2.064 . . . . 0.0 112.831 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 1.024 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -70.86 -52.84 17.78 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.052 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.896 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -51.72 -28.72 15.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.26 0.552 . . . . 0.0 110.53 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.874 ' CB ' ' HB1' ' A' ' 175' ' ' ALA . . . -86.06 -52.97 5.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.428 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.702 ' CB ' HD11 ' A' ' 30' ' ' LEU . . . -60.57 -34.27 73.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.643 ' HB2' HD12 ' A' ' 153' ' ' LEU . 31.6 mt -78.52 -17.82 55.65 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.587 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 9.6 p -84.68 22.6 1.29 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.245 0.545 . . . . 0.0 110.598 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.771 HD21 ' HB2' ' A' ' 182' ' ' LEU . 0.4 OUTLIER -90.04 -73.86 0.51 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.427 -179.71 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -73.19 -116.31 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.699 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.24 94.15 2.09 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.141 0.496 . . . . 0.0 110.58 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.643 ' OD1' HD13 ' A' ' 113' ' ' ILE . 22.7 p30 -146.44 138.32 24.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.467 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.886 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 0.9 OUTLIER -95.21 100.65 12.42 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.656 179.122 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.644 HD12 ' C ' ' A' ' 112' ' ' ASP . 1.1 mp -120.66 147.68 24.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.494 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.865 HG13 ' CD2' ' A' ' 143' ' ' LEU . 58.0 t -117.53 113.22 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 176.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.679 HD23 ' HB2' ' A' ' 90' ' ' LEU . 33.9 mt -102.12 105.41 16.11 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.296 -0.561 . . . . 0.0 111.324 -177.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.813 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -118.14 -172.12 2.2 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.768 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.572 ' H ' HG22 ' A' ' 116' ' ' THR . . . -164.93 -167.97 26.34 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.206 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.609 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 16.9 mt-10 -78.31 171.86 11.38 Favored Pre-proline 0 C--N 1.332 -0.158 0 C-N-CA 122.661 0.384 . . . . 0.0 110.356 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 71.0 Cg_exo -49.5 -39.57 45.33 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.377 2.052 . . . . 0.0 112.77 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -68.23 -23.4 64.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.619 0.247 . . . . 0.0 110.971 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.557 ' O ' ' HG3' ' A' ' 149' ' ' PRO . 9.8 tpt -60.81 -34.45 74.55 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.474 ' HA ' ' HG2' ' A' ' 149' ' ' PRO . 0.0 OUTLIER -61.62 -16.77 51.33 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.614 179.166 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.3 3.19 32.47 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.837 0.351 . . . . 0.0 110.209 178.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.412 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 12.3 mtm180 -127.3 84.79 62.51 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.149 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 124' ' ' ARG . 16.2 Cg_endo -57.13 148.64 68.21 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.867 2.378 . . . . 0.0 112.068 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.7 HD12 ' HE ' ' A' ' 100' ' ' ARG . 0.9 OUTLIER -122.53 0.93 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -179.355 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.511 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -53.36 -39.43 59.19 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.219 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 42.5 m-70 -56.01 -41.61 75.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.783 0.325 . . . . 0.0 110.381 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.742 ' HG ' HD11 ' A' ' 133' ' ' LEU . 12.6 tp -75.48 -43.98 46.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.284 0.564 . . . . 0.0 110.055 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.842 HG13 ' CG2' ' A' ' 140' ' ' ILE . 69.5 t -56.41 -47.36 81.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.593 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.73 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 0.7 OUTLIER -69.2 -38.95 78.88 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.696 -179.603 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.617 ' HB2' HG23 ' A' ' 164' ' ' VAL . . . -58.39 -49.13 78.34 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.596 178.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.742 HD11 ' HG ' ' A' ' 129' ' ' LEU . 7.2 mt -69.92 -50.37 42.8 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.323 178.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.747 ' HG3' ' HB ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -58.14 -27.88 64.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.798 179.56 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.73 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 1.0 OUTLIER -69.79 -30.85 68.5 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.912 178.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -83.36 14.79 38.18 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.966 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 93.69 7.97 61.15 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.593 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.708 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . . . -78.21 152.03 32.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.834 0.349 . . . . 0.0 111.035 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 19.9 mtpt -100.73 103.96 15.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.126 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.842 ' CG2' HG13 ' A' ' 130' ' ' VAL . 34.7 mt -135.65 124.16 38.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.195 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.75 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -120.54 139.51 52.82 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.938 -179.589 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.559 ' CE1' HG11 ' A' ' 130' ' ' VAL . 42.1 m-85 -81.04 132.43 35.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.847 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.865 ' CD2' HG13 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -92.52 -87.16 0.23 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.775 -179.217 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.679 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 2.7 mt-10 -57.38 -82.46 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.397 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.42 ' NE2' ' CE1' ' A' ' 148' ' ' TYR . 25.1 mt-30 -116.69 154.3 30.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.341 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 6.0 mt-10 -66.88 132.82 48.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.373 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.511 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 2.7 m120 71.44 17.08 5.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.442 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.534 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 14.8 m-85 -107.0 168.22 8.36 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.813 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 75.0 Cg_exo -35.96 -60.33 0.35 Allowed 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.991 3.127 . . . . 0.0 115.921 -177.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.813 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 77.8 Cg_exo -52.35 145.5 35.79 Favored 'Trans proline' 0 C--N 1.352 0.736 0 CA-C-N 120.61 1.253 . . . . 0.0 112.118 -178.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.849 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 8.4 mt -156.41 137.59 13.73 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.808 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.75 ' HB2' HG22 ' A' ' 141' ' ' THR . 7.6 mtt85 -109.24 101.6 10.61 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.896 HD11 ' HA ' ' A' ' 103' ' ' ALA . 7.9 mt -90.35 148.01 23.11 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.283 -177.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.598 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 5.7 mt-30 -149.87 24.81 0.85 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.365 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.587 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 56.99 -162.04 7.52 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.322 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.421 ' O ' HG23 ' A' ' 158' ' ' THR . . . 107.35 -16.13 38.39 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.365 -0.922 . . . . 0.0 113.619 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.708 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 11.2 t80 -58.66 122.38 13.34 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 117.858 0.829 . . . . 0.0 110.155 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.738 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 56.9 p -114.76 -31.84 6.01 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 121.594 0.711 . . . . 0.0 111.171 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.442 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 137.19 -160.09 24.9 Favored Glycine 0 C--N 1.307 -1.068 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.049 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.566 ' O ' HG23 ' A' ' 187' ' ' THR . . . 105.5 152.95 21.14 Favored Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.008 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -47.01 116.47 1.37 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.98 -0.61 . . . . 0.0 110.83 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.569 ' CG1' ' HB1' ' A' ' 132' ' ' ALA . 68.6 t -109.49 144.88 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.48 119.97 39.4 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.477 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.893 HG21 HD11 ' A' ' 176' ' ' LEU . 1.0 OUTLIER -131.86 121.37 47.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.695 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.89 137.94 37.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.954 0.407 . . . . 0.0 111.191 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.802 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.43 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.75 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.497 ' HB2' ' HB3' ' A' ' 200' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.116 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.584 ' O ' ' HB3' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -82.24 -11.08 58.88 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.811 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.499 ' CD1' ' HG2' ' A' ' 100' ' ' ARG . 6.4 m-85 -74.13 -54.88 6.86 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.882 HD11 ' CG1' ' A' ' 191' ' ' ILE . 0.5 OUTLIER -65.62 -37.78 87.54 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.436 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.489 ' HB ' ' HA ' ' A' ' 171' ' ' GLN . 4.4 m -58.26 -34.57 70.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.063 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.874 ' HB1' ' CB ' ' A' ' 104' ' ' ALA . . . -68.28 -39.05 82.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.843 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.893 HD11 HG21 ' A' ' 164' ' ' VAL . 0.3 OUTLIER -76.78 -34.26 58.0 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.275 0.559 . . . . 0.0 110.899 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.817 HD11 ' CD2' ' A' ' 223' ' ' PHE . 2.4 mp -59.68 -38.41 81.47 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.529 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.742 ' HE1' ' HA ' ' A' ' 27' ' ' ARG . 3.8 mtp -81.76 -43.61 18.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.389 0.614 . . . . 0.0 112.509 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.594 HG23 ' HG ' ' A' ' 108' ' ' LEU . 48.5 m -73.11 -39.88 65.42 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.684 -178.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.576 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . -59.49 -41.55 87.34 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -177.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 30.3 Cg_endo -65.59 -28.32 52.97 Favored 'Trans proline' 0 CA--C 1.501 -1.161 0 C-N-CA 121.046 1.164 . . . . 0.0 111.723 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.771 ' HB2' HD21 ' A' ' 108' ' ' LEU . 5.4 mt -83.15 -0.19 48.1 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.079 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.738 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -82.19 137.29 46.0 Favored Pre-proline 0 N--CA 1.455 -0.209 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.183 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.697 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 11.7 Cg_endo -50.94 -33.18 40.94 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.685 2.257 . . . . 0.0 113.357 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -113.28 139.52 48.76 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.842 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' A' ' 186' ' ' ASP . 0.8 OUTLIER -53.68 144.59 17.44 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.15 179.227 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.574 ' HB ' ' HB1' ' A' ' 180' ' ' ALA . 94.1 m -123.83 145.88 48.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.258 0.552 . . . . 0.0 112.441 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.673 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 40.2 t -126.63 117.83 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.366 177.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.744 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 3.5 mp -101.12 118.08 47.32 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.579 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 3.6 ttt180 -100.93 124.82 47.2 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.882 ' CG1' HD11 ' A' ' 173' ' ' LEU . 1.5 mp -93.61 123.41 45.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.952 -175.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -83.03 96.88 8.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.11 -1.405 . . . . 0.0 110.361 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 102.06 -134.28 11.7 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.804 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -116.43 127.32 54.5 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.727 HD11 ' HZ ' ' A' ' 223' ' ' PHE . 1.0 OUTLIER -41.37 144.72 0.31 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.486 179.447 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.415 ' N ' ' O ' ' A' ' 166' ' ' GLY . 11.1 p -72.92 -30.53 32.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.999 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.496 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 0.2 OUTLIER -162.09 62.43 0.23 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.024 0.44 . . . . 0.0 110.611 -179.412 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.578 ' HA ' HD13 ' A' ' 195' ' ' LEU . 3.1 tttp -39.68 -45.92 4.31 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.175 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . 0.496 ' HD2' ' C ' ' A' ' 197' ' ' SER . 88.6 Cg_exo -47.8 -37.35 28.18 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 121.99 1.794 . . . . 0.0 111.622 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.954 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.3 OUTLIER -64.18 -45.79 86.83 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.637 HG21 ' HE2' ' A' ' 223' ' ' PHE . 12.5 mm -60.76 -37.33 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.584 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.442 ' OD2' ' HE3' ' A' ' 198' ' ' LYS . 83.8 m-20 -59.06 -46.78 87.39 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.857 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.954 HD12 ' HA ' ' A' ' 200' ' ' TYR . 3.1 mt -61.17 -46.26 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.977 0 CA-C-O 121.719 0.771 . . . . 0.0 108.986 178.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.55 HG22 ' SD ' ' A' ' 208' ' ' MET . 92.5 m -54.13 -51.44 64.23 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.699 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.874 HD22 ' HB ' ' A' ' 215' ' ' ILE . 26.8 mt -68.53 -28.37 66.93 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 120.531 -0.467 . . . . 0.0 111.246 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . 0.496 ' HA ' ' HE3' ' A' ' 209' ' ' LYS . 15.0 t30 -77.84 -46.09 22.48 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.793 0.806 . . . . 0.0 109.577 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.99 ' O ' HG22 ' A' ' 210' ' ' THR . 3.1 tp -69.57 -34.46 74.21 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.188 -1.369 . . . . 0.0 109.297 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' MET . . . . . 0.79 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 50.1 mtp -72.57 -33.82 67.03 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.467 0.651 . . . . 0.0 109.328 177.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.623 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 15.5 mtmt -62.57 -37.57 86.69 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.862 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.99 HG22 ' O ' ' A' ' 207' ' ' LEU . 5.8 t -62.86 -28.45 70.03 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.409 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.569 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 39.3 m-85 -82.82 -6.04 59.24 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.913 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.99 6.9 25.81 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 116.226 1.25 . . . . 0.0 116.226 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.623 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.2 m -123.66 148.7 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 119.101 1.451 . . . . 0.0 112.729 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.571 ' O ' HD13 ' A' ' 215' ' ' ILE . 18.9 mt-10 -129.63 140.66 51.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.821 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.874 ' HB ' HD22 ' A' ' 205' ' ' LEU . 15.9 mm -123.29 148.31 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-O 120.871 0.367 . . . . 0.0 110.691 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.64 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 31.0 tt0 -103.45 119.19 38.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.603 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . 0.881 HD22 ' H ' ' A' ' 217' ' ' ASN . 0.0 OUTLIER -82.85 151.17 26.15 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.541 179.431 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . 0.745 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -112.58 -146.09 0.4 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 121.182 -0.207 . . . . 0.0 110.49 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.425 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 7.0 m80 -68.01 66.23 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.416 ' CE1' ' HD2' ' A' ' 198' ' ' LYS . 3.4 t80 52.93 34.6 17.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.887 0.851 . . . . 0.0 110.266 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.648 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -164.35 -124.09 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 179.652 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.745 ' O ' ' HB2' ' A' ' 218' ' ' GLN . 0.0 OUTLIER -8.36 133.59 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.817 ' CD2' HD11 ' A' ' 177' ' ' LEU . 0.8 OUTLIER -124.75 139.26 54.01 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.269 -1.787 . . . . 0.0 109.79 -179.218 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.64 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 40.1 t -120.96 113.87 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.871 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -122.16 126.05 73.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.531 -178.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.527 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -74.4 126.76 31.4 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.608 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -81.92 -178.97 52.71 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.268 -0.968 . . . . 0.0 113.021 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 66.01 21.25 69.57 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 121.375 -0.44 . . . . 0.0 112.872 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' GLN . . . . . 0.527 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 27.2 mt-30 -78.72 -176.04 4.71 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.213 0.53 . . . . 0.0 111.476 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.4 t -148.64 147.77 29.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.043 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' TYR . . . . . 0.67 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 7.2 m-85 -103.32 129.95 50.47 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.87 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -121.53 148.07 44.97 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.756 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.439 ' HB2' ' OG1' ' A' ' 39' ' ' THR . 10.9 p -71.52 110.99 8.68 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 120.981 -0.287 . . . . 0.0 110.516 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.493 ' HB3' ' O ' ' A' ' 210' ' ' THR . 55.7 Cg_endo -70.08 1.66 4.44 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.199 1.933 . . . . 0.0 112.213 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 98.59 -101.75 2.51 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 56.1 m -117.39 137.78 52.25 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . 0.609 ' CD2' HG21 ' A' ' 210' ' ' THR . 10.6 t80 -134.32 125.49 27.74 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.928 0.394 . . . . 0.0 111.314 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.892 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -94.78 110.91 22.72 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.105 0.479 . . . . 0.0 111.017 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.606 ' N ' HD22 ' A' ' 238' ' ' LEU . 21.7 t -81.61 111.11 17.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.212 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.533 ' HG3' HD13 ' A' ' 238' ' ' LEU . 6.3 mt-10 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.078 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.691 ' HB2' HD21 ' A' ' 207' ' ' LEU . 1.0 OUTLIER . . . . . 0 CA--C 1.516 -0.351 0 CA-C-O 121.277 0.56 . . . . 0.0 110.69 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.863 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -37.23 -46.83 0.75 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.001 -0.999 . . . . 0.0 112.321 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.043 HD22 HD11 ' A' ' 75' ' ' ILE . 11.0 mt -75.51 -33.14 60.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.937 0.399 . . . . 0.0 111.256 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.895 HD22 ' HB2' ' A' ' 101' ' ' PRO . 46.4 tp -68.6 -49.71 57.15 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.489 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.628 HD22 ' CZ ' ' A' ' 231' ' ' TYR . 39.5 mt -68.71 -26.99 65.55 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.451 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.825 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -65.29 -37.46 87.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.084 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.81 ' CB ' HG11 ' A' ' 62' ' ' VAL . . . -80.83 -41.12 23.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.234 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.689 HD23 ' O ' ' A' ' 80' ' ' GLY . 32.4 mt -67.52 -3.78 9.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.368 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.427 ' O ' ' HA3' ' A' ' 77' ' ' GLY . . . -83.57 171.95 12.83 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -112.31 34.67 4.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.984 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -168.81 175.43 43.31 Favored Glycine 0 C--N 1.309 -0.936 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.74 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.759 ' HE2' HD12 ' A' ' 76' ' ' ILE . 10.6 ttmt -95.39 117.83 31.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.642 0.721 . . . . 0.0 111.373 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 235' ' ' GLY . 0.9 OUTLIER -123.14 148.28 45.89 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.615 -179.291 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.708 HG22 ' HB2' ' A' ' 74' ' ' GLU . 76.1 t -104.78 141.42 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 CA-C-O 121.393 0.616 . . . . 0.0 112.474 -179.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.896 HD23 HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -114.51 116.2 28.45 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 175.034 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.907 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.5 OUTLIER -102.99 151.68 22.2 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.149 -178.364 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.447 ' HB2' HD23 ' A' ' 238' ' ' LEU . 1.8 t-20 68.15 25.64 7.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.419 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.807 HD21 ' CB ' ' A' ' 41' ' ' LEU . 70.9 mt -53.4 -175.6 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.552 ' HB3' HG21 ' A' ' 50' ' ' VAL . 54.1 tp -113.0 130.91 55.97 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.509 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.417 ' O ' ' CG ' ' A' ' 46' ' ' ASP . 10.1 p-10 -85.45 87.41 7.39 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.302 0.573 . . . . 0.0 110.619 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.447 ' HB2' ' OD1' ' A' ' 49' ' ' ASP . 4.4 m -164.02 142.91 7.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.306 -178.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -36.27 -32.08 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.689 0.281 . . . . 0.0 111.578 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 1.065 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 29.4 p-10 -57.74 -42.62 84.3 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.055 0.455 . . . . 0.0 110.66 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.552 HG21 ' HB3' ' A' ' 45' ' ' LEU . 98.5 t -82.73 -45.78 19.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.788 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.912 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -48.65 -40.08 26.59 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.644 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 13.8 m-70 -78.62 -33.2 47.56 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.017 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.558 ' O ' HD13 ' A' ' 57' ' ' LEU . 7.8 tpt -54.36 -32.41 56.86 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 176.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.912 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.6 OUTLIER -84.08 -42.48 16.05 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.53 176.411 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.701 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 25.2 t-20 -60.25 -42.62 95.68 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.538 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 1.081 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -57.66 -47.23 82.87 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.752 0.787 . . . . 0.0 109.207 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.815 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -64.23 -39.71 94.54 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.253 -1.34 . . . . 0.0 107.775 177.147 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.701 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.1 m -61.44 -35.4 77.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.802 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.637 ' CB ' HD11 ' A' ' 90' ' ' LEU . . . -75.97 -38.04 57.91 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.267 -178.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.705 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -80.59 -14.01 58.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.287 0.565 . . . . 0.0 110.657 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.94 34.97 4.99 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.217 -0.901 . . . . 0.0 114.259 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.815 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 35.6 t -90.5 121.71 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.775 ' O ' HG12 ' A' ' 76' ' ' ILE . 2.7 t -85.68 135.06 33.92 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.462 -178.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.787 ' HB3' HG23 ' A' ' 75' ' ' ILE . 40.1 p90 -161.33 172.07 17.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.577 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 74' ' ' GLU . 85.9 m -135.68 146.41 47.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.462 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.652 HD12 ' HB2' ' A' ' 73' ' ' CYS . 9.3 tp -117.78 136.53 53.34 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.088 0.47 . . . . 0.0 110.716 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.432 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 1.2 t -59.95 -162.7 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.133 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -95.01 -29.4 14.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.157 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.03 1.88 25.94 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.181 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.493 ' HA ' HD21 ' A' ' 66' ' ' LEU . 1.3 mtt180 56.42 33.51 22.57 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.38 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.411 HG22 ' O ' ' A' ' 44' ' ' LEU . 1.1 p -130.95 -9.25 3.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.575 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -117.61 121.48 41.03 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.191 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.652 ' HB2' HD12 ' A' ' 66' ' ' LEU . 37.9 t -132.07 129.1 39.54 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.245 0.545 . . . . 0.0 112.041 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.708 ' HB2' HG22 ' A' ' 40' ' ' VAL . 64.2 tt0 -112.22 130.29 55.97 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 177.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 1.043 HD11 HD22 ' A' ' 29' ' ' LEU . 17.9 mt -126.35 122.17 60.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 -177.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.775 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -67.67 103.72 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-O 121.343 0.592 . . . . 0.0 109.508 175.78 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' A' ' 35' ' ' ALA . . . -43.44 151.44 0.45 Allowed Glycine 0 C--N 1.32 -0.324 0 CA-C-N 115.219 -0.9 . . . . 0.0 113.847 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 35' ' ' ALA . 5.8 t30 -97.34 -17.25 19.86 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.795 0.331 . . . . 0.0 111.347 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.11 -0.48 56.12 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.159 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.689 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 154.8 -150.71 22.32 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.167 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.598 ' CG ' ' HB3' ' A' ' 108' ' ' LEU . 73.1 Cg_exo -50.15 125.26 14.48 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.992 2.462 . . . . 0.0 112.98 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.705 ' HB2' HD13 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -74.21 106.27 5.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.901 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -81.67 133.77 35.4 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.333 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.607 ' CB ' HD11 ' A' ' 113' ' ' ILE . . . -97.05 129.8 44.44 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.25 123.97 23.45 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 176.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.59 -178.81 2.2 Favored Glycine 0 N--CA 1.44 -1.049 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 -175.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 112' ' ' ASP . . . -80.06 144.5 33.1 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 118.725 1.262 . . . . 0.0 112.025 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.636 HD21 ' C ' ' A' ' 59' ' ' ALA . 0.5 OUTLIER -114.63 161.06 18.59 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.089 -178.833 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.481 ' HG3' ' HB ' ' A' ' 114' ' ' VAL . 28.9 mp0 -139.31 105.28 5.19 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.099 178.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.748 ' HB3' HD11 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -105.11 116.92 32.76 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.886 -178.476 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.565 ' C ' HD13 ' A' ' 92' ' ' LEU . 7.6 m-85 -96.59 96.8 8.9 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.914 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -103.88 57.57 0.73 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.275 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.646 ' HA3' ' H ' ' A' ' 118' ' ' GLU . . . -50.35 -68.04 1.61 Allowed Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.592 -0.731 . . . . 0.0 113.499 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.526 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 83.5 m-20 -76.49 1.07 17.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.554 0.216 . . . . 0.0 111.299 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 1.065 ' HB2' ' HA ' ' A' ' 49' ' ' ASP . . . -99.87 54.12 0.92 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.948 0.404 . . . . 0.0 111.656 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -56.85 -25.39 52.41 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.31 -0.947 . . . . 0.0 111.339 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.478 HG23 ' OE1' ' A' ' 171' ' ' GLN . 0.1 OUTLIER -89.05 -14.36 36.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.685 -0.257 . . . . 0.0 111.656 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.863 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -96.83 -32.56 12.04 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.603 ' CG ' HD13 ' A' ' 126' ' ' ILE . 0.9 OUTLIER -61.73 -43.25 99.22 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.766 ' HD2' HD12 ' A' ' 126' ' ' ILE . 6.7 mpt_? -56.81 -60.5 9.24 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.895 ' HB2' HD22 ' A' ' 30' ' ' LEU . 14.1 Cg_endo -58.57 -34.73 99.05 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.513 2.142 . . . . 0.0 112.446 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 1.081 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -72.07 -52.49 16.6 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.145 179.703 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 1.018 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -53.13 -27.83 22.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.483 0.659 . . . . 0.0 110.311 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.858 ' CB ' ' HB1' ' A' ' 175' ' ' ALA . . . -86.5 -54.5 4.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.343 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.721 ' CB ' HD11 ' A' ' 30' ' ' LEU . . . -60.65 -34.44 74.29 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -177.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.704 ' HB2' HD12 ' A' ' 153' ' ' LEU . 31.2 mt -78.54 -23.06 46.41 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -176.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.558 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 13.7 p -78.42 16.1 0.87 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.161 0.505 . . . . 0.0 110.791 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.695 HD21 ' HB2' ' A' ' 182' ' ' LEU . 0.3 OUTLIER -82.98 -75.81 0.3 Allowed 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.032 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -70.69 -113.77 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.134 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.57 94.44 1.9 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.206 0.527 . . . . 0.0 110.793 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.812 HD22 HD13 ' A' ' 113' ' ' ILE . 0.8 OUTLIER -145.27 139.12 26.88 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.378 -179.113 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.877 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 1.2 m-20 -97.74 98.26 9.7 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.812 HD13 HD22 ' A' ' 111' ' ' ASN . 1.6 mp -120.35 147.92 23.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.253 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.859 HG13 ' CD2' ' A' ' 143' ' ' LEU . 47.1 t -115.34 113.76 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 176.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.617 HD23 ' HB2' ' A' ' 90' ' ' LEU . 77.6 mt -101.72 106.36 17.37 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.518 -178.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.663 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -119.04 -169.36 1.72 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.318 -179.232 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.479 ' HA3' ' HA2' ' A' ' 93' ' ' GLY . . . -171.35 -179.64 42.57 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.524 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.646 ' H ' ' HA3' ' A' ' 93' ' ' GLY . 39.0 mt-10 -70.15 169.61 12.86 Favored Pre-proline 0 C--N 1.331 -0.211 0 C-N-CA 123.207 0.603 . . . . 0.0 111.08 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.63 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 4.1 Cg_endo -45.08 -40.04 15.34 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.082 2.521 . . . . 0.0 113.077 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.3 mtm180 -67.84 -23.93 65.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.73 0.3 . . . . 0.0 110.716 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.633 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 10.5 tpt -60.96 -36.21 78.78 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.455 ' HA ' ' HG2' ' A' ' 149' ' ' PRO . 0.0 OUTLIER -61.47 -16.5 47.76 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.665 179.249 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -83.99 3.18 35.46 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.573 ' HB3' HH22 ' A' ' 100' ' ' ARG . 66.0 mtt-85 -127.62 83.26 66.55 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.352 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.466 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 38.1 Cg_exo -56.79 149.28 61.08 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.761 2.307 . . . . 0.0 111.701 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.766 HD12 ' HD2' ' A' ' 100' ' ' ARG . 1.0 OUTLIER -129.07 8.66 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.377 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.553 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -59.88 -39.84 96.02 Favored Glycine 0 CA--C 1.517 0.193 0 C-N-CA 120.749 -0.739 . . . . 0.0 113.764 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.591 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 26.0 m80 -55.71 -37.97 69.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.902 0.351 . . . . 0.0 110.54 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.772 ' HG ' HD11 ' A' ' 133' ' ' LEU . 29.3 tp -75.42 -40.46 57.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.241 0.544 . . . . 0.0 109.804 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.881 HG21 HD21 ' A' ' 151' ' ' LEU . 40.3 t -56.54 -47.98 81.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.331 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.692 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 0.1 OUTLIER -72.18 -35.94 69.13 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 121.298 0.571 . . . . 0.0 109.58 179.272 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.669 ' O ' HG13 ' A' ' 162' ' ' VAL . . . -57.31 -47.73 80.76 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.75 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.772 HD11 ' HG ' ' A' ' 129' ' ' LEU . 3.5 mt -75.94 -50.32 15.27 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.06 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.745 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.1 OUTLIER -54.71 -28.32 47.13 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.107 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.692 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 8.1 tp -69.01 -31.82 70.91 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 120.958 0.408 . . . . 0.0 110.902 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.464 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -81.86 11.64 46.45 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.787 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.49 6.54 56.44 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.764 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.673 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . . . -76.36 153.59 35.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.973 0.416 . . . . 0.0 111.481 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 0.4 OUTLIER -102.83 106.35 16.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.646 178.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.767 ' CG2' HG13 ' A' ' 130' ' ' VAL . 23.1 mt -137.91 125.88 30.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.485 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.781 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -123.56 139.48 53.96 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.519 -179.541 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.41 ' CE1' HG21 ' A' ' 130' ' ' VAL . 40.3 m-85 -79.71 131.05 35.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.469 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.859 ' CD2' HG13 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -91.52 -91.04 0.16 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.62 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.6 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 7.6 mm-40 -58.56 -81.68 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.676 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.512 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 0.2 OUTLIER -112.76 151.21 30.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.914 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 12.8 mt-10 -67.41 129.75 40.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.827 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.553 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 2.8 m120 71.04 17.91 6.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.068 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.62 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 16.8 m-85 -108.59 169.48 6.49 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 121.046 0.45 . . . . 0.0 111.992 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.918 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 48.9 Cg_exo -31.43 -62.67 0.12 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 124.384 3.389 . . . . 0.0 116.061 -177.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.918 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 65.3 Cg_exo -52.5 144.79 39.83 Favored 'Trans proline' 0 C--N 1.354 0.827 0 CA-C-N 120.626 1.259 . . . . 0.0 112.683 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.881 HD21 HG21 ' A' ' 130' ' ' VAL . 7.4 mt -155.9 136.85 13.59 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.023 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.781 ' HB2' HG22 ' A' ' 141' ' ' THR . 5.8 mtt180 -108.08 102.77 11.9 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 1.018 HD11 ' HA ' ' A' ' 103' ' ' ALA . 7.0 mt -90.73 145.83 24.49 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.861 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.657 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 6.5 mt-30 -149.3 26.19 0.87 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.164 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 53.78 -163.22 2.98 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.421 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.436 ' O ' HG23 ' A' ' 158' ' ' THR . . . 108.38 -16.27 35.06 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.005 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.73 ' HE2' ' HA ' ' A' ' 180' ' ' ALA . 67.0 t80 -58.55 122.97 14.71 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 117.081 0.44 . . . . 0.0 110.693 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.709 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 60.7 p -116.9 -28.84 6.18 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.495 0.664 . . . . 0.0 111.431 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 120.95 -169.47 14.27 Favored Glycine 0 C--N 1.306 -1.092 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.215 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.616 ' O ' ' HA ' ' A' ' 187' ' ' THR . . . 128.39 -126.13 5.26 Favored Glycine 0 N--CA 1.434 -1.468 0 N-CA-C 111.126 -0.789 . . . . 0.0 111.126 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.41 130.34 55.73 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.779 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 82.0 t -130.21 123.54 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 121.004 0.431 . . . . 0.0 110.687 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.17 119.99 38.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.665 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.714 HG11 ' HG ' ' A' ' 173' ' ' LEU . 1.0 OUTLIER -130.14 120.51 49.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.953 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.683 ' HA ' ' HG3' ' A' ' 192' ' ' LYS . 0.1 OUTLIER -51.94 137.89 25.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.298 0.571 . . . . 0.0 111.649 -179.737 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.881 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . . . . . . 0 N--CA 1.441 -0.968 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.603 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.496 ' N ' HG11 ' A' ' 196' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.462 0.127 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.54 ' O ' ' HB3' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -74.37 -6.01 45.64 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.122 -179.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.598 ' HA ' HD13 ' A' ' 129' ' ' LEU . 5.5 m-85 -76.27 -55.96 5.08 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.898 HD11 ' CG1' ' A' ' 191' ' ' ILE . 0.4 OUTLIER -61.74 -40.95 96.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.606 0.717 . . . . 0.0 109.084 178.057 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.482 ' HB ' ' HA ' ' A' ' 171' ' ' GLN . 5.5 m -55.82 -36.49 67.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.528 -1.214 . . . . 0.0 110.01 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.858 ' HB1' ' CB ' ' A' ' 104' ' ' ALA . . . -69.17 -40.29 78.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.563 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.695 HD11 HG21 ' A' ' 164' ' ' VAL . 0.4 OUTLIER -76.64 -33.32 58.34 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.149 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.783 HD11 ' CD2' ' A' ' 223' ' ' PHE . 5.1 mp -59.76 -38.13 80.94 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.908 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.649 ' HE1' ' HA ' ' A' ' 27' ' ' ARG . 0.4 OUTLIER -82.07 -43.03 18.4 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.469 0.652 . . . . 0.0 112.112 -179.66 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.619 HG23 ' HG ' ' A' ' 108' ' ' LEU . 54.4 m -71.41 -41.13 69.97 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.471 -178.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.73 ' HA ' ' HE2' ' A' ' 157' ' ' PHE . . . -59.72 -42.15 89.78 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -177.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 29.8 Cg_endo -64.77 -29.04 59.45 Favored 'Trans proline' 0 CA--C 1.5 -1.205 0 C-N-CA 120.956 1.104 . . . . 0.0 111.637 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.695 ' HB2' HD21 ' A' ' 108' ' ' LEU . 6.9 mt -83.73 1.56 42.12 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.358 178.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.66 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -83.59 138.53 41.12 Favored Pre-proline 0 C--O 1.224 -0.289 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.709 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 12.9 Cg_endo -51.84 -31.86 44.26 Favored 'Trans proline' 0 CA--C 1.518 -0.28 0 C-N-CA 122.45 2.1 . . . . 0.0 113.117 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -114.89 143.6 44.88 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.892 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -57.8 141.01 50.36 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.076 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 160' ' ' GLY . 70.7 m -119.01 145.85 45.51 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.652 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 35.3 t -125.63 118.94 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.438 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.779 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 4.1 mp -104.03 117.09 48.99 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.655 0 C-N-CA 120.079 -0.648 . . . . 0.0 109.276 178.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.888 ' HG3' ' HG3' ' A' ' 222' ' ' GLN . 1.7 ttt180 -99.88 123.57 44.27 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.898 ' CG1' HD11 ' A' ' 173' ' ' LEU . 1.3 mp -93.11 121.88 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.088 -176.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.683 ' HG3' ' HA ' ' A' ' 165' ' ' ASP . 0.5 OUTLIER -74.87 96.62 3.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.346 -178.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 97.36 -126.9 9.03 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.793 -0.717 . . . . 0.0 111.702 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -116.85 133.54 55.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.769 0.318 . . . . 0.0 111.321 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.721 HD11 ' HZ ' ' A' ' 223' ' ' PHE . 0.8 OUTLIER -41.91 144.68 0.4 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.211 0.529 . . . . 0.0 111.902 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.496 HG11 ' N ' ' A' ' 170' ' ' SER . 13.9 p -74.48 -25.38 19.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.975 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.475 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 0.3 OUTLIER -168.48 64.7 0.07 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.833 0.349 . . . . 0.0 110.934 -179.531 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.56 ' HA ' HD13 ' A' ' 195' ' ' LEU . 4.4 tptp -39.48 -46.23 4.13 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.382 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 72.6 Cg_exo -49.61 -36.78 41.72 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.006 1.804 . . . . 0.0 111.843 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.943 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.2 OUTLIER -65.62 -44.53 86.2 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 178.42 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.46 HG21 ' HE2' ' A' ' 223' ' ' PHE . 30.9 mm -60.9 -38.4 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.472 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.45 -43.63 93.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.229 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.943 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.6 mt -62.43 -50.95 77.83 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 CA-C-O 121.569 0.7 . . . . 0.0 109.635 178.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.544 HG22 ' SD ' ' A' ' 208' ' ' MET . 78.5 m -53.66 -51.65 62.49 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.991 -178.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.755 HD22 ' HB ' ' A' ' 215' ' ' ILE . 32.2 mt -65.31 -30.18 71.0 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.001 0.429 . . . . 0.0 111.534 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . 0.559 ' HA ' ' HE3' ' A' ' 209' ' ' LYS . 1.0 OUTLIER -77.5 -46.37 22.65 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.734 0.778 . . . . 0.0 109.77 179.007 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.91 ' O ' HG22 ' A' ' 210' ' ' THR . 2.6 tp -71.26 -30.02 65.8 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.24 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' MET . . . . . 0.759 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 40.8 mtp -75.04 -35.63 61.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.647 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 12.8 mtmt -60.65 -37.71 82.43 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.046 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.91 HG22 ' O ' ' A' ' 207' ' ' LEU . 5.8 t -62.61 -28.88 70.2 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.718 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.574 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 42.7 m-85 -80.52 -6.98 59.01 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.579 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.99 7.65 24.9 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 115.98 1.152 . . . . 0.0 115.98 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.2 m -123.36 148.59 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 118.929 1.364 . . . . 0.0 112.794 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.509 ' O ' HD13 ' A' ' 215' ' ' ILE . 18.0 mt-10 -130.84 136.21 48.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.811 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.755 ' HB ' HD22 ' A' ' 205' ' ' LEU . 16.8 mm -118.66 148.12 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 120.845 0.355 . . . . 0.0 110.565 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.55 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 2.6 tt0 -100.63 118.26 36.42 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.916 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -82.84 150.98 26.24 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.934 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . 0.517 ' CB ' ' HB3' ' A' ' 222' ' ' GLN . 3.5 tp60 -106.74 -138.26 0.37 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.114 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.493 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 0.1 OUTLIER -84.87 66.67 9.81 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.827 0.346 . . . . 0.0 111.008 -179.451 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 5.5 t80 60.07 33.04 21.24 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.82 0.819 . . . . 0.0 110.439 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.675 ' CB ' ' HB ' ' A' ' 191' ' ' ILE . 1.8 pt20 -166.39 -124.77 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.888 ' HG3' ' HG3' ' A' ' 190' ' ' ARG . 0.7 OUTLIER -5.43 130.09 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.783 ' CD2' HD11 ' A' ' 177' ' ' LEU . 1.2 m-85 -125.07 133.37 52.93 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 112.977 -1.92 . . . . 0.0 109.509 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 61.3 t -116.96 113.51 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-O 121.573 0.702 . . . . 0.0 109.206 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.739 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -120.22 122.29 67.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.152 -178.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.572 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 0.1 OUTLIER -76.84 123.43 26.24 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.806 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -75.54 -177.11 40.71 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.718 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 65.5 21.72 69.0 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 121.573 -0.346 . . . . 0.0 113.036 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' GLN . . . . . 0.572 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 15.7 mt-30 -77.41 179.58 6.36 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.298 0.57 . . . . 0.0 111.338 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 13.6 t -138.01 147.8 44.53 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.869 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' TYR . . . . . 0.681 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 1.1 m-30 -107.83 123.76 49.07 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.894 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.96 161.3 20.02 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.553 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.12 113.34 57.95 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-O 120.835 0.35 . . . . 0.0 111.43 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.517 ' HG3' HG23 ' A' ' 210' ' ' THR . 58.8 Cg_endo -69.65 1.98 3.88 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.656 2.237 . . . . 0.0 112.875 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 98.99 -100.5 2.29 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.344 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 92.2 m -119.35 133.15 55.87 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . 0.712 ' CD2' HG21 ' A' ' 210' ' ' THR . 4.4 t80 -129.74 133.21 46.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.873 0.368 . . . . 0.0 111.117 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.907 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -97.18 110.52 23.05 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.201 0.524 . . . . 0.0 110.524 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.621 ' N ' HD22 ' A' ' 238' ' ' LEU . 21.9 t -79.06 113.51 18.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.421 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.212 -0.899 . . . . 0.0 111.156 -179.984 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.596 ' HB2' HD21 ' A' ' 207' ' ' LEU . 0.5 OUTLIER . . . . . 0 CA--C 1.518 -0.274 0 CA-C-O 121.345 0.593 . . . . 0.0 110.171 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.692 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -40.73 -44.39 2.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.958 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.975 HD22 HD11 ' A' ' 75' ' ' ILE . 14.2 mt -71.68 -37.47 70.74 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.918 0.39 . . . . 0.0 111.213 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.681 HD11 ' CB ' ' A' ' 105' ' ' ALA . 56.9 tp -65.32 -49.95 67.48 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.917 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.692 HD11 ' HG2' ' A' ' 208' ' ' MET . 20.1 mt -69.33 -26.17 64.57 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.765 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -63.79 -41.82 97.85 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.221 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.83 ' CB ' HG11 ' A' ' 62' ' ' VAL . . . -80.47 -40.17 26.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.73 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.687 HD11 ' HB1' ' A' ' 105' ' ' ALA . 9.1 mt -67.48 -3.4 8.43 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.451 178.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.505 ' HA ' ' CB ' ' A' ' 231' ' ' TYR . . . -99.84 177.26 5.17 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -177.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.546 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.3 OUTLIER -111.28 114.39 27.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.656 178.357 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 114.28 167.48 15.97 Favored Glycine 0 C--O 1.228 -0.28 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.202 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.653 ' HG3' HG23 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -95.34 117.53 30.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 117.284 0.542 . . . . 0.0 111.55 -179.439 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 0.9 OUTLIER -118.8 147.03 44.34 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.242 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.672 HG22 ' HB2' ' A' ' 74' ' ' GLU . 96.6 t -105.91 141.25 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 CA-C-O 121.385 0.612 . . . . 0.0 112.437 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.923 HD23 HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -116.02 116.32 27.69 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 174.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.867 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.5 OUTLIER -103.15 152.93 20.86 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.228 -177.75 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.4 t30 68.8 24.71 6.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.514 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.813 HD21 ' CB ' ' A' ' 41' ' ' LEU . 34.8 mt -53.86 -175.55 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.951 0.405 . . . . 0.0 110.151 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.558 ' HB3' HG21 ' A' ' 50' ' ' VAL . 28.3 tp -111.78 132.28 54.77 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.163 -0.472 . . . . 0.0 109.995 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -88.52 89.26 7.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.835 0.35 . . . . 0.0 110.896 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 50' ' ' VAL . 36.5 m -163.79 142.17 7.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.057 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.583 ' HA ' ' HB3' ' A' ' 51' ' ' ARG . 1.6 p30 -37.89 -31.25 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.662 0.268 . . . . 0.0 111.429 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.875 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 0.7 OUTLIER -57.29 -42.72 82.25 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.024 0.44 . . . . 0.0 110.435 179.308 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.671 HG23 ' OD1' ' A' ' 49' ' ' ASP . 98.0 t -81.66 -45.08 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.873 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -49.62 -39.13 34.64 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 177.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.618 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 14.7 m-70 -78.64 -33.25 47.38 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.908 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.588 ' O ' HD13 ' A' ' 57' ' ' LEU . 9.4 tpt -55.5 -35.58 65.74 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 176.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.873 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.5 OUTLIER -81.88 -44.43 16.85 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 114.162 -1.381 . . . . 0.0 108.522 176.598 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.732 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 0.3 OUTLIER -57.31 -38.59 74.27 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.354 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 1.036 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -60.54 -44.79 95.73 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.801 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.2 OUTLIER -65.59 -38.83 90.6 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.1 -1.409 . . . . 0.0 107.752 176.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.732 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.2 m -63.02 -33.76 76.11 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.528 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.782 ' CB ' HD11 ' A' ' 90' ' ' LEU . . . -74.22 -37.13 63.93 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.341 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.714 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -83.54 -13.92 53.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.171 0.51 . . . . 0.0 111.058 -179.464 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.07 35.01 4.65 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.42 -0.809 . . . . 0.0 114.123 178.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.83 HG11 ' CB ' ' A' ' 33' ' ' ALA . 38.2 t -90.69 122.13 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.756 ' O ' HG12 ' A' ' 76' ' ' ILE . 5.5 m -84.88 132.54 34.38 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 120.911 0.386 . . . . 0.0 111.711 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.755 ' HB3' HG23 ' A' ' 75' ' ' ILE . 41.4 p90 -158.03 167.93 28.51 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.378 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 74' ' ' GLU . 40.7 m -129.81 147.31 51.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.372 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.45 HD12 ' HB2' ' A' ' 73' ' ' CYS . 12.3 tp -115.59 132.4 56.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.235 0.541 . . . . 0.0 110.487 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 0.2 OUTLIER -59.22 -161.2 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.554 -179.451 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -95.56 -32.02 13.03 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.549 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -79.84 1.24 27.7 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.261 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 30.6 mtt-85 57.88 35.33 25.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.996 0.426 . . . . 0.0 110.888 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -134.21 -4.5 2.71 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.626 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.545 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 3.4 mtp-105 -121.62 122.09 38.86 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.622 ' HB3' HD11 ' A' ' 44' ' ' LEU . 28.8 t -131.18 126.9 36.81 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 120.989 0.424 . . . . 0.0 112.069 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.672 ' HB2' HG22 ' A' ' 40' ' ' VAL . 58.6 tt0 -110.63 131.65 54.87 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 176.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.975 HD11 HD22 ' A' ' 29' ' ' LEU . 13.2 mt -126.42 121.81 59.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.756 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -67.23 98.4 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-O 121.486 0.66 . . . . 0.0 109.252 175.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -35.15 145.04 0.06 OUTLIER Glycine 0 C--N 1.32 -0.344 0 CA-C-N 114.56 -1.2 . . . . 0.0 114.125 -178.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.47 ' CB ' HD12 ' A' ' 82' ' ' LEU . 1.1 t-20 -90.74 -13.11 34.66 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.06 0.457 . . . . 0.0 110.789 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.546 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 91.81 1.78 70.25 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.697 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.637 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 149.97 -147.61 18.01 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.035 -0.602 . . . . 0.0 111.742 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.429 ' HD2' ' HA3' ' A' ' 80' ' ' GLY . 5.7 Cg_endo -49.05 122.66 8.71 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.596 2.198 . . . . 0.0 112.524 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.714 ' HB2' HD13 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -73.33 110.75 7.86 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.27 179.653 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -82.24 130.31 35.06 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.592 ' CB ' HD22 ' A' ' 88' ' ' LEU . . . -94.46 122.79 37.39 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.672 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -71.19 123.74 22.89 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 176.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.86 174.54 1.2 Allowed Glycine 0 N--CA 1.439 -1.124 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 -175.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 112' ' ' ASP . . . -72.95 144.8 47.14 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 118.705 1.253 . . . . 0.0 111.923 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.666 HD21 ' C ' ' A' ' 59' ' ' ALA . 0.5 OUTLIER -112.27 160.94 17.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.001 -0.999 . . . . 0.0 112.127 -178.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 18.8 mt-10 -140.21 101.3 4.11 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.022 177.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.782 HD11 ' CB ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -100.79 120.1 39.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.872 0.368 . . . . 0.0 111.346 -178.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.46 ' C ' HD13 ' A' ' 92' ' ' LEU . 1.4 m-85 -95.27 96.45 9.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.823 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.807 HD23 ' SD ' ' A' ' 99' ' ' MET . 0.1 OUTLIER -103.54 52.89 0.76 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.351 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.572 ' HA3' ' H ' ' A' ' 118' ' ' GLU . . . -49.82 -75.13 0.22 Allowed Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.408 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 50.0 m-80 -77.51 -0.68 27.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.501 0.191 . . . . 0.0 110.97 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.894 ' HB1' ' HB3' ' A' ' 98' ' ' ALA . . . -92.18 46.53 1.27 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.81 0.338 . . . . 0.0 111.336 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -52.74 -24.37 18.5 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.297 -0.954 . . . . 0.0 111.811 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.504 HG22 ' OE1' ' A' ' 171' ' ' GLN . 0.9 OUTLIER -87.69 -19.69 27.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.471 0.177 . . . . 0.0 111.167 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.894 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -94.18 -31.69 14.03 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.648 0.261 . . . . 0.0 111.452 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.807 ' SD ' HD23 ' A' ' 92' ' ' LEU . 5.3 tpp -64.57 -47.35 79.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.716 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.67 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -55.18 -56.35 29.33 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.67 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 18.7 Cg_exo -64.73 -30.49 59.43 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.126 1.884 . . . . 0.0 112.63 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 1.036 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -72.57 -53.16 12.72 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.193 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.898 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -52.89 -27.08 16.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.33 0.586 . . . . 0.0 110.509 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.695 ' HB2' ' HB1' ' A' ' 175' ' ' ALA . . . -86.62 -53.92 4.68 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.131 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.687 ' HB1' HD11 ' A' ' 34' ' ' LEU . . . -60.57 -36.51 78.67 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -177.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.644 ' HB2' HD12 ' A' ' 153' ' ' LEU . 27.4 mt -76.28 -12.88 60.15 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.593 ' SG ' HD22 ' A' ' 153' ' ' LEU . 69.3 m -86.73 20.12 2.67 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.25 0.548 . . . . 0.0 110.427 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.722 HD21 ' HB2' ' A' ' 182' ' ' LEU . 2.4 mt -85.93 -75.02 0.39 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.019 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -69.7 -117.07 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.487 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.35 96.4 1.92 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.045 0.45 . . . . 0.0 110.123 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.703 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 8.8 m120 -148.51 143.99 27.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.116 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.837 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 13.4 m-20 -95.99 99.98 11.7 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.303 0.573 . . . . 0.0 110.149 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.53 HG13 ' CB ' ' A' ' 88' ' ' LEU . 1.9 mp -118.15 146.08 23.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.941 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.785 HG13 ' CD2' ' A' ' 143' ' ' LEU . 48.5 t -115.49 112.86 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 176.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.673 HD23 ' HB2' ' A' ' 90' ' ' LEU . 31.0 mt -102.03 106.52 17.43 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.497 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.767 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -118.88 -170.83 1.98 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.037 -179.044 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.476 ' HA3' ' HG2' ' A' ' 121' ' ' MET . . . -170.08 179.13 42.53 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.968 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.661 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 2.9 mt-10 -72.32 169.72 15.61 Favored Pre-proline 0 C--N 1.332 -0.188 0 C-N-CA 123.573 0.749 . . . . 0.0 111.248 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.661 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 2.5 Cg_endo -43.56 -39.78 9.98 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.096 2.531 . . . . 0.0 113.193 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.8 mtm-85 -67.63 -24.4 65.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.667 0.27 . . . . 0.0 110.838 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.631 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 9.2 tpt -61.1 -34.94 75.75 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.424 ' HA ' ' HG2' ' A' ' 149' ' ' PRO . 0.0 OUTLIER -61.92 -16.69 52.81 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.463 179.139 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -87.59 4.17 44.76 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.934 0.397 . . . . 0.0 109.986 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 34.1 mtt85 -127.12 83.77 65.15 Favored Pre-proline 0 N--CA 1.454 -0.242 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.866 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.505 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 19.7 Cg_endo -58.02 148.76 75.12 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.675 2.25 . . . . 0.0 111.501 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.471 ' O ' HG13 ' A' ' 126' ' ' ILE . 0.6 OUTLIER -125.48 -2.49 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -179.262 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.547 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -54.03 -34.7 52.73 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.713 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.508 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 13.3 m80 -58.53 -40.14 82.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.146 0.473 . . . . 0.0 110.142 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.786 ' HG ' HD11 ' A' ' 133' ' ' LEU . 16.4 tp -76.12 -40.59 52.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.705 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.733 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 46.1 t -56.0 -47.42 80.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.262 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.792 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 3.3 m-20 -71.27 -35.93 71.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.019 0.437 . . . . 0.0 110.025 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.62 ' HB2' HG23 ' A' ' 164' ' ' VAL . . . -60.84 -44.55 96.81 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.578 178.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.786 HD11 ' HG ' ' A' ' 129' ' ' LEU . 6.2 mt -77.08 -50.32 13.32 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.315 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.733 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -56.75 -27.94 60.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.759 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.792 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 5.6 tp -69.45 -31.76 70.27 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.779 178.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.48 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -83.09 13.52 44.13 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.038 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.78 3.15 58.3 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.941 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.513 ' HB2' ' HD1' ' A' ' 157' ' ' PHE . . . -71.53 152.12 43.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.737 0.304 . . . . 0.0 111.568 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 0.6 OUTLIER -101.74 101.44 11.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.76 178.418 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.716 ' HB ' ' HG3' ' A' ' 134' ' ' ARG . 19.8 mt -133.39 126.91 53.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.369 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.671 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -124.05 139.56 53.82 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 116.262 -0.427 . . . . 0.0 109.938 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.515 ' HE1' HG21 ' A' ' 130' ' ' VAL . 31.3 m-85 -80.58 132.81 35.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.652 0.263 . . . . 0.0 111.278 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.785 ' CD2' HG13 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -92.57 -91.33 0.17 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.698 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.556 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 40.6 mt-10 -57.18 -81.87 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.649 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.428 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 23.2 mt-30 -113.61 151.05 32.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.788 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 0.8 OUTLIER -67.91 130.98 44.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.839 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.547 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 1.9 m-20 71.82 17.75 5.29 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.04 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.571 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 18.7 m-85 -111.14 168.25 7.85 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-O 121.294 0.569 . . . . 0.0 112.352 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.894 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 1.4 Cg_exo -29.59 -63.12 0.09 OUTLIER 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 124.796 3.664 . . . . 0.0 116.779 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.894 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 58.5 Cg_exo -54.37 147.18 47.7 Favored 'Trans proline' 0 C--N 1.356 0.954 0 CA-C-N 121.301 1.501 . . . . 0.0 112.94 -178.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.78 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 7.8 mt -156.81 136.57 12.44 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.938 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.671 ' HB2' HG22 ' A' ' 141' ' ' THR . 6.8 mtp180 -106.99 102.75 12.08 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.898 HD11 ' HA ' ' A' ' 103' ' ' ALA . 6.6 mt -91.12 145.45 24.67 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.569 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.703 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 5.6 mt-30 -147.24 24.79 1.13 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.472 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 53.41 -173.38 0.46 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.894 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 118.35 -10.07 13.17 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.039 -1.076 . . . . 0.0 112.948 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.638 ' HE2' ' HA ' ' A' ' 180' ' ' ALA . 44.6 t80 -61.41 124.62 21.12 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 117.257 0.529 . . . . 0.0 110.441 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.671 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 66.4 p -118.32 -29.51 5.5 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 121.429 0.633 . . . . 0.0 111.411 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.407 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 133.13 -160.68 23.99 Favored Glycine 0 C--N 1.308 -1.02 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.416 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.6 ' O ' HG23 ' A' ' 187' ' ' THR . . . 105.46 154.31 21.77 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.814 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -46.72 114.47 0.83 Allowed 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.407 -0.396 . . . . 0.0 111.019 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.754 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 69.1 t -107.9 121.66 61.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.317 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -91.6 119.69 31.73 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.682 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.78 HG11 ' HG ' ' A' ' 173' ' ' LEU . 1.2 t -132.27 122.29 47.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.72 139.43 50.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.059 0.456 . . . . 0.0 111.638 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.678 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . . . . . . 0 N--CA 1.449 -0.485 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.657 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.597 ' HB2' ' HB3' ' A' ' 200' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.155 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.562 ' HB3' HH21 ' A' ' 27' ' ' ARG . 0.0 OUTLIER -81.71 -12.2 58.73 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.983 -179.692 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.563 ' CD2' ' HB2' ' A' ' 129' ' ' LEU . 6.2 m-85 -75.33 -56.67 4.49 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.959 HD13 HD21 ' A' ' 195' ' ' LEU . 0.2 OUTLIER -62.26 -43.6 98.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.454 178.587 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.706 HG23 ' CG2' ' A' ' 204' ' ' THR . 1.8 m -56.06 -41.11 74.58 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.902 178.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.695 ' HB1' ' HB2' ' A' ' 104' ' ' ALA . . . -57.87 -37.79 74.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.52 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.756 HD13 HG12 ' A' ' 189' ' ' ILE . 0.7 OUTLIER -76.63 -37.04 57.03 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.383 0.611 . . . . 0.0 110.238 178.88 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.699 HD11 ' CD2' ' A' ' 223' ' ' PHE . 4.3 mp -59.61 -34.48 72.82 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.693 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.621 ' CE ' HD21 ' A' ' 31' ' ' LEU . 8.8 mtp -81.84 -42.38 19.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.373 0.606 . . . . 0.0 112.185 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.527 HG23 ' HG ' ' A' ' 108' ' ' LEU . 88.3 m -75.04 -40.82 60.12 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.546 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.638 ' HA ' ' HE2' ' A' ' 157' ' ' PHE . . . -59.88 -39.74 72.61 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 -176.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.596 ' HD3' ' O ' ' A' ' 177' ' ' LEU . 31.2 Cg_endo -68.4 -27.4 33.86 Favored 'Trans proline' 0 CA--C 1.498 -1.305 0 CA-C-N 120.241 1.122 . . . . 0.0 111.949 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.722 ' HB2' HD21 ' A' ' 108' ' ' LEU . 9.6 mt -85.05 0.35 51.84 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.643 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -81.79 137.43 47.26 Favored Pre-proline 0 C--O 1.224 -0.241 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.187 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.671 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 14.3 Cg_endo -52.27 -30.68 43.27 Favored 'Trans proline' 0 CA--C 1.519 -0.269 0 C-N-CA 122.483 2.122 . . . . 0.0 113.178 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.76 138.48 50.69 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.905 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -55.1 142.3 31.23 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.049 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 160' ' ' GLY . 87.0 m -120.31 144.42 47.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.205 0.526 . . . . 0.0 112.21 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 18.0 t -125.73 118.03 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.187 177.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.766 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 2.7 mp -101.16 117.86 47.04 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.722 ' HG3' ' HG3' ' A' ' 222' ' ' GLN . 0.2 OUTLIER -99.78 123.66 44.26 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.848 ' CG1' HD11 ' A' ' 173' ' ' LEU . 1.7 mp -93.71 124.99 46.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.063 -175.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -83.05 96.92 8.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.064 -1.426 . . . . 0.0 110.502 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 100.98 -129.81 10.02 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.933 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.32 129.0 56.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.709 0.29 . . . . 0.0 111.577 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.959 HD21 HD13 ' A' ' 173' ' ' LEU . 1.9 mt -41.43 144.68 0.33 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.419 HG11 ' N ' ' A' ' 170' ' ' SER . 8.6 p -71.56 -36.64 60.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.196 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.425 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 2.0 t -160.72 62.33 0.31 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.258 0.552 . . . . 0.0 109.977 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.699 ' HA ' HD13 ' A' ' 195' ' ' LEU . 5.5 tmtt? -38.93 -47.68 3.72 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.829 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . 0.671 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 5.0 Cg_endo -46.68 -33.71 14.09 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.178 1.919 . . . . 0.0 111.771 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.955 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.2 OUTLIER -67.26 -44.36 79.59 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.502 HG21 ' HE2' ' A' ' 223' ' ' PHE . 14.7 mm -56.71 -39.79 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 CA-C-N 114.286 -1.324 . . . . 0.0 110.348 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -58.05 -45.15 87.51 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.044 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.955 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.8 mt -61.27 -50.4 80.6 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.022 0 CA-C-O 121.786 0.803 . . . . 0.0 109.068 178.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.706 ' CG2' HG23 ' A' ' 174' ' ' THR . 87.1 m -53.15 -51.6 61.46 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.971 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.903 HD22 ' HB ' ' A' ' 215' ' ' ILE . 34.1 mt -67.99 -29.24 68.22 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 120.98 0.419 . . . . 0.0 111.663 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -78.07 -46.56 20.51 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.733 0.778 . . . . 0.0 109.664 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.961 ' O ' HG22 ' A' ' 210' ' ' THR . 2.3 tp -69.7 -29.65 67.11 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.288 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' MET . . . . . 0.692 ' HG2' HD11 ' A' ' 31' ' ' LEU . 3.9 mmm -75.98 -34.23 59.77 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.551 0.691 . . . . 0.0 109.624 178.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.652 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 7.4 mtmt -63.52 -35.97 82.22 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.439 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.961 HG22 ' O ' ' A' ' 207' ' ' LEU . 3.9 t -62.6 -27.29 69.09 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.629 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.563 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 27.5 m-85 -83.64 -6.81 59.54 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.019 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.63 7.29 26.05 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 115.782 1.073 . . . . 0.0 115.782 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 5.0 m -123.29 148.76 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 118.513 1.157 . . . . 0.0 112.049 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.471 ' CG ' ' HG2' ' A' ' 209' ' ' LYS . 13.2 mt-10 -130.09 134.33 47.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.403 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.903 ' HB ' HD22 ' A' ' 205' ' ' LEU . 8.9 mm -117.5 148.66 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 120.818 0.342 . . . . 0.0 110.247 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.618 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 19.9 tt0 -104.81 116.65 32.37 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.612 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.18 151.01 27.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.596 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . 0.694 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -109.08 -148.31 0.42 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.65 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.55 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 0.2 OUTLIER -72.38 66.91 0.69 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.847 0.356 . . . . 0.0 111.515 -179.491 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 1.7 t80 56.75 31.73 19.95 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.06 0.934 . . . . 0.0 110.625 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.689 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 0.4 OUTLIER -159.33 -129.27 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 178.779 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.766 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.1 OUTLIER -4.02 131.12 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 179.698 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.83 ' HZ ' HD11 ' A' ' 195' ' ' LEU . 1.1 m-85 -125.17 129.89 51.05 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 113.107 -1.86 . . . . 0.0 108.852 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.618 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 42.9 t -114.98 113.94 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-O 121.602 0.715 . . . . 0.0 109.62 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.674 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -120.35 124.3 72.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.121 -178.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.605 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 2.0 mptt -76.76 125.06 28.62 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -78.64 -178.31 50.01 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.393 -0.908 . . . . 0.0 113.23 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 64.81 21.26 67.26 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 121.346 -0.454 . . . . 0.0 112.935 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' GLN . . . . . 0.605 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 34.5 mt-30 -75.2 176.39 7.39 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.386 0.612 . . . . 0.0 111.649 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 5.4 p -136.09 147.88 48.03 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.323 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' TYR . . . . . 0.653 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 5.2 m-30 -107.75 132.07 53.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.759 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.63 147.92 48.23 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.505 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.38 111.46 14.11 Favored Pre-proline 0 N--CA 1.45 -0.435 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.657 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.475 ' HG3' HG23 ' A' ' 210' ' ' THR . 56.2 Cg_endo -69.59 3.04 2.91 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.454 2.102 . . . . 0.0 112.622 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 95.84 -103.9 3.02 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.242 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.495 HG23 ' HB ' ' A' ' 40' ' ' VAL . 27.2 m -115.42 137.11 52.4 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . 0.719 ' CD2' HG21 ' A' ' 210' ' ' THR . 7.5 t80 -132.72 126.7 33.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.955 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.867 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -94.53 111.03 22.79 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.099 0.476 . . . . 0.0 110.942 -179.685 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.618 ' N ' HD22 ' A' ' 238' ' ' LEU . 43.1 t -81.02 113.36 20.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.95 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.164 -179.75 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.641 ' HA ' ' HE1' ' A' ' 178' ' ' MET . 66.4 mtm-85 . . . . . 0 CA--C 1.518 -0.28 0 CA-C-O 121.52 0.676 . . . . 0.0 110.338 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.577 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -40.73 -45.89 2.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.633 -1.167 . . . . 0.0 112.077 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.095 HD22 HD11 ' A' ' 75' ' ' ILE . 12.6 mt -73.87 -34.57 64.52 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 120.92 0.39 . . . . 0.0 111.163 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.785 HD22 ' HB2' ' A' ' 101' ' ' PRO . 45.6 tp -68.58 -50.33 52.52 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.911 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.78 HD22 ' CZ ' ' A' ' 231' ' ' TYR . 50.7 mt -67.08 -27.15 67.12 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.416 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.82 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -66.14 -39.18 89.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.104 178.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.782 ' CB ' HG11 ' A' ' 62' ' ' VAL . . . -80.73 -40.79 24.64 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.013 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.782 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 14.0 mt -67.54 -3.61 9.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.102 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.637 ' HB2' ' HB3' ' A' ' 231' ' ' TYR . . . -99.72 -179.86 4.31 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -177.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.627 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.3 OUTLIER -113.89 111.52 21.84 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.526 178.165 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.72 166.15 14.2 Favored Glycine 0 C--N 1.32 -0.315 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -178.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.604 ' HE2' HG23 ' A' ' 76' ' ' ILE . 2.5 ttmt -95.81 118.66 32.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.992 0.396 . . . . 0.0 111.902 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.577 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 0.9 OUTLIER -117.47 145.08 44.41 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.249 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.502 ' C ' HD13 ' A' ' 41' ' ' LEU . 97.1 t -102.66 141.34 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-O 121.581 0.705 . . . . 0.0 112.423 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.826 HD23 HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -115.74 116.47 28.12 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 174.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.971 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.5 OUTLIER -103.93 148.11 26.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.868 0.365 . . . . 0.0 110.992 -177.601 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.461 ' HB2' HD23 ' A' ' 238' ' ' LEU . 2.0 t30 69.12 26.18 5.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.063 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.783 HD21 ' CB ' ' A' ' 41' ' ' LEU . 79.6 mt -52.66 -178.21 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.153 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.577 HD23 ' OD2' ' A' ' 49' ' ' ASP . 34.7 tp -109.79 131.21 55.27 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.205 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -86.78 87.14 7.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.008 0.433 . . . . 0.0 110.386 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.562 ' HB3' ' OD1' ' A' ' 49' ' ' ASP . 11.2 t -164.11 142.64 7.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.702 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.577 ' HB2' ' HB2' ' A' ' 94' ' ' ASN . 5.2 m-20 -37.09 -30.3 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.648 ' CB ' ' HA ' ' A' ' 95' ' ' ALA . 34.5 p-10 -56.85 -42.59 80.0 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.36 0.6 . . . . 0.0 110.208 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.521 HG21 ' HB3' ' A' ' 45' ' ' LEU . 64.6 t -83.44 -47.95 17.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.191 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.905 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -50.41 -37.97 40.59 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 178.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.659 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 7.4 m-70 -80.44 -32.69 37.26 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.842 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.504 ' O ' HD13 ' A' ' 57' ' ' LEU . 8.6 tpt -55.09 -35.27 64.41 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 176.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.905 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.5 OUTLIER -81.82 -42.49 19.6 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.398 176.328 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.694 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 24.6 t30 -60.77 -34.25 74.17 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.178 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 1.026 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -64.6 -46.95 80.46 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.877 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.2 OUTLIER -63.89 -39.61 94.58 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 113.914 -1.494 . . . . 0.0 107.807 177.103 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.694 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 2.6 m -59.96 -34.46 73.31 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.36 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.838 ' CB ' HD11 ' A' ' 90' ' ' LEU . . . -76.84 -36.91 56.51 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.485 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.663 HD13 ' CB ' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -82.74 -13.92 55.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.419 0.628 . . . . 0.0 110.719 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.14 35.02 5.18 Favored Glycine 0 C--N 1.32 -0.361 0 CA-C-N 115.228 -0.896 . . . . 0.0 114.174 177.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.877 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 38.6 t -90.27 118.53 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.823 ' O ' HG12 ' A' ' 76' ' ' ILE . 10.8 m -81.39 134.5 35.57 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.293 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.872 ' HB3' HG23 ' A' ' 75' ' ' ILE . 42.0 p90 -158.23 160.58 37.29 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 74' ' ' GLU . 63.3 m -122.82 149.65 43.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.565 0.221 . . . . 0.0 110.993 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.73 HD21 ' HA ' ' A' ' 70' ' ' ARG . 4.0 tp -121.01 138.96 53.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.925 0.393 . . . . 0.0 110.636 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.481 ' HB2' ' CB ' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -69.66 -165.64 0.09 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.675 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.99 -23.43 22.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.171 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.427 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 0.1 OUTLIER -81.35 1.15 34.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.272 179.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.73 ' HA ' HD21 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 53.09 26.41 4.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.807 0.337 . . . . 0.0 111.286 179.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.463 HG22 ' O ' ' A' ' 44' ' ' LEU . 1.3 p -127.93 -10.86 5.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.86 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.54 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 7.2 mtp180 -112.88 115.48 28.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.105 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.621 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -133.12 128.32 35.86 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -179.342 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 39' ' ' THR . 13.7 tt0 -107.73 133.78 51.65 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.613 178.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 1.095 HD11 HD22 ' A' ' 29' ' ' LEU . 8.2 mt -123.45 122.27 64.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.823 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -68.13 101.58 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-O 121.462 0.648 . . . . 0.0 109.516 175.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 35' ' ' ALA . . . -39.61 143.2 0.46 Allowed Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 114.737 -1.12 . . . . 0.0 113.844 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.46 HD22 HD12 ' A' ' 82' ' ' LEU . 6.2 t-20 -87.89 -7.54 57.04 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 120.771 0.319 . . . . 0.0 110.82 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.627 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 88.38 2.66 79.48 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.278 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.487 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 151.35 -147.43 17.35 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.005 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.678 ' HG3' ' HB3' ' A' ' 108' ' ' LEU . 77.0 Cg_exo -49.72 127.59 19.16 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.379 2.052 . . . . 0.0 112.727 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.663 ' CB ' HD13 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -72.78 110.54 7.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.125 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.495 ' HA ' ' CG ' ' A' ' 111' ' ' ASN . 4.6 p80 -82.19 133.99 35.28 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.88 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.567 ' CB ' HD22 ' A' ' 88' ' ' LEU . . . -98.69 124.33 43.44 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.047 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -71.19 123.36 22.02 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 176.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.88 176.97 0.82 Allowed Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -175.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 112' ' ' ASP . . . -73.1 144.7 46.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 118.668 1.234 . . . . 0.0 111.11 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.723 HD21 ' C ' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -112.81 160.99 17.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.34 -178.532 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 7.3 mt-10 -141.53 102.91 4.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.43 177.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.838 HD11 ' CB ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -102.25 115.5 30.68 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.657 -177.693 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.472 ' CD1' ' HB ' ' A' ' 116' ' ' THR . 0.9 OUTLIER -90.52 98.12 11.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.734 179.085 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.616 HD11 ' HB3' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -103.66 52.9 0.76 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.602 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.625 ' CA ' ' H ' ' A' ' 118' ' ' GLU . . . -59.86 -67.28 2.24 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.421 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.577 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 69.5 m-80 -75.43 15.26 0.48 Allowed 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.413 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.752 ' HB1' ' HB3' ' A' ' 98' ' ' ALA . . . -94.88 -70.15 0.72 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.56 -68.08 0.4 Allowed Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.923 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.417 ' O ' ' CD ' ' A' ' 101' ' ' PRO . 2.6 p -71.65 -8.42 53.98 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.752 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -98.88 -30.1 12.58 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.655 0.264 . . . . 0.0 111.043 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.433 ' CG ' HD13 ' A' ' 126' ' ' ILE . 1.0 OUTLIER -64.67 -42.75 95.15 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.043 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.69 ' O ' HD21 ' A' ' 129' ' ' LEU . 1.4 mpt_? -55.84 -60.95 7.24 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.796 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.785 ' HB2' HD22 ' A' ' 30' ' ' LEU . 21.0 Cg_endo -60.78 -30.47 90.3 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.469 2.113 . . . . 0.0 112.488 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 1.026 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -75.22 -52.5 10.77 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 120.335 -0.546 . . . . 0.0 109.998 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.894 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -51.6 -27.26 10.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.5 0.666 . . . . 0.0 110.509 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.948 ' HB2' ' HB1' ' A' ' 175' ' ' ALA . . . -86.55 -53.99 4.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.377 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.712 ' CB ' HD11 ' A' ' 30' ' ' LEU . . . -60.63 -33.61 73.02 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -177.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.688 ' HB2' HD12 ' A' ' 153' ' ' LEU . 26.9 mt -78.35 -20.76 50.67 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.704 ' SG ' ' HB1' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -83.22 21.89 1.06 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.335 0.588 . . . . 0.0 110.87 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.855 HD21 ' HB2' ' A' ' 182' ' ' LEU . 0.5 OUTLIER -85.75 -76.05 0.35 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.74 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -70.28 -110.31 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.64 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.1 m -158.38 96.08 1.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.957 0.408 . . . . 0.0 110.595 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.646 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 13.7 m-80 -148.99 140.14 23.07 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.275 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.857 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 1.9 m-20 -92.95 98.59 11.46 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.171 0.51 . . . . 0.0 110.087 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.566 HG13 ' CB ' ' A' ' 88' ' ' LEU . 1.5 mp -119.17 145.68 24.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.918 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.782 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 59.1 t -113.63 112.97 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 176.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.791 HD23 ' HB2' ' A' ' 90' ' ' LEU . 58.8 mt -102.63 110.99 23.1 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.903 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.743 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -125.06 -171.97 2.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.253 -179.712 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.494 ' H ' HG22 ' A' ' 116' ' ' THR . . . -166.73 -173.12 34.77 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.514 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.646 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 1.3 mm-40 -76.83 172.49 9.54 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 123.245 0.618 . . . . 0.0 110.123 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.646 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 7.4 Cg_endo -47.97 -33.06 19.4 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.605 2.203 . . . . 0.0 112.744 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -67.62 -28.18 67.52 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.021 0.439 . . . . 0.0 110.219 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.578 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 9.8 tpt -61.19 -39.56 90.66 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.559 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.449 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 0.0 OUTLIER -63.01 -16.96 61.58 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.29 179.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.568 ' O ' ' HG3' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -85.68 -3.95 59.03 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.486 ' HB3' ' NH2' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -123.74 88.63 51.97 Favored Pre-proline 0 N--CA 1.452 -0.332 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.763 179.807 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.457 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 15.8 Cg_endo -56.67 149.09 61.04 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.651 2.234 . . . . 0.0 111.599 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.49 HG22 ' O ' ' A' ' 148' ' ' TYR . 0.8 OUTLIER -119.88 8.98 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.946 0.403 . . . . 0.0 111.763 -179.121 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.454 ' HA3' ' CG ' ' A' ' 147' ' ' ASN . . . -57.19 -45.24 92.83 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.801 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.591 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 3.9 m80 -55.25 -38.62 68.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.013 0.406 . . . . 0.0 110.782 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.929 HD11 ' HB3' ' A' ' 175' ' ' ALA . 17.7 tp -74.8 -45.71 41.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.962 0.411 . . . . 0.0 110.372 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.922 HG21 HD21 ' A' ' 151' ' ' LEU . 49.9 t -56.58 -47.73 81.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.339 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.731 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 0.5 OUTLIER -71.88 -34.43 69.18 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.029 0.442 . . . . 0.0 110.297 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.64 ' HB2' HG23 ' A' ' 164' ' ' VAL . . . -62.42 -45.0 95.07 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.901 178.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.756 HD11 ' HG ' ' A' ' 129' ' ' LEU . 6.2 mt -77.27 -50.32 13.13 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.357 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.754 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -55.88 -27.59 52.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.764 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.731 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.6 OUTLIER -67.83 -33.02 73.96 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.586 178.616 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.526 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -82.55 13.63 40.25 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.015 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.07 2.45 60.83 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.329 -0.939 . . . . 0.0 112.833 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.704 ' HB1' ' SG ' ' A' ' 107' ' ' CYS . . . -70.74 152.42 43.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.895 0.379 . . . . 0.0 111.048 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 37.6 mttm -101.28 103.2 14.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.346 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.627 ' HB ' ' HG3' ' A' ' 134' ' ' ARG . 25.7 mt -134.4 126.48 48.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.367 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.818 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -121.72 139.37 53.66 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.718 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.549 ' CZ ' HG11 ' A' ' 130' ' ' VAL . 47.5 m-85 -81.6 130.02 34.9 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.033 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.942 HD11 ' HG3' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -90.96 -91.59 0.15 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.473 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.599 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 17.7 mt-10 -56.1 -80.98 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.021 0.439 . . . . 0.0 110.439 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.533 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 31.6 mt-30 -115.67 151.32 35.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.426 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 31.2 mt-10 -67.9 137.54 55.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.117 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.458 HD22 ' N ' ' A' ' 147' ' ' ASN . 1.2 m-80 66.36 20.21 10.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.965 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.616 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 20.5 m-85 -113.79 170.04 5.82 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.948 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 27.6 Cg_exo -32.57 -63.39 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 124.345 3.363 . . . . 0.0 116.221 -177.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.948 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 77.8 Cg_exo -53.55 146.84 41.13 Favored 'Trans proline' 0 C--N 1.353 0.809 0 CA-C-N 120.706 1.288 . . . . 0.0 112.588 -178.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.922 HD21 HG21 ' A' ' 130' ' ' VAL . 9.7 mt -156.32 136.45 12.85 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.345 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.942 ' HG3' HD11 ' A' ' 143' ' ' LEU . 0.0 OUTLIER -108.5 102.94 11.99 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.022 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.894 HD11 ' HA ' ' A' ' 103' ' ' ALA . 8.5 mt -91.29 146.81 23.51 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.738 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.646 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 2.8 mt-30 -148.83 25.74 0.92 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.368 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.566 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 54.88 -170.26 1.5 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.85 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 158' ' ' THR . . . 114.79 -15.43 19.26 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.119 -1.039 . . . . 0.0 113.389 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.713 ' HE2' ' HA ' ' A' ' 180' ' ' ALA . 55.4 t80 -58.33 123.69 16.98 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 117.258 0.529 . . . . 0.0 110.647 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.697 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 75.7 p -117.05 -33.55 4.68 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 121.382 0.61 . . . . 0.0 111.392 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.446 ' O ' ' HA2' ' A' ' 136' ' ' GLY . . . 138.56 -161.64 25.75 Favored Glycine 0 C--N 1.307 -1.083 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.987 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.584 ' O ' HG23 ' A' ' 187' ' ' THR . . . 105.22 153.95 21.93 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.54 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -46.93 116.53 1.38 Allowed 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.321 -0.44 . . . . 0.0 111.093 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.755 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 73.4 t -109.59 130.62 62.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.829 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.16 120.38 39.41 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.522 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.808 HG21 HD11 ' A' ' 176' ' ' LEU . 1.2 t -133.78 120.03 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 120.922 0.391 . . . . 0.0 110.12 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.44 141.83 18.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.657 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.876 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . . . . . . 0 N--CA 1.446 -0.671 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.076 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.452 ' N ' HG11 ' A' ' 196' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.718 0.294 . . . . 0.0 111.361 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.562 ' HB3' ' CB ' ' A' ' 100' ' ' ARG . 0.8 OUTLIER -76.53 -10.64 59.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.937 -179.092 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.734 ' HA ' HD13 ' A' ' 129' ' ' LEU . 8.4 m-85 -72.48 -50.43 26.09 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.581 0.705 . . . . 0.0 109.559 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 1.002 HD21 HD11 ' A' ' 191' ' ' ILE . 0.2 OUTLIER -68.64 -43.5 76.15 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.16 178.693 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.588 HG21 HH11 ' A' ' 27' ' ' ARG . 2.1 m -54.03 -35.31 61.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.501 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.948 ' HB1' ' HB2' ' A' ' 104' ' ' ALA . . . -63.88 -45.23 90.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.495 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.808 HD11 HG21 ' A' ' 164' ' ' VAL . 0.1 OUTLIER -76.58 -33.07 58.49 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.054 -179.814 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.821 HD11 ' CD2' ' A' ' 223' ' ' PHE . 3.4 mp -59.97 -39.1 84.48 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.62 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.641 ' HE1' ' HA ' ' A' ' 27' ' ' ARG . 1.9 mtp -81.55 -44.35 17.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.407 0.622 . . . . 0.0 112.226 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.623 HG23 ' HG ' ' A' ' 108' ' ' LEU . 58.3 m -71.4 -41.0 70.17 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.796 -178.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.713 ' HA ' ' HE2' ' A' ' 157' ' ' PHE . . . -59.9 -39.84 73.36 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -176.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.557 ' HD3' ' O ' ' A' ' 177' ' ' LEU . 28.2 Cg_endo -65.66 -28.59 52.29 Favored 'Trans proline' 0 CA--C 1.497 -1.354 0 CA-C-N 120.108 1.074 . . . . 0.0 111.657 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.855 ' HB2' HD21 ' A' ' 108' ' ' LEU . 4.7 mt -84.06 0.49 48.08 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.724 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.697 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -83.19 136.57 43.37 Favored Pre-proline 0 C--O 1.224 -0.279 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.856 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.641 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 10.7 Cg_endo -50.18 -33.49 35.98 Favored 'Trans proline' 0 CA--C 1.518 -0.278 0 C-N-CA 122.597 2.198 . . . . 0.0 113.443 -179.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.79 139.54 48.32 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.731 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 187' ' ' THR . 10.1 t0 -55.33 143.89 26.95 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.835 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 160' ' ' GLY . 87.8 m -121.2 148.98 43.52 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.949 0.404 . . . . 0.0 111.606 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.622 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 44.0 t -130.38 117.75 40.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.819 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 4.6 mp -100.23 119.79 48.79 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 0.1 OUTLIER -100.78 125.57 47.28 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 1.002 HD11 HD21 ' A' ' 173' ' ' LEU . 1.6 mp -94.04 125.18 46.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.807 -176.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -77.91 96.86 5.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 113.948 -1.478 . . . . 0.0 110.458 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 96.58 -126.99 9.03 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.263 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -116.41 130.87 56.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.79 0.329 . . . . 0.0 111.582 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.84 HD21 HD13 ' A' ' 173' ' ' LEU . 1.5 mt -41.72 144.22 0.42 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.385 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.452 HG11 ' N ' ' A' ' 170' ' ' SER . 14.8 p -72.33 -28.28 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.039 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.461 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 0.1 OUTLIER -168.85 65.19 0.06 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.058 0.456 . . . . 0.0 110.49 -179.15 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.682 ' HA ' HD13 ' A' ' 195' ' ' LEU . 0.0 OUTLIER -40.66 -46.72 6.44 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.498 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . 0.462 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 83.5 Cg_exo -47.49 -33.81 18.36 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 121.842 1.694 . . . . 0.0 111.411 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.956 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.2 OUTLIER -69.16 -41.94 76.57 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.373 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.566 HG21 ' HE2' ' A' ' 223' ' ' PHE . 18.5 mm -64.64 -38.69 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.917 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.15 -44.14 83.14 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.256 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.956 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.1 mt -62.79 -48.82 86.27 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.918 0 CA-C-O 121.739 0.781 . . . . 0.0 109.358 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.563 HG22 ' SD ' ' A' ' 208' ' ' MET . 87.6 m -54.12 -51.26 64.79 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.121 -178.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.903 HD22 ' HB ' ' A' ' 215' ' ' ILE . 32.5 mt -65.77 -31.15 71.96 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 120.922 0.392 . . . . 0.0 111.517 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -77.48 -46.07 23.62 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.901 0.858 . . . . 0.0 109.51 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.857 ' O ' HG22 ' A' ' 210' ' ' THR . 6.4 tp -69.91 -30.46 67.88 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.526 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' MET . . . . . 0.81 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 37.9 mtp -76.38 -34.2 58.88 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.584 0.707 . . . . 0.0 109.231 177.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.716 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 2.6 mtmt -60.95 -38.3 85.37 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.346 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.857 HG22 ' O ' ' A' ' 207' ' ' LEU . 4.7 t -60.92 -33.37 73.05 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.161 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.558 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 50.0 m-85 -76.1 -5.94 48.9 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.801 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 109.51 7.33 28.16 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 115.671 1.028 . . . . 0.0 115.671 177.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.716 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.8 m -123.62 148.58 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 118.549 1.174 . . . . 0.0 112.799 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.595 ' O ' HD13 ' A' ' 215' ' ' ILE . 6.0 mt-10 -129.9 138.61 51.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.659 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.903 ' HB ' HD22 ' A' ' 205' ' ' LEU . 17.1 mm -122.04 148.64 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.694 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 1.6 tp10 -103.89 117.76 35.09 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.983 0.421 . . . . 0.0 111.905 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -83.02 151.11 25.96 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.525 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . 0.676 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 5.4 mm-40 -109.43 -144.1 0.39 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.72 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.598 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 7.8 t-80 -73.9 65.88 1.1 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.813 0.34 . . . . 0.0 111.492 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 4.1 t80 56.01 35.12 25.0 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.931 0.872 . . . . 0.0 110.785 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.658 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 1.7 pt20 -163.92 -127.45 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.819 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -8.04 134.43 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.821 ' CD2' HD11 ' A' ' 177' ' ' LEU . 0.6 OUTLIER -125.35 137.32 54.04 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 113.038 -1.892 . . . . 0.0 109.654 -179.234 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.694 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 23.7 t -117.39 114.27 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.801 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.5 OUTLIER -122.25 120.71 61.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.804 -179.393 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.498 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -74.59 127.37 32.92 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -80.03 -171.29 42.47 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.236 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 61.51 21.16 59.91 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 121.398 -0.43 . . . . 0.0 113.006 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' GLN . . . . . 0.498 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 23.9 mt-30 -80.63 -173.45 4.15 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.257 0.551 . . . . 0.0 111.158 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 17.2 t -151.94 147.64 26.81 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.934 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' TYR . . . . . 0.782 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 4.7 m-85 -100.74 130.23 46.75 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.452 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . 0.408 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -120.99 146.77 46.34 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.06 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.55 111.04 8.88 Favored Pre-proline 0 N--CA 1.447 -0.59 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.383 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.542 ' HD2' ' OG1' ' A' ' 39' ' ' THR . 54.6 Cg_endo -69.6 -0.32 6.61 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 121.942 1.762 . . . . 0.0 112.076 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 99.6 -101.18 2.34 Favored Glycine 0 C--O 1.226 -0.349 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.772 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.417 HG23 ' HB ' ' A' ' 40' ' ' VAL . 90.3 m -119.03 135.55 54.57 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . 0.545 ' CD2' HG21 ' A' ' 210' ' ' THR . 1.5 t80 -131.21 129.73 42.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.906 0.384 . . . . 0.0 111.046 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.971 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.1 OUTLIER -95.0 110.96 22.81 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.382 179.242 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.669 ' N ' HD22 ' A' ' 238' ' ' LEU . 21.7 t -82.57 111.91 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.092 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.975 -179.98 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.746 ' HA ' ' HE1' ' A' ' 178' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.515 -0.396 0 CA-C-O 121.277 0.561 . . . . 0.0 110.754 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.871 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -40.5 -47.53 2.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.004 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.06 HD22 HD11 ' A' ' 75' ' ' ILE . 12.9 mt -75.76 -35.36 60.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.846 0.355 . . . . 0.0 111.882 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.798 HD22 ' HB2' ' A' ' 101' ' ' PRO . 50.7 tp -68.92 -49.8 54.94 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.186 0.517 . . . . 0.0 110.674 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.728 ' HB2' ' CE2' ' A' ' 211' ' ' PHE . 27.5 mt -67.91 -27.02 66.28 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.395 179.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.728 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -66.3 -40.27 89.87 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.092 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.751 ' CB ' HG11 ' A' ' 62' ' ' VAL . . . -81.1 -41.31 22.71 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.253 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.663 HD11 ' HB1' ' A' ' 105' ' ' ALA . 16.1 mt -67.94 -4.15 12.14 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.066 178.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.5 ' HB2' ' HB3' ' A' ' 231' ' ' TYR . . . -96.9 176.56 5.93 Favored 'General case' 0 CA--C 1.523 -0.089 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -177.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.571 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.3 OUTLIER -109.84 112.65 24.81 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.636 -1.166 . . . . 0.0 108.941 178.367 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 116.78 166.68 14.35 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.595 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.631 ' HG2' ' HG2' ' A' ' 74' ' ' GLU . 10.6 tttt -95.09 117.81 30.83 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.809 0.304 . . . . 0.0 111.174 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.715 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 0.8 OUTLIER -119.2 148.24 43.32 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-O 120.644 0.259 . . . . 0.0 111.559 -179.462 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.616 HG22 ' HB2' ' A' ' 74' ' ' GLU . 56.8 t -103.67 135.63 40.4 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.668 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.871 ' HG ' ' HB1' ' A' ' 28' ' ' ALA . 0.3 OUTLIER -111.23 115.97 30.25 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 174.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.859 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.6 OUTLIER -104.23 149.89 24.89 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.232 -177.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 69.18 26.01 5.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.268 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.74 HD21 ' HB3' ' A' ' 41' ' ' LEU . 67.5 mt -55.59 -174.87 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.524 ' HB3' HG21 ' A' ' 50' ' ' VAL . 41.6 tp -111.42 131.68 55.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.594 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -88.83 89.36 7.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.96 0.41 . . . . 0.0 110.312 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -164.02 142.72 7.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.062 -179.104 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.421 ' HA ' ' HB3' ' A' ' 51' ' ' ARG . 0.6 OUTLIER -36.6 -31.25 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.57 0.224 . . . . 0.0 111.342 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.725 ' OD1' HG23 ' A' ' 50' ' ' VAL . 1.6 p30 -58.7 -42.64 89.07 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.906 0.384 . . . . 0.0 110.712 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.725 HG23 ' OD1' ' A' ' 49' ' ' ASP . 82.0 t -81.85 -44.18 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.66 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.827 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -49.5 -40.07 36.27 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.682 ' HA ' ' HB2' ' A' ' 55' ' ' ASN . 19.9 m-70 -79.62 -32.29 41.72 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.978 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.624 ' O ' HD13 ' A' ' 57' ' ' LEU . 7.3 tpt -53.74 -35.61 61.41 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 176.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.827 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.3 OUTLIER -84.03 -45.76 12.74 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 114.317 -1.31 . . . . 0.0 109.028 176.482 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.682 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -57.77 -36.38 72.06 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.776 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 1.129 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -65.81 -43.05 89.82 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.774 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -65.34 -38.43 90.11 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 176.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.682 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.1 m -61.81 -39.67 92.57 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 113.875 -1.511 . . . . 0.0 111.813 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.709 ' CB ' HD11 ' A' ' 90' ' ' LEU . . . -71.07 -37.24 72.46 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.392 -178.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.561 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.6 OUTLIER -80.07 -16.25 55.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.345 0.593 . . . . 0.0 110.429 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.88 35.57 3.96 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.142 -0.935 . . . . 0.0 114.194 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.774 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 25.4 t -90.6 122.37 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.76 ' O ' HG12 ' A' ' 76' ' ' ILE . 12.9 m -85.02 131.88 34.41 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.887 0.375 . . . . 0.0 111.523 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.815 ' HB3' HG23 ' A' ' 75' ' ' ILE . 40.1 p90 -158.69 172.23 18.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.535 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.401 ' N ' ' O ' ' A' ' 74' ' ' GLU . 86.5 m -131.59 148.38 52.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.785 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.442 ' CD1' ' HB2' ' A' ' 73' ' ' CYS . 14.6 tp -119.68 134.78 55.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.162 0.506 . . . . 0.0 111.114 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.426 ' CB ' ' HB2' ' A' ' 72' ' ' ARG . 88.1 p -61.71 -169.26 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.001 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.91 -41.7 18.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.311 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.36 1.98 17.25 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.634 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 59.81 30.01 19.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.733 0.302 . . . . 0.0 111.262 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.458 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 2.0 p -119.6 -14.73 9.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.911 0.386 . . . . 0.0 111.217 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.591 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 14.7 mtp180 -113.43 119.23 36.88 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.4 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.62 ' HB3' HD11 ' A' ' 44' ' ' LEU . 42.5 t -131.12 126.9 36.94 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.715 ' HA ' ' O ' ' A' ' 39' ' ' THR . 35.9 tt0 -110.98 129.06 56.0 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 1.06 HD11 HD22 ' A' ' 29' ' ' LEU . 10.7 mt -126.59 123.56 63.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -177.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.76 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -67.69 99.27 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-O 121.571 0.701 . . . . 0.0 109.256 175.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -37.77 146.41 0.12 Allowed Glycine 0 C--N 1.32 -0.343 0 CA-C-N 114.53 -1.214 . . . . 0.0 114.05 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.87 -11.21 39.9 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.959 0.409 . . . . 0.0 111.046 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.571 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 89.86 -0.57 79.65 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.258 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.534 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 152.81 -148.36 19.11 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.902 -0.665 . . . . 0.0 112.143 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.578 ' HG3' ' HB3' ' A' ' 108' ' ' LEU . 77.7 Cg_exo -49.36 127.98 19.23 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.788 2.325 . . . . 0.0 112.704 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.561 ' HB2' HD13 ' A' ' 60' ' ' LEU . 0.9 OUTLIER -78.23 105.64 9.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.901 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -82.13 128.1 33.79 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.055 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.486 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -92.44 126.44 37.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.041 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.97 123.89 23.08 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 176.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.85 172.88 0.91 Allowed Glycine 0 N--CA 1.438 -1.185 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 -175.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.34 144.88 46.33 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 118.469 1.135 . . . . 0.0 111.762 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.622 HD21 ' C ' ' A' ' 59' ' ' ALA . 1.2 tp -113.71 160.54 18.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.047 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 10.9 mt-10 -139.75 102.13 4.36 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.958 178.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.709 HD11 ' CB ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -101.56 130.01 47.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.955 0.407 . . . . 0.0 111.346 -178.736 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.591 ' C ' HD13 ' A' ' 92' ' ' LEU . 16.5 m-85 -101.03 96.77 7.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.608 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.817 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -110.34 51.22 0.77 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.814 -179.596 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.798 ' HA3' ' H ' ' A' ' 118' ' ' GLU . . . -58.26 -61.16 7.73 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.817 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.509 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 17.9 m-80 -76.97 -3.16 37.49 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.111 -0.235 . . . . 0.0 110.585 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 1.01 ' HB1' ' HB3' ' A' ' 98' ' ' ALA . . . -94.47 56.3 2.09 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.915 0.388 . . . . 0.0 111.338 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -56.75 -29.99 59.06 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.468 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.501 ' O ' ' HG3' ' A' ' 101' ' ' PRO . 6.1 p -93.84 -6.54 45.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.682 -0.259 . . . . 0.0 111.421 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 1.01 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -101.63 -37.85 8.18 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.836 0.351 . . . . 0.0 111.185 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.537 ' HB2' ' HB2' ' A' ' 92' ' ' LEU . 3.0 tpp -61.72 -45.58 93.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.339 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.531 ' HD2' HD12 ' A' ' 126' ' ' ILE . 0.1 OUTLIER -53.63 -60.5 6.99 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.227 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.798 ' HB2' HD22 ' A' ' 30' ' ' LEU . 18.5 Cg_endo -60.77 -33.16 93.33 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.477 2.118 . . . . 0.0 112.86 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 1.129 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -71.56 -53.13 14.8 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.836 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.873 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -51.38 -28.52 12.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.177 0.513 . . . . 0.0 110.311 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.895 ' CB ' ' HB1' ' A' ' 175' ' ' ALA . . . -86.6 -52.52 5.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.599 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.706 ' CB ' HD11 ' A' ' 30' ' ' LEU . . . -60.51 -34.09 73.59 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.678 ' HB2' HD12 ' A' ' 153' ' ' LEU . 37.3 mt -78.68 -15.6 58.29 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -176.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.656 ' HB3' ' HB1' ' A' ' 138' ' ' ALA . 90.3 m -87.84 22.8 2.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.322 0.582 . . . . 0.0 110.433 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.786 HD21 ' HB2' ' A' ' 182' ' ' LEU . 2.0 mt -87.16 -75.04 0.42 Allowed 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.545 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.63 -113.6 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.235 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.07 96.4 2.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.049 0.452 . . . . 0.0 110.762 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.589 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 0.1 OUTLIER -148.25 140.91 24.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.53 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.865 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 3.4 m-20 -94.21 102.49 14.52 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.831 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.646 HG13 HD13 ' A' ' 106' ' ' LEU . 20.7 mm -121.35 140.92 43.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.556 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.856 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 61.8 t -111.71 112.37 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 175.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.67 HD23 ' HB2' ' A' ' 90' ' ' LEU . 74.6 mt -102.17 105.85 16.61 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.492 -178.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.787 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -114.66 -170.48 1.75 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.322 -178.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.526 ' HA3' ' HG2' ' A' ' 121' ' ' MET . . . -171.4 175.15 45.01 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.629 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.798 ' H ' ' HA3' ' A' ' 93' ' ' GLY . 36.6 mm-40 -68.9 169.41 11.31 Favored Pre-proline 0 CA--C 1.531 0.227 0 C-N-CA 123.214 0.605 . . . . 0.0 111.339 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.716 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 2.8 Cg_endo -44.35 -40.82 13.38 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.192 2.595 . . . . 0.0 113.196 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.44 -23.73 65.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.679 0.276 . . . . 0.0 110.722 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.57 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 9.1 tpt -62.2 -35.13 77.94 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -16.85 54.35 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.59 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.01 1.59 52.33 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.859 0.362 . . . . 0.0 110.333 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.472 ' HD3' ' NH2' ' A' ' 100' ' ' ARG . 55.6 mtt-85 -127.03 84.22 64.04 Favored Pre-proline 0 CA--C 1.529 0.161 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.57 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -56.49 148.57 62.31 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.715 2.277 . . . . 0.0 111.755 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.531 HD12 ' HD2' ' A' ' 100' ' ' ARG . 0.8 OUTLIER -124.17 8.43 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.27 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.559 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -61.61 -36.54 92.79 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.061 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.19 -40.08 76.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.74 0.27 . . . . 0.0 110.67 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.715 ' HG ' HD11 ' A' ' 133' ' ' LEU . 14.1 tp -75.37 -41.39 56.56 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.425 0.631 . . . . 0.0 110.023 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.791 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 39.8 t -56.42 -47.74 81.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.579 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.795 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 4.7 m-20 -72.08 -31.81 66.43 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.422 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.545 ' HB1' ' CG1' ' A' ' 162' ' ' VAL . . . -64.1 -49.81 70.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.449 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.715 HD11 ' HG ' ' A' ' 129' ' ' LEU . 7.7 mt -71.65 -48.93 44.45 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.845 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.791 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -57.85 -27.77 63.51 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.651 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.795 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 1.5 tp -67.19 -33.45 75.42 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.466 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.49 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -81.81 12.73 40.41 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.966 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.34 3.34 60.06 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.325 -0.941 . . . . 0.0 112.749 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.656 ' HB1' ' HB3' ' A' ' 107' ' ' CYS . . . -71.59 149.43 45.65 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.882 0.341 . . . . 0.0 111.234 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 21.6 mttm -97.78 103.24 15.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.149 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.733 HG21 HG22 ' A' ' 130' ' ' VAL . 21.0 mt -134.02 126.89 50.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.309 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.737 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -123.51 139.71 53.74 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.925 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.523 ' CZ ' HG11 ' A' ' 130' ' ' VAL . 43.4 m-85 -81.41 132.62 35.33 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.409 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.801 ' CD2' HG13 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -90.17 -82.26 0.28 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.297 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.845 ' HG3' ' H ' ' A' ' 145' ' ' GLN . 11.2 pt-20 -63.5 -78.2 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.926 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.845 ' H ' ' HG3' ' A' ' 144' ' ' GLU . 1.5 mt-30 -121.38 154.19 36.81 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 6.8 mt-10 -64.48 135.6 56.22 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.074 0.464 . . . . 0.0 111.285 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.559 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 9.2 m-20 71.83 18.73 5.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.086 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.516 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 18.6 m-85 -107.77 167.12 9.79 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.898 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 51.3 Cg_exo -35.69 -63.3 0.2 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 124.159 3.239 . . . . 0.0 116.07 -177.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.898 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 71.5 Cg_exo -50.72 145.6 22.86 Favored 'Trans proline' 0 C--N 1.355 0.885 0 CA-C-N 120.773 1.312 . . . . 0.0 112.393 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.856 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 8.5 mt -155.89 137.04 13.76 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.846 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.737 ' HB2' HG22 ' A' ' 141' ' ' THR . 0.2 OUTLIER -106.78 101.59 11.02 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 177.411 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.873 HD11 ' HA ' ' A' ' 103' ' ' ALA . 6.6 mt -91.46 145.61 24.48 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.023 -178.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.589 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 3.0 mt-30 -147.79 29.27 0.92 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.691 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 51.37 -170.3 0.34 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.222 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 114.83 -12.09 20.54 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.086 -1.054 . . . . 0.0 113.369 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.661 ' HE2' ' HA ' ' A' ' 180' ' ' ALA . 54.4 t80 -58.82 122.82 14.52 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 117.51 0.655 . . . . 0.0 110.595 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.817 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 43.3 p -113.12 -38.37 4.48 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 121.668 0.747 . . . . 0.0 111.243 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.42 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 139.04 -165.03 25.76 Favored Glycine 0 C--N 1.306 -1.089 0 CA-C-N 114.526 -1.216 . . . . 0.0 112.304 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.591 ' O ' HG23 ' A' ' 187' ' ' THR . . . 109.48 155.59 16.2 Favored Glycine 0 N--CA 1.437 -1.298 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.882 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -46.94 115.48 1.08 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.216 -0.492 . . . . 0.0 111.333 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 72.1 t -108.02 137.71 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -107.09 119.77 40.29 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.256 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.824 HG21 HD11 ' A' ' 176' ' ' LEU . 1.0 OUTLIER -132.09 120.43 43.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.113 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.432 ' CA ' ' HE3' ' A' ' 192' ' ' LYS . 23.0 t0 -55.58 138.51 46.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.933 0.396 . . . . 0.0 111.141 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.667 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.427 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.204 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.625 ' HB2' ' HB3' ' A' ' 200' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.101 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.586 ' HA ' ' HB ' ' A' ' 174' ' ' THR . 0.5 OUTLIER -92.7 -13.85 28.83 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.443 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.448 ' HE1' ' CZ ' ' A' ' 100' ' ' ARG . 5.9 m-85 -66.73 -54.36 23.78 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 1.115 HD13 HD21 ' A' ' 195' ' ' LEU . 0.2 OUTLIER -64.95 -45.91 83.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.921 178.675 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.586 ' HB ' ' HA ' ' A' ' 171' ' ' GLN . 1.1 m -55.1 -33.01 62.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.969 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.895 ' HB1' ' CB ' ' A' ' 104' ' ' ALA . . . -66.39 -41.61 89.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.329 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.824 HD11 HG21 ' A' ' 164' ' ' VAL . 0.2 OUTLIER -76.71 -32.51 57.88 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.545 179.361 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.72 ' HG ' HD21 ' A' ' 205' ' ' LEU . 2.7 mp -59.89 -39.35 85.02 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.142 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.746 ' HE1' ' HA ' ' A' ' 27' ' ' ARG . 0.7 OUTLIER -82.16 -41.43 20.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.351 0.596 . . . . 0.0 111.912 179.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.437 HG23 ' HG ' ' A' ' 108' ' ' LEU . 100.0 m -71.06 -42.07 69.9 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.644 -178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.661 ' HA ' ' HE2' ' A' ' 157' ' ' PHE . . . -59.08 -40.37 80.93 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -176.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.567 ' HD3' ' O ' ' A' ' 177' ' ' LEU . 38.1 Cg_endo -66.76 -28.78 43.34 Favored 'Trans proline' 0 CA--C 1.498 -1.292 0 C-N-CA 120.787 0.992 . . . . 0.0 112.06 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.786 ' HB2' HD21 ' A' ' 108' ' ' LEU . 5.3 mt -84.67 1.5 46.0 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.626 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.817 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -82.86 139.46 43.19 Favored Pre-proline 0 C--O 1.223 -0.298 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.226 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.752 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 11.6 Cg_endo -52.03 -33.37 52.54 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.206 1.938 . . . . 0.0 112.782 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.53 143.05 45.6 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.582 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -58.54 145.27 39.81 Favored 'General case' 0 N--CA 1.46 0.074 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.453 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.611 ' HB ' ' HB1' ' A' ' 180' ' ' ALA . 65.9 m -122.14 144.42 48.95 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.644 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 25.2 t -122.45 117.81 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.069 176.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.738 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 2.7 mp -101.53 117.63 47.11 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.801 ' HG3' ' HG3' ' A' ' 222' ' ' GLN . 0.1 OUTLIER -99.4 122.49 42.58 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.4 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.965 HD11 HD21 ' A' ' 173' ' ' LEU . 1.6 mp -93.47 119.72 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.954 -175.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.432 ' HE3' ' CA ' ' A' ' 165' ' ' ASP . 0.7 OUTLIER -75.14 96.63 3.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.769 -179.468 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 95.47 -134.11 11.78 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.265 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -117.09 137.27 52.39 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 1.115 HD21 HD13 ' A' ' 173' ' ' LEU . 8.9 mt -40.81 147.03 0.13 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.184 0.516 . . . . 0.0 111.124 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.433 HG11 ' N ' ' A' ' 170' ' ' SER . 7.2 p -68.66 -21.07 25.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.896 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.864 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 26.7 t -138.55 -67.43 0.46 Allowed 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.249 178.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.812 ' HA ' HD13 ' A' ' 195' ' ' LEU . 8.0 tmtt? 96.82 -56.57 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 114.656 -1.157 . . . . 0.0 111.177 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . 0.864 ' HD2' ' C ' ' A' ' 197' ' ' SER . 18.3 Cg_endo -62.71 -25.7 75.09 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 120.868 1.045 . . . . 0.0 110.021 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.971 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.2 OUTLIER -67.48 -48.2 67.83 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.625 HG21 ' HE2' ' A' ' 223' ' ' PHE . 15.6 mm -63.28 -35.09 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.443 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.15 -42.86 99.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.102 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.971 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.5 mt -60.36 -50.78 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.488 ' O ' ' HG3' ' A' ' 208' ' ' MET . 45.8 m -53.47 -51.85 61.37 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.107 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.863 HD22 ' HB ' ' A' ' 215' ' ' ILE . 36.8 mt -65.54 -30.62 71.39 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.38 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . 0.416 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 2.6 m-80 -77.86 -46.3 21.82 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.772 0.796 . . . . 0.0 109.956 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.84 ' O ' HG22 ' A' ' 210' ' ' THR . 0.8 OUTLIER -68.76 -29.77 68.22 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.211 178.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' MET . . . . . 0.703 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 37.0 mtp -69.95 -33.23 71.84 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.655 178.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.604 ' HE2' ' HA ' ' A' ' 214' ' ' GLU . 6.7 mmtp -57.54 -38.6 74.98 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.813 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.84 HG22 ' O ' ' A' ' 207' ' ' LEU . 1.0 OUTLIER -60.6 -27.25 67.59 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.645 -178.523 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.728 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 76.9 m-85 -85.19 -8.88 58.38 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.541 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.1 9.38 24.23 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 115.658 1.023 . . . . 0.0 115.658 177.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.545 HG21 ' HE3' ' A' ' 208' ' ' MET . 4.2 m -124.18 148.84 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 118.683 1.242 . . . . 0.0 112.133 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.604 ' HA ' ' HE2' ' A' ' 209' ' ' LYS . 22.5 mt-10 -129.74 141.75 50.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.149 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 1.03 HD12 ' HB ' ' A' ' 225' ' ' VAL . 24.7 mm -123.5 148.45 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-O 120.89 0.376 . . . . 0.0 110.552 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.603 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 40.2 tt0 -104.74 116.44 32.03 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.726 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -82.49 150.18 27.15 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . 0.63 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.2 OUTLIER -110.16 -148.05 0.42 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.606 0.241 . . . . 0.0 110.909 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.547 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 4.0 t-160 -67.83 63.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.457 ' CE1' ' HG3' ' A' ' 198' ' ' LYS . 6.3 t80 58.87 33.88 23.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.902 0.858 . . . . 0.0 110.867 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.639 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 12.2 pt20 -164.69 -124.63 0.02 OUTLIER 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.801 ' HG3' ' HG3' ' A' ' 190' ' ' ARG . 0.5 OUTLIER -3.97 132.37 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 179.495 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.644 ' O ' ' HA ' ' A' ' 188' ' ' VAL . 3.2 m-85 -126.55 129.89 49.48 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.432 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.603 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 41.6 t -114.17 113.68 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 121.588 0.708 . . . . 0.0 109.739 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 1.03 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -123.15 125.51 72.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.095 -179.028 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 181' ' ' PRO . 0.0 OUTLIER -76.62 141.52 41.02 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.838 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -91.18 -178.21 43.15 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.457 -178.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 66.47 20.22 69.53 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 121.54 -0.362 . . . . 0.0 113.081 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' GLN . . . . . 0.513 ' NE2' ' HB3' ' A' ' 181' ' ' PRO . 47.7 mt-30 -77.79 -173.77 3.2 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.19 0.519 . . . . 0.0 110.896 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.14 147.57 24.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.543 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' TYR . . . . . 0.653 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 5.5 m-85 -99.26 133.81 43.02 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.056 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -120.76 148.84 43.44 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 84.1 p -76.54 111.43 15.72 Favored Pre-proline 0 N--CA 1.446 -0.636 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.834 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.557 ' HG3' HG23 ' A' ' 210' ' ' THR . 46.7 Cg_endo -68.3 -2.38 8.91 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.947 1.765 . . . . 0.0 112.422 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 96.34 -84.0 0.82 Allowed Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.29 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 93.5 m -130.56 127.13 38.45 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . 0.705 ' CD2' HG21 ' A' ' 210' ' ' THR . 24.8 t80 -130.33 134.47 47.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.995 0.426 . . . . 0.0 111.373 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.859 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.1 OUTLIER -97.94 110.73 23.25 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.687 179.846 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.648 ' N ' HD22 ' A' ' 238' ' ' LEU . 20.1 t -81.65 112.77 20.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.11 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.347 -0.835 . . . . 0.0 111.129 -179.948 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.733 ' HE ' HD23 ' A' ' 207' ' ' LEU . 77.3 mtm-85 . . . . . 0 CA--C 1.52 -0.206 0 CA-C-O 121.046 0.45 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.617 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -46.07 -42.38 13.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.763 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.055 HD22 HD11 ' A' ' 75' ' ' ILE . 10.6 mt -71.1 -34.56 71.22 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 120.983 0.42 . . . . 0.0 110.833 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.921 HD22 ' HB2' ' A' ' 101' ' ' PRO . 53.3 tp -68.9 -49.74 55.63 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.377 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.59 ' HB2' ' CE2' ' A' ' 211' ' ' PHE . 34.1 mt -67.28 -27.13 66.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.521 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.774 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -65.77 -39.03 90.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.056 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.655 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . . . -81.32 -41.39 22.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.615 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.745 HD11 ' HB1' ' A' ' 105' ' ' ALA . 21.9 mt -69.05 -3.36 12.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.286 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.482 ' HB2' ' HB3' ' A' ' 231' ' ' TYR . . . -96.81 176.1 6.11 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.524 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.1 OUTLIER -112.18 113.4 25.63 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.596 178.247 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.59 167.99 15.29 Favored Glycine 0 C--N 1.32 -0.323 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.635 ' HG3' HG23 ' A' ' 76' ' ' ILE . 1.0 OUTLIER -95.3 117.78 30.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 117.32 0.56 . . . . 0.0 111.443 -179.371 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.495 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.9 OUTLIER -119.6 145.84 46.06 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.22 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.55 HG22 ' HB2' ' A' ' 74' ' ' GLU . 96.6 t -104.91 139.08 26.96 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 1.003 HD23 HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -114.77 116.1 28.1 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 174.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.922 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.6 OUTLIER -105.06 152.3 22.92 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.078 -178.29 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 36.9 t30 68.99 25.44 5.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.724 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.691 HD21 ' CB ' ' A' ' 41' ' ' LEU . 16.0 mt -55.32 -169.97 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.501 ' HB3' HG21 ' A' ' 50' ' ' VAL . 32.9 tp -112.46 131.9 55.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.596 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -89.05 85.92 6.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.021 0.439 . . . . 0.0 110.55 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.46 ' O ' ' N ' ' A' ' 50' ' ' VAL . 1.0 OUTLIER -164.25 142.88 7.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.926 -179.479 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 47' ' ' SER . 0.5 OUTLIER -33.07 -34.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.764 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.803 ' OD1' HG23 ' A' ' 50' ' ' VAL . 3.1 p30 -55.33 -42.59 73.97 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.043 0.449 . . . . 0.0 110.836 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.803 HG23 ' OD1' ' A' ' 49' ' ' ASP . 78.5 t -84.63 -44.51 17.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.013 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.815 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -50.68 -39.77 51.93 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.653 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.696 ' HA ' ' HB3' ' A' ' 55' ' ' ASN . 18.9 m-70 -80.9 -32.42 34.79 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.888 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.508 ' O ' HD13 ' A' ' 57' ' ' LEU . 9.0 tpt -53.5 -34.74 59.17 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 176.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.815 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -83.49 -43.04 16.21 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.648 176.465 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.696 ' HB3' ' HA ' ' A' ' 52' ' ' HIS . 67.0 t30 -56.73 -42.11 78.67 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-O 121.05 0.452 . . . . 0.0 110.131 179.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 1.055 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -57.11 -49.06 77.07 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.812 0.815 . . . . 0.0 108.956 178.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.778 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -61.8 -37.83 85.87 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.006 -1.452 . . . . 0.0 107.871 177.066 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.679 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -63.8 -35.02 79.24 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.877 179.271 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.85 ' CB ' HD11 ' A' ' 90' ' ' LEU . . . -73.52 -37.59 65.6 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.356 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.684 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -82.24 -13.13 57.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.255 0.55 . . . . 0.0 110.893 -179.622 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.58 35.76 4.81 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.38 -0.827 . . . . 0.0 114.137 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.778 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 37.2 t -90.51 124.34 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.789 ' O ' HG12 ' A' ' 76' ' ' ILE . 4.3 m -85.96 130.8 34.43 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.499 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.826 ' HB3' HG23 ' A' ' 75' ' ' ILE . 38.4 p90 -157.64 171.68 19.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.84 0.352 . . . . 0.0 110.622 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.43 ' N ' ' O ' ' A' ' 74' ' ' GLU . 99.7 m -138.1 149.16 45.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.305 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.732 HD12 ' HB2' ' A' ' 73' ' ' CYS . 7.3 tp -117.76 137.34 52.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.968 0.413 . . . . 0.0 110.756 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.7 p -59.93 179.91 0.12 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.989 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.79 -28.32 40.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.88 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -80.29 -0.11 35.16 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.247 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 55.89 48.73 17.4 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.797 0.332 . . . . 0.0 111.197 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.423 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -153.4 0.63 0.25 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.277 -0.419 . . . . 0.0 112.081 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.5 OUTLIER -129.48 110.97 12.3 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.732 ' HB2' HD12 ' A' ' 66' ' ' LEU . 42.9 t -118.37 132.34 56.27 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.55 ' HB2' HG22 ' A' ' 40' ' ' VAL . 43.4 tt0 -111.76 133.13 54.19 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 1.055 HD11 HD22 ' A' ' 29' ' ' LEU . 11.3 mt -130.46 122.97 54.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -178.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.789 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -67.75 100.93 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.763 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 35' ' ' ALA . . . -39.27 144.17 0.33 Allowed Glycine 0 C--N 1.319 -0.39 0 CA-C-N 114.717 -1.128 . . . . 0.0 113.844 -178.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.41 ' CB ' HD12 ' A' ' 82' ' ' LEU . 52.9 t30 -88.86 -11.36 44.91 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.003 0.43 . . . . 0.0 110.861 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.524 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 85.86 15.61 65.03 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.217 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.527 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 139.55 -150.34 21.31 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.326 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.521 ' HB3' ' CB ' ' A' ' 108' ' ' LEU . 4.2 Cg_endo -49.2 123.55 10.27 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.71 2.274 . . . . 0.0 113.13 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.684 ' HB2' HD13 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -72.24 108.54 5.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.139 179.198 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.429 ' HA ' ' CG ' ' A' ' 111' ' ' ASN . 4.4 p80 -81.87 131.88 35.26 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.564 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -96.0 120.45 36.3 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.669 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -70.96 123.94 23.2 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.46 173.87 1.39 Allowed Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 -175.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 112' ' ' ASP . . . -73.03 144.75 47.04 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 118.616 1.208 . . . . 0.0 111.816 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.747 HD21 ' C ' ' A' ' 59' ' ' ALA . 0.7 OUTLIER -112.52 161.03 17.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.198 -178.536 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.419 ' HG2' ' HB ' ' A' ' 114' ' ' VAL . 32.6 mt-10 -142.05 101.39 3.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.136 177.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.85 HD11 ' CB ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -100.2 125.79 46.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.314 -178.622 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.52 ' C ' HD13 ' A' ' 92' ' ' LEU . 1.2 m-85 -98.37 96.44 8.03 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.849 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -105.18 48.25 0.84 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.472 -179.479 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.646 ' HA3' ' H ' ' A' ' 118' ' ' GLU . . . -53.6 -66.0 3.04 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.65 -0.705 . . . . 0.0 113.247 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.485 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 23.0 m-80 -76.27 -0.98 24.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.559 0.218 . . . . 0.0 110.913 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.975 ' HB1' ' HB3' ' A' ' 98' ' ' ALA . . . -91.86 68.73 5.45 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.989 0.423 . . . . 0.0 111.307 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.07 -24.38 71.74 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.76 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.49 HG22 ' OE1' ' A' ' 171' ' ' GLN . 0.6 OUTLIER -106.54 4.79 28.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.463 0.173 . . . . 0.0 111.167 179.595 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.975 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -107.26 -40.82 5.29 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.875 0.369 . . . . 0.0 111.503 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.466 ' HB2' ' HB2' ' A' ' 92' ' ' LEU . 6.3 tpp -59.96 -46.31 89.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.609 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.548 ' O ' HD21 ' A' ' 129' ' ' LEU . 5.3 mpt_? -53.72 -60.24 7.69 Favored Pre-proline 0 C--N 1.323 -0.571 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.006 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.921 ' HB2' HD22 ' A' ' 30' ' ' LEU . 11.7 Cg_endo -59.24 -34.38 98.14 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 121.958 1.772 . . . . 0.0 112.409 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 1.055 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -71.31 -53.25 14.88 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.025 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.897 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -51.29 -28.34 11.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.534 178.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.901 ' CB ' ' HB1' ' A' ' 175' ' ' ALA . . . -86.75 -53.65 4.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.357 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.752 ' CB ' HD11 ' A' ' 30' ' ' LEU . . . -60.32 -37.47 80.69 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -177.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.734 ' HB2' HD12 ' A' ' 153' ' ' LEU . 25.8 mt -75.24 -11.62 60.11 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.215 -177.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.59 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 21.9 m -83.23 17.76 1.95 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.185 0.517 . . . . 0.0 110.247 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.648 HD21 ' HB2' ' A' ' 182' ' ' LEU . 2.6 mt -95.92 -68.36 0.8 Allowed 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.365 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.07 151.96 27.83 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.669 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 m -66.54 98.29 0.49 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.982 0.42 . . . . 0.0 110.855 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.672 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 5.8 m-80 -148.53 137.44 21.62 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.103 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.8 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 1.7 m-20 -95.29 100.28 12.09 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.191 0.52 . . . . 0.0 109.926 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.569 HG12 HD13 ' A' ' 106' ' ' LEU . 1.6 mp -118.38 148.37 21.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.903 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.821 HG13 ' CD2' ' A' ' 143' ' ' LEU . 43.9 t -118.0 112.58 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 176.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.722 ' O ' ' HA ' ' A' ' 150' ' ' PRO . 24.0 mt -102.36 105.58 16.22 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.905 -178.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.526 HG23 ' HB3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -116.42 -170.39 1.8 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.802 0.334 . . . . 0.0 111.206 -179.736 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.551 ' HA3' ' HG2' ' A' ' 121' ' ' MET . . . -168.32 172.58 42.94 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.006 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.651 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 18.1 mt-10 -68.85 176.36 1.55 Allowed Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 122.639 0.375 . . . . 0.0 110.903 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.651 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 81.7 Cg_exo -47.78 -41.06 31.89 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.759 2.306 . . . . 0.0 113.581 -179.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -67.37 -23.15 65.56 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.661 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.575 ' O ' ' HG3' ' A' ' 149' ' ' PRO . 10.5 tpt -61.84 -35.19 77.55 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.489 ' HA ' ' HG2' ' A' ' 149' ' ' PRO . 3.4 mmtp -61.64 -16.78 51.56 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.673 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -86.34 3.48 43.28 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 120.827 0.346 . . . . 0.0 110.289 178.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.436 ' HB3' ' NH2' ' A' ' 100' ' ' ARG . 3.5 mtt180 -127.3 81.18 70.5 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.075 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.413 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 14.8 Cg_endo -56.9 149.21 62.56 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.937 2.425 . . . . 0.0 112.032 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.508 HD11 HD23 ' A' ' 129' ' ' LEU . 0.7 OUTLIER -124.14 17.67 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.349 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.43 ' HA3' ' CB ' ' A' ' 147' ' ' ASN . . . -61.29 -46.16 95.0 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.927 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.626 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 37.6 m80 -56.87 -35.53 69.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.982 0.391 . . . . 0.0 111.322 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.763 HD11 ' HB3' ' A' ' 175' ' ' ALA . 15.4 tp -75.79 -47.71 24.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.927 0.394 . . . . 0.0 111.318 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.826 HG13 ' CG2' ' A' ' 140' ' ' ILE . 51.9 t -56.25 -47.43 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.395 -178.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.67 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 82.8 m-20 -68.81 -39.8 79.86 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.031 0.443 . . . . 0.0 110.12 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.568 ' HB2' HG23 ' A' ' 164' ' ' VAL . . . -59.4 -45.24 92.06 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.012 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.728 HD11 ' HG ' ' A' ' 129' ' ' LEU . 10.7 mt -75.15 -48.42 23.74 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.446 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.696 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -58.65 -28.37 65.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.959 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.67 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 5.8 tp -68.3 -32.57 72.81 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.278 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 159' ' ' GLY . . . -79.35 9.96 38.5 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.153 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.39 6.64 57.48 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.329 -0.939 . . . . 0.0 112.755 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.415 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . . . -74.48 151.97 39.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.882 0.372 . . . . 0.0 111.146 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.446 ' CB ' ' HB2' ' A' ' 154' ' ' GLN . 9.9 mmmt -99.22 100.14 11.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.687 178.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.826 ' CG2' HG13 ' A' ' 130' ' ' VAL . 28.5 mt -131.68 127.44 59.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.477 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.765 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -125.14 139.03 54.12 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.004 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.469 ' CE1' HG11 ' A' ' 130' ' ' VAL . 29.1 m-85 -78.54 133.48 37.36 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.847 0.356 . . . . 0.0 110.955 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.899 HD11 ' HG3' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -94.02 -87.84 0.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.734 -179.55 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.509 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 2.5 mm-40 -59.36 -81.99 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.34 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.441 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 35.0 mt-30 -115.14 154.45 28.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.112 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 5.0 mt-10 -67.66 131.96 46.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.31 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.43 ' CB ' ' HA3' ' A' ' 127' ' ' GLY . 1.1 m-20 70.57 19.41 6.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.954 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.558 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 13.2 m-85 -109.72 168.63 7.41 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.634 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 10.5 Cg_exo -30.91 -62.1 0.12 Allowed 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 125.264 3.976 . . . . 0.0 117.477 -177.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.86 ' HB2' ' HB2' ' A' ' 143' ' ' LEU . 26.3 Cg_endo -62.24 150.17 87.93 Favored 'Trans proline' 0 C--N 1.351 0.677 0 CA-C-N 120.655 1.27 . . . . 0.0 112.117 -177.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.763 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 7.6 mt -155.64 138.63 15.43 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.866 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.899 ' HG3' HD11 ' A' ' 143' ' ' LEU . 0.7 OUTLIER -104.71 104.31 14.09 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 176.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.897 HD11 ' HA ' ' A' ' 103' ' ' ALA . 4.1 mt -95.6 141.54 28.99 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.817 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.672 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 2.8 mt-30 -145.47 31.1 1.09 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.665 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.59 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 48.18 -158.02 0.84 Allowed Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.323 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.44 -11.08 46.95 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.264 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.547 ' CD1' ' HB2' ' A' ' 183' ' ' ALA . 31.6 t80 -59.77 122.93 15.41 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 117.467 0.634 . . . . 0.0 110.367 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.736 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 70.0 p -115.96 -35.53 4.41 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 121.54 0.686 . . . . 0.0 111.182 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.457 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 140.21 -160.76 26.4 Favored Glycine 0 C--N 1.307 -1.049 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.085 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.57 ' O ' HG23 ' A' ' 187' ' ' THR . . . 105.88 152.64 20.43 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.545 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -47.02 123.03 4.85 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.084 -0.558 . . . . 0.0 110.597 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 160' ' ' GLY . 42.7 t -116.06 146.39 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.123 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -113.27 120.16 40.22 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.117 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.836 HG21 HD11 ' A' ' 176' ' ' LEU . 1.0 OUTLIER -133.95 119.92 33.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.499 ' HB2' ' HD2' ' A' ' 128' ' ' HIS . 0.8 OUTLIER -56.47 141.18 43.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.929 0.395 . . . . 0.0 111.041 -179.223 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.677 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . . . . . . 0 N--CA 1.447 -0.618 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.595 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.084 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.507 ' HB2' ' HB2' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -86.26 -11.86 51.16 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.005 -179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.682 ' HA ' HD13 ' A' ' 129' ' ' LEU . 5.9 m-85 -71.3 -56.77 5.35 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.746 ' HG ' HG11 ' A' ' 164' ' ' VAL . 0.5 OUTLIER -62.81 -44.43 96.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.39 178.741 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.703 HG21 ' HD3' ' A' ' 27' ' ' ARG . 2.5 m -54.82 -33.19 61.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.826 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.901 ' HB1' ' CB ' ' A' ' 104' ' ' ALA . . . -68.32 -39.3 82.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.242 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.836 HD11 HG21 ' A' ' 164' ' ' VAL . 0.7 OUTLIER -76.58 -35.45 58.16 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.839 179.753 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.78 ' O ' ' HE1' ' A' ' 208' ' ' MET . 3.8 mp -59.82 -37.85 80.37 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.191 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.62 ' HE1' ' HA ' ' A' ' 27' ' ' ARG . 2.6 mtp -81.68 -43.15 18.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.338 0.59 . . . . 0.0 112.086 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 95.9 m -72.01 -42.4 66.43 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.105 -178.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.573 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . -58.71 -41.44 88.86 Favored Pre-proline 0 C--N 1.32 -0.716 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -176.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 28.5 Cg_endo -64.43 -28.54 62.53 Favored 'Trans proline' 0 CA--C 1.501 -1.167 0 C-N-CA 120.831 1.02 . . . . 0.0 112.128 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.648 ' HB2' HD21 ' A' ' 108' ' ' LEU . 5.6 mt -84.26 0.83 47.43 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.51 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.736 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -83.51 137.71 41.71 Favored Pre-proline 0 C--O 1.224 -0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.396 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.721 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 11.4 Cg_endo -51.34 -34.31 49.47 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.688 2.258 . . . . 0.0 113.404 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.81 140.2 46.66 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.733 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -55.16 143.69 26.62 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.046 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 160' ' ' GLY . 92.0 m -123.6 148.23 46.6 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.687 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 40.3 t -128.7 118.27 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.878 177.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.733 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 5.0 mp -99.09 119.09 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.548 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 2.4 ttt180 -100.74 125.46 47.2 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.677 HG23 ' HA2' ' A' ' 166' ' ' GLY . 1.5 mp -93.37 127.33 45.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.867 -176.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -82.65 96.67 8.19 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.231 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 98.66 -127.55 9.28 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.708 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -116.66 133.54 55.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.708 0.29 . . . . 0.0 111.471 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.672 HD11 ' HZ ' ' A' ' 223' ' ' PHE . 1.1 mt -41.62 144.13 0.42 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.166 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.447 ' HB ' ' O ' ' A' ' 166' ' ' GLY . 12.4 p -72.87 -25.03 21.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.637 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.572 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 0.4 OUTLIER -170.78 68.63 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.096 0.474 . . . . 0.0 110.235 -179.575 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.733 ' HG3' ' HD3' ' A' ' 199' ' ' PRO . 0.0 OUTLIER -48.17 -29.37 1.4 Allowed Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.344 179.712 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . 0.733 ' HD3' ' HG3' ' A' ' 198' ' ' LYS . 23.3 Cg_exo -64.78 -28.9 59.41 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 121.094 1.196 . . . . 0.0 110.724 178.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.936 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.1 OUTLIER -69.79 -42.3 73.93 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 177.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 11.9 mm -60.15 -39.61 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.255 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -58.07 -44.86 87.74 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.327 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.936 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.0 mt -62.66 -50.42 79.83 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 CA-C-O 121.569 0.699 . . . . 0.0 109.551 178.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.579 HG22 ' SD ' ' A' ' 208' ' ' MET . 97.4 m -53.43 -51.54 62.31 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.843 -178.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.762 HD22 ' HB ' ' A' ' 215' ' ' ILE . 29.8 mt -67.01 -29.22 68.99 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.028 0.442 . . . . 0.0 111.369 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . 0.443 ' HA ' ' HE3' ' A' ' 209' ' ' LYS . 5.1 t-20 -77.63 -46.47 21.96 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.633 0.73 . . . . 0.0 109.876 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.953 ' O ' HG22 ' A' ' 210' ' ' THR . 4.4 tp -71.75 -29.7 64.79 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.574 -1.193 . . . . 0.0 109.404 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' MET . . . . . 0.78 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 43.0 mtp -76.13 -35.31 59.3 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 14.4 mtmt -61.43 -38.71 88.14 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.654 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.953 HG22 ' O ' ' A' ' 207' ' ' LEU . 6.6 t -61.04 -26.85 67.92 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.3 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.59 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 27.6 m-85 -83.88 -7.31 59.47 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.903 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.89 7.43 25.37 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 116.31 1.284 . . . . 0.0 116.31 177.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.2 m -123.55 148.54 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 118.983 1.392 . . . . 0.0 112.604 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.538 ' O ' HD13 ' A' ' 215' ' ' ILE . 12.0 mt-10 -130.35 139.41 50.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.008 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.9 HD12 ' HB ' ' A' ' 225' ' ' VAL . 18.4 mm -122.46 148.78 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 120.836 0.351 . . . . 0.0 110.744 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.589 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 1.3 tp10 -104.67 122.4 45.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.032 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . 0.562 ' C ' HD22 ' A' ' 217' ' ' ASN . 0.4 OUTLIER -86.84 151.01 23.72 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.182 179.016 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . 0.521 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 2.8 mm-40 -111.12 -141.57 0.38 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.14 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.535 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 28.3 m170 -73.92 65.03 1.03 Allowed 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 2.0 t80 57.24 36.3 27.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.706 0.765 . . . . 0.0 110.944 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.651 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 4.5 pt20 -168.73 -124.5 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.733 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -8.61 130.88 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.687 ' O ' ' HA ' ' A' ' 188' ' ' VAL . 0.7 OUTLIER -121.87 140.23 52.65 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.119 -1.855 . . . . 0.0 109.625 -179.163 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 40.1 t -120.84 114.25 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-O 121.297 0.57 . . . . 0.0 109.696 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.9 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.2 OUTLIER -122.29 125.87 73.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.087 -179.017 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -77.88 127.55 32.56 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -80.52 -178.51 52.11 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.351 -178.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 67.5 21.01 72.29 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 121.623 -0.322 . . . . 0.0 113.285 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' GLN . . . . . 0.468 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 46.5 mt-30 -78.32 -173.43 3.27 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.268 0.556 . . . . 0.0 111.214 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.09 147.8 26.25 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.365 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' TYR . . . . . 0.536 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 7.2 m-85 -102.89 130.35 49.9 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.886 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.04 151.78 37.62 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.48 111.09 12.45 Favored Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.97 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.495 ' HD2' ' OG1' ' A' ' 39' ' ' THR . 52.0 Cg_endo -69.37 1.11 4.46 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.249 1.966 . . . . 0.0 112.27 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 98.68 -101.04 2.4 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.303 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 49.2 m -118.42 136.97 53.46 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . 0.685 ' CE2' HG21 ' A' ' 210' ' ' THR . 9.3 t80 -133.23 124.2 26.95 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.989 0.423 . . . . 0.0 111.362 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.922 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -94.99 110.83 22.69 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.8 179.866 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.631 ' N ' HD22 ' A' ' 238' ' ' LEU . 21.5 t -77.93 112.52 16.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.474 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.413 ' HG2' HD13 ' A' ' 238' ' ' LEU . 2.7 mt-10 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.296 -0.859 . . . . 0.0 111.018 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.784 ' HB3' HG22 ' A' ' 50' ' ' VAL . 22.7 t . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.328 0.109 . . . . 2.0 110.933 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.8 m120 63.84 -81.91 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.682 0.277 . . . . 1.4299999999999999 111.713 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.556 ' HA ' ' HE1' ' A' ' 178' ' ' MET . 37.7 mtm-85 -76.94 -61.51 1.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.094 0.405 . . . . 2.3300000000000001 112.094 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.73 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -35.76 -42.75 0.27 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.584 -0.735 . . . . 0.17999999999999999 112.601 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.01 HD22 HD11 ' A' ' 75' ' ' ILE . 12.4 mt -75.9 -39.55 56.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.896 0.379 . . . . 0.14000000000000001 111.587 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.782 HD22 ' HB2' ' A' ' 101' ' ' PRO . 31.7 tp -64.91 -50.85 64.88 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.034 -0.53 . . . . 0.23999999999999999 110.873 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.549 HD21 ' CE ' ' A' ' 178' ' ' MET . 31.4 mt -64.78 -28.06 69.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.992 -0.549 . . . . 0.38 109.684 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.785 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -64.75 -40.03 94.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.523 -0.762 . . . . 0.20000000000000001 110.238 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.601 ' CB ' HG11 ' A' ' 62' ' ' VAL . . . -77.82 -39.46 43.64 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.046 -0.525 . . . . 0.14000000000000001 111.273 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.589 HD11 ' HB1' ' A' ' 105' ' ' ALA . 20.7 mt -70.69 -3.0 16.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.95 -0.568 . . . . 0.25 110.534 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.444 ' HA ' ' CB ' ' A' ' 231' ' ' TYR . . . -96.39 172.9 7.65 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 113.144 0.794 . . . . 0.33000000000000002 113.144 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.461 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.2 OUTLIER -110.11 108.76 19.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.845 -1.07 . . . . 1.03 108.593 178.001 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 120.57 170.1 14.09 Favored Glycine 0 C--N 1.319 -0.38 0 C-N-CA 120.822 -0.704 . . . . 0.56000000000000005 111.375 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.825 ' HG3' HG23 ' A' ' 76' ' ' ILE . 0.1 OUTLIER -94.48 119.3 32.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.227 0.514 . . . . 1.72 111.609 -179.228 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.533 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 1.0 OUTLIER -120.3 142.13 49.38 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 120.715 0.293 . . . . 0.52000000000000002 110.401 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.416 ' C ' HD13 ' A' ' 41' ' ' LEU . 69.5 t -102.08 139.21 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-O 121.324 0.583 . . . . 0.25 111.937 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.855 HD23 HD23 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -113.21 114.96 27.48 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 107.217 -1.401 . . . . 0.23999999999999999 107.217 175.759 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.8 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.6 OUTLIER -102.81 149.34 24.58 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.487 -0.485 . . . . 0.33000000000000002 111.04 -178.317 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 69.4 24.5 5.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.03 -0.532 . . . . 1.1899999999999999 111.756 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.787 HD21 ' HB3' ' A' ' 41' ' ' LEU . 86.8 mt -52.92 -177.47 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.832 0.349 . . . . 0.28000000000000003 110.138 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.494 ' O ' HG21 ' A' ' 50' ' ' VAL . 48.4 tp -108.75 131.39 54.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.439 -0.346 . . . . 0.44 110.369 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -89.17 88.87 7.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.855 0.359 . . . . 1.6399999999999999 110.247 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 49' ' ' ASP . 0.6 OUTLIER -165.48 144.64 6.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.97999999999999998 110.073 -179.154 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -36.1 -32.31 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.638 0.256 . . . . 1.6100000000000001 111.449 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.635 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 4.6 p30 -56.13 -42.2 76.55 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.899 0.381 . . . . 1.5600000000000001 110.841 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.784 HG22 ' HB3' ' A' ' 25' ' ' SER . 84.1 t -84.4 -45.82 17.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.036 -0.529 . . . . 0.23000000000000001 110.531 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.892 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -48.73 -38.65 22.17 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.989 -0.285 . . . . 2.04 110.615 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.564 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 19.6 m-70 -79.88 -36.22 36.88 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 109.634 -0.506 . . . . 0.26000000000000001 109.634 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.484 ' O ' HD13 ' A' ' 57' ' ' LEU . 8.5 tpt -53.36 -31.55 45.14 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 106.086 -1.82 . . . . 0.16 106.086 176.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.892 HD12 ' HA ' ' A' ' 51' ' ' ARG . 2.2 mt -83.42 -45.41 13.69 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 113.914 -1.494 . . . . 0.20999999999999999 108.645 176.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.596 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 18.2 t-20 -58.94 -39.75 82.59 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 115.82 -0.627 . . . . 1.24 111.002 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.824 ' CB ' HD11 ' A' ' 102' ' ' LEU . . . -62.37 -49.96 73.45 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.69 0.757 . . . . 0.14000000000000001 109.249 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.646 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.5 OUTLIER -57.95 -37.66 74.55 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.246 -1.39 . . . . 0.22 107.246 176.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.596 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -62.59 -44.43 96.34 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.005 -1.452 . . . . 0.27000000000000002 112.021 179.227 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.655 ' C ' HD21 ' A' ' 88' ' ' LEU . . . -67.78 -39.13 84.13 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.712 0.634 . . . . 0.23999999999999999 112.712 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.636 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.7 OUTLIER -75.26 -17.13 60.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.426 0.631 . . . . 0.26000000000000001 110.28 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.81 37.16 3.75 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 114.894 -1.048 . . . . 0.31 113.935 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.646 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 22.0 t -90.3 125.57 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 109.09 -0.707 . . . . 0.25 109.09 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.716 ' O ' HG12 ' A' ' 76' ' ' ILE . 12.5 m -86.55 130.61 34.43 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 120.469 -0.492 . . . . 1.0 111.13 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.813 ' HB3' HG23 ' A' ' 75' ' ' ILE . 32.4 p90 -159.78 168.87 24.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.18 -0.464 . . . . 0.20000000000000001 110.291 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 99.0 m -134.76 148.65 50.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.284 -0.416 . . . . 0.20999999999999999 110.561 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.417 HD12 ' HB2' ' A' ' 73' ' ' CYS . 14.4 tp -117.19 136.79 52.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.09 0.472 . . . . 0.42999999999999999 110.776 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.514 ' HB2' ' CB ' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -63.94 -158.99 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.612 -0.722 . . . . 1.7 111.281 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -95.7 -31.98 12.97 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.413 -0.358 . . . . 1.78 111.178 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.53 1.09 30.95 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.413 -0.358 . . . . 1.8899999999999999 111.375 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 59.79 24.72 13.7 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.48 -0.327 . . . . 1.8600000000000001 111.67 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.644 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -122.4 -11.23 8.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.823 0.344 . . . . 0.38 111.406 179.573 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.514 ' CB ' ' HB2' ' A' ' 67' ' ' SER . 2.0 mtt180 -112.56 117.96 33.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.439 -0.346 . . . . 3.0099999999999998 110.275 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.766 ' HB3' HD11 ' A' ' 44' ' ' LEU . 43.4 t -131.11 127.52 38.27 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 120.958 0.408 . . . . 0.17999999999999999 111.735 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.535 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 51.3 tt0 -112.24 133.1 54.55 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 109.04 -0.726 . . . . 1.49 109.04 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 1.01 HD11 HD22 ' A' ' 29' ' ' LEU . 11.8 mt -128.7 123.86 60.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 113.948 1.092 . . . . 0.17999999999999999 113.948 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.825 HG23 ' HG3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -67.73 98.86 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 109.157 -0.683 . . . . 0.94999999999999996 109.157 175.764 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -37.23 142.91 0.2 Allowed Glycine 0 C--N 1.321 -0.262 0 CA-C-N 115.138 -0.937 . . . . 0.22 113.579 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -90.31 -13.32 35.45 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.917 0.389 . . . . 1.21 111.113 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.461 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 86.24 14.51 66.34 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.037 -0.601 . . . . 0.28999999999999998 112.606 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.585 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 145.36 -155.58 26.55 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.792 -0.718 . . . . 0.14999999999999999 112.581 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.516 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 5.8 Cg_endo -49.3 127.41 17.76 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.682 2.255 . . . . 0.51000000000000001 112.436 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.653 ' H ' HD22 ' A' ' 82' ' ' LEU . 0.3 OUTLIER -74.88 109.25 8.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.124 -0.489 . . . . 0.23000000000000001 109.935 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.411 ' HA ' HD22 ' A' ' 111' ' ' ASN . 3.9 p80 -80.42 124.12 28.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.2 0.524 . . . . 0.59999999999999998 112.111 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.667 ' CB ' HD11 ' A' ' 113' ' ' ILE . . . -89.34 124.2 34.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.505 -0.77 . . . . 0.19 111.275 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.51 122.92 20.0 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 105.621 -1.992 . . . . 1.95 105.621 176.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.24 -175.39 5.5 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 108.559 -1.816 . . . . 0.20000000000000001 108.559 -175.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.38 145.03 30.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 118.787 1.294 . . . . 0.17999999999999999 111.832 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.655 HD21 ' C ' ' A' ' 59' ' ' ALA . 0.8 OUTLIER -114.16 161.78 17.35 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.003 -0.998 . . . . 0.20999999999999999 112.278 -178.656 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -139.63 102.89 4.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.612 -1.176 . . . . 1.8700000000000001 108.707 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.699 ' HB3' HD11 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -99.2 127.54 45.19 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 120.99 0.424 . . . . 0.16 111.276 -178.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.609 ' C ' HD13 ' A' ' 92' ' ' LEU . 0.9 OUTLIER -99.09 95.51 7.16 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.86 -0.609 . . . . 1.48 109.679 179.185 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.746 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -104.03 54.82 0.73 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.846 -0.615 . . . . 0.62 110.085 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -56.63 -68.5 1.66 Allowed Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.71 -0.677 . . . . 0.72999999999999998 112.984 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.507 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 33.2 m-20 -79.12 -1.76 37.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.575 0.226 . . . . 2.04 110.801 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.959 ' HB1' ' HB3' ' A' ' 98' ' ' ALA . . . -92.76 45.58 1.19 Allowed 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 116.475 -0.33 . . . . 0.93000000000000005 110.919 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -50.42 -27.58 12.17 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.429 -0.891 . . . . 0.47999999999999998 112.032 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.795 HG22 ' CD ' ' A' ' 171' ' ' GLN . 1.1 p -88.83 -14.94 35.77 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.529 0.196 . . . . 0.79000000000000004 111.529 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.959 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -93.46 -37.19 12.07 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.074 0.398 . . . . 0.33000000000000002 112.074 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.1 tpp -59.17 -46.37 88.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.693 -0.23 . . . . 0.39000000000000001 110.737 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.509 ' HB3' ' O ' ' A' ' 171' ' ' GLN . 2.2 mpt_? -52.89 -60.68 6.08 Favored Pre-proline 0 C--N 1.324 -0.537 0 C-N-CA 120.755 -0.378 . . . . 1.3799999999999999 110.056 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.782 ' HB2' HD22 ' A' ' 30' ' ' LEU . 18.1 Cg_endo -60.31 -31.63 93.11 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.422 2.082 . . . . 0.39000000000000001 112.773 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.824 HD11 ' CB ' ' A' ' 56' ' ' ALA . 2.1 mt -73.76 -54.03 8.98 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 120.403 -0.519 . . . . 0.20000000000000001 109.945 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.855 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -47.42 -29.6 2.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.673 -0.694 . . . . 0.17000000000000001 110.543 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.733 ' CB ' ' HB1' ' A' ' 175' ' ' ALA . . . -88.08 -52.11 5.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.872 -0.604 . . . . 0.17000000000000001 112.226 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.67 ' CB ' HD11 ' A' ' 30' ' ' LEU . . . -59.89 -35.42 74.8 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.193 0.812 . . . . 0.17000000000000001 113.193 -177.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.729 ' HB2' HD12 ' A' ' 153' ' ' LEU . 28.3 mt -78.74 -10.98 59.96 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 112.705 0.631 . . . . 0.23000000000000001 112.705 -177.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.754 ' SG ' HD13 ' A' ' 153' ' ' LEU . 99.0 m -93.07 24.86 3.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.287 0.565 . . . . 1.48 110.067 178.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.829 HD21 ' HB2' ' A' ' 182' ' ' LEU . 0.5 OUTLIER -85.51 -75.95 0.35 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.335 -0.848 . . . . 0.40999999999999998 111.213 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -76.76 -105.61 0.14 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.581 -0.819 . . . . 1.1399999999999999 112.141 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.63 96.33 1.5 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.057 0.456 . . . . 0.82999999999999996 110.523 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.69 ' HB2' HD13 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -141.39 140.1 33.61 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.76 -0.654 . . . . 1.96 110.799 -178.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.795 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 5.6 m-20 -95.44 99.25 11.18 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 109.087 -0.708 . . . . 1.1200000000000001 109.087 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.69 HD13 ' HB2' ' A' ' 111' ' ' ASN . 1.3 mp -123.28 144.11 33.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.553 -0.749 . . . . 0.52000000000000002 111.663 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.89 HG13 ' CD2' ' A' ' 143' ' ' LEU . 48.0 t -113.9 113.22 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 107.922 -1.14 . . . . 0.17000000000000001 107.922 176.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' A' ' 90' ' ' LEU . 25.7 mt -101.23 105.67 16.81 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 119.869 -0.733 . . . . 0.16 110.346 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.699 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -117.48 -171.61 2.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.573 -0.285 . . . . 0.23999999999999999 111.315 -179.364 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -167.27 -166.22 25.98 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.547 -0.835 . . . . 0.28999999999999998 113.278 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.578 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 40.2 mt-10 -85.85 166.82 27.42 Favored Pre-proline 0 C--N 1.33 -0.273 0 C-N-CA 122.606 0.363 . . . . 1.79 110.678 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.578 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 2.1 Cg_endo -44.83 -37.25 11.74 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.725 2.283 . . . . 0.41999999999999998 112.696 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -67.62 -26.55 66.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.807 0.337 . . . . 2.25 110.381 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.517 ' O ' ' HG3' ' A' ' 149' ' ' PRO . 7.3 tpt -62.5 -31.81 72.62 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.532 -0.544 . . . . 0.28999999999999998 109.532 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 119' ' ' PRO . 0.1 OUTLIER -61.7 -18.08 58.22 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 115.923 -0.58 . . . . 1.51 110.257 179.067 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -85.25 4.9 32.64 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.957 0.408 . . . . 2.3199999999999998 110.086 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 124' ' ' ARG . 5.9 mtt-85 -127.16 80.58 71.38 Favored Pre-proline 0 N--CA 1.455 -0.197 0 CA-C-N 116.013 -0.54 . . . . 2.1099999999999999 110.51 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.83 148.89 63.8 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.583 2.188 . . . . 0.47999999999999998 111.712 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 148' ' ' TYR . 1.2 tt -126.13 10.4 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 112.386 0.513 . . . . 0.23000000000000001 112.386 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.526 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -59.99 -39.83 96.16 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.559 -0.829 . . . . 0.23000000000000001 113.107 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.415 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 14.4 m-70 -57.41 -37.02 72.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.747 0.308 . . . . 1.5600000000000001 111.03 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.749 ' HG ' HD11 ' A' ' 133' ' ' LEU . 12.5 tp -75.65 -44.49 42.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.273 0.559 . . . . 0.29999999999999999 110.514 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.76 HG13 ' CG2' ' A' ' 140' ' ' ILE . 47.8 t -55.48 -48.13 77.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.367 -0.833 . . . . 0.22 111.275 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.662 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 4.1 m-20 -67.77 -41.45 83.25 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 120.993 0.425 . . . . 1.3200000000000001 110.562 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.617 ' HB2' HG23 ' A' ' 164' ' ' VAL . . . -56.84 -44.06 81.72 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.553 -0.749 . . . . 0.16 110.003 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.749 HD11 ' HG ' ' A' ' 129' ' ' LEU . 6.5 mt -77.4 -51.32 11.0 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.596 -0.729 . . . . 0.19 110.769 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.658 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -55.16 -26.41 38.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.598 -0.728 . . . . 2.8700000000000001 109.912 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.662 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 3.4 tp -69.51 -32.5 71.4 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.175 -0.466 . . . . 0.44 110.556 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.47 12.06 41.76 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.646 -0.788 . . . . 0.20000000000000001 112.049 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.91 5.57 58.41 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.25 -0.976 . . . . 0.25 112.689 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.655 ' HB1' ' HB3' ' A' ' 107' ' ' CYS . . . -75.77 149.66 37.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.029 0.442 . . . . 0.22 111.305 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.0 mttp -97.0 109.22 22.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.948 -0.569 . . . . 2.1000000000000001 110.277 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.76 ' CG2' HG13 ' A' ' 130' ' ' VAL . 28.1 mt -140.6 126.9 21.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.838 0.351 . . . . 0.20000000000000001 111.638 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.655 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -124.2 139.96 53.43 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.124 -0.489 . . . . 0.27000000000000002 110.258 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.403 ' HE1' HG21 ' A' ' 130' ' ' VAL . 32.5 m-85 -80.56 130.14 34.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.837 0.351 . . . . 0.33000000000000002 110.867 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.89 ' CD2' HG13 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -88.5 -85.03 0.19 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.136 -0.484 . . . . 0.29999999999999999 112.076 -178.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.444 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 1.2 mt-10 -66.28 -83.87 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.838 -0.345 . . . . 1.77 110.586 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.481 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 75.5 mt-30 -109.49 153.95 23.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.407 -0.36 . . . . 1.76 110.139 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -69.1 131.74 45.47 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.874 0.368 . . . . 1.6599999999999999 110.865 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.526 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 0.9 OUTLIER 71.43 19.93 5.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.934 -0.575 . . . . 0.77000000000000002 111.155 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.56 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 14.6 m-85 -106.8 169.12 7.15 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 112.277 0.473 . . . . 0.45000000000000001 112.277 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.755 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 65.4 Cg_exo -36.09 -57.26 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.86 3.04 . . . . 0.26000000000000001 115.481 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.755 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 52.3 Cg_exo -56.79 144.97 85.72 Favored 'Trans proline' 0 C--N 1.353 0.806 0 CA-C-N 120.432 1.19 . . . . 0.20000000000000001 112.05 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.679 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 12.2 mt -156.81 134.98 11.2 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.841 -1.072 . . . . 0.23999999999999999 109.894 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.655 ' HB2' HG22 ' A' ' 141' ' ' THR . 3.7 mtt180 -105.33 105.43 15.47 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.009 -1.108 . . . . 2.0800000000000001 108.009 176.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.855 HD11 ' HA ' ' A' ' 103' ' ' ALA . 3.4 mt -94.35 144.62 25.39 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.865 -1.061 . . . . 0.19 110.904 -177.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.681 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 3.6 mt-30 -145.87 27.23 1.2 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.508 -0.769 . . . . 1.1799999999999999 110.72 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 51.06 179.05 0.03 OUTLIER Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.015 -0.612 . . . . 0.40000000000000002 112.622 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 158' ' ' THR . . . 125.68 -10.27 7.58 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.143 -1.027 . . . . 0.25 113.405 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.577 ' CD1' ' HB2' ' A' ' 183' ' ' ALA . 21.4 t80 -58.87 122.64 14.12 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 117.381 0.591 . . . . 0.53000000000000003 110.482 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.687 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 73.1 p -117.53 -38.29 3.33 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.334 0.588 . . . . 0.25 111.625 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.553 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 144.64 -170.92 26.11 Favored Glycine 0 C--N 1.308 -1.022 0 C-N-CA 120.239 -0.981 . . . . 0.25 112.583 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.573 ' O ' HG23 ' A' ' 187' ' ' THR . . . 112.58 155.06 12.19 Favored Glycine 0 N--CA 1.436 -1.323 0 N-CA-C 111.189 -0.764 . . . . 0.62 111.189 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -47.76 125.67 9.04 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 120.833 0.349 . . . . 1.9299999999999999 110.68 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 132' ' ' ALA . 74.7 t -117.11 144.42 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.66 -0.496 . . . . 0.27000000000000002 109.66 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -113.26 119.39 37.57 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.865 -0.334 . . . . 1.1200000000000001 110.794 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.846 HG21 HD11 ' A' ' 176' ' ' LEU . 1.1 t -131.83 119.17 40.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 120.598 -0.441 . . . . 0.31 109.851 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.493 ' HB3' HG23 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -55.44 138.39 46.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 1.48 111.288 -178.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.709 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . -60.8 -46.17 95.02 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.588 -0.815 . . . . 0.52000000000000002 112.431 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.3 m -91.5 87.36 6.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.729 0.3 . . . . 1.3600000000000001 111.432 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.493 HG23 ' HB3' ' A' ' 165' ' ' ASP . 72.4 t -146.22 -79.86 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.248 0.547 . . . . 1.8700000000000001 110.674 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.58 ' CA ' HG11 ' A' ' 196' ' ' VAL . 0.6 OUTLIER -169.99 132.8 1.13 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.362 -0.835 . . . . 1.1699999999999999 110.685 179.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.463 ' HB2' ' HB3' ' A' ' 200' ' ' TYR . 71.9 p -58.22 -16.96 15.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.919 -0.582 . . . . 1.25 111.993 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.795 ' CD ' HG22 ' A' ' 97' ' ' THR . 8.7 mp0 -85.5 -11.01 55.25 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.815 -0.354 . . . . 2.3700000000000001 111.111 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.486 ' CD2' ' HB2' ' A' ' 129' ' ' LEU . 10.8 m-85 -75.07 -59.19 2.85 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.317 -0.623 . . . . 0.39000000000000001 109.317 178.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.841 HD11 ' CG1' ' A' ' 191' ' ' ILE . 0.3 OUTLIER -60.7 -39.14 87.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.475 -0.784 . . . . 0.57999999999999996 109.18 178.42 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.463 HG23 HG21 ' A' ' 204' ' ' THR . 1.7 m -59.84 -38.96 83.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.922 -1.036 . . . . 0.31 109.62 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.733 ' HB1' ' CB ' ' A' ' 104' ' ' ALA . . . -60.65 -41.5 95.08 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.815 -0.629 . . . . 0.19 110.911 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.846 HD11 HG21 ' A' ' 164' ' ' VAL . 0.3 OUTLIER -77.37 -32.16 54.78 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.473 -0.785 . . . . 0.63 110.891 179.657 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.687 ' CD2' HD21 ' A' ' 205' ' ' LEU . 3.5 mp -61.51 -38.44 87.36 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.342 -0.845 . . . . 0.34999999999999998 110.759 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.667 ' HA ' ' HE1' ' A' ' 208' ' ' MET . 1.5 mtp -82.65 -40.6 20.49 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.51 0.559 . . . . 0.68000000000000005 112.51 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.498 HG23 ' HG ' ' A' ' 108' ' ' LEU . 50.3 m -77.1 -39.43 49.56 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.343 -0.844 . . . . 0.27000000000000002 113.071 -178.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.53 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . -58.7 -42.52 94.72 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 114.428 1.27 . . . . 0.37 114.428 -177.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 27.0 Cg_endo -64.82 -27.56 59.42 Favored 'Trans proline' 0 CA--C 1.501 -1.154 0 CA-C-N 119.795 0.962 . . . . 0.52000000000000002 112.387 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.829 ' HB2' HD21 ' A' ' 108' ' ' LEU . 4.0 mt -83.26 -2.36 55.42 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 109.31 -0.626 . . . . 0.51000000000000001 109.31 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.68 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -78.17 135.8 61.9 Favored Pre-proline 0 C--O 1.224 -0.274 0 CA-C-N 116.049 -0.523 . . . . 0.25 110.122 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.687 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 11.3 Cg_endo -51.14 -34.4 47.77 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.378 2.052 . . . . 0.25 113.11 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -112.4 143.64 43.18 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.697 -0.683 . . . . 2.0899999999999999 111.112 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -58.07 153.43 14.67 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.285 -0.416 . . . . 2.2400000000000002 110.286 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.574 HG23 HG23 ' A' ' 162' ' ' VAL . 56.4 m -133.75 145.65 50.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.077 0.465 . . . . 0.27000000000000002 112.223 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.573 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 54.6 t -124.48 117.58 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.584 -0.735 . . . . 0.25 110.197 178.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.687 HG12 HD13 ' A' ' 176' ' ' LEU . 3.4 mp -100.13 117.9 45.99 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 N-CA-C 108.731 -0.84 . . . . 0.23000000000000001 108.731 177.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 7.7 ttt180 -100.66 124.71 46.64 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.322 -0.992 . . . . 2.4300000000000002 108.322 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.841 ' CG1' HD11 ' A' ' 173' ' ' LEU . 1.6 mp -92.27 122.37 43.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.933 -1.03 . . . . 0.31 111.746 -176.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -80.46 96.87 6.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.072 -1.422 . . . . 0.98999999999999999 110.595 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 101.56 -132.39 10.94 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.747 -0.74 . . . . 0.46999999999999997 111.884 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -116.74 127.51 54.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.711 0.291 . . . . 1.1000000000000001 111.628 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.556 HD11 ' HZ ' ' A' ' 223' ' ' PHE . 1.1 mt -40.42 144.87 0.2 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.157 -0.474 . . . . 0.44 111.269 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.58 HG11 ' CA ' ' A' ' 169' ' ' SER . 10.5 p -72.52 -30.74 35.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.995 -0.548 . . . . 0.60999999999999999 112.2 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.478 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 0.2 OUTLIER -165.23 63.61 0.12 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.977 0.417 . . . . 0.88 110.734 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.51 ' HA ' HD13 ' A' ' 195' ' ' LEU . 6.1 tttm -40.25 -46.21 5.41 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 115.851 -0.613 . . . . 2.02 111.355 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.478 ' HD2' ' C ' ' A' ' 197' ' ' SER . 87.6 Cg_exo -47.37 -34.09 18.22 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.027 1.818 . . . . 0.62 111.798 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.958 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.3 OUTLIER -70.34 -42.06 72.39 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.804 -0.813 . . . . 1.4099999999999999 108.804 178.056 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.442 HG21 ' HE2' ' A' ' 223' ' ' PHE . 26.4 mm -63.21 -33.8 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 114.819 -1.082 . . . . 0.41999999999999998 110.44 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.7 -45.28 94.8 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.121 0.486 . . . . 1.1399999999999999 109.914 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.958 HD12 ' HA ' ' A' ' 200' ' ' TYR . 3.8 mt -62.14 -50.95 77.95 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 CA-C-O 121.633 0.73 . . . . 0.62 110.163 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.463 HG21 HG23 ' A' ' 174' ' ' THR . 74.9 m -51.63 -51.11 58.29 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.478 -1.237 . . . . 0.46999999999999997 111.449 -178.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.692 HD22 ' HB ' ' A' ' 215' ' ' ILE . 21.3 mt -66.84 -28.59 68.47 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 120.892 0.377 . . . . 0.26000000000000001 111.661 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.415 ' HA ' ' HE3' ' A' ' 209' ' ' LYS . 1.9 t30 -78.48 -46.64 19.18 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.588 0.708 . . . . 1.6000000000000001 109.827 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.979 ' O ' HG22 ' A' ' 210' ' ' THR . 0.2 OUTLIER -71.11 -30.31 66.36 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.687 -1.142 . . . . 0.52000000000000002 109.192 178.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . 0.667 ' HE1' ' HA ' ' A' ' 178' ' ' MET . 35.5 mtp -72.76 -35.03 67.37 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.848 -0.615 . . . . 0.38 109.534 177.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 10.4 mtmt -60.97 -36.39 79.3 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 115.092 -0.958 . . . . 0.98999999999999999 110.856 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.979 HG22 ' O ' ' A' ' 207' ' ' LEU . 4.8 t -62.04 -22.98 66.19 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.633 -0.712 . . . . 0.96999999999999997 109.33 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.536 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 61.3 m-85 -85.76 -9.07 57.68 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.749 -0.66 . . . . 1.51 111.587 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 111.54 5.33 26.17 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 116.006 1.162 . . . . 2.9300000000000002 116.006 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.5 m -123.54 148.96 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 118.969 1.385 . . . . 1.6899999999999999 112.81 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.476 ' HG2' ' CG ' ' A' ' 209' ' ' LYS . 8.5 mt-10 -131.01 135.88 48.0 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.341 -0.845 . . . . 2.6699999999999999 111.291 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.988 HD12 ' HB ' ' A' ' 225' ' ' VAL . 20.0 mm -118.26 148.59 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 120.772 0.32 . . . . 1.0800000000000001 110.225 178.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.542 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 9.2 tt0 -104.86 116.56 32.2 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.302 -0.408 . . . . 1.54 112.004 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.571 HD22 ' N ' ' A' ' 217' ' ' ASN . 0.0 OUTLIER -84.94 151.25 24.37 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.091 -0.504 . . . . 2.2400000000000002 110.396 179.223 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 5.0 tp60 -108.18 -143.23 0.38 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.477 0.179 . . . . 1.97 110.785 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.409 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 4.5 m-70 -73.3 66.51 0.92 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.886 0.374 . . . . 2.4199999999999999 111.491 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.41 ' CE1' ' HD2' ' A' ' 198' ' ' LYS . 6.4 t80 58.43 33.65 23.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.788 0.804 . . . . 0.97999999999999998 111.11 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.636 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 5.1 pt20 -165.74 -129.99 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 106.69 -1.596 . . . . 1.5600000000000001 106.69 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.617 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -3.06 128.7 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 114.36 1.244 . . . . 1.3500000000000001 114.36 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.597 ' CD1' ' O ' ' A' ' 221' ' ' GLN . 5.1 m-85 -123.02 140.93 52.52 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.262 -1.79 . . . . 0.63 110.042 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.542 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 42.3 t -123.03 112.78 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 121.329 0.585 . . . . 0.33000000000000002 109.841 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.988 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -119.44 135.27 60.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.222 -0.899 . . . . 0.44 111.49 -178.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.431 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 3.7 mptt -83.76 127.8 34.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.038 -0.528 . . . . 2.71 109.823 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.428 ' CA ' ' O ' ' A' ' 183' ' ' ALA . . . -83.03 167.99 46.41 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.442 -0.885 . . . . 0.38 113.347 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 77.73 19.81 75.02 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 121.703 -0.284 . . . . 0.28999999999999998 113.412 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 19.6 mt-30 -77.22 -176.22 4.0 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.39 0.614 . . . . 1.8400000000000001 111.728 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.6 147.67 30.3 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.116 -0.947 . . . . 1.21 110.636 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' TYR . . . . . 0.495 ' CE2' HD22 ' A' ' 31' ' ' LEU . 6.3 m-30 -103.19 132.06 49.74 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.975 -0.557 . . . . 0.76000000000000001 110.995 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -119.74 155.14 33.04 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.697 -0.483 . . . . 2.5299999999999998 109.697 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.484 ' HB2' ' OG1' ' A' ' 39' ' ' THR . 51.8 p -82.42 109.71 17.57 Favored Pre-proline 0 N--CA 1.451 -0.411 0 C-N-CA 121.077 -0.249 . . . . 1.3500000000000001 110.56 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.533 ' HD2' ' OG1' ' A' ' 39' ' ' THR . 54.9 Cg_endo -68.45 -2.34 8.97 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.089 1.859 . . . . 0.33000000000000002 112.233 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 102.21 -94.7 1.21 Allowed Glycine 0 C--O 1.227 -0.313 0 C-N-CA 120.629 -0.796 . . . . 0.28000000000000003 111.666 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 95.9 m -121.51 135.41 55.03 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.344 -0.613 . . . . 0.29999999999999999 109.344 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.739 ' CD2' HG21 ' A' ' 210' ' ' THR . 12.3 t80 -133.58 134.74 43.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.93 0.395 . . . . 0.55000000000000004 111.516 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.8 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -98.91 113.05 25.01 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.981 -0.554 . . . . 0.40999999999999998 111.529 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.744 ' N ' HD22 ' A' ' 238' ' ' LEU . 25.1 t -84.59 112.75 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.731 -0.668 . . . . 0.40999999999999998 110.908 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.251 -0.881 . . . . 1.6899999999999999 111.124 -179.699 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.907 ' HB3' HD22 ' A' ' 44' ' ' LEU . 65.4 p . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.795 0.331 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.474 HD22 ' HB2' ' A' ' 98' ' ' ALA . 19.8 m120 56.93 -87.43 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.514 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.782 HH12 ' HB ' ' A' ' 203' ' ' ILE . 29.1 mtm180 -74.69 -58.41 3.31 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.876 0.37 . . . . 0.0 110.985 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.748 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -39.32 -48.42 1.86 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.667 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.08 HD22 HD11 ' A' ' 75' ' ' ILE . 11.0 mt -72.31 -36.42 68.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.905 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.79 HD22 ' HB2' ' A' ' 101' ' ' PRO . 35.9 tp -65.86 -50.19 65.44 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.719 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.712 HD22 ' CZ ' ' A' ' 231' ' ' TYR . 60.0 mt -67.0 -27.64 67.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.728 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.754 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -65.91 -39.18 90.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.14 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.813 ' CB ' HG11 ' A' ' 62' ' ' VAL . . . -81.73 -41.07 21.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.212 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.727 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 14.4 mt -68.33 -4.01 12.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.227 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.534 ' HB2' ' HB3' ' A' ' 231' ' ' TYR . . . -97.6 179.19 4.93 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -177.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.58 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.4 OUTLIER -112.19 113.5 25.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.931 178.543 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 114.12 169.08 16.52 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.608 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.568 ' HG2' ' HG2' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -95.06 117.57 30.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 117.154 0.477 . . . . 0.0 111.475 -179.223 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 235' ' ' GLY . 0.9 OUTLIER -119.58 145.71 46.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.445 -179.697 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.51 HG22 ' HB2' ' A' ' 74' ' ' GLU . 75.8 t -104.37 142.31 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 CA-C-O 121.344 0.592 . . . . 0.0 112.548 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.874 HD23 HD23 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -116.51 116.36 27.49 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 174.632 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.931 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.5 OUTLIER -102.96 151.35 22.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.108 -177.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.7 t30 66.08 27.26 10.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.179 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.907 HD22 ' HB3' ' A' ' 25' ' ' SER . 86.2 mt -54.68 -172.94 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.562 ' HB3' HG21 ' A' ' 50' ' ' VAL . 29.7 tp -114.03 131.38 56.38 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -88.46 88.45 7.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.149 0.5 . . . . 0.0 110.565 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 49' ' ' ASP . 1.7 m -164.31 142.91 7.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.1 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.421 ' HA ' ' HB3' ' A' ' 51' ' ' ARG . 0.6 OUTLIER -36.42 -30.45 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.602 0.239 . . . . 0.0 111.455 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.939 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 1.5 p30 -58.19 -42.77 86.82 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 121.028 0.442 . . . . 0.0 110.905 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.797 HG23 ' OD1' ' A' ' 49' ' ' ASP . 88.8 t -84.24 -44.66 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.57 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.943 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -50.89 -39.01 53.11 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.017 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.668 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 7.4 m-70 -80.31 -32.58 37.96 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.595 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.574 ' O ' HD13 ' A' ' 57' ' ' LEU . 9.5 tpt -55.0 -34.62 63.6 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.943 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.5 OUTLIER -82.42 -41.54 19.75 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 114.22 -1.354 . . . . 0.0 108.58 176.346 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.675 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 34.4 t30 -59.13 -41.56 88.52 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-O 120.922 0.391 . . . . 0.0 110.749 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 1.029 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -59.24 -46.76 87.62 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 121.702 0.763 . . . . 0.0 108.96 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.851 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.4 OUTLIER -63.41 -41.11 98.71 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.245 -1.343 . . . . 0.0 107.745 177.243 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.675 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -59.78 -32.9 71.03 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 114.187 -1.369 . . . . 0.0 111.564 179.044 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.748 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -77.66 -38.33 47.91 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.073 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.698 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.5 OUTLIER -79.89 -12.91 59.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.407 0.622 . . . . 0.0 110.566 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.43 33.33 5.42 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 114.967 -1.015 . . . . 0.0 114.244 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.851 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 40.5 t -90.55 117.67 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.791 ' O ' HG12 ' A' ' 76' ' ' ILE . 26.0 m -82.98 132.89 35.13 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 121.078 0.466 . . . . 0.0 112.167 -178.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.723 ' HB3' HG23 ' A' ' 75' ' ' ILE . 41.1 p90 -158.31 171.87 19.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.463 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 62.1 m -131.37 148.51 52.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.182 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.415 ' CD1' ' HB2' ' A' ' 73' ' ' CYS . 12.5 tp -115.04 133.7 55.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.177 0.513 . . . . 0.0 110.685 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.527 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 0.6 OUTLIER -61.21 -167.22 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.378 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.75 -44.47 14.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.553 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.33 1.79 10.79 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.596 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 58.81 39.83 23.62 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.868 0.366 . . . . 0.0 111.54 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -133.95 -10.46 2.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.225 179.292 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.572 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 14.8 mtp180 -114.92 120.59 40.45 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.676 ' HB3' HD11 ' A' ' 44' ' ' LEU . 34.2 t -129.53 125.62 36.72 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.568 ' HG2' ' HG2' ' A' ' 38' ' ' LYS . 56.8 tt0 -106.98 130.62 54.6 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 176.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 1.08 HD11 HD22 ' A' ' 29' ' ' LEU . 10.4 mt -127.72 124.49 63.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -177.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.791 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -68.51 99.62 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-O 121.104 0.478 . . . . 0.0 109.712 175.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' A' ' 35' ' ' ALA . . . -38.77 143.71 0.29 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.843 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -89.31 -10.71 45.75 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.093 0.473 . . . . 0.0 110.921 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.58 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 90.14 3.11 73.32 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.14 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.505 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 150.07 -148.49 19.8 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.012 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.579 ' CG ' ' HB3' ' A' ' 108' ' ' LEU . 88.1 Cg_exo -49.09 125.14 12.73 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.783 2.322 . . . . 0.0 112.973 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.707 ' H ' HD22 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -74.58 110.52 8.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.792 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.409 ' HA ' ' ND2' ' A' ' 111' ' ' ASN . 4.4 p80 -82.08 135.06 35.37 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.072 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.639 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -98.03 123.78 42.22 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.061 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -71.04 123.67 22.61 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.61 175.71 0.96 Allowed Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -175.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.65 144.8 47.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 118.735 1.268 . . . . 0.0 111.411 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.748 HD21 ' HB1' ' A' ' 59' ' ' ALA . 1.3 tp -116.26 160.54 20.31 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.393 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 22.4 mt-10 -139.22 104.23 4.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.288 178.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.686 ' HB2' HD23 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -100.63 118.83 37.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.143 -178.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.424 ' C ' HD13 ' A' ' 92' ' ' LEU . 4.3 m-85 -92.99 96.26 9.98 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.906 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.923 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -104.89 47.31 0.88 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.089 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.782 ' HA3' ' H ' ' A' ' 118' ' ' GLU . . . -54.4 -44.66 76.78 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.848 -0.692 . . . . 0.0 113.281 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.625 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 74.2 m-20 -94.43 -6.89 42.99 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.666 0.27 . . . . 0.0 110.733 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 1.005 ' HB1' ' HB3' ' A' ' 98' ' ' ALA . . . -98.16 61.7 1.49 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.011 0.434 . . . . 0.0 111.311 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.617 ' O ' ' HD3' ' A' ' 100' ' ' ARG . . . -63.82 -25.2 68.94 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.068 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.434 ' HA ' ' HG2' ' A' ' 171' ' ' GLN . 0.9 OUTLIER -88.19 -17.11 31.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.707 0.289 . . . . 0.0 110.882 179.497 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 1.005 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -95.27 -29.21 14.61 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.925 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.668 ' SD ' ' HB3' ' A' ' 115' ' ' LEU . 5.6 tpp -64.3 -47.4 79.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.168 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.671 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 1.9 mpt_? -54.34 -58.87 11.9 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.79 ' HB2' HD22 ' A' ' 30' ' ' LEU . 18.1 Cg_endo -59.71 -33.04 96.57 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.286 1.991 . . . . 0.0 112.635 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 1.029 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.4 OUTLIER -74.16 -53.43 9.88 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.056 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.884 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -50.04 -28.09 6.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.429 0.633 . . . . 0.0 110.279 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.858 ' HB2' ' HB1' ' A' ' 175' ' ' ALA . . . -86.96 -54.44 4.34 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.316 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.67 ' HB1' HD11 ' A' ' 34' ' ' LEU . . . -59.93 -32.76 71.09 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -176.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.739 ' HB2' HD12 ' A' ' 153' ' ' LEU . 20.2 mt -78.99 -12.89 60.05 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.046 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.559 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 20.2 m -81.23 15.32 1.99 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.219 0.533 . . . . 0.0 110.936 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.691 HD21 ' HB2' ' A' ' 182' ' ' LEU . 2.3 mt -91.91 -71.02 0.66 Allowed 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.267 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.86 146.19 22.06 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.707 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.426 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 3.2 p -58.16 98.84 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.803 0.335 . . . . 0.0 111.141 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.616 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 9.7 m120 -148.28 135.51 20.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.874 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.881 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 5.0 m-20 -91.66 101.05 13.67 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.252 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.639 HD11 ' HB2' ' A' ' 84' ' ' ALA . 31.5 mm -118.89 137.48 52.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.161 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.815 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 62.9 t -110.17 112.39 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 176.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.686 HD23 ' HB2' ' A' ' 90' ' ' LEU . 63.9 mt -102.21 105.83 16.56 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.327 -178.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.776 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -119.37 -175.37 2.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.844 0.354 . . . . 0.0 111.624 -178.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.602 ' H ' HG22 ' A' ' 116' ' ' THR . . . -166.17 178.07 40.91 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.994 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.782 ' H ' ' HA3' ' A' ' 93' ' ' GLY . 3.9 mt-10 -70.79 172.63 5.97 Favored Pre-proline 0 C--N 1.328 -0.333 0 C-N-CA 123.096 0.558 . . . . 0.0 110.793 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.645 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 81.5 Cg_exo -46.65 -39.57 23.34 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.682 2.254 . . . . 0.0 113.105 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.419 ' O ' ' HB3' ' A' ' 123' ' ' GLU . 2.1 mpp_? -67.8 -23.57 65.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.681 0.277 . . . . 0.0 110.961 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.664 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 10.8 tpt -60.92 -35.65 77.25 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.42 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 3.5 mptp? -62.78 -16.86 59.79 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.149 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.651 ' O ' ' HG3' ' A' ' 123' ' ' GLU . 1.0 OUTLIER -80.92 -0.17 38.05 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.307 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.442 ' HB3' HH22 ' A' ' 100' ' ' ARG . 6.5 mtt180 -126.31 83.71 63.45 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.71 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.532 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 15.8 Cg_endo -56.86 148.75 65.03 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.646 2.231 . . . . 0.0 111.538 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 148' ' ' TYR . 0.7 OUTLIER -123.48 -0.76 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.012 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.573 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -53.69 -39.01 60.16 Favored Glycine 0 CA--C 1.516 0.138 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.707 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.745 ' CG ' HG21 ' A' ' 168' ' ' VAL . 1.4 m80 -55.58 -39.29 70.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.023 0.412 . . . . 0.0 110.735 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.747 ' HG ' HD11 ' A' ' 133' ' ' LEU . 14.4 tp -75.36 -40.86 57.7 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.347 0.594 . . . . 0.0 110.141 178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.762 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 55.1 t -56.19 -48.17 79.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.562 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.738 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 75.2 m-20 -69.5 -37.26 77.12 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.133 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.639 ' HB2' HG23 ' A' ' 164' ' ' VAL . . . -58.99 -49.62 77.2 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.936 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.747 HD11 ' HG ' ' A' ' 129' ' ' LEU . 6.6 mt -73.6 -47.44 40.36 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.591 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.762 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -59.53 -27.47 66.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.702 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.738 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 5.6 tp -70.89 -28.69 64.73 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.998 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 159' ' ' GLY . . . -85.55 15.26 47.27 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.709 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.91 4.73 61.45 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.522 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.512 ' HB3' ' C ' ' A' ' 133' ' ' LEU . . . -73.95 152.99 39.96 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 120.865 0.364 . . . . 0.0 111.417 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.446 ' CB ' ' HB2' ' A' ' 154' ' ' GLN . 13.5 mmtm -102.29 103.43 13.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.249 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.681 ' CG2' HD22 ' A' ' 151' ' ' LEU . 14.7 mt -134.86 127.35 48.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.431 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.714 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -124.62 139.23 54.06 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.101 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.494 ' HE1' HG21 ' A' ' 130' ' ' VAL . 36.3 m-85 -78.08 130.35 36.31 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.125 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.759 ' CD2' HG13 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -91.09 -90.26 0.16 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.57 -179.723 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.834 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 2.6 mt-10 -58.99 -81.51 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 122.083 -0.386 . . . . 0.0 110.903 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.428 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 14.2 mt-30 -114.73 151.86 33.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.505 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -66.93 135.2 53.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.919 0.39 . . . . 0.0 110.68 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.573 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 4.3 m-20 66.91 19.73 10.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.196 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.568 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 10.9 m-85 -110.28 169.64 6.15 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 121.085 0.469 . . . . 0.0 112.128 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.914 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 36.5 Cg_exo -33.23 -62.32 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 124.547 3.498 . . . . 0.0 116.252 -177.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.914 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 52.4 Cg_exo -53.56 145.73 46.28 Favored 'Trans proline' 0 C--N 1.352 0.746 0 CA-C-N 120.723 1.294 . . . . 0.0 112.678 -178.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.815 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 6.5 mt -156.3 136.31 12.76 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.62 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.714 ' HB2' HG22 ' A' ' 141' ' ' THR . 11.7 mtt180 -106.42 103.18 12.58 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.884 HD11 ' HA ' ' A' ' 103' ' ' ALA . 6.6 mt -93.6 145.39 24.57 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.797 -178.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.616 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 2.6 mp0 -147.35 26.93 1.04 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.43 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 52.14 -158.59 3.11 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.027 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.39 -12.86 43.69 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 119.922 -1.132 . . . . 0.0 112.917 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.538 ' HE1' ' HA ' ' A' ' 180' ' ' ALA . 51.6 t80 -60.29 122.75 15.27 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 117.14 0.47 . . . . 0.0 110.852 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.689 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 54.3 p -115.31 -33.12 5.41 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.575 0.703 . . . . 0.0 111.206 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.414 ' O ' ' HA2' ' A' ' 136' ' ' GLY . . . 136.46 -160.39 24.74 Favored Glycine 0 C--N 1.305 -1.148 0 CA-C-N 114.667 -1.151 . . . . 0.0 112.247 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.612 ' O ' HG23 ' A' ' 187' ' ' THR . . . 105.97 154.85 21.35 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 120.625 -0.797 . . . . 0.0 111.35 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -47.04 119.22 2.44 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 120.869 0.366 . . . . 0.0 110.944 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.745 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 75.3 t -110.36 129.87 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.929 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.11 119.41 37.79 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.521 -0.472 . . . . 0.0 109.74 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.872 HG21 HD11 ' A' ' 176' ' ' LEU . 1.0 OUTLIER -132.32 120.19 42.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.581 ' HB2' ' CD2' ' A' ' 128' ' ' HIS . 0.6 OUTLIER -53.32 141.89 22.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.246 -179.228 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.899 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . -60.38 -51.69 57.21 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.653 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.427 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 88.8 p -92.93 95.41 9.48 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.454 0.169 . . . . 0.0 111.188 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.745 HG21 ' CG ' ' A' ' 128' ' ' HIS . 8.5 p -179.31 67.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 120.997 0.427 . . . . 0.0 111.539 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.612 ' C ' HG11 ' A' ' 196' ' ' VAL . 0.4 OUTLIER 64.53 126.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.599 179.292 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.466 ' HB3' ' CB ' ' A' ' 197' ' ' SER . 2.8 p -72.29 -16.98 61.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.056 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.671 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 1.5 mp0 -81.62 -11.66 59.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.361 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.532 ' HZ ' ' O ' ' A' ' 125' ' ' PRO . 5.3 m-85 -69.53 -51.84 31.96 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.718 0.77 . . . . 0.0 109.272 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.916 HD21 HD11 ' A' ' 191' ' ' ILE . 0.4 OUTLIER -67.48 -43.21 81.51 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.513 -1.222 . . . . 0.0 109.106 178.71 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.615 ' O ' ' HG3' ' A' ' 178' ' ' MET . 5.1 m -55.01 -33.52 62.69 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.55 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.858 ' HB1' ' HB2' ' A' ' 104' ' ' ALA . . . -66.92 -41.05 87.74 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.874 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.872 HD11 HG21 ' A' ' 164' ' ' VAL . 1.1 mt -76.17 -34.89 59.36 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.404 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.81 HD11 ' CD2' ' A' ' 223' ' ' PHE . 3.8 mp -60.37 -36.95 79.24 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.336 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.624 ' HA ' ' HE1' ' A' ' 208' ' ' MET . 6.0 mtp -81.6 -43.68 18.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.558 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 88.2 m -72.16 -42.48 65.86 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.988 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.542 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . -59.28 -38.93 68.57 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -176.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.652 ' HA ' ' O ' ' A' ' 226' ' ' LYS . 27.0 Cg_endo -65.79 -29.67 50.42 Favored 'Trans proline' 0 CA--C 1.499 -1.236 0 CA-C-N 120.163 1.094 . . . . 0.0 111.699 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.691 ' HB2' HD21 ' A' ' 108' ' ' LEU . 5.6 mt -83.8 2.0 40.28 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.765 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.689 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -84.7 138.29 38.05 Favored Pre-proline 0 C--O 1.224 -0.285 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.201 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.676 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 12.1 Cg_endo -51.47 -31.19 38.01 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.444 2.096 . . . . 0.0 113.028 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.45 140.89 48.87 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.522 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -57.07 147.77 23.51 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.197 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 160' ' ' GLY . 78.8 m -122.99 147.29 46.8 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 36.0 t -126.24 117.9 49.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.745 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 2.6 mp -103.83 117.35 49.19 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.954 0 C-N-CA 120.029 -0.669 . . . . 0.0 109.368 178.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.644 ' HG3' ' HG3' ' A' ' 222' ' ' GLN . 1.3 ttt85 -99.85 124.68 45.41 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.916 HD11 HD21 ' A' ' 173' ' ' LEU . 1.5 mp -94.08 123.48 46.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.976 -176.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -76.21 96.33 3.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.835 -1.529 . . . . 0.0 110.47 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 97.75 -126.72 8.98 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.972 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.59 132.72 56.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.845 0.355 . . . . 0.0 111.633 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.837 HD21 HD13 ' A' ' 173' ' ' LEU . 0.9 OUTLIER -42.07 144.42 0.46 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.044 179.267 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.612 HG11 ' C ' ' A' ' 169' ' ' SER . 12.5 p -73.87 -26.52 21.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.165 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.466 ' CB ' ' HB3' ' A' ' 170' ' ' SER . 0.3 OUTLIER -168.51 65.05 0.07 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.176 0.513 . . . . 0.0 109.741 -179.663 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.49 ' HA ' HD13 ' A' ' 195' ' ' LEU . 0.0 OUTLIER -42.93 -46.02 12.55 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.096 -179.812 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 198' ' ' LYS . 79.8 Cg_exo -48.27 -34.83 25.65 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.903 1.735 . . . . 0.0 111.638 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.927 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.3 OUTLIER -67.91 -42.45 81.12 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.401 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.453 HG21 ' CE2' ' A' ' 223' ' ' PHE . 20.0 mm -60.12 -39.49 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.026 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -57.15 -47.2 81.76 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.224 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.927 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.9 mt -60.55 -50.38 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 CA-C-O 121.486 0.66 . . . . 0.0 109.457 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.579 ' CG2' HG23 ' A' ' 174' ' ' THR . 89.7 m -52.83 -52.01 58.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.756 -177.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.889 HD22 ' HB ' ' A' ' 215' ' ' ILE . 45.2 mt -65.02 -31.36 72.55 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 120.985 0.422 . . . . 0.0 111.415 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -76.86 -44.89 30.35 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.751 0.786 . . . . 0.0 109.743 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.889 ' O ' HG22 ' A' ' 210' ' ' THR . 8.0 tp -71.8 -29.6 64.63 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.301 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . 0.726 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 41.7 mtp -75.99 -35.42 59.6 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.677 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 3.5 mtmt -61.54 -38.66 88.25 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 114.438 -1.255 . . . . 0.0 111.001 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.889 HG22 ' O ' ' A' ' 207' ' ' LEU . 6.1 t -61.54 -31.64 71.67 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.388 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.598 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 40.6 m-85 -78.74 -5.26 52.74 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.83 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.29 5.62 28.22 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 115.891 1.116 . . . . 0.0 115.891 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.3 m -123.53 148.69 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 118.878 1.339 . . . . 0.0 112.78 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.617 ' O ' HD13 ' A' ' 215' ' ' ILE . 20.4 mt-10 -129.18 140.14 51.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.893 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.889 ' HB ' HD22 ' A' ' 205' ' ' LEU . 16.3 mm -122.76 148.3 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 120.699 0.285 . . . . 0.0 110.314 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.738 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 38.8 tt0 -101.21 115.09 29.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.656 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -81.51 150.78 28.08 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.302 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 222' ' ' GLN . 5.5 tp60 -108.3 -136.7 0.36 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.759 -0.2 . . . . 0.0 111.321 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.423 ' CD2' ' HG3' ' A' ' 218' ' ' GLN . 77.3 m-70 -84.6 69.53 10.63 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 120.832 0.349 . . . . 0.0 110.307 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.408 ' CE1' ' HG3' ' A' ' 198' ' ' LYS . 4.0 t80 54.16 31.28 13.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 122.11 0.957 . . . . 0.0 109.967 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.676 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -160.69 -128.32 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 113.632 -1.622 . . . . 0.0 106.838 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.735 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -4.53 129.24 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -179.446 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.81 ' CD2' HD11 ' A' ' 177' ' ' LEU . 0.7 OUTLIER -124.44 128.33 48.85 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.104 -1.862 . . . . 0.0 109.091 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.738 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 46.2 t -111.24 114.06 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 121.544 0.688 . . . . 0.0 109.393 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.74 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.4 OUTLIER -124.35 119.91 57.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.181 -178.651 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.652 ' O ' ' HA ' ' A' ' 181' ' ' PRO . 4.0 pttt -74.17 143.41 45.25 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -92.93 -173.15 40.82 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.678 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 62.72 21.13 62.64 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 121.49 -0.386 . . . . 0.0 113.253 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . 0.411 ' HB2' ' HB2' ' A' ' 181' ' ' PRO . 17.9 mt-30 -80.68 -172.94 3.88 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.272 0.558 . . . . 0.0 111.361 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 2.3 t -158.18 147.95 19.86 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.625 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' TYR . . . . . 0.727 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 7.8 m-85 -99.04 136.02 39.61 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.149 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.401 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 0.1 OUTLIER -123.09 148.02 46.11 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.697 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.502 ' HB2' ' OG1' ' A' ' 39' ' ' THR . 19.5 p -72.47 110.93 9.2 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.575 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.441 ' HD2' ' OG1' ' A' ' 39' ' ' THR . 55.7 Cg_endo -69.95 1.1 4.87 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.195 1.93 . . . . 0.0 112.141 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 100.28 -99.61 2.05 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 93.0 m -120.03 136.82 54.42 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.674 ' CD2' HG21 ' A' ' 210' ' ' THR . 10.9 t80 -132.96 128.07 35.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.974 0.416 . . . . 0.0 111.707 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.931 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -92.97 111.87 23.64 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.587 179.526 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.67 ' N ' HD22 ' A' ' 238' ' ' LEU . 21.7 t -85.87 111.68 21.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.143 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.404 ' HG3' HD13 ' A' ' 238' ' ' LEU . 1.6 mt-10 . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.15 -0.928 . . . . 0.0 111.083 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.732 ' HB2' HD22 ' A' ' 44' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 120.843 0.354 . . . . 0.0 111.601 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.402 ' OD1' ' OG1' ' A' ' 97' ' ' THR . 70.0 m-80 62.99 -81.2 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.191 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.871 ' HE ' HD23 ' A' ' 207' ' ' LEU . 78.6 mtm-85 -74.15 -57.48 3.93 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.849 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -43.21 -45.16 5.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.139 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.053 HD22 HD11 ' A' ' 75' ' ' ILE . 9.8 mt -75.54 -33.42 60.68 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.043 0.449 . . . . 0.0 111.154 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.733 HD11 ' CB ' ' A' ' 105' ' ' ALA . 66.1 tp -69.55 -50.11 48.04 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.115 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.889 HD22 ' CZ ' ' A' ' 231' ' ' TYR . 21.4 mt -68.61 -26.8 65.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.94 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.799 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -65.22 -39.35 92.63 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.645 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.856 ' CB ' HG11 ' A' ' 62' ' ' VAL . . . -81.35 -41.32 22.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.071 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.719 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 14.2 mt -67.32 -3.4 7.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.0 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.56 ' HB2' ' HB3' ' A' ' 231' ' ' TYR . . . -98.51 177.89 5.19 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -177.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.548 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.7 OUTLIER -110.87 112.29 24.02 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.787 178.281 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 114.83 167.11 15.46 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.787 ' HE3' HD12 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -94.89 117.83 30.79 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 117.144 0.472 . . . . 0.0 111.55 -179.097 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 235' ' ' GLY . 0.8 OUTLIER -119.61 146.84 45.17 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.94 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.544 HG22 ' HB2' ' A' ' 74' ' ' GLU . 91.8 t -103.55 142.14 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 CA-C-O 121.77 0.795 . . . . 0.0 112.653 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.986 HD23 HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -117.25 116.3 26.99 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 174.437 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.967 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.6 OUTLIER -105.06 152.41 22.79 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.437 -177.32 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.2 t30 66.57 26.67 9.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.098 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.817 HD21 ' HB3' ' A' ' 41' ' ' LEU . 65.1 mt -55.05 -170.82 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.653 ' HB3' HG21 ' A' ' 50' ' ' VAL . 48.9 tp -114.15 131.71 56.34 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.816 0.341 . . . . 0.0 110.245 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -88.98 87.06 7.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.097 0.475 . . . . 0.0 110.738 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.468 ' HB3' ' OD1' ' A' ' 49' ' ' ASP . 27.8 t -164.14 142.61 7.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.06 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.452 ' OD2' ' HB2' ' A' ' 94' ' ' ASN . 33.9 p-10 -36.71 -29.14 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.946 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 37.6 p-10 -60.58 -42.48 96.77 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.187 0.518 . . . . 0.0 110.365 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.653 HG21 ' HB3' ' A' ' 45' ' ' LEU . 99.3 t -82.13 -46.02 19.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.701 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.92 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -49.28 -39.34 30.45 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.465 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.682 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 11.3 m-70 -78.86 -32.33 45.96 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.197 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.611 ' O ' HD13 ' A' ' 57' ' ' LEU . 8.0 tpt -54.2 -37.43 64.53 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 176.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.92 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.3 OUTLIER -80.58 -43.94 19.79 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.666 176.105 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.718 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 2.0 t30 -58.41 -36.41 73.54 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.01 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 1.002 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -63.52 -44.61 93.78 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 122.034 0.921 . . . . 0.0 108.88 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.876 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -64.95 -40.97 95.82 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.558 -1.655 . . . . 0.0 107.011 177.164 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.718 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.2 m -60.19 -31.69 70.38 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 113.757 -1.565 . . . . 0.0 111.233 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.724 ' C ' HD21 ' A' ' 88' ' ' LEU . . . -79.55 -37.53 36.26 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.024 -179.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.709 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.5 OUTLIER -81.73 -14.45 56.5 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.375 0.607 . . . . 0.0 110.765 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.87 33.32 5.04 Favored Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.292 -0.867 . . . . 0.0 114.47 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.876 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 21.6 t -90.44 118.71 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.844 ' O ' HG12 ' A' ' 76' ' ' ILE . 7.5 t -84.03 136.02 34.2 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 120.944 0.402 . . . . 0.0 110.799 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.926 ' HB3' HG23 ' A' ' 75' ' ' ILE . 35.3 p90 -160.71 170.39 20.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.542 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.411 ' N ' ' O ' ' A' ' 74' ' ' GLU . 83.5 m -133.65 147.89 51.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.491 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.519 HD12 ' HB2' ' A' ' 73' ' ' CYS . 10.5 tp -116.56 136.22 53.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.182 0.515 . . . . 0.0 110.956 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.578 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 1.6 m -61.43 -167.44 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.912 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.42 -31.76 18.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.811 0.339 . . . . 0.0 110.926 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.44 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 0.2 OUTLIER -76.64 1.26 17.44 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.266 179.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 56.86 27.84 13.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.752 0.31 . . . . 0.0 111.515 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.44 ' OG1' ' HB3' ' A' ' 69' ' ' ASP . 0.9 OUTLIER -127.25 -11.26 5.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.293 179.716 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.578 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 2.1 mtt85 -111.06 121.42 45.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.325 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.626 ' HB3' HD11 ' A' ' 44' ' ' LEU . 40.4 t -130.8 125.14 32.94 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 112.386 0.514 . . . . 0.0 112.386 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.544 ' HB2' HG22 ' A' ' 40' ' ' VAL . 29.7 tt0 -107.72 131.3 54.57 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 176.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 1.053 HD11 HD22 ' A' ' 29' ' ' LEU . 7.8 mt -127.57 123.22 60.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.844 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -68.53 100.93 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 121.682 0.753 . . . . 0.0 109.16 176.027 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -38.88 144.79 0.23 Allowed Glycine 0 C--N 1.32 -0.351 0 CA-C-N 114.415 -1.266 . . . . 0.0 114.16 -178.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.49 ' CB ' HD12 ' A' ' 82' ' ' LEU . 33.6 t30 -90.45 -11.2 41.06 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 120.962 0.41 . . . . 0.0 110.612 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.548 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 86.56 9.18 75.86 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.435 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.402 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 146.51 -151.12 23.42 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.888 -0.673 . . . . 0.0 111.976 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.548 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 9.3 Cg_endo -50.75 128.67 24.87 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.511 2.141 . . . . 0.0 111.805 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.709 ' HB2' HD13 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -77.68 115.04 17.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.304 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.469 ' HA ' ' CG ' ' A' ' 111' ' ' ASN . 4.5 p80 -83.22 134.83 34.94 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.127 0.489 . . . . 0.0 112.022 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.519 ' CB ' HD11 ' A' ' 113' ' ' ILE . . . -96.48 123.57 40.18 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.863 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -71.71 123.65 23.04 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 176.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.93 178.17 1.01 Allowed Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 -175.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 112' ' ' ASP . . . -73.41 144.87 46.19 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 118.601 1.2 . . . . 0.0 111.342 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.751 ' CB ' HG13 ' A' ' 113' ' ' ILE . 0.9 OUTLIER -112.94 161.08 17.41 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.064 -178.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 4.1 mt-10 -143.0 102.8 4.07 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.108 177.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.828 ' HB2' HD23 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -98.29 122.08 41.01 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.779 -178.696 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.641 ' C ' HD13 ' A' ' 92' ' ' LEU . 18.3 m-85 -96.07 96.58 8.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.694 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 1.026 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -114.29 57.93 0.69 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.193 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.827 ' HA3' ' H ' ' A' ' 118' ' ' GLU . . . -59.64 -48.42 86.12 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.145 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.452 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 0.7 OUTLIER -94.87 -2.18 51.23 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.642 0.258 . . . . 0.0 110.687 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 1.026 ' HB3' ' HB3' ' A' ' 92' ' ' LEU . . . -92.63 45.53 1.2 Allowed 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.803 0.335 . . . . 0.0 110.989 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.664 ' O ' ' HD3' ' A' ' 100' ' ' ARG . . . -53.14 -23.26 16.2 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.352 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.751 HG22 ' OE1' ' A' ' 171' ' ' GLN . 15.9 p -88.7 -19.02 26.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.414 0.149 . . . . 0.0 111.037 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.875 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -98.12 -26.83 14.45 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.627 ' SD ' ' HB3' ' A' ' 115' ' ' LEU . 9.8 tpp -63.92 -44.03 94.13 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.712 0.291 . . . . 0.0 111.016 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.784 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 1.1 mpt_? -60.72 -55.74 41.9 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.784 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 23.7 Cg_exo -61.16 -32.14 90.77 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 121.633 1.555 . . . . 0.0 111.411 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 1.002 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -74.62 -53.31 9.59 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.804 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.86 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -51.58 -28.57 14.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.523 0.678 . . . . 0.0 110.236 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.72 ' HB2' ' HB1' ' A' ' 175' ' ' ALA . . . -86.76 -53.85 4.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.807 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.733 ' CB ' HD11 ' A' ' 30' ' ' LEU . . . -59.82 -28.06 67.14 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -176.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.627 ' HB2' HD12 ' A' ' 153' ' ' LEU . 35.2 mt -81.62 -28.16 33.82 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.139 -177.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.754 ' HB2' ' HB1' ' A' ' 138' ' ' ALA . 12.4 p -72.95 12.26 0.55 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.189 0.519 . . . . 0.0 111.085 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.713 ' HG ' HG23 ' A' ' 179' ' ' THR . 1.4 mt -79.81 -76.6 0.21 Allowed 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.083 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.505 ' O ' ' HA3' ' A' ' 155' ' ' GLY . . . -71.78 -117.54 0.05 OUTLIER Glycine 0 N--CA 1.454 -0.146 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.884 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -150.9 96.85 2.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.964 0.411 . . . . 0.0 110.884 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.684 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 18.6 m-80 -149.06 139.37 22.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.273 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.872 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 1.9 m-20 -94.34 96.32 9.46 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.046 0.45 . . . . 0.0 110.126 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.751 HG13 ' CB ' ' A' ' 88' ' ' LEU . 1.4 mp -118.99 144.21 27.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.48 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.814 HG13 HD23 ' A' ' 143' ' ' LEU . 47.8 t -110.05 112.95 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.828 HD23 ' HB2' ' A' ' 90' ' ' LEU . 59.7 mt -101.98 106.67 17.62 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.02 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.838 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.7 OUTLIER -122.66 -172.15 2.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.165 -178.709 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.684 ' H ' HG22 ' A' ' 116' ' ' THR . . . -167.07 179.05 41.01 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.832 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.827 ' H ' ' HA3' ' A' ' 93' ' ' GLY . 8.4 pt-20 -71.16 173.51 4.87 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 123.277 0.631 . . . . 0.0 110.549 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.789 ' HD2' ' HB2' ' A' ' 118' ' ' GLU . 7.6 Cg_endo -47.47 -36.61 24.28 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.699 2.266 . . . . 0.0 113.606 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.479 ' CG ' ' HG3' ' A' ' 118' ' ' GLU . 0.4 OUTLIER -67.37 -25.06 65.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.905 0.383 . . . . 0.0 110.443 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.651 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 8.1 tpt -60.55 -35.53 76.26 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.629 ' HE3' ' HG2' ' A' ' 149' ' ' PRO . 0.1 OUTLIER -62.51 -16.84 57.88 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.995 179.266 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.668 ' O ' ' HG3' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -85.06 -1.85 57.31 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.186 0.517 . . . . 0.0 109.645 178.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.662 ' HB3' HH22 ' A' ' 100' ' ' ARG . 1.3 mpt_? -126.12 86.35 58.08 Favored Pre-proline 0 CA--C 1.531 0.25 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.746 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.557 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 17.9 Cg_endo -58.7 148.71 81.32 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.677 2.251 . . . . 0.0 111.696 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.483 ' O ' HG13 ' A' ' 126' ' ' ILE . 0.7 OUTLIER -123.01 -0.13 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.194 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.632 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -53.98 -34.7 52.47 Favored Glycine 0 CA--C 1.516 0.12 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.513 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.503 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 57.4 m80 -58.5 -40.01 81.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.163 0.506 . . . . 0.0 110.851 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.847 ' HG ' HD11 ' A' ' 133' ' ' LEU . 34.0 tp -75.33 -39.28 59.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.202 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.72 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 54.8 t -56.91 -47.78 82.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.555 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.764 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 77.7 m-20 -71.23 -38.5 71.96 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.472 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.448 ' HA ' HG13 ' A' ' 162' ' ' VAL . . . -60.15 -44.66 94.81 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.534 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.847 HD11 ' HG ' ' A' ' 129' ' ' LEU . 5.7 mt -75.73 -50.27 15.79 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 121.086 0.47 . . . . 0.0 110.66 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.72 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -57.81 -28.3 63.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.055 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.764 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 5.5 tp -67.63 -30.97 70.68 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-O 121.004 0.431 . . . . 0.0 110.312 178.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 159' ' ' GLY . . . -81.4 12.75 37.64 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.892 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.16 3.74 63.33 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.459 -0.876 . . . . 0.0 112.429 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.754 ' HB1' ' HB2' ' A' ' 107' ' ' CYS . . . -73.88 153.87 39.67 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.837 0.351 . . . . 0.0 111.654 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 9.4 mttp -100.85 104.58 15.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.643 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.641 ' CG2' HG13 ' A' ' 130' ' ' VAL . 30.3 mt -136.27 125.23 37.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.954 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.914 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -124.15 139.99 53.4 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.005 0.431 . . . . 0.0 110.554 -179.483 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.52 ' CE1' HG21 ' A' ' 130' ' ' VAL . 43.7 m-85 -79.6 132.07 36.17 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.358 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.814 HD23 HG13 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -96.46 -88.5 0.28 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.795 -179.578 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.722 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 36.0 mt-10 -57.38 -80.98 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.546 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.567 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 15.0 mt-30 -117.77 148.95 41.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.991 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.64 135.22 56.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.951 0.405 . . . . 0.0 110.154 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.632 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 5.6 m-20 65.93 20.05 11.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.293 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.598 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 14.5 m-85 -111.72 169.25 6.53 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 121.202 0.525 . . . . 0.0 111.838 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.96 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 21.8 Cg_exo -31.19 -65.36 0.09 OUTLIER 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 124.385 3.39 . . . . 0.0 116.271 -178.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.96 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 72.3 Cg_exo -50.84 145.95 22.53 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 121.186 1.257 . . . . 0.0 113.305 -178.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.786 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 7.3 mt -156.49 136.64 12.82 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.422 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.914 ' HB2' HG22 ' A' ' 141' ' ' THR . 4.3 mtt180 -106.81 102.25 11.63 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.872 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 9.8 mt -92.53 145.53 24.37 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.909 -178.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.684 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 6.8 mt-30 -148.33 24.98 1.0 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.455 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 55.19 -166.99 2.79 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.53 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.425 ' O ' HG23 ' A' ' 158' ' ' THR . . . 112.6 -14.44 24.84 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.16 -1.019 . . . . 0.0 113.387 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.647 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 4.3 t80 -58.69 122.6 13.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.434 0.617 . . . . 0.0 110.395 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.691 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 82.0 p -115.86 -26.75 7.25 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 121.375 0.607 . . . . 0.0 111.39 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.458 ' O ' ' HA2' ' A' ' 136' ' ' GLY . . . 132.66 -159.62 23.51 Favored Glycine 0 N--CA 1.438 -1.189 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.346 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.559 ' O ' HG23 ' A' ' 187' ' ' THR . . . 104.77 151.99 21.49 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.729 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -46.29 116.36 1.25 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.01 -0.595 . . . . 0.0 110.66 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.76 ' HB ' HG13 ' A' ' 189' ' ' ILE . 79.2 t -108.81 137.94 38.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.693 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.41 119.67 39.49 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.629 -0.429 . . . . 0.0 110.796 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 1.077 HG21 HD11 ' A' ' 176' ' ' LEU . 1.7 t -130.25 119.96 47.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.784 ' HB3' HG23 ' A' ' 168' ' ' VAL . 4.1 t70 -59.56 141.71 54.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.942 0.401 . . . . 0.0 110.797 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.846 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . -63.4 -26.23 69.32 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.219 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.4 t -82.66 -10.86 58.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.673 0.273 . . . . 0.0 111.313 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.784 HG23 ' HB3' ' A' ' 165' ' ' ASP . 26.8 t -61.34 150.98 7.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.287 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.606 ' HB3' ' CD1' ' A' ' 172' ' ' PHE . 2.5 t -50.34 159.26 0.49 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.071 0.463 . . . . 0.0 111.134 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.11 -17.37 60.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.865 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.771 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 0.1 OUTLIER -88.17 -14.72 37.94 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.399 -178.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.813 ' HA ' HD13 ' A' ' 129' ' ' LEU . 8.4 m-85 -72.54 -49.8 30.14 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.472 0.653 . . . . 0.0 109.545 178.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.786 ' HG ' HG11 ' A' ' 164' ' ' VAL . 0.5 OUTLIER -70.46 -43.7 69.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.39 178.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.606 HG21 ' HD3' ' A' ' 27' ' ' ARG . 1.5 m -56.79 -34.58 67.79 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.458 178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.755 ' HB3' HD11 ' A' ' 129' ' ' LEU . . . -63.98 -39.78 94.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.493 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 1.077 HD11 HG21 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -77.01 -33.82 57.48 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.496 179.4 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.863 ' O ' ' HE1' ' A' ' 208' ' ' MET . 3.0 mp -59.56 -37.96 79.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.384 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.735 ' HE1' ' HG2' ' A' ' 27' ' ' ARG . 1.9 mtp -82.02 -43.12 18.38 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.47 0.652 . . . . 0.0 112.498 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.713 HG23 ' HG ' ' A' ' 108' ' ' LEU . 100.0 m -72.94 -43.25 62.56 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.792 -1.094 . . . . 0.0 113.077 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.603 ' HB1' ' HB ' ' A' ' 187' ' ' THR . . . -59.33 -38.98 68.87 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -177.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.561 ' HD3' HG21 ' A' ' 225' ' ' VAL . 33.6 Cg_endo -66.29 -28.34 47.42 Favored 'Trans proline' 0 CA--C 1.501 -1.129 0 C-N-CA 120.904 1.069 . . . . 0.0 111.37 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.66 ' HB2' HD21 ' A' ' 108' ' ' LEU . 7.3 mt -84.72 1.82 44.78 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.913 -1.039 . . . . 0.0 109.206 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.612 ' HB1' ' C ' ' A' ' 158' ' ' THR . . . -83.15 135.2 44.86 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.03 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.691 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 10.8 Cg_endo -49.23 -32.12 24.17 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.54 2.16 . . . . 0.0 113.015 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -115.03 140.16 49.28 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.586 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -55.61 145.65 22.85 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.301 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.603 ' HB ' ' HB1' ' A' ' 180' ' ' ALA . 86.3 m -122.39 144.0 49.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.231 0.539 . . . . 0.0 112.335 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.698 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 50.3 t -125.11 118.18 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 176.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.841 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 4.9 mp -101.56 117.47 46.9 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.93 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.596 ' HB2' ' HG3' ' A' ' 222' ' ' GLN . 0.2 OUTLIER -100.43 124.19 45.61 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.103 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.846 HG23 ' HA2' ' A' ' 166' ' ' GLY . 1.6 mp -93.52 123.33 45.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.96 -176.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.418 ' CG ' ' HA ' ' A' ' 165' ' ' ASP . 38.0 mttt -80.08 97.23 6.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.002 -1.454 . . . . 0.0 110.47 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 98.39 -133.92 11.51 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.171 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.07 125.73 52.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.225 0.536 . . . . 0.0 111.719 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.634 HD11 ' HZ ' ' A' ' 223' ' ' PHE . 1.9 mt -41.84 145.66 0.31 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.55 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 8.0 p -70.57 -29.12 37.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.725 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.465 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 28.6 t -168.16 65.49 0.07 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.98 0.419 . . . . 0.0 110.737 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.678 ' N ' ' HD2' ' A' ' 199' ' ' PRO . 2.5 tmpt? -37.26 -47.46 2.07 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.806 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.678 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 4.8 Cg_endo -47.31 -34.06 17.78 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.376 2.051 . . . . 0.0 111.434 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.955 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.2 OUTLIER -67.11 -43.49 82.34 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.685 0.755 . . . . 0.0 109.065 178.072 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.752 HG21 ' HE2' ' A' ' 223' ' ' PHE . 27.8 mm -64.44 -32.46 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.921 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.74 -41.94 95.56 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.796 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.955 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.4 mt -61.47 -50.14 81.57 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 CA-C-O 121.701 0.762 . . . . 0.0 109.41 178.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.633 HG22 ' SD ' ' A' ' 208' ' ' MET . 100.0 m -53.71 -52.32 60.45 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.119 -178.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.938 HD22 ' HB ' ' A' ' 215' ' ' ILE . 44.6 mt -65.99 -30.79 71.4 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.109 0.481 . . . . 0.0 111.56 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -77.2 -46.71 22.4 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.772 0.796 . . . . 0.0 109.715 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.871 HD23 ' HE ' ' A' ' 27' ' ' ARG . 3.3 tp -70.34 -29.55 66.28 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.242 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . 0.863 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 49.8 mtp -73.85 -34.14 64.39 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.591 0.71 . . . . 0.0 109.194 177.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.76 ' HE2' ' O ' ' A' ' 205' ' ' LEU . 5.1 mtmm -61.59 -40.17 93.82 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.236 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.866 HG22 ' O ' ' A' ' 207' ' ' LEU . 4.7 t -60.52 -28.35 68.33 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.069 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.716 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 49.5 m-85 -80.25 -7.67 59.11 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.519 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.7 7.64 25.47 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 115.503 0.961 . . . . 0.0 115.503 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.696 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 5.3 m -123.42 148.83 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 118.775 1.287 . . . . 0.0 112.811 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.589 ' HG2' ' CG ' ' A' ' 209' ' ' LYS . 4.7 mt-10 -130.22 138.19 50.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.818 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.976 HD12 ' HB ' ' A' ' 225' ' ' VAL . 22.1 mm -122.41 147.74 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-O 120.836 0.35 . . . . 0.0 110.236 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.708 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 20.5 tt0 -103.63 115.86 31.29 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.774 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.51 149.44 27.54 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.588 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . 0.744 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -108.07 -144.86 0.39 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.597 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 8.1 m-70 -72.66 65.3 0.68 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.917 0.389 . . . . 0.0 111.523 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 1.7 t80 56.52 32.73 21.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.838 0.827 . . . . 0.0 110.609 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.662 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 9.1 pt20 -159.78 -126.22 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.841 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.4 OUTLIER -10.11 134.98 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 115.024 1.491 . . . . 0.0 115.024 -179.671 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.752 ' HE2' HG21 ' A' ' 201' ' ' ILE . 0.9 OUTLIER -126.31 138.24 53.57 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 113.032 -1.894 . . . . 0.0 110.139 -179.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.708 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 36.9 t -118.24 114.19 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.976 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.5 OUTLIER -122.4 120.39 60.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.806 -178.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.611 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -74.65 122.74 23.66 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.517 179.232 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -74.39 -173.39 29.78 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.251 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 62.23 19.65 59.78 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 121.401 -0.428 . . . . 0.0 113.158 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . 0.611 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 47.1 mt-30 -75.52 -171.96 1.67 Allowed 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.347 0.594 . . . . 0.0 111.006 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 23.3 t -155.55 147.45 23.32 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.133 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' TYR . . . . . 0.889 ' CZ ' HD22 ' A' ' 31' ' ' LEU . 2.2 m-30 -102.01 134.97 44.38 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.7 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.427 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 2.6 mt-30 -126.21 145.55 50.34 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.428 ' HB2' ' OG1' ' A' ' 39' ' ' THR . 25.0 p -72.39 109.42 5.88 Favored Pre-proline 0 N--CA 1.445 -0.685 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.7 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.515 ' HG3' HG23 ' A' ' 210' ' ' THR . 43.5 Cg_endo -66.75 0.1 3.98 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.865 1.71 . . . . 0.0 112.185 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 101.38 -102.55 2.41 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.498 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 90.0 m -117.3 132.86 56.52 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.637 ' CD2' HG21 ' A' ' 210' ' ' THR . 6.5 t80 -132.64 127.42 34.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.129 0.49 . . . . 0.0 111.696 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.967 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -90.16 113.0 24.69 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.396 179.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.672 ' N ' HD22 ' A' ' 238' ' ' LEU . 21.2 t -85.78 111.38 20.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.622 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.447 ' HG2' HD11 ' A' ' 238' ' ' LEU . 32.5 mt-10 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.235 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.9 ' HB3' HD22 ' A' ' 44' ' ' LEU . 88.4 p . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.726 0.298 . . . . 0.0 111.222 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.4 m120 59.63 -95.21 0.05 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.816 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.577 ' HE ' HD23 ' A' ' 207' ' ' LEU . 16.4 mtm-85 -76.43 -56.05 4.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.823 0.344 . . . . 0.0 110.989 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.761 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -35.55 -47.97 0.48 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.643 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.031 HD22 HD11 ' A' ' 75' ' ' ILE . 9.8 mt -73.48 -34.44 65.33 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.872 0.368 . . . . 0.0 111.433 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.819 HD22 ' HB2' ' A' ' 101' ' ' PRO . 54.3 tp -68.46 -50.1 54.98 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.732 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.713 HD13 ' HA ' ' A' ' 208' ' ' MET . 49.0 mt -68.23 -26.71 65.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.583 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.779 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -65.63 -38.27 88.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.552 178.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.714 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . . . -81.26 -41.53 22.05 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.996 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.803 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 9.9 mt -68.93 -2.91 10.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.279 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.538 ' HA ' ' CB ' ' A' ' 231' ' ' TYR . . . -100.13 179.26 4.54 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -176.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.582 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.3 OUTLIER -112.59 113.83 26.17 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.012 178.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.11 166.85 16.68 Favored Glycine 0 C--N 1.322 -0.243 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.321 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.616 ' HG3' HD13 ' A' ' 76' ' ' ILE . 1.1 ttmt -95.37 117.68 30.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 117.155 0.478 . . . . 0.0 111.59 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.585 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 0.8 OUTLIER -117.73 148.59 41.87 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.387 179.59 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.515 HG22 ' HB2' ' A' ' 74' ' ' GLU . 92.4 t -105.47 141.27 21.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.144 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.931 HD23 HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -114.8 116.27 28.34 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 174.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.984 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.5 OUTLIER -102.84 151.67 22.16 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.869 0.366 . . . . 0.0 111.437 -177.48 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 64.97 28.29 12.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.844 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.9 HD22 ' HB3' ' A' ' 25' ' ' SER . 91.4 mt -53.55 -174.26 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.195 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.528 ' HB3' HG21 ' A' ' 50' ' ' VAL . 56.6 tp -113.19 131.42 55.88 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -88.89 88.76 7.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.98 0.419 . . . . 0.0 110.323 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 50' ' ' VAL . 6.2 m -164.76 143.15 6.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.116 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.406 ' HA ' ' HB3' ' A' ' 51' ' ' ARG . 1.2 m-20 -36.34 -30.95 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 O-C-N 123.046 0.216 . . . . 0.0 111.575 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.858 ' OD1' HG23 ' A' ' 50' ' ' VAL . 1.4 p30 -57.78 -42.57 84.39 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-O 121.103 0.478 . . . . 0.0 110.617 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.858 HG23 ' OD1' ' A' ' 49' ' ' ASP . 74.6 t -83.91 -44.44 18.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.115 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.876 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -50.21 -39.18 43.44 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.618 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 9.6 m-70 -80.39 -32.43 37.58 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.771 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.526 ' O ' HD13 ' A' ' 57' ' ' LEU . 8.4 tpt -54.79 -34.64 62.92 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 176.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.876 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -83.49 -44.06 15.12 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.902 176.34 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.686 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 1.7 t30 -59.23 -37.8 78.43 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.816 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 1.054 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -62.15 -47.78 83.03 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.868 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.2 OUTLIER -61.42 -40.95 96.32 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.161 -1.382 . . . . 0.0 107.556 177.001 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.686 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.1 m -59.31 -33.93 71.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.056 -1.429 . . . . 0.0 111.417 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.734 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -78.34 -38.39 42.19 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.318 -178.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.714 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.6 OUTLIER -79.49 -14.37 58.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.42 0.629 . . . . 0.0 110.531 -179.626 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.77 35.78 4.48 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 114.938 -1.028 . . . . 0.0 113.854 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.868 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 25.0 t -90.41 121.29 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.782 ' O ' HG12 ' A' ' 76' ' ' ILE . 6.8 t -86.06 135.67 33.53 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.143 0.497 . . . . 0.0 111.148 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.8 ' HB3' HG23 ' A' ' 75' ' ' ILE . 36.0 p90 -161.99 172.29 16.22 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.324 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.9 m -134.66 147.32 50.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.321 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.552 HD21 ' HA ' ' A' ' 70' ' ' ARG . 5.5 tp -117.79 138.28 52.17 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.163 0.506 . . . . 0.0 110.852 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.525 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 1.1 m -63.88 -164.51 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.94 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -93.18 -34.04 13.76 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.438 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.52 1.06 15.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.661 0.267 . . . . 0.0 111.276 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.552 ' HA ' HD21 ' A' ' 66' ' ' LEU . 0.3 OUTLIER 57.6 39.86 27.25 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.943 0.402 . . . . 0.0 111.059 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.502 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 1.1 p -139.18 -10.52 1.27 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.441 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.525 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 7.6 mtt180 -114.16 117.67 31.85 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.778 ' HB3' HD11 ' A' ' 44' ' ' LEU . 13.9 t -130.08 128.91 42.86 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.585 ' HA ' ' O ' ' A' ' 39' ' ' THR . 29.0 tt0 -112.11 128.95 56.36 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 176.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 1.031 HD11 HD22 ' A' ' 29' ' ' LEU . 16.2 mt -124.22 123.35 66.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -178.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.782 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -68.73 97.92 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-O 121.427 0.632 . . . . 0.0 109.664 175.833 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 35' ' ' ALA . . . -37.82 144.25 0.19 Allowed Glycine 0 C--N 1.322 -0.237 0 CA-C-N 114.804 -1.089 . . . . 0.0 113.974 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.665 HD22 HD12 ' A' ' 82' ' ' LEU . 2.6 t-20 -90.17 -10.87 42.89 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.957 0.408 . . . . 0.0 110.91 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.582 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 93.36 -1.35 69.49 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.921 -0.582 . . . . 0.0 112.6 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.551 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 154.69 -145.96 13.58 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.172 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.599 ' HG3' ' HB3' ' A' ' 108' ' ' LEU . 53.7 Cg_exo -49.8 124.84 13.12 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.74 2.293 . . . . 0.0 112.718 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.714 ' HB2' HD13 ' A' ' 60' ' ' LEU . 0.9 OUTLIER -77.25 106.38 8.94 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.637 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -81.92 138.77 34.94 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.519 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.617 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -100.38 126.96 46.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.955 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.77 123.69 22.53 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 176.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.62 174.2 0.76 Allowed Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 -175.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.84 144.69 47.37 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 118.588 1.194 . . . . 0.0 111.556 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.734 HD21 ' HB1' ' A' ' 59' ' ' ALA . 1.2 tp -116.43 160.43 20.57 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.224 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 2.3 mt-10 -138.77 102.99 4.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.078 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.665 ' HB2' HD23 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -98.77 120.85 39.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.152 -178.716 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.451 ' CE1' ' HB ' ' A' ' 116' ' ' THR . 0.2 OUTLIER -94.1 96.67 9.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.572 179.217 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.613 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -104.35 56.7 0.71 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.952 -179.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.629 ' CA ' ' H ' ' A' ' 118' ' ' GLU . . . -62.92 -70.01 1.16 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.017 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 3.3 m-80 -76.04 18.47 0.27 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.356 -0.238 . . . . 0.0 110.356 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.732 ' HA ' ' HB3' ' A' ' 49' ' ' ASP . . . -93.59 -70.62 0.69 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.38 -66.82 0.25 Allowed Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.093 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.483 ' HA ' ' HG2' ' A' ' 171' ' ' GLN . 8.4 p -71.88 -8.15 52.66 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.728 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -99.65 -34.46 10.2 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.577 0.227 . . . . 0.0 111.468 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.7 -45.58 89.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.755 0.312 . . . . 0.0 110.193 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.838 ' HE ' HD12 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -52.73 -60.88 5.55 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.142 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.819 ' HB2' HD22 ' A' ' 30' ' ' LEU . 19.5 Cg_endo -60.13 -30.61 91.78 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.342 2.028 . . . . 0.0 112.646 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 1.054 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -75.91 -53.31 8.61 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.159 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.9 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -49.45 -27.98 4.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.227 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.934 ' HB2' ' HB1' ' A' ' 175' ' ' ALA . . . -87.1 -54.1 4.5 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.787 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.636 ' HB1' HD11 ' A' ' 34' ' ' LEU . . . -60.6 -31.19 70.37 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -177.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.717 HD13 HG13 ' A' ' 113' ' ' ILE . 30.3 mt -79.27 -21.61 45.85 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.509 -177.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.752 ' SG ' HD22 ' A' ' 153' ' ' LEU . 89.8 m -82.18 17.94 1.52 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.198 0.523 . . . . 0.0 111.186 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.761 HD21 ' HB2' ' A' ' 182' ' ' LEU . 2.8 mt -81.23 -77.0 0.22 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.275 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.14 -109.0 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.392 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 m -156.79 96.69 1.64 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.08 0.467 . . . . 0.0 111.108 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.518 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 37.8 p-10 -147.0 139.19 24.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.174 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.886 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 2.5 m-20 -90.87 101.0 13.76 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.771 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.717 HG13 HD13 ' A' ' 106' ' ' LEU . 28.7 mm -120.81 137.59 54.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.574 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.813 HG13 ' CD2' ' A' ' 143' ' ' LEU . 58.0 t -110.22 112.29 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 175.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.665 HD23 ' HB2' ' A' ' 90' ' ' LEU . 24.9 mt -102.27 107.09 18.01 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.608 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.764 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.7 OUTLIER -117.38 -173.91 2.51 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.087 -179.085 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.661 ' H ' HG22 ' A' ' 116' ' ' THR . . . -163.14 -174.54 33.16 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.921 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.629 ' H ' ' CA ' ' A' ' 93' ' ' GLY . 15.1 mt-10 -76.77 172.7 8.95 Favored Pre-proline 0 C--N 1.328 -0.352 0 C-N-CA 122.853 0.461 . . . . 0.0 110.582 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.576 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 87.4 Cg_exo -47.52 -38.6 28.2 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.448 2.099 . . . . 0.0 112.488 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 38.8 mtm180 -69.25 -23.19 63.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.962 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.714 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 11.0 tpt -60.69 -31.86 71.11 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -16.88 63.27 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.768 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 120' ' ' ARG . 3.4 mm-40 -82.56 -0.54 47.3 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.775 0.321 . . . . 0.0 110.534 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.416 ' O ' ' NH2' ' A' ' 100' ' ' ARG . 3.5 mtp85 -127.44 87.1 57.03 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.892 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.465 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 18.4 Cg_endo -59.51 148.81 85.5 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.519 2.146 . . . . 0.0 111.399 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.838 HD12 ' HE ' ' A' ' 100' ' ' ARG . 0.6 OUTLIER -120.48 6.08 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.908 0.385 . . . . 0.0 111.947 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.636 ' HA3' ' OD1' ' A' ' 147' ' ' ASN . . . -55.55 -44.14 85.74 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.94 -0.648 . . . . 0.0 114.179 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.482 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 60.0 m-70 -55.63 -36.26 66.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 117.442 0.621 . . . . 0.0 110.06 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.806 HD11 ' HB3' ' A' ' 175' ' ' ALA . 21.5 tp -75.85 -43.27 46.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.143 0.497 . . . . 0.0 110.162 178.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.779 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 40.5 t -56.4 -47.78 80.94 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.385 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.725 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 0.1 OUTLIER -70.95 -36.23 72.49 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.405 -179.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.548 ' HB1' ' CG1' ' A' ' 162' ' ' VAL . . . -61.65 -50.27 73.21 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.803 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.728 HD11 ' HG ' ' A' ' 129' ' ' LEU . 9.7 mt -70.74 -48.0 56.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.933 178.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.779 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -59.22 -27.38 65.69 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.72 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.725 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.5 OUTLIER -68.47 -31.72 71.22 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.966 0.412 . . . . 0.0 110.759 178.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.559 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -83.84 14.71 41.24 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.894 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.69 3.87 62.3 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.589 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.667 ' HB1' ' HB3' ' A' ' 107' ' ' CYS . . . -71.9 150.45 44.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.884 0.373 . . . . 0.0 111.298 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 0.5 OUTLIER -98.88 102.97 14.87 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.122 178.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.596 HG21 HG22 ' A' ' 130' ' ' VAL . 8.8 mt -134.77 126.93 48.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.264 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.729 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -124.35 139.44 53.9 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.204 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.588 ' CE1' HG11 ' A' ' 130' ' ' VAL . 33.6 m-85 -79.03 130.04 35.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.121 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.883 HD11 ' HG3' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -91.72 -89.04 0.18 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.542 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.636 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 6.3 mm-40 -59.67 -81.19 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.529 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.452 ' O ' ' HB2' ' A' ' 148' ' ' TYR . 18.5 mt-30 -113.91 151.49 32.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.128 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -67.25 137.52 56.21 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.636 ' OD1' ' HA3' ' A' ' 127' ' ' GLY . 7.9 m-80 65.55 19.13 11.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.138 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.522 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 8.2 m-85 -110.14 168.88 7.0 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-O 121.105 0.479 . . . . 0.0 112.167 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.915 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 37.8 Cg_exo -32.49 -62.27 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 124.409 3.406 . . . . 0.0 116.087 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.915 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 66.6 Cg_exo -54.86 145.26 62.71 Favored 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-N 120.515 1.219 . . . . 0.0 112.747 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.797 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 12.3 mt -156.17 133.97 11.1 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.602 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.883 ' HG3' HD11 ' A' ' 143' ' ' LEU . 3.2 mtt180 -105.74 102.68 12.11 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 176.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.9 HD11 ' HA ' ' A' ' 103' ' ' ALA . 10.0 mt -91.73 147.97 22.59 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.941 -178.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.579 ' HG3' ' O ' ' A' ' 153' ' ' LEU . 3.5 mt-30 -148.73 27.48 0.89 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.352 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 51.73 -175.61 0.12 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.162 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.426 ' O ' HG23 ' A' ' 158' ' ' THR . . . 121.46 -11.81 9.65 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.182 -1.009 . . . . 0.0 112.817 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.823 ' HE2' ' HA ' ' A' ' 180' ' ' ALA . 50.8 t80 -59.78 123.14 16.05 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.006 0.403 . . . . 0.0 110.832 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.697 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 81.4 p -118.38 -28.43 5.75 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.301 0.572 . . . . 0.0 111.682 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.493 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 134.35 -161.73 24.47 Favored Glycine 0 C--N 1.308 -1.02 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.503 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.59 ' O ' HG23 ' A' ' 187' ' ' THR . . . 105.21 153.3 21.68 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.351 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -47.09 119.39 2.54 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.292 -0.454 . . . . 0.0 111.077 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.662 ' HB ' HG13 ' A' ' 189' ' ' ILE . 78.7 t -111.28 134.96 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.48 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.44 119.65 39.46 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.269 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.789 HG21 HD11 ' A' ' 176' ' ' LEU . 1.0 OUTLIER -131.14 120.13 46.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.05 0.453 . . . . 0.0 110.424 179.453 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.482 ' HB2' HG21 ' A' ' 168' ' ' VAL . 1.9 m-20 -52.18 137.43 28.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.466 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.854 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . -61.83 -48.47 83.66 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.962 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.3 m -88.64 87.97 7.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.968 0.413 . . . . 0.0 110.365 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.617 ' H ' ' HB ' ' A' ' 196' ' ' VAL . 46.5 t -147.41 -105.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.964 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.709 ' HB2' ' CD1' ' A' ' 172' ' ' PHE . 40.7 m -141.98 128.41 20.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.942 0.401 . . . . 0.0 110.076 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.75 ' HB3' ' HB3' ' A' ' 197' ' ' SER . 53.3 p -55.5 -19.21 8.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.245 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.688 ' HB3' ' CB ' ' A' ' 100' ' ' ARG . 1.2 mp0 -86.53 -10.15 54.66 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.28 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.709 ' CD1' ' HB2' ' A' ' 169' ' ' SER . 3.6 m-85 -75.02 -53.0 9.68 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.861 HD11 ' CG1' ' A' ' 191' ' ' ILE . 0.9 OUTLIER -65.9 -39.97 91.09 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.112 178.409 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.509 HG23 ' CG2' ' A' ' 204' ' ' THR . 1.8 m -60.15 -32.24 70.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.354 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.934 ' HB1' ' HB2' ' A' ' 104' ' ' ALA . . . -66.81 -41.48 87.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.44 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.795 HD12 ' HA ' ' A' ' 173' ' ' LEU . 0.2 OUTLIER -76.31 -35.42 58.83 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.794 -179.809 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.824 HD11 ' CD2' ' A' ' 223' ' ' PHE . 4.1 mp -59.59 -36.82 77.01 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.514 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.566 ' HA ' ' HE1' ' A' ' 208' ' ' MET . 2.6 mtp -81.88 -45.35 15.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.559 0.695 . . . . 0.0 112.219 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.67 HG23 ' HG ' ' A' ' 108' ' ' LEU . 93.0 m -70.9 -42.04 70.5 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.739 -1.119 . . . . 0.0 112.596 -178.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.823 ' HA ' ' HE2' ' A' ' 157' ' ' PHE . . . -59.86 -41.62 86.43 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.577 ' HD3' ' O ' ' A' ' 177' ' ' LEU . 17.9 Cg_endo -63.88 -30.07 67.65 Favored 'Trans proline' 0 CA--C 1.502 -1.122 0 C-N-CA 120.822 1.015 . . . . 0.0 111.321 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.761 ' HB2' HD21 ' A' ' 108' ' ' LEU . 10.8 mt -84.5 2.9 38.91 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.701 178.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.645 ' HB1' ' C ' ' A' ' 158' ' ' THR . . . -84.74 135.94 39.78 Favored Pre-proline 0 N--CA 1.454 -0.237 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.697 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 14.2 Cg_endo -52.51 -29.7 41.33 Favored 'Trans proline' 0 CA--C 1.518 -0.316 0 C-N-CA 122.523 2.149 . . . . 0.0 112.95 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.5 138.37 50.69 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.587 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -55.94 142.9 33.91 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.353 -0.385 . . . . 0.0 109.99 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 160' ' ' GLY . 88.8 m -120.89 147.45 45.4 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.871 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.671 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 55.1 t -128.26 117.84 46.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 176.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.819 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 5.2 mp -99.82 117.7 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.906 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.586 ' HB2' ' HG3' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -100.63 123.63 45.1 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.861 ' CG1' HD11 ' A' ' 173' ' ' LEU . 1.5 mp -93.77 121.16 44.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.454 -176.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.413 ' HD2' ' CG ' ' A' ' 165' ' ' ASP . 58.4 mttt -79.08 96.95 5.95 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.824 -1.534 . . . . 0.0 110.648 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 100.24 -132.73 11.04 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.958 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -114.09 127.52 55.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.051 0.453 . . . . 0.0 111.267 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.862 HD11 ' HZ ' ' A' ' 223' ' ' PHE . 1.1 mt -42.33 145.22 0.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.917 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.617 ' HB ' ' H ' ' A' ' 168' ' ' VAL . 12.9 p -71.61 -29.92 36.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.346 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.75 ' HB3' ' HB3' ' A' ' 170' ' ' SER . 5.9 t -164.92 62.15 0.13 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.84 0.352 . . . . 0.0 111.174 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.651 ' N ' ' HD2' ' A' ' 199' ' ' PRO . 13.5 tptp -36.45 -49.08 1.8 Allowed Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.571 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.651 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 6.3 Cg_endo -48.0 -34.69 23.56 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.097 1.864 . . . . 0.0 112.178 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.981 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.2 OUTLIER -68.34 -44.82 74.46 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.537 HG21 ' HE2' ' A' ' 223' ' ' PHE . 19.2 mm -59.84 -35.68 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.194 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.6 -41.53 97.58 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.014 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.981 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.1 mt -63.98 -49.27 82.38 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.915 0 CA-C-O 121.711 0.767 . . . . 0.0 109.233 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.52 HG22 ' SD ' ' A' ' 208' ' ' MET . 88.5 m -53.6 -51.19 63.82 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.933 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.902 HD22 ' HB ' ' A' ' 215' ' ' ILE . 33.4 mt -65.24 -32.7 74.5 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 120.541 -0.464 . . . . 0.0 111.465 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -76.89 -46.04 25.9 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.717 0.77 . . . . 0.0 109.414 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.938 ' O ' HG22 ' A' ' 210' ' ' THR . 4.4 tp -67.41 -33.28 74.84 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.595 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . 0.754 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 42.9 mtp -74.99 -33.89 61.91 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.62 0.724 . . . . 0.0 109.232 177.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.654 ' HE2' ' O ' ' A' ' 205' ' ' LEU . 4.5 mtmt -61.35 -39.05 89.16 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.667 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.938 HG22 ' O ' ' A' ' 207' ' ' LEU . 5.8 t -61.93 -27.21 68.66 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.422 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.653 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 57.0 m-85 -84.07 -6.74 59.46 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.627 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.97 6.87 25.87 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 116.282 1.273 . . . . 0.0 116.282 177.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.597 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.6 m -123.17 148.41 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 118.973 1.387 . . . . 0.0 112.198 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.557 ' O ' HD13 ' A' ' 215' ' ' ILE . 10.9 mt-10 -130.06 141.69 50.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.972 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.919 HD12 ' HB ' ' A' ' 225' ' ' VAL . 21.1 mm -123.7 148.33 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-O 120.851 0.358 . . . . 0.0 110.502 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.66 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 1.5 tt0 -102.87 118.52 37.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.918 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.476 ' ND2' ' HE2' ' A' ' 198' ' ' LYS . 1.5 t30 -83.01 150.8 26.13 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.601 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . 0.66 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 9.8 mm-40 -109.48 -142.44 0.38 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 121.203 -0.199 . . . . 0.0 110.615 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.577 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 0.3 OUTLIER -75.02 65.91 1.52 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.88 0.371 . . . . 0.0 111.632 -179.023 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 4.0 t80 55.56 37.53 29.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.929 0.871 . . . . 0.0 110.598 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.67 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 12.6 pt20 -167.1 -125.29 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.819 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -9.0 133.62 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 179.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.862 ' HZ ' HD11 ' A' ' 195' ' ' LEU . 0.6 OUTLIER -124.84 138.55 54.26 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 112.975 -1.921 . . . . 0.0 109.853 -179.082 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.66 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 27.0 t -119.47 113.9 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-O 121.319 0.58 . . . . 0.0 109.506 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.919 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.5 OUTLIER -120.94 121.12 64.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.034 -179.197 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.558 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 2.7 mptp? -75.63 118.99 19.06 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -69.1 -174.58 10.37 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.046 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 62.36 21.31 62.03 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 121.226 -0.511 . . . . 0.0 113.076 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . 0.558 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 8.1 mm100 -68.11 -166.2 0.06 Allowed 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.434 0.635 . . . . 0.0 111.157 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 75.0 m -158.02 147.28 19.57 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.602 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' TYR . . . . . 0.803 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 3.8 m-30 -111.09 127.97 55.73 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.59 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.97 150.78 41.56 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 60.4 p -76.33 110.91 12.66 Favored Pre-proline 0 N--CA 1.442 -0.835 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.822 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.459 ' HB3' ' O ' ' A' ' 210' ' ' THR . 36.5 Cg_endo -65.94 -2.75 7.14 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.044 1.829 . . . . 0.0 112.29 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 99.81 -103.13 2.63 Favored Glycine 0 C--O 1.225 -0.442 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 73.0 m -115.46 133.93 55.57 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.678 ' CD2' HG21 ' A' ' 210' ' ' THR . 8.3 t80 -132.62 126.95 33.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.959 0.409 . . . . 0.0 111.405 -178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.984 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -90.82 110.53 21.74 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.597 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.566 ' N ' HD22 ' A' ' 238' ' ' LEU . 21.8 t -83.63 113.0 21.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.094 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.409 ' HG2' ' CD1' ' A' ' 238' ' ' LEU . 11.3 mt-10 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.253 -0.879 . . . . 0.0 111.245 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.866 ' HB2' HD22 ' A' ' 44' ' ' LEU . 7.6 t . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 120.868 0.366 . . . . 0.0 111.282 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 63.07 -80.87 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.303 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.761 ' HD3' HG21 ' A' ' 174' ' ' THR . 78.1 mtm180 -74.37 -57.99 3.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.095 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.777 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -43.12 -48.54 6.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.737 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.053 HD22 HD11 ' A' ' 75' ' ' ILE . 11.3 mt -72.09 -32.42 67.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.898 0.38 . . . . 0.0 111.371 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.877 HD22 ' HB2' ' A' ' 101' ' ' PRO . 53.2 tp -68.66 -50.18 53.17 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.355 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.768 HD22 ' CZ ' ' A' ' 231' ' ' TYR . 33.4 mt -68.16 -26.43 65.75 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.77 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.752 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -65.84 -39.52 90.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.302 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.804 ' CB ' HG11 ' A' ' 62' ' ' VAL . . . -81.44 -41.24 22.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.269 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.659 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 13.3 mt -67.72 -4.57 12.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.245 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.535 ' HA ' ' CB ' ' A' ' 231' ' ' TYR . . . -94.58 177.51 5.9 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.651 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.1 OUTLIER -117.48 114.89 24.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.623 178.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.626 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 128.51 -142.84 13.91 Favored Glycine 0 C--O 1.224 -0.508 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.025 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.678 ' HG3' HG23 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -136.66 117.47 14.1 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.186 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 235' ' ' GLY . 0.8 OUTLIER -128.68 145.79 51.06 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.541 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.637 HG22 ' HB2' ' A' ' 74' ' ' GLU . 78.3 t -109.3 143.58 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 CA-C-O 121.51 0.671 . . . . 0.0 112.312 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.881 ' HB3' HD21 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -115.84 116.3 27.77 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 174.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.898 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.5 OUTLIER -103.53 151.57 22.72 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.863 0.364 . . . . 0.0 111.277 -177.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.426 ' HB2' HD23 ' A' ' 238' ' ' LEU . 7.2 t30 65.78 26.37 11.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.044 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.881 HD21 ' HB3' ' A' ' 41' ' ' LEU . 84.6 mt -54.6 -172.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.832 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.554 ' HB3' HG21 ' A' ' 50' ' ' VAL . 61.9 tp -112.94 131.59 55.68 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.384 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -89.39 86.96 6.92 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.965 0.412 . . . . 0.0 110.153 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 49' ' ' ASP . 4.0 m -165.09 143.37 6.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.462 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 47' ' ' SER . 34.6 m-20 -34.71 -31.64 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.714 0.292 . . . . 0.0 111.721 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.868 ' OD1' HG23 ' A' ' 50' ' ' VAL . 2.0 p30 -57.91 -42.2 84.26 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.066 0.46 . . . . 0.0 110.848 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.868 HG23 ' OD1' ' A' ' 49' ' ' ASP . 92.9 t -84.47 -45.1 17.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.859 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -48.34 -39.67 22.79 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.636 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 23.2 m-70 -80.15 -32.17 38.9 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.021 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.586 ' O ' HD13 ' A' ' 57' ' ' LEU . 9.4 tpt -55.55 -35.31 65.58 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.859 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -81.93 -44.2 17.08 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.102 -1.408 . . . . 0.0 108.694 176.149 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.722 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 4.7 t-20 -58.8 -35.59 73.09 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.742 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 1.024 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -63.04 -46.8 85.84 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.833 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.4 OUTLIER -63.96 -39.37 93.99 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.758 -1.565 . . . . 0.0 107.752 177.276 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.722 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -59.27 -41.0 87.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.154 178.793 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.632 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -71.21 -38.51 72.04 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.139 -178.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.673 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.6 OUTLIER -78.83 -16.23 57.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.241 0.543 . . . . 0.0 110.834 -179.69 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.82 35.22 4.37 Favored Glycine 0 C--N 1.319 -0.369 0 CA-C-N 115.272 -0.876 . . . . 0.0 114.372 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.833 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 39.7 t -90.56 120.5 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.813 ' O ' HG12 ' A' ' 76' ' ' ILE . 27.1 m -83.26 127.43 33.64 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.538 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.912 ' HB3' HG23 ' A' ' 75' ' ' ILE . 42.7 p90 -155.84 172.17 18.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.848 0.356 . . . . 0.0 110.266 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 87.0 m -133.94 148.91 51.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.221 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.419 HD12 ' HB2' ' A' ' 73' ' ' CYS . 14.0 tp -117.05 135.85 53.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.969 0.414 . . . . 0.0 110.4 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.467 ' HB3' ' CB ' ' A' ' 72' ' ' ARG . 33.8 p -61.71 -172.19 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.382 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.89 -43.53 19.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.189 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.36 0.54 11.86 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.555 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.1 mtp85 59.54 46.74 11.7 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.069 0.462 . . . . 0.0 110.956 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.521 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -141.24 -14.91 0.87 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.973 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 8.6 mtp180 -113.94 116.74 29.73 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.643 ' HB3' HD11 ' A' ' 44' ' ' LEU . 28.9 t -124.89 123.18 39.36 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.637 ' HB2' HG22 ' A' ' 40' ' ' VAL . 34.3 tt0 -104.37 134.36 47.71 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 176.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 1.053 HD11 HD22 ' A' ' 29' ' ' LEU . 8.1 mt -131.32 122.21 50.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -177.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.813 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -67.89 98.63 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.695 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -35.68 140.81 0.18 Allowed Glycine 0 CA--C 1.518 0.219 0 CA-C-N 115.232 -0.895 . . . . 0.0 114.02 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -86.82 -11.43 50.91 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.101 0.477 . . . . 0.0 110.786 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.651 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 90.73 -1.01 77.8 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.205 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.578 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 154.34 -150.02 21.52 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.542 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 87.3 Cg_exo -49.32 121.54 7.16 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.759 2.306 . . . . 0.0 112.639 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.673 ' HB2' HD13 ' A' ' 60' ' ' LEU . 0.7 OUTLIER -70.71 112.12 6.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.726 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.448 ' HA ' ' CG ' ' A' ' 111' ' ' ASN . 4.9 p80 -82.93 136.14 34.66 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.705 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -97.9 123.64 41.97 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.762 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -70.92 123.44 22.01 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 176.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.27 177.14 1.01 Allowed Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 108.692 -1.763 . . . . 0.0 108.692 -175.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.97 144.3 47.31 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 118.738 1.269 . . . . 0.0 111.085 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.632 HD21 ' HB1' ' A' ' 59' ' ' ALA . 1.0 OUTLIER -115.77 160.41 20.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.179 -178.829 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 9.9 mt-10 -139.71 103.85 4.77 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.86 178.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.734 ' HB2' HD23 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -97.19 122.73 40.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.884 0.373 . . . . 0.0 110.928 -178.531 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -95.47 96.31 9.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.817 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.968 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.2 OUTLIER -107.29 46.28 0.94 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.538 -179.392 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.616 ' CA ' ' H ' ' A' ' 118' ' ' GLU . . . -56.38 -27.74 53.95 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.721 -0.672 . . . . 0.0 113.152 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.531 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 1.0 OUTLIER -106.65 -21.14 13.14 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.586 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.975 ' HB1' ' HB3' ' A' ' 98' ' ' ALA . . . -86.02 57.84 4.71 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.057 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.581 ' O ' ' HD3' ' A' ' 100' ' ' ARG . . . -59.82 -38.04 93.4 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.051 -1.071 . . . . 0.0 111.146 178.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.45 HG22 ' HG3' ' A' ' 171' ' ' GLN . 0.6 OUTLIER -78.46 -15.67 58.38 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.506 0.188 . . . . 0.0 111.506 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.975 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -96.91 -27.33 14.71 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.716 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.689 ' SD ' ' HB3' ' A' ' 115' ' ' LEU . 4.3 tpp -62.07 -41.2 97.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.903 0.382 . . . . 0.0 110.156 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.62 ' O ' HD21 ' A' ' 129' ' ' LEU . 1.6 mpt_? -59.52 -60.11 11.65 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.877 ' HB2' HD22 ' A' ' 30' ' ' LEU . 18.6 Cg_endo -58.87 -31.11 94.72 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.057 1.838 . . . . 0.0 112.029 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 1.024 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -74.84 -53.34 9.28 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.055 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.835 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -50.35 -28.56 8.2 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.475 0.655 . . . . 0.0 110.503 178.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.722 ' HB2' ' HB1' ' A' ' 175' ' ' ALA . . . -87.19 -52.99 5.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.214 -0.903 . . . . 0.0 113.065 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.771 ' CB ' HD11 ' A' ' 30' ' ' LEU . . . -60.39 -27.83 67.75 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.713 0.635 . . . . 0.0 112.713 -177.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.709 HD13 HG13 ' A' ' 113' ' ' ILE . 33.6 mt -82.23 -27.08 32.7 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.737 ' HB2' ' HB1' ' A' ' 138' ' ' ALA . 11.1 p -74.38 12.33 0.79 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.18 0.514 . . . . 0.0 111.422 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.673 ' HG ' HG23 ' A' ' 179' ' ' THR . 1.3 mt -78.14 -76.57 0.18 Allowed 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.433 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.418 ' O ' ' HA3' ' A' ' 155' ' ' GLY . . . -71.79 -115.57 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.64 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.9 p -150.88 95.49 2.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.97 0.414 . . . . 0.0 110.245 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.597 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 14.8 m120 -148.47 138.36 22.31 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.51 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.92 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 0.7 OUTLIER -90.35 100.01 12.92 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.15 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.709 HG13 HD13 ' A' ' 106' ' ' LEU . 24.7 mm -119.27 136.54 56.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.496 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.851 HG13 ' CD2' ' A' ' 143' ' ' LEU . 60.9 t -108.33 111.98 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 176.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.734 HD23 ' HB2' ' A' ' 90' ' ' LEU . 52.7 mt -102.25 107.96 19.18 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.53 -178.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.929 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -124.2 -170.41 2.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.89 0.376 . . . . 0.0 111.675 -179.04 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.599 ' H ' HG22 ' A' ' 116' ' ' THR . . . -168.59 -169.05 31.54 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.144 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.743 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 50.7 mt-10 -81.24 172.73 9.04 Favored Pre-proline 0 N--CA 1.455 -0.223 0 C-N-CA 123.213 0.605 . . . . 0.0 110.254 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.743 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 8.0 Cg_endo -48.1 -39.62 33.64 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.666 2.244 . . . . 0.0 112.336 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 120' ' ' ARG . 10.2 ttp180 -67.97 -23.95 65.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.702 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.611 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 9.7 tpt -61.14 -31.87 71.58 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.415 ' HD3' ' HG2' ' A' ' 149' ' ' PRO . 12.0 mmtt -63.63 -17.14 62.59 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.559 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -79.57 0.65 29.02 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.845 0.355 . . . . 0.0 110.621 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.565 ' HB3' ' NH2' ' A' ' 100' ' ' ARG . 0.8 OUTLIER -126.98 83.03 66.96 Favored Pre-proline 0 N--CA 1.454 -0.262 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.235 179.546 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.513 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 43.6 Cg_exo -56.29 148.68 59.6 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.577 2.184 . . . . 0.0 111.618 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.701 HD11 HD23 ' A' ' 129' ' ' LEU . 1.3 tt -128.84 22.56 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.525 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -69.2 -46.4 57.93 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.183 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.68 ' CE1' ' HB2' ' A' ' 165' ' ' ASP . 1.7 m-70 -55.68 -37.58 68.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.832 0.349 . . . . 0.0 110.929 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.791 ' HG ' HD11 ' A' ' 133' ' ' LEU . 16.9 tp -70.19 -44.32 68.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.353 0.597 . . . . 0.0 109.527 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.874 HG21 HD21 ' A' ' 151' ' ' LEU . 36.2 t -56.85 -47.31 83.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.16 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.77 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 2.8 m-20 -71.04 -38.29 72.54 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 120.881 0.372 . . . . 0.0 110.704 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.516 ' HA ' HG13 ' A' ' 162' ' ' VAL . . . -57.96 -46.97 84.28 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.537 0.684 . . . . 0.0 109.87 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.791 HD11 ' HG ' ' A' ' 129' ' ' LEU . 5.8 mt -76.02 -50.18 15.54 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.798 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.722 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -57.17 -27.7 62.15 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.01 179.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.77 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 5.0 tp -70.55 -30.09 66.72 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.941 0.4 . . . . 0.0 110.915 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 159' ' ' GLY . . . -84.22 14.42 44.92 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.838 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.63 4.48 60.58 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.892 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.738 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . . . -75.2 155.75 36.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.985 0.421 . . . . 0.0 111.533 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.451 ' CB ' ' HB2' ' A' ' 154' ' ' GLN . 3.7 mttm -102.58 105.55 16.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.303 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.747 HG21 HG22 ' A' ' 130' ' ' VAL . 13.6 mt -138.68 127.57 30.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.542 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.809 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -126.38 139.83 52.97 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.594 -179.544 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -78.07 132.37 37.7 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.382 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.851 ' CD2' HG13 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -95.16 -90.97 0.22 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.909 -179.568 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.793 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 16.0 mm-40 -59.15 -81.05 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.025 0.44 . . . . 0.0 110.692 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.504 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 31.6 mt-30 -113.09 148.86 34.38 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.788 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 4.7 mt-10 -65.5 132.54 49.17 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.428 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.525 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 2.1 m-20 67.85 17.82 9.67 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.124 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.598 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 16.8 m-85 -108.75 169.17 6.8 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.035 0.445 . . . . 0.0 111.603 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.918 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 8.2 Cg_exo -32.23 -62.73 0.14 Allowed 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 124.164 3.243 . . . . 0.0 116.656 -177.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.929 ' HG3' HG23 ' A' ' 116' ' ' THR . 59.2 Cg_exo -53.05 143.89 48.51 Favored 'Trans proline' 0 C--N 1.351 0.68 0 CA-C-N 120.982 1.387 . . . . 0.0 112.892 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.874 HD21 HG21 ' A' ' 130' ' ' VAL . 10.4 mt -155.58 133.23 11.15 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.67 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.837 ' HG3' HD11 ' A' ' 143' ' ' LEU . 2.8 mtt85 -103.29 100.76 10.66 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.92 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 10.0 mt -90.62 148.54 22.59 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.987 -178.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.597 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 3.6 mt-30 -149.64 23.79 0.88 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.048 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.595 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 54.52 -168.57 1.78 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.226 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 158' ' ' THR . . . 114.89 -14.57 19.45 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.243 -0.98 . . . . 0.0 113.216 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.738 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 45.4 t80 -58.18 122.75 13.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 117.396 0.598 . . . . 0.0 110.742 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.708 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 76.6 p -114.87 -29.88 6.59 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.375 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.492 ' O ' ' HA2' ' A' ' 136' ' ' GLY . . . 133.73 -157.99 23.06 Favored Glycine 0 C--N 1.305 -1.153 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.115 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.596 ' O ' HG23 ' A' ' 187' ' ' THR . . . 103.06 153.57 24.26 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.289 -0.958 . . . . 0.0 111.347 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -47.16 115.84 1.21 Allowed 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.296 -0.452 . . . . 0.0 111.081 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 60.9 t -107.85 140.28 26.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.64 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.96 119.79 40.1 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.057 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.945 HG11 ' HG ' ' A' ' 173' ' ' LEU . 1.6 t -129.27 120.56 51.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.68 ' HB2' ' CE1' ' A' ' 128' ' ' HIS . 7.8 t0 -55.04 139.62 40.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.234 0.54 . . . . 0.0 112.066 -178.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.91 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . -62.11 -12.73 38.58 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.47 -0.787 . . . . 0.0 112.68 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.612 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -145.06 98.85 3.23 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.028 0.442 . . . . 0.0 111.483 -179.462 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.573 HG21 ' HB2' ' A' ' 128' ' ' HIS . 10.5 p -160.82 -33.31 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.401 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.503 ' CB ' ' CD1' ' A' ' 172' ' ' PHE . 0.6 OUTLIER 167.26 126.91 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.976 179.455 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.571 ' HB3' ' HB2' ' A' ' 197' ' ' SER . 46.2 p -67.25 -17.49 64.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.249 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.576 ' HA ' ' HB ' ' A' ' 174' ' ' THR . 8.3 mm-40 -89.6 -12.09 40.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.579 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.589 ' CZ ' ' HA ' ' A' ' 126' ' ' ILE . 3.1 m-85 -69.26 -54.36 15.08 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.945 ' HG ' HG11 ' A' ' 164' ' ' VAL . 1.0 OUTLIER -64.84 -46.69 80.84 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.793 178.468 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.761 HG21 ' HD3' ' A' ' 27' ' ' ARG . 4.1 m -54.41 -35.0 62.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.172 178.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.722 ' HB1' ' HB2' ' A' ' 104' ' ' ALA . . . -64.13 -46.77 82.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.497 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.941 HD11 HG21 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -76.52 -31.75 57.86 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.315 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.853 HD11 ' CD2' ' A' ' 223' ' ' PHE . 1.6 mp -58.99 -39.18 81.02 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.181 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.693 ' HE1' ' HA ' ' A' ' 27' ' ' ARG . 2.0 mtp -81.08 -40.71 23.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.892 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.673 HG23 ' HG ' ' A' ' 108' ' ' LEU . 66.4 m -71.28 -41.85 69.48 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.949 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.552 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . -59.63 -40.51 79.95 Favored Pre-proline 0 C--N 1.321 -0.674 0 N-CA-C 115.132 1.531 . . . . 0.0 115.132 -176.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.577 ' HD3' ' O ' ' A' ' 177' ' ' LEU . 27.9 Cg_endo -64.93 -28.82 58.11 Favored 'Trans proline' 0 CA--C 1.502 -1.112 0 CA-C-N 120.081 1.064 . . . . 0.0 111.511 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.587 ' HB2' HD21 ' A' ' 108' ' ' LEU . 8.1 mt -83.58 0.81 45.07 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.485 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.623 ' HB1' ' C ' ' A' ' 158' ' ' THR . . . -83.36 136.89 42.58 Favored Pre-proline 0 C--O 1.223 -0.304 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.287 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.708 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 11.1 Cg_endo -50.53 -32.53 35.25 Favored 'Trans proline' 0 CA--C 1.516 -0.415 0 C-N-CA 122.715 2.277 . . . . 0.0 113.363 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -114.96 141.35 48.09 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.717 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -56.1 141.88 38.74 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.124 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.596 HG23 ' O ' ' A' ' 160' ' ' GLY . 91.5 m -119.97 143.41 48.04 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 50.8 t -123.69 118.15 53.37 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 176.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.816 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 2.7 mp -102.55 117.85 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.596 ' HB2' ' HG3' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -100.65 123.66 45.16 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.241 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.91 HG23 ' HA2' ' A' ' 166' ' ' GLY . 1.6 mp -93.69 119.59 41.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.605 -1.179 . . . . 0.0 111.142 -176.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.5 ' HE2' ' N ' ' A' ' 165' ' ' ASP . 1.7 mtmt -75.26 97.06 3.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.834 -178.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 99.64 -133.06 11.16 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.693 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -112.66 131.09 55.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.855 0.36 . . . . 0.0 111.135 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.753 HD11 ' HZ ' ' A' ' 223' ' ' PHE . 1.5 mt -41.77 144.48 0.4 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.836 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.612 ' HB ' ' HA ' ' A' ' 167' ' ' SER . 14.2 p -73.75 -27.72 23.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.184 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.571 ' HB2' ' HB3' ' A' ' 170' ' ' SER . 0.3 OUTLIER -165.51 63.01 0.11 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.184 0.516 . . . . 0.0 110.25 -179.19 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.686 ' N ' ' HD2' ' A' ' 199' ' ' PRO . 0.0 OUTLIER -42.07 -46.63 10.44 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.5 179.7 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.686 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 9.5 Cg_endo -49.31 -33.09 27.67 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 121.944 1.763 . . . . 0.0 111.39 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.991 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.1 OUTLIER -69.1 -43.82 73.7 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.785 0.803 . . . . 0.0 108.87 178.242 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.606 HG21 ' HE2' ' A' ' 223' ' ' PHE . 27.5 mm -62.69 -35.79 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.452 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.29 -44.13 95.65 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.695 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.991 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.0 mt -63.12 -49.76 82.04 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.927 0 CA-C-O 121.66 0.743 . . . . 0.0 108.996 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.537 ' CG2' HG23 ' A' ' 174' ' ' THR . 90.8 m -53.02 -51.48 61.54 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.893 -178.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.877 HD22 ' HB ' ' A' ' 215' ' ' ILE . 29.3 mt -66.13 -30.48 70.97 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.437 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.464 ' HA ' ' HE3' ' A' ' 209' ' ' LYS . 29.8 m-20 -77.02 -46.13 24.84 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.837 0.827 . . . . 0.0 109.527 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.801 ' O ' HG22 ' A' ' 210' ' ' THR . 5.1 tp -70.55 -29.47 65.93 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.09 -1.413 . . . . 0.0 109.618 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . 0.72 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 52.2 mtp -77.13 -34.09 56.66 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.714 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 9.4 mtmt -62.04 -40.59 96.26 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.015 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.801 HG22 ' O ' ' A' ' 207' ' ' LEU . 5.0 t -60.5 -31.25 70.31 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.583 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.598 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 56.1 m-85 -78.61 -5.94 54.27 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.871 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.6 7.95 25.27 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.166 -1.016 . . . . 0.0 115.638 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.714 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 5.1 m -124.0 148.07 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 118.768 1.284 . . . . 0.0 112.829 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.467 ' CG ' ' HG2' ' A' ' 209' ' ' LYS . 16.2 mt-10 -130.02 137.72 50.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.126 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.877 ' HB ' HD22 ' A' ' 205' ' ' LEU . 18.0 mm -120.56 148.38 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-O 120.875 0.369 . . . . 0.0 110.557 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.665 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 2.4 tt0 -103.01 116.22 32.1 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.864 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.601 ' H ' ' ND2' ' A' ' 217' ' ' ASN . 0.9 OUTLIER -82.79 151.21 26.2 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.969 179.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . 0.633 ' HG3' ' HB3' ' A' ' 222' ' ' GLN . 10.2 mm100 -109.47 -139.12 0.38 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 121.146 -0.222 . . . . 0.0 110.821 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.642 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 5.5 t-80 -78.82 66.6 4.34 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 3.7 t80 57.25 33.38 23.22 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.974 0.893 . . . . 0.0 110.234 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.685 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 3.3 pt20 -163.92 -126.63 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.816 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -8.56 132.66 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.853 ' CD2' HD11 ' A' ' 177' ' ' LEU . 0.9 OUTLIER -124.76 138.69 54.27 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 112.867 -1.97 . . . . 0.0 110.181 -179.295 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.665 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 38.7 t -118.37 114.44 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.784 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.4 OUTLIER -121.78 125.66 73.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.443 -178.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.547 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -79.79 127.65 32.48 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.206 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.554 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -79.46 -173.84 45.24 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.404 -178.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 62.75 21.0 62.57 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 121.61 -0.329 . . . . 0.0 113.193 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 12.5 mt-30 -76.78 -175.39 3.41 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.364 0.602 . . . . 0.0 111.557 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.22 147.81 28.84 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.654 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' TYR . . . . . 0.768 ' CZ ' HD22 ' A' ' 31' ' ' LEU . 1.9 m-30 -104.47 131.71 51.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.109 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.42 144.83 48.79 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.435 ' HB3' ' OG1' ' A' ' 39' ' ' THR . 50.1 m -69.99 110.81 7.34 Favored Pre-proline 0 N--CA 1.45 -0.453 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.259 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.503 ' HG3' HG23 ' A' ' 210' ' ' THR . 40.5 Cg_endo -66.44 -1.0 4.91 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.017 1.811 . . . . 0.0 112.41 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . 0.579 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 99.45 -96.41 1.66 Allowed Glycine 0 C--O 1.226 -0.383 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.631 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 30.7 m -119.91 134.4 55.25 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.563 ' CD2' HG21 ' A' ' 210' ' ' THR . 12.8 t80 -132.97 126.76 32.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.997 0.427 . . . . 0.0 111.314 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.898 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -93.25 112.2 24.06 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.033 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.693 ' N ' HD22 ' A' ' 238' ' ' LEU . 25.0 t -86.74 111.83 22.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.789 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.211 -179.667 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.58 ' HB2' HD22 ' A' ' 44' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.845 0.355 . . . . 0.0 111.195 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.7 m120 67.25 -82.34 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.97 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.874 HH11 HD23 ' A' ' 207' ' ' LEU . 6.6 mtm105 -76.01 -62.49 1.58 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.877 0.37 . . . . 0.0 111.316 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.751 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -35.21 -45.41 0.3 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.378 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.054 HD22 HD11 ' A' ' 75' ' ' ILE . 11.4 mt -75.65 -38.93 58.46 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.977 0.418 . . . . 0.0 111.608 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.839 HD22 ' HB2' ' A' ' 101' ' ' PRO . 51.5 tp -65.22 -49.67 68.8 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.435 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.585 HD13 ' HA ' ' A' ' 208' ' ' MET . 45.3 mt -67.09 -26.9 66.94 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.657 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.847 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -66.28 -40.05 89.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.044 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.776 ' CB ' HG11 ' A' ' 62' ' ' VAL . . . -81.21 -41.21 22.66 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.793 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.671 HD11 ' HB1' ' A' ' 105' ' ' ALA . 13.3 mt -67.95 -3.69 10.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.246 178.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.493 ' HB2' ' HB3' ' A' ' 231' ' ' TYR . . . -100.22 178.34 4.8 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.565 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.1 OUTLIER -113.04 113.6 25.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.8 178.186 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.412 ' HA3' ' OG ' ' A' ' 233' ' ' SER . . . 116.75 167.91 14.73 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.357 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.819 ' HG3' HG23 ' A' ' 76' ' ' ILE . 1.1 ttmt -95.45 117.95 31.3 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 117.127 0.463 . . . . 0.0 111.692 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 0.9 OUTLIER -120.19 148.12 44.06 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.321 179.753 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.669 HG22 ' HB2' ' A' ' 74' ' ' GLU . 98.8 t -107.41 141.64 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.767 ' CB ' HD21 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -116.1 116.0 27.07 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 174.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.892 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.6 OUTLIER -103.92 152.83 21.51 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.93 -178.314 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 65.69 26.81 11.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.469 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.767 HD21 ' CB ' ' A' ' 41' ' ' LEU . 76.2 mt -54.14 -173.31 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.789 0.328 . . . . 0.0 110.127 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.525 ' HB3' HG21 ' A' ' 50' ' ' VAL . 56.8 tp -111.69 131.31 55.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.469 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -87.78 88.79 7.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.992 0.425 . . . . 0.0 110.11 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 50' ' ' VAL . 74.6 m -163.97 142.66 7.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.994 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.437 ' HA ' ' HB3' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -37.44 -29.92 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.736 0.303 . . . . 0.0 111.374 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.761 ' OD1' HG23 ' A' ' 50' ' ' VAL . 1.2 p30 -58.3 -42.51 86.8 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 121.043 0.449 . . . . 0.0 110.631 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.761 HG23 ' OD1' ' A' ' 49' ' ' ASP . 93.0 t -84.12 -44.55 18.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.672 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.782 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -49.32 -39.72 32.4 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.447 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.58 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 22.6 m-70 -81.04 -32.67 33.97 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.081 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.628 ' O ' HD13 ' A' ' 57' ' ' LEU . 7.5 tpt -53.69 -34.64 59.44 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 176.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.782 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.7 OUTLIER -82.52 -44.46 15.89 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 113.892 -1.503 . . . . 0.0 108.837 176.698 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.729 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 24.8 t-20 -57.97 -42.28 84.68 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-O 120.882 0.372 . . . . 0.0 110.655 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 1.024 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -57.27 -46.8 82.74 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.875 0.845 . . . . 0.0 109.012 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.777 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -64.33 -37.61 88.1 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.134 -1.394 . . . . 0.0 107.779 177.21 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.729 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -64.14 -33.13 75.07 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.179 -1.373 . . . . 0.0 111.933 179.411 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.789 ' CB ' HD11 ' A' ' 90' ' ' LEU . . . -76.21 -37.55 57.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.221 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.641 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -81.4 -12.5 58.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.289 0.566 . . . . 0.0 110.686 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.06 35.54 5.02 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.262 -0.881 . . . . 0.0 114.293 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.777 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 39.8 t -90.45 123.24 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.788 ' O ' HG12 ' A' ' 76' ' ' ILE . 7.2 m -85.32 131.44 34.41 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.0 0.428 . . . . 0.0 111.723 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.824 ' HB3' HG23 ' A' ' 75' ' ' ILE . 40.6 p90 -158.7 171.08 20.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.685 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 98.1 m -135.19 149.03 49.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.301 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.626 HD12 ' HB2' ' A' ' 73' ' ' CYS . 11.7 tp -120.25 138.69 53.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.028 0.442 . . . . 0.0 110.874 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 87.1 p -57.71 -175.31 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.339 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.1 -42.24 23.96 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.197 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -76.41 0.67 18.79 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.398 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.9 mtt-85 59.36 53.56 5.19 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.873 0.368 . . . . 0.0 111.176 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.445 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -149.19 4.16 0.61 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.76 179.657 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.612 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 9.5 ttm180 -136.97 110.78 8.14 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.626 ' HB2' HD12 ' A' ' 66' ' ' LEU . 36.9 t -121.61 134.48 55.0 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.669 ' HB2' HG22 ' A' ' 40' ' ' VAL . 24.6 tt0 -115.45 132.61 56.57 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.245 -0.888 . . . . 0.0 108.728 177.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 1.054 HD11 HD22 ' A' ' 29' ' ' LEU . 12.2 mt -127.79 123.45 61.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -177.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.819 HG23 ' HG3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -67.72 100.13 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 175.178 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 35' ' ' ALA . . . -39.19 144.73 0.27 Allowed Glycine 0 C--N 1.323 -0.189 0 CA-C-N 115.145 -0.934 . . . . 0.0 113.483 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -90.02 -12.41 38.69 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.947 0.404 . . . . 0.0 111.038 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.565 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 95.19 1.63 62.65 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.94 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.553 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 150.88 -148.96 20.69 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.683 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.52 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 77.3 Cg_exo -49.63 123.52 10.63 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.712 2.274 . . . . 0.0 112.218 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.641 ' HB2' HD13 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -74.27 106.33 5.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.225 -179.5 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -83.66 132.42 34.88 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.573 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.578 ' CB ' HD11 ' A' ' 113' ' ' ILE . . . -96.86 126.81 42.28 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.065 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.19 123.93 23.32 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.31 175.3 1.15 Allowed Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 -175.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 112' ' ' ASP . . . -74.04 144.98 44.85 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 118.559 1.179 . . . . 0.0 112.215 -178.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.661 HD21 ' C ' ' A' ' 59' ' ' ALA . 0.9 OUTLIER -115.26 161.12 18.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.649 -1.16 . . . . 0.0 112.557 -178.273 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.449 ' HG3' ' HB ' ' A' ' 114' ' ' VAL . 1.6 tt0 -140.26 112.26 7.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.758 177.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.789 HD11 ' CB ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -108.64 117.87 35.3 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.505 -178.427 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.632 ' C ' HD13 ' A' ' 92' ' ' LEU . 0.1 OUTLIER -88.97 96.67 10.82 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.508 179.042 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.808 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -105.37 53.04 0.72 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.267 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.459 ' CA ' ' H ' ' A' ' 118' ' ' GLU . . . -53.13 -75.11 0.24 Allowed Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.711 -0.677 . . . . 0.0 113.022 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.503 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 3.1 m120 -75.49 -1.06 22.4 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.768 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 1.05 ' HB1' ' HB3' ' A' ' 98' ' ' ALA . . . -87.96 47.66 1.53 Allowed 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.363 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.401 ' O ' ' HD2' ' A' ' 100' ' ' ARG . . . -56.37 -23.59 42.23 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.173 -1.013 . . . . 0.0 111.458 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.462 HG22 ' HG2' ' A' ' 171' ' ' GLN . 2.1 p -92.91 -16.69 24.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.464 0.173 . . . . 0.0 111.176 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 1.05 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -95.5 -37.17 11.01 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.469 ' HB2' ' HB2' ' A' ' 92' ' ' LEU . 2.2 tpp -59.3 -44.52 92.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.594 0.235 . . . . 0.0 110.524 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.7 ' HE ' HD12 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -54.13 -60.22 8.03 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.284 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.839 ' HB2' HD22 ' A' ' 30' ' ' LEU . 18.3 Cg_endo -62.0 -32.89 84.32 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.396 2.064 . . . . 0.0 112.831 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 1.024 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -70.86 -52.84 17.78 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.052 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.896 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -51.72 -28.72 15.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.26 0.552 . . . . 0.0 110.53 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.874 ' CB ' ' HB1' ' A' ' 175' ' ' ALA . . . -86.06 -52.97 5.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.428 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.702 ' CB ' HD11 ' A' ' 30' ' ' LEU . . . -60.57 -34.27 73.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.643 ' HB2' HD12 ' A' ' 153' ' ' LEU . 31.6 mt -78.52 -17.82 55.65 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.587 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 9.6 p -84.68 22.6 1.29 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.245 0.545 . . . . 0.0 110.598 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.771 HD21 ' HB2' ' A' ' 182' ' ' LEU . 0.4 OUTLIER -90.04 -73.86 0.51 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.427 -179.71 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -73.19 -116.31 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.699 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.24 94.15 2.09 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.141 0.496 . . . . 0.0 110.58 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.643 ' OD1' HD13 ' A' ' 113' ' ' ILE . 22.7 p30 -146.44 138.32 24.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.467 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.886 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 0.9 OUTLIER -95.21 100.65 12.42 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.656 179.122 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.644 HD12 ' C ' ' A' ' 112' ' ' ASP . 1.1 mp -120.66 147.68 24.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.494 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.865 HG13 ' CD2' ' A' ' 143' ' ' LEU . 58.0 t -117.53 113.22 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 176.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.679 HD23 ' HB2' ' A' ' 90' ' ' LEU . 33.9 mt -102.12 105.41 16.11 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.296 -0.561 . . . . 0.0 111.324 -177.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.813 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -118.14 -172.12 2.2 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.768 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.572 ' H ' HG22 ' A' ' 116' ' ' THR . . . -164.93 -167.97 26.34 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.206 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.609 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 16.9 mt-10 -78.31 171.86 11.38 Favored Pre-proline 0 C--N 1.332 -0.158 0 C-N-CA 122.661 0.384 . . . . 0.0 110.356 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 71.0 Cg_exo -49.5 -39.57 45.33 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.377 2.052 . . . . 0.0 112.77 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -68.23 -23.4 64.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.619 0.247 . . . . 0.0 110.971 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.557 ' O ' ' HG3' ' A' ' 149' ' ' PRO . 9.8 tpt -60.81 -34.45 74.55 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.474 ' HA ' ' HG2' ' A' ' 149' ' ' PRO . 0.0 OUTLIER -61.62 -16.77 51.33 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.614 179.166 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.3 3.19 32.47 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.837 0.351 . . . . 0.0 110.209 178.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.412 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 12.3 mtm180 -127.3 84.79 62.51 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.149 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 124' ' ' ARG . 16.2 Cg_endo -57.13 148.64 68.21 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.867 2.378 . . . . 0.0 112.068 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.7 HD12 ' HE ' ' A' ' 100' ' ' ARG . 0.9 OUTLIER -122.53 0.93 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -179.355 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.511 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -53.36 -39.43 59.19 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.219 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.433 ' HD2' HG13 ' A' ' 168' ' ' VAL . 42.5 m-70 -56.01 -41.61 75.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.783 0.325 . . . . 0.0 110.381 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.742 ' HG ' HD11 ' A' ' 133' ' ' LEU . 12.6 tp -75.48 -43.98 46.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.284 0.564 . . . . 0.0 110.055 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.842 HG13 ' CG2' ' A' ' 140' ' ' ILE . 69.5 t -56.41 -47.36 81.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.593 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.73 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 0.7 OUTLIER -69.2 -38.95 78.88 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.696 -179.603 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.617 ' HB2' HG23 ' A' ' 164' ' ' VAL . . . -58.39 -49.13 78.34 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.596 178.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.742 HD11 ' HG ' ' A' ' 129' ' ' LEU . 7.2 mt -69.92 -50.37 42.8 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.323 178.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.747 ' HG3' ' HB ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -58.14 -27.88 64.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.798 179.56 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.73 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 1.0 OUTLIER -69.79 -30.85 68.5 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.912 178.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -83.36 14.79 38.18 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.966 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 93.69 7.97 61.15 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.593 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.708 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . . . -78.21 152.03 32.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.834 0.349 . . . . 0.0 111.035 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 19.9 mtpt -100.73 103.96 15.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.126 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.842 ' CG2' HG13 ' A' ' 130' ' ' VAL . 34.7 mt -135.65 124.16 38.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.195 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.75 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -120.54 139.51 52.82 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.938 -179.589 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.559 ' CE1' HG11 ' A' ' 130' ' ' VAL . 42.1 m-85 -81.04 132.43 35.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.847 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.865 ' CD2' HG13 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -92.52 -87.16 0.23 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.775 -179.217 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.679 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 2.7 mt-10 -57.38 -82.46 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.397 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.42 ' NE2' ' CE1' ' A' ' 148' ' ' TYR . 25.1 mt-30 -116.69 154.3 30.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.341 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 6.0 mt-10 -66.88 132.82 48.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.373 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.511 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 2.7 m120 71.44 17.08 5.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.442 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.534 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 14.8 m-85 -107.0 168.22 8.36 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.813 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 75.0 Cg_exo -35.96 -60.33 0.35 Allowed 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.991 3.127 . . . . 0.0 115.921 -177.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.813 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 77.8 Cg_exo -52.35 145.5 35.79 Favored 'Trans proline' 0 C--N 1.352 0.736 0 CA-C-N 120.61 1.253 . . . . 0.0 112.118 -178.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.849 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 8.4 mt -156.41 137.59 13.73 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.808 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.75 ' HB2' HG22 ' A' ' 141' ' ' THR . 7.6 mtt85 -109.24 101.6 10.61 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.896 HD11 ' HA ' ' A' ' 103' ' ' ALA . 7.9 mt -90.35 148.01 23.11 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.283 -177.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.598 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 5.7 mt-30 -149.87 24.81 0.85 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.365 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.587 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 56.99 -162.04 7.52 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.322 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.421 ' O ' HG23 ' A' ' 158' ' ' THR . . . 107.35 -16.13 38.39 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.365 -0.922 . . . . 0.0 113.619 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.708 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 11.2 t80 -58.66 122.38 13.34 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 117.858 0.829 . . . . 0.0 110.155 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.738 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 56.9 p -114.76 -31.84 6.01 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 121.594 0.711 . . . . 0.0 111.171 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.442 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 137.19 -160.09 24.9 Favored Glycine 0 C--N 1.307 -1.068 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.049 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.566 ' O ' HG23 ' A' ' 187' ' ' THR . . . 105.5 152.95 21.14 Favored Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.008 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -47.01 116.47 1.37 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.98 -0.61 . . . . 0.0 110.83 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.569 ' CG1' ' HB1' ' A' ' 132' ' ' ALA . 68.6 t -109.49 144.88 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.48 119.97 39.4 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.477 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.893 HG21 HD11 ' A' ' 176' ' ' LEU . 1.0 OUTLIER -131.86 121.37 47.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.695 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.89 137.94 37.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.954 0.407 . . . . 0.0 111.191 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.802 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . -58.99 -22.84 56.09 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.75 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 13.2 m -84.6 -134.53 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.965 -0.384 . . . . 0.0 109.965 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.599 HG11 ' CD2' ' A' ' 172' ' ' PHE . 2.9 t 67.15 -124.8 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 O-C-N 122.341 -0.225 . . . . 0.0 111.018 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.491 ' C ' HG11 ' A' ' 196' ' ' VAL . 0.1 OUTLIER -136.92 145.24 44.03 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.901 0.382 . . . . 0.0 110.418 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.497 ' HB2' ' HB3' ' A' ' 200' ' ' TYR . 0.1 OUTLIER -60.73 -17.54 49.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.878 -179.581 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.584 ' O ' ' HB3' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -82.24 -11.08 58.88 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.811 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.599 ' CD2' HG11 ' A' ' 168' ' ' VAL . 6.4 m-85 -74.13 -54.88 6.86 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.882 HD11 ' CG1' ' A' ' 191' ' ' ILE . 0.5 OUTLIER -65.62 -37.78 87.54 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.436 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.489 ' HB ' ' HA ' ' A' ' 171' ' ' GLN . 4.4 m -58.26 -34.57 70.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.063 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.874 ' HB1' ' CB ' ' A' ' 104' ' ' ALA . . . -68.28 -39.05 82.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.843 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.893 HD11 HG21 ' A' ' 164' ' ' VAL . 0.3 OUTLIER -76.78 -34.26 58.0 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.275 0.559 . . . . 0.0 110.899 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.817 HD11 ' CD2' ' A' ' 223' ' ' PHE . 2.4 mp -59.68 -38.41 81.47 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.529 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.742 ' HE1' ' HA ' ' A' ' 27' ' ' ARG . 3.8 mtp -81.76 -43.61 18.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.389 0.614 . . . . 0.0 112.509 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.594 HG23 ' HG ' ' A' ' 108' ' ' LEU . 48.5 m -73.11 -39.88 65.42 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.684 -178.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.576 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . -59.49 -41.55 87.34 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -177.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 30.3 Cg_endo -65.59 -28.32 52.97 Favored 'Trans proline' 0 CA--C 1.501 -1.161 0 C-N-CA 121.046 1.164 . . . . 0.0 111.723 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.771 ' HB2' HD21 ' A' ' 108' ' ' LEU . 5.4 mt -83.15 -0.19 48.1 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.079 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.738 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -82.19 137.29 46.0 Favored Pre-proline 0 N--CA 1.455 -0.209 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.183 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.697 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 11.7 Cg_endo -50.94 -33.18 40.94 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.685 2.257 . . . . 0.0 113.357 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -113.28 139.52 48.76 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.842 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' A' ' 186' ' ' ASP . 0.8 OUTLIER -53.68 144.59 17.44 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.15 179.227 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.574 ' HB ' ' HB1' ' A' ' 180' ' ' ALA . 94.1 m -123.83 145.88 48.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.258 0.552 . . . . 0.0 112.441 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.673 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 40.2 t -126.63 117.83 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.366 177.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.744 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 3.5 mp -101.12 118.08 47.32 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.579 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 3.6 ttt180 -100.93 124.82 47.2 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.882 ' CG1' HD11 ' A' ' 173' ' ' LEU . 1.5 mp -93.61 123.41 45.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.952 -175.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -83.03 96.88 8.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.11 -1.405 . . . . 0.0 110.361 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 102.06 -134.28 11.7 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.804 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -116.43 127.32 54.5 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.727 HD11 ' HZ ' ' A' ' 223' ' ' PHE . 1.0 OUTLIER -41.37 144.72 0.31 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.486 179.447 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.491 HG11 ' C ' ' A' ' 169' ' ' SER . 11.1 p -72.92 -30.53 32.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.999 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.496 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 0.2 OUTLIER -162.09 62.43 0.23 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.024 0.44 . . . . 0.0 110.611 -179.412 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.578 ' HA ' HD13 ' A' ' 195' ' ' LEU . 3.1 tttp -39.68 -45.92 4.31 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.175 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.496 ' HD2' ' C ' ' A' ' 197' ' ' SER . 88.6 Cg_exo -47.8 -37.35 28.18 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 121.99 1.794 . . . . 0.0 111.622 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.954 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.3 OUTLIER -64.18 -45.79 86.83 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.637 HG21 ' HE2' ' A' ' 223' ' ' PHE . 12.5 mm -60.76 -37.33 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.584 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.442 ' OD2' ' HE3' ' A' ' 198' ' ' LYS . 83.8 m-20 -59.06 -46.78 87.39 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.857 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.954 HD12 ' HA ' ' A' ' 200' ' ' TYR . 3.1 mt -61.17 -46.26 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.977 0 CA-C-O 121.719 0.771 . . . . 0.0 108.986 178.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.55 HG22 ' SD ' ' A' ' 208' ' ' MET . 92.5 m -54.13 -51.44 64.23 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.699 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.874 HD22 ' HB ' ' A' ' 215' ' ' ILE . 26.8 mt -68.53 -28.37 66.93 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 120.531 -0.467 . . . . 0.0 111.246 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.496 ' HA ' ' HE3' ' A' ' 209' ' ' LYS . 15.0 t30 -77.84 -46.09 22.48 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.793 0.806 . . . . 0.0 109.577 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.99 ' O ' HG22 ' A' ' 210' ' ' THR . 3.1 tp -69.57 -34.46 74.21 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.188 -1.369 . . . . 0.0 109.297 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . 0.79 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 50.1 mtp -72.57 -33.82 67.03 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.467 0.651 . . . . 0.0 109.328 177.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.623 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 15.5 mtmt -62.57 -37.57 86.69 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.862 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.99 HG22 ' O ' ' A' ' 207' ' ' LEU . 5.8 t -62.86 -28.45 70.03 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.409 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.569 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 39.3 m-85 -82.82 -6.04 59.24 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.913 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.99 6.9 25.81 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 116.226 1.25 . . . . 0.0 116.226 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.623 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.2 m -123.66 148.7 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 119.101 1.451 . . . . 0.0 112.729 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.571 ' O ' HD13 ' A' ' 215' ' ' ILE . 18.9 mt-10 -129.63 140.66 51.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.821 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.874 ' HB ' HD22 ' A' ' 205' ' ' LEU . 15.9 mm -123.29 148.31 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-O 120.871 0.367 . . . . 0.0 110.691 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.64 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 31.0 tt0 -103.45 119.19 38.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.603 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.881 HD22 ' H ' ' A' ' 217' ' ' ASN . 0.0 OUTLIER -82.85 151.17 26.15 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.541 179.431 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . 0.745 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -112.58 -146.09 0.4 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 121.182 -0.207 . . . . 0.0 110.49 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.425 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 7.0 m80 -68.01 66.23 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.416 ' CE1' ' HD2' ' A' ' 198' ' ' LYS . 3.4 t80 52.93 34.6 17.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.887 0.851 . . . . 0.0 110.266 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.648 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -164.35 -124.09 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 179.652 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.745 ' O ' ' HB2' ' A' ' 218' ' ' GLN . 0.0 OUTLIER -8.36 133.59 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.817 ' CD2' HD11 ' A' ' 177' ' ' LEU . 0.8 OUTLIER -124.75 139.26 54.01 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.269 -1.787 . . . . 0.0 109.79 -179.218 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.64 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 40.1 t -120.96 113.87 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.871 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -122.16 126.05 73.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.531 -178.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.527 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -74.4 126.76 31.4 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.608 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -81.92 -178.97 52.71 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.268 -0.968 . . . . 0.0 113.021 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 66.01 21.25 69.57 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 121.375 -0.44 . . . . 0.0 112.872 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . 0.527 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 27.2 mt-30 -78.72 -176.04 4.71 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.213 0.53 . . . . 0.0 111.476 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.4 t -148.64 147.77 29.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.043 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' TYR . . . . . 0.67 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 7.2 m-85 -103.32 129.95 50.47 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.87 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -121.53 148.07 44.97 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.756 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.439 ' HB2' ' OG1' ' A' ' 39' ' ' THR . 10.9 p -71.52 110.99 8.68 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 120.981 -0.287 . . . . 0.0 110.516 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.493 ' HB3' ' O ' ' A' ' 210' ' ' THR . 55.7 Cg_endo -70.08 1.66 4.44 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.199 1.933 . . . . 0.0 112.213 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 98.59 -101.75 2.51 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 56.1 m -117.39 137.78 52.25 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.609 ' CD2' HG21 ' A' ' 210' ' ' THR . 10.6 t80 -134.32 125.49 27.74 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.928 0.394 . . . . 0.0 111.314 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.892 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -94.78 110.91 22.72 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.105 0.479 . . . . 0.0 111.017 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.606 ' N ' HD22 ' A' ' 238' ' ' LEU . 21.7 t -81.61 111.11 17.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.212 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.533 ' HG3' HD13 ' A' ' 238' ' ' LEU . 6.3 mt-10 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.078 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.523 ' CB ' HD22 ' A' ' 44' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.88 0.371 . . . . 0.0 111.437 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.513 HD22 ' HB2' ' A' ' 98' ' ' ALA . 33.7 m120 61.96 -78.41 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.946 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.691 ' HB2' HD21 ' A' ' 207' ' ' LEU . 1.0 OUTLIER -73.75 -63.2 1.26 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.277 0.56 . . . . 0.0 110.69 179.602 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.863 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -37.23 -46.83 0.75 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.001 -0.999 . . . . 0.0 112.321 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.043 HD22 HD11 ' A' ' 75' ' ' ILE . 11.0 mt -75.51 -33.14 60.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.937 0.399 . . . . 0.0 111.256 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.895 HD22 ' HB2' ' A' ' 101' ' ' PRO . 46.4 tp -68.6 -49.71 57.15 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.489 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.628 HD22 ' CZ ' ' A' ' 231' ' ' TYR . 39.5 mt -68.71 -26.99 65.55 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.451 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.825 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -65.29 -37.46 87.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.084 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.81 ' CB ' HG11 ' A' ' 62' ' ' VAL . . . -80.83 -41.12 23.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.234 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.689 HD23 ' O ' ' A' ' 80' ' ' GLY . 32.4 mt -67.52 -3.78 9.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.368 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.427 ' O ' ' HA3' ' A' ' 77' ' ' GLY . . . -83.57 171.95 12.83 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -112.31 34.67 4.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.984 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -168.81 175.43 43.31 Favored Glycine 0 C--N 1.309 -0.936 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.74 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.759 ' HE2' HD12 ' A' ' 76' ' ' ILE . 10.6 ttmt -95.39 117.83 31.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.642 0.721 . . . . 0.0 111.373 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 235' ' ' GLY . 0.9 OUTLIER -123.14 148.28 45.89 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.615 -179.291 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.708 HG22 ' HB2' ' A' ' 74' ' ' GLU . 76.1 t -104.78 141.42 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 CA-C-O 121.393 0.616 . . . . 0.0 112.474 -179.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.896 HD23 HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -114.51 116.2 28.45 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 175.034 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.907 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.5 OUTLIER -102.99 151.68 22.2 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.149 -178.364 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.447 ' HB2' HD23 ' A' ' 238' ' ' LEU . 1.8 t-20 68.15 25.64 7.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.419 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.807 HD21 ' CB ' ' A' ' 41' ' ' LEU . 70.9 mt -53.4 -175.6 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.552 ' HB3' HG21 ' A' ' 50' ' ' VAL . 54.1 tp -113.0 130.91 55.97 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.509 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.417 ' O ' ' CG ' ' A' ' 46' ' ' ASP . 10.1 p-10 -85.45 87.41 7.39 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.302 0.573 . . . . 0.0 110.619 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.447 ' HB2' ' OD1' ' A' ' 49' ' ' ASP . 4.4 m -164.02 142.91 7.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.306 -178.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -36.27 -32.08 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.689 0.281 . . . . 0.0 111.578 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 1.065 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 29.4 p-10 -57.74 -42.62 84.3 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.055 0.455 . . . . 0.0 110.66 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.552 HG21 ' HB3' ' A' ' 45' ' ' LEU . 98.5 t -82.73 -45.78 19.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.788 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.912 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -48.65 -40.08 26.59 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.644 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 13.8 m-70 -78.62 -33.2 47.56 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.017 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.558 ' O ' HD13 ' A' ' 57' ' ' LEU . 7.8 tpt -54.36 -32.41 56.86 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 176.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.912 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.6 OUTLIER -84.08 -42.48 16.05 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.53 176.411 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.701 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 25.2 t-20 -60.25 -42.62 95.68 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.538 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 1.081 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -57.66 -47.23 82.87 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.752 0.787 . . . . 0.0 109.207 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.815 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -64.23 -39.71 94.54 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.253 -1.34 . . . . 0.0 107.775 177.147 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.701 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.1 m -61.44 -35.4 77.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.802 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.637 ' CB ' HD11 ' A' ' 90' ' ' LEU . . . -75.97 -38.04 57.91 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.267 -178.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.705 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -80.59 -14.01 58.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.287 0.565 . . . . 0.0 110.657 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.94 34.97 4.99 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.217 -0.901 . . . . 0.0 114.259 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.815 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 35.6 t -90.5 121.71 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.775 ' O ' HG12 ' A' ' 76' ' ' ILE . 2.7 t -85.68 135.06 33.92 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.462 -178.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.787 ' HB3' HG23 ' A' ' 75' ' ' ILE . 40.1 p90 -161.33 172.07 17.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.577 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 74' ' ' GLU . 85.9 m -135.68 146.41 47.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.462 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.652 HD12 ' HB2' ' A' ' 73' ' ' CYS . 9.3 tp -117.78 136.53 53.34 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.088 0.47 . . . . 0.0 110.716 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.432 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 1.2 t -59.95 -162.7 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.133 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -95.01 -29.4 14.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.157 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.03 1.88 25.94 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.181 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.493 ' HA ' HD21 ' A' ' 66' ' ' LEU . 1.3 mtt180 56.42 33.51 22.57 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.38 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.411 HG22 ' O ' ' A' ' 44' ' ' LEU . 1.1 p -130.95 -9.25 3.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.575 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -117.61 121.48 41.03 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.191 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.652 ' HB2' HD12 ' A' ' 66' ' ' LEU . 37.9 t -132.07 129.1 39.54 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.245 0.545 . . . . 0.0 112.041 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.708 ' HB2' HG22 ' A' ' 40' ' ' VAL . 64.2 tt0 -112.22 130.29 55.97 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 177.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 1.043 HD11 HD22 ' A' ' 29' ' ' LEU . 17.9 mt -126.35 122.17 60.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 -177.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.775 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -67.67 103.72 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-O 121.343 0.592 . . . . 0.0 109.508 175.78 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' A' ' 35' ' ' ALA . . . -43.44 151.44 0.45 Allowed Glycine 0 C--N 1.32 -0.324 0 CA-C-N 115.219 -0.9 . . . . 0.0 113.847 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 35' ' ' ALA . 5.8 t30 -97.34 -17.25 19.86 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.795 0.331 . . . . 0.0 111.347 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.11 -0.48 56.12 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.159 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.689 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 154.8 -150.71 22.32 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.167 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.598 ' CG ' ' HB3' ' A' ' 108' ' ' LEU . 73.1 Cg_exo -50.15 125.26 14.48 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.992 2.462 . . . . 0.0 112.98 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.705 ' HB2' HD13 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -74.21 106.27 5.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.901 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -81.67 133.77 35.4 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.333 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.607 ' CB ' HD11 ' A' ' 113' ' ' ILE . . . -97.05 129.8 44.44 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.25 123.97 23.45 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 176.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.59 -178.81 2.2 Favored Glycine 0 N--CA 1.44 -1.049 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 -175.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 112' ' ' ASP . . . -80.06 144.5 33.1 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 118.725 1.262 . . . . 0.0 112.025 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.636 HD21 ' C ' ' A' ' 59' ' ' ALA . 0.5 OUTLIER -114.63 161.06 18.59 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.089 -178.833 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.481 ' HG3' ' HB ' ' A' ' 114' ' ' VAL . 28.9 mp0 -139.31 105.28 5.19 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.099 178.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.748 ' HB3' HD11 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -105.11 116.92 32.76 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.886 -178.476 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.565 ' C ' HD13 ' A' ' 92' ' ' LEU . 7.6 m-85 -96.59 96.8 8.9 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.914 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -103.88 57.57 0.73 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.275 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.646 ' HA3' ' H ' ' A' ' 118' ' ' GLU . . . -50.35 -68.04 1.61 Allowed Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.592 -0.731 . . . . 0.0 113.499 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.526 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 83.5 m-20 -76.49 1.07 17.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.554 0.216 . . . . 0.0 111.299 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 1.065 ' HB2' ' HA ' ' A' ' 49' ' ' ASP . . . -99.87 54.12 0.92 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.948 0.404 . . . . 0.0 111.656 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -56.85 -25.39 52.41 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.31 -0.947 . . . . 0.0 111.339 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.478 HG23 ' OE1' ' A' ' 171' ' ' GLN . 0.1 OUTLIER -89.05 -14.36 36.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.685 -0.257 . . . . 0.0 111.656 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.863 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -96.83 -32.56 12.04 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.603 ' CG ' HD13 ' A' ' 126' ' ' ILE . 0.9 OUTLIER -61.73 -43.25 99.22 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.766 ' HD2' HD12 ' A' ' 126' ' ' ILE . 6.7 mpt_? -56.81 -60.5 9.24 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.895 ' HB2' HD22 ' A' ' 30' ' ' LEU . 14.1 Cg_endo -58.57 -34.73 99.05 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.513 2.142 . . . . 0.0 112.446 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 1.081 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -72.07 -52.49 16.6 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.145 179.703 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 1.018 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -53.13 -27.83 22.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.483 0.659 . . . . 0.0 110.311 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.858 ' CB ' ' HB1' ' A' ' 175' ' ' ALA . . . -86.5 -54.5 4.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.343 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.721 ' CB ' HD11 ' A' ' 30' ' ' LEU . . . -60.65 -34.44 74.29 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -177.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.704 ' HB2' HD12 ' A' ' 153' ' ' LEU . 31.2 mt -78.54 -23.06 46.41 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -176.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.558 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 13.7 p -78.42 16.1 0.87 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.161 0.505 . . . . 0.0 110.791 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.695 HD21 ' HB2' ' A' ' 182' ' ' LEU . 0.3 OUTLIER -82.98 -75.81 0.3 Allowed 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.032 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -70.69 -113.77 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.134 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.57 94.44 1.9 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.206 0.527 . . . . 0.0 110.793 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.812 HD22 HD13 ' A' ' 113' ' ' ILE . 0.8 OUTLIER -145.27 139.12 26.88 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.378 -179.113 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.877 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 1.2 m-20 -97.74 98.26 9.7 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.812 HD13 HD22 ' A' ' 111' ' ' ASN . 1.6 mp -120.35 147.92 23.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.253 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.859 HG13 ' CD2' ' A' ' 143' ' ' LEU . 47.1 t -115.34 113.76 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 176.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.617 HD23 ' HB2' ' A' ' 90' ' ' LEU . 77.6 mt -101.72 106.36 17.37 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.518 -178.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.663 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -119.04 -169.36 1.72 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.318 -179.232 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.479 ' HA3' ' HA2' ' A' ' 93' ' ' GLY . . . -171.35 -179.64 42.57 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.524 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.646 ' H ' ' HA3' ' A' ' 93' ' ' GLY . 39.0 mt-10 -70.15 169.61 12.86 Favored Pre-proline 0 C--N 1.331 -0.211 0 C-N-CA 123.207 0.603 . . . . 0.0 111.08 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.63 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 4.1 Cg_endo -45.08 -40.04 15.34 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.082 2.521 . . . . 0.0 113.077 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.3 mtm180 -67.84 -23.93 65.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.73 0.3 . . . . 0.0 110.716 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.633 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 10.5 tpt -60.96 -36.21 78.78 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.455 ' HA ' ' HG2' ' A' ' 149' ' ' PRO . 0.0 OUTLIER -61.47 -16.5 47.76 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.665 179.249 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -83.99 3.18 35.46 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.573 ' HB3' HH22 ' A' ' 100' ' ' ARG . 66.0 mtt-85 -127.62 83.26 66.55 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.352 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.466 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 38.1 Cg_exo -56.79 149.28 61.08 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.761 2.307 . . . . 0.0 111.701 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.766 HD12 ' HD2' ' A' ' 100' ' ' ARG . 1.0 OUTLIER -129.07 8.66 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.377 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.553 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -59.88 -39.84 96.02 Favored Glycine 0 CA--C 1.517 0.193 0 C-N-CA 120.749 -0.739 . . . . 0.0 113.764 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.803 ' CG ' HG21 ' A' ' 168' ' ' VAL . 26.0 m80 -55.71 -37.97 69.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.902 0.351 . . . . 0.0 110.54 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.772 ' HG ' HD11 ' A' ' 133' ' ' LEU . 29.3 tp -75.42 -40.46 57.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.241 0.544 . . . . 0.0 109.804 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.881 HG21 HD21 ' A' ' 151' ' ' LEU . 40.3 t -56.54 -47.98 81.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.331 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.692 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 0.1 OUTLIER -72.18 -35.94 69.13 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 121.298 0.571 . . . . 0.0 109.58 179.272 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.669 ' O ' HG13 ' A' ' 162' ' ' VAL . . . -57.31 -47.73 80.76 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.75 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.772 HD11 ' HG ' ' A' ' 129' ' ' LEU . 3.5 mt -75.94 -50.32 15.27 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.06 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.745 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.1 OUTLIER -54.71 -28.32 47.13 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.107 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.692 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 8.1 tp -69.01 -31.82 70.91 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 120.958 0.408 . . . . 0.0 110.902 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.464 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -81.86 11.64 46.45 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.787 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.49 6.54 56.44 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.764 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.673 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . . . -76.36 153.59 35.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.973 0.416 . . . . 0.0 111.481 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 0.4 OUTLIER -102.83 106.35 16.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.646 178.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.767 ' CG2' HG13 ' A' ' 130' ' ' VAL . 23.1 mt -137.91 125.88 30.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.485 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.781 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -123.56 139.48 53.96 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.519 -179.541 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.41 ' CE1' HG21 ' A' ' 130' ' ' VAL . 40.3 m-85 -79.71 131.05 35.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.469 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.859 ' CD2' HG13 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -91.52 -91.04 0.16 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.62 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.6 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 7.6 mm-40 -58.56 -81.68 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.676 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.512 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 0.2 OUTLIER -112.76 151.21 30.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.914 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 12.8 mt-10 -67.41 129.75 40.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.827 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.553 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 2.8 m120 71.04 17.91 6.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.068 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.62 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 16.8 m-85 -108.59 169.48 6.49 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 121.046 0.45 . . . . 0.0 111.992 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.918 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 48.9 Cg_exo -31.43 -62.67 0.12 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 124.384 3.389 . . . . 0.0 116.061 -177.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.918 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 65.3 Cg_exo -52.5 144.79 39.83 Favored 'Trans proline' 0 C--N 1.354 0.827 0 CA-C-N 120.626 1.259 . . . . 0.0 112.683 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.881 HD21 HG21 ' A' ' 130' ' ' VAL . 7.4 mt -155.9 136.85 13.59 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.023 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.781 ' HB2' HG22 ' A' ' 141' ' ' THR . 5.8 mtt180 -108.08 102.77 11.9 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 1.018 HD11 ' HA ' ' A' ' 103' ' ' ALA . 7.0 mt -90.73 145.83 24.49 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.861 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.657 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 6.5 mt-30 -149.3 26.19 0.87 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.164 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 53.78 -163.22 2.98 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.421 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.436 ' O ' HG23 ' A' ' 158' ' ' THR . . . 108.38 -16.27 35.06 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.005 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.73 ' HE2' ' HA ' ' A' ' 180' ' ' ALA . 67.0 t80 -58.55 122.97 14.71 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 117.081 0.44 . . . . 0.0 110.693 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.709 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 60.7 p -116.9 -28.84 6.18 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.495 0.664 . . . . 0.0 111.431 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 120.95 -169.47 14.27 Favored Glycine 0 C--N 1.306 -1.092 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.215 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.616 ' O ' ' HA ' ' A' ' 187' ' ' THR . . . 128.39 -126.13 5.26 Favored Glycine 0 N--CA 1.434 -1.468 0 N-CA-C 111.126 -0.789 . . . . 0.0 111.126 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.41 130.34 55.73 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.779 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 82.0 t -130.21 123.54 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 121.004 0.431 . . . . 0.0 110.687 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.17 119.99 38.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.665 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.714 HG11 ' HG ' ' A' ' 173' ' ' LEU . 1.0 OUTLIER -130.14 120.51 49.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.953 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.683 ' HA ' ' HG3' ' A' ' 192' ' ' LYS . 0.1 OUTLIER -51.94 137.89 25.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.298 0.571 . . . . 0.0 111.649 -179.737 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.881 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . -59.63 -50.6 66.03 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.603 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 92.5 p -95.93 91.96 6.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.705 0.288 . . . . 0.0 111.04 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.803 HG21 ' CG ' ' A' ' 128' ' ' HIS . 8.7 p -175.58 58.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.008 0.432 . . . . 0.0 111.243 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.733 ' C ' HG11 ' A' ' 196' ' ' VAL . 2.0 m 67.99 128.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.959 0.409 . . . . 0.0 110.833 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.496 ' N ' HG11 ' A' ' 196' ' ' VAL . 0.3 OUTLIER -75.74 -17.4 59.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.698 -179.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.54 ' O ' ' HB3' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -74.37 -6.01 45.64 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.122 -179.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.663 ' CD1' ' HB2' ' A' ' 169' ' ' SER . 5.5 m-85 -76.27 -55.96 5.08 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.898 HD11 ' CG1' ' A' ' 191' ' ' ILE . 0.4 OUTLIER -61.74 -40.95 96.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.606 0.717 . . . . 0.0 109.084 178.057 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.482 ' HB ' ' HA ' ' A' ' 171' ' ' GLN . 5.5 m -55.82 -36.49 67.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.528 -1.214 . . . . 0.0 110.01 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.858 ' HB1' ' CB ' ' A' ' 104' ' ' ALA . . . -69.17 -40.29 78.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.563 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.695 HD11 HG21 ' A' ' 164' ' ' VAL . 0.4 OUTLIER -76.64 -33.32 58.34 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.149 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.783 HD11 ' CD2' ' A' ' 223' ' ' PHE . 5.1 mp -59.76 -38.13 80.94 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.908 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.649 ' HE1' ' HA ' ' A' ' 27' ' ' ARG . 0.4 OUTLIER -82.07 -43.03 18.4 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.469 0.652 . . . . 0.0 112.112 -179.66 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.619 HG23 ' HG ' ' A' ' 108' ' ' LEU . 54.4 m -71.41 -41.13 69.97 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.471 -178.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.73 ' HA ' ' HE2' ' A' ' 157' ' ' PHE . . . -59.72 -42.15 89.78 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -177.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 29.8 Cg_endo -64.77 -29.04 59.45 Favored 'Trans proline' 0 CA--C 1.5 -1.205 0 C-N-CA 120.956 1.104 . . . . 0.0 111.637 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.695 ' HB2' HD21 ' A' ' 108' ' ' LEU . 6.9 mt -83.73 1.56 42.12 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.358 178.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.66 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -83.59 138.53 41.12 Favored Pre-proline 0 C--O 1.224 -0.289 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.709 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 12.9 Cg_endo -51.84 -31.86 44.26 Favored 'Trans proline' 0 CA--C 1.518 -0.28 0 C-N-CA 122.45 2.1 . . . . 0.0 113.117 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -114.89 143.6 44.88 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.892 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -57.8 141.01 50.36 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.076 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 160' ' ' GLY . 70.7 m -119.01 145.85 45.51 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.652 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 35.3 t -125.63 118.94 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.438 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.779 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 4.1 mp -104.03 117.09 48.99 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.655 0 C-N-CA 120.079 -0.648 . . . . 0.0 109.276 178.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.888 ' HG3' ' HG3' ' A' ' 222' ' ' GLN . 1.7 ttt180 -99.88 123.57 44.27 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.898 ' CG1' HD11 ' A' ' 173' ' ' LEU . 1.3 mp -93.11 121.88 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.088 -176.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.683 ' HG3' ' HA ' ' A' ' 165' ' ' ASP . 0.5 OUTLIER -74.87 96.62 3.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.346 -178.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 97.36 -126.9 9.03 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.793 -0.717 . . . . 0.0 111.702 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -116.85 133.54 55.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.769 0.318 . . . . 0.0 111.321 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.721 HD11 ' HZ ' ' A' ' 223' ' ' PHE . 0.8 OUTLIER -41.91 144.68 0.4 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.211 0.529 . . . . 0.0 111.902 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.733 HG11 ' C ' ' A' ' 169' ' ' SER . 13.9 p -74.48 -25.38 19.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.975 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.475 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 0.3 OUTLIER -168.48 64.7 0.07 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.833 0.349 . . . . 0.0 110.934 -179.531 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.56 ' HA ' HD13 ' A' ' 195' ' ' LEU . 4.4 tptp -39.48 -46.23 4.13 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.382 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 72.6 Cg_exo -49.61 -36.78 41.72 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.006 1.804 . . . . 0.0 111.843 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.943 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.2 OUTLIER -65.62 -44.53 86.2 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 178.42 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.46 HG21 ' HE2' ' A' ' 223' ' ' PHE . 30.9 mm -60.9 -38.4 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.472 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.45 -43.63 93.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.229 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.943 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.6 mt -62.43 -50.95 77.83 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 CA-C-O 121.569 0.7 . . . . 0.0 109.635 178.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.544 HG22 ' SD ' ' A' ' 208' ' ' MET . 78.5 m -53.66 -51.65 62.49 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.991 -178.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.755 HD22 ' HB ' ' A' ' 215' ' ' ILE . 32.2 mt -65.31 -30.18 71.0 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.001 0.429 . . . . 0.0 111.534 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.559 ' HA ' ' HE3' ' A' ' 209' ' ' LYS . 1.0 OUTLIER -77.5 -46.37 22.65 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.734 0.778 . . . . 0.0 109.77 179.007 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.91 ' O ' HG22 ' A' ' 210' ' ' THR . 2.6 tp -71.26 -30.02 65.8 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.24 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . 0.759 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 40.8 mtp -75.04 -35.63 61.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.647 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 12.8 mtmt -60.65 -37.71 82.43 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.046 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.91 HG22 ' O ' ' A' ' 207' ' ' LEU . 5.8 t -62.61 -28.88 70.2 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.718 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.574 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 42.7 m-85 -80.52 -6.98 59.01 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.579 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.99 7.65 24.9 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 115.98 1.152 . . . . 0.0 115.98 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.2 m -123.36 148.59 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 118.929 1.364 . . . . 0.0 112.794 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.509 ' O ' HD13 ' A' ' 215' ' ' ILE . 18.0 mt-10 -130.84 136.21 48.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.811 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.755 ' HB ' HD22 ' A' ' 205' ' ' LEU . 16.8 mm -118.66 148.12 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 120.845 0.355 . . . . 0.0 110.565 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.55 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 2.6 tt0 -100.63 118.26 36.42 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.916 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -82.84 150.98 26.24 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.934 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . 0.517 ' CB ' ' HB3' ' A' ' 222' ' ' GLN . 3.5 tp60 -106.74 -138.26 0.37 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.114 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.493 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 0.1 OUTLIER -84.87 66.67 9.81 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.827 0.346 . . . . 0.0 111.008 -179.451 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 5.5 t80 60.07 33.04 21.24 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.82 0.819 . . . . 0.0 110.439 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.675 ' CB ' ' HB ' ' A' ' 191' ' ' ILE . 1.8 pt20 -166.39 -124.77 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.888 ' HG3' ' HG3' ' A' ' 190' ' ' ARG . 0.7 OUTLIER -5.43 130.09 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.783 ' CD2' HD11 ' A' ' 177' ' ' LEU . 1.2 m-85 -125.07 133.37 52.93 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 112.977 -1.92 . . . . 0.0 109.509 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 61.3 t -116.96 113.51 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-O 121.573 0.702 . . . . 0.0 109.206 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.739 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -120.22 122.29 67.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.152 -178.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.572 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 0.1 OUTLIER -76.84 123.43 26.24 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.806 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -75.54 -177.11 40.71 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.718 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 65.5 21.72 69.0 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 121.573 -0.346 . . . . 0.0 113.036 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . 0.572 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 15.7 mt-30 -77.41 179.58 6.36 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.298 0.57 . . . . 0.0 111.338 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 13.6 t -138.01 147.8 44.53 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.869 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' TYR . . . . . 0.681 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 1.1 m-30 -107.83 123.76 49.07 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.894 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.96 161.3 20.02 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.553 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.12 113.34 57.95 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-O 120.835 0.35 . . . . 0.0 111.43 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.517 ' HG3' HG23 ' A' ' 210' ' ' THR . 58.8 Cg_endo -69.65 1.98 3.88 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.656 2.237 . . . . 0.0 112.875 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 98.99 -100.5 2.29 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.344 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 92.2 m -119.35 133.15 55.87 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.712 ' CD2' HG21 ' A' ' 210' ' ' THR . 4.4 t80 -129.74 133.21 46.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.873 0.368 . . . . 0.0 111.117 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.907 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -97.18 110.52 23.05 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.201 0.524 . . . . 0.0 110.524 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.621 ' N ' HD22 ' A' ' 238' ' ' LEU . 21.9 t -79.06 113.51 18.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.421 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.212 -0.899 . . . . 0.0 111.156 -179.984 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.492 ' N ' HG11 ' A' ' 239' ' ' VAL . 5.0 p . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.536 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 17.5 m120 -73.23 -65.63 0.78 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.837 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.596 ' HB2' HD21 ' A' ' 207' ' ' LEU . 0.5 OUTLIER -65.37 -57.99 7.0 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.345 0.593 . . . . 0.0 110.171 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.692 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -40.73 -44.39 2.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.958 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.975 HD22 HD11 ' A' ' 75' ' ' ILE . 14.2 mt -71.68 -37.47 70.74 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.918 0.39 . . . . 0.0 111.213 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.681 HD11 ' CB ' ' A' ' 105' ' ' ALA . 56.9 tp -65.32 -49.95 67.48 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.917 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.692 HD11 ' HG2' ' A' ' 208' ' ' MET . 20.1 mt -69.33 -26.17 64.57 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.765 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -63.79 -41.82 97.85 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.221 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.83 ' CB ' HG11 ' A' ' 62' ' ' VAL . . . -80.47 -40.17 26.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.73 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.687 HD11 ' HB1' ' A' ' 105' ' ' ALA . 9.1 mt -67.48 -3.4 8.43 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.451 178.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.505 ' HA ' ' CB ' ' A' ' 231' ' ' TYR . . . -99.84 177.26 5.17 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -177.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.546 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.3 OUTLIER -111.28 114.39 27.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.656 178.357 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 114.28 167.48 15.97 Favored Glycine 0 C--O 1.228 -0.28 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.202 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.653 ' HG3' HG23 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -95.34 117.53 30.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 117.284 0.542 . . . . 0.0 111.55 -179.439 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 0.9 OUTLIER -118.8 147.03 44.34 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.242 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.672 HG22 ' HB2' ' A' ' 74' ' ' GLU . 96.6 t -105.91 141.25 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 CA-C-O 121.385 0.612 . . . . 0.0 112.437 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.923 HD23 HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -116.02 116.32 27.69 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 174.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.867 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.5 OUTLIER -103.15 152.93 20.86 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.228 -177.75 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.4 t30 68.8 24.71 6.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.514 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.813 HD21 ' CB ' ' A' ' 41' ' ' LEU . 34.8 mt -53.86 -175.55 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.951 0.405 . . . . 0.0 110.151 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.558 ' HB3' HG21 ' A' ' 50' ' ' VAL . 28.3 tp -111.78 132.28 54.77 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.163 -0.472 . . . . 0.0 109.995 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -88.52 89.26 7.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.835 0.35 . . . . 0.0 110.896 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 50' ' ' VAL . 36.5 m -163.79 142.17 7.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.057 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.583 ' HA ' ' HB3' ' A' ' 51' ' ' ARG . 1.6 p30 -37.89 -31.25 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.662 0.268 . . . . 0.0 111.429 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.875 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 0.7 OUTLIER -57.29 -42.72 82.25 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.024 0.44 . . . . 0.0 110.435 179.308 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.671 HG23 ' OD1' ' A' ' 49' ' ' ASP . 98.0 t -81.66 -45.08 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.873 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -49.62 -39.13 34.64 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 177.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.618 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 14.7 m-70 -78.64 -33.25 47.38 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.908 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.588 ' O ' HD13 ' A' ' 57' ' ' LEU . 9.4 tpt -55.5 -35.58 65.74 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 176.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.873 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.5 OUTLIER -81.88 -44.43 16.85 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 114.162 -1.381 . . . . 0.0 108.522 176.598 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.732 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 0.3 OUTLIER -57.31 -38.59 74.27 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.354 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 1.036 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -60.54 -44.79 95.73 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.801 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.2 OUTLIER -65.59 -38.83 90.6 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.1 -1.409 . . . . 0.0 107.752 176.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.732 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.2 m -63.02 -33.76 76.11 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.528 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.782 ' CB ' HD11 ' A' ' 90' ' ' LEU . . . -74.22 -37.13 63.93 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.341 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.714 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -83.54 -13.92 53.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.171 0.51 . . . . 0.0 111.058 -179.464 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.07 35.01 4.65 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.42 -0.809 . . . . 0.0 114.123 178.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.83 HG11 ' CB ' ' A' ' 33' ' ' ALA . 38.2 t -90.69 122.13 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.756 ' O ' HG12 ' A' ' 76' ' ' ILE . 5.5 m -84.88 132.54 34.38 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 120.911 0.386 . . . . 0.0 111.711 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.755 ' HB3' HG23 ' A' ' 75' ' ' ILE . 41.4 p90 -158.03 167.93 28.51 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.378 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 74' ' ' GLU . 40.7 m -129.81 147.31 51.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.372 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.45 HD12 ' HB2' ' A' ' 73' ' ' CYS . 12.3 tp -115.59 132.4 56.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.235 0.541 . . . . 0.0 110.487 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 0.2 OUTLIER -59.22 -161.2 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.554 -179.451 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -95.56 -32.02 13.03 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.549 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -79.84 1.24 27.7 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.261 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 30.6 mtt-85 57.88 35.33 25.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.996 0.426 . . . . 0.0 110.888 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -134.21 -4.5 2.71 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.626 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.545 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 3.4 mtp-105 -121.62 122.09 38.86 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.622 ' HB3' HD11 ' A' ' 44' ' ' LEU . 28.8 t -131.18 126.9 36.81 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 120.989 0.424 . . . . 0.0 112.069 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.672 ' HB2' HG22 ' A' ' 40' ' ' VAL . 58.6 tt0 -110.63 131.65 54.87 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 176.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.975 HD11 HD22 ' A' ' 29' ' ' LEU . 13.2 mt -126.42 121.81 59.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.756 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -67.23 98.4 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-O 121.486 0.66 . . . . 0.0 109.252 175.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -35.15 145.04 0.06 OUTLIER Glycine 0 C--N 1.32 -0.344 0 CA-C-N 114.56 -1.2 . . . . 0.0 114.125 -178.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.47 ' CB ' HD12 ' A' ' 82' ' ' LEU . 1.1 t-20 -90.74 -13.11 34.66 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.06 0.457 . . . . 0.0 110.789 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.546 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 91.81 1.78 70.25 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.697 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.637 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 149.97 -147.61 18.01 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.035 -0.602 . . . . 0.0 111.742 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.429 ' HD2' ' HA3' ' A' ' 80' ' ' GLY . 5.7 Cg_endo -49.05 122.66 8.71 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.596 2.198 . . . . 0.0 112.524 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.714 ' HB2' HD13 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -73.33 110.75 7.86 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.27 179.653 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -82.24 130.31 35.06 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.592 ' CB ' HD22 ' A' ' 88' ' ' LEU . . . -94.46 122.79 37.39 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.672 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -71.19 123.74 22.89 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 176.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.86 174.54 1.2 Allowed Glycine 0 N--CA 1.439 -1.124 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 -175.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 112' ' ' ASP . . . -72.95 144.8 47.14 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 118.705 1.253 . . . . 0.0 111.923 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.666 HD21 ' C ' ' A' ' 59' ' ' ALA . 0.5 OUTLIER -112.27 160.94 17.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.001 -0.999 . . . . 0.0 112.127 -178.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 18.8 mt-10 -140.21 101.3 4.11 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.022 177.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.782 HD11 ' CB ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -100.79 120.1 39.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.872 0.368 . . . . 0.0 111.346 -178.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.46 ' C ' HD13 ' A' ' 92' ' ' LEU . 1.4 m-85 -95.27 96.45 9.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.823 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.807 HD23 ' SD ' ' A' ' 99' ' ' MET . 0.1 OUTLIER -103.54 52.89 0.76 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.351 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.572 ' HA3' ' H ' ' A' ' 118' ' ' GLU . . . -49.82 -75.13 0.22 Allowed Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.408 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 50.0 m-80 -77.51 -0.68 27.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.501 0.191 . . . . 0.0 110.97 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.894 ' HB1' ' HB3' ' A' ' 98' ' ' ALA . . . -92.18 46.53 1.27 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.81 0.338 . . . . 0.0 111.336 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -52.74 -24.37 18.5 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.297 -0.954 . . . . 0.0 111.811 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.504 HG22 ' OE1' ' A' ' 171' ' ' GLN . 0.9 OUTLIER -87.69 -19.69 27.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.471 0.177 . . . . 0.0 111.167 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.894 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -94.18 -31.69 14.03 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.648 0.261 . . . . 0.0 111.452 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.807 ' SD ' HD23 ' A' ' 92' ' ' LEU . 5.3 tpp -64.57 -47.35 79.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.716 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.67 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -55.18 -56.35 29.33 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.67 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 18.7 Cg_exo -64.73 -30.49 59.43 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.126 1.884 . . . . 0.0 112.63 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 1.036 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -72.57 -53.16 12.72 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.193 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.898 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -52.89 -27.08 16.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.33 0.586 . . . . 0.0 110.509 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.695 ' HB2' ' HB1' ' A' ' 175' ' ' ALA . . . -86.62 -53.92 4.68 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.131 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.687 ' HB1' HD11 ' A' ' 34' ' ' LEU . . . -60.57 -36.51 78.67 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -177.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.644 ' HB2' HD12 ' A' ' 153' ' ' LEU . 27.4 mt -76.28 -12.88 60.15 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.593 ' SG ' HD22 ' A' ' 153' ' ' LEU . 69.3 m -86.73 20.12 2.67 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.25 0.548 . . . . 0.0 110.427 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.722 HD21 ' HB2' ' A' ' 182' ' ' LEU . 2.4 mt -85.93 -75.02 0.39 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.019 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -69.7 -117.07 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.487 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.35 96.4 1.92 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.045 0.45 . . . . 0.0 110.123 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.703 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 8.8 m120 -148.51 143.99 27.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.116 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.837 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 13.4 m-20 -95.99 99.98 11.7 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.303 0.573 . . . . 0.0 110.149 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.53 HG13 ' CB ' ' A' ' 88' ' ' LEU . 1.9 mp -118.15 146.08 23.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.941 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.785 HG13 ' CD2' ' A' ' 143' ' ' LEU . 48.5 t -115.49 112.86 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 176.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.673 HD23 ' HB2' ' A' ' 90' ' ' LEU . 31.0 mt -102.03 106.52 17.43 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.497 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.767 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -118.88 -170.83 1.98 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.037 -179.044 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.476 ' HA3' ' HG2' ' A' ' 121' ' ' MET . . . -170.08 179.13 42.53 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.968 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.661 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 2.9 mt-10 -72.32 169.72 15.61 Favored Pre-proline 0 C--N 1.332 -0.188 0 C-N-CA 123.573 0.749 . . . . 0.0 111.248 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.661 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 2.5 Cg_endo -43.56 -39.78 9.98 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.096 2.531 . . . . 0.0 113.193 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.8 mtm-85 -67.63 -24.4 65.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.667 0.27 . . . . 0.0 110.838 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.631 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 9.2 tpt -61.1 -34.94 75.75 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.424 ' HA ' ' HG2' ' A' ' 149' ' ' PRO . 0.0 OUTLIER -61.92 -16.69 52.81 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.463 179.139 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -87.59 4.17 44.76 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.934 0.397 . . . . 0.0 109.986 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 34.1 mtt85 -127.12 83.77 65.15 Favored Pre-proline 0 N--CA 1.454 -0.242 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.866 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.505 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 19.7 Cg_endo -58.02 148.76 75.12 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.675 2.25 . . . . 0.0 111.501 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.471 ' O ' HG13 ' A' ' 126' ' ' ILE . 0.6 OUTLIER -125.48 -2.49 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -179.262 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.547 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -54.03 -34.7 52.73 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.713 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.508 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 13.3 m80 -58.53 -40.14 82.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.146 0.473 . . . . 0.0 110.142 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.786 ' HG ' HD11 ' A' ' 133' ' ' LEU . 16.4 tp -76.12 -40.59 52.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.705 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.733 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 46.1 t -56.0 -47.42 80.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.262 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.792 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 3.3 m-20 -71.27 -35.93 71.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.019 0.437 . . . . 0.0 110.025 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.62 ' HB2' HG23 ' A' ' 164' ' ' VAL . . . -60.84 -44.55 96.81 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.578 178.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.786 HD11 ' HG ' ' A' ' 129' ' ' LEU . 6.2 mt -77.08 -50.32 13.32 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.315 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.733 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -56.75 -27.94 60.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.759 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.792 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 5.6 tp -69.45 -31.76 70.27 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.779 178.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.48 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -83.09 13.52 44.13 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.038 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.78 3.15 58.3 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.941 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.513 ' HB2' ' HD1' ' A' ' 157' ' ' PHE . . . -71.53 152.12 43.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.737 0.304 . . . . 0.0 111.568 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 0.6 OUTLIER -101.74 101.44 11.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.76 178.418 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.716 ' HB ' ' HG3' ' A' ' 134' ' ' ARG . 19.8 mt -133.39 126.91 53.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.369 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.671 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -124.05 139.56 53.82 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 116.262 -0.427 . . . . 0.0 109.938 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.515 ' HE1' HG21 ' A' ' 130' ' ' VAL . 31.3 m-85 -80.58 132.81 35.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.652 0.263 . . . . 0.0 111.278 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.785 ' CD2' HG13 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -92.57 -91.33 0.17 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.698 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.556 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 40.6 mt-10 -57.18 -81.87 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.649 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.428 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 23.2 mt-30 -113.61 151.05 32.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.788 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 0.8 OUTLIER -67.91 130.98 44.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.839 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.547 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 1.9 m-20 71.82 17.75 5.29 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.04 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.571 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 18.7 m-85 -111.14 168.25 7.85 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-O 121.294 0.569 . . . . 0.0 112.352 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.894 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 1.4 Cg_exo -29.59 -63.12 0.09 OUTLIER 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 124.796 3.664 . . . . 0.0 116.779 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.894 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 58.5 Cg_exo -54.37 147.18 47.7 Favored 'Trans proline' 0 C--N 1.356 0.954 0 CA-C-N 121.301 1.501 . . . . 0.0 112.94 -178.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.78 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 7.8 mt -156.81 136.57 12.44 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.938 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.671 ' HB2' HG22 ' A' ' 141' ' ' THR . 6.8 mtp180 -106.99 102.75 12.08 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.898 HD11 ' HA ' ' A' ' 103' ' ' ALA . 6.6 mt -91.12 145.45 24.67 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.569 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.703 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 5.6 mt-30 -147.24 24.79 1.13 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.472 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 53.41 -173.38 0.46 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.894 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 118.35 -10.07 13.17 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.039 -1.076 . . . . 0.0 112.948 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.638 ' HE2' ' HA ' ' A' ' 180' ' ' ALA . 44.6 t80 -61.41 124.62 21.12 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 117.257 0.529 . . . . 0.0 110.441 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.671 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . 66.4 p -118.32 -29.51 5.5 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 121.429 0.633 . . . . 0.0 111.411 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.407 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 133.13 -160.68 23.99 Favored Glycine 0 C--N 1.308 -1.02 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.416 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.6 ' O ' HG23 ' A' ' 187' ' ' THR . . . 105.46 154.31 21.77 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.814 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -46.72 114.47 0.83 Allowed 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.407 -0.396 . . . . 0.0 111.019 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.754 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 69.1 t -107.9 121.66 61.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.317 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -91.6 119.69 31.73 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.682 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.78 HG11 ' HG ' ' A' ' 173' ' ' LEU . 1.2 t -132.27 122.29 47.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.459 ' HB3' ' CG2' ' A' ' 168' ' ' VAL . 0.6 OUTLIER -56.72 139.43 50.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.059 0.456 . . . . 0.0 111.638 -179.153 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.678 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . -61.0 -51.03 61.08 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.657 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.9 m -85.0 90.47 7.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.865 0.364 . . . . 0.0 110.642 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.654 ' H ' ' HB ' ' A' ' 196' ' ' VAL . 58.8 t -149.45 -92.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.246 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.585 ' C ' HG11 ' A' ' 196' ' ' VAL . 0.6 OUTLIER -157.43 127.83 6.4 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.317 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.597 ' HB2' ' HB3' ' A' ' 200' ' ' TYR . 0.3 OUTLIER -55.9 -23.78 33.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.001 -178.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.562 ' HB3' HH21 ' A' ' 27' ' ' ARG . 0.0 OUTLIER -81.71 -12.2 58.73 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.983 -179.692 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.563 ' CD2' ' HB2' ' A' ' 129' ' ' LEU . 6.2 m-85 -75.33 -56.67 4.49 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.959 HD13 HD21 ' A' ' 195' ' ' LEU . 0.2 OUTLIER -62.26 -43.6 98.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.454 178.587 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.706 HG23 ' CG2' ' A' ' 204' ' ' THR . 1.8 m -56.06 -41.11 74.58 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.902 178.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.695 ' HB1' ' HB2' ' A' ' 104' ' ' ALA . . . -57.87 -37.79 74.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.52 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.756 HD13 HG12 ' A' ' 189' ' ' ILE . 0.7 OUTLIER -76.63 -37.04 57.03 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.383 0.611 . . . . 0.0 110.238 178.88 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.699 HD11 ' CD2' ' A' ' 223' ' ' PHE . 4.3 mp -59.61 -34.48 72.82 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.693 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.621 ' CE ' HD21 ' A' ' 31' ' ' LEU . 8.8 mtp -81.84 -42.38 19.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.373 0.606 . . . . 0.0 112.185 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.527 HG23 ' HG ' ' A' ' 108' ' ' LEU . 88.3 m -75.04 -40.82 60.12 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.546 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.638 ' HA ' ' HE2' ' A' ' 157' ' ' PHE . . . -59.88 -39.74 72.61 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 -176.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.596 ' HD3' ' O ' ' A' ' 177' ' ' LEU . 31.2 Cg_endo -68.4 -27.4 33.86 Favored 'Trans proline' 0 CA--C 1.498 -1.305 0 CA-C-N 120.241 1.122 . . . . 0.0 111.949 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.722 ' HB2' HD21 ' A' ' 108' ' ' LEU . 9.6 mt -85.05 0.35 51.84 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.643 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -81.79 137.43 47.26 Favored Pre-proline 0 C--O 1.224 -0.241 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.187 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.671 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 14.3 Cg_endo -52.27 -30.68 43.27 Favored 'Trans proline' 0 CA--C 1.519 -0.269 0 C-N-CA 122.483 2.122 . . . . 0.0 113.178 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.76 138.48 50.69 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.905 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -55.1 142.3 31.23 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.049 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 160' ' ' GLY . 87.0 m -120.31 144.42 47.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.205 0.526 . . . . 0.0 112.21 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 18.0 t -125.73 118.03 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.187 177.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.766 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 2.7 mp -101.16 117.86 47.04 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.722 ' HG3' ' HG3' ' A' ' 222' ' ' GLN . 0.2 OUTLIER -99.78 123.66 44.26 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.848 ' CG1' HD11 ' A' ' 173' ' ' LEU . 1.7 mp -93.71 124.99 46.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.063 -175.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -83.05 96.92 8.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.064 -1.426 . . . . 0.0 110.502 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 100.98 -129.81 10.02 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.933 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.32 129.0 56.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.709 0.29 . . . . 0.0 111.577 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.959 HD21 HD13 ' A' ' 173' ' ' LEU . 1.9 mt -41.43 144.68 0.33 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.654 ' HB ' ' H ' ' A' ' 168' ' ' VAL . 8.6 p -71.56 -36.64 60.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.196 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.425 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 2.0 t -160.72 62.33 0.31 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.258 0.552 . . . . 0.0 109.977 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.699 ' HA ' HD13 ' A' ' 195' ' ' LEU . 5.5 tmtt? -38.93 -47.68 3.72 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.829 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.671 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 5.0 Cg_endo -46.68 -33.71 14.09 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.178 1.919 . . . . 0.0 111.771 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.955 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.2 OUTLIER -67.26 -44.36 79.59 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.502 HG21 ' HE2' ' A' ' 223' ' ' PHE . 14.7 mm -56.71 -39.79 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 CA-C-N 114.286 -1.324 . . . . 0.0 110.348 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -58.05 -45.15 87.51 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.044 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.955 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.8 mt -61.27 -50.4 80.6 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.022 0 CA-C-O 121.786 0.803 . . . . 0.0 109.068 178.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.706 ' CG2' HG23 ' A' ' 174' ' ' THR . 87.1 m -53.15 -51.6 61.46 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.971 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.903 HD22 ' HB ' ' A' ' 215' ' ' ILE . 34.1 mt -67.99 -29.24 68.22 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 120.98 0.419 . . . . 0.0 111.663 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -78.07 -46.56 20.51 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.733 0.778 . . . . 0.0 109.664 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.961 ' O ' HG22 ' A' ' 210' ' ' THR . 2.3 tp -69.7 -29.65 67.11 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.288 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . 0.692 ' HG2' HD11 ' A' ' 31' ' ' LEU . 3.9 mmm -75.98 -34.23 59.77 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.551 0.691 . . . . 0.0 109.624 178.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.652 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 7.4 mtmt -63.52 -35.97 82.22 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.439 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.961 HG22 ' O ' ' A' ' 207' ' ' LEU . 3.9 t -62.6 -27.29 69.09 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.629 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.563 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 27.5 m-85 -83.64 -6.81 59.54 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.019 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.63 7.29 26.05 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 115.782 1.073 . . . . 0.0 115.782 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 5.0 m -123.29 148.76 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 118.513 1.157 . . . . 0.0 112.049 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.471 ' CG ' ' HG2' ' A' ' 209' ' ' LYS . 13.2 mt-10 -130.09 134.33 47.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.403 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.903 ' HB ' HD22 ' A' ' 205' ' ' LEU . 8.9 mm -117.5 148.66 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 120.818 0.342 . . . . 0.0 110.247 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.618 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 19.9 tt0 -104.81 116.65 32.37 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.612 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.18 151.01 27.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.596 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . 0.694 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -109.08 -148.31 0.42 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.65 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.55 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 0.2 OUTLIER -72.38 66.91 0.69 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.847 0.356 . . . . 0.0 111.515 -179.491 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 1.7 t80 56.75 31.73 19.95 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.06 0.934 . . . . 0.0 110.625 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.689 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 0.4 OUTLIER -159.33 -129.27 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 178.779 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.766 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.1 OUTLIER -4.02 131.12 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 179.698 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.83 ' HZ ' HD11 ' A' ' 195' ' ' LEU . 1.1 m-85 -125.17 129.89 51.05 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 113.107 -1.86 . . . . 0.0 108.852 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.618 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 42.9 t -114.98 113.94 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-O 121.602 0.715 . . . . 0.0 109.62 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.674 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -120.35 124.3 72.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.121 -178.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.605 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 2.0 mptt -76.76 125.06 28.62 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -78.64 -178.31 50.01 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.393 -0.908 . . . . 0.0 113.23 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 64.81 21.26 67.26 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 121.346 -0.454 . . . . 0.0 112.935 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . 0.605 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 34.5 mt-30 -75.2 176.39 7.39 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.386 0.612 . . . . 0.0 111.649 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 5.4 p -136.09 147.88 48.03 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.323 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' TYR . . . . . 0.653 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 5.2 m-30 -107.75 132.07 53.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.759 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.63 147.92 48.23 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.505 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.38 111.46 14.11 Favored Pre-proline 0 N--CA 1.45 -0.435 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.657 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.475 ' HG3' HG23 ' A' ' 210' ' ' THR . 56.2 Cg_endo -69.59 3.04 2.91 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.454 2.102 . . . . 0.0 112.622 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 95.84 -103.9 3.02 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.242 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.495 HG23 ' HB ' ' A' ' 40' ' ' VAL . 27.2 m -115.42 137.11 52.4 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.719 ' CD2' HG21 ' A' ' 210' ' ' THR . 7.5 t80 -132.72 126.7 33.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.955 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.867 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -94.53 111.03 22.79 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.099 0.476 . . . . 0.0 110.942 -179.685 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.618 ' N ' HD22 ' A' ' 238' ' ' LEU . 43.1 t -81.02 113.36 20.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.95 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.164 -179.75 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.753 ' HB2' HG22 ' A' ' 50' ' ' VAL . 1.5 m . . . . . 0 N--CA 1.485 1.315 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.525 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 3.0 m120 -77.72 -71.56 0.41 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.912 0.387 . . . . 0.0 111.102 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.641 ' HA ' ' HE1' ' A' ' 178' ' ' MET . 66.4 mtm-85 -60.99 -57.7 11.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.52 0.676 . . . . 0.0 110.338 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.577 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -40.73 -45.89 2.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.633 -1.167 . . . . 0.0 112.077 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.095 HD22 HD11 ' A' ' 75' ' ' ILE . 12.6 mt -73.87 -34.57 64.52 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 120.92 0.39 . . . . 0.0 111.163 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.785 HD22 ' HB2' ' A' ' 101' ' ' PRO . 45.6 tp -68.58 -50.33 52.52 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.911 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.78 HD22 ' CZ ' ' A' ' 231' ' ' TYR . 50.7 mt -67.08 -27.15 67.12 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.416 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.82 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -66.14 -39.18 89.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.104 178.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.782 ' CB ' HG11 ' A' ' 62' ' ' VAL . . . -80.73 -40.79 24.64 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.013 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.782 ' HB3' ' HD2' ' A' ' 231' ' ' TYR . 14.0 mt -67.54 -3.61 9.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.102 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.637 ' HB2' ' HB3' ' A' ' 231' ' ' TYR . . . -99.72 -179.86 4.31 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -177.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.627 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.3 OUTLIER -113.89 111.52 21.84 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.526 178.165 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.72 166.15 14.2 Favored Glycine 0 C--N 1.32 -0.315 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -178.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.604 ' HE2' HG23 ' A' ' 76' ' ' ILE . 2.5 ttmt -95.81 118.66 32.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.992 0.396 . . . . 0.0 111.902 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.577 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 0.9 OUTLIER -117.47 145.08 44.41 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.249 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.502 ' C ' HD13 ' A' ' 41' ' ' LEU . 97.1 t -102.66 141.34 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-O 121.581 0.705 . . . . 0.0 112.423 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.826 HD23 HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -115.74 116.47 28.12 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 174.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.971 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.5 OUTLIER -103.93 148.11 26.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.868 0.365 . . . . 0.0 110.992 -177.601 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.461 ' HB2' HD23 ' A' ' 238' ' ' LEU . 2.0 t30 69.12 26.18 5.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.063 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.783 HD21 ' CB ' ' A' ' 41' ' ' LEU . 79.6 mt -52.66 -178.21 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.153 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.577 HD23 ' OD2' ' A' ' 49' ' ' ASP . 34.7 tp -109.79 131.21 55.27 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.205 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -86.78 87.14 7.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.008 0.433 . . . . 0.0 110.386 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.562 ' HB3' ' OD1' ' A' ' 49' ' ' ASP . 11.2 t -164.11 142.64 7.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.702 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.577 ' HB2' ' HB2' ' A' ' 94' ' ' ASN . 5.2 m-20 -37.09 -30.3 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.648 ' CB ' ' HA ' ' A' ' 95' ' ' ALA . 34.5 p-10 -56.85 -42.59 80.0 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.36 0.6 . . . . 0.0 110.208 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.753 HG22 ' HB2' ' A' ' 25' ' ' SER . 64.6 t -83.44 -47.95 17.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.191 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.905 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -50.41 -37.97 40.59 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 178.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.659 ' HA ' ' CB ' ' A' ' 55' ' ' ASN . 7.4 m-70 -80.44 -32.69 37.26 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.842 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.574 ' HG2' ' O ' ' A' ' 25' ' ' SER . 8.6 tpt -55.09 -35.27 64.41 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 176.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.905 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.5 OUTLIER -81.82 -42.49 19.6 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.398 176.328 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.694 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 24.6 t30 -60.77 -34.25 74.17 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.178 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 1.026 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -64.6 -46.95 80.46 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.877 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.2 OUTLIER -63.89 -39.61 94.58 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 113.914 -1.494 . . . . 0.0 107.807 177.103 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.694 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 2.6 m -59.96 -34.46 73.31 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.36 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.838 ' CB ' HD11 ' A' ' 90' ' ' LEU . . . -76.84 -36.91 56.51 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.485 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.663 HD13 ' CB ' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -82.74 -13.92 55.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.419 0.628 . . . . 0.0 110.719 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.14 35.02 5.18 Favored Glycine 0 C--N 1.32 -0.361 0 CA-C-N 115.228 -0.896 . . . . 0.0 114.174 177.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.877 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 38.6 t -90.27 118.53 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.823 ' O ' HG12 ' A' ' 76' ' ' ILE . 10.8 m -81.39 134.5 35.57 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.293 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.872 ' HB3' HG23 ' A' ' 75' ' ' ILE . 42.0 p90 -158.23 160.58 37.29 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 74' ' ' GLU . 63.3 m -122.82 149.65 43.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.565 0.221 . . . . 0.0 110.993 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.73 HD21 ' HA ' ' A' ' 70' ' ' ARG . 4.0 tp -121.01 138.96 53.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.925 0.393 . . . . 0.0 110.636 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.481 ' HB2' ' CB ' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -69.66 -165.64 0.09 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.675 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.99 -23.43 22.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.171 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.427 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 0.1 OUTLIER -81.35 1.15 34.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.272 179.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.73 ' HA ' HD21 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 53.09 26.41 4.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.807 0.337 . . . . 0.0 111.286 179.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.463 HG22 ' O ' ' A' ' 44' ' ' LEU . 1.3 p -127.93 -10.86 5.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.86 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.54 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 7.2 mtp180 -112.88 115.48 28.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.105 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.621 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -133.12 128.32 35.86 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -179.342 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 39' ' ' THR . 13.7 tt0 -107.73 133.78 51.65 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.613 178.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 1.095 HD11 HD22 ' A' ' 29' ' ' LEU . 8.2 mt -123.45 122.27 64.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.823 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -68.13 101.58 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-O 121.462 0.648 . . . . 0.0 109.516 175.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 35' ' ' ALA . . . -39.61 143.2 0.46 Allowed Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 114.737 -1.12 . . . . 0.0 113.844 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.46 HD22 HD12 ' A' ' 82' ' ' LEU . 6.2 t-20 -87.89 -7.54 57.04 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 120.771 0.319 . . . . 0.0 110.82 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.627 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 88.38 2.66 79.48 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.278 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.487 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 151.35 -147.43 17.35 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.005 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.678 ' HG3' ' HB3' ' A' ' 108' ' ' LEU . 77.0 Cg_exo -49.72 127.59 19.16 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.379 2.052 . . . . 0.0 112.727 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.663 ' CB ' HD13 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -72.78 110.54 7.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.125 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.495 ' HA ' ' CG ' ' A' ' 111' ' ' ASN . 4.6 p80 -82.19 133.99 35.28 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.88 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.567 ' CB ' HD22 ' A' ' 88' ' ' LEU . . . -98.69 124.33 43.44 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.047 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -71.19 123.36 22.02 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 176.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.88 176.97 0.82 Allowed Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -175.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 112' ' ' ASP . . . -73.1 144.7 46.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 118.668 1.234 . . . . 0.0 111.11 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.723 HD21 ' C ' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -112.81 160.99 17.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.34 -178.532 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 7.3 mt-10 -141.53 102.91 4.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.43 177.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.838 HD11 ' CB ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -102.25 115.5 30.68 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.657 -177.693 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.472 ' CD1' ' HB ' ' A' ' 116' ' ' THR . 0.9 OUTLIER -90.52 98.12 11.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.734 179.085 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.616 HD11 ' HB3' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -103.66 52.9 0.76 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.602 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.625 ' CA ' ' H ' ' A' ' 118' ' ' GLU . . . -59.86 -67.28 2.24 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.421 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.577 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 69.5 m-80 -75.43 15.26 0.48 Allowed 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.413 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.752 ' HB1' ' HB3' ' A' ' 98' ' ' ALA . . . -94.88 -70.15 0.72 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.56 -68.08 0.4 Allowed Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.923 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.417 ' O ' ' CD ' ' A' ' 101' ' ' PRO . 2.6 p -71.65 -8.42 53.98 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.752 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -98.88 -30.1 12.58 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.655 0.264 . . . . 0.0 111.043 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.433 ' CG ' HD13 ' A' ' 126' ' ' ILE . 1.0 OUTLIER -64.67 -42.75 95.15 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.043 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.69 ' O ' HD21 ' A' ' 129' ' ' LEU . 1.4 mpt_? -55.84 -60.95 7.24 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.796 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.785 ' HB2' HD22 ' A' ' 30' ' ' LEU . 21.0 Cg_endo -60.78 -30.47 90.3 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.469 2.113 . . . . 0.0 112.488 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 1.026 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -75.22 -52.5 10.77 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 120.335 -0.546 . . . . 0.0 109.998 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.894 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -51.6 -27.26 10.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.5 0.666 . . . . 0.0 110.509 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.948 ' HB2' ' HB1' ' A' ' 175' ' ' ALA . . . -86.55 -53.99 4.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.377 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.712 ' CB ' HD11 ' A' ' 30' ' ' LEU . . . -60.63 -33.61 73.02 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -177.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.688 ' HB2' HD12 ' A' ' 153' ' ' LEU . 26.9 mt -78.35 -20.76 50.67 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.704 ' SG ' ' HB1' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -83.22 21.89 1.06 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.335 0.588 . . . . 0.0 110.87 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.855 HD21 ' HB2' ' A' ' 182' ' ' LEU . 0.5 OUTLIER -85.75 -76.05 0.35 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.74 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -70.28 -110.31 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.64 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.1 m -158.38 96.08 1.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.957 0.408 . . . . 0.0 110.595 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.646 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 13.7 m-80 -148.99 140.14 23.07 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.275 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.857 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 1.9 m-20 -92.95 98.59 11.46 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.171 0.51 . . . . 0.0 110.087 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.566 HG13 ' CB ' ' A' ' 88' ' ' LEU . 1.5 mp -119.17 145.68 24.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.918 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.782 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 59.1 t -113.63 112.97 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 176.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.791 HD23 ' HB2' ' A' ' 90' ' ' LEU . 58.8 mt -102.63 110.99 23.1 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.903 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.743 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -125.06 -171.97 2.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.253 -179.712 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.494 ' H ' HG22 ' A' ' 116' ' ' THR . . . -166.73 -173.12 34.77 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.514 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.646 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 1.3 mm-40 -76.83 172.49 9.54 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 123.245 0.618 . . . . 0.0 110.123 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.646 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 7.4 Cg_endo -47.97 -33.06 19.4 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.605 2.203 . . . . 0.0 112.744 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -67.62 -28.18 67.52 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.021 0.439 . . . . 0.0 110.219 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.578 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 9.8 tpt -61.19 -39.56 90.66 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.559 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.449 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 0.0 OUTLIER -63.01 -16.96 61.58 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.29 179.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.568 ' O ' ' HG3' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -85.68 -3.95 59.03 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.486 ' HB3' ' NH2' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -123.74 88.63 51.97 Favored Pre-proline 0 N--CA 1.452 -0.332 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.763 179.807 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.457 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 15.8 Cg_endo -56.67 149.09 61.04 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.651 2.234 . . . . 0.0 111.599 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.49 HG22 ' O ' ' A' ' 148' ' ' TYR . 0.8 OUTLIER -119.88 8.98 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.946 0.403 . . . . 0.0 111.763 -179.121 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.454 ' HA3' ' CG ' ' A' ' 147' ' ' ASN . . . -57.19 -45.24 92.83 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.801 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.661 ' CG ' HG21 ' A' ' 168' ' ' VAL . 3.9 m80 -55.25 -38.62 68.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.013 0.406 . . . . 0.0 110.782 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.929 HD11 ' HB3' ' A' ' 175' ' ' ALA . 17.7 tp -74.8 -45.71 41.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.962 0.411 . . . . 0.0 110.372 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.922 HG21 HD21 ' A' ' 151' ' ' LEU . 49.9 t -56.58 -47.73 81.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.339 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.731 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 0.5 OUTLIER -71.88 -34.43 69.18 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.029 0.442 . . . . 0.0 110.297 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.64 ' HB2' HG23 ' A' ' 164' ' ' VAL . . . -62.42 -45.0 95.07 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.901 178.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.756 HD11 ' HG ' ' A' ' 129' ' ' LEU . 6.2 mt -77.27 -50.32 13.13 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.357 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.754 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -55.88 -27.59 52.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.764 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.731 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 0.6 OUTLIER -67.83 -33.02 73.96 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.586 178.616 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.526 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -82.55 13.63 40.25 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.015 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.07 2.45 60.83 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.329 -0.939 . . . . 0.0 112.833 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.704 ' HB1' ' SG ' ' A' ' 107' ' ' CYS . . . -70.74 152.42 43.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.895 0.379 . . . . 0.0 111.048 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 37.6 mttm -101.28 103.2 14.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.346 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.627 ' HB ' ' HG3' ' A' ' 134' ' ' ARG . 25.7 mt -134.4 126.48 48.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.367 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.818 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -121.72 139.37 53.66 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.718 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.549 ' CZ ' HG11 ' A' ' 130' ' ' VAL . 47.5 m-85 -81.6 130.02 34.9 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.033 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.942 HD11 ' HG3' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -90.96 -91.59 0.15 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.473 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.599 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . 17.7 mt-10 -56.1 -80.98 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.021 0.439 . . . . 0.0 110.439 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.533 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 31.6 mt-30 -115.67 151.32 35.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.426 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 31.2 mt-10 -67.9 137.54 55.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.117 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.458 HD22 ' N ' ' A' ' 147' ' ' ASN . 1.2 m-80 66.36 20.21 10.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.965 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.616 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 20.5 m-85 -113.79 170.04 5.82 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.948 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 27.6 Cg_exo -32.57 -63.39 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 124.345 3.363 . . . . 0.0 116.221 -177.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.948 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 77.8 Cg_exo -53.55 146.84 41.13 Favored 'Trans proline' 0 C--N 1.353 0.809 0 CA-C-N 120.706 1.288 . . . . 0.0 112.588 -178.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.922 HD21 HG21 ' A' ' 130' ' ' VAL . 9.7 mt -156.32 136.45 12.85 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.345 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.942 ' HG3' HD11 ' A' ' 143' ' ' LEU . 0.0 OUTLIER -108.5 102.94 11.99 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.022 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.894 HD11 ' HA ' ' A' ' 103' ' ' ALA . 8.5 mt -91.29 146.81 23.51 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.738 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.646 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 2.8 mt-30 -148.83 25.74 0.92 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.368 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.566 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 54.88 -170.26 1.5 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.85 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 158' ' ' THR . . . 114.79 -15.43 19.26 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.119 -1.039 . . . . 0.0 113.389 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.713 ' HE2' ' HA ' ' A' ' 180' ' ' ALA . 55.4 t80 -58.33 123.69 16.98 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 117.258 0.529 . . . . 0.0 110.647 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.697 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 75.7 p -117.05 -33.55 4.68 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 121.382 0.61 . . . . 0.0 111.392 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.446 ' O ' ' HA2' ' A' ' 136' ' ' GLY . . . 138.56 -161.64 25.75 Favored Glycine 0 C--N 1.307 -1.083 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.987 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.584 ' O ' HG23 ' A' ' 187' ' ' THR . . . 105.22 153.95 21.93 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.54 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -46.93 116.53 1.38 Allowed 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.321 -0.44 . . . . 0.0 111.093 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.755 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 73.4 t -109.59 130.62 62.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.829 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.16 120.38 39.41 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.522 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.808 HG21 HD11 ' A' ' 176' ' ' LEU . 1.2 t -133.78 120.03 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 120.922 0.391 . . . . 0.0 110.12 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.508 ' O ' HG12 ' A' ' 168' ' ' VAL . 0.8 OUTLIER -52.44 141.83 18.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.657 -179.362 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.876 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . -59.55 -51.26 60.12 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.076 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.43 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 0.2 OUTLIER -94.12 95.8 9.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.598 0.237 . . . . 0.0 111.368 179.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.661 HG21 ' CG ' ' A' ' 128' ' ' HIS . 8.2 p -177.15 59.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.131 0.491 . . . . 0.0 110.755 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.722 ' C ' HG11 ' A' ' 196' ' ' VAL . 20.2 m 63.88 130.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.2 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.452 ' N ' HG11 ' A' ' 196' ' ' VAL . 0.2 OUTLIER -70.9 -17.55 62.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.361 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.562 ' HB3' ' CB ' ' A' ' 100' ' ' ARG . 0.8 OUTLIER -76.53 -10.64 59.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.937 -179.092 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.734 ' HA ' HD13 ' A' ' 129' ' ' LEU . 8.4 m-85 -72.48 -50.43 26.09 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.581 0.705 . . . . 0.0 109.559 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 1.002 HD21 HD11 ' A' ' 191' ' ' ILE . 0.2 OUTLIER -68.64 -43.5 76.15 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.16 178.693 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.588 HG21 HH11 ' A' ' 27' ' ' ARG . 2.1 m -54.03 -35.31 61.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.501 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.948 ' HB1' ' HB2' ' A' ' 104' ' ' ALA . . . -63.88 -45.23 90.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.495 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.808 HD11 HG21 ' A' ' 164' ' ' VAL . 0.1 OUTLIER -76.58 -33.07 58.49 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.054 -179.814 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.821 HD11 ' CD2' ' A' ' 223' ' ' PHE . 3.4 mp -59.97 -39.1 84.48 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.62 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.641 ' HE1' ' HA ' ' A' ' 27' ' ' ARG . 1.9 mtp -81.55 -44.35 17.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.407 0.622 . . . . 0.0 112.226 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.623 HG23 ' HG ' ' A' ' 108' ' ' LEU . 58.3 m -71.4 -41.0 70.17 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.796 -178.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.713 ' HA ' ' HE2' ' A' ' 157' ' ' PHE . . . -59.9 -39.84 73.36 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -176.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.557 ' HD3' ' O ' ' A' ' 177' ' ' LEU . 28.2 Cg_endo -65.66 -28.59 52.29 Favored 'Trans proline' 0 CA--C 1.497 -1.354 0 CA-C-N 120.108 1.074 . . . . 0.0 111.657 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.855 ' HB2' HD21 ' A' ' 108' ' ' LEU . 4.7 mt -84.06 0.49 48.08 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.724 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.697 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -83.19 136.57 43.37 Favored Pre-proline 0 C--O 1.224 -0.279 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.856 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.641 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 10.7 Cg_endo -50.18 -33.49 35.98 Favored 'Trans proline' 0 CA--C 1.518 -0.278 0 C-N-CA 122.597 2.198 . . . . 0.0 113.443 -179.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.79 139.54 48.32 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.731 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 187' ' ' THR . 10.1 t0 -55.33 143.89 26.95 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.835 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 160' ' ' GLY . 87.8 m -121.2 148.98 43.52 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.949 0.404 . . . . 0.0 111.606 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.622 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 44.0 t -130.38 117.75 40.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.819 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 4.6 mp -100.23 119.79 48.79 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 0.1 OUTLIER -100.78 125.57 47.28 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 1.002 HD11 HD21 ' A' ' 173' ' ' LEU . 1.6 mp -94.04 125.18 46.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.807 -176.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -77.91 96.86 5.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 113.948 -1.478 . . . . 0.0 110.458 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 96.58 -126.99 9.03 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.263 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -116.41 130.87 56.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.79 0.329 . . . . 0.0 111.582 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.84 HD21 HD13 ' A' ' 173' ' ' LEU . 1.5 mt -41.72 144.22 0.42 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.385 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.722 HG11 ' C ' ' A' ' 169' ' ' SER . 14.8 p -72.33 -28.28 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.039 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.461 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 0.1 OUTLIER -168.85 65.19 0.06 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.058 0.456 . . . . 0.0 110.49 -179.15 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.682 ' HA ' HD13 ' A' ' 195' ' ' LEU . 0.0 OUTLIER -40.66 -46.72 6.44 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.498 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.462 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 83.5 Cg_exo -47.49 -33.81 18.36 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 121.842 1.694 . . . . 0.0 111.411 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.956 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.2 OUTLIER -69.16 -41.94 76.57 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.373 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.566 HG21 ' HE2' ' A' ' 223' ' ' PHE . 18.5 mm -64.64 -38.69 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.917 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.15 -44.14 83.14 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.256 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.956 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.1 mt -62.79 -48.82 86.27 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.918 0 CA-C-O 121.739 0.781 . . . . 0.0 109.358 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.563 HG22 ' SD ' ' A' ' 208' ' ' MET . 87.6 m -54.12 -51.26 64.79 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.121 -178.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.903 HD22 ' HB ' ' A' ' 215' ' ' ILE . 32.5 mt -65.77 -31.15 71.96 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 120.922 0.392 . . . . 0.0 111.517 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -77.48 -46.07 23.62 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.901 0.858 . . . . 0.0 109.51 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.857 ' O ' HG22 ' A' ' 210' ' ' THR . 6.4 tp -69.91 -30.46 67.88 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.526 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . 0.81 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 37.9 mtp -76.38 -34.2 58.88 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.584 0.707 . . . . 0.0 109.231 177.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.716 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 2.6 mtmt -60.95 -38.3 85.37 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.346 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.857 HG22 ' O ' ' A' ' 207' ' ' LEU . 4.7 t -60.92 -33.37 73.05 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.161 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.558 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 50.0 m-85 -76.1 -5.94 48.9 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.801 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 109.51 7.33 28.16 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 115.671 1.028 . . . . 0.0 115.671 177.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.716 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.8 m -123.62 148.58 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 118.549 1.174 . . . . 0.0 112.799 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.595 ' O ' HD13 ' A' ' 215' ' ' ILE . 6.0 mt-10 -129.9 138.61 51.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.659 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.903 ' HB ' HD22 ' A' ' 205' ' ' LEU . 17.1 mm -122.04 148.64 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.694 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 1.6 tp10 -103.89 117.76 35.09 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.983 0.421 . . . . 0.0 111.905 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -83.02 151.11 25.96 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.525 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . 0.676 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 5.4 mm-40 -109.43 -144.1 0.39 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.72 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.598 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 7.8 t-80 -73.9 65.88 1.1 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.813 0.34 . . . . 0.0 111.492 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 4.1 t80 56.01 35.12 25.0 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.931 0.872 . . . . 0.0 110.785 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.658 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 1.7 pt20 -163.92 -127.45 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.819 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -8.04 134.43 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.821 ' CD2' HD11 ' A' ' 177' ' ' LEU . 0.6 OUTLIER -125.35 137.32 54.04 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 113.038 -1.892 . . . . 0.0 109.654 -179.234 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.694 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 23.7 t -117.39 114.27 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.801 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.5 OUTLIER -122.25 120.71 61.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.804 -179.393 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.498 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -74.59 127.37 32.92 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -80.03 -171.29 42.47 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.236 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 61.51 21.16 59.91 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 121.398 -0.43 . . . . 0.0 113.006 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . 0.498 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 23.9 mt-30 -80.63 -173.45 4.15 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.257 0.551 . . . . 0.0 111.158 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 17.2 t -151.94 147.64 26.81 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.934 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' TYR . . . . . 0.782 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 4.7 m-85 -100.74 130.23 46.75 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.452 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.408 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -120.99 146.77 46.34 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.06 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.55 111.04 8.88 Favored Pre-proline 0 N--CA 1.447 -0.59 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.383 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.542 ' HD2' ' OG1' ' A' ' 39' ' ' THR . 54.6 Cg_endo -69.6 -0.32 6.61 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 121.942 1.762 . . . . 0.0 112.076 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 99.6 -101.18 2.34 Favored Glycine 0 C--O 1.226 -0.349 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.772 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.417 HG23 ' HB ' ' A' ' 40' ' ' VAL . 90.3 m -119.03 135.55 54.57 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.545 ' CD2' HG21 ' A' ' 210' ' ' THR . 1.5 t80 -131.21 129.73 42.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.906 0.384 . . . . 0.0 111.046 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.971 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.1 OUTLIER -95.0 110.96 22.81 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.382 179.242 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.669 ' N ' HD22 ' A' ' 238' ' ' LEU . 21.7 t -82.57 111.91 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.092 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.975 -179.98 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.676 ' HB2' HG22 ' A' ' 50' ' ' VAL . 2.9 m . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.765 0.317 . . . . 0.0 111.383 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 26' ' ' ASN . 2.2 p-10 -38.14 -74.35 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.977 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.746 ' HA ' ' HE1' ' A' ' 178' ' ' MET . 0.0 OUTLIER -63.81 -56.23 17.06 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.277 0.561 . . . . 0.0 110.754 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.871 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -40.5 -47.53 2.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.004 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.06 HD22 HD11 ' A' ' 75' ' ' ILE . 12.9 mt -75.76 -35.36 60.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.846 0.355 . . . . 0.0 111.882 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.798 HD22 ' HB2' ' A' ' 101' ' ' PRO . 50.7 tp -68.92 -49.8 54.94 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.186 0.517 . . . . 0.0 110.674 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.728 ' HB2' ' CE2' ' A' ' 211' ' ' PHE . 27.5 mt -67.91 -27.02 66.28 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.395 179.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.728 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -66.3 -40.27 89.87 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.092 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.751 ' CB ' HG11 ' A' ' 62' ' ' VAL . . . -81.1 -41.31 22.71 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.253 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.663 HD11 ' HB1' ' A' ' 105' ' ' ALA . 16.1 mt -67.94 -4.15 12.14 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.066 178.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.5 ' HB2' ' HB3' ' A' ' 231' ' ' TYR . . . -96.9 176.56 5.93 Favored 'General case' 0 CA--C 1.523 -0.089 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -177.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.571 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.3 OUTLIER -109.84 112.65 24.81 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.636 -1.166 . . . . 0.0 108.941 178.367 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . 116.78 166.68 14.35 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.595 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.631 ' HG2' ' HG2' ' A' ' 74' ' ' GLU . 10.6 tttt -95.09 117.81 30.83 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.809 0.304 . . . . 0.0 111.174 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.715 ' O ' ' HA ' ' A' ' 74' ' ' GLU . 0.8 OUTLIER -119.2 148.24 43.32 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-O 120.644 0.259 . . . . 0.0 111.559 -179.462 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.616 HG22 ' HB2' ' A' ' 74' ' ' GLU . 56.8 t -103.67 135.63 40.4 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.668 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.871 ' HG ' ' HB1' ' A' ' 28' ' ' ALA . 0.3 OUTLIER -111.23 115.97 30.25 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 174.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.859 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.6 OUTLIER -104.23 149.89 24.89 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.232 -177.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 69.18 26.01 5.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.268 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.74 HD21 ' HB3' ' A' ' 41' ' ' LEU . 67.5 mt -55.59 -174.87 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.524 ' HB3' HG21 ' A' ' 50' ' ' VAL . 41.6 tp -111.42 131.68 55.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.594 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -88.83 89.36 7.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.96 0.41 . . . . 0.0 110.312 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -164.02 142.72 7.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.062 -179.104 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.421 ' HA ' ' HB3' ' A' ' 51' ' ' ARG . 0.6 OUTLIER -36.6 -31.25 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.57 0.224 . . . . 0.0 111.342 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.725 ' OD1' HG23 ' A' ' 50' ' ' VAL . 1.6 p30 -58.7 -42.64 89.07 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.906 0.384 . . . . 0.0 110.712 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.725 HG23 ' OD1' ' A' ' 49' ' ' ASP . 82.0 t -81.85 -44.18 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.66 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.827 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -49.5 -40.07 36.27 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.682 ' HA ' ' HB2' ' A' ' 55' ' ' ASN . 19.9 m-70 -79.62 -32.29 41.72 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.978 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.624 ' O ' HD13 ' A' ' 57' ' ' LEU . 7.3 tpt -53.74 -35.61 61.41 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 176.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.827 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.3 OUTLIER -84.03 -45.76 12.74 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 114.317 -1.31 . . . . 0.0 109.028 176.482 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.682 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -57.77 -36.38 72.06 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.776 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 1.129 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -65.81 -43.05 89.82 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.774 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -65.34 -38.43 90.11 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 176.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.682 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 1.1 m -61.81 -39.67 92.57 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 113.875 -1.511 . . . . 0.0 111.813 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.709 ' CB ' HD11 ' A' ' 90' ' ' LEU . . . -71.07 -37.24 72.46 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.392 -178.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.561 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.6 OUTLIER -80.07 -16.25 55.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.345 0.593 . . . . 0.0 110.429 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.88 35.57 3.96 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.142 -0.935 . . . . 0.0 114.194 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.774 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 25.4 t -90.6 122.37 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.76 ' O ' HG12 ' A' ' 76' ' ' ILE . 12.9 m -85.02 131.88 34.41 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.887 0.375 . . . . 0.0 111.523 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.815 ' HB3' HG23 ' A' ' 75' ' ' ILE . 40.1 p90 -158.69 172.23 18.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.535 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.401 ' N ' ' O ' ' A' ' 74' ' ' GLU . 86.5 m -131.59 148.38 52.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.785 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.442 ' CD1' ' HB2' ' A' ' 73' ' ' CYS . 14.6 tp -119.68 134.78 55.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.162 0.506 . . . . 0.0 111.114 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.426 ' CB ' ' HB2' ' A' ' 72' ' ' ARG . 88.1 p -61.71 -169.26 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.001 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.91 -41.7 18.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.311 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.36 1.98 17.25 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.634 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 59.81 30.01 19.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.733 0.302 . . . . 0.0 111.262 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.458 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 2.0 p -119.6 -14.73 9.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.911 0.386 . . . . 0.0 111.217 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.591 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 14.7 mtp180 -113.43 119.23 36.88 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.4 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.62 ' HB3' HD11 ' A' ' 44' ' ' LEU . 42.5 t -131.12 126.9 36.94 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.715 ' HA ' ' O ' ' A' ' 39' ' ' THR . 35.9 tt0 -110.98 129.06 56.0 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 1.06 HD11 HD22 ' A' ' 29' ' ' LEU . 10.7 mt -126.59 123.56 63.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -177.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.76 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -67.69 99.27 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-O 121.571 0.701 . . . . 0.0 109.256 175.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 37' ' ' GLY . . . -37.77 146.41 0.12 Allowed Glycine 0 C--N 1.32 -0.343 0 CA-C-N 114.53 -1.214 . . . . 0.0 114.05 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.87 -11.21 39.9 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.959 0.409 . . . . 0.0 111.046 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.571 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 89.86 -0.57 79.65 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.258 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.534 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 152.81 -148.36 19.11 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.902 -0.665 . . . . 0.0 112.143 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.578 ' HG3' ' HB3' ' A' ' 108' ' ' LEU . 77.7 Cg_exo -49.36 127.98 19.23 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.788 2.325 . . . . 0.0 112.704 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.561 ' HB2' HD13 ' A' ' 60' ' ' LEU . 0.9 OUTLIER -78.23 105.64 9.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.901 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -82.13 128.1 33.79 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.055 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.486 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -92.44 126.44 37.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.041 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.97 123.89 23.08 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 176.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.85 172.88 0.91 Allowed Glycine 0 N--CA 1.438 -1.185 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 -175.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.34 144.88 46.33 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 118.469 1.135 . . . . 0.0 111.762 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.622 HD21 ' C ' ' A' ' 59' ' ' ALA . 1.2 tp -113.71 160.54 18.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.047 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 10.9 mt-10 -139.75 102.13 4.36 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.958 178.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.709 HD11 ' CB ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -101.56 130.01 47.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.955 0.407 . . . . 0.0 111.346 -178.736 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.591 ' C ' HD13 ' A' ' 92' ' ' LEU . 16.5 m-85 -101.03 96.77 7.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.608 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.817 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -110.34 51.22 0.77 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.814 -179.596 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.798 ' HA3' ' H ' ' A' ' 118' ' ' GLU . . . -58.26 -61.16 7.73 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.817 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.509 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 17.9 m-80 -76.97 -3.16 37.49 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.111 -0.235 . . . . 0.0 110.585 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 1.01 ' HB1' ' HB3' ' A' ' 98' ' ' ALA . . . -94.47 56.3 2.09 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.915 0.388 . . . . 0.0 111.338 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -56.75 -29.99 59.06 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.468 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.501 ' O ' ' HG3' ' A' ' 101' ' ' PRO . 6.1 p -93.84 -6.54 45.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.682 -0.259 . . . . 0.0 111.421 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 1.01 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -101.63 -37.85 8.18 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.836 0.351 . . . . 0.0 111.185 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.537 ' HB2' ' HB2' ' A' ' 92' ' ' LEU . 3.0 tpp -61.72 -45.58 93.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.339 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.531 ' HD2' HD12 ' A' ' 126' ' ' ILE . 0.1 OUTLIER -53.63 -60.5 6.99 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.227 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.798 ' HB2' HD22 ' A' ' 30' ' ' LEU . 18.5 Cg_endo -60.77 -33.16 93.33 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.477 2.118 . . . . 0.0 112.86 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 1.129 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -71.56 -53.13 14.8 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.836 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.873 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -51.38 -28.52 12.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.177 0.513 . . . . 0.0 110.311 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.895 ' CB ' ' HB1' ' A' ' 175' ' ' ALA . . . -86.6 -52.52 5.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.599 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.706 ' CB ' HD11 ' A' ' 30' ' ' LEU . . . -60.51 -34.09 73.59 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.678 ' HB2' HD12 ' A' ' 153' ' ' LEU . 37.3 mt -78.68 -15.6 58.29 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -176.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.656 ' HB3' ' HB1' ' A' ' 138' ' ' ALA . 90.3 m -87.84 22.8 2.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.322 0.582 . . . . 0.0 110.433 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.786 HD21 ' HB2' ' A' ' 182' ' ' LEU . 2.0 mt -87.16 -75.04 0.42 Allowed 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.545 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.63 -113.6 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.235 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.07 96.4 2.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.049 0.452 . . . . 0.0 110.762 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.589 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 0.1 OUTLIER -148.25 140.91 24.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.53 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.865 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 3.4 m-20 -94.21 102.49 14.52 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.831 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.646 HG13 HD13 ' A' ' 106' ' ' LEU . 20.7 mm -121.35 140.92 43.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.556 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.856 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 61.8 t -111.71 112.37 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 175.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.67 HD23 ' HB2' ' A' ' 90' ' ' LEU . 74.6 mt -102.17 105.85 16.61 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.492 -178.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.787 HG23 ' HG3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -114.66 -170.48 1.75 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.322 -178.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.526 ' HA3' ' HG2' ' A' ' 121' ' ' MET . . . -171.4 175.15 45.01 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.629 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.798 ' H ' ' HA3' ' A' ' 93' ' ' GLY . 36.6 mm-40 -68.9 169.41 11.31 Favored Pre-proline 0 CA--C 1.531 0.227 0 C-N-CA 123.214 0.605 . . . . 0.0 111.339 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.716 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 2.8 Cg_endo -44.35 -40.82 13.38 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.192 2.595 . . . . 0.0 113.196 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.44 -23.73 65.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.679 0.276 . . . . 0.0 110.722 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.57 ' HG3' ' HG3' ' A' ' 149' ' ' PRO . 9.1 tpt -62.2 -35.13 77.94 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -16.85 54.35 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.59 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.01 1.59 52.33 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.859 0.362 . . . . 0.0 110.333 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.472 ' HD3' ' NH2' ' A' ' 100' ' ' ARG . 55.6 mtt-85 -127.03 84.22 64.04 Favored Pre-proline 0 CA--C 1.529 0.161 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.57 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -56.49 148.57 62.31 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.715 2.277 . . . . 0.0 111.755 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.531 HD12 ' HD2' ' A' ' 100' ' ' ARG . 0.8 OUTLIER -124.17 8.43 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.27 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.559 ' CA ' ' HA ' ' A' ' 147' ' ' ASN . . . -61.61 -36.54 92.79 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.061 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.19 -40.08 76.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.74 0.27 . . . . 0.0 110.67 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.715 ' HG ' HD11 ' A' ' 133' ' ' LEU . 14.1 tp -75.37 -41.39 56.56 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.425 0.631 . . . . 0.0 110.023 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.791 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 39.8 t -56.42 -47.74 81.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.579 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.795 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 4.7 m-20 -72.08 -31.81 66.43 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.422 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.545 ' HB1' ' CG1' ' A' ' 162' ' ' VAL . . . -64.1 -49.81 70.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.449 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.715 HD11 ' HG ' ' A' ' 129' ' ' LEU . 7.7 mt -71.65 -48.93 44.45 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.845 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.791 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -57.85 -27.77 63.51 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.651 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.795 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 1.5 tp -67.19 -33.45 75.42 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.466 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.49 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -81.81 12.73 40.41 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.966 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.34 3.34 60.06 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.325 -0.941 . . . . 0.0 112.749 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.656 ' HB1' ' HB3' ' A' ' 107' ' ' CYS . . . -71.59 149.43 45.65 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.882 0.341 . . . . 0.0 111.234 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 155' ' ' GLY . 21.6 mttm -97.78 103.24 15.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.149 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.733 HG21 HG22 ' A' ' 130' ' ' VAL . 21.0 mt -134.02 126.89 50.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.309 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.737 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -123.51 139.71 53.74 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.925 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.523 ' CZ ' HG11 ' A' ' 130' ' ' VAL . 43.4 m-85 -81.41 132.62 35.33 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.409 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.801 ' CD2' HG13 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -90.17 -82.26 0.28 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.297 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.845 ' HG3' ' H ' ' A' ' 145' ' ' GLN . 11.2 pt-20 -63.5 -78.2 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.926 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.845 ' H ' ' HG3' ' A' ' 144' ' ' GLU . 1.5 mt-30 -121.38 154.19 36.81 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 6.8 mt-10 -64.48 135.6 56.22 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.074 0.464 . . . . 0.0 111.285 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.559 ' HA ' ' CA ' ' A' ' 127' ' ' GLY . 9.2 m-20 71.83 18.73 5.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.086 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.516 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 18.6 m-85 -107.77 167.12 9.79 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.898 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 51.3 Cg_exo -35.69 -63.3 0.2 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 124.159 3.239 . . . . 0.0 116.07 -177.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.898 ' HD3' ' HB2' ' A' ' 149' ' ' PRO . 71.5 Cg_exo -50.72 145.6 22.86 Favored 'Trans proline' 0 C--N 1.355 0.885 0 CA-C-N 120.773 1.312 . . . . 0.0 112.393 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.856 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 8.5 mt -155.89 137.04 13.76 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.846 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.737 ' HB2' HG22 ' A' ' 141' ' ' THR . 0.2 OUTLIER -106.78 101.59 11.02 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 177.411 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.873 HD11 ' HA ' ' A' ' 103' ' ' ALA . 6.6 mt -91.46 145.61 24.48 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.023 -178.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.589 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 3.0 mt-30 -147.79 29.27 0.92 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.691 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 51.37 -170.3 0.34 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.222 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 114.83 -12.09 20.54 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.086 -1.054 . . . . 0.0 113.369 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.661 ' HE2' ' HA ' ' A' ' 180' ' ' ALA . 54.4 t80 -58.82 122.82 14.52 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 117.51 0.655 . . . . 0.0 110.595 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.817 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 43.3 p -113.12 -38.37 4.48 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 121.668 0.747 . . . . 0.0 111.243 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.42 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 139.04 -165.03 25.76 Favored Glycine 0 C--N 1.306 -1.089 0 CA-C-N 114.526 -1.216 . . . . 0.0 112.304 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.591 ' O ' HG23 ' A' ' 187' ' ' THR . . . 109.48 155.59 16.2 Favored Glycine 0 N--CA 1.437 -1.298 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.882 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -46.94 115.48 1.08 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.216 -0.492 . . . . 0.0 111.333 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 72.1 t -108.02 137.71 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -107.09 119.77 40.29 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.256 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.824 HG21 HD11 ' A' ' 176' ' ' LEU . 1.0 OUTLIER -132.09 120.43 43.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.113 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.65 ' HB3' ' CG2' ' A' ' 168' ' ' VAL . 23.0 t0 -55.58 138.51 46.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.933 0.396 . . . . 0.0 111.141 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.667 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . -67.55 -31.03 75.53 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.204 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.2 t -97.81 64.29 1.74 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.98 0.419 . . . . 0.0 110.856 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.65 ' CG2' ' HB3' ' A' ' 165' ' ' ASP . 22.3 t -125.93 -111.75 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.78 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.515 ' HB2' ' CD1' ' A' ' 172' ' ' PHE . 0.5 OUTLIER -134.5 134.08 41.08 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.97 0.414 . . . . 0.0 109.985 179.521 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.625 ' HB2' ' HB3' ' A' ' 200' ' ' TYR . 0.1 OUTLIER -55.69 -17.28 5.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.762 -179.531 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.586 ' HA ' ' HB ' ' A' ' 174' ' ' THR . 0.5 OUTLIER -92.7 -13.85 28.83 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.443 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.515 ' CD1' ' HB2' ' A' ' 169' ' ' SER . 5.9 m-85 -66.73 -54.36 23.78 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 1.115 HD13 HD21 ' A' ' 195' ' ' LEU . 0.2 OUTLIER -64.95 -45.91 83.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.921 178.675 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.586 ' HB ' ' HA ' ' A' ' 171' ' ' GLN . 1.1 m -55.1 -33.01 62.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.969 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.895 ' HB1' ' CB ' ' A' ' 104' ' ' ALA . . . -66.39 -41.61 89.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.329 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.824 HD11 HG21 ' A' ' 164' ' ' VAL . 0.2 OUTLIER -76.71 -32.51 57.88 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.545 179.361 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.72 ' HG ' HD21 ' A' ' 205' ' ' LEU . 2.7 mp -59.89 -39.35 85.02 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.142 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.746 ' HE1' ' HA ' ' A' ' 27' ' ' ARG . 0.7 OUTLIER -82.16 -41.43 20.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.351 0.596 . . . . 0.0 111.912 179.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.437 HG23 ' HG ' ' A' ' 108' ' ' LEU . 100.0 m -71.06 -42.07 69.9 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.644 -178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.661 ' HA ' ' HE2' ' A' ' 157' ' ' PHE . . . -59.08 -40.37 80.93 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -176.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.567 ' HD3' ' O ' ' A' ' 177' ' ' LEU . 38.1 Cg_endo -66.76 -28.78 43.34 Favored 'Trans proline' 0 CA--C 1.498 -1.292 0 C-N-CA 120.787 0.992 . . . . 0.0 112.06 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.786 ' HB2' HD21 ' A' ' 108' ' ' LEU . 5.3 mt -84.67 1.5 46.0 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.626 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.817 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -82.86 139.46 43.19 Favored Pre-proline 0 C--O 1.223 -0.298 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.226 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.752 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 11.6 Cg_endo -52.03 -33.37 52.54 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.206 1.938 . . . . 0.0 112.782 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.53 143.05 45.6 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.582 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -58.54 145.27 39.81 Favored 'General case' 0 N--CA 1.46 0.074 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.453 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.611 ' HB ' ' HB1' ' A' ' 180' ' ' ALA . 65.9 m -122.14 144.42 48.95 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.644 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 25.2 t -122.45 117.81 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.069 176.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.738 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 2.7 mp -101.53 117.63 47.11 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.801 ' HG3' ' HG3' ' A' ' 222' ' ' GLN . 0.1 OUTLIER -99.4 122.49 42.58 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.4 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.965 HD11 HD21 ' A' ' 173' ' ' LEU . 1.6 mp -93.47 119.72 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.954 -175.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.432 ' HE3' ' CA ' ' A' ' 165' ' ' ASP . 0.7 OUTLIER -75.14 96.63 3.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.769 -179.468 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 95.47 -134.11 11.78 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.265 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -117.09 137.27 52.39 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 1.115 HD21 HD13 ' A' ' 173' ' ' LEU . 8.9 mt -40.81 147.03 0.13 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.184 0.516 . . . . 0.0 111.124 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.499 HG21 ' O ' ' A' ' 168' ' ' VAL . 7.2 p -68.66 -21.07 25.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.896 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.864 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 26.7 t -138.55 -67.43 0.46 Allowed 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.249 178.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.812 ' HA ' HD13 ' A' ' 195' ' ' LEU . 8.0 tmtt? 96.82 -56.57 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 114.656 -1.157 . . . . 0.0 111.177 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.864 ' HD2' ' C ' ' A' ' 197' ' ' SER . 18.3 Cg_endo -62.71 -25.7 75.09 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 120.868 1.045 . . . . 0.0 110.021 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.971 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.2 OUTLIER -67.48 -48.2 67.83 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.625 HG21 ' HE2' ' A' ' 223' ' ' PHE . 15.6 mm -63.28 -35.09 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.443 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.15 -42.86 99.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.102 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.971 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.5 mt -60.36 -50.78 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.488 ' O ' ' HG3' ' A' ' 208' ' ' MET . 45.8 m -53.47 -51.85 61.37 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.107 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.863 HD22 ' HB ' ' A' ' 215' ' ' ILE . 36.8 mt -65.54 -30.62 71.39 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.38 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.416 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 2.6 m-80 -77.86 -46.3 21.82 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.772 0.796 . . . . 0.0 109.956 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.84 ' O ' HG22 ' A' ' 210' ' ' THR . 0.8 OUTLIER -68.76 -29.77 68.22 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.211 178.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . 0.703 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 37.0 mtp -69.95 -33.23 71.84 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.655 178.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.604 ' HE2' ' HA ' ' A' ' 214' ' ' GLU . 6.7 mmtp -57.54 -38.6 74.98 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.813 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.84 HG22 ' O ' ' A' ' 207' ' ' LEU . 1.0 OUTLIER -60.6 -27.25 67.59 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.645 -178.523 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.728 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 76.9 m-85 -85.19 -8.88 58.38 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.541 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.1 9.38 24.23 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 115.658 1.023 . . . . 0.0 115.658 177.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.545 HG21 ' HE3' ' A' ' 208' ' ' MET . 4.2 m -124.18 148.84 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 118.683 1.242 . . . . 0.0 112.133 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.604 ' HA ' ' HE2' ' A' ' 209' ' ' LYS . 22.5 mt-10 -129.74 141.75 50.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.149 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 1.03 HD12 ' HB ' ' A' ' 225' ' ' VAL . 24.7 mm -123.5 148.45 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-O 120.89 0.376 . . . . 0.0 110.552 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.603 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 40.2 tt0 -104.74 116.44 32.03 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.726 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -82.49 150.18 27.15 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . 0.63 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.2 OUTLIER -110.16 -148.05 0.42 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.606 0.241 . . . . 0.0 110.909 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.547 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 4.0 t-160 -67.83 63.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.457 ' CE1' ' HG3' ' A' ' 198' ' ' LYS . 6.3 t80 58.87 33.88 23.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.902 0.858 . . . . 0.0 110.867 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.639 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 12.2 pt20 -164.69 -124.63 0.02 OUTLIER 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.801 ' HG3' ' HG3' ' A' ' 190' ' ' ARG . 0.5 OUTLIER -3.97 132.37 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 179.495 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.644 ' O ' ' HA ' ' A' ' 188' ' ' VAL . 3.2 m-85 -126.55 129.89 49.48 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.432 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.603 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 41.6 t -114.17 113.68 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 121.588 0.708 . . . . 0.0 109.739 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 1.03 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.3 OUTLIER -123.15 125.51 72.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.095 -179.028 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 181' ' ' PRO . 0.0 OUTLIER -76.62 141.52 41.02 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.838 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -91.18 -178.21 43.15 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.457 -178.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 66.47 20.22 69.53 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 121.54 -0.362 . . . . 0.0 113.081 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . 0.513 ' NE2' ' HB3' ' A' ' 181' ' ' PRO . 47.7 mt-30 -77.79 -173.77 3.2 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.19 0.519 . . . . 0.0 110.896 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.14 147.57 24.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.543 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' TYR . . . . . 0.653 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 5.5 m-85 -99.26 133.81 43.02 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.056 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -120.76 148.84 43.44 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 84.1 p -76.54 111.43 15.72 Favored Pre-proline 0 N--CA 1.446 -0.636 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.834 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.557 ' HG3' HG23 ' A' ' 210' ' ' THR . 46.7 Cg_endo -68.3 -2.38 8.91 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.947 1.765 . . . . 0.0 112.422 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 96.34 -84.0 0.82 Allowed Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.29 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 93.5 m -130.56 127.13 38.45 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.705 ' CD2' HG21 ' A' ' 210' ' ' THR . 24.8 t80 -130.33 134.47 47.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.995 0.426 . . . . 0.0 111.373 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.859 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.1 OUTLIER -97.94 110.73 23.25 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.687 179.846 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.648 ' N ' HD22 ' A' ' 238' ' ' LEU . 20.1 t -81.65 112.77 20.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.11 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.347 -0.835 . . . . 0.0 111.129 -179.948 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.673 ' N ' HG11 ' A' ' 239' ' ' VAL . 58.7 p . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 120.823 0.344 . . . . 0.0 111.348 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.43 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 46.9 m-80 67.57 -79.0 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.545 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.733 ' HE ' HD23 ' A' ' 207' ' ' LEU . 77.3 mtm-85 -70.17 -58.22 4.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.046 0.45 . . . . 0.0 110.879 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.617 ' HB1' ' HG ' ' A' ' 41' ' ' LEU . . . -46.07 -42.38 13.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.763 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.055 HD22 HD11 ' A' ' 75' ' ' ILE . 10.6 mt -71.1 -34.56 71.22 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 120.983 0.42 . . . . 0.0 110.833 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.921 HD22 ' HB2' ' A' ' 101' ' ' PRO . 53.3 tp -68.9 -49.74 55.63 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.377 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.59 ' HB2' ' CE2' ' A' ' 211' ' ' PHE . 34.1 mt -67.28 -27.13 66.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.521 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.774 ' HB3' HD12 ' A' ' 75' ' ' ILE . . . -65.77 -39.03 90.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.056 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.655 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . . . -81.32 -41.39 22.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.615 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.745 HD11 ' HB1' ' A' ' 105' ' ' ALA . 21.9 mt -69.05 -3.36 12.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.286 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.482 ' HB2' ' HB3' ' A' ' 231' ' ' TYR . . . -96.81 176.1 6.11 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.524 ' CG ' ' HA2' ' A' ' 79' ' ' GLY . 0.1 OUTLIER -112.18 113.4 25.63 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.596 178.247 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.59 167.99 15.29 Favored Glycine 0 C--N 1.32 -0.323 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.635 ' HG3' HG23 ' A' ' 76' ' ' ILE . 1.0 OUTLIER -95.3 117.78 30.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 117.32 0.56 . . . . 0.0 111.443 -179.371 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.495 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.9 OUTLIER -119.6 145.84 46.06 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.22 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.55 HG22 ' HB2' ' A' ' 74' ' ' GLU . 96.6 t -104.91 139.08 26.96 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 1.003 HD23 HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -114.77 116.1 28.1 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 174.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.922 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.6 OUTLIER -105.06 152.3 22.92 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.078 -178.29 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 36.9 t30 68.99 25.44 5.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.724 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.691 HD21 ' CB ' ' A' ' 41' ' ' LEU . 16.0 mt -55.32 -169.97 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.501 ' HB3' HG21 ' A' ' 50' ' ' VAL . 32.9 tp -112.46 131.9 55.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.596 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -89.05 85.92 6.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.021 0.439 . . . . 0.0 110.55 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.46 ' O ' ' N ' ' A' ' 50' ' ' VAL . 1.0 OUTLIER -164.25 142.88 7.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.926 -179.479 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 47' ' ' SER . 0.5 OUTLIER -33.07 -34.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.764 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.803 ' OD1' HG23 ' A' ' 50' ' ' VAL . 3.1 p30 -55.33 -42.59 73.97 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.043 0.449 . . . . 0.0 110.836 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.803 HG23 ' OD1' ' A' ' 49' ' ' ASP . 78.5 t -84.63 -44.51 17.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.013 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.815 ' HA ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -50.68 -39.77 51.93 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.653 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.696 ' HA ' ' HB3' ' A' ' 55' ' ' ASN . 18.9 m-70 -80.9 -32.42 34.79 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.888 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.508 ' O ' HD13 ' A' ' 57' ' ' LEU . 9.0 tpt -53.5 -34.74 59.17 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 176.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.815 HD12 ' HA ' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -83.49 -43.04 16.21 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.648 176.465 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.696 ' HB3' ' HA ' ' A' ' 52' ' ' HIS . 67.0 t30 -56.73 -42.11 78.67 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-O 121.05 0.452 . . . . 0.0 110.131 179.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 1.055 ' HB1' HD11 ' A' ' 102' ' ' LEU . . . -57.11 -49.06 77.07 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.812 0.815 . . . . 0.0 108.956 178.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.778 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -61.8 -37.83 85.87 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.006 -1.452 . . . . 0.0 107.871 177.066 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.679 ' HB ' ' HA ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -63.8 -35.02 79.24 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.877 179.271 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.85 ' CB ' HD11 ' A' ' 90' ' ' LEU . . . -73.52 -37.59 65.6 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.356 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.684 HD13 ' HB2' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -82.24 -13.13 57.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.255 0.55 . . . . 0.0 110.893 -179.622 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.58 35.76 4.81 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.38 -0.827 . . . . 0.0 114.137 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.778 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 37.2 t -90.51 124.34 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.789 ' O ' HG12 ' A' ' 76' ' ' ILE . 4.3 m -85.96 130.8 34.43 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.499 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.826 ' HB3' HG23 ' A' ' 75' ' ' ILE . 38.4 p90 -157.64 171.68 19.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.84 0.352 . . . . 0.0 110.622 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.43 ' N ' ' O ' ' A' ' 74' ' ' GLU . 99.7 m -138.1 149.16 45.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.305 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.732 HD12 ' HB2' ' A' ' 73' ' ' CYS . 7.3 tp -117.76 137.34 52.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.968 0.413 . . . . 0.0 110.756 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.7 p -59.93 179.91 0.12 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.989 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.79 -28.32 40.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.88 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -80.29 -0.11 35.16 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.247 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 55.89 48.73 17.4 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.797 0.332 . . . . 0.0 111.197 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.423 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -153.4 0.63 0.25 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.277 -0.419 . . . . 0.0 112.081 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.5 OUTLIER -129.48 110.97 12.3 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.732 ' HB2' HD12 ' A' ' 66' ' ' LEU . 42.9 t -118.37 132.34 56.27 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.55 ' HB2' HG22 ' A' ' 40' ' ' VAL . 43.4 tt0 -111.76 133.13 54.19 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 1.055 HD11 HD22 ' A' ' 29' ' ' LEU . 11.3 mt -130.46 122.97 54.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -178.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.789 HG12 ' O ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -67.75 100.93 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.763 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 35' ' ' ALA . . . -39.27 144.17 0.33 Allowed Glycine 0 C--N 1.319 -0.39 0 CA-C-N 114.717 -1.128 . . . . 0.0 113.844 -178.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.41 ' CB ' HD12 ' A' ' 82' ' ' LEU . 52.9 t30 -88.86 -11.36 44.91 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.003 0.43 . . . . 0.0 110.861 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.524 ' HA2' ' CG ' ' A' ' 36' ' ' HIS . . . 85.86 15.61 65.03 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.217 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.527 ' O ' HD23 ' A' ' 34' ' ' LEU . . . 139.55 -150.34 21.31 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.326 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.521 ' HB3' ' CB ' ' A' ' 108' ' ' LEU . 4.2 Cg_endo -49.2 123.55 10.27 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.71 2.274 . . . . 0.0 113.13 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.684 ' HB2' HD13 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -72.24 108.54 5.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.139 179.198 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.429 ' HA ' ' CG ' ' A' ' 111' ' ' ASN . 4.4 p80 -81.87 131.88 35.26 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.564 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -96.0 120.45 36.3 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.669 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -70.96 123.94 23.2 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.46 173.87 1.39 Allowed Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 -175.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 112' ' ' ASP . . . -73.03 144.75 47.04 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 118.616 1.208 . . . . 0.0 111.816 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.747 HD21 ' C ' ' A' ' 59' ' ' ALA . 0.7 OUTLIER -112.52 161.03 17.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.198 -178.536 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.419 ' HG2' ' HB ' ' A' ' 114' ' ' VAL . 32.6 mt-10 -142.05 101.39 3.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.136 177.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.85 HD11 ' CB ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -100.2 125.79 46.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.314 -178.622 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.52 ' C ' HD13 ' A' ' 92' ' ' LEU . 1.2 m-85 -98.37 96.44 8.03 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.849 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -105.18 48.25 0.84 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.472 -179.479 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.646 ' HA3' ' H ' ' A' ' 118' ' ' GLU . . . -53.6 -66.0 3.04 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.65 -0.705 . . . . 0.0 113.247 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.485 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 23.0 m-80 -76.27 -0.98 24.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.559 0.218 . . . . 0.0 110.913 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.975 ' HB1' ' HB3' ' A' ' 98' ' ' ALA . . . -91.86 68.73 5.45 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.989 0.423 . . . . 0.0 111.307 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.07 -24.38 71.74 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.76 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.49 HG22 ' OE1' ' A' ' 171' ' ' GLN . 0.6 OUTLIER -106.54 4.79 28.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.463 0.173 . . . . 0.0 111.167 179.595 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.975 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . . . -107.26 -40.82 5.29 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.875 0.369 . . . . 0.0 111.503 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.466 ' HB2' ' HB2' ' A' ' 92' ' ' LEU . 6.3 tpp -59.96 -46.31 89.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.609 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.548 ' O ' HD21 ' A' ' 129' ' ' LEU . 5.3 mpt_? -53.72 -60.24 7.69 Favored Pre-proline 0 C--N 1.323 -0.571 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.006 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.921 ' HB2' HD22 ' A' ' 30' ' ' LEU . 11.7 Cg_endo -59.24 -34.38 98.14 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 121.958 1.772 . . . . 0.0 112.409 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 1.055 HD11 ' HB1' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -71.31 -53.25 14.88 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.025 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.897 ' HA ' HD11 ' A' ' 153' ' ' LEU . . . -51.29 -28.34 11.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.534 178.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.901 ' CB ' ' HB1' ' A' ' 175' ' ' ALA . . . -86.75 -53.65 4.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.357 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.752 ' CB ' HD11 ' A' ' 30' ' ' LEU . . . -60.32 -37.47 80.69 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -177.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.734 ' HB2' HD12 ' A' ' 153' ' ' LEU . 25.8 mt -75.24 -11.62 60.11 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.215 -177.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.59 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 21.9 m -83.23 17.76 1.95 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.185 0.517 . . . . 0.0 110.247 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.648 HD21 ' HB2' ' A' ' 182' ' ' LEU . 2.6 mt -95.92 -68.36 0.8 Allowed 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.365 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.07 151.96 27.83 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.669 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 m -66.54 98.29 0.49 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.982 0.42 . . . . 0.0 110.855 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.672 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 5.8 m-80 -148.53 137.44 21.62 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.103 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.8 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 1.7 m-20 -95.29 100.28 12.09 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.191 0.52 . . . . 0.0 109.926 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.569 HG12 HD13 ' A' ' 106' ' ' LEU . 1.6 mp -118.38 148.37 21.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.903 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.821 HG13 ' CD2' ' A' ' 143' ' ' LEU . 43.9 t -118.0 112.58 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 176.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.722 ' O ' ' HA ' ' A' ' 150' ' ' PRO . 24.0 mt -102.36 105.58 16.22 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.905 -178.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.526 HG23 ' HB3' ' A' ' 150' ' ' PRO . 0.2 OUTLIER -116.42 -170.39 1.8 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.802 0.334 . . . . 0.0 111.206 -179.736 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.551 ' HA3' ' HG2' ' A' ' 121' ' ' MET . . . -168.32 172.58 42.94 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.006 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.651 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 18.1 mt-10 -68.85 176.36 1.55 Allowed Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 122.639 0.375 . . . . 0.0 110.903 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.651 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 81.7 Cg_exo -47.78 -41.06 31.89 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.759 2.306 . . . . 0.0 113.581 -179.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -67.37 -23.15 65.56 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.661 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.575 ' O ' ' HG3' ' A' ' 149' ' ' PRO . 10.5 tpt -61.84 -35.19 77.55 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.489 ' HA ' ' HG2' ' A' ' 149' ' ' PRO . 3.4 mmtp -61.64 -16.78 51.56 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.673 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -86.34 3.48 43.28 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 120.827 0.346 . . . . 0.0 110.289 178.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.436 ' HB3' ' NH2' ' A' ' 100' ' ' ARG . 3.5 mtt180 -127.3 81.18 70.5 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.075 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.413 ' O ' ' HZ ' ' A' ' 172' ' ' PHE . 14.8 Cg_endo -56.9 149.21 62.56 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.937 2.425 . . . . 0.0 112.032 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.508 HD11 HD23 ' A' ' 129' ' ' LEU . 0.7 OUTLIER -124.14 17.67 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.349 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.43 ' HA3' ' CB ' ' A' ' 147' ' ' ASN . . . -61.29 -46.16 95.0 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.927 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.626 ' HB2' ' CE2' ' A' ' 172' ' ' PHE . 37.6 m80 -56.87 -35.53 69.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.982 0.391 . . . . 0.0 111.322 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.763 HD11 ' HB3' ' A' ' 175' ' ' ALA . 15.4 tp -75.79 -47.71 24.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.927 0.394 . . . . 0.0 111.318 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.826 HG13 ' CG2' ' A' ' 140' ' ' ILE . 51.9 t -56.25 -47.43 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.395 -178.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.67 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 82.8 m-20 -68.81 -39.8 79.86 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.031 0.443 . . . . 0.0 110.12 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.568 ' HB2' HG23 ' A' ' 164' ' ' VAL . . . -59.4 -45.24 92.06 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.012 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.728 HD11 ' HG ' ' A' ' 129' ' ' LEU . 10.7 mt -75.15 -48.42 23.74 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.446 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.696 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -58.65 -28.37 65.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.959 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.67 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 5.8 tp -68.3 -32.57 72.81 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.278 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 159' ' ' GLY . . . -79.35 9.96 38.5 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.153 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.39 6.64 57.48 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.329 -0.939 . . . . 0.0 112.755 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.415 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . . . -74.48 151.97 39.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.882 0.372 . . . . 0.0 111.146 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.446 ' CB ' ' HB2' ' A' ' 154' ' ' GLN . 9.9 mmmt -99.22 100.14 11.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.687 178.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.826 ' CG2' HG13 ' A' ' 130' ' ' VAL . 28.5 mt -131.68 127.44 59.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.477 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.765 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.3 OUTLIER -125.14 139.03 54.12 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.004 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.469 ' CE1' HG11 ' A' ' 130' ' ' VAL . 29.1 m-85 -78.54 133.48 37.36 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.847 0.356 . . . . 0.0 110.955 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.899 HD11 ' HG3' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -94.02 -87.84 0.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.734 -179.55 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.509 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 2.5 mm-40 -59.36 -81.99 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.34 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.441 ' HB3' ' CD1' ' A' ' 148' ' ' TYR . 35.0 mt-30 -115.14 154.45 28.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.112 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 5.0 mt-10 -67.66 131.96 46.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.31 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.43 ' CB ' ' HA3' ' A' ' 127' ' ' GLY . 1.1 m-20 70.57 19.41 6.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.954 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.558 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 13.2 m-85 -109.72 168.63 7.41 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.634 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 10.5 Cg_exo -30.91 -62.1 0.12 Allowed 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 125.264 3.976 . . . . 0.0 117.477 -177.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.86 ' HB2' ' HB2' ' A' ' 143' ' ' LEU . 26.3 Cg_endo -62.24 150.17 87.93 Favored 'Trans proline' 0 C--N 1.351 0.677 0 CA-C-N 120.655 1.27 . . . . 0.0 112.117 -177.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.763 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 7.6 mt -155.64 138.63 15.43 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.866 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.899 ' HG3' HD11 ' A' ' 143' ' ' LEU . 0.7 OUTLIER -104.71 104.31 14.09 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 176.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.897 HD11 ' HA ' ' A' ' 103' ' ' ALA . 4.1 mt -95.6 141.54 28.99 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.817 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.672 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 2.8 mt-30 -145.47 31.1 1.09 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.665 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.59 ' HA2' ' HA ' ' A' ' 107' ' ' CYS . . . 48.18 -158.02 0.84 Allowed Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.323 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.44 -11.08 46.95 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.264 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.547 ' CD1' ' HB2' ' A' ' 183' ' ' ALA . 31.6 t80 -59.77 122.93 15.41 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 117.467 0.634 . . . . 0.0 110.367 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.736 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 70.0 p -115.96 -35.53 4.41 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 121.54 0.686 . . . . 0.0 111.182 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.457 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 140.21 -160.76 26.4 Favored Glycine 0 C--N 1.307 -1.049 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.085 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.57 ' O ' HG23 ' A' ' 187' ' ' THR . . . 105.88 152.64 20.43 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.545 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -47.02 123.03 4.85 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.084 -0.558 . . . . 0.0 110.597 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 160' ' ' GLY . 42.7 t -116.06 146.39 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.123 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -113.27 120.16 40.22 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.117 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.836 HG21 HD11 ' A' ' 176' ' ' LEU . 1.0 OUTLIER -133.95 119.92 33.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.499 ' HB2' ' HD2' ' A' ' 128' ' ' HIS . 0.8 OUTLIER -56.47 141.18 43.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.929 0.395 . . . . 0.0 111.041 -179.223 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.677 ' HA2' HG23 ' A' ' 191' ' ' ILE . . . -57.32 -51.36 58.1 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.595 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.424 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 18.6 p -97.56 111.32 23.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.615 0.245 . . . . 0.0 111.268 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.496 HG21 ' CG ' ' A' ' 128' ' ' HIS . 14.2 p -175.21 -35.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.588 ' C ' HG11 ' A' ' 196' ' ' VAL . 0.4 OUTLIER 162.69 128.5 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.245 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.61 -17.4 64.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.572 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.507 ' HB2' ' HB2' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -86.26 -11.86 51.16 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.005 -179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.682 ' HA ' HD13 ' A' ' 129' ' ' LEU . 5.9 m-85 -71.3 -56.77 5.35 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.746 ' HG ' HG11 ' A' ' 164' ' ' VAL . 0.5 OUTLIER -62.81 -44.43 96.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.39 178.741 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.703 HG21 ' HD3' ' A' ' 27' ' ' ARG . 2.5 m -54.82 -33.19 61.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.826 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.901 ' HB1' ' CB ' ' A' ' 104' ' ' ALA . . . -68.32 -39.3 82.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.242 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.836 HD11 HG21 ' A' ' 164' ' ' VAL . 0.7 OUTLIER -76.58 -35.45 58.16 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.839 179.753 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.78 ' O ' ' HE1' ' A' ' 208' ' ' MET . 3.8 mp -59.82 -37.85 80.37 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.191 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.62 ' HE1' ' HA ' ' A' ' 27' ' ' ARG . 2.6 mtp -81.68 -43.15 18.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.338 0.59 . . . . 0.0 112.086 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 95.9 m -72.01 -42.4 66.43 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.105 -178.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.573 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . -58.71 -41.44 88.86 Favored Pre-proline 0 C--N 1.32 -0.716 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -176.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 28.5 Cg_endo -64.43 -28.54 62.53 Favored 'Trans proline' 0 CA--C 1.501 -1.167 0 C-N-CA 120.831 1.02 . . . . 0.0 112.128 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.648 ' HB2' HD21 ' A' ' 108' ' ' LEU . 5.6 mt -84.26 0.83 47.43 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.51 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.736 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -83.51 137.71 41.71 Favored Pre-proline 0 C--O 1.224 -0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.396 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.721 ' HD2' ' HA ' ' A' ' 158' ' ' THR . 11.4 Cg_endo -51.34 -34.31 49.47 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.688 2.258 . . . . 0.0 113.404 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.81 140.2 46.66 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.733 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -55.16 143.69 26.62 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.046 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 160' ' ' GLY . 92.0 m -123.6 148.23 46.6 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.687 ' HA ' ' O ' ' A' ' 223' ' ' PHE . 40.3 t -128.7 118.27 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.878 177.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.733 ' O ' ' HA ' ' A' ' 222' ' ' GLN . 5.0 mp -99.09 119.09 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.548 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 2.4 ttt180 -100.74 125.46 47.2 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.677 HG23 ' HA2' ' A' ' 166' ' ' GLY . 1.5 mp -93.37 127.33 45.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.867 -176.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -82.65 96.67 8.19 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.231 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 98.66 -127.55 9.28 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.708 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -116.66 133.54 55.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.708 0.29 . . . . 0.0 111.471 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.672 HD11 ' HZ ' ' A' ' 223' ' ' PHE . 1.1 mt -41.62 144.13 0.42 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.166 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.588 HG11 ' C ' ' A' ' 169' ' ' SER . 12.4 p -72.87 -25.03 21.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.637 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.572 ' C ' ' HD2' ' A' ' 199' ' ' PRO . 0.4 OUTLIER -170.78 68.63 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.096 0.474 . . . . 0.0 110.235 -179.575 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.733 ' HG3' ' HD3' ' A' ' 199' ' ' PRO . 0.0 OUTLIER -48.17 -29.37 1.4 Allowed Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.344 179.712 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.733 ' HD3' ' HG3' ' A' ' 198' ' ' LYS . 23.3 Cg_exo -64.78 -28.9 59.41 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 121.094 1.196 . . . . 0.0 110.724 178.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.936 ' HA ' HD12 ' A' ' 203' ' ' ILE . 0.1 OUTLIER -69.79 -42.3 73.93 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 177.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 11.9 mm -60.15 -39.61 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.255 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -58.07 -44.86 87.74 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.327 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.936 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.0 mt -62.66 -50.42 79.83 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 CA-C-O 121.569 0.699 . . . . 0.0 109.551 178.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.579 HG22 ' SD ' ' A' ' 208' ' ' MET . 97.4 m -53.43 -51.54 62.31 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.843 -178.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.762 HD22 ' HB ' ' A' ' 215' ' ' ILE . 29.8 mt -67.01 -29.22 68.99 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.028 0.442 . . . . 0.0 111.369 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.443 ' HA ' ' HE3' ' A' ' 209' ' ' LYS . 5.1 t-20 -77.63 -46.47 21.96 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.633 0.73 . . . . 0.0 109.876 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.953 ' O ' HG22 ' A' ' 210' ' ' THR . 4.4 tp -71.75 -29.7 64.79 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.574 -1.193 . . . . 0.0 109.404 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . 0.78 ' HE1' ' O ' ' A' ' 177' ' ' LEU . 43.0 mtp -76.13 -35.31 59.3 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 213' ' ' VAL . 14.4 mtmt -61.43 -38.71 88.14 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.654 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.953 HG22 ' O ' ' A' ' 207' ' ' LEU . 6.6 t -61.04 -26.85 67.92 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.3 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.59 ' CE2' ' HB2' ' A' ' 31' ' ' LEU . 27.6 m-85 -83.88 -7.31 59.47 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.903 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 110.89 7.43 25.37 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 116.31 1.284 . . . . 0.0 116.31 177.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 4.2 m -123.55 148.54 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 118.983 1.392 . . . . 0.0 112.604 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.538 ' O ' HD13 ' A' ' 215' ' ' ILE . 12.0 mt-10 -130.35 139.41 50.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.008 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.9 HD12 ' HB ' ' A' ' 225' ' ' VAL . 18.4 mm -122.46 148.78 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 120.836 0.351 . . . . 0.0 110.744 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.589 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 1.3 tp10 -104.67 122.4 45.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.032 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.562 ' C ' HD22 ' A' ' 217' ' ' ASN . 0.4 OUTLIER -86.84 151.01 23.72 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.182 179.016 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . 0.521 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 2.8 mm-40 -111.12 -141.57 0.38 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.14 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.535 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 28.3 m170 -73.92 65.03 1.03 Allowed 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 2.0 t80 57.24 36.3 27.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.706 0.765 . . . . 0.0 110.944 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.651 ' HA ' ' HB ' ' A' ' 191' ' ' ILE . 4.5 pt20 -168.73 -124.5 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.733 ' HA ' ' O ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -8.61 130.88 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.687 ' O ' ' HA ' ' A' ' 188' ' ' VAL . 0.7 OUTLIER -121.87 140.23 52.65 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.119 -1.855 . . . . 0.0 109.625 -179.163 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 40.1 t -120.84 114.25 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-O 121.297 0.57 . . . . 0.0 109.696 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.9 ' HB ' HD12 ' A' ' 215' ' ' ILE . 0.2 OUTLIER -122.29 125.87 73.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.087 -179.017 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -77.88 127.55 32.56 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -80.52 -178.51 52.11 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.351 -178.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 67.5 21.01 72.29 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 121.623 -0.322 . . . . 0.0 113.285 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . 0.468 ' HG3' ' O ' ' A' ' 226' ' ' LYS . 46.5 mt-30 -78.32 -173.43 3.27 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.268 0.556 . . . . 0.0 111.214 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.09 147.8 26.25 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.365 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' TYR . . . . . 0.536 ' HD2' ' HB3' ' A' ' 34' ' ' LEU . 7.2 m-85 -102.89 130.35 49.9 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.886 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.04 151.78 37.62 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.48 111.09 12.45 Favored Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.97 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.495 ' HD2' ' OG1' ' A' ' 39' ' ' THR . 52.0 Cg_endo -69.37 1.11 4.46 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.249 1.966 . . . . 0.0 112.27 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 39' ' ' THR . . . 98.68 -101.04 2.4 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.303 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 49.2 m -118.42 136.97 53.46 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.685 ' CE2' HG21 ' A' ' 210' ' ' THR . 9.3 t80 -133.23 124.2 26.95 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.989 0.423 . . . . 0.0 111.362 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.922 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -94.99 110.83 22.69 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.8 179.866 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.673 HG11 ' N ' ' A' ' 25' ' ' SER . 21.5 t -77.93 112.52 16.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.474 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.413 ' HG2' HD13 ' A' ' 238' ' ' LEU . 2.7 mt-10 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.296 -0.859 . . . . 0.0 111.018 179.882 . . . . . . . . 1 1 . 1 stop_ save_